Co
Chemicals Identified In
Human Biological Media,
A Data Base
Third Annual Report
October 1981
Volume III Part 2
-------
EPA 560/5-81-008A
ORNL/EIS-163/V3-P2
CHEMICALS IDENTIFIED IN HUMAN BIOLOGICAL MEDIA,
A DATA BASE
Third Annual Report, October 1981
Volume III, Part 2
Records 3501-5271
Compiled by
M. Virginia Cone, Margaret F. Baldauf,
and Fay M. Martin
Chemical Effects Information Center
Information Center Complex
Information Division
OAK RIDGE NATIONAL LABORATORY
Oak Ridge, Tennessee 37830
operated by
UNION CARBIDE CORPORATION
for the
DEPARTMENT OF ENERGY
Contract No. W-7405-eng-26
This effort was accomplished under the aegis
of the Interagency Collaborative Group on
Environmental Carcinogenesis, National Cancer
Institute, National Institutes of Health,
Chairperson, Dr. Herman F. Kraybill.
Date Published — December 1981
Cindy Stroup, Project Officer
Design and Development Branch
Exposure Evaluation Division
Office of Toxic Substances
U.S. Environmental Protection Agency
Washington, D.C. 20460
-------
CONTENTS
Part 1
Acknowledgments v
Introduction . ^
Users' Guide 3
Abbreviations for Analytical Methods 7
References for Data Base 9
References for Physical and Chemical Data 51
Appendix A. Journals Searched 55
Appendix B. Chemicals in Data Base (1979-1981) by CAS
Preferred Names 59
Appendix C. Chemicals (1981) by CAS Registry Numbers and
Preferred Names 83
Appendix D. Cross-Referenced Chemical Lists 103
1. CAS Preferred Names — Common Names 105
2. Common Names — CAS Preferred Names 141
Appendix E. Tissues and Body Fluids in Data Base
(1979-1981) 325
Indices 329
Author
Corporate Author
Tissue
Keyword ............................ 367
Directory of Chemicals (1981) .................. 377
CAS Pref
Formulas
CAS Preferred Names ...................... 379
090
Part 2
Data Base
Nondrugs ........................... -,
Drugs ..................... ........ 345
iii
-------
NONDRUGS
-------
Icctaldehyde
75-C7-0
CS-M-0
!« M.05. IP -123.5 C, BP 20.8 C
TISSUE
3501
Blood
3502
Blood
3503
Ereath
3584
Ereath
EIEOSOBE BOUT!
Inhalation
Xngestion
AIALTTICAL
BETHOD
SC
GC/!!S
CC-IS
IUHEEB
OF CASES
4
8
54 (387
samples)
IAIGE
a] 0.403-0. 593*110 (E-3)
1» 0.545-0.847*110(8-3)
a) 5.015-16.387 ag/«l
b) 9.160-11.050 ug/»l
Hot detected-79. 0 ug/hr
Hot given
HSAI |
1
I
a) 0.494M10(E-3) |
b) 0.6611I10(E-3) |
1
1
I
1
a) 10.41 + or - 3.76
uq/ml
b) 12.88 + or - 3.31
22.7 ug/hr
3.3 ng/1
oeoietric
GUIEiL IIFORBATIOI
a) Mo trickloroe thy lens treatnent
t) 100 ppi trichloroethylene
Banqe and lean foe 6 hr period
20-26 vr old students, wt 62-77 kg.
CE1CRIMTID BTDFOCABBOHS; ALCOHOLIC
EIVMACBS: BIOOD: BLOOD PLASBA;
OSIII: BETABOLITES; BETABOLISB;
AUDITS; SEBSJHT
--- -
a) After 0.5 q/k
-------
Icetic acia ethyl eater
H1-78-*
C(-68-02
Bl 88. Id, BF -83,6 C, BP 77.15 C, T? 100 II 3g at 27.0 C
iissnz
3505
E«ath
3506
Enath
_
ZIEOSOBE goal
minicii
RETROD
SC/BS
SC-SS
irasEts
or c»sss
8
5« (337
saiplas)
f SJfSE
I
lot detected- 1«l»TICH: BETIEOLISB; BII1BOUTES:
( PCPOllTICH ElPOSOSBi JBBlll »IiS
1 _ .
BEFES5SCE
Contla, J.3-.
CaBpr B.J.
telch, E. E.
1»75
irdilTes of
iDnicouectal Bejlth
30 CJ) =290-395
EiotaszjDStl, B. K.
BcaBeao, G. 9.
C'Keill. H.J.
1979
Coacnal of Aaalrtical
Tolicologi 1:225-234
tcttlc acil. allrl *«« (9 CD
Icetic atria. 2-prapeirl est«r (3 CI)
"1-8T-7
CJ-B8-02
*t IOfl.13. SP 10« C
I 1ISS01
1
3507
treat!
titosats scan
lutmcit
GC--TS
1 imsss
1 Of (USES
5t [387
sai pies)
I IKE
Rot fire*
BEil
0.296 ng/l
Geometric
GEIIB1L 1»F05BJTIO»
naaued at 25 C at 3 7iO ai B?
Jtf . *T occurrence
l<:»er a»J upper one-Sign limits
0,0»3 aid 0.435 nq/1
BeaItkT< T9-35 rr old, coosioHlxr,
•Ttan blacks aid caocasiais.
Chicago. II. Bigiflly contiolled
expcriaentBl condltiois.
tll»9; 1ICOG01S; IILI1IOIS; IDHITS;
CEiCRimirn trosociseois; TOUTIIE
CS01.1IC COBKWDS; BULTB BlZ>BIS:
HBIHTICII-. BETISOHSB: BETIBOUTBS:
ICPOLlTIOfl riPOSOil; tllBiS IEEIS
EEFEE29CE
FTOtOEZfESlli, 3. K.
C'«eill^ B^jJ
1979
Journal at lealrtical
Toiicology 3:225-230
-------
ic«tic acid, butyl ester
1S3-8«-«
C6-B12-02
B« 116.16. BF 126 C. TP IS •• Bq at 25 C
iissns
3503
Heath
3509
Breath
ErPOSBBE FOOT!
IHlTTICAl
flETBOB
GC/BS
GC-BS
JDlEla
OF C1SSS
8
5» (387
Maples)
EMGE
Hot givea-41.0 ag/hc
lot given
BEM | GtlEHL IHT08HTIOS
1
1
9.1 ug/hr (Ccatound related to aoraal
I tetabolisi. So other details given
|C cyoqenic saiplinq technique.
1
inealthr illitairy and civilian-
(eiployees. U.S. tic Force school of
| Aerospace Beaicine, ages 23-47 yr. 3
jsioters.
1
|MSZE«ES; CBIOP.IMTED BTDBOCH.BOHS;
|C FLOS HE OBGHIC COBPOOSDS;
ICH10BOBEHZIIIS; FIOOBISE COHPOIUDS:
IEHI1TH; llCCHOLS; TEIAS; 1DU1TS
1
|
0.200 ng/1 | teasuced at 25 C and 760 la Bq
Seoaetric , I 30. «t occurrence
1 lover aid upper one-Sigaa lliits
1 0,055 and 0.139 nq/1
IBcalthy, 18-35 yr old, nonsaofcinq.
I Chicago, II. Bigidly controlled
I
)EB!»TH: tlCOGOlS; I III SOI S; IDOLTS :
| CItOBI!HTE5 ETDBOC»BBO»S; VOI»TI1E
| CTGIHIC CODECOHDS; RZkLTB SUZiRCS;
II1B1UTICK: SETiEOLISn; HET1E01ITSS:
| FOPHL1TIOII IIPOSOBS! OSB»H 1BE1S
BEFERERCE
Ccn*le. J.P.
Caap, B.J.
Kelch, S.E.
1975
Irchives of
Environaental Health
30(21:290-295
Krotoszynski, B. K.
Craneaa, G. H.
O'Neill, B.J.
1979
Journal of Analytical
Toxicology 3:225-23*
Icetic acid, octyl ester
112-1H-1
C10-B20-02
If 172.27, BE -38.S C, BP 210 C
tissue
3510
Ereath
SIEOSOHE ROUT!
»»»trric»i
BETHOD
GC-SS
808 EES
OT C1SSS
5» (387
Saaples)
HUGE
Rot given
SEkl | GEH'BAL INFC5SXTTC*
!
0. 168 ng/1 I Xasarei at 25 C and 760 >a Rg
Geometric |«.U occurrence
t lever and upper one-sigaa liiits
|0.0»2 and 0.679 nd/1
1
(Bealthy, 18-35 yr old, nonsmoking.
I urtan blacks and Caucasians.
(Chicago, II. BiqidlT controlled
jeiperiieatal conditions.
(BBS4TH: HCCHOIS; IlimOIS; M91TS:
|CB108I!HTEB FIDBOC1BBOSS; ?Ol»TIL!
ICBGMIC C09PCDHDS: BEAITH BIZSSDS;
| IIHIHTICH; 8ET1EOLIS9; BF.TKOLITE5:
| PCPOL1TIOI EIPOSOBE; D5BAS AFEAS
1
BEFEBERCE I
rrotoszjnski, B. K.
Brtinean, G.B.
O'Seill, H.J.
1979
Journal of Analytical
Toxicology 3:225-23«
-------
Icetic acid, phenyl- (8 ell
Eexzeneacetic acid (9 CI)
103-82-2
CE-B8-02
BS 136.1«, BE 76.7 C, BP 265.5 C, T? 1 •• Rq at 97.0 C
tISSOE
3511
Breath
EXFOSDBE BOOT!
1S1IITIC11
HETBCD
QC-BS
HOHBEB
OP C1SBS
54 [387
sag pies)
HUGE
Vot given
SE«»
0. 161 ng/1
Geoietric
S!IIE»L MKJSaaTJOH
Eeasnred at 25 C and 760 11 BS 161.2, HI 276 C, BP 227 C
I1SSBE
3512
Breat
IIFOSD55 ROOTE
HJLItlCH
SETHcn
5C-BS
SOBBFE
or cisEs
5* (387
sanp es)
BIISE
Hot given
K»J
0.115 ng/1
CltlSll IirOBUTIOl
feasared at 25 c and 7CO » Eg
Ic«er and apper one-Sigia Units
0.038 and 0.3«9 og/1
Bealthy, 19-35 yr old, nonsmoking*
nrtao blacks and Caucasians.
Chicago, It. eigidly controlled
cxperinental conditions.
tBIJTB; JICCBOIS; IltlHOIS; «DDLTS;
CBI05IMTED EIDROCIEEOBS ; V011TILE
CFG1M1C COICCDIDS; RI4ITH BiZlBUS;
IIHlItTICN; BEIJtOLISS; HEI1EO11TES;
ICPDLITIOH flPOSDPE; 1BBJLB IBEJS
1 SEFESEHCE
KIoto«,S£Xi, M.
C'Keill^ B. J.
1979
Toxicology 3:225-23»
tcctic acid, propTl ester
1C9-60->
C5-B10-02
II 102.13, HP -92.5 C, BP 101.6 C, »P 10 In tig at 23.8 C
1ISSOE
3S1J
Exeath
1
IFOSOE; BOTIIE
SfTBOB |
GC/SS
I
1
OF C1SSS
8
I
1
SJKGE
Hot detected-2.0 ug/hr
HEX
0.5 ug/hr
GEHBJL IWFO«31TIO>
Ccipound related to norial
•etabolisn. Ho other details given
Cryogenic sampling technique.
Sealthy military and civilian
eiployees. U.S. lir Force School of
Aerospace nedicine, ages 23-il'7 yr. 3
siokers.
IISIME5: CBICBIHITIB HTDBCC1BBOSS;
CG10SIHE OESinC COBPOnKDS;
CElCBOBSlimtS; FLDCTHE COaPOUKDS ;
ISinH; XICCBO^S; THIS; ITBITS
BEfERBKCS
Cockle, J.P.
Canp, B.J.
Delch, B. E.
197S
Archives of
Environnental Health
30(21:290-295
-------
Icetic acid, propyl ester
1C9-60-4
CE-B10-02
BS 102.13, (!E -92.5 C, BP 101.6 C. It 40 •« Hg at 28.8 C
(COITIROZD)
1ISSOB
3514
Breath
ZT.POSOBE BOUT!
AUITTICAI
BETHOD
GC-BS
HOBBIB
OF CJSSS
54 (387
sai pies)
BHGE
Not given
BEi«
2.» ng/1
Geometric
GEH5AL IKFOBBATIOH
Measured at 25 C and 760 •• Eg
49.4* occurrence
letter and upper one-sigaa liaits 1.1
ana 5.2 nq/1
Healthy* 18-35 yr old, nonsioking,
acfcan blacks and Caucasians.
Chicago, II. Rigidly contcolled
ISEITH; A1CCBOLS; ILLIHOIS; ADULTS ;
CELOBIHATEC BTDEOCA5EOSS; TOHTIl!
CEGtlTC COHECH!IDS: BE1LTH BI2JECS;
HB«liTIOI(: BETJEOLISS: BETASOLITES;
ECPmtTIOl EIPOSaBE; HBBAH IBEtS
SEFEBEHCE
Krotoszyoski, B. K.
Braneaa, G. H.
O'Seill, B. J.
1979
Journal of Analytical
Toiicology 3:225-231
cetic acid, thio- (8 CI>
thanethioic acid (9 CD
07-09-5
:-H»-O-S
« 76.11. HP <-17 C, 3? 93 C, TP 1 » Hg at 50.0 C
USSOE
3515
Breath
EIPOSUBI BOOTE
KltTTICtl.
BETBOD
GC-BS
KOBBES
0? C4SSS
5» (387
saiples)
B»KGE
lot given
1
MEtS
3.7 ng/1
Geoietric
GEHEE1L IBF08B1TIOH
ecasured at 25 C and 760 n H
-------
Icetlc acid, trichloro-
7«-03-9
CI-B-C13-02
St 163.t3. If 57-58 C, Sf 1»*-197 C
(COMTITOBD)
1 TISSD1
I
~
3517
Brine
EJfOSOBt ROOM IWITlcre
BETBOD
Inhalation EC
BOSSIS
or cisss
s
1
1
1
1 i
3518 1 fhotoaetrr 1 2117
Brins 1
1
1 1
1 1
1
I 1
sitai
a; 99-5 mg
b) 5-65 119 '
-
less than t->500 mq/l
BUB 1 GEXIEIL IfFOBBaTXOB 1 BEFE5EICZ
1 f
1
I
a) Hot alien I a) Day 5 and 17 of 50 PP«
b) Sot gi»en 1 tricaloroettrlene. 6 iir/dar, on 5
| cctioecati»e days. Initial Talae, 20
1 *4 an day 1
1 t) 1 and 1« dars after 50 ppl
1 tricblaroetbfleoe, 6 tr/a«r, on 5
1 conseeatiie dars. plus etkanol
1 pretrejtaett. Final raloe, 7 aq on
I d.T 1«
I 2* br excretions
1 latinated frcm orapb.
1
1 20-26 T? old students, *t €2-77 kg.
1
1 CBtOBIBlTri BTDIOCUBOIS: IICOBOLIC
I BiHBKis; Biooi; Bicor PI.ISBI:
1 OBHE; BBHB01ITIS: BITIBOIISIf:
I ICOtTS; seism
1
1
•ot ?irea I Jfter erposare to trjcfiloroethrJene
j [at* also qiTen for age- and
I sei-specific aactalitr tram aeopltsms
| nd total icrtalitr >s coipared «ith
I portalitr of Finnish population.
1
I Iges V5-65 rx or aorc.
1
| riBUBt; JDDIIS; OEISE; COBPIS1TITI
| CIIIOITIOBS; CHLOBIIIS CBGJUIC
| CCBICHIDS ; IJCffSTBIH 1TBOSPHFBES;
1
Bailer, G.
SpassavsXi, B.
Benschler, D.
1975
Irchives of Toxicology
33:173-189
Tola, S.
Tllhanen, B.
Jfttvinen, E.
KorSala, a.
19BO
Jqoinil of Occupational
BeSicine 22 (It) : 737-700
t
oc
Icctoacetic acid. b«trl ester (9 CD
Eatanoic acid, 3-oxo-« fcutTl ester |9 CI)
5S1-60-*
1«S. 20, BE -3S.6 C, DP
ussai
35t»
Bceata
I
IIKtSOBI SO9TI
AIlltlJCAI
BET9CD
GC-BE
BOBEeB
or cjsss
S« (387
salples)
J1FEB
lot givea
»!i» I or»fsn ijrrosaifior
t
i
I
0.192 tj/1 [ fejsnrej at 25 C aad 760 >i B?
S«oiettic 1 19.1V occocrence
1 lover ana eppec aoe-Sigma liiits
1 0.059 as a O.€13 aq/1
(
1 SealthT, 18-35 re old, nonsiofcinq,
( attta clactf and Caucasians.
1 Chicago. II. SiqidlT contcollea
1 «iperi>egtal cocdttions.
1
I ISUTH: HCCEOir; TIUSOIS; MH1IS;
ICELCftllkTII ETDPOC1SBORS; 1011TILE
1 CIG1B1C COJPCU1DS; BEaLTB «IZ15tS;
1 IHILITIOIt BIT4E01IS1; HIT4EOLITE5;
f eCTULttlOl EinsniE; DEBill IBI1S
L
lire sires
FrotosjTDEki, 3. IT.
Euneau^ S.9.
C'seill, E.J.
1971!
Toiicologj 3:225-23*
-------
lc«tOM 18 Cl)
2-PtOBaiOM (9 CI)
«7-««-1
C3-I6-0
81 58.08. IP -9«.« C. BP 56.«8 C. fP «00 •• Ba at 39.5 C
1ISSOB
3520
EE«ltk
3S21
Breath
3522
Breath
.
3523
Breath
EZFOSOBE mrai
-
alllTTIClL
BRIOB
OC/HS
GC/BS
GC-HS
GC
inaeia
or c»sss
-
13
8
5« (387
saaples)
a) 5
b) 5
IllGE
0.22-4.87 pps
1.3-2000.0 ng/hr
lot given
a) lot given
b) lot given
RIM
0.52 ppn
500.6 ag/ir
101.3 ogA
Seaietric
a) 309.0 * or - 3.1
nioleVl
b| 20.3 * or - 3.1
moles/1
entni. nroiiiTioi
comctea fci level it inhaled aic
EealtkT alalt>
siBDBi; loitis: ansinzBZii BRBODS;
IIIBHOl
Ccipoma related to noiaal
ntabolisi. lo other details givea
Ccyoganic saepliag techaigne.
Bealthy ailitary and clTilUn
eiplorees. O.S. llr Toroe School of
leco^paec Heaicine, ages 23-47 jr. 3
tickers.
EIKIIBS; CBIOBIItlH BIBBOC1BBOIS;
CBLOBIII OBGIIXC COBPOOIDS;
CBtOSOBIIZEIIS; FL001UE COBFOniDS;
EBIITB: IICCEOLS; TZXIS; 1D01TS
«ea«Eed at 25 C and 7CO •• flg
lOOf occurrence
lewc and upper one-Siqu liaits 5«. 6
aid 181.7 gg/1
Bealtkr* 18-35 Tt old, nonsiokiag.
oxfcaa blacks and Caucasians.
Chicago, It. RigidlT controlled
eiperiaental conUtiona.
tIEITS: HCCEOIS; I1IIIOIS; ID HITS;
CElOBIllIir BTDEOCIBBOIS; fOUTILE
cioiiic coipomiDS: HHITH H»I»BDS;
IlHlIiTICl; BETIEOLIS8; HZHBOLITBS;
ECPU11TIOI IIPOSOSE; Visit SBIIS
a) Snblects taking 250 ag/day
tulfiraa
b| Controls
Significant increase (P < 0.001) la
drag-treated subjects.
lea-fasting sablccts. ages 25-«a jr.
taking dicalfiran for treatneat of
alcoholisa fee 1-7 so. (ornal.
ion-fasting controls, ages 20-55 re.
[BOG TUtlPT; Hf»ESOTa: » DOITS;
INKS
BiniBlCI
Jansson, B.o.
larsson, B.I.
1969
Journal of Laboratory
and Clinical Bethods
7« (6) -.961-9(6
Conkle, I.P.
Canp, B.J.
Reich, B.I.
1975
archives of
Environmental Bealth
30(2):290-29S
Rrotoszvnski, B. K.
Braneaa, 6.1.
d'leill. B.J.
1979
Journal of Inalytical
Toxicology 3:225-23*
DeHaster, E.G.
Kagasva, B.T.
1977
Research Coaannicatioas
in Caeiical Pathology
and Pharaacology
18(2):3C1-36«
-------
icetonitril*
7«-«S-8
C5-B3-I
SI 41.05. IF -45 C, IF 81.1 C. TP 100 •• Bg It 27 C
TISSUJ
3524
Breatt
ZIPOSOBJ BOBIB
iiiinicaL
HIT BOB
6C-BS
IBBBra
OT C1SE9
54 (387
sanplea)
I1IGI
lot jiie«
BUI
7.4 ng/1
Seonetrle
GIHMl motlallOl
tcanrcd at 25 C and 7«0 nn Bq
19.4* oecnirence
I»»er and upper one-sigsa Units 3.0
and 16.0 ng/1
IMltny. 18-35 re old, nonsnokinq,
oi Ian blacks and Caucasians.
Cklcago, ii. Eloidlr controlled
«ip€rlnentnl conditions.
ItZITB; klCOeOLS; IILIIOIS: UILTS:
CElOBUlTfO BTDlOClBBOIS; JOlaTIlE
CES1IIC CQBPCUIDS; HltlTB BlllSrS-
IiaiLlTIOI; HttlBOIISH; «BT»BOIITIS!
ECPVL1TIOI HPOSOBB: HUH 1EEIS
itmssct
rcotoszmski, 8.K.
Brnnenn, S.s.
c-it«ill, a.J.
1979
Journal of analftical
Toxicalogr 3:225-23*
, dlchloro- (8 CI)
aictloro- (9 CI)
7«72-29-»
CJ-C12
If S4.9t, IF -«6 to -C«.2 C
3525
Sreatli
nrracB
oc-as
or ctsis
54 (387
saaples)
lot jirca
•si" i eimii itroxBiiioi
i
10.6 nq/i | Beasarel at 25 C and 760 an Ea
Seonetric | tf.»» occerence
t Io»er and npper one-sioia liaits 2.8
1 and 41.9 Dq/1
1
1 lc*m*. 18-35 1C old, oonanoJtlK,.
1 irtan blacks and Caucasians.
1 Chicago, n. Bidiilr-controlled
1 eipcrlnental conditions.
1 HIITR: 1ICOEOLS; IILIIOIS: 1BB1IS:
1 CELOKIMTH BT080CJB9OIS: TOlaTIlE
J CIBMIC COBPTOIDS; BMIIB giZlBES;
( II»LaTIO«; HCTIEOLISB; BII1BOLITIS-
1 EC?011TIO» EIPOS08B; OBB»» 1BB1S
BlFEBtfCI
rcotasTTnskl, «.)!.
Bmnenn, G. 8.
O'leiii, H.J.
1979
Journal of analytical
Toiicolo^r 3:225-234
-------
llaaiaa, 3-lMthTltkle}-, t- (8 CI)
l-CT*tOla«. S-MtbTl- (9 CI)
1187-8*-*
c*-i9-t-o2-s
II 13*.20
1ISSOI
3126
oriaa
BI tost is BOWK
Inhalation
iiiinicii
BETBOD
CC
•oaazi
or cisss
a)
b)
c)
d)
n
91 7
IIIGI
a) 100-475 aaol
b) 200-425 aaol
c) 25-90 aaol
d) 175-415 aaol
•) 2*0-675 uol
f) 40-150 aaol
all are /aol ereatlalae
- -
nil
a) 336 BBOl
b) 3*0 aaol
c) 38 aaol
4) 289 aaol
e) SI 2 aaol
f) 72 aaol
«) «S » or - 23 aaol
111 aM /aol
creatinino
GIIE111 IBPOIB1TICI
a) Bethyl ckloride aiposue, 30-70
KB
b) Retkyl cklorido exposure, 30-50
KB
c) Mtkyl eklorida oapoaan, 40-40
EFB
d) flctkyl cklorido oapoaaro, 40-70
a) Sotkrl eklorida exposure. 35-65
Fpa
f) Batkyl ckloride azpoaar«. 50-90
q) coatrcl
laaple* taken 2X/day 7 days
Ckaalcal plaat vorkera
IITIEKIIIOS; 1DOLTS; VIIBE: 1E1LTR
Biiisos; innsniu MBOSPBIBES;
IIBU1TIOI; IET1801IIES; CBIOIIIITED
BItBOC>B«OI5
1
BEtEBEICE
Tan Doom, B.
Bora, P.J.I.
Benderaoa. P.I.
Beavara. J.
Tan Borgia, T. J.
1980
International IrckiTaa
of Occapational and
EBTironaeBtal Bealtk
46:99-109
llaaln, 3-l«-C*-kT4ro>r-3-lodopbaaoxr1-3.5-Uloaopaanrl|-. 1- 18 CH
l-Trroaia«, e-(»-kT*roiy-3-lo4ojko»Tl)-3.S-411odo- (9 CI)
CEU-02-3
C15-812-13-1-0*
II tS1.01. tt 236-237 C (lac)
IlSSflt
352T
Blood,
tlKSVVS JOOTt
iiitmciL
HCTHOD
III
•VIBZS
or cisss
a) 2*3
h) 42
O 27
d) 22
»MS
a) 80-250 aoytOO al
b) 273->1»Ofl no/100 al
c) < 36-145 og/100 al
d) 174-410 (0/100 al
BE1I
a) 183 B4/100 al
b) lot giTBB
e) lot jlTon
d) 275 aq/100 al
GIIHU IirOSBlIIOI
a) CatkTtold Tolastoora
b) Hypoctkrcold patioata
c) HTpotkTTCld pattoata
4) Boraal, proqaant mien
Halt of dotactloa, 36 nq/100 al
iciBoiis; iiisoiBmt BRBODS; BLOOD
SIBOS: TIMS
(ETEBEICB
BtO*Bl I.I.
BotkeaBT> •>•
197*
Joaxaal of
Pkaraacoatical Sclencea
63 («): 1214-1217
IllTl aleokel (8 CI)
2-Itoiwa-l-ol (9 CI)
107-18-6
C--86-0
» 58.08, » -SO C. BP 96-97 C. TP 10 aa fq at 10.S C
1ISSOB
3528
tiaath
EXtoson mm
tin men
BETBOD
ec/ns
inan
or cisss
8
11TCI
«ot d«t«et«d-9.S ui/kt
•Ell
1.3 no/kx
etiitii iBroiBinoi
Ccipoaad relatad to aozaal
•otabollaa. lo otkoc detailt 9lT*a
Cryogoalc aaapllai tockuiqne.
••altkr ailltarr and elTilian
«aplOTMl. D.S. lie force School of
Icrospaea n«liclo«, aq«s 23-47 TT. 3
aaokeca.
EllZNCS; CIIOBIBKED BTDIOC1BBOIS;
CBIOBIII oieinc coipomnis:
CBtomiBiziKS: FIIOBIIS coamms;
IBIHI; 11CCBOLS: TZMS: HOHS
IEIBIEICS
coakl*. i.e.
Caap, S.J.
••lek, I.E.
197S
IrekiTca of
EBTiroaautal Boaltk
30(21:290-295
-------
linings
7*29-90-5
11
lt» 2«.98151, » «60 C, BP 2327 C.
TP 1 •• Ig at 15*0 C
:
TISSai EIPOSSSI ROOT!
lorta
1
1
3 5 JO
51004,
sera a
31
rod.
2
1
1
f
1
1
1
1
1
1
1
1
1ULTTIC1L
BETBCD
11
US
1
t
us
115
I OH BIB
OF C1SBS
2
1
a) «
b| 69
c) 23
U f«
It 30
:J 57
1) 3g
E1IGS
8.5-20 ag/s [net vt)
a) lot applicable
b> lot applicable
c> lot applicable
d) lot applicable
a) Vot given
b) Sot given
c) lot given
>t lot giTei
>) lot given
:J lot given
[| lot given
BUI
11 » or - 8 I Hodge, K.C.
desCerrioranine I 1^80
d! Final leasareaant, dar 290 I lancet 2<8196) :692-693
Levels sLoaed sbort-teca cyclic 1
•artatlags, and long-tera opvard 1
trend luting treataent. E3tiaated t
(cos grapb. 1
36 Tr old aen vitV dialysis |
encephslopatbv. |
1
Irileptlc seizures, svoclonlc larks, I
CialTsis eaceptalopatkr, 1
etteodvstrachv, prosisal aiopatliT. 1
1
noiiim; i»troos STSTEB OISEISZS; I
BiTODiiiisis: anus; DSITID KIIGQCB: t
EtOCD SEBHI |
i
1
a) controls I Gilli, t.
b) Drenic patients on besodlalrsis. I Farlnelli, 1.
Elalrsate. 7.7 * or - 7.51 og/1. pH | Fagiali, I.
7.3 I DeBastlani, P.
c) TIretic patients on internittent I Rnoncristiani, 0.
rerltoneal dlalrsls. Dlalrsate, 10.07 I 1480
« or - 5.3 ag/1, pa < 5.5 | lancet 2(8197) sT»J-7»3
>IDIET DI SEISES; 1LOHI»DB; IRltS; I
HCOB SEltll; ITIII: BIBOD111ISIS t
1
t
i| Control: fron U.S. I llfroy, i.e.
t) loalialTZcd patients 1 Regg. 1.
c) DialTT«d patients I Crasvell, p.
encepItalopatliT t Inerican Journal of
1 Clinical nutrition
Orealc patients in U.S. and 1 33:1509-1516
Instralia. Sose died of dialysis I
msTmti: limit STITES: nno?siEs: i
IIIOIET OISIISES; 1EETOIS STSTIB |
CTStlStS; BOIES; BBlT-f; 8E1BI; LITER; 1
uses; losciis; S?LIEI: EEBCDIILISIS: i
ItC Slim: HE11LS |
1
-------
llCliniB
II
Itl 26.981S4. -IP 660 C. BT 2327 C, T? 1 •• Hg at 15*0 C
(COBTIigSD)
1ISSQB
3533
Sralo
3534
Praia
3135
Bair
3536
Hair
EXFOSDSE BOOTS
iiittncu
BETHOD
11
US
ItllBES
or CISES
a) 16
b) 30
c) 57
d) 38
-
a) 42
b) 40
llBSS
a) 8.0-19 gg/g (rat vt)
b) 22-23 ug/g (vet vt)
c) 6.9- 15 gg/g (vet vt)
d) 12-22 ag/g (vet vt)
a) lot given
b) lot given
c) lot given
d) lot given
a) 1-17 ag/g
b) <1-29 ag/g
(HIT
Bill
a) 15 » or - 4 «g/g
(vet vt)
b) 23 » or - 1 ag/g
(vet vt)
c) 11 * or - 2 ag/g
(vet vt)
d) 15 » or - 5 ng/g
(vet vt)
a) 2.4 * or - 1.3
b) 4.1 * or - 1.7
no /kg
c) 8.5 » or - 3.5
•q/kg
d) 24.5 « or - 9.9
•I/kg
Defatted saeples
») 5 ug/g
b) 5 ng/g
ledians
?HS!)
GE1IB11 IIFOSHMIC1
a) Bales, eerebree, 9 sabjects
t) Teeales. eerebmn. 2 sabjects
c) Bales, cerebellum, 6 snblects
i) Tenales, cerebellua, S subjects
Tron a groat of 61 autopsies.
forensic nedical eianinations, Japan.
Bales, nean age 40.6 rr. Feiales,
nean age 37.4 vr.
T11CI niBtllS; 10TOPSIZS; JIPII;
iioBiinB: iBSERic; CIDBIUB; COBALT;
etBCain*.: COFPZB: MOB; BSBCUBT:
IIBIUB; BlGICSIUfl: BA1611ESB:
IOBIDIOB: iniBoit; sciiDing;
siLEBioB; Timim: TiiioioB; zinc;
GCLC; BBOBIII; lITEli KT91ITS;
CIBEBBH1; CtEIBEHTIB; H!1BT: [HJSCLES;
FHCB11S; SPXEEp; 1I1GS; lOBll;
BITH.S: coipiBHTirs ETiLomcas: SEX;
rcBEisic BICJCHI
a) Controls fron O.s.
r) londialvxed patients
c) Dialrxed patients
d) Bialried patients vith
encephalofathf
Oreele patients in O.S. and
lastralla. Sone died of dialysis
encepbalofattT.
lOSIDlLII: 01ITED STITIS; 10TOPSIES:
II It BIT 9ISE1SES; HIBTO03 SIS1EB
CISI1SIS: BCBES; BB11J: BEIBT: LITEB;
IBISS; IDSCltS; SPlItiT; RlilODIllTSIS;
1IBBI1H!!; BEIU.S
leviev. 24 representative
cte-aaaly*is treataents are
tabulated. Ibe feasibility of a
bclistie, no-vash policy for bair
analysis is cut lined and supported.
ftTIEv; TP1C! riMEITTS; BUB;
mSTfiH.lt; atlSO«EBEIT NETBOOS;
gitus: pBoums; COBPIBITITE
IISEIIC: B»BKIS; BBOIIIE; ClCTlm;
cucin-i; cHicEiiE: CBBOHIIIB: COMIT;
CCPPH: SIIH0B: sEBBtnvi; eoiD:
icon!: IBOI: iiiTHiinB: lilt:
BI61ESI»; BU61I2S1; BEBCDBI;
tClTB9E!TJB: HCKtl: PBOSPHCBOS;
iciisstvii: BUBIDIOB; snumB;
SIUC01: SIIVB5; SODIVB; SIBCIIIIB;
tlic: ilacoiion
a) Controls
c) Boltitle sclerosis patients
Saaples fren 7 scalp sites in each
•vc^ect.
CI11B1; 1E01IS: CEITBll BtBVCOS
!TSTZ9 DIS'JSES; 3»IB: KIDBIBU!!;
IlCHIIt; C1ICIOB: CB10BIBE: COPPER;
ecu: Km*!: >iiisiiis:; IESILS;
S1I»«11!; SIITEl; SCDIOH; SOIF3B;
71110131; TIIC
BEIBBEBCE
Tvkava, B.
snzaki-Iasaaoto, B.
leaao, 1C.
Terai, B.
1980
1 retires of
Enrironnental Health
35(1):3«-44
•
Alfrey, I.e.
Heqg, 1.
crasvell, P.
1980
laerican Journal of
clinical latritioa
33: 1^09-1516
cbittleboroagh, G.
1980
Science of the Total
Environment 14:53-75
Byan, D.E.
Bolzbecher, J.
Stuart, D.C.
1978
Clinical Chemistry
24(11):1996-2000
-------
II mi cai
7g29.90-5
II
Its 26.98154.
HP 660 C. BP 2327 C. 7P 1 •• Ha, at 1590 C
(COITIIOBD)
1I3SOS
3537
Beart
3538
Mart
3539
Kidney
BIPOStJBS BOOtS
atunxcii
IRBOD
U
1>3
U
BOMBS
0? CISBS
a) 4
b) 2
a) 16
b) 30
c) 57
4) 38
a) 6
b) 2
sues
a) 4.7-26 ug/g (net «t)
b) 23-34 a«/9 (oet «t|
a) Hot given
b) lot given
c) lot given
d) lot given
a) 10-41 ag/g (net »t)
b) 12-12 ag/g (net lit)
flEIT
•Ell
16 » or - 9 ug/g (««t
•t»
b) 29 * or - 8 ag/g
(«et »t|
a) 1.0 * or - 0.8
eg/kg
b) 6.9 » or - 10.6
ag/kg
c) 22.5 » or - 20.5
aq/kg
d) 42.7 « or - 22.9
•g/kg
Defatted saaples
a) 20 » or - 11 og/g
(vet »tj
bj 12 * or - 0 ag/g
(vet «t)
PIGB)
GEIIBll nPOBUTXCB
a) Hales
1} resales
tcoi a <|coap of 61 autopsies.
forensic aedlcal examinations, Japan.
Bales, aaan age 40.6 ft- Females,
•ean age 37.4 vr.
1B1CB EI.BBZBIS: 40TOPSIBS; J1P1S;
iioBUns; iBsziic; CIDUOB; COBILT;
CEBOSTBB; CCPPBB; IBOB; HEBCOBI;
IltlOH; IfaGBZSIVB; UBeiBBSB;
BOEIDIOHl IBIIBOBT; SCaBDIOB;
SntBIOIt; TIIMIOI; TABIDIDI; ZIBC;
«cit; BBOHUi; tirra; KIDIBTS;
C1BBBBOB; ClBEBniOH: HB1BT; BOSC1BS;
SIICBBU: SPIEM; LOK3S: 10BT1;
BRILS; COBPUMIV8 BVilOHIOSS; SSI;
fCBJISIC BiriCIBI
a) control! tiow 0. S.
t) Bondlalyiei patients
c) olalysed patients
d) Halted patients >ith
•acephalopatby
Dteiie patients in O.S. and
lastralla. Sone died of dialysis
encephalopatfey.
losnuii: omsD SHTBS: IVTOPSIBS;
HC8BI DISBISBS; IBBVOOS STSIBH
tlSHSBS! BOIES; BEIIH; BElBTt 117 IB:
loses! nosciis; SPLBB>; BBBODIIITSIS;
11CBIBHB; BB1US
a) Bales
t) reiales
fron a gtonp of 61 autopsies.
forensic ledical exaainationa, Japan.
Bales, aean age 40.6 yr. Feaales.
aean age 37.4 yr.
1D1CE BLBHIITS; IOTOPSIBS; JlPH;
HOnBDR; IBSIHICJ CiDBIOB; COB1LT;
CEBO»IUR; CCPPBB; IBOB; BBBCOBTj
1BIIOS; BaGIESIUB; BalGaBSSE;
fnEIDMB; IBIIHOBT; SCaHDIOB;
milTOH: TT1MIOR; T1BIDIOB; ZIBC;
CCtll: 9BOHIBE; LIVES: KIOIETS;
CIBZBBOB; CBBIBELUJB: BE1BT; HOSCISS:
fllCBBIS: SflEBB; LOBSS; JOBTi:
BITUS: COBPUtTITB BTAIOATICHS; SEX;
PCBBKStC HIEICIHE
BBFBBBVCB
Tnkava, B.
Suzaki-Tasanoto, B.
Isano, R.
Terai. B.
1980
archives of
Bnvlronaental Health
3S(1):36-i)4
alfrey, I.e.
Regg, 1.
Crasvell, P.
1980
liecican Joornal of
Clinical Bntrition
33:1509-1516
Tnkava. B.
Sazaki-Tasaooto. n.
liana. E.
Terai. B.
1980
archives of
Environaental Health
35(1): 36-40
-------
llaelaas
T«29-90-S
II
Itl 2C.9S15I. It CCO C. If 2327 C. ft 1 M Ba It ISM C
(CORIIOED)
1XS39I
35*0
llvor
35*1
35*2
Lviq
35*3
Lung
NCOSOIS 1OOT1
1I11TCZCAL
BCTBOD
•1
us
•1
us
IBBBM
or CISBS
a) 9
b) 3
a) 1«
b) 30
4 57
d) 38
a) 2
b) 2
a) 16
b) 30
d 57
d) 38
B1KB
a) 10-25 ag/g (vet *t)
b) 5.5-20 ag/g (vet vt)
a) lot given
b) lot given
c) lot given
d) lot given
a) 18-100 ig/g (wt vt)
b) 10-23 ag/g (vet vt)
a) lot given
b) lot given
c) lot given
d) lot given
RZ1B
a) 18 * or - 6 ag/g
(vet vt)
b) 15 * or - 7 »g/g
(vet vt)
a) ».1 » or - 1.7
b) 25.5 « or - 33.1
agAg c| K1 * or -
12* ng/kg
1) 301 « or - 21*
Defatted saaples
a) 59 » or - 58 ag/g
|v«t vtj
b) 17 » or - 9 ag/g
fvet vt)
a) »3 » or - »3 ag/kg
b) 75.2 » or - 77.3
•g/kg
c) 89.5 * or - 76.8
1) 215 « or - 220
ng/kg
Defatted sanplea.
SEIIIll XBFOIBHIOB
a) Bales
Iron a groap of 61 aatopsias.
forensic nodical •xaninatlons. Japan.
Bales, aeaa age «0.6 jr. fesales.
seen age 37.1 yr.
IBICB xiSBsns: IOTOPSISS; JIPIB;
llOBIRvB; IBSniC; C10RIOS; COBUT:
CBICRina; COPM1; IIOI; HBBCVBT;
HtlDB; SISIISIOH: R1IG1IISB;
inEIDIHI; 1ITIROBT: SCIIDIOR;
SHEim; TITIIIOR; TIHDIUB: Hie;
eciB: Btoiiit: um: KDESTS:
CIBZBBM: ciBZBEiuiR: BEIBI; HOSCLES;
E11CBI1S: SPtBBB; LOBGS; 1CR1;
IRUS; COflPUlTIVB ByilDlTIOBS; SSX;
ICIIISIC BKICIIB
a) Coatrols froa U.S.
t| loaaialyxed patleats
c) tlalyzed patioats
4) Blalysed catiaats a 1th
eieepkalopatby
flrenic patleits la O.S. and
laatralia. Soae diad of dialysis
eaeepbalopatby.
llSnilll; OUTID STIIIS; lOTOtSIBS;
If DIET BISB1SB5: RSTOOS STSTBR
t is lists: BOIES; mil; BBIBT; iirsi:
IDIGS: Rosens; SPLIE*: HHOtimsis;
I10IIIOR; H1111S
a) Rales
1) Teaales
froa a groap of 61 autopsies.
forensic aeUcal oxaaliationa, Japan.
I tics, lean ago *0.6 yr. Peaales.
aeaa age 37.* yr.
T11CB BIBBBItS: 10TOPSXZS; JlPHi
iioniins; IBSZIIC; CIDRXDR; COBUT;
cc
-------
ilmlm
7«S»-«0-5
11
Itl 26.9815», at 660 C, BP 2337 C, TP 1 •• Bg at 15W C
(OOVTIBBXD)
IISSBE EirosotE BOWB IBUTIICU
BETBOD
35«» Ba
BaBcte
1
1
j
3515
Basel*
1
US
I
f
1
1
1
1
1 1
t
35« u
BttBBSJ
or ctsss
*1 *
b] a
) i«
1 30
) 57
1 38
1115! |
1
|
a| 8.3-16 gg/g («et >t| 1 a| 13
b) 7.4-29 «g/g (Mt >t| 1 (rat
1 b) 17
1 (*et
1
f
1
1
1
1
1
r
i
i
i
i
i
a] lot gtrea I a) 1.2
b) lot livei | 11/tg
) tot glrea I 6) 2.S
) Bot given | eg/kg
I e) 9.1
1 ag/ltg
1 d) 1«.S
t e?/'Jt?
BE1B | SHIIlt moiBHXCI
1
1
1
+ or - 3 ug/g f a) Bales
vt) 1 II Tevalev
+ or - 7 ug/j t
vt) 1 fro i * ?rc«f of 61 autopsies.
1 fcreaslc aedlcal exaaiaationa, Japa
f a*a2*av tutt a^e 40. C fr* faaalea.
I aeaa a Ualraed patleats
1 d) Clalned patieata vlth
« or - 14.6 | encephalopatbr
1
* or - 13.7 | Create patients la (r. 3. aad
; Joetralia. So»e died of dial/aix
I
1
1 llfrei. I.e.
1 B«gg. 1.
1 crasrell, f.
I 1980
1 laerlcan Journal o
i clinical (otcitioa
1 33:1509-1516
i
t
I Defatted sanples eaccpfcalopatlf. 1
1
t
1 1
5 1 a} 9.3-30 nq/q fust vt> la] 15 *
Pancreas 1 1 t) 2 I b) 18-25 «g/g (vet vl) I (ret «t)
1 II »> 22 *
I f«at vl)
i
1
1
1
insTBiLii; nme STITIS; JBTOPSISS,-
Kinzr DISUSES: IZBTOOS SHTEB
CISUS'3; BOIES: BBalf; 1Z1IT; UTJB;
I1BGS; BOSCLIS: SPLEII; HSlOIIlltSIS;
lIOBinB; BE1J1S
or - 9 pj/9 1 •' Bales
| t) Teaales
or - 5 ag/g 1
f tram a graft o- 61 autopsies.
| Coreaslc avdical eiTaaiaatioar, Japan.
1 Bales, swan ag* *0. € rr. Peial«8.
I aeaa ag« 37.* TC,
1
( SMC* nlBEBIS; ItlTOPSIES; J1T1I;
| IIUBIITB: ItSEBIC; CaDBIOB; COBllT;
| CESCflll': CCFPBB; IBOJ; REBCOEIi
| IBDIH!I; IlCBZSItIB; B1BS1BZSI;
| SOBIDITI; linBOIT; SC1IDHJB;
| SUHI11; Tinting; fl I1BIOII; ZIIC;
t fiCID: BBOBIBI; I.ITEE; XTOIETS:
| CltEBRlH: CIBtBEUOB; BSlIf; BVSCLXS;
I >1ICIB»: SPIXE*: lOKS; lOSTl;
| BIT11S: COBPU1TITE CTILD1TIC1S; SIX;
| fCIIISIC HICICIII
|
t
1
t
1
1
1
I
1
1 Tokava, B.
t Sazakl-Tasaaoto, I.
1 laaao, t.
1 lerai, B.
1 "BO
1 IrctUes of
1 lOTlronaental Bealth
1 35(1):36-««
1
1
t
t
I
f
1
t
1
1
|
1
(Btlt PtGt)
-------
7129-90-5
II
Itl 26.4115*. W 660 C. BP 2327 C, fp 1 aa Hg at 1540 C
nssai
3547
Splem
35*8
Spleen
Exiosns icon
alUTXICU
IR10B
u
us
BOBBIE
or CISES
•I s
b) 3
'
a) 16
b) 30
0 57
1) 38
1
11ISI
a) 6.7-25 ag/g (««t «t)
I) 16-»4 ag/g («et it)
a) lot gi»«i
b) nt gl»««
O lot gif*B
d) lot gi»«
RIM
a) 14 + oc - 8 ng/9
(net lit)
b) 26 * or - 16 *J/g
(»«t rtl
a) 2.6 » or - 2.1
•i/kg
b) 35.3 * 01 - 72.3
•9A9
C) 2»3 » or - 250
aqAg
3) 493 • or - 463
•9 A?
Mfattcd saiplaa
CtllllL IlTOlSUIOH
•} lain
t) f«Ml«S
Txoi a gcovp of 61 attopsics.
fot«»lc aeileal axaaiaatloia, Japan.
Bales. Ma> «g« «0.6 yr- r«aleB.
•*a> «g« 37.4 TT.
»ici ncims: IBTOPSIIS; juu;
ittnna; iismc; cutiva: COBILT;
CtBCSIBS; CCPPHJ I10PJ B1JCUI1;
IICIH«; laSIISIOB; nlURESI:
»UBiT)in»; ininont; scuoira;
itiinaHi TiiuiDi: TIHD«B: zinc;
CCID: BBOBIItS HTBB: KIDBITS:
CIBBBBCI; citniiiaa: BEIBI: susais;
EUCBZI3; spun: IDKSJ ICBI*;
BITUS; COIIPUHin ETJLniTIOIS: SXI;
TCBIISIC KBICIIX
a| Controls flroi 0. s.
t) tmtitlmS patl«nts
e) ui»lri«a fatluts
d) DlalT>td patltnti «lth
•accpaalopatkT
Ircslc patients ta U.S. asd
Usttalla. Sow di«d of dialysis
•aecpaalopatkT.
lostBiui: miTED STiTis; inapsiss;
IIC1EI DISUSES; niTOOS STSTI9
rijzisis: BOIES: BIHI; min; IITBB;
inss: aosciis; SFIIBI: BEBODIIIISIS;
iitniw; units
BIIEIEVCE
Takava, B.
SoiaKi-Tasnioto, a.
liana. It.
T«al. B.
1*80
Archives of
tSTllonieBtal Baalth
35 (1(: 36- 44
tlfMT. »-C.
B^g, i.
Ctasvell. ?.
1980
laericaa Joarnal of
Cliaical Bntritton
33:1509-1516
1318-09-8
IIKT CODPOSmoi USR1IOII CB DIBBTMBIIBB
nssnB
3541
latastlie
ZXtOSOBZ BOOt!
Ingest Ion
MHTTICH
nrrncn
tn
BOSSES
or ciszs
a) 21
b) 32
IIIGE
a) lot glT«o
b) lot girtn
•an
a) 0
b) 3.20110(1-5)
flb«u/g
Ish «t
?fe
SHIBII HfOBBlTICK
a) Controls
t) Kesldeiits witb 1014 ten, high
l«tal exposnu fcoi drinking
ccataainat«d «at«r
|gtopsl«s, Jflonoa wall
!!2-89 Tr old rasldeats neat t&conite
Ftocessin? plant, niaatsatt. 17-77 jr
tld controls, IHnnesota and Texas.
eilBESOTl; THIS; aOTOFSIES;
IBIESIIBES; IITEE; lOISS; DBIIUnS
««!•>; HtdSnitl EBISSIOIS;
IBOH5TBIU EC11DTIOB; (aTEB
EC1LDII01: ISBISTOS
-
BETEBEKCE
Carter, B.E.
larlor, B.r.
19SO
Environmental Besearch
21:85-93
(IEI1 ?JGE)
-------
latklboles
13 10-0«-e
mc» COSPOSITIOI oinon 01 mtirninra
iissiiB
3550
tine
3551
law
BirOSOBB lOOtl
laaectiaa
Iag«stion
1
i
1
1
1IU.TTIC11
HB9BC&
N
Bl
•(mm
or CISBS
•1 30
b) 32
UTCB
a) tat givea
b) tot glvea
a) lot aim
b) lot gin*
BUI 1 etIIMl ZtrOBMTIOl
1
I
a) 0.3«I10(l-5) | » coatrola
flbers/g 1 b) lesideats «itk long tera. hivk
bt S.KIIO(B-S) I 1«*«1 ««a»*n lea* IrUkiij
fibers/? | ccnt«iii«t«ii «t«r
t*k *t I Ktopdw
1
t i2-n rr eld nsil«its i«*r tacanlt*
I F'oc««aiiq pl«t, linMCota. 17*77 yr
1 cltf coitrali, Rin*«ot« aid Texas.
1
1 eiinsori: Tizist umrsus;
t itTismis; irrii; luics; onntiie
i inn; iimntxii mssiois:
I IIEOSTMII EO.IDTJOI: HTIi
I icunioi: tmsios
i
1
a) O.SUtOtI-5) I I) Controls
fibers/9 1 t) lesUeit* «itk lo>« tera. blah
b) 16.21110(1-5) I level exponce free drlaxiif
fibers/g 1 ceataaiaated natex
ish »t | lotopaiea
1
I S2-89 ji old resideata neat taeeaite
1 ftocessiag rlaat, liaaeaota. 17-77 rr
1 eld coatrolSp ffiaaesota aad Texas.
1
1 HIIESOT1; IZIISi 10TOPSIBS;
I miSTIIIS; UTZI; tDTCS; DBIHtCTS
1 ntn: itDisniii insstots;
I iievsniit tctmiiot: MTBI
1 ICIIOTIOI: J5HSTOS
i
IBRIBICI
Carter* B.E.
Tirlor, t.r.
19*0
BBvlroaaeatal Reaearcb
21:85-93
1
1
1
Carter, B.E. |
Saflor^ W.F. i
1*80
Earlroaaeatal Beaearca
21:85-93
00
IrlllM, •.••-•etkrle*ebia(2-ealaro- (8 Cl)
I«neaasine, a,«'-a«UTleoebIsf2-chloro- (9 CI)
101-ta-a
C13-B1Z-C12-H
If 267.2
I IIS301
1
1
1 3552
1 Oriae
1
BIfOSVK! B0«r
laaalatloa
Penal
1 tinmen
I IBTVOD
i
1
Coloriictrr
•maEx
or cuss
*
1 tires
i
0.0«-3.8 a«/l
| IE1I
tot giTea
etiiui iiroiuTioi
lir coneeatratloBS oalr sliahtl;
above tkrestold of detectioa (0.01
>«/c< e) .
Iiposed icriers. lev Jersey
CCCOMTIOI1I BHiUS; OBIIE; CBlOBItE
CISIBIC cotrcnos: BstsmBUR
fKIOnS: UCBSTKIU ReiBII
tETEBnCX
liack, I.I.
1S7«
laericaa ladastrial
HTgieae IssociatioB
JoatMl 3S:*26-«32
-------
intisony
1«40-36-0
st
Itl 121.75, n C30 C, B? 163J C. IP 1 •• 19 at 866 C. 10 •• Bq at 960
USStJB
3553
lorta
355*
Brain
3555
Bale
BIPOSOJE BOOTE
1BUITICU.
BBTBOD
Bl
Bl
•OBBSS
OF CUSS
3
B1B6B
lot given
a) Bot given
b) Bone detected
(IEIT
BBaB
0.01 » or - 0.02 ng/g
(net »t)
a) 0.01 « or - 0.02
•g/g («et «t)
b) Bone detected
PISE)
GZBEttl IBPOBSITIOB
Bales
iron n grosp of 61 autopsies.
forensic medical exaninations, Japan.
Bales, sean age 40.6 yr. resales.
i«an age 37. a yr.
II1CI ILEHEBTS; JUTOfSIES; J1P1B;
JIUBIBUB; JBSBIIC; CIDRIUfl: COB JIT;
CBSOaXVB; COPPEB; I BOB; BBBCOST;
IICI01; BlGBtSIDH; B1B61IZSE;
1B8IDI05; IBtXBOBT; 9C1BDXBB;
jiiBBiuB; TITJBIOB: YIBIDIOS: znc;
GC1C; IKOBIlIi LITEB; KIDBETS;
C!BBBBB!l; CZBISEUBB; BE1S1; BOSCLBS;
FIBCBZIS; SPIEEI; IIBGS; 1OBT1;
BIT US; COBf J11TITB ET1L01TIOIS; SEX;
KIIBSIC B1DICIBI
a) Tesales, cerebrvn, a subjects
t) resales, cerebellns, 4 sab-fects
Tton a groa; of 61 autopsies.
forensic sedical exasinations, Japan.
Bales, seas age ao.6 yr. resales.
•ean age 37.* yr.
TBICE EtlRBIISi 1VTOPSIBS; J1P1B;
ItBBXBOB; 1BSEBIC; C1DBIHB; COBUT;
CEBCBIHB: CCPPEB; XBOB; BEBCOBX;
IBCItIB; BlGltSIOB; BlBGiBBSE;
IVEIDIOB; IBIIROBT; SCUDIOH;
SE1BBXUH; TII1BIOB; T1R1DIOB; ZIBC;
ecic: BsoaxiE; LITBB: KXDIETS;
CBfBBlVB; CBBtBELLUB; RB1BT; BVSC1B5;
PIBCBB1S; SPIRB; IDICS: JOBT1;
•IIILS: COBP1B1TITB BT1LD1IICBS; SIX;
TCBIBSXC REEICXBZ
It vie*. 2» lepreseatative
pie-analysis treatments are
tatnlated. The feasibility of a
>«listic, no-«ash policy for hair
analysis is outlined and supported.
IfTIZB; TB1CI IIBBEBTS; HUB;
inSTBUIl; BEISOBBIBBT BET BODS;
EITILS; PBOT1IIS; COBP191TITB
IY1L01TIOIS: 110BIIOB; JSTIBCBT;
USHIC: EJRIDB; BBOIIBB: CJDBIDB:
CHCI01; CBICBUB; CB30BIOB; CO E JIT:
CCPPEB; GI11.I1J!!; GEBB1IIOB; SOID;
ICDIBB; laCB; 11BTR1IBB; lElt;
IIGIZSIHB: BiBOtitsE: BEBCVBT;
BCITBDIBOB; IICKIL; SBOSPHCBOS;
fciissitji; tDBioioR; SIIEBIDB:
SIIICOB; SIITBS; SODIHH; STBOBTIUH;
SVIPOB: TIB; TITHIOB: TOBGSTEB;
E1BC; ZIBCOUOB
IZPZBIBCB
Tokaia, B.
Sazvki-Tasnsoto, B.
Isano, K.
Teral, B.
15-80
Irchives of
ZnTironmeatal Bealth
Tokava, B.
Snzoki-Xasasoto, H.
Inano, K.
Terai, B.
1930
Irchives of
Enviroasental Bealth
Chlttlebocoagh, 6.
1980
Science of the Total
Environnent It: 5 3-75
-------
;«10-36-0
St
l« 1J1.75, RP 630 C. BP 1«3« C, TP 1 an 89 at BS« C. 10 us 89 at 960
(COBTUOED)
TISSUE
3556
Bale
_— .
3557
Heart
3558
Kidney
STPOSflSH BOOTH
iBimreii
iWBOB
B»
B*
.
SnaSBB
0? CaSBS
a) 10
b) »
a) 22
b) 3
SiBOE
.
_
a) Dot given
b) lot given
-
a) lot given
b| Hot given
BBXB
..
a) 0.01 •» or - 0.02
«a/g (»e* **l
b) 0.02 * or - 0.02
aq/q («et «t)
a) 0.01 t or - 0.03
B9/g (»et »t)
b) 0.01 * oc - 0.02
aq/g (vet vt)
G!BFB»l IHFOBiiTIOH
1 revie» of >orld lltetatnre on to«
accnivlBtioti an« blocoDCeotietion of
selected to tic trace netals ill bnaai
hair and mils aafl other nansaHin
baicr fact nails* clavs and boofs.
labaiatai by geographic area.
•abjeete. «ei» «qe. axpasate
9£adieotr analytics in ppa* and
anthocity frqn ovec 000 E«tenaces.
tr«ICt; inSlBslUl CUaDat CIHltM.
IHIBICIt BOiCPE; HIttDLE BJSt: Ht»
niiMDt sooia aBEnict; somnist
• Sla; OHITII KIveDOI: OBHED STSTBS;
BUB; JJIIS! BEYICT; ABTIBOBT;
is3tmc; BO BOS: caoiimi: CBHOFntms
ccfitT; COPPIB; IBID: BBBCOBI:
IICFEI; S?lS!lI13nj TIB; TiSADIDH; ilE
FCllBTIOB; IBIBil POP014IICI3:
IIOaCCDIOimOVi BIOIBDICMOIIS; t»«B
tOtlOTIOS; POPOHTICB EtPOSOBB; RlTtR
FC11DTTOH; TB1CE BLBRBRSt BETalS
-
a) Bales
t) F«Mles
FCOl t qtaap of 61 autopsies.
fatensie asflical exaainatlons. Japan.
Bales* a«ao age 40.6 ji, Feaales*
lean »q« 37. 4 yr.
TB1CE 8189EI1S; JTITOP3IBS; J1PM:
llOBIIIOilt S8SESIC; CUDBIDB; CD E JIT;
CFSC8HJB; COPPBB; ISO!); BEBCOBYJ
IltlDX; BaGBISIOB; BtBGaBISl:
JCSIBIHI; UTISOBY; SCIHOlOM;
SIllBIOH; TI11RIOBS TaBtDIOB; ZTBC;
ecin: BBOHUB: LIT BE i KIDBKIS;
CIBIKtQK; CISEBEHOn; H5ABT; BVSCLES;
PIBCSB»S: SPIES*; LDVGS; ACBTI;
StTlIS: COIPJBiTIVS B7iL0JT30BS; S2X;
fOBIBSIC BECICI8E
a) Bales
t) feaales
Proa a groop of 61 aatopsies.
totensic aedlcal ezailnationa. Japan,
Bales, man age 40.fi yr. peasles.
aean a4« 37.4 yr.
191CE ELEMBIS; tOTOPStBS: JaPaB:
UOBTII1B; 1BSEHIC: CaDBIQBi COSUTi
ctDOHIOK; COPPBB: IEO»; BEBCIJBT;
IICIDH; 1»aS!5IOB; BaSGiBSSB;
ROBIDI3!l! tKIKOBT: SC4SDIOI":
StlEBlni; TJTHIII01; Ta»DtOB; ZtBC;
GC1I: 3BOHIBI: LIVEH; KIOBITS;
CIBEBBTS: CZBBBEUOR: HElBlt BDSCLSS;
eilCBBaS; SPIEB8; lUDlSS; JOBtl!
R'TllS; C01E»B»TI»! E»»ld«TIOSS: SSI;
fCBHSIC BEEICIBR
8EKBESCB
_
Jenkins. B.B.
1979
«Sl-600/»-79-Oll9, 18»
PP-
Taka«a, fl.
Soiuki-taaaaoto, H.
Amanov K.
Terai, B.
1980
Archives of
In*iioni«ntal Health
35(1)i36-«a
Takaiia, H.
Sniakl-Iasumoto. n.
Itano. K.
Terai, B.
1940
archives of
?n>itonaental H«altn
35<1).-36-«a
(BBXT PJGB)
-------
Ittiiony
1MO-36-0
-------
IrtlaoiT
•JMO-36-fl
SI
lt« 121.75. H 830 C. B? I63S C. »P 1 M 89 *t 886 C. 10 •• Eg at 960
(CORIIttED)
lissas
3562
Hn.,
3563
Long
1
EIPOSOBE BOUTE
1
1
1
1
1
I 356*
1 Riscle
4 1
f 1
1 1
|
t
|
|
|
1
1
1IUTTXC1L
HETHOD
U
n
•QMS*.
or cisis
a) 3
M 2
a) 9
b) 13
c) 23
«
M a) 5
b) *
I1IOE
a) 0.22-0.52 ag/g («et
•t)
b) tot giT«n
a) 0.011-S.067 iig/g
b) 0.033-0.58 ag/g
c) 0.023-2. « ag/g
Vet *t
SIJI | GEIIUL IBFOSRHIOl
1
1
1
a) 0.33 * or - 0.17 | I) Sales
ng/g (*et it) | t) Paaalaa
b) 0.28 * or - O.ao |
>9/9 (*«t >t) j Proa a groip of *1 antepaiec.
I foienatc aedlcal exialnatiooa, Japaa
j t*l*m, aeaa aae 40.6 jr. Fcaalea,
I lean aga 37. • 7r.
1
| IF 1C! ElEHIItS: 1 CITOPS IBS; J1PK;
I I10III8R: 1BSZIIC; CIDBIOR; CO Bill;
| CRBORIVK: COPPEE; I BOB; HEJCDBI:
| IIDItH; glGIISIII; R1IG1VE5E;
| BDBIOIIB; IIIIBOIT: SC1IDIOB;
| SILIIMS: TH1EIBB; T1R19IDR: IIITC:
| C3CIB; SBOalBZ; UTEB; KIOBEIS;
| CIBIBBOU; CZBEBEUIB: BI1BI; I1TSCLES;
| IHCBEISi SHEER: LUISS; 1OSII;
| BITHS; COUPMiTIT! EHIB1TICITS; SEI;
| PCBIISIC BIOICIRE
1
1
M 0.029 B9/J | a) Controls
b) 0. 27 ag/g | b) Vorfcer qcoap I
c) 0.32 ag/g 1 c) lorker qreip II
fet vt I
Medians | Ecceaaed r«fiaerr and saelter
| vorkers, ages 55-76 jr, exposed to
1 >«a*T Mtals 1-3 iecadas. Tiae
1 tctncn zetlreieat and Aeatli 0-1.5 fr
I Centrals, ages 43-72 jt, »ao lived SO
I ka froa t&e factory. Svedea.
1
| SIEDEI; ClBl'ESS; KINETS: LITER:
| ICIGS; COBPaBaTirS ITllVAIIOIS:
| IICOSTSIll RIGIEBE; SEaSBBERERT
| ItTBODS; SITIKOJI; 1BSBBIC; CSDBItJB;
I | CISIDR; CEIOBIDR; COB1LT; COPPEE;
| | 60IE; IBOI; UBTHlIiri; LIU;
1 | B1BS1BESI: SnCOBT; BOLYSDEIOg;
I | EBOSPBOSBS: 8V9IDI«R: SC» IDIOT;
I [ 2HEIX1M; SIITEl; TIB: TOBGSIEI;
I | HIC; SMITE R1ZMOS: HDOSTBIll
1 | Enrrs; SBEITEBS; TiLinaitu
r i
1
a) lot gir«n a) 0.01 * or - 0.01 1 at Bales
bj Rot glf«t tg/g (w«t vt) | t) Faailas
b) 0.02 + or - 0.02 I
"3/9 C*et vt) 1 Ftoi a qrcuF of 61 aatopsiea.
1 fcienslc a«Ucal •zaainatiaiw. Japaa.
I S«l«s, Man ag» «0. S rr. Tcaales,
I aaaa aga 37.4 yr.
I HtCE ELIRERIS; 10TOPSIBS; JIP1I;
I itiBini; usEiic; cjsHioa: cosiiT;
| CEEC9II4; COPPBBJ 1801; HBtCOBI;
1 iinaa: aiGiisitjB; uicansE;
1 lOEltm; iiiiROH: scuDioa:
I KlIBCTBi TIIHIDE; TUlDlna; IIVC;
I CC1B; MOBIBE: ill ft; KIOIETS;
| CII!Bt"«.: CltEBEU-OH; BE11I; 809CIES:
I tttctMS: SPtlBI; IOIGS; lOBTl;
I RITUS; COIPUlTIf! ITILUITICHS; SIX;
I fCICISIC RIIICIIE
1-
BZFTBEVCE
lakava, R.
Sazafci-Tasvaoto, H.
ftaano« K.
Tcrai. 1.
1980
accaircf of
EaTlronaeotal aealtk
J5(1):36-«
Braaeff D.
lordberg, G.
Matet, P.O.
1980
Science of tie Total
EDTlronaent 16:13-35
Tnkava* B.
Sazaki-Iasaaoto, S.
laaaOf K.
Tecai, B.
1990
lrcfclr«s of
ZBTlroiiB«Btal Baaltb
3 (1):3«-4«
tsJ
to
(itrt tiGE)
-------
HtO-36-0
itl 121.75, » (30 C. BP 1«3S C, TP 1 aa 89 at «8< C, 10 u Bg at 960
(COITIUBD)
man
35«
•aieteaa
3566
Spleea
ZirOSVH BOOTB
lUlITXCal
BZTICD
II
11
•man
OF CUES
a) C
b) 3
aj 9
b) 3
sues
a) lot give*
b) lot given
a) lot give*
b) lot give*
BE1I
a) 0.01 * or - 0.02
ag/g (vet vt)
b) 0.01 » or - 0.01
ag/g (vat vt)
a) 0.03 » or - 0.08
ag/g (vet vt)
b) 0.01 « or - 0.01
ag/g (vet vt)
etltUL XBTOIB1TXOI
a) lalaa
t) reaalea
ftoa a groan ol 61 aotopaiea.
forensic nodical ezaainatioaa, Japan.
Rales, aeaa aga ao.e jr. Taaalaa.
aaaa age 37.1 vr.
IBICI E1EBEB1S: aOTOPSISS; J1P1I;
•maim: iBsiiic; CISBXVB; COBU.T;
cBiosiua; COPIIB; 1101; BIBCDBI:
1ICCTI; BlGIESinB; BlieillSS:
toEiDiia: iniBOR; SCIIDIOM;
snmii; Tiiiiioi; wiiDioa: ziic;
601D: BBOBIBS: 1ITIB; KIDI1TS;
CIBIBS55; CIBEBCUOB; B11B1; BOSO.BS;
EIBC1I1S; SPlEllj LOBSS; ICBTi;
BITltS; COBPUITITI ITlLVmOIS; SEX:
FCBliSIC BlOICin
a) Bales
t) rcaalaa
fcoa a group of (1 aatopaiea.
focaasie aaalcal ezaaiaatioaa, Japan.
Bales, *eaa aga ao.6 re. Faaalea,
acaa age 37.* TE.
1B1CB ILBBIBU: 1CTOP3IES: J»1B:
ItSIIVIl; IBSIIIC: ClDBtOI; COBUT;
CIIOBIVR: CCEPE1; I BOB; SEBCUBT;
XIDIOB; B16IZSXVB; B1I61IISE;
BVBIDIIffl; 1BIIHOBT; SC1BDZOB;
SILBII1!; TITIBIOI: TlUOIOBi IMC;
eciB; iBOBXit; IITEB.- siniirs:
ciinivi: CMDEILOB: IEIII; HBSCIBS;
piicins; sttni; itiiesi IOBTI;
•ITILS; COBMB1TIVE ETILOITIOIS ; SEX;
ICIBISIC BZEICXBI
BBIEtEICB
Tnkava, I.
Suaki-Yasuoto, R.
laano. K.
Terai. B.
1980
Irchivea of
Environmental Health
35(1):3«-«a
Takava, B.
Suzaki-TasuBOto. B.
aaaao, K.
Terai, a.
1980
Irehivea of
Enrlroaaental Health
35(1):3«-aa
U)
-------
ixeclor 1260
11096-82-5
IUCT rosaou OIKIOII OB aiDCTiiaxi»
ussoe
3567
Blood.
nbola
1
1
1
1
I
ElfOSUBE MOT
1
t
1
1
1
1
immcii
RBTBOD
CC-EC
1
IOHBI8
OF C1SBS
a) 36
bj «
1
1
1
1
SHOE
a) lot applicable
b) lot detected
I IEII
a) 8 ng/g
D) lot detected
GtllBlI. IirOSBmTIOl
>1 1019 Ca»l residents, 1 positire
sinple
B) volunteers
Bean of positive siiplss. Llnlt of
•casareient, 4.4 «g/g
Claselr latched, slnltaneous control
tuples «er« not provided foe
analysis along with those fros the 36
love Canal area residents saipled.
licking leaaingfnl control ot
literature data relative to tie
significance of the lav residues
faand la th« field saiples analyzed.
BO definite conclusions can l« dravn
fro* toe results reported.
lesideits of lew rork. controls.
eiploree* of the Enrironaantal
Protection Igencr anS aiirersity
ttidenta, north Carolina.
Ill 10 K: IOITH CISCtlll! BLOOD;
KaSntraZII BET BOOS; CUlOSItl OKUZC
tcttatns; CHLOBOBiiziiiS;
HflCnOICEEREir; POlICBLOBIHilED
EICBHTIS; POPU11TIOJ EIPOSVII
imsEicz
Bristol, O.I.
1980
EM-MO/1 -90-036, »0
pp.
Irsenic
TMO-38-2
1C
«tl 74.921«, » 817 c at 28 atn, BP «13 c (Biblines), TF 1 nn Eg at 380 c. 10 nn Bg at MO C
N5
1 TISSUE
1
1
1
I j«e
1 tort*
1
1
1
f
1
1
Mood
I EIPOSBBK BOOT
1
1
1
1
1
1
1
1
1
1
: i iinniciL
1 StTtm
ri
I
I
I
I
Coloriietrr
I IOSBSS
1 Of USES
I
1
1 2
1
1
B1BSI
•oge detected
|
1
lot applicable
(IBtl
Bill | Gllllal IIFOBBaTICI
I
|
•one detected | Bales
1
I Tros a gro«p of tt autopsies.
1 forensic sedlcal exasinatioss, Japan.
j Hales, sean age 40.6 yr. resales.
f seas age 37.4 rr.
1
| It ICt cllRIItS; IROFSRS; JIPII;
I lIOBIfM; 1F5ZIZC; C1DJHTB; COBILT;
1 cnonra; COPPEP; 1101; BEBCOST;
1 I IBIS!; giciisna: KaieuzsE:
1 loeiBra; union; scinioi;
f SE1EIIVB: TIIUIOB; nUDIBB; Zinc:
I SCID; Bionit; LITEB; EIDIEIS;
| CIIEBB91: CIHBEIUB; BEIBT; SDSCIES;
| tllCIEaS; SF1EEI; L»CS; 1C«TI;
I amis; CO»FIHTITE ETiioitieis: SEX;
I ICHIStC IttlCIlE
1
1.3 ag/g ( Ceath liTolvisg as. Tiss« speclseos
1 lilt ted 10 SCH casat by prior
1 astoeties.
I
1 ICITB cuotiii: IHTOKI-S: ctBujts:
I errii FOISOIIIG; BLOOD; BOIESJ BBIII;
1 Bill; UTtt; msctBSt sni; »aILS;
I BtimSSltt lETBOSS; BR1LS; TOlEtSlC
\ ciitcm
1
BETEBEBCE
Tekana. B.
Saz«kl-Tass,soto, B.
Isaio, It.
Terai, s.
1980
Ircnires of
En*ixonsental Bealth
35|1):)6-*4
BcBay, l.J.
Bldsoi, B.P.
BolitKj, V.S.
1979
Jonrittl oC Inalrtlcal
Toxicology 3:222-223
-------
•rseilc
7MO-3I-2
If
lt» 74.9216,
Bt 817 C «t 28 ats. H- 613 C (sebUMs). TP 1 aa B« at 380 C, 10 is 89 »t ««0 C
(COR»HED)
«SSOI
3570
BOM
3S71
Brala
3ST2
trail
3573
••it
meson Mtni
iiunxcai
BIT 10t
Color! aetry
I*
Coloriaetry
•mm
or cms
5
2
BUGS
0.1-2.0 ug/g
a) lone detected
b) so»e detected
c) BOM detected
d) < or - 1.3 119/9 (net
«t)
1.0-2.0 ag/g
mi
1.3 ag/g
a) lone detected
b) lace detected
c) Rone detected
4) 0.31 » or - 0.5»
«g/« t««t »t)
1.S ag/g
GEIIUt IIFOBIaTXOI
teatks iavoliing as. lorsals. 0.1
tad 0.2* toy? (secondary raferaace) .
Tii»< specinns Halted in soie
cam by prior autopsies.
11 eikvaed tcdlea baried 2 «k-91 jr.
ICITB cHoiin; tno?siss: CIDITEIS;
eiTlt NISOIIRG; BLOOD; BOISS; EE1I»;
mi; Litrn; TOSCLE3; »ILS: SKU:
iiisvinni BIT BODS: IRILS; FOBEISIC
(IBKIII
a) Hales* cerebral* 13 subjects
k) Vesales, cerebrva, 5 sabjects
c> Rales, cerebellne. 11 aabjects
d) feiales. cerebell.ua. T labjects
fcoa a vcoap of 61 autopsies.
forensic aedical ezaaiBatioas, Japan.
Hales, aeaa aae 40.6 yr. resales.
M«B aqe 37.* yr.
tBICt ILBHtlTS; 1BTOP3IIS; J»P11;
lIOHIin; 1BSEIIC; C1DBIOB; COB1LT:
CBlCHIOl: COPPBE; IBOl; BESCOBT;
IBCIDB: aiGiisiua: IMGHISE:
tiEiDioK: iniROBi: SCMDXDH:
SUKim: TITUIDR; 7HIDIOB; ZIHC;
GCID; BBOBIII; 1ITE1; KIDIETS;
CIBBBBOl; CEBEBEtlOB; BUST; HO SCI. IS:
E1ICRE1S; SntXt; IDIOS; ICBTl;
BITIIS; CO'PIBiTITZ ETlLDiTIOIS; SEX;
KlflSIC BEDICXBE
faaths larolvinq Is. Tissue
iieelsens llaited Is aoae cases by
prior aatopsies.
11 eihased bodies bocied 2 ttk-97 TC.
BCPTI citoiiBi: imopsus: CIDMEBS;
DITIL POISOIIISi BLCOD; BOIES; EB1II;
BUB: llfEB; HOSCIES; SKI I; MIIS;
BB1SOBS1SI1 BETBODS; 1ET11S; FOBSISIC
BtCICII!
ftviev. 2» repreoeitatiTC
Fce-asalTsis treataeats ace
tabelatel. Ihe feasibilitf of a
kclistlc, no-«asli policy for hale
analysis Is eatlised and supported.
BEVIE*; TBtCE I1IIERS; Bill;
IBSTSUII; BElSHBElin SETBODS;
tfllLS; PBOTIIMS; COSPiBlTITI
itiinTiois; iineiioB: HTXHOII:
1ISEBXC; BUIDB; BSOSIBE; C1DBIIB:
cucioii: CBICBXIE; CBROHXOH: COEILI;
CCPPIB; 61ILIOB; GEBBinOHs GOLD;
ICDI1E; IBOl; LlaTBllVB: IE1D;
iieiEsiOR; iiieiiESE; sracnsT;
CCmDEIOH; HCKEL; IBOSPBOBDS;
toiissius; BOBiaiati; SELEIXIH;
SIHCOI: SII1EB; SODXOB; STBCITIDB;
SOLPOB: Til; TXltlXDtl; TOI6S1EI;
IIIC: TIBCOIIOB
BIfllEICE
HcBay, I.J.
Badsoo. S.P.
Baling, T.8.
1979
Jaarnel of analytical
Toxicology 3:222-223
Tukava. fi.
suznki-Tasaaoto. a.
&aano. K.
Terai. H.
1990
IrchiTes of
EnTiconsental Bealth
35(1): 36-4*
IcBay, l.J.
Radso*. H.P.
Boliag, T.B.
1979
Journal of Analytical
Toxicology 3:222-223
Cbittlebocosgh. G.
1980
Science of the Total
Eniiroasent U: 53-75
(HIT PtSZ)
-------
IM0-38-2
if
lt» 7*.921C. IT 817 c at 28 atm, BP *13 C (aabllaea). « 1 » Ig «t 380 C. 10 aa Si *t («0 c
HSSBI
3S7»
«»ir
3575
I«lc
ixposms wot
laatttiox
laaalatioa
1
1
3:16
Stir
amnmi
1ZTBOD
ColoriMtrr
u
r
•VMB>
or cisas
3
*
1
1
Mies
a) lot applicable
1) tot applicable
e) lot applicable
A) lot applicable
•) lot applicable
a) 10.8-76.1 ppa
b) 8,26-11.7 pp>
c) 3.33-K.O J>P«
t) 8.6-63.1 ppa
•) 4.22-12.7 ppa
f) 5.61-38.5 ppa
mi i sunn itrciBitioi i BsreiCTCj
1 1
1 1
1 1
a) C.O 119/4 1 •> <*•* •• ««tr 1 BcSay. l.J.
b) 9.0 «j/« 1 M «*•» 2' »e«lp aalr 1 Hodaon, 8.F.
c) 2T «g/g I c> Caw t, »calp aalr - proilaal I soling. T.S.
tj 10 «j/j I J) CIM 3, acalp balr - U«tal | 197*
«| IS «j/7 I «) Can 3, >aal« 1 Jaanal ot analrtleal
| tmtas livalTtnq >«, T!MM t Taxlcologi 3:222-223
1 *;«eiMm* liilt«4 la IOM caaa* bi 1
1 prior aitocila*. »
1 11 «a«a*d tedl«« 6«ri«d 2 «k-»7 re. 1
i tens citoim; tnorsitss cunmss i
I ittu raisoine; HOOD: BOIISJ BSU»: i
1 Bill: lilts; susciIS; sell: mis; 1
I iiastniHSit iRioas; BETU.S: roiasic i
i ncicni i
i t
1 1
a) lot siren I a) rtoa acaa, steel bconz« >crk«n I claf. J.S.
b) lot gi»«a j tl fcei lead, otMr norkcrs it I sale, I.
cl lot glTea | factory 1 cross, J. p.
dj (at girea 1 c| rrm a«ad, «te»l tcoaie rcrlters at I 1977
e) Hot flT«a 1 ctfcct factories I Journal of tbe SocietT
f) Rot oiren | if mm patlc area, steal broaia 1 of Occupational
I >ctk*r> I MdlclB* 27:102-104
1 <) tmm pabic am. otaar «orkets at I
I tactoiT |
1 f) froa pabic acea, steal brcne 1
I wcikeri at other factories f
1 I
1 letters ID factory ihere arilae 1
f faetorlea, U.K. I
I iiiizd meaci: umrs; MT*I i
r ICIJOiriS; BllB; »I13; CORM9IHTE I
I IH1B1TI01S; IimiSTim HTClni; I
1 iisnic: cisi; HULTB nziBDs: i
| IHIDSItlH IIROSPEEIBS |
i r
t 1
I t r«»iei of «orld literatare ot tie I Jenkitt, D. ».
1 accanlatloa an* blooonceatratiaji of I 1979
I selected toclc tcacw »
-------
Iticiie
1MO-38-2
II
Itl 7«.921C. HP 817 c at 28 »t», BP 613 C (sabliaes). TP 1 •• Eg at 380 C. 10 •• Rg at MO c
(COItliaSD)
1ISSBI
JS77
Mart
3578
Md»«T
3579
Iido«T
iipososs BOUTS
aEURICal
HIT BOB
11
11
11
itmen
or casss
a) 10
b) S
a| 23
b| 3
at 8
b> 9
cl 9
UBSS
a) < Or • 1.* «g/g (««t
•*)
b) BOM detected
a) < or - 1.7 eg/g (Mt
*t)
b) < or « 1.« ag/g (»et
rt)
a) 0.0030-0.01* ag/g
b) 0.0020-0.016 ig/g
c) 0.0020-0.052 ag/g
I«t vt
mil
a) 0.1* * or - 0.«»
»g/g (««t rt|
b) Bone detected
a) 0.1* * or - 0.43
ag/g («et »t)
b) 0.»7 t or - 0.81
ag/» <»et »t)
a) 0.00*0 ag/g
b) 0.0095 ag/g
e) 0.0038 ag/g
let «t
leiiaas
esisui IIPOBIMIOI
a) lales
t) Faialvi
ttoa a groap of Cl aatopziaa.
Coranatc aedlcal exaaiaatioast Japa*.
I<1<«, aetn ag« *0.< IT. F«ul«s.
•cai aga 37.* jc.
nici miens: aoropsiss; JIPII:
itmiioR: iissiic; ciosioa; COBU.T;
ceioiim: CCPPSBI 1101 : RSICOIT;
iirxvi: 816IISIOR: BUGIIISI:
SD3IBIUJ; llHBOiT; SCllDlnB;
snsiiiH; UTiMioB; vinoioR: me:
GC1D; BBOBIII: UTEB; SIDIZIS;
CIBIBinS; ClBEBSUORi HS1BI; HUSCLSS;
limns: sptEE«: miss; IOBTI:
IIT1LS; COSJ1BHITE ETIIDITIOIS; SEX;
fCSHSIC BIOICIHS
•) Ralas
t) T«l«l«s
Troa a group of Cl aatopsies.
fcr*nalc medical •xaainatioos, Japan.
Balas, a«aa ag« »0. 6 yr. ?aaal«s.
iaaa age 37.* jt.
met nsBsns: aotopsisss JIPII;
iiinin: USCTICJ CIDHIDB; coaiu;
ctBOBim: coppiB: xioi; Hiicnsi:
IB tins j siciisiUB; nieiisss:
BdsiDiiia: iBiiROii: sciiDins:
SItSBI0H; TIIMTOB; T1MDXDR: IIIC;
6010; B10HIII; LITBB; HOISTS;
CIBtBBOI: CIBEBBUaH; HS1BT; IVSdBS:
fltCBElS: SPISII; IDBSS: 1CBT1:
IITILS; COBP1B1T1TI ETltOltlCIS; SIX;
ICIIBSIC iinciii
i) Costrolt
k) war liar qroap I
c) lortar gteap II
Caceaaei cafinery aad saelter
vcckars* ag«> 55—76 jcf expoaed to
taaTf aatala 1-3 decaaes. Tiae
betMea retiieaent anl death 0-1. S yr
ia graap I an! 2-19 It, qioaf II.
ceatrols, ages *3-72 yr, iko llni SO
ka froa tb« factory. Sweden.
SBCCIB; CIOITSBS; KIDBETS; IITSB:
UlSSi CORPliHItl 1T1101TIOBS:
IIDCSTH11 II6ISIS; RSISOSERIBT
SIIBODS: 1BTIBOII; IBSEBIC; C1DBIOB;
ClStdl: CBBCHIOR: COEltT; COPPBB:
COLD: IBOB; X1I1R1IOB: IBID;
B1B61BUI: SIBCUBT: HOITBDZBOB;
iiospioivs: BOBiDiua; SCIIDIOS:
EILZBIDB; SXIYiBi TIBj laBGSTSI;
tnc; HSttTl UZ1BDS; IIBBSTBIll
EIIITS; SREIIEBS: TStmiOl
ESnUBCS
lakava. H.
Saiaki-Tacaeoto, R.
taano, K.
Teral. R.
1*80
Irehives of
EBTlrooaentsl Health
35(1):36-«»
Yakava. H-
Soiakl-Iasaaoto. R.
laano. E.
Terai, B.
1*80
arcaivea of
BDTiroiaectal Healtk
35(1|:3<-*«
Brana, D.
Vordberg* 6.
Mater, P.O.
mo
Science of the Total
CnTlronaaat 16:13-35
-------
manic
74*0-18-2
a*
att T*.921C. «P 8IT C at 28 ata, » 613 C (artliaex) . TP 1 aa If *t 380 c, 10 » B« «t **« C
(CORIIITED)
IISSffB
3560
LlMr
3!»f
Ilmt
BZF031BI SOWS
1
immClL
IRBOD
(1
11
(
1
1 3S82 f Colorlaetrr
1 U»er 1
( I
i r
101 em
or ctse
«> IS
b| 8
t| 8
b) 9
c) 10
8
t
1
BMOE U1I 1 EIKU1 IirtJtBlTIOB I SttttXICt
1 1
a> < or - 3.3 ag/g (mt al «. » + or - 0.»S I •) Bal« I Takava, 8.
rt) aa/» (vet «t| 1 It ?«••!•» t S»«W.-raanaota, 9.
») COM tetceted b) ROM *etect«d I 1 *nao. !.
1 rcoi i Troap at SI Mtapai**, I T«r»i, 1.
1 fomdc Mileal «x**ln«tioBs> Japan. I HBO
1 Bil«i, •••• aq« «0.6 rr. r«al», 1 irchires of
1 nu *v> 3^'* rr- 1 ZDTlcg»eBtal Jtalth
1 ( 35<1)i3«-«»
I «ICE taettrs; tmotsitst jwti; i
J liealOTI; IISHIC; CIDnVI; COSU.T: 1
i cnonoi: oo>m: IBO»S BSKOEI: i
I i»iva; sioMsitja; BUGIIBSI; i
i tviigiim: I«TUO»T; sctmim; i
I sniim: Timrtw; nuozvi; z»c: i
I sen; Btoaiii; IITEB; KIOIETS; i
i ciiuan: cnnriLOB; IBUT: SOSO.BS: (
1 Micsus! SPIHI; IDKJS: tont: I
I srms: coapiiinn iruomoTS; six: i
| KinSIC VEDICtK 1
> i
*> 0.0019-0.013 •«/«
fe| t.0030-C.(»J >g/4
C) 0.0020-0.0050 04/9
let lit
2-SS ig/a
1 1
a) 0.0030 09/9 1 «l co.troJs r Sraa*. 0.
b) 0.0085 ay/g r t) larkec fccan I 1 tortbarg, 6.
c) 0.0**0 «j/g | c) forkar grcop II 1 lestM, S.O.
rat «t I 1 W80
Hediaiu f X«c«as«d r«£in*ry and *a«lt«c I Science of tfce fotal
| «ort«n, a««* 55-76 fr, aipoced to 1 tn¥lcoo«ent 16:13-35
I «g«x 1J-7J TC, iia llnd SO (
I ti fcea tie laetarr. Svaaen. 1
1 1
1 5«lt!«; cm»E8S; KioiRSi lirfs: I
1 tnes: COBPISKITI miuiiois; i
| IJMSTBIU BIGIHB; B!lSti!Bt»T I
f HttOOS; IRUOir; USZVIC; ODHBB; I
cisiai: cBBoeidd; COULT: COPPH.- I
coit; iso«: unBHns: uio: i
FJIGIIISB: mean; BotiBDUm: i
taaspvnvs; BOSIDWB: sciinra; i
smiiaii; sitfre: TI»: Ttrissrjs; I
ZIIC; g»HB BaZIEOS; IHDttStEIll |
TllltS; SRItTEBS; 1XUQHV8 1
1
13.6 09/9 tcath* i»»ol»ioq it. taimtlt, 0. OS 1 BcBay, l.o.
aid 0.2* 04/4 (aecoataiT referance). I Badaoa, P.P.
Ilane speclaeaa Uaitel la soie 1 Bolinq, r.B.
c»e* br prlcr aatoasiea. 1 1979
1 Joicnal of mlrttcil
It eskaaad bcdiea bortel 2 rt-*7 rt. 1 Toxlcoloar 3:222-223
t
ICBia CIIOITU; 10TOPSIIS; C101TKS; I
sun POISOIIK3: aiooi; BO»S; miij i
Bill: UTtE; BUSC1ES; »»HS; sri>; 1
•tisninn IRBOKS: SHT*I.S: rosusrc i
ttnatt i
i
(KIT PIGI)
os
-------
linilc
7MO-38-2
II
»t» 7I.921C.
BP 817 C at 28 ata. tt 613 c (snMiMS). TP 1 •• 84 at 380 C, 10 a* Hg at atg c
(COITHDBD)
1ISSTJE
3583
lung
358*
Ing
3585
Raacle
EIPOSOBB S001I
luinictt
BXTBOD
It
Ik
U
IHBESS
OF CASES
a) 5
b) »
a) 9
b) 13
0 22
a) 5
b) 10
URGE
a) < or • 5.3 99/9 (wet
*t)
b) < or » 0.5* ag/g (wet
•t)
a) 0.0010-0.018 ag/g
b) 0.023-0.013 ng/g
c) 0.01»-0.21 ag/g
let "t
a) < or » 0.50 ag/g (wet
"t)
b) < or * 0.85 ag/g (net
Wt)
Bill
a) 1.3 * or - 2.3
ug/g (wet wt)
b) 0. 1« » or - 0.27
ug/g (vet lit)
a) 0.0080 ag/g
b) 0,013 ag/g
c) 0.0*8 ag/g
Set *t
Bella as
a) 0.10 « or - 0.22
ag/g (wet wt)
b) 0.09 « or - 0.27
vg/g (vet vt)
etIZBlI. IIFOXB1TIC1
a) Rales
I) Feaales
It am a groap of 61 aatapsles.
forensic nedieal examinations. Japan.
Bales, aean age «0.6 yr. Feaales,
aean age 37. a yr.
IB1CZ ZIZBI1TS: HJTOPSIBS; J1P1I;
noiiim: iBszvic: ctsaioa; COBH.T:
CHORUM; COfPSB.: IBO«; BEBCOBT;
IICIUB; BlGHlSIHB; RafGkBlSE;
IIIIIXDR; JITIBOIT; SCSIDIOB;
GCIO: BKORIIZ: IITZ8: KlfilZtS;
CIBZEKD!!; ClfEBZUOB: HE1BI; RDSCLBS:
fllCBZAS; SPlEZ-Ij 1QBGS; AGBTk;
BIT11S; COBP»B>TITS ZTUD1TIOI5; SBX;
ICBIISIC R1CICIIZ
«) Controls
t) Vorker gccqp I
c) Vorker grcnp IX
leceasai refinery and snelter
•crkers, ages 55-76 yr, exposes to
teavy aetals 1-3 decades. Tine
tctmea retireaent and death 0-1.5 yr
It group I and 2-19 yr, group II.
Ccntrols, ages 13-72 yr. vho lited 50
ka froa the factory. Sweden.
StZDZl; C1E1TZBS; KXDIZTS; 1ITEB;
imest coapiBiTiT! zTiigiiiois;
XlCISnill. BTGIEIE: BE1SDB1BUT
iHHons; imsovi; iismc: cmaioi;
cisnm; c HBO sio a ; CCBIIT; COPPII;
COII; IROI; HHIBIIOB; LEU;
E1161KS1: BtECOBY; B01TBDIIOB;
tlOSPBOBdSi BOBIBinB; SCUDIOT:
SKZIIM: SIITIP. ; ?II; TBiGSltM;
IHC: BZtlTB B1Z1SBS: IHIOSTBIil
PltHTS; SBZITEBS; TILLnBlOR
» Bales
t) resales
Iroa a groap of 61 autopsies.
forensic nedical exaalnations, Japan.
Bales, nean age «0.6 yr. Fcaales,
aean age 37. (1 yr.
isict SLHiiiS; inTO?sizs: JIPSI;
iicBi»oa: iKszmc; UDBIDB: COBU.T:
CBIOBiail; CCPPXB; IBOI; RZBCtBT;
IICIOR: »«isx0fl: BIIGIBZSZ:
BDBIBMl; 1IIIBOK; SCiUBIDB;
sttzixtii; TIUIIDR: TiiiDioa: znc;
GCID; B30BIII; IITIB; KIDSSTS;
CIBEBR31; C1EEBEXLOB; BJiBI; BOSC1BS;
PlICKIS; SPIZZI; LDBGS; 10B11;
BIT«LS: C09P1MTITZ BTlLDtllCBS: SEX;
fCIZISIC BECICI"!
BZFEBEBC5
Takava. H.
Saznki-Iasaioto, a.
leano* K.
Terai. 9.
1*80
archives of
iBTiconnental Bealth
( ): »«
Brane, D.
•ordberg. G.
•ester, P.O.
1980
Science of the Total
Environaeat 16:13-35
Yakava, n.
SvznU-Tasaaoto, a.
laano, 1C.
Terai, S.
1930
irchires of
XnTlronnental Health
35(1):36-«»
(KIT PIG!)
IS3
VD
-------
Itsenic
m0-38-2
Ai
Its 71.9216. IP BIT C at 28 at.. BP 613 C (sublines). TP 1 an Bg at 380 c, 10 •• 89 at 440 C
(C01TIIDBD)
TISSUE
3586
Bnscle
3587
Hall
3588
Bail
BXPO30BE BO01B
Ingestlon
Inhalation
ABA1TTXCAL
8ETBOD
Colociaetry
u
BUBBBB
OF CASES
5
9
BAHGE
0.8-5-0 ug/g
a) 15.0-188.0 ppi
b) 0.97-6.00 ppn
c) 6.45-53.3 ppn
d) 10.8-60.9 ppn
e) 2.98-4.81 ppa
f) 1.06-5.79 ppn
(BEIT
BBaB
3. a ng/g
a) Bat given
b) Bat given
c) Hot given
d) Bot given
e) Bot given
fl Bot given
•
PASE)
GEBIBAl IHFOBBATIOB
Eeaths Involving Is. Bornal, 0.43
ug/g (secondary xefeieDce) . tissue
steclseas United in sone eases by
prior aotopsles.
11 eihued bodies burled 2 «k-»7 vr.
Case adnitted to eaergency roon «itb
gastritis died 1 day later after
x«eoning cyatotic and Incoherent.
ICBTR C1BOUBA; IIROPSIBS; C1DȴEBS;
BITU POISOIIB6; B100D; BOBBS; EE»IB;
BIIB; iiTEB; aoscus; SRTB; i»ns;
mSOBESBST BBTHOOS; RBTA1S; T01EBSIC
BIDICH?
_
a) Fron linq«rs, steel bronze workers
fc) Icon fingers* otber workers at
factory
c) Fron lingers, steel bronse norkers
at other factories
1) Fron toes, steel bronze workers
e) fron toes, other workers at
factory
f) Fron toes, steel bronze vcrkers at
ether factories
Icrkers in factory where arslne
poisoning occurred and in other area
factories, O.K.
OBI1ED KIHGOCB; ADULTS; BBI1I
fOlSOBIBC; BUB; B1I1S; COBPtBlTIVE
IltltUTIOBS; IHDOSTBU1 HIGIIBB;
IBSZHIC; COST; BUITR B1ZABDS;
IIDOSTBIil limSPRBBES
.
1 review of world literature on the
accnnolation and bioconcentcatian of
selected toxic trace netals in ho wan
hair and nails and other nannalian
hair, far, nails, claws and hoofs.
latnlated ty geographic area.
subjects, sei. age, exposure
gradient, analyses in ppn. and
authority frcn over 100 references.
JFSICM IOSTBU.I1: ClBADl; CEHTI1L
IB1BICS; IOBOP8; KIDDIE EAST; BBS
1I1IABD; SOOTH ABEBICA; 500TBEAST
1SIA; OHJTED ICIHBDOB; OH IT ED ST1TSS;
BIIB: BAILS; BETIEW; ABTIBOBy;
IFSEBIC; EOBCB; CADIIDfl; CBBCBIOB;
CCBALT: COPPIB: IEAD; BSBCOBI;
BICKEl; SELIBIOH; TIB; TABAOIOI); AIB
ECIIOTIOB; ABIIAl POFOLATIOBS;
EICACCnaDIATIOB; BIOISDICITOBS; LAHD
ECIIOTIOB; POPDLATIOH EIPOSOEE; B4TBP
ICIIDTIOB; TBACV 31EHEBTS; BETAIS
BEFEBEBCE
IcBay, A.J.
Badson. B.P.
Doling, V.B.
1»79
Journal of Analytical
Tozicology 3:222-223
clay. J.E.
Dale, I.
Cross. J. D.
1977
Journal of the Society
of Occupational
Redlclne 27:102-104
Jenkins. D.W.
1979
EP1-600/H-79-049, 18«
PP-
LO
o
-------
7MO-J8-2
It
Itl 74.9214.
IP 817 C at 28 ata. >? 613 C (sablises) , TP 1 »• tg at 380 c. 10 •• Bg at MO C
(COBTI1DED)
TISSUE
3589
tancreas
3590
Skia
3591
Spleea
EIPOSUBS SOOTE
lllLTIICll
UTBOD
n
Coloriaetry
11
IflaBES
or cisss
a) 8
b) *
4
a) 10
b) 6
SIR6B
a) < or - 1.3 ag/g (mt
b) loae detected
0.4-1.0 ag/g
a) < or - 0.5S ag/g (vet
b) lane detected
BE1I
a) 0.28 * or - 0.48
ag/g (*et *t)
b) lose detected
0.66 og/g
a) 0.07 + or - 0.18
b) loae detected
Gtlliai IIFOiaiTIOl
a) Bales
t) resales
Icoa a groap of 61 autopsies.
forensic sedical exaaiaations. Japan.
Hales* seaa age 40.6 yr. resales.
aeaa age 37.4 yr.
TBICE ZLBBEHS; aUTOPSIZS; JftPIV;
IIOBIIUB; IBSEIIC: CiDBIOB; COB1LT;
CflOBIUB: COPFBB; IBOI; HEBCOBT;
litiuB: aaeiEsiai; aiieiisss;
IltlDIVH: alTIROR: SCIIDIOB;
s ii nua; TiHiioa: Taiaoiui; zitc;
ecu; BBOBIIB; LITIB: KIDIBTS;
C1IEBBHB; CIIEBI1LOB; IUBT; BUSCLIS;
titcftEiS; SMi«»: lines; ICBTI:
IRUS; COBCUHITE ETILUHOCS; SSI;
fCIEISIC IICICIIE
Ciaths iavoltiag as. lorsal 0.59
«g/g (secondary reference) . Tissae
speciaeas liaited in sone cases by
flior antotsies.
11 exhaled bodies boded 2 «k-97 yr.
ICIta C1B01II1; 1UTOPSIES: CIDtfESS;
BlTll POISOII1G; B1000; BOIES; BB»IW;
C1IS; lira; BOSC1ES; SKIB; I1IIS;
aiisnBtim HZTIODS: anaLS; FOBEISIC
itDicias
a) Rales
t) Feaales
Iroi a qcOBf of 61 autopsies.
forensic aedical eiaaiiatieu. Japan.
Bales, nean age 40.6 yr. resales.
scan age 37.4 yr.
Tiaci niazixs; mofsns: JJPAS;
iimnna: USEIIC; cinaiaa: cosui;
CIICRIOR: CCEPEB; IB01; REBCISI;
liriOH; RIGIESIVB; ItlSaiESE;
iiBiomi: niiRoiy; scaroioB;
SZIEIID9; TIiatlOR; flUDIOB: ZIIC;
eett; Bsoaiii: IIVEB; KIBBZTS;
cisiBtan; CZIEBSUOR; IE1IT; ansciES;
EllCSttS; SflEEl: LDieS; 10BU;
BIT IIS; COBPaBlTITE IT»10«IOIS; SZI;
ZCBZSSIC BZtlCIIX
BZRBEICI
Takava, B.
sazaki-Tasaaoto. a.
inaao. S.
Terai. B.
1980
archives of
Eavironaeatal Health
3S(1):3«-4*
RcBay. a.J.
Hudson, I.;.
Boliag, T.E.
1979
Joaraal of analytical
Toxicology 3:222-223
T«ka«a. R.
Sazaki-Tasasoto, Hi
asaao. K.
Terai, a.
1980
archives of
ZiTironsental Bealth
35(1):3«-aa
IIEIT
-------
Irscnie
7M9-38-2
la
lt» 74.9216, HP 817 C at 28 at., BP 613 C (subliaes), TP 1 >• Bg at 380 C, 10 mm Bg at MO C
(COITIIOZ9)
IISSOI
3592
Brine
EIPOSOB! BOOH
1
minion
OTBCD
j
IOHBZH
OF C1SSS
1
tuet reii etizsiL IIFOIBITIOI
a) lot glttm a) 0.8 ag/g •) 9 ratal etildne, inarganic 19
b) lot givca ereatlaina t> 1* cklldm ILiiiq < 1 ka froa
c) lot 9iT«« b) 2.2 ag/g . 2.5 ka froa aaalter.
f) 5 ag/g creatinina tetal Is
I q) 7 ag/g creatinine f) 21 riral bora, total Is
1 Mdlans 9) 22 riral girls, total Is
c)-g) estiiatatf froa graph
Seaool-aga enlldran living naar Pb
sialtar in Ealgiaa. Controls fron
IlieilftSl; C.DBI08; USIIIC; 1SSZIIC
CBS1IIC COiPCOIDS; CBI1DBBI;
iiDosmn. iisosrszsts: SRZUZBS;
tlTUS; BIOOC; ni»; B1LGIOH;
fcpuiiTio iiPosnBi: iniu isiis;
| UIE1B 1RZ1S
1 1
3593 US 1 30 a) 7«-93» ng/1 a) 3«7. 0 ag/1 I a) Iiposad icrkers, 1G-11S technique
1 Urine I 1 bj 91-9S3 og/1 b) 368.8 ug/1 t) Biposad wcrkers, ET-115 technique
| lie) «.»-23. 9 ng/1 e) U.5 09/1 e) Controls, 1G-11S technique
| | d) 6.5-42.5 ng/1 d) 18.66 ag/1 «) Controls. ET-llS technique
III e) 6.9-25.6 «g/l e) 14.73 ug/1 «) Baaitarrnnean sorters, 1G-11S
| | | f) 36-1180 og/1 f) 382.6 09/1 t€Ckniq««
I I g) 15.5-113.1 ug/1 arkars excoscd ta Is203 and S
centrols. 10 Hedit«rra»aans, 10
Klglaa, totb possiblr •zposed to
inorganic Is bat diffarant lisk
ccnsasption. Data arailabla for
velsntaars and attasptad saicidas.
EHSlm; HE HE; COSP1HTIYI
iTiiDiTiois; nismmi HEIBOOS;
IBSnlC; IBSIIIC OI61IIC COaPOOIDS;
tuts; iiDosttlu puras: IIRBU
(IT1BC1ISB
SEfEBEHCE
Backet, j.p.
Foals, B.
laawarra, B.
Braaax, P.
Claars-Tkoraaa, !.
lafontaina, 1.
Verdarn, G.
1980
Invironseatal xasaareb
22:95-108
ncket, J.P.
laanarrs, B.
eels, B.
980
ateraational Irckivas
f Occupational and
nvironsantal Haalth
6:11-29
-------
U»lM
778»-»2-1
II-B3
Bl 77.93. » -117 C, B* -«2.S C
TISSUE
359*
Mir
BIPOSOBZ BOVTZ
InhllltiOn
iiiLrricii
RETROD
IORBZB
or CISBS
«
11KI
•) 39-216 ppa
b) 22-107 Hi
HZ1R
a) 107.3 ppa
b) 18.3 ppl
GEBisiL iirosBancR
•) Iftar 9 flays, loot sagiant
b| >it«r 19 days. 0-1 cm Ito» root
50-51 yc old sailor*.
»«»«r, Matacsa, naasaa, toiitinq.
diarrhaa, abdoainal pain.
BfBoqlobinaria, iatravascular
haiolysls. aarroa leprcssien.
ttioibocTterania. reaal failure.
ptiipliaral utoropatky-
ustmc; BUI; occnpi-ioiii HIUBDS
SEiEincz
slUlnson. s.P.
RcHnih, P.
Borsloy, S.
Tobba. R.
le»ls, 8.
Thooli. 1.
Mnterton. H.
Parsons, V.
Vllllaas. B.
1975
British Radical Journal
3(S983):559-5«3
Irsifta oiide,
Irslalc acid.
C2-B7-1S-O2
Bl 137.99. RI 200 C
- (9 CI)
(8 CI)
1ISSU!
3595
aria*
BltOSOBS BOOT I
aiumcii
BFTBCD
IOHBZS
or cisss
a) 9
b) 1»
tlBSt
a) lot gi»«n
b) lot gi»en
SE»«
a) 9.2 ag/g
croatinine
b) 11.2 09/9
cr«atlniae
S1I!B»L mOBHlTICI
a) Bncal ehlUrea
b) chiHren near sa«lter
Sekool-aije ehildraa liTinq »«ar tts
ciclter in Belqiua. Control* froa
meal aad arban araas.
R1I6IKSZ; CIE8I05; »SmC; 1RSEHIC
GfSirtC COITCTODS: CHI19RII;
IBDDSTBItl IHOSPBSS1S; SBI1TZBS;
BITtIS: BtOOC; UBIIS; BILGIBB;
ICIOL1TIOB IITOSORB; »DS»1 1BZ1S;
DIEII 1BI1S
BirZISBCI
Bucket, J.P.
Eoels, B.
Laanrys, B.
Brnaax. t.
ciMTs-Thoraaa , r.
lafontaina, a.
Terdnrn, 6.
1980
ZnTironaeatal Research
22:95-108
UJ
u>
1tbastos
1332-21-t
IIICT coiposinoi amo*B OB OBIZTZBRMZD
nssm
3596
Gastric
liqola
BIPOSOB! BOITE
HI1LTTICH
BITBOD
Bicroscopy
BVBBSB
or cisss
13
S1BGI
0-2500 ferraqluoas
todies/20 il
(BEXT
BE1B
Hot 9iTen
?1SE)
GZIIBtl IBrOBBlTIOB
33-72 rr olds nit! 1-50 yr
occapatianal axposora
ISBISTOS; OCCUPlTIOItL H.Z1FDS;
IUBSS; ISDOS1BHI 1TSOSPBZBIS; DOST;
II>BCB
lErZBEECI
Biqnon, J.
Sebasties, ?.
Bonchaoz, G.
Boanaad, G.
197*
IBSZBR 29:205-218
-------
ItbeStOS
1332-21-*
IUCT coBfosmoB nno» 01
(COBfttDZD)
IISSOB
3S97
Gastric
llqaid
3598
Intestlae
EXfOS«n BOOM
lagestlos
1IUYIIC1L
BETBCD
Biereseopv
IB
I0BBEB I1ICI Bill | CHIllt IirOlBllICl
or CISBS i
i
a) 0-158/20 nl a) lot given I a) lorkers hiadllaq raw asbestos
b) 0-»/20 al b) lot given I t) lorkers aaat factoring aabestos
c) 0-3/20 si c) lot given j [rodacts
I e) lorkers exposed to sized
1 iadostrial dgsts
1
1 33-M vr olds, »ith varinos disease
| occapatioaally exposed to asbestos.
1
| JStlSTOS; OCCOP1TI011L B1Z1BOS;
1 iciss: occnpiTiont oisusis:
I 1CTOPSKS; IIDOStlllL 1TBOSFITEIIS:
1 IQSI; nilCf
1
a) 21 a) not gives a) 150.0110 (!-5) I a) Controls
b) 32 bl lot given fibers/a I b) lesidents wlta long tern, bigb
b) 1«.3i10
-------
libestos
1332-21-*
IHCT coBposmoi omoiM ct OIDITHHIKD
txssoi
3600
larynx
3601
liver
3602
mag
3«03
HBO
n*OS01J BOOT!
Inhalation
Ingestion
iiunicai
BETBC8
n
licroscepy
n
HI
Bicroscopy
BDBBEB
or cists
2
a) 20
b) 32
1
13
fllGI
a) lot applicable
b) lot applicable
a) let gives
b) lot given
a)
1.4x10(1*7} -3.3x10 (E»71
fibera/g
b)
2. 7x10 (E+7) -6.5x10 (E+7)
fibers/g
Dry »t
lot deternined-200,000
ferruginous bodies/en cs
Hal
a) 590 fibers/eg
b) 3600 fibers/ig
Dry vt
a) 153. 5110 (!-5)
fibers/g
b) 32. «1 10 (1-5)
fibers/9
Ish »t
a) 2.1x10(1*7)
fibers/9
b) 3.9x10(1*7)
fibers/g
3FT Vt
Hot given
6HI11L IIPOS81TIOI
a) Patieat 1. Fiber eea> length 2.»
a, Man Planter 0.08 a. Bate
ctiT'Otile thu aiphlbole fibers, lo
femgieaoc todies
l» Patiemt 2. Fiber Bean length 3. «
i. Bean lianeter 0.1* n. Bore
aapiiaole tkan chrysotile fibers
lorsal tissue.
fatleat 1. age SI yr. Exposure
tetceen aqes 13-15 Tr in welding
factory and tetveen ages 20-10 Tr as
electric arc Holder. Patient 2,
EBoker, aqe 51 yr. HeaTy exposure in
asbestos ceaeat plaetv pre-Vorld Var
2.
EneBsoeoBiosis. bronchitis. Benign
polyp on vocal cord (Patient 1) ,
sqoasoes cell caiciaoaa of larynx
llatieet 2) .
long opacities, costopkrenic angle
obliteration, plevral »all thickened.
FIHCt; ItDITS; CIS! HISTOBI1S;
IIDOSTIIll DISBISIS; M10PLJSBS;
CCCtlflTIOIll DISE1SES;
BHD10COBIOSIS; IHISS; 1TBPB BOOZS;
Eioiccninimoi: nsras; IIBH»TIO«:
1SEISTOS
a) Controls
b) Residents «ith long tern, high
level exposare troe drinking
centeniiated «ater
Chrysotile fibers
latopsies
52-S9 yr old resideats near taconite
riocessiag plant, Binaesota. 17-77 yr
eld controls. Minnesota and Texas.
B11IZSOT1; HUS: 10TOPSIXS:
iiiiSTiiis: urn: LOIGS; DSIMKHG
IITIB; IKtlDSIBIlI SBISSIOSS;
I1DOSTRIH FCIIDTI01; S1TIB
tCIintlOI; 15BBSIOS
a) inalyzel at Dniversity of Cardiff
t) Analyzed by laboratory in Paris
Earencaysa ftoa case of pleura 1
scsothelioia
lOlISS; ISEZSTOS; IE07L1SBS;
CCBFIIITITI ETllOaTIOIS; BK1SUBEREH
BIIBODS; FBItCB
33-72 yr olds «ith 1-50 yr
occapationl exposare
ISBtSTOS; OCCOP»TIO»ll HlZiBDS;
10I6S; IIDOSIBIal ITBOSPflEBES: COST;
ItlKt
(BUT P»Gl)
SIFEBEICK
Birsch, a.
Bignon, J.
Sebastien, p.
Candichet, a.
1979
CBIST 76:697-699
Carter, S.I.
Taylor, ».?.
1980
Environnental Be search
21:85-93
Sebastien, P.
Billon, n.J.
Janson, X.
Bonnand, fl.
Bignon, J.
1978
archives des Maladies
Prafessionnelles, de
(ledicine dn Travail et
de Secorite Socials
(Paris) 39(»-5):229-2»8
Biqnon, J.
Sebastien, p.
Honchaax, G.
Btibnaad, G.
197*
IISEHB 29:205-218
-------
Ifbestos
1332-21-4
IIACT COBPOSmOl niKSOJI OB BISZTE8BIBBB
1ISSDE JMOSOBS SODTB AIAITTICAL lOaBSB IAIGE | BEAI | CBIMI1 IIFOB8ATIOB I BMBBBBCJ
BSTHOB 0? CASES 1 1 |
1 1
3604 IB 1 1.5-3x10(1*6) ferruginous
long bodies/cc
1
1
1
3605 Bicroscopy a) 200,000-700,000
lung fibers/cc
b) 85-135,000 fibers/cc
1
1
1
1
I I
1 1
3606 1 I Sicroscopy 5 «4- 7,840 asbestos bodyyg
lung 1 1 1 (vet vt)
1 1 1
1 1 1
III 1
III 1
II 1 II
II 1 II
11 1 II
II 1 II
II 1 II
II 1 II
II 1 II
III II I
lot given I Intopsy saterial | Sebastien, P.
1 1 Janrand, B.C.
I Occnpationally exposed «6 yr old vith 1 Bonnaad, G.
I flenral nesotheliona. | Gonl, J.
1 I Signon, J.
| ASBESTOS; OCCOPATIOIA1 B1ZABDS; 1 1973
I 10IGS; AOTOPSIBS; BEOPIASBS; FBAKE I Archives des Baladies
1 | Professiognelles. de
1 t Hedecine du Travail et
1 1 de securite Sociale
1 1 {Paris) 34(6) :335-344
1 1
a) lot given 1 i) (orkers handling rav asbestos
b) lot given I r) (orkers nanufacturlng nsbestos
I (toduets
1
1 33-16 yr olds, vith various diseases
I occupationally exposed to asbestos.
| ASBESTOS; OCCDPATXOIAL BAZABBS:
I IDIGS; OCCOPATIOIal DISEASES:
I IBTOPSIES; HDOSTBIAl ATBOSPBEBBS;
I COST; FBAICE
1
1
lot given I Averages of upper and lover lobes, «
I or - 1 SO. Autopsies.
1
1 3 forser asbestos pipe insulation
1 vcrkers and 2 patients vith
1 asbestosls, lung cancer and pleura 1
I aesothelioaa. Ages 48-73 yr.
1
| ACTCPSIES; CCCUPATTO1L HAZAIDS;
1 IIOPIASHS; DISEASES: ASBESTOS; I TIKIS;
| IICTIT
1
III II 1 1
1 3607 | 1 Bicroscopy 1 1 a) 1-20 ferruginous 1 a) lot given I a) 41 eases
1 lung II II bodies/cu a 1 b) Dot given I r) 38 cases
1 1 1 1 | b) 21-100 ferruginous I c) lot given I c) 18 cases
II 1 II bodies/co • 1 d) lot given I 4) 3 cases
II 1 lie) 101-1000 rerrugiaous I 1 lo significant correlation vith sex
III 1 bodies/cu a 1 | or occupation. * of cases vith
II 1 Id) >1000 ferruginous 1 1 21-100 bodies/cu a increased after
III 1 bodies/cu s 1 1 age 60. • of cases vith highest
III 1 1 density decreased after age SO.
1 1 1 24. 7« of cases vith highest density
1 1 1 lived in Paris.
1
Autopsies, 13-91 rr olds, rural and
urban areas, France.
lelatlonship vith lung cancer eannot
r« accurately analyzed because 9M
vere snokers.
TlllCt: 1COIISCEITS; ADULTS; AGt;
AUTOPSIES; nopiASBS: IHIGS:
ASBESTOS; ATBOSPRni: BU11B HI! AIDS;
1IBA1ATICI
1
1 Chatel. A.
1 Blgnoa, F.
1 Sebastieo. p.
1 ftlrsch, A.
, 1 Bignon, J.
1 Bader, J.-p.
1 Chretien, J.
1 1978
I 2:459-464
1
1
1
1 Soggli. T.I.
1 Greenberg, S.D.
1 Bclarty, J. I.
1 Burst, G. A.
1 Spivey, C.G.
1 Bieger, I.B.
1 1980
j Archives of
1 otolaryngology
1 106:533-535
Bignon, J.
Goni, J.
Bonnaud, G.
Jauraad, H.c.
Dufour, G.
Pinchon, B.C.
1970
Enviroasental Research
3:430-442
(HIT PAG1)
-------
Itbe*t03
1332-21-*
IIICT couosrnoi irinofi as OICZTEEHXIED
iissdl
3608
lang
3609
lung
3«10
long
3E11
Loag
IIPOSDIE iOUTf
lageatlon
Inhalation
Inhalation
Inhalation
*»LT1ICU
SBTHCO
EH
EH
Hicroscopy
EH
WO«BU
or cis 33
a] 20
b] 32
1
9
a) 22
b| 22
O 22
d) 12
e) B
fl 1*
(USE
a) not given
h) lot givea
a) lot applicable
b) lot applicable
1000-10 f!*61 ferruginous
bodies per en ci
a) lot giT
b) lot giT
c) Sot giT
d) lot giT
e) lot giT
f) lot giT
IE11
a) 570.6110(8-5)
Cibers/g
b) 11«3. 7110(1-5)
tlbers/g
ish wt
a) 46 ferruginous
bodles/ag
b) 3500 fibers/ag
Dry »t
•ot given
a) 3.7 » or - 1.8
fibers/ng iast
b) a. s * or - 2.5
Eibers/ng dost
_S) SO * oc - 81
fibers/ng dnst
I) 171 » or - 201
fibers/Kg dust
e) 322 .or - 351
Cibers/ng list
() »55 * or - 502
fibers/ng dust
GEimL IIPOBHUIOI
a) Controls
t) lesidents with long tern, high
level expoiin froa drinking
coataaiaated water
CtrvsoHle fiber*
1 1 tops lea
S;-8« jr oia residents near tacoaite
rcocessiag claat. linnesota. 17-77 11
eld controls, linnesota and Texaa.
•XIIESOIa; TIUS: IDIOPSIES;
IlttSTUtS: UT»; tDIGS: OBIVKIie
Itini; ISDUSTKIII BBI5SIOIS;
IICDSTSIil fClLOTIOl; 11TEE
IOIIOTI01: 1SBESTOS
liter aean length 2.8 a. Bean
diaaeter 0.13 a. Hore asphibole thaa
chcisotile fibers
tulaomary parenchvaa staples.
51 vr old patient. Exposure between
age: 13-15 vr in welding factory aad
tetweva ages 20-40 vr as electric arc
*il4er.
Paemocoaiosis, bronchitis. Beaiga
tcltp on Total cord.
long opacities, costophreaic aagle
cfcliteratioa, pleural wall thickeaed.
rtllCE; ICOIIS; USE HISTORIES:
IIOOSTBIH DISUSES; IIOPLIS8S;
CCCOTJTIOlll DISUSES;
fiioiocaiiosis: imrcs; LTIPB VODES:
EioiccointiTio": FIBIIS; ifBiniioi;
JSEISTOS
tata correlated well with ember of
fibers in spotaa.
labestos wocters. teao. age S4 vc.
1C1ICE; ID011S; IESPI1ATOBI
SICSETIOI: IIDU51BHL HTGIEBE:
ISEESIOS: OCCOP4TIOSH. HaZlBCS
a) loraal tissue
t) Spoataneeac Maathellona
c) Occipatioal aesothelioaa
d) isbestosle with aesothelioaa
e) tsbestoai! with bronchial
carcinopa
ft labestosis
OccapationallT exposed workers.
Cersanv
6ISB1IT: lOTOPStES; I»DtJSTBI»L
CISEISH: iniSS; tSBESlOS; flBEIS;
J1BIHTIOM; CCCOP1TIOIII. BiZlEOS
BEFEHEIC1
Carter, B*E.
Tavlor, i.f.
1980
Envlronaeatal B« search
21:85-93
Hirsch, 1.
Eigaon, J.
Sebastien, P.
Gaadicbet, I.
CBSSt 76;«97-699
BigaOB, J.
Sebastien, P.
Jaurand, fl. C.
He*. B.
197*
Eavlronaeatal Bealth
Perspectives 9:155-160
Triedrichs, K.K.
Otto, B.
1981
aaericaB Industrial
Hygiene Issociatioa
Journal 42(2)3150-156
(HIT Pl«)
-------
Asbestos
1332-21-*
met COIPOSIXIOI onion* OB BBBETEBSIIED
(COITIIUED)
TISSUE
3612
inng
1
1
1
1
1
1
3613 |
i £rspi> i
1 node |
1 1
1 1
1 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1
I
361*
tespirato
rr
secretion
1 EIPOSniE BORE AIAIRICAL I08EEB IAIGE IEAI I Gllim IlfOllATIOl 1 IEFESEICE
t HBTHOD OF CASES 1 I
1 1 1
1 II
Inhalation Hicroscopy 21 a) < 0.1-370X10(1*6) a) «3.27X10(E*6) | a) Dncoated fibers, death fron I Dorgan, A.
fibers/g fibers/g | nesothelial tnnors | Holies, A.
b) 3.a-11SOOX10(E*3) b) 1783.7«X10(E*3) I t) Coated fleers, death fros I 1980
1 fibers/j fibers/g 1 lesothelial tutors | British Journal of
1 fibers/g I fibers/g I cancer | 37:25-32
I fibers/g I fibers/g I cancer |
1 e) < 0.1-2. 1X10 (E*6) 1 e) 0.«SX10(E*6) | e) Oncoated fibers, non-cancer deaths I
1 fibers/g fibers/g I f) Coated fibers, non-cancer deaths 1
1 f) 0-210X10(1*3) fibers/g f) 28.93X10 (E*3) I less than 1* of coated fibers "era < I
1 Dry (t fibers/g 1 10 on long. 10* exceeded 80 an. I
1 • Dry »t I I
I lecropsies, 19-88 yr olds. Cancer 1
I cases occnpationallr exposed. Onited I
| Ulngdon. I
1 1
| | ASBESTOS: IOIGS; CABCIIOGEI; |
| | CCBMMTIU ITllOATIOIS: OIITED 1
| | KIIGDCH; OCCOPITIOI »L S1Z1BDS |
II II
1 III
Inhalation 1 EH 1 a) lot applicable a) 0.7 ferraginons | Filer nean length 3.3 o, nean I Birsch, A. |
1 Bicroscopy 1) lot applicable bodies/sg I dianeter 0.15 u. (tore anpbibole than I Bignon, J.
I b) 6, (00 fibers/ng I chrysotile fibers I Sebastien, P.
I Dry »t j lediastinal lysph nodes. I Gaudichet, A.
1 1 1 1979
1 1 1 51 rr old patient. Exposure betireen I CHEST 76:697-699
II II ages 13-15 yr in (elding factory and I
111 | | letween ages 20-«0 ji as electric arc 1
III 1 1 (elder. I
III 1 1
III I Eneanoconiosls, bronchitis. Benign I
III I FclrP OB *ocal cord. |
III 1 1
III I long opacities, costophrenic angle I
III 1 otli tented, plenral (all thickened. 1
1 1
1 1
1 1
1 1
1 1
Inhalation
.
ES
a) 8
W 7
c) 5
1
a) 20-2000 ferriginoas
bodies
b) 10-20 ferrsgiiKMs
bodies
c) 0-10 ferrnginons
bodies
| FIAICE; 1EOITS; CASE BISTOBIES;
| IIDOSTBIII DISEASES: IEOPLASBS;
| CCCDPATIOI1I DISEASES:
1 tiBtrsocoiiosis: miss; LTBPB IODES;
| EIOACCOI10IATICI: FIBE5S; HB1LATIOI:
I A5EISTOS
t
1
a) lot gires I a) High risk exposure for 15 rr
b) lot given I t) Sod era te exposure for 25 jr
c! lot gives I c) Insignificant exposere for 28 re
I falnes for spntns
1
I Ccctpatlonallr exposed persons dth
I thoracic pathology related tc
j asbestos
1
1 Chronic bronchitis in 651 of 18
I stokers and the 2 ton-stokers.
1
I librosls, calcification of pleata.
1 cancer of the Inng or pi Mr a.
j lesions of snail airways foud in 80*
j at cases.
1
| ItAlCE: IICOSTIIAL DISEASES:
| KOtLaSlS; CCCIPATIOIA1 DISEASES:
| llSPItVTOtT SKIRIOIS; ASBESTOS;
1 inns: itAHB BIUIBS: IID
-------
libastos
1332-21-*
tun coBFosmoB imoii 01 oiminmio
(CORIIHED)
1XSSBB
3«15
Basplrato
ry
secretion
3616
lesplrato
ry
secretlos
3617
Spatan
SXFOSBBS Milt
Inhalation
Inhalation
tinmen
BET8OD
ra
Bicrescopy
Bicroscopy
licroscopy
•BBIXB
OF C1SIS
2
•t <«
b) «2
c) 16
«» 13
b) 16
e) «5
d) 6«
Hies
a) let applicable
b) lot applicable
c) lot applicable
a) 2-10 ferragiaoas
bodies (n)
b) 2-300 FI
c) 3-1500 FB
a) 0-1 85 0 ferrsgiaoas
bodies
b) lot git ta
c) lot given
d) lot givea
(•JIT
BBIB
a) 20 ferraginoes
bodies/sasple
b| 3 ferzaglaoa*
bodies/Maple
c) 50.000
fiber s/saaple
a) 1 fecragiaoaa body
(FB)
b) 10 ra
c)' 100 IS
a) lot given
b) 100 ferragiaou
bodies
c) 10 fetcoginoas
bodies
d| 1 feccagiaou bolr
Plot)
GIIII1L IITOIIHIOI
a) latleat 1
b| Patieat 2
c) Patieat 2. Fiber aean lengtk 2.*
i, aeaa diasatet 0.10 a. loce
ektysotile taaa aapaibole (ibers
Talaea tor sfatas
fitieat 1, age 51 yr. Sxposare
tataeea agas 13-15 yt in neldiag
factory aad fcataeea ages 20-«0 yc as
electric arc (elder. Patieat 1,
itoker. age !• yr. Iea*y erposare ia
asbestos ceseat plant, pre-lorld Bar
2.
•aeasocoaiosis, broachitis. Beaiga
pclyp oa vocal coed (Patient 1) ,
iqnaaxiM cell carciaoaa of Itryai
(tatlent 2) .
laag opacities, costopkreaic aagle
ctllteratloa, pleeral «all tblcfcaaed.
isiBCB: IDVITS; CISB msTOKES:
IltHSntU CISUJBS; IBOPUSBS;
CCCOVITIOIll DISUSES;
(Koaocoiiosis; miss; LTIPB BODES;
!io»ccns
-------
»tl«stos
U32-21-*
II1CT COBFOSItXOI
Ql U»BB«MI».HS
(C01TIT7EO)
IlSSffJ
3618
Spotaa
3CI»
snataa
Biposme sour
iiiinieiL
BBTBOD
EB
licroaCOBT
HIIIBJB
OF CISES
1
— — — «__ „.
SJ»C!
lot given
iili eiiuat urossi'ioi
300 ferruginous Occupational!? eiposed, lit. plenral
bodies/sasple sesotaelioia
1
I f( jc old (an
I
1 ISBtSTOS; CCCOVHtO.al EJ21SBS;
1 .rocs: AUTOPSIES; matusas; tsact
I
I
1
szrEtnci
i
Sehutlea, P.
Janraad, H«C.
Poaaand, G*
Gonir J.
Pignon, J.
1973
archives 4ea ealadies
Piofessiooaelles, de
Hedeeloe 4o TcaTail «t
de Secarite Sociale
1 (Paris] 3*{(]:33S-3«*
a) 29-523 f iberi/saapla 1 a) lot given I a) Sorters ta-dlig? rav asbestos chatel, 1.
b) 0-
-------
Enxaldebyde
100-52-7
C7-B«-0
Bl IOC.12, BI -26 C, BP 179 C. ?P 1 •• 19 at 26.2 C
irsstii
3621
Breatk
3622
Breatk
IXPOSVBB B001Z
lEUTTICal
BETBOD
ec/BS
GC-BS
»D8B!S
OF CASES
9
54 (387
saaples)
BJIG1
lot detect ei-1. 5 ttg/ar
Bot given
Bill
0.2 ug/hr
0.513 ng/1
Geosetric
GBIEBal IirOSBITIOI
Ccipoiad froi unknown origin. Bo
ctker details given
cryogenic saspling teckique.
Bealtky nilltary and civilian
esployees, U.S. air Force School of
lerospace Bediclae. ages 23-47 yr. 3
tiokers.
EEIZEBES; CBtOBXEaTZB BTDBOC1BBOBS;
CBIOHIH oBcanc COSPODIDS;
CBLCBOBEBZZBIS; FLOOB.XBE COBPODIDS;
EBE1TB; I1CCBOLS; TBIIS; 1COLTS
Beaauced at 25 C and 760 ss Bg
2*. It occurrence
lexer and upper one-Slgaa Halts
0.15) and 1.6« ng/1
Bealtky. 18-35 yr old. nonsnoklng.
artan blacks and Caucasians.
Chicago, II. Rigidly controlled
eiperlnental conditions.
tBIITB: IICCEOLS; ItlXBOIS; aDOHS;
CElOBUiTID ETDBOCIBBOBS; TOLaTILE
CIG1BIC COBPCOTBS; BEallB BlZaBOS;
IIBIltTICB; BRIEOLISB; BETaBOLITES;
EOPOlaTIOB EIPOSOBI; OBB1B IBEaS
BEFEREBCE
Conkle, J.P.
Caap, B.J.
Belch. B.E.
1975
archives of
Environmental Health
30(2);290-295
Krotoszynski. B.K.
Bruneau. G.fl.
O'Heill. B.J.
1979
Journal of analytical
Toxicology 3:225-234
Einzena
71-»3-2
CC-B6
>< 78.11, n 5.S1 C, BP 80.093-80.09* C, TP 10 nn Eg at 26.1 C
IXSSOI
3(23
Breatk
362»
Breatk
ElPOSalX BOOTE
llUTTXCal
BETRCD
SC/BS
SC-SS
IDHBEB
OF C1SES
8
54 (387
saBples)
Bliez
lot detectsd-250.0 ng/kr
Mot glren
BEal
40.8 U9/hc
».3 ng/1
Geonetzic
GE1IBI1 IIFOB11TIOI
Prevloas eipcsvre to conponnd. Vo
ether totallf given
Ctyogealc saipliag technique.
BealtkT illltary and civilian
eiployees, D.S. llr Force School of
leroapace ledlclne, ages 23-47 TC. 3
stokers.
tmtns: CBIOBIIITIO HTDBOC»BBO»S:
CeiOBXI! O«G»IC COHPOOSDS;
CE1CBOBEIZIIIS: PLOOBXI! CCBPOOIDS;
EPiHi: iicceois; TEIIS; mtn.'is
leasared at 25 C and 760 n* Bq
41.1* ocearrcnce
lever aid upper oae-Sigaa Halts 1.6
and 11.3 nq/1
BfaltbT, 18-35 rr old, nonsnlciag.
artan blacks and Caucasians.
Chicago, II. BigiaiT controlled
ctp«rlaeatal conditions.
IBEaTB; HCCBOtS; XILIIOXS; IDtriTS;
CELOBI11TED ETOBOdBSOIS; TOllTXIE
CEGIIIC CCBECTOBS: BSI1TB BH1EDS:
IIBlItTId: BETlEOlXSa; BETIBOLXTXS;
ICPOLITIOI EXPOSOBE; 3BBal >SEaS
EEFEBEBCE
Conkle, J.P.
canp, B.J.
Belch, B.E.
1975
arckives of
Environmental Health
30(21:290-295
Krotoszynski* B.K.
Brnnean, G. B. '
Ofleill, B.J.
1979
Journal of Analytical
Toxicology 3:225-234
-------
Beaseae, cbloro-
1C8-90-7
CI-B5-C1
» 112.58, BF -«S C, IP 131.7 C. TP 10 »
at 22.1 C
TISSUE
3«25
ireatk
EXPOSTSB BOOTI
i uitmcn
f ffXTBOD
OC/HS
ETFBZE8
OF C1SI5
8
BUGS
lot giTaa-a.OO? a«/fcr
BE1I
0.01)03 ig/hr
CEIEB1L IBFOSBaTICn
Ceapoaal fcoa aaJuton origla. to
ether detail* qlnn
Cryoaeatc aaapliag teekaiqae.
Bcaltkj eilttarr aad civilian
aaplorees, U.S. air Fore* School of
lerospace Bediciae, agea 23-«7 jr. 3
IIBtBBES; CBlOBtBlTtI BTDBOCUBOBS;
CnCBIBI OBG1BIC COBPOBBOS;
CELOEOBNKBES: FLBOillg COHPOHIDS:
CIB1TB; IICOEOIS; TBtlS; IDVtTS
BEPIEEBCI
Cookie, 3. P.
Caap, B.J.
felck, B.E.
1975
IrcklTes of
t»iniiaeital maltk
30 (2): 290-295
Emma. «tk|l-
CS-IIO
Bt 1»(. 1«. Bf -94.97 C, BP 136.25 C. TP 10 •• Hfl at 25.9 C
I 1ISSVS
sxtosmy tent t
OF C1SIS
entiu HFOSBITIOI
3626
I
I lahalatlon
I
I
I
I
I
I
I
I
r
_i_
I «
I
I
I
I
I
I
.1
0.50-0.80 a9/1
0.6925 a
-------
f*i**ie, aeiackloro-
C6-C1«
If 28*. 80. » 231 C. tt 323*326 C, TF 1 •• Bg at 11*.* C
IISSVI
3C29
adipose
3630
adipose
3631
Blood
niosntE Boott
lagestioi
labalation
Deraal
alllTTXCll
1EYIOD
ec
OC-BC
main
or CASES
60
a| 22
b) 1*
cl C
d) 6
e) 6
11KI
0.23-10.70 ppa
a) lot give«
b) lot given
c) lot given
d) lot given
e) lot given
a) 5-1121 ppb
b) 30-9)0 ppb
c) 3-600 ppb
d) 22-«67 ppb
e) lot given
Sglt
1.36 ppa
a) 0.2* » or - 0.09
•g/kg
b) 0.36 » or - 0.2*
ag/kg
c) 0.12 * or - 0.06
•gAg
d) 0.08 «or - 0.07
e) 0.09 4 or - 0.03
•g/kg
a) 310.7 * or - 287.7
PPb
b) 311.5 » or - 2*2.9
ppb
c) 159.9 t or - 1*2.7
PPb
d) 170.3 » or - 111.8
ppb
e) 0.1 * or - 0.6 ppb
Ctmil IIFOIBITIOI
Feripheral tidier fat. roatlve
pathological •xaaliatloas
Iges 6 IO-92 it. Belgian
BHBIBI; 10TOPSIES: IDIPOSE TISSUE;
tlOaCCOROllHOI: PESTICIDB3; DID:
IK; OBI; DIUOEII; HBPT1CB1CB
IPOIIDI; BIIICB10BOBZBIEI1; III CUE;
CBIOBIIB oiemc COBPOOIDS
,
•1 Ilderlr icn
b) BlderlT «enen
c) Toiiq I*B
) Bevborns
crlrenal tissae
176 survey.
•topsles frei 3 donor groipa.
v«rage ages 70 "vr. 2* yr. and 25-35
\, Oslo, lonaj.
ItltOSB TISSBE: BILK; COHPlilTIVB
IflLOiTIOIS; IOBIII: IDOItS;
iVTOFSIlS; IIW8O1I; CnOBIIlTED
BTBBOCISBOIS; IDT: PBSTICIDBS;
ICITCBtOBIIlTtO BIPIMYtS
a) SO exposed vorkers. 197*
b| *9 exposed corkers, 197S
c) *9 exposed vorkeri. 1976
dl «* exposed vorkers. 1977
e) ** controls. 1977
a)-d) aaalrzed by different
lafcoratories.
laplorees of a chlorinated solvents
plait in Ibcrillle parish. 11.
197*-1977. Controls worked In a
polyethylene prediction plant.
Be detected dif fereaces betveen
exposed and controls studied in 1977.
BIIICHIOBOBEHBB1: NI6ICIOIS; BLOOD;
IICDSTIIU. FLUTS; OCCOPITIOHL
iiziiES; let: siciiL STUDIES;
iiinsTiiii iTHospBnis: iionsniit
JICIEIB; COBPU1TITB EY1LU1TIOIS
BIFEBCTCI
Dejoaekheere, I.
Steirbait. 1.
Terstraeten, B.
Rips, I.E.
1978
Toxicological European
Research 2 (2): 93-98
Brevik, E.R,
Bjerk. J.B.
1»78
icta Fhariacologica at
Toxleologica
•3(1)8 59-63
Carrier, I.F.
•cCliians. C.D.
Bana-lloyd, 6.
1980
Joarnal of Toxicology
aid SivironMBtal
Bealth 6:367-377
(HIT fjtet) ' '"
OJ
-------
CcnzeM, aesacaloro-
ce-ci«
1< 28*. 80. K 231 C, BP 323-32* C, »P 1 u tg at 11*.* C
IISSO! BIMSOIB iOOTE UllTTICtl
B1TBCD
3632 00 K
Blood,
ibol*
1
1
1
1
1
1
1 3f33
1 Bilk
1 1
1 1
1 1
1 1
1
|
GC-EC
SC/BS
1
363«
(Ilk
1
1
f
1
1
1
flTSBES
or cises
*) 35
b| «
a
fUGS
a) 0.1-3 ng/g
b) 0.1-1 ng/g
.6-17.1 ng/kg
1
1
I - - -
Bill | GBIrBII I»TOBB»TIO« 1 BKnBEXCX
I |
1 1
a) 0.6 ng/g | *> lore cannl reaidenta, 100T ( Bristol, B.I.
b) 0.3 ng/g 1 to«lti»e caarlea 1 lego
I b) Tolnateer*, 10M positive aaaples I IPI-600/1-80-036, 40
1 Halt at aeatoreaent, 0.011 eq/y | pp.
1 ClctelT aatctol, siaqltaaeoai control I
1 *a*Bl«< vere not pcovttod tor 1
1 i*aly*U along «lta those froa the 3* I
1 Icve Canal area residents aaapled. I
1 lacking aeacingf ol control ot I
1 llteratare data relative to tbe 1
1 ctgnifieaac* of the lo* r«»ldne» I
1 foand la tie field saaplea analrr»d, I
1 no definite conclnslons can be dran I
1 fro* tan reialta reported. (
1 1
1 I««ldents ot >•* lork. Controls, I
1 eaploye** ot the Zsvironaental 1
1 Protection Igeacr and oalveratltT 1
1 «tndeot». Berth Carolina. 1
1 1
t «!« TOSH: IOFTH CUOIIll: EICOD: 1
1 Btismnm Brrsons; CBIOBIBE OSGIIIC i
1 CCBfONBS; CBIOFOBBIIIIBS: 1
1 ItllCnOlOBtKEBI; POirCSLOSMJTIB 1
I HPBiiiis; pcpoiairoi Bifostjsr i
1 1
1 1
.9 «g/kg I Uctatiag aetbers 1 Sodrlc-Snit. R.
1 1 salt. -L.
\ 17-41 vr olds fro* Slavonia Province, 1 oil*, X.
1 Yugoslavia. I I960
1 1 Pesticides Honitoring
1 locosmn; uctalioi: Kin: i journal 1*(1>:l-2
1 iiotccmnKio* ; BBUI aa»s; i
1 CKCtlMTEC BTBBOC1EBOJS; C BIO 8MB I
( CEGMTC COHECTTSDS: CHIOJOBSIlrBtS; 1
1 tIE: DDT; BinCBIOBOCTC£OB»IBB: 1
1 HSTICIDIS 1
1 1
ec-BC I a) 14 aj *ot girt* a) 5.5 • or - 3.7 a) Oslo, large iadusrrialiled city 1 Brer Ik, E.a.
1 b) 11 b) (at girea no/kg t) Berqea. large iada»trialin>a city I Bjerk, O.B.
O 10 c) lot giren » 9.2 « or - 4.0 c) Barstad. saaller dtr vitb large I 1978
6J 9 &) Bot given ng/kg cbealcal/petrochealcal complex 1 act* PbarMcolo?lca et
c| 2. 7 + or - t.O d) Porsgrana, aoa-lBdastrielizod' 1 Toxlcolo?ica
ag/ltg flaking coasmity 1 *3(1|:59-«3
i) 3.2 « or - 1.2 U7« sarnv. Significant difference 1
ng/*g (f < fl.OSI tttveen saapllag *lte»: I
EC r gen > Oale > Barstad, PomgcuiB 1
t
looegian aether*, ages 25-28 ir. f
1 ICIP05I IISSBE; «n.K: COBPJSlTIfF I
I cmgiTiois; IOKIIT; tcans ; \
1 IttOPSIBS: BHBOIB; CBtOBHHED I
1 BUBOCtlEOBS; DM; PISTICIOIS: {
i i fcticaionmiD fiPBfins i
1 1 1 1
-------
It ami*, o-aickloro- (8 CI)
E«I»M. 1.2-aickloro- (9 CI)
CC-B«-C12
S« U7.«, HP -17.5 C, Sf 1*0-183 C, T* 1 « Bg »t 20.0 C
TISSUE
3«35
Btaath
BiniOBS BOOH
iiitnicii
BRIOD
8C-BS
•DBBM
OF CaSIS
» (387
IIICX
lot gl*«
1EII
2.* ng/1
Seoaetric
SEiitiL nrotamoi
Masnct at 2S C ana 760 a* Bg
13.91 oceimnc*
lovtc a*a «pp«r one-Sigsa Haiti 0.«3
aaa 13.5 ng/1
Kalthr, IB-IS TC old. aaaanktig,
attaa blacks ana Caucasians.
Chicago, II. Bigidll conttoll«d
.
Obi, 6.
1975
EBTironaantal Pollntioa
8:2««-274
-------
Mama, p-ajckloro- (t cxt
mm*. 1,1-M.cklora- f» «)
1M-M-T
ee-t«-ci2
II 1*7.01, It S3 C. W »7«.« C, Tf 10 M tg «t 5*.« C
TJS3BS
3S38
flood.
• boll
3639
BMatk
xuosm *om
Inkalatio*
I uitmcu.
imoB
8C
1
I
IK- as
tmtst
or C»SB
c
M per
•UplM)
1MSI
•-16 »g/»l
•Ot 9iT«l
IUI
9.5 »g/«l
1J.« ««/i
e*a»t£ic
czitui inoiMtioi
IWltkf J
-------
lickel
1MO-02-0
li
lt» 58.71, Ht 1«5S c. BP 2637 c, TF 10 » Bg at 2090 C, 100 » Bg at 2370 C
(COITIHOED)
KSSOS
• 306
Blood,
serna
•307
float,
•hole
•308
ireata
4309
Bltaeaii
• 310
nic
EIPOSIU son
Ingestion
lagestion
Xakalation
1 MI men.
IETHOD
IIS
us
PIK
TOBBSB
or c»szs
i
*
i
MIGI
i) 0.3-3.* ag/1
b) I.S-105.0 aa/1
a) 0.t-«.S ug/1
b) Z. 9-79.0 «g/l
lot gireg
aiti i GEEZBII IBPOBBMIOB
1
>) 1.60 * or - 0.93 I •) Baaeline »l««s
14/1 1 t) Wats, 2.5 hr after 5. « ig as
b| 33.9 » or - »3.9 I solfate
og/1 I
1 acalttr 21-32 rr old
j BO ««tal hTP«r*easlti*itr
1
| S«IOB!t; IDOLIS: BIOOO: BIOOO SEIUR;
| DII»: IICEEI
1-
a) 3.25 + or - 2.33 1 at Baseline Talus
09/1 | b) Peaks, 2. 5 hr after 5.« my aa
b) 2S.7 * or - 31. 5 1 tilfate
nq/1 (
1 Health t 21-3! re old
| 10 letal fc7p«r*e»ltlTitr
1 siBDZT; >DHITS: BLOOD: BLOOD siaaa:
| DIXIE; nCKEl
1
23. 1 ag 1 « 1 stapled at rat* of 1 1/ali, 2-10
| iln after tuning a arc vcldlag rods.
1 OniTersitj physics shop, Vlocida
1
1 flOIIIa: IBOLTS; BBZaTR; C1LCIOR;
I cnotiiK; cnonoi: COJPH; moi;
I iiJB: *»6»csB; ncrai; POIISSIBB:
I S01FIB; TITlllm; TIUHOa; H»C; 1IB
1 potiini(H: rtms; I»OSTXZJL
| KROSPHHES: TStCI ElBSEItS
1
t
1 nriev. Pcotl«» la risk analrsis of
I cancer i» It and Cr iidastry are
I prvsentvd* Tarioas coapoands ace
I cited vkieh eaase cancer in practical
| «lpos«ce aitnatioaa. The> need foe
I dose raglstration is e«ph«si»d.
1
1 ICBVIT: ClICHORtS; BLOOD PI1SR1;
t miisi iiDisniu Breinii SITIWJ
i cnomi; tmis; itcsn.; ciBcinsni
| TIIOSTtlil ITflOSPHEHES : IBCISTBISS;
1 eccipaTiovtt BaziiDS: «!OPi»sas
1
1 Berie*. 2* npresentatire
1 pr«-aialr«is treatamti are
I »•*«!» ted. la* f«asibilltT of a
1 aclistic, ac-vtsh poll c 7 for hair
1 amalyaia is cctliaed a>d serrortod.
1
1 tfTXCT: TPICI nmin: HUB;
1 losTBitii: msamsrr svtmes;
| IITUS; PBOTEIIS: COHP1B1TITE
1 ifiiuMiois; uvBnoa: miaviT;
| IBSniC: BilltJH: BBOHIfE; CIEBIOB;
1 cuciTjs; cBLOtnt: cnonvi; COBILT:
1 CCPTEB: enini: cisiiiina: eoti;
| lODMt; ISOB; LlintlDB; l»»t;
| HS1BSHS; B1K1BESE; IEBCOBT;
I tCHBVnOBs ITCKCl; PBOSPBOBOS;
| MtlSSIIH; BIBIDIBI: SSLZIHB;
1 mico*: sutti: somiB; STSomtm;
| SDIMl! TIB; TITIIIDS; TDISStZB;
I me: IUCCIIUB
1
BZFEEEBCX I
1
Ckristeasen, O.B.
Lag«ssot, V.
1)81
annals of Clinical aad
laboratory science
1ir«s119-125
Christeasen, O.B.
lmg»asoa, T.
H81
Innals af Cliaical aad
laboratory Science
1t{2»: 119-125
Ikselsson, K. B.
Desaedeleer, G.S.
Johausoi, T. B.
Bincftester, J.tt.
197S
Innals of Occupational
B»gi«ne 1»:J25-23S
varaeth, I.
1*80
Joaraal of Toricoloo;
and EnTironaiental
ff««lth «<5/*|: 12 W-1227
Chittleboroagb. S.
19 SO
Science of the Total
EDTicouent 10:53-75
(BtR
-------
flcxel
1*40-02-0
II
»tl 51.71. n 1*55 C. BP 2*37 C, Wt TO M Bg at 2090 C. 100 ll Kg at 2370 C
4311
Bale
4312
Orlne
4313
Brine
4314
Urine
Inhalation
HETBOD
US .
us
•OIBBB
OF C1SXS
al 35
bl 18
c} 68
d] 33
e) 32
fl 11
a) 1
b) 1
SIRS:
a} <10-90 og/1
bl <10-IO ag/1
c) 10-200 og/1
d) 20-130 ag/1
el 30-110 ag/1
f) 30-120 ag/1
al 13-54 ag/1
b) 25-47 ag/1
8 Ell
al 28 or - 10 ag/1
b] 3D or - 20 aoyl
c) 65 or - 42 aq/1
d| 52 or - 31 ng/1
e) 68 or - 31 19/1
fl 70 or - 30 e»/l
a} Bot given
b) lot given
enroll UTOBBITIOI
1 review of sorld literatare oa the
accvnlatim and bioconcentration of
(elected toxic trace setals in h1 and Cr industry are
presented. Tatioas conponnds are
cited «nlch cans* cancer in practical
exfossre situations. The need for
dose registration is •aphasized.
ICBS1T; CIBCIBOatS; BLOOD PItS»:
OIIIE: iieisniu HIGTHE: BCTICT-,
CEBosns: »TU,S; no; EL: CIBCIKHSEB;
IBOOSTBIll ITMSIBZBES; IIDOSTBIES:
CCCOflTIOSU BK1BDS; XEOPUSSS
a] contmls
c) Besearchers, ainiaal Bl exposure
c] Prodtct Sorters, soluble li
d) Caleiaers, »l dust exposoce
e) Extractors, exposed to dast and
f) tester plant, ll oosder and li
carbonyl ass expasare
Values corrected to l.t q/1
creatisiae. Data also for
ataospheric dost.
11 refiaery «orkers, 19-C4 yr old,
petro-cheslcal sorters as ccetrola.
IICKIU HITltS; UDOSTEIAL PHITS;
DUST; mm; UIITED KHGDOB;
cccn;»io*ai nzutos
a] Sorter exposed to dast of
insoluble Bi cosponnds* Peak at 10
at
t) sorker exposed to aerosols of
cclable (1 salts. Pea* at 11 as
Dlaraal variation in bats.
Ictksrs in coastina-sseltiia and
electrolytic departments in (orvay.
amis; IICKTL: KXCIT; tiiosTBiu
I1IOSV9BBZS: OCCIJPITIOHL BltlBDS;
IICCD F1ISR1; OBUE
1ERBEBCE
Jenkins. 0.*.
1»79
IP»-«00/4-79-049, 1»4
PP.
Borseth, T.
1*80
Joornal of Toxicology
and Environaental
Health 6 <5/6| : 12 19-1227
Horaan, L.S.
Eouge, P.J.C.
197*
annals of Occupational
Hygiene 22:311-317
BogetTeit, I.e.
Barton, B.T.
Indersen, I.
1980
Journal of Occupational
Bedlcine 22 (91 =597-600
(MM FIG11 •"'
-------
Ilckcl
1MO-C2-0
II
Itf 5*.71. IP t»3S C, W 2«7 C, W 10 u S* at 2«0 C. 100 •• Hf «t 2370 C
(cortmrsD)
TISSII
«315
•rtaa
«316
OElM
EIKWiil tO«TE
MUniCU
since
us
us
* " cram —
or cists
is
*
1IK1
t.9-9.6 u«/l
_
*) 0.3-3.* WJ
b) 17.7-202.0 tg
m» '
*.*5 » or - 1.9 BO/I
a) 1.5* * or - 1.99
b| 69.56 t or - 59. «
••5
ctimi iiroiiHioi
Etctota-pnclpltaUoa saspl«
pctpacatlOB
Maltkr 29-«7 yt old*
•OIMT; IDBtIS; HOOD niSHl! OSII1:
CCBValtTlfC ZTIlnTlOIS; fllaSfflEHSR
inioDS; tiauniminoi; IIDUSTEIII
taissio»: ncni: BETIIS
•
tl m«r «.« B4 i> nlfato
nalUr 31-31 re aid
smii; IDDIB; BUM»: suxa iirra;
onti: ncm
B'smcs
Torjuuo. I.
Zackarlaaa, H.
cllalcal Chaalrtrj
2* (7) si 19*- 1202
-
CBElct«M«B, O.B.
t9*t
•aaals of Cllalcal aad
laboratorr sdaac*
111-84-J
CJ-BM
M IJ8.25. BP -S3.7 C. M ISO.T C. TP 10 •• B9 it 3B.O C
nssot
1317
Irvatk
tinsras tofTf
•UtTTICIt
BIT BOB
OC-IS
imun
OF C1SJS
5« tJ»7
•aipl«s|
MMI
•at «iT«
IUI
O.J48 15T/1
s*«Mtric
eillUl IffOMHIOl
B«a«u»d »t 25 C ail 760 •• B licit*
C.0«* aii 1.J7 14/1
SMltbf. 18-35 yr old, »OB»olilBg>
•TtM blacks aid caicatlans.
Ckicifo. 11. Ilqldlr cg/l
GIIIUL nroiittiof
M«nr*4 at «Bd of working i»j, f«aa
ale Ionia 10-13 BIB.
laboratory aasistaats «orkla« clta
ocqlalc solrtBts.
CCCWII101H utitm GSMatt:
»Ml«; BU>01t CatCIBoen
timnct
l«1m«rt, 6.
latacBBtloaal arcnlTos
of OccapatiOBal aaA
BBTltOBMBtal IMaltfc
• 3-.1W-150
(tin
-------
i en
NBZ*M, 1.2-4i«Url- & CI)
ct-no
II IOC. 1C, IF -IS C. « 1«« C, TV 10 •• Ig tt 32. t C
(CORIIDIO)
tissn
Bnatk
•330
BriB*
mosaic Bons
tBaUaU..
luimcu
BBTBOD
ac-is
•nc
nmt
or cms
5* on
«BDl«)
Bt *
b| «
O 2
_
BUM
Bat giT«
•) Bot git«B
b) lot gins
e) 0-0.1* ag/Bl
Bill
1.0 BO/1
saoBatclc
a) 0.0037 * or -
0.0007 i»»l/kg CM ot
toM)
b] Trie*
Ct lot ftTM
BCBIUI UTOBBHIOB
e Bg
lovK aad «PP*r o»»-Sliaa Halt* 0.36
aa* 2.8 Bg/1
BBBltM. 1«-35 TT DU, BOBIBOxiBg,
irtai tlacfeB aad caacadaaa.
Caicago, 11. Bigifly coatrollvd
«p«rli«BtBl coadltloB*.
IBEUI: IICCBOL3; IIUKHS; IDOLTS-,
CBLCBInlBB EnBOCaBBOBSi TOUT 115
CtGliTC COBPOUtBSj BUUB ItUIOS;
IIBlUTIOBl BXTMOLISa; iniBDimSl
'
a) o-Tolaic actd gl««BcoBl4«
(aatabol.lt*), 2B kr «zcr«tiw att*r
0.3*1 BBol/>g o-zTl«lw, oral. Paak
la 3-< be
E) o-lolalc add glvCQCoaida, att*v 3
ti «xp«*«x* to 13* ppB tr-irlcaa
c( p-BBtkn*ipB«rle Bell
(BBtBbollt*), attac oecnpttloBal
«*POCBC« tO 17l«.B*. B«tiBBt«d CTOB
9Kapa
telBBtOTT** aaaa »a« S3 ft total).
nl »* rr (vapor). f»lBt«r« in
aaippatldiBg rard, a«aa ag* 32 jr.
HUB: iRIBGUTIS: tllS;
eccwHioBii iiittDS; wminoB
tlPOSOU: 1K1TL HBRlLSj P1IB1S;
1IIUUIOB
mctnci
KrotoniBBkl, B.K.
Braaaa, e.g.
O'Belll, B.J.
1979
Joaraal of laalytlcal
Toiioologr 3:225-23-*
Ogata, B.
TaBazakl, T.
Sagikara. I.
SblBBla, T.
1980
lataraational areklra
of OccipatloBal aa«
EBTiroiaeBtal Boaltk
*6: 127-139
U)
Ul
cctaa«
111-CS-4
CI-BU
tl 1U.21. B» 5t.« C, BV 125.B C, TV 10 •• B« at 19.2 C
imti
«121
Bt«ath
EttOSOB lOOt I
taunicu.
IB1BU1)
OC-S3
BtBlZB
oi cats
5* (3B7
•»»!••)
laKB
lot glit*
Bill
0.296 ag/1
e*o««tcle
'
cBimi iipOBamaB
. _
8«anna at M C ul T60 aa Bg
21. K oecnme*
loaac ud IPPBC oa*-Slgaa Haiti
D.079 *>d 1. 10 ag/1
Kaltar, 1S-35 re old, noBtBoklag,
»tu blaeka aad caaeailan*.
Ckleaqo, 11. ttgiAIr ooBtnlKl
•*P«rlMBtal oaBditleai.
EBEITB; 1LCOK>1S: ItlllOIS: 1DOMS:
CnCKIaTBD BTOtOCIBWISi TOIaTIU
cHinc coBPtmns; IULTB aiuics-.
IIBUITIOV; BKIBOIISI; mUOlRBS;
tatmma* tttonn; »BU MEIS
_.-._,
IfcfBBIlCE
Kcotonfa*ki, B.I.
axBaaa*, 6.8.
C'Belll, E.4.
1979
Jooraal of taalTtieal
Toxioologr 3:225-23*
-------
Cctuolc acid, peatadecafliioio-, aeaonUe salt
3(25-26-1
Cf-R-T15-02.B3-I
BS 430.98
1ISSOB
4322
Urine
t
EIPOSVU BOOTE
• U1TTIC1L
HETBOD
ec
BOBBES
OF CISBS
1
SIEGE
a) lot applicable
b) lot applicable
c) lot applicable
Hill
a) 387 eg/24 he
b) ITS 19/2* hr
c) 80 ug/24 hr
GSIIBll IITOIUTIOI
•1 1 »k
b| 3 10
c) 14 M
Interval follo«ia
-------
CI)
. «-(t-MtkTl«tkrl|- f» CI)
II 150.22, Bf 2« C, BF 2«» C, T* t » Ig at 7«.2 C
1ISSII
•125
Srtatk
citoswv Bone
uumcu
GC-BS
•DBBIt
or CISTS
5* (317
•aaplfs)
UIG1
lot giT«
till
._
0.2«1 »9/l
GaoMtric
Gimal IITOIBMIOt
l«a»r«4 at 25 C aid 7(0 n 89
It. S* oecwraBO*
lewt »»1 vppn «a%- slga*, lliiti
0.03* aad l.ti Bg/l
••alt-VTi 1%— 3S yr old* BOB8BOkiii9r
attn blacks ud eaaeaslau.
Ckicaqe. II. tloiair coBtrvjUad
*icaria«Btal eaBditiont.
E1I1TB; ttCCBOI.!; IlXIfOIS; IDBITS;
cnoiinTti miocaiBois: TOIITILI
C1GMIC CO8PCOID3; HH1TB B1I1IDS;
IIBltkTICI: SIT1KJIIS*; BETIBOHTBS;
ropouTiot uposm: onii tins
unmci i
Braiaaa. S.a!
O'Mill, 1.3.
Jonraal of IMljtlcil
7oxicolO9T 3:225-234
I-Di«XtM It CI)
1.«-Iioxtce (» CI)
1J3-»1-1
C«-I«-02
11 €1.10. » 11.80 C. IP 191.1 C. T; »0 •• 19 *t 25.2 C
tiss«
Bnatk
Bnatk
titosui JCHTI
BMBCD
ac/as
ac-gs
or cisis
- - -
5* on
sMplatf)
I1IE1
tot 4*tactad-0.a| ag/br
lot 9lwu
Jill
0.05 «g/kr
0.253 ng/1
eiinii iiratnnoi
CcifovBi r«laua to aonal
Mtakollca. 10 etkar tetail* gl»»
CiTogoic aaipliBg tackolgB*.
laaltkr illitarr mi ei*illai
aaplor««a, o.s. ale Foce* School of
Mraapaea BcdielB*. ag«* 23-*7 yr. 3
nolacs.
IlltZISS; CHOtlllTBD RDBOCHBOIS:
cnmitt fiKjnc COBMIKDS:
ciLCMBtnnis: nnotiij COBSOHIDS:
EIUTI; 1ICCROIS; TB1U: IDCITS
!«aanat at 2S C »m« 7«O ma 89
21. B< occnnne*
lame »nd upper aa*-SiqM lliits
0.0«7 aa.1 1.37 Bq/l
BaalthT* 1B-3S TI olt, BOBiMkUg,
CUcaqo, 11. tlgldlr coatioll«4
«ip«cta«Btal coiditiog*.
{111*9; ilCOBOiS; IILIKIS; 1D01TS:
CIIOIIUTtD RBMCtlBOIS: T01ITHI
tisnic coitcnDS; nun BIZUIIS;
IIBlllTTCI; aitlBOlISB; attlBOimS;
fopntTioi IDOSVR: otan mis
HTXRffTCE
Coakte, J.I.
Caap, B.a.
**lea. B.I.
1»7S
lreklT«0 of
ZavlroBBCBtal Rcaltk
30(21 :2«0-2«5
CtotonjBskl, B.X.
D'lallli *••>'.
•\m
Joarasl of taalrtlcal
toxleologT 3:225-23*
OJ
-------
(I CI)
Cyclokoxcaa, 1-B«thyl-4-(1-Mtkyl*thmyl)- (9 CI)
C10-B16
If 134.23. K 174.6 C. TP 1 u Bg at 14.0 C
1I3SOB
432»
Bxoatk
BXNsni toni
1I1LTTICU
HBTHOD
OC-IS
tana
or CUES
54 (387
•aipics)
S1IGS
lot givra
BUI
2.9 ag/i
6«OMtrle
6SIZB1L ICFOBUTIOI
Ma«U*4 «t 25 C »d 760 aa Bg
94.5* ocetrrwc*
lowtr aal ippar o>*-SiqM limits 1.07
•>4 7.9 B9/1
Icilthr, 18-35 TT oil. aoBSMkiag.
irtan blacka ud CMCuicu.
Ckiecfo, n. llgUlr eoBtroll«d
«sp«rlimttl coiditlOB*.
Ellin: ILCOK>LS: IILIKISS IDIHTS:
CtlOBIUTIV IIDBOC1BBOBS: TOI1THI
cieinc coircons: HMITH usues;
IHItlTIOI; 8R1B01ISI; BBTUO1RBS:
loraimoi nnsoii: HIBM tuts
nnBEBCB
KZOtOSTIBSki, 3.K.
Br«B«fta« G.H.
C'Klll, B.J.
1979
Joarial of faulytleal
Toxlcolegi 3:225-234
'
-»k««Tl*»«Uula« C CI)
4-SnMMdlailM |9 CI)
106-£0-3
C6-M-I2
II 108.7 C, H 1W C. BP 267 C
IISCTB
4329
orlM
BXPOS0B BORI
.
1U1RIC11
•BTBOO
IV1BBB
OF CUBS
11KB
mi
6EIEBI1 IirOIUTXOB
l«Ti«w. Xocil ui *TSt«iic «f fccts
c«l«tli9 to kair IT* fonalatioi.
l*4t«dl««t testa, til •xp«ti«ac«a In
IIB and aiiials.
Cmtaet 4«riatitis it uan. tktir
tfoiMS, dcatists or etlwra in
ccataet vltk tcecatly 3l*& hate.
Iaa«dlat« krp*rma*ltlYlty
lirticacia) ivpoctei.
ItOHSi DBBIKITISi IBOPI1SHS; BSI««;
II TITBO II1ITSIS; II TITO 1111 ISIS;
IZTIBV; DIBS; CUCIIOSEB: COSBITICS;
SIIBTIC BFrBCTS; nUTI I1Z1B9S;
IIT1BOIISR: IR1BOLITBS
BBFBBBICB
larziUll, r.t.
6re«a, S.
•alback. B.I.
197*
Jovraal of
BaviroBBoatal Pathology
and Toxicology
1! 509-530
U)
oo
F-Tolulfakyte (« CX)
Hnxalookyl*, 4-Mtkyl- (9 CI)
104-B7-0
Ct-»8-o
(I 120.16. BP 204-205 C
IISSOI
•330
Btaatk
t
I
BXPOSDIB BOnX
iiumcu
HBTBOD
OC-BS
1
t
BOIBZB
OF C1SBS
-
54 (3*7
M«pl«S)
1
»
111GB
lot glT«n
I
BB1I
J.3 »g/l
SeoMtrie
1
6IIIB1L IirOBUTIOl
laasvrod at 25 C a*4 760 •• Bg
!.7f occirrvac*
Ic«r aad ipp*r OM-Sigaa. llaita 0.7
aa4 15.4 ig/1
l«altkT. 18-35 yc oH, soaaaokloq.
•ttaa blacks aid caacaalaaa.
Chicago. XI. ligidly controlled
aip«rla«atal coaaitloM.
(1BRI: HCOB01S; lUXKIS; UHIIS;
CnOlXHTIB IIDBOC1BBOIS: TOtlTILI
CIGWIC coBPcnDS: IUITH iituns;
mtllTIQl; IBTltOLISfl; ItlUOLTTES;
I (O?«U1XO« CnoSVR; «BB» HEIS
1
SZRMICB
Krotoaxyuki. S.It.
Braaoaa. 6.B.
O'H.ill, B.J.
1979
Joaraal of analytical
Toxicology 3:225-234
-------
«»a (« co
IUMM, 1.4-41actftrl- 19 CI)
10«-42-3
CB-B10
•I 10C.1t. «f 13-1* C, n 137-138 C, »* 10 II B9 at 27.3 C
TISSUE
•331
IlaoS
4332
Cnata
4333
traata
sitosrac sons
lakalatton
11U.TTICU,
tames
oc
sc/is
SC-BS
mnxi
or CUBS
*
*
5* (3*7
saapl**]
11161
1.04-1. (9 tg/i
lot 4«t*ct«a-0.»03 ig/hr
lot 9l**a
m*
1.3075 »o/l
0.000* oaAt
.. -
3.1 ng/1
SMMtcic
6IBHU, nromixoB
It p»r« » Mta, Ma*u«d «t od of
forking 4a|. B«u *lr !«•!< 5«-6«
**•-
CCCIMTIOIII BI111DS; SB1B1II;
HULTS; BLOOt; CUCItOUII
Ce«poi«l ftoi ukion oriqla. >o
«th*r 4«t«ll« qlnc
Ciragvmie «ipliiq tcehxlqo*.
Bmltkr illltacT ud clTilUs
«iplor««9, U.S. lit Force school of
l«nsp*c« ••fllciM. «?«s 23-**7 jr. 3
iiolwn.
tlllltfS; CBIC1HKIB RDIOCUBO1S:
cBioint oisinc coiMms;
CBiciosmnts; nooitn conoviDS;
HiiTB; iicoBois: THIS; icnvs
I«*>drtl «t 2S C «*a 7SO •• Bg
9t.7< oceoTTcne*
lenr M4 vfpct OM-slqu llilti 1.2
»4 7.4 B9/1
BtaltkT, 1S-35 yr aU, noacMfclng.
ntu bl«ck> Mi nietslu*.
Ciiragot 11. liqidlT ca»ttoll*A
«lp«tlwit«l co*tttio»s.
Itlltl; HCOBOlSi IIIIIOI3; lOOltS;
tBtotiiiTiB iraiociiwis: foums
aiamc coRfcnDS: HILTB IUUDS;
HBiittia*; reritouss; IBTUOLIRS;
icmnTiof inosiu: D»B»I usts
itrisnci
tnq*»r, J.
I«Ia«ct, 6.
H7»
Interaction*! icchlTca
of Occvpctlonal ana
initoaMBtal B«*ltk
•3:154-150
CoukU, J.P.
Ca«p« B.J.
Mich. B.I.
1»7S
liefeln* of
fariroBMntal B««ltb
30 (2): 2*0-295
KrotoczfMki, B.K.
Braa«a*« 6. B.
O'Mlll. B.J.
tm
lonnal of laalytleal
Toxicology 3:225-23*
to
1440-05-3
I«
It! M«.4. II IMS C, « 3167 C. n 1 aa Bg at 1*70 C. 10 aa Bo at 2290 C
IISSOB
«33*
lAlBOB*
IHOSDtl WJBTl
HllRXClt
BETBOD
US
10B1S1
or casts
10
(1KB
- -
Bat gti«a
.
{•in
SEtl
O.« pnb
.
rteo
eimti nroiBMiOB
.
loa k«7«l«« nciteat*
UtopiUa, 12-79 rr olds.
ntus; pnumB: PIILIDIOII: isu>s
TOfDllTIOB BimSOIB; OCCONTIOBU
Bixites: cunosBii: iirropsr«s;
HOOD; 1IDKIS: SniBB; Bill; D1I1B:
HISS; «VSCltS; UIMSB TISSUI;
HTM! COBtlUNfB EIliH«IOlS: BS<
onsiT: calm; BIS»B: IOTOBOTITB
•EtEtXBCB
Joha*oa. O.E.
Fc«*oct, J.J.
T111«T. l.t.
Caaaaa. 9.1.
(OMafela. J.B.
197C
B*»-«0«/1-7«-019. 235
PP-
-------
tainau*
7MO-05-3
n
Itl 106.*. at 1S55 C, If 3167 C, TP 1 aa Bg at 1*70 C, 10 M Bg at 2240 C
(comnsoi
IXSStll
1335
Hood
•336
lilr
•337
XldMT
•33*
1 1 MI
xxtoson tooi
1
1
1
1
t
1
t immcu
EETIOD
US
us
US
us
•oasis
or CUES
2»3
2*3
10
met
a) lot git«n
b) lot giT«
c) lot si no
lot giro
lot sires
'ot givaa
SMI I cEBtiu iiroBBinoB i IETESXICS
1 1
1 t
i) <0,9 19/1*0 «1 | i) lorn ligclaa aad laacastar | Jekaao*. O.K.
b) -»•
1 «>fl* 1 Cuaia, D.I.
1 c) Iue»t«r rtaid«*ts. cotjwsita | Hos«afeM, J.I.
I ««npl« | t»7S
t I CTI-«00/1-7«-OI9, 235
1 CiltforilM* liTiig do»«ii4 fro* a I pp.
1 tk« kigfc I
I 4<>ert rwjlei of lue**t«r. »g« 1
1 gtonps: 1-1f. 17-34, 35 or mor« re. |
1 «OV «hit«, »0« aoa-ihlta t* lo> I
1 >•«•!«. 80* «klt«, 20* »oi-«hit« l» [
\ I«eist«r. |
1 |
1 inus: pinnras; ruium: tin; t
t iefOLKtiai KPOSOM: occopuiofit i
1 nxiEtS; ctiirotnt; itrrofsizs: i
1 HOOD; (IBHTS: SM.IEI; uii- raill; 1
1 muss: mscust ivttost Tissra; i
1 iirra: CORPIMTIR tniUTioiSt »s» i
1 JESSiT; CHIN: mm: UTOMTITI i
i - - - i
1 !
<0.02 aaV9 1 lo* MaolM «nd Laacutn ro«ia«nt« 1 Jofcnson, g.i.
1 | Pt«TOJt, S.J.
1 callMntai* llrlaa dovnled Iroa a I tilled. J-B.
t ft««»«T In Ic« lag* In or in tk* kiafc I Caaaiia, O.K.
1 d«Mrt caglci of laactttcc. lg« | BoMafcU, J.B.
1 atoips: 1-16. 17-3». 35 at *oc« T*. 1 «*T«
1 tot chit*, *0f 90t-«kita la tos t Kl-600/1-76-019. 23S
1 Jn^«l««. to* vklt*, 20< aoB-vklto ia I pp.
1 laacastvc. |
1 »TRS; PLITHUB; PHUDIOB; 1EID; 1
1 ICPtUlTIOR HPOSIHIt; OCCOP1TIOIU. 1
1 IlliS IS; CllITOMIl: tVTOPSIB; 1
i ztooo: KIOKIS: spun; HIIJ; nun; i
1 tO«SS; !I9SCUS: 40IPOS! TISSOI: I
t iifEt; coipitinn miMTiois; n* t
1 JttSBT; C1I1E1: IIIIK; 10TOBOTITI |
1 1
t 1
*7 ppt f toa la?al«a r«aiil«>ta I joknsoa, P.I.
1 1 Prorost, ».J.
1 latopsUs, 1Z-7« rr old». | TUl«rr, j.».
t 1 C«a««n, D.r.
I HT»is; PIIIIIIB; PUIIVIOI: LBID: i goa*tf«u, J.B.
I Topnmoi EXPOSOIE; OCCO?ITID»M. i 117*
i Binars; curromi; IBTOPSIIS: i iM-«oo/i-7t-oi«, 235
1 HOOD; KiDBtis; SPIES*: nit: ttn»; i pp.
t loies; SOSCKS: taiposi tissast I
1 IDtP.; C01PIHT1TS tfllVtTIOfS; RV I
1 JHsn: ci»u: mites IOTOIOTITI i
i i
t ppt | lac la«al*> resldeats I Johasoa. D.I.
1 t Iftnst, i.j.
I Ittopsios. 12-7* rr olds. I llllwr. J.B.
1 1 caa»n, D.I.
1 fltlLS: PIITITOB; puikBiai; ttiv: I BosaafaU, J.B.
I lOPOHflOI IXPOSVIE; OCCnPITIOBJL I 1*76
i B im«; CU.IIOMII: amopstiss i Kp«-sao/i-7«-oi», 235
1 HOOP; KIBIIIS; SPIMI; Mil; milt; | pp.
I ines; nvscits: asipos: Tissue- i
i tun: coRpimxn mmiTiois; n« i
t JHSlt; CHItt; ft* IK; 13VMOTITE I
1 1
(Kit PIGE| . .
N>
.p-
o
-------
falladi*!
7MO-05-J
ft
M •»«.«. n 1555 C, SP J1S7 C, fp 1 •• Hg at 1»tt C. 10 » Eg at 2290 C
(COBTMBED)
nssoi
4339
LHfifl
aaWinj
wo
*3«1
*3«2
Oriaa
iiposon BOOH
tinmen
•ETBOD
US
US
us
us
BWBEB
OF C1SES
10
10
10
a| 203
b) S8
I1IGE
lot glT*n
Mot girea
- —
lot gitaa
a) Bot glfea
b) 0.10-2.61 ag/1
Mil
<3.3 ppb
<2.2 ppb
a) <0.3 ag/1
bl 1.07 » or - 1.68
ag/1
««ni i»o»»i<»
lea lagelea caatdcata
latopaim. 12-79 yc oils.
BFIILS; PHIIBOB; MtllDIOB; 1EU>;
PCPOHTIOI 1IPOSHBB: OCCDP1TIOHL
tazutfiS; ciiirtnni: IOTOPSIES:
P.1009; KIDIII3; SPMEl: Ball; null;
miss: mjsctis; iinposi TISSDI:
iiTij; coHPaunrr EniOHiois; IEV
JEBSET; Clllta; BtlHG; moBOTITE
loa lBg*l*a xaaldcata
lotopaias. 12-7» TT olds.
EIT1IS; PlaTIBDB; P1LHDIOS; LIU:
corniTTOi EjposDEB: occur ITIOI it.
« ins is-, cinpoBinj imotsizs;
BIOOD; nmns: SPIEEI; B»B: OEIIE;
UIGS; BOSCIB: 101 POSE TISSUE;
IIVEB; COKPltaTITC ETtLDITIOBS; IER
JtBSEI; CUata; BIBIB6; inoBOIITE
lea laaalva naideata
tntopalea, 12-79 TT olds.
enus; PI1TIBUH; PUIIIIDB; LBaD;
topoiiuoi txposrae; OCCOPITIOBU
aiziBDS; ctiiroBBia: ITTTOPSIES;
BIOOD; KIOIZTS; SP1ECT: Ball; UBIIE;
10IGSJ 10SC1ZS: 101 POSE TISSOE;
IITBI; COnallTITE CTHDaTIOBS; BIV
JIBSEI; Clllla; BIBI1S; 1DIOBOTITE
at los lagelaa aid Laa caster
c«aid«Bta
t) OccanatloBallT cxpOHd. Bighast
»«!»« i» stoiarocm »oiX«
CalifocBlaaa litiag dovnvlid £ loa a
fracnar la lea lag«l«s or IB the high
d»«rt reglaa of laacaster. iga
gtospa: 1-16, 17-3*. 35 01 aoi«
-------
t«ntaa«. 2-ntkyl-
1C7-83-S
C«-B1»
n 86. 18. ft -153.47 C. It 5«-«fl C. It 109 •• "« «t •* 1 C
IIS SOI
«3«3
MPOSIIS BOOTI
iBkalatioB
t»i. mot
HXTBOD
ec/BS
loam
or cuss
10
I DOS
0.5-5.1 19/1
Silt
2.5 » or - 1.6 sg/1
siiini IITOSUTIOI
is 2-awtkyl-2-p*ataBol (••tabollte)
Icrters In ska* factory IB Italy
BBiiE; BTDtocauois: inuoims;
mil: iiBDsniii ITBOSPHSBIS:
IlIDSniU BTGIBK; *XB POllUTIOl;
OCCDMTIOiai DXSI1SSS
nrzszBcx
P«rb«lliBl, 1.
P*T«BV I.
1980
Toileology and Ippliai
Phar.acology 53:229-229
«. 2.2,*-trlMtkyl-
••O-M-1
CI-Btl
II 1U.2. tt 99.2 C. TP *O.C •• •« at 21 C
IISSOI
«3««
Br«ath
Biposni toni
IMlItlCll
•moo
GO IS
IUHBIB
or CISES
S* (387
saBplra)
I1ISI
Bot gir«
Mil
0.60* Bg/1
G«OMtrie
GIKIlt IirolBITIOB
§«aior»a at 25 C aid 7*0 •• 89
29. ?t occurrence
loocc aai
-------
CC-I1*
•i tf.n, BF 63.3 c, TF in mm 09 it lo.s c
IISSVI
•3*6
DrlM
IHOStB BORB
Dvraal
1*UITICII
•SWOB
«C/BS
I lOHEt
or cuss
10
I1I6E
a. 1-1.1 ig/i
.
Bill
0.5 » or - 0.» mq/l
enziii HFOI-UTIOI
is 3-*ctkTl-2-P«tamol (»talx>liU)
Oat* also «s Eolnatx is factory ail
1«rk*t» 1» aho* factor} in Italy
inn; nnocmais; nruoutis:
nui; iiogsniu IMOSFRIIS;
IKOSTtllt neiltti III POI1BTIOT;
CCCVFKIOIll IISIU13
-
•EFIUICI
F«rb«Ul*l. 1.
iteo
Toilcologj aid Ippllad
PharaacolojT 53:220-229
{•ctuelc
3JJ55-3J-I
11SS11
»3»7
imtk
TIJOSOSI 1ORI
uunicii
HRBOD
SC-BS
man
or cuts
5« C3*7
OMflW)
I1H> 1
1
1
lot gir«B
Sill
0.062 ig/1
G«oa«tcic
eilttll IlFOttlTICl
Mint*! «t 25 C »a 7*0 » Bp«r oM-sifn li*its
0.032 «l4 0.114 »V1
l«»ltfcT. 1«-3S Tt olfl, noABMUiig,
«rt»» blicki «J Caucasians.
C41cai]o. 11. lifillr coattoU»a
• ipvrtmtal oaoditlaai.
HIITB-. 1ICCBOLS: IUIIOIS; 1DV1TS;
tBLOHMIID ngBOCanOIS; T011TILI
tlSlKC COBFCraiS; 1ULTB B1IIBDS;
iiiumci; BEIIBOIISB: airiBoirris:
raFOiiTioi xiFosnE; ami istis
imsracB
KCOtOSXfMki. 8.X.
BTUMV. G.l.
O'Weill. fl.J.
1««
Joaraal -of Inalrtical
toiicoloqi 3:225-23*
laatil alcatel (» CD
1-lwt»ol t« CI|
7V»1-0
C5-I12-0
ii w.i. w -T* c. BF m.e c. IF i » B« at u.t c. 10 u
it
.S c
1ISSHI t
1
I
*3«f
Bnatk
BXFOSIB KX1I
-
uuniciL
action
Be/us
"
BUBBEl
OF C15XS
8
Rim
•at 4«t«ct«a-fl.6D ag/kr
(HIT
«E»»
0.13 V9/1T
F1GE)
SI»»t TIFOtBlTIOl
Ce*Fon4 r«l«t«fl to aonal
i«t«bolisa. lo otk«r detain qlnt
CTT»9«aic saapliaq tccbnlgt*-
B««ltkT illltarr ail ciriliai
«iplore«». 0.3. lit Tare* Sckool of
l«rospae« a, a4«s 23-«7 jr. 3
saokera.
IfllEfBS; CBlCBIlltIO ITDtCCHBOIS;
CBtonn 03S1HC coBFoms:
tiioioBnzim; nuoBii! COBPODIDS;
tBtlTf: ItCCBOU; 1EIIS; 1BBIIS
nnanci
COBil*. J.P.
C»«pr B.J.
Mick, B.I.
1»75
irekiraa at
FBTironacnttl H«»ltk
30(2):2<0-2*5
-------
alcohcl (8 CD
1-Pentaaol (9 CI)
7 IT* 1-0
C5-B12-0
n 88.1, IIP -79 C. It 137.8 C. TP 1 •• Eg at 13.6 C. 10 •• Eg at *».9 C
(COEIXI9ED)
TISSUE
«3»»
Breath
ntosDBX BomB
IBalRICll
BET BOD
GOBS
BOB EBB
OF C1SES
5* (387
saaplas)
B1B6E
lot given
Bill
0.505 ng/1
Geometric
GBEBB1I, IiroBBlTIOE
teetered at 25 C aid 7«0 •• Eg
21.7* occurrence
IOMC and apper oae-Sigaa Halts
0.128 aid 1.99 mq/1
Btalthy, 18-35 yr old, nonsaokiag.
gttaa blacks aid ca«ea«tai».
Chicago, n. Kigiair controllaj
•ipcriMatal coalitions.
EHITfl; ItCCBOLS; IllIIOIS; IDD1TS;
enoiiMTte imociiMis; TOUTHS
CIS1IIC COBPCUIDS; BJilTB BltlRBS;
HBIL1TIOI: BIT1BOLISI; BEtlBOLITBS;
poroiiTioi ziposaiB: OBBIB u»s
SBFBBBICB
Krotossjaaki, B.K.
Braacao, G.B.
O'Mill, R.J.
H7»
Journal of inalftical
Toxicology 3:225-23*
1
Ihtaol
108-9S-2
CC-B6-0
II 9«.It. HI W.85 C, BP 182 C. T? 1 aa tg at »0.1 C
Tissue
• 350
OCiM
• 351
DtlM
BIPOSOBE BOOH
D«raal
Inoestioa
Jllimcil
HRBOD
9C
OC
ins Bra
or cases
a) 15
b) *0
a) 39
b) 119
BUSS
a) 1.0-5.0 aq/q
cr«atinin«
b) 5.2-13.2 ag/g
er«atiaia«
a) lot gira
b) lot gi*ea
HUB | eilllll nrOBIATIOB
1
a) lot giTen | a) Coitrcls
b) lot giv«B 1 b) Vorkars espos«d to chloropheaols
1
1 Icrkats in herbicide laaufaetaring
I plaats.
1
| BfBBICIDES** UDVSTKZ&L PLANTS!
1 OCCOPlTIOItl B1ZH9S: PISTICID1S:
I fOPOHTIO» HPOSISE; BS1SU1BEEIT
| BITBODS; CBICBIIB OB61IIC COBPODBDS;
I tttlOlS; CIB1S1; 7BIBE
1
a) 11.97 » or - 11.60 I •) Besldaats lliinq 120-310 a fcoa
•9/1 | still site
b) 11.56 « or - 10.86 | b) Coatcola
KJ/I 1 B«asar«d « mo after Incident
1 >0.1 ag/1 fenad at least oaee in veil
1 «ater of study group
1
1 Bcsideats of East Tror, II. site of
I accldeatal rail car spill of 37,900
1 1, 197«.
1
1 Ciarrhea. aovth sores, dark vriae.
1 taraiig loath, reported by
1 significantly eore persons In study
1 groap than ia controls
1
I BISCOBSIl; OIXBZ: CCBPmTIK
1 BULUITIOIS; PBBBOLS; DBIHIB6 1»EB;
1 6BOn9 »T(B POlLtJTIOH; BETlBOinSS
BZIEIEBCB
Tan Koogaalen, p.B.
Klein, 1.1.
Draaaond. I.
19«0
International IrchiTOS
of Occapatioaal and
•5:5>«2
Baker, E.I.
landrigaa, P.J.
Bertozzi, p. I.
Field, P.B.
Pasteyns, B.J.
Skinner, B.C.
1978
Archives of
EBTiroaaeBtal Health
33 (2) : i9-«
-------
fttmel, c-ckJoro- ft CD
rkeiol. 3-ckloro- (9 CI)
tOf-U-0
C6-BS-C1-0
II 121.58. » J3.S C. BP 21« C
IlSStff
• 152
tlaoi.
viols
WWSflS 80 Ott
ilUTTIClI
HETBOD
BMC
inatra
Of CISSS
a) 35
b| U
BliGE
*] 1-i« »«/g
»l 32 -U D4/g
BUI
a) 19 ag/g
li| SI »»/g
[
GIIIUL IIPOSU-IOI
«| loia Canal rullmt*. *« (1C)
FCiltlra
l| tolwtMca. 1st (2) positive
Huge *n
-------
fhnol, p-ehloro- (8 ci)
Iheaol. *-cbloro- t» ci)
106-M-9
C«-«5-Cl-0
(I 12S.S6. H «3.2-«3.T C. SP 220 C
tissos
«33«
BlOOl.
• bole
JIPOS01E BOOM
imnxcii
RTBOD
HP 1C
IB8BSB
or CASES
a) 3«
b) 13
flies
a) 1-90 a«/g
b) lot applicable
mi
a) 29 «o/g
b) 2 a«/g
GiiniL nroiRHioB
a) love Canal residents. 29* (10)
positive
b| Tolante«r>. 8* (1) positive
laiq* aal aeaa of positive aaaples.
Tilaes corcected for tecofety
Closelr satched, sisaltaneois control
sasples >ere not pcorlded foe
•aalTsis aloig «itk those ftoa the 36
IOT» caaal acea r«siA«ata sa«pl«d.
lacklnq seaalavfal control or
litecatace data relative to the
siwiflcance of the lo» reailaea
toned ia the field saaples analfxea.
ao tefialte conclusions can be dra»n
froa the resolts reported.
lesldeats of lev Tork. Controls,
esplovees of the SaTlroaseatal
frotection loeacy aad oaiTcraltj
atadeats. lorth Carolina.
II« TOIK; 10ITR CUOUM; BLOOD;
Bitsnzgsii mooDs; CHLOSIH OBGIIIC
CCIPOH»S: ciioioBtmns:
IIIaCHLOROBIREII; POITCEIOBWHID
fI«»ITLS: POPVtlTIOl RPOSOI8
mtSEICI
Bristol. O.I.
1960
IP1-600/1-80-03*. *0
pp.
(heaol, p-altro- (• CI)
thesol, *-altro- (9 CI)
100-02-7
e«-»5-w-o3
M 139.11, HF 114.9-115.6 C, BP 279 C (decoap)
to
IXSSII
•3SS
Oriae
IIPOSOU BODTI
1IUTTICU
IZTBOD
SC
•OBBEB
OF C1SIS
12
I1IGE
0-0.5 ppa
8E1I
lot applicable
GEIIilt IIFOM1TIOI
fang* of seaas daring cotton spraying
caaaoa. RonthlT levels correlated
•ith orqaaorhosphate pesticide ase.
Cetton insect scovts, college-aoe,
•orkiag vithcat special protective
clctbiaq, bitalag » ith In 2 hr after
dallr «ork.
1C algns cr «Taptoa« of
orqaaophaspbate poiaoaiag.
levels iavereelr related to blood
ehcliaesterise activity.
IISnCIDSS; tniBOtlTSS; OIIIE;
atOlfS; OieitOPBOSfUTIS:
cccopHiomi guuis; tnnis
FIFEBEJCI
Barns, J.E.
Parker. B.fl.
1975
Archives of
Znviroaneatal
Contaaination and
Toxicology 3:3«*-351
-------
faeaol. peitacaloro-
tl-tt-S
C«-B-CIS-O
SI 26C.3S, H 190-191 C, B* 309-310 C (decaap), TO »0 an >« at S11.2
TlSSffl
• 356
Blood,
HEM
•357
Hood,
aania
«35«
Blood,
vkole
msiu lont
akalatlon
I>ka la tl 01
aiaimcai
BSTHGD
nic
IOUZ8
OF C1SES
I 2
1 32
0 T1
•22
a) 35
b| 12
illGE
) 1.68-1.15 ppa
) 0.116-1. OM ppa
) 0.015-0.055 ppa
a) 0.15-17.* ppa
b) 0.02-7.70 ppa
c) <0.01-S.«0 ppa
4) 0.02-7.20 ppa
a) 3-39 ag/«.
b) 3-15 ng/g
(III]
mi
a) 1.72 ppa
b) lot given
e) lot given
a) 3.7» * or - 3.99
ppn
b) 1.72 * or - 2.02
ppn
cl 0.25 * or - 0.88
ppn
d) 0.32 » or - 1.25
ppn
a) 13 ng/g
b) 7 ng/g
P.BB) •" "
61IEI11 IIFO1UTXOI
«) Girls, aqca 2 and * yr. Iron log
teae «itk 0. IK on Interior mod
nc face, 0.2f «
-------
Chenel, pentaehloro-
67-85-5
ce-H-cis-o
>« 266.35. HP 190-191 C. BP 309-310 C (deconp) . It 40 H
at 211.2
(COITII32D)
IISSOE
4359
Urine
4360
Orine
EXPOSURE ROUT
Inhalation
Inhalation
IHLRICIL
BET HOD
lUBEEB
or CISES
a) 11
b) 33
e) 1
422
I1*GZ
a) 2-87 ppb
b) 1-7 ppb
C) lot applicable
a) <0.01-7.80 ppn
b) <0.01-2.40 ppn
c) <0. 01-0. 40 ppn
d) <0. 01-1. 00 ppn
8E1I
a) Wot given
b) Wot given
c) 216 ppb
a) 0.95 * or - 1.93
ppn
b) 0.27 * or - 0.56
ppn
c) 0.01 » or - 0.05
PP»
d) 0.03 * or - 0.18
ppn
GtlZBil IITOBimOI
a) log hones residents
b) controls, untreated hoaes
c) 2 yr old girl fron log hose sith
0.11* on interior vood surface, 0.29
ng/cn n in air
logs dipped er sprayed with 5*
Fentachlorophenol
Kentucky residents of log bones bnilt
retneen 1975 and 1971 Controls.
10 pentachlorophenol-related health
croblens.
KHT0CKT: (DOLTS; CHILOREI: BLOOD
S1BOH; U3IJI; roiGICIDBS; FOFDLITIOI
HPOSORJ; PBE»OLS
a) Open-vat sood treatecs
b) Pressnre-tank rood treaters
c) Parners or pest control operators
d) Controls
Occspatlonally exposed subjects or
centrols in HI.
Increases in innatnre leucocytes and
rasophils, plasna cholinesterase.
alkaline phosphatase, gnita globnlin.
and nric acid. Decreases in serai
c«.
I111II: 1D01TS; BLOOD SERB"; OBI»H;
IIR1CRLOIOPBEIOL: BEILTB B1ZUDS;
IinaSTRIlt IIBOSPHEIES: IIBU1TIOI
SEFEREHCE
Belt!, 8. I., Ed.
1980
Chenicnl Regnlatioa
Reporter « (26): 823
Kleiner, B.s.
Vong, L.
Sato, 1.1.
Beicbert, B.L.
Korsak, R.J.
Rashad, H. H.
1980
archives of
Environnental
Contasination and
Toxicology 9:715-725
00
Pbatol, 2,«-Jichloro-
120-83-2
C€-B«-C1J-0
II 163.0, IP «S C, BP 209-210 C
TISSUE
1361
Blood,
•kale
t
t
I
*
XXMSOtB SO DTK
\
\
t
IMLniClL
RETWD
me
1
t
«
M01IIR
or cisis
«l 35
b) 13
t
_l
I1IGS
-
•) lot applicable
b) sot detected
1
«
i
IE1I
•
a) 5 ng/g
b) lot detected
\
\
GlIEBlt IiroRUTIOl
a) tove Canal residents, 3* (1)
pe«lti*e
b) Talnn teecs
lean of positive sanples. Talnes
corrected for recovery
Closely Mtchcd, sinaltaoeons control
saeples vere not provided for
analysis along vlth those fron tne 36
love Caaal area residents saspled.
tacking neaningfol control or
literature data relative to the
significance of the lo» residnes
fcand in the field sanples analyzed.
no definite conclasions can be drawn
Cron the resalts reported.
Issidents of lev Torr. Controls,
eiployees of the tnvlrouental
Protection agency and (Diversity
stadents, lorth Carolina.
Ill TOM: 1CRH CMtOUIt: BLOOD:
aitsoBmni IRHODS: CBLORIIE oBcinc
ccuponios; cau>BOBtit»ss;
nniCVlOVCBIRllt: KUTCBIOBHITID
1 fUBllTLS; TOlnUIIQl nCOSTIBB
1
lEfERHCE
Bristol, 0.*.
1980
EPJ-SOO/1-80-036, 40
pp.
1 l
-------
Phenol. 2.»,r-tcichloro-
C6-S3-CU-0
Rl 1*7.5, IT 2S2 C. It 1 •• 04 at 72 C
IISSBI
*3C2
Blood,
•hole
EITCSVH tamt
Hitmen
MTBOD
8PLC
•
IDS in
OF cms
a) 35
i) 13
UK2
a| 2-3 ng/g
t) lot detected
mi
a) 3 »g/g
b| lot detected
1
1
efttm iBTOSBMiot
a| lore Canal residents, lit (t)
positive
b» Volvftteera
tange ago Be an of positive staples.
Values corrected tor recovery
CloselT Batched, simltaneons control
saaples me not provided for
aaalTsls alcng with tHoae Croc the 36
Io»« canal area cesUeats saapled.
lacklaq aeaninqfal control oz
literature data relative to the
slgalf tcance of tke lev resificei
fooBd In tie fleU sacples aoaljiea.
ae definite conclanioas can be dravn
Iron the reavlts reported.
l«>llents ot ••• tort. Controls,
cnployees of the InTicotaeotal
Protection locncr and naiTerslty
etgdents, lorth Carolina.
Ill JOtK; Km ClBOLUl; BLOOD;
HIlSriSMKlT BBTBOBS; CBLO1II1 OSG1HIC
CCIMBSBS; CBlOBOBEIIHESi
l»tCRIOICBtn»Z; POtTCBLOBUlTEB
tlPS!«LS; VCnUTIOI CTFOSDIE
IEPESIBCE
Bristol, D.I.
1980
IP»-600/1-80-036, BO
PP-
Ihenl. 2,»,«-tric«l.oco-
86-06-2
C6-B3-C13-0
» 197.5, HP 68 C, BP 2M.5 C, TO 1 an Hq at T6.5 C
N>
-P-
VO
4363
Blood.
AVtltllCAl
BETHOD
HPLC
BUHBES
07 CUES
a) 35
b) 13
luci
a) 2-« ng/g
t) lot detected
(HIT
""
a) 3 no;/g
b) lot detected
PiGE)
G"mt "»««««•
«) love Canal resldmts, «» (2)
positive
hi Tolonteers
Bange and nena of positive sanples.
values corrected for recovery
Closely natched, sianltaaeau control
sasilec *ere not provided for
analysis along with those Iron the 36
love Caaal area residents «a«ple«.
lacking neanlngfnl control at
literatnre dnta relative to the
significance of the lo> relidoes
fcond in the field sanples analyzed.
no definite conclnslons can be drain
fren the resells reported.
lesldents of lev lock, controls.
•itloyees of the Invironnental
Protection tgency aid eniversity
students, locth Carolina.
in tOBi: ions cuouBi; BLOOD;
flUSTJBMMT BIT BOBS; CHLOBI1B OBG»»IC
ccaioiiDS; CBIOBOBHZZIIS;
IIPHIITLS: POPHUTIOI EIPOSOIE
tEFIBEICE
Bristol, D.».
1980
1P1-SOO/1-80-036, ao
pp.
-------
fhaaol. 2.4 Fro* cord coatrol*
aaol/1 | «] Fro* infants with Titaaln
i) 1.76 » or - 0.31 1 tipplecent
aaol/1 1 (1 Froi infant controls
e) 2. 56 » or - 0.43 I tea* of 10 aa.
uol/1 |
f) 2.73 * or - 0.40 I 506 pregnant voau, 613 pregnant
aaol/1 1 centrals. Scotland.
j
1 SCOniBD; DinCT ntSDOB; IDOT.TS;
t lirins: BIOCI: OBBIHCIL COBB:
I ClICIUl; BTDWITCHOHC»LCIUBOIS;
1 Bisnsng; BIBSULS: nosnosas;
1 T41C? BLBBCB1S; TmnTB' PS OIST5j
I BIIZBlt BRIZOLISB; PIBGItlCT
1
|
a) 3. 51 « or - 0.07 f a| Kaasas Cltr. ts, harl-iater ar«a
•1/100 *1 | b) Kansas City. BO. soft-Hater area
b) 3. 66 * or - 0.04 |
•g/100 il | IS and to reslients satched for age
1 <>*aa agas 37 ana 37.7 rr), sex.
1 langtli of cesldeHe, larltal aad
1 aeonosic states, occapation, naalwr
I ef children, ssoklag habits, it, st.
1
1 I* hari-ratex araa. significant
1 licreaw in kyperteaslon, ICC
1 afenocsalitie*. and kTPecariceaia.
1
I iiisis; iisseni: anBits;
i ciiatoTiscnu DISSISSS:
i Btmnisxci; sroon snoa;
t c«aPUiTiTt triminois: cimitii:
I CUCIB«; cncBini: imtius:
I tieissiva; t«os?Bo»oos! FQMSSIOB;
I sctiasj me: Bioiccmnmoi:
1 ninais BIID
i
IIFESEICB
Cockbar*. F.
Belton, I.E.
P«rTl», I.J.
Giles, B.B.
Browa, J.I.
Turner, T.I.
VllkiBSOl, E.g.
Focfar, J.O.
Barrie, I.J.B.
BeKar. G.3.
Pocock. S,J.
1490
British Radical Jomrnal
28 1(6232): 11-14
Biareabaaa, B. t.
Fleischnan, I.I
9a*n, 3.
mold, J.
1»7S
lancet
H19H):100I-1016
OKI use)
10
01
o
-------
flcarkoraa
7723-ia-o
i
in J0.9737C, m M.I c. B* jga c, n 19 •• i« *t 12? c
(COETItOED)
ussvt
a 367
Bale
• 36*
Sidaar
4369
Llw
XFOS01! ROOT*
luimcit
BET SOB
n
11
•01 US
OF C1SIS
U 8
e» 12
at »
W 9
c| 11
11KS 1
t
a) 2*5-39*0 *q/1
hi 373-300* «g/9
fl 215-3310 ao/j
a«t «t
m) 606-3019 aq/9
b) (22-2315 09/9
c) 260-3600 og/5
•at «t
(III
•Ell | eSBItll nrOIUTIOl
1
1
1
1 Bavta*. 2* npraawitatl**
I f ca— aaaliaia tractaaata aca
1 tabaUtad. Ika feasibility of a
1 Idllfltlc, ao-nak palter for hair
1 aaalyala l« eatlla«d aad sapportad.
1
1 mm: TSUI nmBts: Din:
1 IDSTBaLTa: BUSVBEIEK BET1ODS:
I eftus; FMTCTS', COBFIUTITC
1 iiiioiTioBS: uonn*; IBTIBOBI;
1 ISSEBIC; Blind; nOBTBE; C1MIOH;
i cuciuB: cnenBi: cBionoi; COBIH;
l ccppM; eiiina: esBiiinoB: COLD:
l lemiu 1101 j LunuTOBj mo;
1 B16BESIII: B1M1ISSE: SEECOBT;
\ tctrmDinB: ncin: THostBoiQS;
1 {CTJ3SIW: 10BIDIOB: SBXinOB;
1 SIIICOB; SILTEK: SODIBB; STBCWTMB;
1 sotroi: ti»: TTTHIBB; TOIGSTIII
1 TIIC; HBCOBHTI
1
1
a) 829 »q/g 1 at Coatcola
b) 1157 nj/f | b) Berkac I
e) 12 £9 ag/g 1 c» torkat qreap n
•«t «t |
leiliu | caoaasai Mflaery aid saaltac
1 aotkaca, aq«a 5S-76 yr, crpoaad to
1 kaa*r aatal« 1-3 4aea4«a. Tla*
1 batavam tatitmaat a»4 tactk 0-1. S }t
I la icoap I aad 2-19 re, Itott II.
I ccatrol*, a<)«» «3-72 yr, ako U«l SO
1 ta fcoa tb« factory. s*ad«>.
1
1 SflOBB; Claims; HDinS; llTBBi
l Hies; coBfiiHiTE snmTiois:
t ntasTBiii H6II11: msmcBim
1 BIT BODS; lITlBOtT: IBStllC; CIDBIIB:
1 ctsm: CBKISIIJB; coBitt; COFIE*;
1 GCIO: IIOC IlRItBOB: HID;
1 BIB61IESE; BRCOIT; BOtlBIlBITS:
1 ciamnias; IOBIDIOB: SCIBDIDB:
1 SIIIBTVl: SIITEB: TIB; TOISSTEB;
i 1ITC: BSalTB BalllBS: IBDVSmn
1 (iins: SBiiTfflj; Tsuinivi
1
1
a) 1876 «g/g I a) Coatcola
b) »10 «j/9 1 B) Mtkac group I
e) 1S2« ag/9 t c) lortar qtoap n
Bat «t |
Badlaaa | cacaaaal raf laacr aaA aaaltac
1 aotk«ca. iqaa 55- 76 yt, axpoMl to
1 kaarr avtala 1-3 4aea9a«. Tlaa
I t«tM«a ratlraaaat »4 Oaatk 0-1.5 fc
1 1m group I aid 2-19 yr. groap It.
1 Ccatrols. «g«a *3-72 yr, *ko Unl SO
1 tt {TOB tka factorr. Saaflaa.
i stiBE*; cioMMS; Kirans: imi;
1 10BSS; COBP111TITE XT1101TIOBS;
1 IIOOSTEI11 ilOIIBE; VSlSOBEinT
1 B1TSODSJ iniBOtlj HSniCi ClDIKtB;
l CISIHB: cRBoranc coani: corpus
1 SOLO: HOB; 11BTB1BOB; tMD:
1 ii»ciwst: BiictjiTs MtTBDinm:
1 (lOSfBosvs: EOTIDIOB: ackisira;
1 siiifin: snrts; in: IOBSSIEB;
1 tlBC! BEtLTB BU1SOS: IfDOStllU
1 fllBTS; 3BHTEBSI TEUVIIOB
1
C f>61)
BEFBBEICE
Cbittlcboroagh. a.
980
Seianoa of tk« Total
BTlroBieat 14:53-75
Brnn«, V.
Bordbaro.« Q.
feat«c« V.Q.
1990
sci«*ca of the total
E»lrt>Ba*Bt 16:13-35
Broaa. D.
Bordbacq. G.
Faster, ?.c.
1990
Selaaoa of the Total
Eavlnuatt 16:13-35
N)
tn
-------
Ikospkoras
1723-1»-0
t
tt« 30.9737C, IP M.I C, BP 280 C, vp 10 » Ig at 127 C
(COBtllTOD}
TISSOS
«370
Inng
*371
Brine
1
EIPOSOIS BOUT:
lagestion
» MI men.
BETHOD
11
.
Chen
BOBBES
OF CASES
a) 8
b) 9
0 11
10
BIKE
a) 38»-2«21 ag/g
fe) 67«-3516 ng/g
c) 1«(-98«* ag/g
Wet rt
lot given
I
mi
a) 777 ag/g
b> 898 ug/g
c) 799 og/g
Ret vt
ledians
0.69 » or - 0.1*
g/day
etIEUl IIPOSEITIOB
a) controls
b| torkec gronp I
c) Vorker grovp XI
Cecensel refinery and sselter
lorkera, ages 55-76 yr, exposed to
keavy aetals 1-3 decades. Tine
retveen retirenent and death 0-1.5 yr
in gronp I and 2-19 yr, group II.
Controls. ag«s *3-72 yr. vho lived SO
ka fron tke factory. Sveden.
SIBDBH: ciDifEBS: Kioisys; IITES;
IBBSSs COBPiBaTITB mLDlTXOIS;
IIBOSTSI11 BTGIEBE: lOiSOBBBDIT
BETioDS; inxniy; IBSSBXC: CIDMIBH;
CIStffB; CBBOBIDB; COEUT; COPPE1;
(OLD; IIOB; ItBTMBim; IE1D;
BIBGIIESB; BBSCOBT: BOLIBDEBHB;
fK)SPttO«9S: 61TBIDHJB: SCIBOXOB:
SfLEIlng; SIIfH; TIB; TDBGSTCT:
TIIC; BUITB B1Z1BOS; IIDOSTBIll
Pit ITS; SiBLTEBSi TEUnXDB
less after daily intake of 1.3* * or
- 0.28 g. Data fron *7 7-day
experinental periods.
University stadents and enployees, a
avrse and a teacker. Balliparovs.
ages 19-29 yr.
Fkospkoras talance slightly positive.
reflecting adeqaate intake.
IHEESSE*: OBiiE: iioi: ciiciim:
ilCIESIIg; RIIBBILS; PBOSPHOBdS;
CIETS; IXIZBlt BITIBCLISB; PBESI1ICT I
1
EERBNCE
Brane. 9.
Bordberg, 6.
Vester, P.O.
1980
science of the Total
Environsent 16:13-35
(she, J.E.
Sckotteld, r.l.
Gran. 8.8.
tnecican Journal of
Clinical Intrition
32:286-291
1
1
K>
<_n
N3
Iktkalie acid, bla(2-«tkrlbezrlt ester (8 CI)
1.2-Benzenedicarboxrlic acid. bla(2-ethrlkezTl) ester (9 CE)
117-81-7
C2*-B3B-O*
I« 390.5*
TISSOS
• 372
Idlpose
«373
Spleen
IXPOSITBE BOOTE
1I1LTTIC11
IETROO
t
1
BOUSES
OF C1SES
BalG!
BE1I
SEIEU1 IIPOSUTIOI
Beview of effects oa biological
systess with enpkasis on safety
CTalnation aad levels encountered in
aedical devices
iriwsi TTSSOE: spun; BSTII«;
IBTHLIC iciDS: reriBouss;
nitBOLIIES
tevie* of effects on biological
ststens vltk eapkasls on safety
evaluation anfl levels encoaatered in
aedical devices
ttltOSE TISSUE; SPLEtl; BEVIZV;
tmuic tens; BSTIBOLISH:
mnOLTtis
EETEBEBCZ
Thoaas. J.I.
Darby, T.O.
Kallin, B.F.
Garvin, P.J.
Hartis, L.
1978
Toxicology and Ipplied
Pkarnacology *S: 1-27
Tkonas, J.i.
Darby. T.D.
•allin. B.r.
Garvin. P.J.
Hart Is, I.
1978
toxicology and Ipplied
Pkarnacology «S:1-27
-------
Ilatiaaa
74*0-0«-«
Pt
It* 195. Of, IP 1773.5 C. IP 3827 C. TP 1 u H« at 2600 C, 10 as 89 »t 29*0 C
iissirs
»37t
HlpOM
»37S
BlOOl
«376
Bair
•377
Kidner
BXPOSRSE BOITE
aflinXCaL
H ETHOS
US
us
us
us
IVRBEt
or CISES
0
83
.
283
10
suet
lot aiTsa
lot given
) lot git«n
] lot glvaa
«J lot giian
lot glraa
lot glToa
nn i SBiiui iiroBuraoi i IEFBBEICE
1 i
i i
I I
1 <1.3 ppb | a) los lagalaa r«sld«a.ts | Jotaaoi, D.B.
I ». ? ppb | ft) Occapatleaallf «xpottd | PreToBt. l.J.
( | Hilary, J.B.
I latopalas, los Itgalas, 12-74 TI olds I Caaau. D.E.
| tit » 51 yt oU *aok«r »ho »U«8 uA I BoMif«U. J.B.
I fioc«ss*d ft. Pi it Ottirio. | H7S
1 | IP1-&00/1-76-019, 235
| tZTlLS; niTIIDI; PUUIim; t!U»J | pp.
t (QPOltnO* IHOSV1B; OCC1»lTIOItt |
1 gillBIS; CIUPOSIH; IDTOPSItS; |
1 tlOOI; XI tills : SPLBZI; Bill; OSJiE; |
1 ivies; mscus: impost TISSVB: i
I inra; comiuTiTB miiatiois; IB* i
1 J1BS1T; Cllltl; milSl atROBOTITB |
i i
I 1
a) <3.1 «g/100 mi [ a) los ia««l«s aad laacastn ( Johiwm, D.J.
b) 0.0*9 aq/lOO ml I taai«««t«. laolTlaaal inn; CO«P»I»THI ininiuoas: m i
I JtBSBTi CIIIC1: iniM; mOHOTITI |
i i
I i
<0.05 a?/g | lot lioalcs lad Lancaster EMlOots I Johana, B.S.
1 I vc«ost. t.J.
1 Callforalaaa llTiaq ao«n»i»4 froa a 1 TUlar?, J.B.
1 (r«*»ay 1> los iigclas or 1* tka klot 1 Caaaaa, O.e.
1 ats-art roctea of Lancalter. lq* I BosaafeU, J.e.
1 gtoaps; 1-61. 17-3*. 35 or aot« TC> 1 1*7i
1 «0t «alt«. »W loa-ihlt« ia las | BP1-«00/1-7C-019. 235
t laaalas. 80* vtita. JO'S aoa-«1iit« U I pp.
1 lageaator. I
1 1
1 tit us: IIIIHOB; riiiiMOB; IBID; r
1 (OPIUTtOI tXPOSVKZ: OCCHTMIO111 |
1 UZaBES; CILirotlll; iDTOPSItS; |
1 BtOOD; CIDKIS; SfllH; H1IBJ VHIB: 1
| IOI6S; SDSCIES; 1DIP03! TISSUE: I
| IT1B1; COBTlMTln mWitlOIS; IB1 t
I iiisBT; emu; inriia; HITOBOTITE t
i t
<2.« ppb | tea *mo*laa milnta | jahasoa, D.B.
1 1 Frawst. t.J.
I autopsies, 12-7» yr olas. 1 TiH«ry, J.B.
1 1 caaaan, D.B.
1 tnus: TimnB: PUIIIIOB; LBUI i nsoafeid, J.B.
| iOSOllTIOI tlPOSBK; OCCOPKIOail 1 1»7«
1 Bins is: cuirosiii; IVTOPSIBS; i tM-«oo/i-7«-o». 23$
t HOOD: titiiTS; snEBii BIIB: OBIIB: i pp.
1 iwesj aasciis; IDIPOSE nssoz; i
| tltt»; COHPalltlfB BntVltlOU; IBB 1
1 jt»BT: ciini; BniK; IOTOOOTITI i
i i
tint MGE) '
-------
ruttm
7WO-W-*
Ft
»M 1*5.09, I* 1773.5 C. B* 3827 C. T» 1 «• »9 «t 2COO C. 10 •• 84 at 24*0 C
tcorcmmi
1
1
1
1
ttsssi
«J7t
tl«r
«37»
t««
«3«0
B
•Ot fiTU
BMB i sBBitti imiiraoB I immcs '
i i
<0.2« ppb | Io» 1>9*1«* cai4mti | Jaks«o>, ».«.
1 1 *r«TO»t. S.J.
I lltapiiM. 12-19 it old«. | TillMf. J.B.
1 1 Camu, 9.B.
I sntis; KJimi: »iu»m: t«»; t lowitcu, i.g.
1 rerramoi nrosni; OCCPPITIOMI j i»7«
I IIM1C3I CIIIFOIIU; kITOFSIBSt > t?t-«00/1-7«-019, 235
1 HOOD! KIBMIS; SniH; Bill; UHII; | pp.
1 idlest nsctts; UIKSI nssoi; t
I inn; cotPtuTm inumois; tvi i
I jetsrr; cuict; BIBIMI totontm i
*) <1.3 ppb | •) tos Ii9«l«i t««13«ta | Jokiwom. B.S.
») 3.T ppb | t| Oec«p.tlo««llr •rpaOT4 | tmemt, t.J.
1 1 Till try, J.B.
I litop«l««. to* l««*ln. 12-7» yr alts I Own, ».».
I »a • 52 Tt eU rto *ta«« ud I Boamtcld, J.B.
1 fioeMMt Ft, Fd i» Oxterie. 1 im
! mo., »«mi, F.UOI.B, lun ! »f-*°fl/1-7<-ow- M5
t toinmoi nFosoii! occmiTioiti i
I milts: cuiroinii inoFsiis; i
1 BIOODJ nntis; spttM: BIII: unrs; t
\ tnss: iffsctcs: IDIFOSE Tissoi; i
I Hint coRpmnrs zntnnois: 13* i
I JHSBT; ciMct; lima; anoaotm i
i i
• i ,'
«) <».» ppb | *> los 1>?«1<« n«t4«t> | Jok.wi. D.B.
b> 2S.O ppb 1 t) Oeeapatloully •zpowd I Pr.TMt, J.J.
1 I Till«j. J.B.
1 »ltop»l«8, m li^ilm, 12-79 ft olds I cum. B.E.
t »d * 22 TT old nokir
-------
»t
m.«9, 0 1773. S c. BP 3i27 C, TP 1 M Rg «t 2600 C, 10 •• Sg at 29*0 C
(coniivio)
nssn
nn
Vrln
mosnu BOBtt
iiumcii
RBTBOD
us
mm
at cms
a) 213
b) <
•MSB
a) tot glim
b) 0.23-2.58 ig/1
nu
a) <0.6 «oyi
b) LOT 09/1
6EIH1I I1TOI1UTIOI
a) lo« lag«l«a aid la»ea«t«r
z**id«Bts
11 Oce«patlo»llT «xpowd
CallteTBiaac li.Ti.Kj domviad from a
fr*««T !• los 1*9«1« or ii th« higk
ItMrt c*qlo> of lamca«t«c. kg*
qrotp*: 1-K, 17- 3», 35 ot mor« jr.
COf «kit«. *o< «m-«Ut* li lot
U4«l«s. ««« *Ut«, 20« UB-vhit* IB
I>ica«t«c. !•« J*C<«T r«fi»«rr
•ottir*
JITU3; H-ltlWH; fltUDIDl: LIU;
to?nmoi nposmti occnettioiti
•nuts: ciinoint; IOTOPSIIS;
HOOD: ximiTS: snt»; BUI: ami:
i»«st nscus: igitosi nssns;
inn: comtuTin imautaist HI
JIISIT; CtllDl: 8II1BS; IDTOIOTITS
tmisicx
Johaioi, 0.1.
PrVTOBt, B.J.
Tlll«cr> J-3.
Caiun. 9.1.
«OMBt*U. J.B.
1«7«
IPl-«00/1-7«-Ot9, 23S
PP-
PlubaM. cklorotrirtkyl-
1067-M-T
e«-«is-ci-Pb
•* 324.9
1ISSDI
«3*3
idr*Bal
glaaft
»3»«
•loot
•3«S
IralB
txposoiB tons
1ULT1ICM.
BRBOD
«8BES
OF CiSES
met
-
HIM
etmii nroiamoi
>6»: nsBis: POOD
cotMHiuTioii rons: usoLin;
enmc tmcrs; mvsniii
icciDtns: imitRai: HBBH tstis
**Ti«. ToiicaklMtlo aad to lie
•ftcctB of ocgaaolBad coapoaBdv*
eirtBat occiiitloul and
•BTlcoaBoBtal (ipoiit* data.
•IITtO StlTIS; SVBOPt; IEW CietRIC
cctKmiBS; imoBotm; in PcitmoB;
<«iciiosti: ftsBis; FOOD
com«m?ioi; runs; sisoini;
entile iincn; WDUSTSIII
iccieiirsi iHuinov; UIBII uiu
Kria*. ToxleoklBotles aad toilc
•tfocti of otqaaolcad eoapoaads,
e«tr*>t ocetfatloaal aid
•artragMirtal KBOBBC* d*ta.
eiltlt STITtS: EIBOPI; USD CB61RC
coiFOTiDS; amoRoiiTB: in PCIIOTIOB;
ciiciKaii; nsBis; TOOD
COITlRIIHIOfi TOESS; 51SO1IIB:
cnrrrc CPTICTS: noDsnui
icetgiRS; tmunois isti* IBEIS
t
tirBIEICI
GzandjaaBi p.
IlclMl, T.
1979
Kealda* Barivwa
22S97-1M
ecaaljoan. f.
IlslMi, I.
1979
ItBSldW S«ll«»S
22:97-1**
GzaBdfcaa. p.
Uelaea, T.
197»
s«si.4m BBTlwis
22:97-1*1
(HIT pun
Ul
(Jl
-------
1«7-1*-7
C6-B15-C1-M
«I 329.1
Ccomvtm)
TISSUE
«3«6
B««rt
»387
«3I8
4390
•aacccas
«391
I
EIPOSBBE BOUT
immcii.
IITBOP
rrasn
or c»sss
BUGS
m> i 6MI1U xmtiiTxei i EEHSEBCE
i f
i l
1 Mvlo*. ToxicokiMtica- and toxic 1 GraadlaaB. P.
1 «f facts of orgaaoload coapoonds, | Bi«lMB, T.
1 cort«Bt occvcatioaal aad I 1979
1 €BTirOBB«Btal *xponr« data. t B«sU«« B*T!««B
1 1 22S97-1U
I IBI1IO ST1TH; ITOOPB; LI1B CBGMIC t
1 CCBPOVflS: IROBOTIVE: III PCLIKXOB; |
l CHCIBOSH: USB**; torn i
| CCRlBIBinOB; T«BXS; 61SOIIBE: 1
l SIBRIC tiptcxs; IIODSTBIU i
l icciDEBTS: iwiiMiati trsBtf IBHS i
i i
1 i
1 Bavie*. Toxieokiaatiea and toxic t 6raadj«u. P.
1 affects of orgtooUad coapoaala. | litlatc, t.
1 cgtrut ocncatioaal and | 1979
1 " 1 22:97- 1M
1 oimg sTiTis; sraopt; tew nsanc i
1 COBPOmSS; iniOSOTITE: III PCIIRIOB; I
t CISCIBOBIU fMIIS: fOOD |
1 COBIIBIB»IIO«: VmtS; S1SO1IIB; I
I eiBtric crrscTS; mosisiu i
l iccxpnrs: iraitiTxai: nati IBUS i
i i
1 l«»ie». Toxieoklactle* aad toxic 1 CrudTaaa, P.
1 •tf«eta of orouolMd oovpooads. | Bialaam, T.
1 cirtmt eccafatioaal aad I 1979
1 *atiroaa«t*I •xposace data. | P«»ia«« g«ri«r*
( 1 22:97-1*8
1 BBTTXD 1T1IIS; EOBOPI; »AD CJSMIC I
1 CC9POOVBS; lUTOHOTITB: 111 POllVTIOB: |
1 CIBCIBDSK; flSBES; FOOD |
1 CCBTIHMTIOB; THUS; eiSOIIBZ; |
1 CIBRIC SriBCTS: IBODSniU I
1 iccnrars: IBBIUTIOB; TOBIB IBIIS i
i i
i i
I !•*!•*. Toxicokiaetica aad toxic I Graadjaaa, P.
1 aifacta of otvaaolmd ooapoaads. I Bielaaa. t.
1 citnat cceicatloaal aad 1 1979
1 »«Tlro»B«0tal oxposat* data. I Pesidne Sawieas
1 t 22397-1W
| VBXRI SIIIIS: EOBOPB: 1113 CIGIBIC I
1 ccBpcrais; ittoRcnrs: ax* rcivmoi; »
l CHCiiosm: IXSBES; POOD i
l coBTiixiiTiOB: raiss: eisoim; i
1 CIBRIC inters-. IBBOSTIIU i
l iccxonrs; IIBIUTIO»: OBBM IBIIS i
i i
1 l
I !€*!•>. toxicoklMtica aad toxic I Grand 1«aa, p.
1 *ff«ets of onjaBol«ad coaponada, I Heist t, T.
1 corrent cecacationtl »d I 1979
1 tiTlroBMBtal •xpomca data. I Besldaa B«ris»a
1 1 22:97-1*8
1 OBITED suns.- tmort; IEU cseinc i
l ccBpcgBos: amoBtmtx; us paimioB: i
| CISCIBOSIB; TISBIS: POOD |
I ccBTiiiuTioi: rnns: eisaxiR; i
1 sunic srrecrs; IIBDSTSUI i
1 iccntRS: iBBtunai; OBBH IB us i
i i
1 l "
i ««»ie». Toxlcoklactics aad toxic 1 eraadjoaa, P.
I affacts ot oigaaolaad coapoaats. t BlelMa. 1.
t c«rr«t eccatational aad I 1979
t «niroBa«Btal vxposnr* data. 1 Casidne S«rie»s
t 1 22:97- 1»»
1 tiBTno sTiits; IBBOPE: LIID CXCIBXC i
1 CCBfOVBOS; IVTOBOIXTt; KB PC1HJTIOB: |
t OBCIBOSIB: IISBE5; MO9 I
I ccBTMiiiaTiOB: rnns; cisotnt: i
l eiiRic inccis: IIBUSTSIII i
| ICCIfiinS; 11S11ATIOB; OTBH 1511S |
' - t
-------
eklo»trli«tkrl-
•1 287.77
tissm
•392
Drln
BIMSDtl lOtRC
itiimcii
BETROD
iraitt
OF C1SSS
UMH
BSlB
.
-
eniui xtroBBiTiai
(«!•«. 1axicoki«*tie* »»4 toxic
tlfccts of orgaaotead coipouda.
decent oeemcatlaul *ml
(ETicoiMitil eiponr* data.
tlTTZD 3TITI5; 101OK; IZ1D CBOHIC
coBEOtmos: IBTOHOTITB; in raionoi:
CIKttOGtl; TI58K; MOD
ccntBiiMioi; rons; cisaini:
eiimc ti tiers; iiovmiu.
ICCIDMIS; IIBIIITIOI; 5BB»Ji 1BU3
BITHEIC!
Ciaaajui, t.
li«lMD, 1.
1»7»
K»llie E«tl«»»
22s 9 7- 1*S
, t«tr>«tkrl-
78-00-2
CI-BIO-Pb
g« 3Z3. »5. 4? 125-150 c, BP approi 200 C, TF 1 m Bg at 3«.» C
tiasai
•»3
11004
139*
Btla»
nrasmc EOTTI
UllTTIClI.
BITIOO
•TIBBn 1
or cisss
SU61
mil
Sttllll 1IFOIB1T10» |
1
1
•cftn. ToxloaklMtles aad toxic
•fleets of orgaaolaal cocponds.
cictvat occafatiooal and
««Tlroi*««t*l •xposat* data.
0»I1« SUTtS; fOton; UU CB6MIC
ccipotuss; unoaoTUB: in PCLIOTXOI;
CIBCIIOS1I; flSHBSS IQQD
coiT»ii»»Tioi; rums; GISOIIBX;
EIItTIC XIItCTS: IIDOSTBI11
ICCIDIMS; nauiTioi: nsaii tiiu
f«vi«v. Toxicokiaetics and toxic
•tCcets of ocfaaolvad coaiiott»S«.
cocreot occafatioaal a»d
• evicoaMatal eipoavre data.
DIIIID suns: ztnoPE; iziv CRGIIIC
COBfOIJlDS; imoBOTITB; UK PCU.DTIOH:
ciBcnosH: lisa is; FOOD
cciriBi!HTio»: tans; eisotnx:
GIIITIC tillers: noosmii
1CCIBMTS: IIBltlTIOI; VBBtl 11US
tXTEBZICB
CC&aijc*D, f .
nielMB. T.
1»7»
gcsidie S«Tl«a
22:97-U8
Grand jeaa, T.
HUlMIL, 1.
H7»
Kealdae B«rl»s
2S:»7-1«8
Ln
-------
Tolybronlnated biphenyls (Bo postings i» CBiniR).
TISSBt
»39S
Blood
«39«
Blood,
plan*
4397
ood.
sens
ETPOSB1E WOT
gestlon
imrticit
MTBOD
8C/BS
6C/BS
6C-EC
BOB an i sites
OF C1S3S |
1
21 I a) 1.1-57.3 tg/mg prot«
I b) 0.03-0. CT »g/sg
I protein
1 c) 224-282 ng/eg prot«i
1 4) lot detected
I
I
I
I
1
1
1
•
1
1
1
1
1
1
t
1
1
1
21 | a) 0.13-10.2 ng/ng
1 protein
1 b) Wot detected
1
1
1
1
1
1
1
1
1
1
1
1
|
1
1
290 I a) lot given
1 b) lot given
1 c) lot given
1 d) lot given
I e) lot given
1 f) lot given
1 g) lot given
1 h) lot give*
1
1
1
1
1
1
1
1
1
1
1
1
1
I
|
1
1
1
»
nil i ciniu IIFOBIITXOI
I
t
a) 23.75 ng/ng 1 a) leukocytes. » exposed chenical
protein 1 icrkers
b) 0.35 ng/ng protein I k) Brythrocytes. » expos*! cheeical
c) 253 ng/ng protein | workers
d) lot detected I c) Beta-lipofroteln fractioa, 2
j «xpoeed ckeeieal workers
1 d) Leukocytes or erythrocytes, W
| csbjeets. including ezpoMd dairy
1 farn residents and controls.
1
1 Bichigaa ckenical workers and dairy
j fare residents exposed to Firenaster
j IF-C. Controls, dairy far* residents
j ie liseonsin.
1
I Stimulation dysfnnetioB of
j lynphocyt*sl tested *ith
| rkytohenagglitiBin and pokeeeed
I nitogen, especially in the * exposed
1 ekeiieal verkers.
1
| ICITBJO1II1TID BIPISITLS;
1 IlTtnOCTTIS; BLOOD niSHl;
I IIOKOCTTIS; HCHieil; IIDOSTtTIL
| IlirtS; IIDDSTBI11 ICTOSPHEBISi
| IIDCSTKI11 DISE1SSS: IISCOISII
I
1
a) S. 1* ng/ng protein | a) 4 exposed ckenical workers
b) lot detected I e) 18 sab-fects. laclwdiag exposed
I dairy fare residents and controls
1
I Blckigan cheiical workers aad dairy
1 farn residents exposed to rirenaster
1 EP-6. Coatrcls* dairy fars residents
I In llceonsln.
1
I Stinlatlon dysfnnctlon of
I lyapnocytes, tested with
j piytoheingglatinln and pokeweed
j eitogen. especially in the * exposed
1 ekenical workers.
1
| fClTBiOIIMTID BIPB1IT1S:
| UTTnoCTTcS; B100B FLlSBt;
| IIDROCTTIS: mCHIGll; IIDOSTIIIL
1 Fiins; iiDosrstai ITBOSPBEIFS;
| IICOSTBIll DISB1S1S; WISCOISIW
1
1
4.23 ppb I •! 1*» sales
2.72 ppb I t) 1(3 fenales
2.75 ppb | c) 0-« yr of age, 33 soblects
7.08 ppb 1 d) 5-8 yr old sales. »0 snblects
a. 32 ppb | e) 5-8 yr old fenales, 37 sablects
3. 18 ppb I f) 9-12 yr cf age, 81 subjects
3.»5 ppb f g) 13-16 yr old nales, 59 subjects
1.87 ppb t h) 13-16 yr old feeales, «3 subjects
1
1 lleklgan children living on
1 Pie-contaninited fans or children
1 censoeiag neat or nilk froe these
t fares.
1
1 lo significant association of
1 atnoraallties and seres PBB levels.
1 Significant negative correlation
1 tetween Hunter of reported synptons
1 aid oer«n PBI.
1
I FCITItCHIKlTlD IIPHBniS; B1OOD
1 si80«: CHn»in: ncwietii: nscoisii;
| TCtD COB1»1IHIOB; 1IIH11
1 tOPDHTIOlS; TUBS; COBFllVIIVB
| miUlltOIS; BtOIIIB 01111 1C
| CCBIO019S: Sit; X6B: BlaltB BIX1B9S;
I tins
i
UriBEICB
BobOI, J.
Snznkl, B.X.
Bexesi, J.E.
Bolland, J.F.
1980
Journal of
Bnvironnental Pathology
and Toxicology
3:3«3-37i
Boboz. J.
Suzuki. B.K.
Bekesl. J.6.
Holland, J.F.
1980
Journal of
Eavlroueatal Pathology
and Toxicology
3:3*3-378
Barr, R., Jr.
1980
Environnental Se search
21:255-27*
N3
Ln
00
-------
relrferoalaatad
l»o pe*ti»9» la
(cotnimo)
IHSM
•3M
•Ilk
•HOSm MDTC
1M1TTIC1I
IJTBOD
mm
or CISBS
UKI
m»
CEIfUt IIFOBBITIOI
_
l«i*v of Mr«aaat«r coattalntioB ef
cattl* e««d la Bickiga» ul
T«eon«4*tiau for anslag lotlwra
jipii: ignis; Hurts; ssn
Bisiisis: ntxr imn:
fOlinOinillD BIPHMTIS:
tCIYCHlOMIllIB BIPBWTLS:
iioiccomiiio*; mi iiriisins;
iocs coniuuTioi; rooos; LICTITIOI;
pofjiiTioi inosvn
unmet
Rilltr, I.«.
Tinb«rg, 1.
1ST7
Jonn*l at Pediatrics
*0 (3) -.510-512
.
tetwslM
1»
I
c.
100 M sg »t wo c
TISSVZ
•3*9
Hood.
aartta
a»09
Iraata
aalr
nosou SOBTE
Inhalatlaa
IHLTTICIJ.
BBl'BOD
US
mi
us
•BSSSS
or cisis
«1 2«0
b) 260
1
a) 31
b) 22
11TCS
a) lot gl»«»
b) lot gl»««
-
lot gl*aa
a) lot alvaa
b) lot gl*an
mi
a) a. 11 » or - 0.05
M^/l
bl *.32 + ot - 0.03
aaq/1
10S.O ng
a) 1359 ppa
b) 12W ppa
GEIIttl mOSIlTXOI
at taaaa* city, IS. k*rd-aat«r am
b) Kaasaa City, to', aoft-vatcr ana
IS and HO raaldaata aatch«d for aq«
laeaa aq«a 37 and 37.7 re) . aex.
laaqtk of caaidaaca. aarltal ana
«eoaoalc atatu. occapatlon, aaabar
of eklldcaa, aaoklag kablta, it, »t.
la bard vatac araa, algaitlcaat
leeraasa la fcTB«ttaaaleD. TCS
ataoraalltlaa. aad krpcrnrlcaaia.
I1IS1S; dlSSCVBI: 1DOLTS;
cijtiOTiscniit gissisis;
BtPISIEISIOl; BLOOD SBBUB:
CCBHSlTtTl miOHIOIS; C1D8HS:
CHCI09; CBBoaina: LITHIDB;
tienstnt; nosrsnsoos: POIISSIOB;
SCMDS; tllC: SlOUCCtrauHTIOl;
tlllKIIS 1HIB
( 1 saaplad at rat* of 1 1/aln, 2-10
ala aftat bnralag * arc vaiaiaq rods.
DilTcrsltr pkyalca shop, Tlorlda
Tionot; linns; Bi»TB: cucins;
cno>n«: cnomB: CCP»I»; IBOI;
HID: aiieiiisE: ncm: foiissiim:
SOlTIl; fnillOi; T»1BI1!I: II »C; 118
*oimto«: FOBIS; iievsmu
itMsrann; tiici nirairs
t| Coatrolt
laanisg dlsaalad and aerial 3rd aid
«tb grada atadaata la Caaada.
citcnu MSBSins: roussina;
SCCHJB; CUJBTOB; COB11T; COPPER;
isci: ism: uicmsz: ziic;
cncBinx; LiTHina; uncogT; sntis-.
nit: cnxtDizi: ciiiDi
1BTIRE1CS
Blaraabaaa. H. I.
Tleisctiaa, I.I
Icnold.'j.
1975
lancat
1(19ia) :1008-1016
•kselxzon, K.E.
Desaedelevc, E.G.
Johaasaov. T.B.
»ioc»e»ter, J. «.
197«
laaals of Occupational
IT?1«« 19:225-238
Pihl, 1.0.
1977
seine*
i»a(a3i3i:20*-20t
(HIT MSI)
NJ
Ul
VO
-------
Potassina
7MO-09-7
K
>t* 39.096, HP 63.2 C, BP 765.5 C, Tt 100 mm Bg at 590 C
(COBYIBVED)
TISSUE
M02
Bair
>>03
Heart
Ezposvn Boon
1BU.THCU
HITBOD
Plaae photometry
BOBBEI
OF CASES
al «
b) 7
BAEGE
a) 0.035-0.086 mSq/g
b) 0.068-0.082 iZ9/a
let »t
BUI
a) 0.063 * or - 0.013
aEg/9
b) 0.07* » or - 0.006
aSq/g
let >t
61BI1U IIFOEB1IIOI
l«rl*>. 2« t«pr«sentatiT«
Ft«-aaalysia tr«at>«nts arc
tabilat«4. Ike feasibility of a
tollatic, no-»«s» policy foe kair
analysis is out lined and sapporteij.
flTII*; TB»CI BIMSITS; BUB:
ItSTBiLIl; niSUBMZBT SBTBODS:
CIT1LS: PEOTZIBS; COIPIBlTIfZ
ETlinniOBS; 110BHOS; MIIHOIT;
ISSIIIC; BIBIUB; BIOB1IB; CIDRIDH:
C11CIDB; CnCRHBi CnOBIDB; COBilT;
CCFPIB: 3111IUH; GBIB1BIOB; COLD:
IOBIIE; IBOI: HBTBlBtlH: LUC:
SIGSISIOB; IUS1IESB: BBKCDRT;
cciTBomi; imn: PBOSPHOBDS;
pcTissran; SUSIDI09; sBtzBim:
siiicoi: sjiTKB; SOOIDR; STBcnivB:
sniroB: TII; TITIIIDB; TOIESIBI;
?i«c; zncointB
a) Sxlden death fros ischeiic heart
aiaease
t) Sullen oeath fro« ttaaia
Veatcicalar ayocardiva
< 60 TC olds
B1GIBSIOB: POTISSHJB; BZ1B1 EIS.B1SBS:
tiropsizs; BfisT: imis
I lirlBBICZ
t
Chittleboioagh, S.
1980
Science of the total
taTlroiMat 14:53-75
JohasoBr C.J.
Peterson, D.8.
Ssitk. Z.K.
1979
laericaa Joornal of
Clinical latrition
32:967-970
Piopaae
7«-98-«
C3-H8
SB at. 09, BP -189.69 C, BP -«2.1 C, TP 100 •• Eg at -79.6 C
TISSUE
MMAk
Breath
EIPOS02B ftODTZ
illLTTIClL
HETBOO
OC/HS
VORBEB
OF CASSS
_
BUGS
Vot detected— 2. 2 noXbr
(BAB
0 8 Qd/hr
GPItlll IirOBBlTIOB
•etabolias. Bo other details giYea
Cryogenic saipllig techBlqoe.
Bealthy eilitarr and civilian
eaployees, n.S. air force School of
l«rospae« Bedieii*, aaes 23-*7 yr. 3
stokers.
tlBZBUBS; CBIOTIHTBC 9TDEOC1BBOIS:
CBIOKtn OI6IBTC COBPOOSDS:
CBIOBOBSBZZBZS; naOBIBE COBPOOIDS;
III1TB; 1ICCBO1S; THIS; » DOITS
BZnBZBCS
Conkle J.P.
Caap, B.J.
Sslch, S.Z.
1975
Archives of
Environmental Health
30 (2): 290-295
-------
fropaae, 2-aitro-
CJ-I7-B-02
H 89,09, BP 170 C, TP TO •• Bg at IS. 8 C
IMSOB
sao;
Breath
BTPOSBBB BOBTB
iiiiTTicit
KTTOD
SC-BS
Of C1SBS
S« (3*7
staples)
MBSI
lot qlrea
•
mi
O.aos nq/1
Seoaetric
eiitUL urasRitioi
Masacad at 25 C aad 760 aa Bq
11.1V occvrraac*
loer aid upper oae-SlqM Halts
0.111 ud 1.3* ftoyi
laaltkr. t8-JS yr old. noaaMklaq,
artan blacks and Caucasians.
Cbicauo, II. Ilqldlr coattolleft
«Dcriae«tal eoadltloas.
CB1CBIIITBB BTDBOC1BBOIS; TOliTILE*
cesmc coBtcnos; HBJLHE HKIEBS-.
HHiUTIOl: 5BT1IOLISB: BETlEOlItES:
popirnTioi iiposintB: OBB»« IBEIS
EEIEBUCB
KrotoazTnski, B.K.
Brnaaav^ G. R.
O'ReUl, B.J.
1979
Jotmial of Analytical
Toxicoloqi it 225- 23%
Proplonie aclj. 3-aaceapto-, etkyl aster (S CI)
l£op«BOle acid. 3-iorcapto-, etk^l eater (9 CI)
:t«6-06-l
e«-aio-o?-s
ni 13*.21
TISSOB
aao«
Braatk
BXCOSIIB BO1RB
alULTTXCaL
Hit BOD
SC-BS
MBBBES
OF ClSSS
W (317
samples)
ttlEI
lot given
Ull I
5.3 m/i
Geoietrlc
SIieBlL IITO1H»I01
reaanred at 25 C ud 760 aa Bq
21.2* occacrence
Lower aad apper oae*slqia llilta 2,S
aid 11.2 9Vl
aealtkr, 1S-35 re old. vonsaoktaq.
at tan blacka ud cancaaians.
CUcaqo. II. ElgldlT co»troll«l
•ipcrlaeital eoadltioia.
IBUTB; ElCCBOLS; 1111 IO1S; 1DQ1T5;
Ctla»IliTlg BTOlOCaSBOIS; TO1ITHB
CtSllIC CQItOQIDS: SB11TH B»HB5S;
iisiUTtci: nmoiisH: BITIBOLITES:
(O;HUTIOI BIPOSIBB: HEBII HE us
SMIBISCB ' |
Frotasiynaki, S.K.
Bconeaa, C.a.
O'weill, H.J.
197*
Joacaal of laalrtleal
Toilcol<*31 3: 223- 23*
iroplophmoae (8 CI1
1-PTOpa>o«e, 1-phanyl- {9 CI)
S3-55-9
M-H10-0
B« 13«.2, RP 21 C, BP 218.0 C. TP 1 a* ft? at 50.0 C
MSSUE
MOT
Breath
ziposim BOUTS
ifumcii.
BETBOD
GC-BS
IDS BIB
OF CASKS
5« (387
euples)
EIIGB
Vot givea
REII
0.261 ng/1
Geoaetric
GEHBIL nfOMUIOl
Beamced at 25 C aad 760 aa IKj
2*.a« occ«ct«Dce
lever aad neper oae'Sigia Hilts
0.05* a*d 1.1» nq/1
BcaltkT. IS- 35 it old. nonsaoklnq.
actan blacks aid caacaaiaaa.
Chicago, 11. Biqidlr coatcolled
HIKB-, IICCBOLS; IlltjoiS-. iOULTS;
CB1OBI»»TID ETB50C4BBOIS; TOltllLS
CECinc COIfCnDS; SMITH BlIiBDS;
1IBIIKICI; SETJKL1S1: BET1BOLITES:
ECPfltlTIOf 1IPOSUBE: 18BH IBflS
fiZTBBZICB
KrotorryasXi, B.K.
Bmnaaa, G.I.
o>Welll, B. J.
W9
Jouraal of analytical
Tozicology J-.225-23*
-------
»lcohol (8 CIt
1-tcopMOl (» CI|
TV23-»
C3-«»-0
« «0.1, W -117 C. OT 97.19 C. n 10 M *t lit W.7 C
tissrrt
Bnatk
**09
BCMtk
HIPO50IS xore
imrrtoi
»mo»
ec/ss
SC-BS
IVBBEt
OF ClStS
S
......
S» (387
iliei
lot d«t«ct«4- 1400.0 ««/kr
lot glT*a
•Ell
175. « «j/kr
21.1 »«/!
MOM trie
BEIIUt Xiromiioi
CecpoHd related to oorial
Mtabolln. la other detail* aim
cryogenic saipllBa tecktiqve.
•eeltfcT allitarT Aad cirillav
**plOf*n, t.S. Hi rorc. school of
Krorptc* KllclB*. *?•» 23-*7 jr. 3
s*ak«*.
Btnns; cnatiHTiE BTDIOCUBOIS:
cnoinv oteinc COSPOBIDS,-
CBiOMinznis: ruoun COIEOORSS:
E1IITB: ItCOBOlSt TIUS: 1D01TS
!»•««! »t 25 C MJ 7«0 n aa
50. Jt oce«rr«e«
tCMT Ml IppW OU-SlgM lllltl 3.9
ail 11*. 1 »q/l
B»althy, 18-35 TC oil. ooBiMklK;.
vxt<* blAcks ud Cftcotflua.
Cklcaao. IL. llgldlr coattJllod
• iporlMitil onaitlooB.
MIITB; JUCCBOIS; IU.HOIS; 1DDWS;
CBIOIIUTZD EniDClIBOIS; fOllTIl!
cusirrc COBPCITWBJ: asirrs BIZISDS;
IHUIIIOI; IET1J01ISB; *M»BOimS;
POPOIIIIOB ttPOSVEB; 1SB1I ISStS
tERSEICE
Covkl*. J.P.
c«»p, B.J.
Mick. B.I.
197S
VBTicoBBental Maltk
30 (2) 5 290-295
rcotamrMki. B.X.
Iramtc, S.3.
O'Mlll, S.J.
Joirtil of lutytlcal
Toxieoloaf 3:225-23*
Prapria (• Cl)
l-Pro»T»« (S CI|
T«-99-7
CJ-»«
•i 40. »s. nr -10* c. tf -23.3 c,
387C •• 19 «t 20 c
TtSSBI
BTMtk
Etpajots lomi
1 iiitrticit
•ZTHOD
ec/HS
fVBBES
OF C1SSS
8
MKE
lot 4«t*ct«d-2.3 mf/kr
W»I 1 GIltllL IIFOK111IOI
t
1
I
O.S «g/kr ( CC*F««I] c«lit«A to nonsl
1 Mtabollsi. lo ot*»t tetill* 5lT»»
1 Ccyaqvalc mpllaq teclniqn*.
|
1 B«tltkT Illitur ud clTlllu
1 «plOT««», 0.5. tic P»c« School of
{ l«ro*p«e« ftdleln, tgn 23-*7 jr. 3
1
1 mints: ciiotimm miocitaois;
I cnosm omnc coipanvs;
I cnoBotmtns: nvoan coRpogim;
i mirs; ticcioLS: TRIS; IBOITS
i
uniEin
Coakl*. J.]>,
C««p, 3.J.
«*lck, B.E.
1975
IccklTci of
30 (Z): 290-295
-------
llfcldiai
fb
It* «S.««7«, IP 39 C, «P <•• C, n 10 mm B? at 3»0 C
1ISSV1
Mil
Braia
»»«
, lair
Mil
••met
RIOStltl tOOTI
aMITTXCU
RETROD
n
n
»n»BEt
or cure
•t 7
b| 3
MICE | Bill | GtiniL motlatlOI
t 1
< 1
1 1
1.6-4.6 »9/9 (nt «t) I »1 3.0 » or - 1.2 I a) laics, c*t*bru, 6 mblacts
1.«-2.« «j/9 (»«t «t) | ao/g f«at »t) | t) F«ial*B, c«r«brn, 3 *«t »tl I b| 2.3 « or - O.M 1 c| Bal««, c«c«b«U». S nbjecta
1.1-3.* «j/g (nt «t| | uf/g <««t it) I 4| F«aala>. oanbellaa, * aabj«cts
|c| 2.3 * or - 0.*3 1
I «9/9 {»«* *t) 1 Tcoi a qcoip of *1 a«topsi«i,
| d| 2.6 * or - 1.0 I fonacte n«lcal eza*lBatloi«, Japan.
1 »9/9 (««t »t> I ••!•>. naa 19* 10. t ji. r«ul«s.
1 | a«ai ai« 37. < yr.
1 1
1 i TSICI niRtiTSi » BIOPSIES: jwii:
1 i itniitus; aisnic: cunos; COSU.T-.
1 i cctoixm; ccipn; iio»: aitcrai;
1 i ncigi: iieitsioi: lueinsz:
I i iranm: iinnoir; SCMDIVI;
1 i snni»t Titimi: finoina: IIK;
1 i sciB: noviitt lira: KIDIIIS;
1 | CIBMB89; CMtSBllDII: IBlEt; HOSCLES:
1 I «UOtIMl Slim: tOKS; 1OIT1:
1 | IR1LS; COIPUKITB STU01TI01S; SK;
I | ICBIISIC RSIICIIE
1 1
1 1
1 1 MTiwt. 2» npc*>nta«iT«
1 I ir«-nalfili tr*atamta ac<
1 4 tahml»t«4. Ik* faaslbilit? of a
1 1 lollstlc. >o*«aaa policr tec hair
1 1 aaalTaia it emtll»«a aid ««it«ct«i.
1 1
I i mm: mici nmirs; HHJ,
l i usriiin: magunn IETBODS:
1 i CITU.S; pwmiis: CCHUMITITI
1 i iiiwiTiois-. uvinm; uriMit;
1 i aisnic; niioa: Bioain; ciMim:
l i cuctoi; cticciH: cnoaiOH; coetLT:
1 i cettes] ettmn: SIBBIITTIB; SOLD:
l i icBtni 1101: iimanra: i»i:
t 1 H1SIBSIOI: BII3I18SI; mCUIT;
l i ICITBOIIVIS nciiL: PMSFHOSUS:
< 1 COIUSNtCl SraillH; SILWOT:
I i «ttico«: sntit; sotnt; siieinva;
1 l sutrns; Tin imntn; tvi«srn;
1 l tiic: SIICOIIVR
• i
I t
•) 1.2-8.1 «g/« («t *t) | a) 3.» « or - 2.2 1 a) ial«<
b) 1.I-2.H *q/l (»«t «t> | » | t) Ma*l*«
1 bt 2. 1 » or - 0.1 |
1 aq/4 (>*t »t) | fcoa a qro«t at *1 a«top«t«*.
1 1 fot«a«lc Kdlcal •zailaatloM, Japan.
1 1 lain, Mai «qe «0.« it. r
; COBU.T;
i i cBiQun-i-, cemi; noi; Hucnt;
1 i iimn"!: auitsiOB: »ien»t;
l i tocTDni; miBon: scinoioa;
l i sntiioa? tRinoi: T»«BI«I; me;
i i SCLD: BMBIIII iirai neitrs;
1 i ci*fwn»5 ciiracun: HUT; BDSCIES;
l i P net sis: sfttti: latest lorta;
l i untLS: coiimtm naimiiois; sti;
i i music aioicxn
i i
(HIT PlOE)
raiEncz
Tikaoa, H.
Sgzaki'Tanioto, a.
laaao, K.
Terai, 8.
1««0
IrcblTM of
CBTlconMital Health
35(1):36-a«
Chlttl«bocoagli. 6.
1S80
Seine* of the Total
EBTlcaaMit 1»: 55-75
Tnkava* R.
Satoki-Tanaoto, a.
auaa, K.
fatal, H.
mo
arealTM of
KnTlroiMBtal H«alti
35(1}:3C-a«
to
o\
OJ
-------
7MO-17-7
III
Its 85.»678, Bf
39 c, B* sea c, is 10 » E« at
(COITXfTCD)
IlSSHS
Mil
Kltaer
a*,t5
Kidner
MIS
lime
BTPOSJSS BOVt
lialYTICU.
HTTBOD
«
n
n
JOBBSB
or casxs
»l 15
tj lot
giT«n
•) 8
of 9
q 12
) 2
) «
BIKE
a) 1.0-6.0 B«/g f»t it)
bl 2.3-5.2 agSg {ret «t)
a) 2.»«-8.40 11/9
b) 1.50-13.5 09/9
e) 2.01 -4.0 a»/«
•et irt
) ».«-9.7 »j/» (net «t)
) 2.7-5.* og/j fwt *t|
nil i GII mi IITOIUTIOI
1
i
l
a) 3. 3 » or - 1.5 I •) Bales
ag/y (vat »t) 1 t) F«ial«s
k| 3. 1 » or - 1.6 I
H9/9 t»«t »t) | frot « groop of f1 autopsies.
1 tar««te ••itcal •mlnatiou. Japan
1 S«l«s, i«an «g« 40. C rr. r«al*s.
| i«a* a
IT
vat >t |
^etl*BS 1 teceaie^ retloerr and n«lter
I >ozt«rs, «ge» 55-78 yr, exposed to
1 b«a*y let all 1-3 d*ea4«s. Us*
( t«tvM> ceticeoeat a>4 d«ath 0-1.5 fr
I it group I aid 2-19 Tt. gronp tl.
1 Cntcols, aqts «3-72 Tr, »ho liwd 50
J ti fr« tke faetorr. 5v«l«i).
| 5IBDH; C»1TEBS; KID1ITS; 1ITSB;
1 I OSES: CO«P»B»TITI rfimiTloiS:
1 IIDITSTSIll ITTnE»i JBlSOBEHIT
1 (ROODS; UTISOIT; IBSZHC: CUBIOH;
1 cism; cpBOsmd; cam?: casrst:
\ ccto; isoi: luieumt teia:
1 niGinss: stscnEt: HOITBDIIOH;
t tsosjHoins.- BBBlDios: scaiDimi;
| SlmlDS; StlTEE; Til; TOIGSTCI;
1 ZliC; BHITH RlEiRBS: IJDUSTSUl
I ttlRSi SinTRS; TH.1BSI3S
1 9.7 * or - 0.07 | a) Bales
1/y (ret irt) r t) Females
J ». 8 » or - 1.4 I
g/9 (net irt) 1 rcos a qronp of £1 jatopsles.
1 (oreasie >«41cal etaalutloss, Japan.
1 falsa, «ean tqa 90, ( Tr. Itnla*,
1 nan aqe 37.1 jr.
\
l nice nmrts; mopsrzs; Jtric
I iigami; nsnic: cumin; COBUT;
1 CBBOBIH; Corn's; ISOI; IZBCmT;
1 itnoi: iiemsiOB; aueuisi;
1 SOBinWS; ItTIHOfT; SCWDI99;
1 snniin; Tinim; TIIIDIOJ; zinc;
1 Gain: Bioniit; ii»i: KIDICTS;
1 CHEStBl: CIBEBEtiBfl: BMSI; BDSC1ES;
1 Eiictiis: spusi; LI«GS: aoni:
< anus: ccipmnrz ETUHITIOFS; six:
I ICSMSIC K1I1CIIE
i
IHFEEnCI
Tikam, B.
sazakl-Tasasoto, 1.
Jtaano. S.
Teral, B.
1980
IrehlTcs of
Enfironsaatal Health
3S(U{3«-»*
Btoae, 9.
locaberg. 6.
ff«3t«r. f.O.
19AO
Science of the Total
Environment 16:13-35
Talcaia, R.
smiaU-I«sa»oto, S.
inna. E.
Teral, 1.
1980
IrcStKs of
EnTic«nMi.tal Scaltk
35(1):3C-4«
(•EIT PaSE)
-------
ItbillM
7MO-1T-?
n
Itf 85,a«7«, m 39 C. B* 688 C, TJ 10 H Rg at 390 C
TISS5I
MIT
liter
»«»
tm»g
*ei9
in?
nans BOUTS
iiumcu.
NETIOI
n
n
it
IUBSEE
T CUES
B
9
11
a) «
b) 9
4 11
lives
3.11-9.10 •»/»
1.W-S. SO ao/S
O.C7-T.»fl «o/g
t «t
.6-3.3 19/9 (««t »t)
•1 2.50-7.»9 ag/g
b| 1.W-5.70 qj/g
d 1.0-9.9 ag/g
«lt It
"BUI " i siiim, HTOHHXOI i amines
i i
t i
i 1
5.20 «n/g I •) Control* I Bcaae, 0.
a. 01 «g/9 I bl inker groan I 1 foraberg, 6.
3. M «g/g 1 c) Barker grow IT 1 (ester, P.O.
t «t 1 1 1*80
itua 1 C«c«u«l c*ei*«T a»4 BMltec t Science of the total
1 *ork«a. *«•* SS-T6 yr, elposed to t EvrlronMBt 16:13-35
1 t*»rjr MtalB t-3 tffil-*s. !!•« 1
1 tctma c«tlreM«t itA dcatb 0-1.5 ir |
1 Is group I »4 2-19 yr, group II. 1
1 Controls, «q«i «3-1J yc. vtto Xlwt SO I
1 lii frei tie factory. S«e4«. 1
1 1
1 siion: ciiifiES; it Dins; IITIB; t
1 IVIGS; COBPIMTITB KTIIOITXOIS; I
t IlDOSTitll. nolEd: «!»SflSSSCTT |
I IITWOS; IRIBOII; lISEIIC; UDim; 1
1 cisnui: cmoBXni; COBILT; COPP»: I
| 601,0; INI; URUIII; LEIBs I
1 flivsmsi: BncmiT; 9OLTBDK«on: (
I tnsMOBis; inipioB; SCMOIHB: i
1 sn/iBiira; sunB: it«: TOIGJTE*: i
| IIIC; (II11B HIIBBS; X»VSTBIlt 1
I tints: sBums: uumm i
1 .!..._
I 1
2.2 » or - 0.90 ag/g 1 «•!«• 1 Tnkava, B.
(««t it) 1 1 Sankl-Tasuoto, B.
1 fco« a «ro«v of (t aatop«l». t imo, K.
1 Coceviic aejical •xaaiBatioms, Japan. 1 Tecai^ B.
t Bil««, mtta age *8.t yx- Teaales, I 1*S»
1 iea« agat 37. • yr. I IrcklTe* ot
1 1 Imlronaeatal Health
I TSUI ILEBtlTS; 10TQPSIIS: JUIBs I 35(1> : J«-«»
I noBinm nsniCi CIDBI«B: COEILT; I
I CBSCS11W; comi; JIM: Encnsi; i
1 1ICIDB; 1»e»ESIOIl: BUeifESB; 1
t lOeiDTBH; IIIIKOIT; SCiWDITH; I
1 SILtnia; ITTUin; tllltlDSt 1IK; |
I ECIDI B*o»Bt; LiTN: nuins; i
1 ciBKBW: cnranuiB: BSIBT: BDSCIES; i
I Clients; s»LRf: iwflS: loiti: I
I amis: comtiTin zruoitiois; SEI: i
I ICRKSTC BltlCTX |
i i
1 (
a) 2.99 m/g 1 •) coatcoli \ Bcu«, 0.
b) 2.6* tg/« 1 b> (orlcer group X 1 lordtwrg, G.
c) 3.«2 aj/1 t •=! «ot\«c gceip TI t Hester. 7.O.
Vet »t I r 19«0
lealaas 1 tcceasel reflaery aid smelter 1 Scieace of tie Total
1 lackers, aqe* 55-76 yr, eiposed to \ EaTlroaieat 16:11-35
I heavy «etalt 1-1 4ecales. Uee t
I tctveem letiteseBt »a oeath 0-1.5 jt |
1 It grow I anl 2-19 yr, groep II. I
I Ccntrola, ag«s *3-7i yr, vho llted 50 I
I kt fros the factory, svedea. |
1 1
I SSICII; CWHIBS: KIS1BTS; LIT It; I
I IOISS; COBV1B1TITI EV1101TIOBS: |
I I»BSTEtll BT6IDR; SUSDHmT |
1 MTBOD5: iiriBon; usmc: caosim-. <
1 ctsnn; cnoBinv; COBIIT; COPPEB: i
t GfllB; I9O»; IURHUOB; tUD; t
i B1K1BE5ES tllBcaiT; 901I3D11TIII; I
1 teosPBoirjs: BtrBUJnrn; scivmtm; t
1 sniBTfi; SIITEB; Tt«: TOB«5T»; I
4 TIBC; IBUTO B1Z1BDS; UDOSTBUL |
1 1 m«TS; SBT11EBS; IBIIDIITIB I
I 1 1
• " (BEIT MGE)
to
a>
Ul
-------
Ilbl4i.il
7440-17-7
It
Itl 8S.4678, B? 39 C. BP 688 C. T? 10 u Bg at 390 C
TISSOE
4420
Biscle
4421
Fasereas
4422
Spleen
EIPOSOU SOO
alUTTICU
METHOD
U
M
a
nnst
OF CUSS
I) »
b) 3
a) *
b) 3
> «
I 3
UIGS
•) 3.3-5.6 ng/g (Mt >t|
b) 2.1-5.2 «g/g (vet vt|
a) 1.3-6.3 uj/g (vet «t)
b) 3.1-*.8 sg/g (net vt)
) 2.7-7.0 vg/g (vet m)
I 2.5-5.1 «g/g (vet wt)
BUI i siiiin iBFOBRHioi
1
i
I
a) 4.2 * or - 1.0 1 •> Biles
•g/9 <«•* vt) | I) resales
bt 3.9 * or - 1.2 I
ng/g (rat it) I »ros * group of C1 aatopsiei.
j forensic •eolcal eiasinatlcns, Japan
1 Rales, »«aD *9» »0. 6 rr. r«alu.
1 i«an «q« 37.* rr.
^
I IJICI BLBBBIIS; HJTOPSHS; J1PII;
I itoBtin: IZSCUIT;
1 mini; !U6izsiia; mtsntst;
t BCSIOI11: 1ITIBOIT; SCIIDIDB;
1 stiEitvs; TiiiniR: Tinoiua; ZIBC;
1 eoiD: B80HHI: LIT IB: nnns;
| CISIESOS; CHZBE119B; HIIBI; BVSCL3S;
1 Fiicaiis; SFiixi: Ln»GS; IOBTI:
I 1 IT HIS: CORFUITITE Bf HB1IIOIS : SIX;
I ICRIISIC HIDICI»E
) ».2 * or - 1.7 | a) Bales
g/g (vet vt) I D resales
) 3.S » or - 1.4 1
g/g (vet vt) | Fcos a group of 61 autopsies.
| forensic twaical ezasiaatioas, Japan.
j Bales, seas age »0. 6 rr. resales.
j iea> age 37.4 rr.
1
1 TBICE six«:iis: itnopsiss; Jip«i;
I uvRins; iBsiiic: CJDMOI: COBILT;
I cntoarus; COFFES; IFOI; IEKDF.T;
1 tiDioa: BiensiiB: snoiitsB;
| BUBIDIll: IRIHOBT; SCilDIOB;
1 sntnm: TiT»»TOfi; IIHBIB«: ziic;
| GOIB; BSOnil; IITBB: KIDflTS;
| CIBEBBB1: CEBEBZ1LOR: BUST; IVSCLZS;
| F1ICBE1S; SFtEEl: 101X53: IOBTl:
| 1FT1LS; CCSPIBHITE BTU.B1TIOHS; SSI;
| •OHIISIC BF.DKIIE
1
tBFBBEBCE
Takava, B.
Svxskl-Iasasoto, B.
tsano, E.
Teral, 9.
H80
Irchlves of
BOTironasatal Health
35 (1) : 3«-44
Kkava, B.
Snlaki-Taausoto, R.
Isano, K.
Teral, B.
1980
IrchiTes of
Enrlrotseatal Health
35(1) :3«-4<
rakava, B.
SnzvU'Iasaioto, B.
liana, K.
Teral, B.
1980
Ircblres of
EnTiconsental Health
35(1): 36-44
to
-------
7MO-20-2
se
at* M.«S». Bf 1S18 C. tt 2B« C
TISSBB
023
ketta
M2»
Brain
«25
Heart
MSBII MVfB
IBUTTICIl
BRBOB
I
Ik
BBBBSB
at cms
al 6
bt 2
HISS
BOB* detected
a) IOBO detected
b) Km* detected
e) MB* detected
at (OB* detected
B) < or • 0.001 ao/e, (n
•t)
b) Boa* detected
B»I i snniL nroiBinoi
I
i
l
oae detected | talea
1
| ftOB B OTOBP Of C1 aatOpSl*B,
1 (areialc aadlcal ezaalnatioea. Japaa.
1 Baloe, Beaa ao* 40.6 yr. leaalea.
t Baa* a«* 31.* If,
1
l TIKE nums; tnovsKs; JWH-.
I KUBIBVB: kBSBtlC) CaDRIBB; CO BUT;
I CEBOBCTBl CCfPIlI ItOI; BIBCOIT;
1 innBt siei>sma: BMSHZSI;
I SBIIBim; iBTIBOIt: SCIBBIVB;
1 snnrivB; line;
1 CCIBs BBOBIII; 1ITSB; tlDIITS;
l ctiiBton-, cEitBBtuiiit tnun; MSO.K;
I BilCKkS; SHIN; mwjS; 1CKI;
l Bitats; cotsmnn trunnions; s:x;
I fOtEBSK BIBKIBI
1
a) BOB* detected I a) Bilos, cetebcai, ) nblecta
b| BOB* detected I I) fcialee, cerebna, 2 >«b]cels
e) »oae detected | c) Bale*, ce.nbell.aB, 8 mnbjecta
at BOB* detected I a] Teaalea. cecebellaa. 5 «ab1ect»
1
1 HOB a 9COBV of 61 aitopiiea.
1 formale aedlcal eiaaiaatloaa, Japaa.
1 Balos, aeaa aoa BO. 6 rr. Tesalos,
t te«a 19* 37.4 Tt.
I ItlCB BIBBBBTS; WTOPSIKS; JlPlI;
< UVBIIOI; 1BSWTC! C10BIBI; COBUT;
1 CEBCBIBB; COMSIl 1BO»: BIKBIti
1 IIBHJ": HUKSiOB! Bueiiiss:
1 SQIIDI^B; aBTlROBT! SCaBDIOB;
< stiiim«-. tiiiiivii; mum; live;
1 6CIB; BI08IBI: LITEB; KIBB1TS:
1 CIBIBI9S: CZIDEUKt «»lt; BHSCLIS;
l ciictttj; spitn: mtsj; ten*;
1 amis: COBTUITITB CTILOITIOBSJ sn;
1 fc^nSIC BEBICIBI
1
t
a] lot 9iv*B I a) sal«
bl Boa* detected | t| Teealei
1
1 ICOB a qroap of 61 tttopsl**.
1 (oc*BBlc aedical eiailaatlon, Japaa.
1 ealea, lean aqe ao.t jc. Fenlex,
1 BCBB »9* 37. » TE.
1 tt»ci sunns: nrrotsus: JWIB-.
l niBimn: ktstnc; CIBIIOB; COBM.T;
I cttcHH; canst: ttat; RBKVK:
1 IIBIB4: Bk«lESIVB: UlGtBBSX;
1 BtBiotm: imsoit: SCUDIOB;
1 Stllim; TlTIBlBBi TkBU)lnfl; ZIBC;
1 6CIB; BlOBIIt: IXTBI: XIBIITS;
1 CltBBCIM; CnEBCUVB; Kilt; RVSCLIS
1 (IfCBIkS; StlBSt; In BUS; lOMk;
1 units i ccspiiiTiTE mtoiTioiS; six
1 ICBtlSIC SKICIIB
tBTBIEVCE
takava, B.
Sankl-TamBOto, B.
1B*BO, B.
Total, a.
1*80
lEchlte* of
EBTlcniaeatal Health
(5pt :3^-a*
TBkaira, B.
svzaU~laviBOto, B.
liana, E.
Total. B.
1*80
IICklTCB Of .
BBTlcoBB*atal Bealth
35(1|:36-«
Tikava, B.
S%nkl~Taaaao^o, ai*
laaao, K.
Terat, B.
1*80
atckiTu of
Ca*lcoBB*Bt*l Hoaltk
3S(1|:3»-««
(*in pisi)
N3
-------
seaadian
TMO-ZO-2
sc
ItB M.«S5«, IP 1538 C, B» 2*32 C
(COBTIBVBD)
TISSOB
MK
Kldner
••27
Xldaer
1
1
• •20
IIPOSHBB IO
I
i
a BitniCal
BSTH09
M
n
BVBBEB
OF CIS3S
a) 10
b) 2
a| 8
b| 20
a) K
b) 3
IU8E
a) < or • 0.003 ag/g (•
wt)
b) BOM detected
a) < 0.0001-0.00053 03/7
b) < 0.0001-0.0020 aj/j
Bat wt
< or - 0.01 ag/j (wet
t)
lone detected
SSiB 1 CtBIBal IBFOBMTIOB 1 BEFEBBBCI
1 1
1 1
1 1
al Bat given | at Bale* I tgkawa. B.
b) Bane detected | t| Fesale* I Saxaki-Tasnaoto, S.
1 1 aaano. t.
| fcoa a groat at 61 eatepsies, I Tacai, B.
I forensic aedlcal •taalBationt. Japan. ( 1*80
I Bales, Man eg* ««. 6 TC. resales, ( Archives of
1 Ma* a 1
1 1
Bat gives | t) Bales I Takawa, a.
Boae detected 1 1) Females f Smakl-Tasaaato, 8.
1 I laano. K,
I Fc«a * ?coap of 61 aatopsleg, I Tecai, B,
f (oces*ic Mdlcal exaaiBations, Japan. I 1980
1 tales, aeaa a«je »0. S yc. resales. 1 acealves of
I Man aae 37. • vc. I Bnviconaeatal Health
1 t 3S(l|:3«-««
1 TSICE ntetnst IDTOFSISS; JIFIB; i
f nOBIWOT; ttSSBIC; C1BBIDH; COB.LI; I
I CnCBIOl: COFPES; ItOB; SEICOBT: 1
1 IIDTOII; HiensinB: UBGIEESS; i
I Ft'ioini: iRiBOBT: SCIBDIOI: i
I stiBBiia: TIIHIOB; TiuDias; life: i
I GOIO; BSOBIBf; tirn; RDBETS; I
1 CEBCB£0T: C7BEBE1LBB* B3ABIJ B0SCLBS; I
1 pjicsm: spiHM: IVBQS; tent: i
| "TTUS; COBCUITITS B»ttUtTIC«S: SBtj |
| YCBEB8IC imiCIBE I
1 1
•00
-------
sciadina
7MO-20-2
»tf «,»55». 0? 1538 C. B? 2832 C
(COVTZVOXD)
IISSW
M24
Ilnr
M30
VMO
»«31
linn
SITOSIK torn
lIUTTICll
RRMD
U
M
•ram
or cisss
8
20
) S
) 2
4 »
1» 9
0) 11
11IGE
< C. 0001-0.8005 sg/g
< 0.0001-0.0029 a«/g
t lit
1 < or • 2.7 «<|/ qtoop I aid 2-11 TC« qtatp II. I
| Cemtiola, a?«a «-72 re. «lo Iln4 SO I
| Hi ttoa tk» faetocr. 5>*daa. j
1 1
I snni; claims; smns; HTIS; i
1 IONS: coiMimn tnuiiioiss i
I iiDTSTiiai iteiiii: Biasviiint i
| BI1BOBS; 1RIIOIT; HSmC: C19MBB; |
| CIS1U11-. CBBOHIUB; COBUT: COPPMJ 1
1 ton: imi: IIKBMMI 1.110; i
1 iimiist; Rncnii; BOITBDIIOB; |
| tBOSPBORBS; BOBIDIHI: SC11DIOI; t
I sninovlTOnaa«tal Bealti
( I 3S(1|:3C-M
1 tiici ncBfiis; IOTOPSHS: jute i
I itOBTIUB; UStBIC: CIDBIDB; CO3U.T: |
I CBICBIOB: copfis; ito«; incms 1
1 iitim: sisHswa: UKIKSK; i
| 1C1I9I9B! IHIBOITl SC»«DIDS: |
t smnn; tutnos: TIIIDIOR: znc; t
| «O19: BIOBI1I-. IITS«5 KIISIIS; |
1 cnnina: CMtszuni; is»i; MSCLCSS i
I PKCSHS; SPIK»: LOBS:; loni: i
I itiits; cowaimn ETIIOIHOIS; sn: i
I TC5M3IC HIEJCIII |
1 1
1 1
al 0.0023 aj/g 1 a) coatrola I >ru«* D.
b) 0.0023 n9/g I b) »ort«r iToan I 1 focdbarg. 6.
e| 0.00(2 09/9 1 c) *otkac ttmv II I Vaster, P.O.
let »t | t 1«BO
lediau 1 t«cmaa4 rafiasry a>« aaaltar 1 Sclaace of the Total
I lorkars, «««s ?5-76 yr, axpoaad to 1 tariroaaaM 16:13-35
I kaavr aatala 1-3 aoealaa. tlaa I
1 tctmaa c«tli*a«at and Oaatk 0-1.5 Tt 1
I la group I aad 2-19 vr, ?co«f II. |
I Ccatrola. agca U-72 Tc. nbo llwd 50 I
I ki froa tka taetory. s«*4aa. 1
1 1
1 si»n: cmimsj iimnss L«S«; i
I IC15S: COBPU1TITC miVHIOBS; |
I iieosmu BteiiB; BSISUBBBIIIT i
| 1ITBODS-. intMII; MSinC; ClMIORi 1
1 CMIOS; CBIOtrilB; COBllt; C0»»; I
I CCID; IBOt; ItfTIUOa; LHD; I
I tiKiitsE: iincnBi: BOLIBBMOT; i
1 H05PB01DS: Bromwi: SCIBSIDB: i
| StUBIlM; SIlTtt; TI»: 10JSSTI1: I
I niC: BSalTB lUilDS; 11003TEHL |
1 nins; sfintRS; TnimoB i
i i
(Itxt flSl)
N>
-------
ScuUw
74*0-20-2
sc
lt» »«.9SS9, B» 153* C. tt 2«32 C
TtSSTTI
M32
nascle
«•»
Paacreas
4»3»
Spl««a
ntosm ton
tUI. TTIC*l.
BWBOB
n
n
n
•ram
or cisss
•1 »
bl »
•I «
bl 2
6
3
MKI
*) ROM detected
b> «>•• detected
a) < or • 0.001 »9/q <«•
•t)
b) ion* detected
< or • 0.007 m/a liet
•t)
Boae detected
un i mini ivmamoi i icnmcB
I i
i i
I I
t) »o«« detected I •} Bales 1 irtaam, B.
b) »o»e detected I t) resales 1 SlxmU-Unwto. S.
I | liana, t.
j fros a groat of il ••topaics, 1 T«r«i, 1.
j for«n»lc ««UcOITI: i
I imtS; TOBPUlTltl mi0>TIOtS: SSI; I
I IC1MS1C tlBICIK |
1 1
a) lot jina I «) **!•* I lokarn, a.
b) »o*« tet«et*A I 1) P«aal«s | s«nkl-Tas»oto. 1.
1 I laano. K.
j Irca a gtoif of 1 1 aatop«i«a, | 1«rai, I.
1 Caroalc Mtieal «a«lutloM. Japan. | t990
I lalcB, Mas «qc «0.< rr. f ••>!«, I Irekircs of
1 f«aa ao* 37.* rr- t CiTiroBMatal Health
1 1 3S(1)i 3«-*l
I met nsnits; mopsiss; JIPH: i
1 niBim; iisnic; cioima; COBUT: i
t CBICMBH: ccmf; ito*; BircnBr: i
I iigio-a; »JSKsro«: BMSIIISI: i
1 inEiain*: imooiT: scinnoB; i
1 annum; TIUIIOT; TIUDIOB; H«C: i
| CCU; BEOBIlt; tITII; ICtDlITS; |
1 ciimv«: ciBZBCiiai; nan: RosciiS; i
1 tncttti; silts*: i BBSS: IOBT»: r
1 «rms: cottumn ETIIITJIICWS; sn; i
1 rcmsic BIIICIII i
i i
I I
) lot gltoa | a| Bal«s | nkam, B.
} Ion a«t«ct«a i t) F«Hl«s | smkl-Tamioto, a.
I | anno, I.
( Icoi * vroif of 61 a«top*i«, I T*rai, B.
I fora*ic xdical aiaaiiation*, Jspan. | 1990
I Rales, »a> aq* »0.6 jx. r*Ml«s, 1 arc>i*«s of
1 a«aa aq< 37.1 rr. I ZaTicoai«ot*l Health
1 I 35{1}:3«-«4
| T»C« nifttHS! aUTOMIKi JU»; |
1 iiUiiTOB; itsmc: ciniDB; COBII.I: i
1 cnnniB; co«m; IK»; BIKOIT: i
1 litni: SI5HSIOB: atis»ni; i
I imioioa; aitnon: SC»R>I«B; i
I snuiTsc IITHIDB: TIIIDIITB: snc: i
I eciD; «ton>t: urn; SIMMS; i
1 CMIBS71: czinnuB: >uit: BBSCLES; i
1 tuciMS: svtni: imos-. iom: i
1 BRUS: contniTiTi iTuoiiioBS: ssi: i
1 tcinsic BfEmn i
' '
to
^J
o
-------
s«
1M 78.»6. » 170-217 C, BP 685 C, T* 1 •• Rg at 35t C, 10 II 89 at
IISSV*
M3S
lorta
M3S
float
Blool.
MSB
wkole*
tiNsgiE son*
laqestloa
IMITTICII
BSTBOD
I
Tlaoroaetrr
US
PlvoroaetrT
•DBBSS
or cms
a) «2«
b) 6
33
210
MKB
.0-6.* og/e (**t lit)
a) 0.1 1-0. 60 ng/al
1) 0.2»-0. «2 ug/al
13.3-2«.B (4/100 al
10-3* 119/100 al
BUI | GBIIMI nrOBHTIOB | BRBBEBCC
1 1
. » * or - 3.0 sg/q I «tl«s i Intau, B.
rtt rt) | | Saznkl-Tasesoto, a.
j ttoi a gro«p of (1 attopsles, | laano. I.
I tcrvaslc soaical exaslaatloas. Japaa. 1 Teral. B.
j Bales, caaa age »0.« rr. Feaales, | 1980
| aeaa age 37. a jr. t IrcklTes of
1 1 BaYlroaaeatal Health
( TtiCI BtBBtns; IROrSIBS; J»lf; | 35(1|:J6-M
j itoaiwDS; iBsiiic; CADBUJB; COBILT-, i
I cmcaios; conn; xioi; BSBCOIT; 1
1 iicius; aisiisina: UBetiBsi; i
t BIBIDIDR; iniHon: sciionni; i
I stLBBinH: niuim: TIHSIOB; site; j
I CCID; BBOBIIt; LITI1: EIDBITS; |
I ciBtnm; ctiaziui: BBUI; HBSCLES; t
1 tiBCBiut SPIIM: ia«GS; IOBTI; t
| BtlllS; COHP1BMITE ST>LD1T1OIS: SBX; I
I toiiisic neicin i
1 1
1 1
a) 0.265 ng/il | a) Basldeats at Soatk Dakota a«4 I Bo««, B.
b) 0.29 ag/al I igzroaailug anas | 1979
1 t) n«sll«its of kmo«a solenltecoos | axc&lTes of
I »«a, Eanld clti, 3D. «a«kl} or I Znrlco»»tal Bealtk
I teatklr saiplUii, a-2* «lt. | 3a(C);aaa-ta8
1 1
1 !*«ltaY blooa aoior» of various ao.es, 1
j Scnth Dakota, »Tomlnq, I«biaaka, aai 1
1 lotth Dakota. 1
1 1
1 SltlBTUa; BICOD; HIl; ffUBI; |
I ccapiBiTiTi miOMioss: SOILS ; SOUTH i
1 CIKOTl; lOtTB DUOT>: BEBMSU; 1
I S10III6 |
1 1
17.12 * or - 2.53 I Seaifteats vslaq eatez fcoa veils «ltk 1 TaleatlM, 3.1.
ag/lftO si | 2C-1BOO aq Se/1 | Kaoq. B.s.
1 | Dana, P-B
1 Illaa. BB | Sefclvckter, B.
1 I 1980
1 Itl Hit ICO; BLOOD; S»IB; DBIH-, | 3onx>al ol Toxicology
t SITUS : SBIB1IOB: DMIKIIO IITBBi I aaa BBTlroaMBta 1
I 11IIBIS: POPOUTIOB KPOSOBI I Bealtk 6: 731-736
1 1
1 1
20.6 aq/100 al t Safejects (roi 19 collection sites la 1 Ula«aT. I.B.
1 tke U.S. | Fnbota, J,
1 1 Losoe, T.
\ mtBioa: BoinDnoB: IHIBIIM; i Both, s.
1 HOOD; SBI; SOUTH DtlOTl; K> TOSK: | 1968
t BTCBIK: Bonni: oaio; BISSISSIPPI: i jrcbi»«« of
1 THIS; BOBTB D1ICOTJ: tlSBIB6K>«; I ZBTlroaaaatal Bealtk
1 CUiniBIa; 18IIOU: milll; I 1«:3«2-3»«
I lensiiBi; IBHBSIS: noaiBi: i
1 fttBOWt] TMCE SUBIITS I
1 1
N)
-------
Seleninn
77S2-M-2
Se
»tw 7».»6. HP 170-217 C. B« 685 C. TP 1 nn Hg at 356 C. 10 an Bg at »29 C
TISS05
M39
Brain
»««0
Brain
•Ml
Hair
•M2
Hair
IIPOSOBZ BOOT
Ingestioa
I
1
lB9C*tioa
IIIITTICIL
HITBOD
n
sc
us
BOBBSB
or ciss
9
30
JIWSK
a) 0.19-5.0 «9/g C»»t »t
b) O.»1-1.« OS/5 (••* »t
c) 0.50-7.» «g/9 (»et »t
4) 0.35-2.2 ag/g (net »
a) 226.S-423.2 ppb
b) 15.2-23*. 7 ppb
2-1.98 ag/g
BUI | 6EBnu iiroiiaixoi 1 BBFBBZBCZ
i •
1 1
a) 2.0 + or - 1.8 I •) Hales, c«t«brm, 7 subjects 1 Tokana, B.
19/9 («t «t) I Pro« a group of tl aatopalvs, I JicehiTM of
I) 1.0 » or - 0.8« I forensic ••dleal eiaiinatioos, Japan. I Enriro»»«ntal Health
119/9 (««t wt) I iales, Man age 40.C rr. Feules, | 3S(1):3«-«*
1 i«aa aqe 37. a ^r. j
1 1
1 Inez niBtiis: iwopsies; juii; t
I lIOBirjB; 1ISNIC; C1DBIUB; COBILT: I
I CBIOBIOB; CCFPES: IBO»: BZBCOSI; |
1 IBCI01: BIGIHSHJB: BlfGlBBSI; I
I IOBIDIOB: 1IHBOR; SC1B9IDB: |
I snmaii: imiioa: nnoioB; znc; i
I 6C10: 9BOBIII; 1ITBR; SIDIBTS; I
1 CIBBBK91: CHEBILlOa: BZ1BT; BOSC1BS; I
1 PHCBIIS; SPIRI: LOBSS; IOBT«; |
1 SITUS; COSPHJTITI ET1101TIOIS; SBI; I
I rOBISIC BIDICIWB |
1 1
1 1
a) 311.6 ppb I a) S* II, IT | Cappoi. C.J.
b) 111.5 ppb | t) Se TI | Saith. J.C.
Fresh lit | Igtopstes | 1981
1 I Jonraal of Inalrtical
1 Ciiadlaa Indiaas, aortkvcst Ontario 1 Toxicology 5:90-98
1 1
I IISBES; FOOD COITlRIBlTIOf ; 1
1 iicosTiiii tciiaiioi; eornaiot i
1 IXPOSVIS; BDB1I 1BI1S; nSBAI ISB1S; 1
I iura poiinioB; aiBcoBi; BIECOIT i
I CISIBIC COBFCOWOS; SKiniDS; 91IIB; I
I BflRT: KIDBETS; IITZB: PLICBIT1; |
I StlZBB; CIBlCa; iOTOPSIZS |
1 1
I F«Tie*. 2* rspresentatlTe 1 Chittleboroagh, 6.
I Fee-analysis treatnents ate I 1980
1 tibnlateJ. The feasibility of a I Science of the Total
I holistic, no-vast policy for hair I Eo»iron««t 1«:53-75
1 nalysis is oatlliei] and snprortei. |
t t
I ittrii*: TPICI nzBCBTs: BUB; i
I msnmn: BZISUBZMBT HZTBOOS; i
1 SITUS; PSOTHBS; COBPlStTin |
1 ITllOtTIOBS; ILOnBVB; 1HTIBOBI; |
| ISSEItC: BISItJB; BBOBIBB; CltBIDH; I
I CllCItHI; CBICBIBE; CBBOBITIH; COtltT; |
1 CCPPBI: sunns: GKBBIBIOI: COLD; i
( ICDIBB: IBOI; LJnBlIDB; I SIC; |
1 BISHISHJB; B1BG1BBSB; BSBCOBT: I
1 (CITBOBBQ8: IICKEL; PROSPBOBOS: I
1 (CTissni: JOBiDiis; samoa; i
1 SIITCOf; SIIRB; SODIOB; STBCIT10S; |
1 SOirn; Til; TITanm; TOBGSTBB; 1
1 IIK; ZIBCCBIOB I
1 1
1 1
«6 » or - 0.** U9/9 1 lefUents using water fron veils «ith I Talentine, J.L.
1 2«-1*00 09 Sc/1 | Kang. B.K.
1 I Dang. P-S
1 lila«, IS | schlachter. B.
1 | 1980
1 III R3IICO; BLOOD; BUS; OUR; | Journal of Toxicology
1 BflLlS; SCIZBIVB; BSIBHIO 11TBB; I and invironaental
I imns: POPHUTIOB ZIPOSVII i Health «:73i-736
1 1
(HIT ?IGB)
-------
77*2-44-2
5«
att 7«.f«. n no-217 c. a* «e? c, w •» •• »g it 3S« c, 10
•• 19 at »» c
(COM TWED)
TIS5VI
•«*3
•air
4M4
Hill
44*5
Balr
««««
la-art
fosm tom
A lit RICH
HESflOD
TlnoroMtry
»
•0BBM
T CaSSS
42. b)
a) 5
b) 1
a) 8
*1 »
UBS1
0.24-37. J« ng/g
«. 15-121.43 »g/«
.
*) 0.25-1.11 ag/g
t| 61. 2-10*. 5 uoyg
») 0.44-5.0 19/9 (vet «t
b) 0.81-3.7 wj/q (Mt «t
1
1-
ui> I eiinit MFOIUTIOI i nntnci
1 1
i i
0.44 ij/g | •) Coitrol* | Bran, B.I.
O.SO «9/g I fe) Biltifli (derail patieats I Bolsbeckar, J.
dUu | s*ipl«s fre> 7 »calp »it*s 1* «»cb | Stuct, D.C.
1 Irt}«ct | 1471
t 1 clinical ch«*lotrr
1 Cklltl: »BTI1B: Cllim IlltOOS r 24(11)I1»M-2000
i Sinn usiiSK: nn: uaimii i
t »iosi«-. cncniii caunnts com*: i
i eciD; IODIII; atistRsc; anus; t
I snwrtusj siimt; SOBIM; suirns; i
1 IlllOIOt; ZIK I
1 1
1 t t«lm oe «orl4 llt«nt«x« em th« 1 J«akl», D.I.
1 >ee«nl*tta« ud blocoic«tntl« of 1 1979
1 l»l«ct»d taxle tne* ««l»l» IB ta«»m | H»-«00/»-79-Ot9, 1*4
1 k«lr »»J Bills ail otkcr iiiiillai | pp.
1 *ilr, f«. 1*11 «, diva ui hoofs. 1
1 1»b»l«t«a br 9io«npkie irii, I
1 «»b1«ct», ••>. *9«, izpocuti i
I qtillnt. aiilTMS la ppi. and 1
1 nthorltT fen ons 400 r«f«mno*>. 1
1 1
I mica: mstin.ii; cum; ctmu i
I tmici; mien; nom cm; in i
1 TJILltO; SODII 1ISIIC1; SonBClST 1
i »si«: uiiro nteDOB! TOITID srms; (
1 IIII; »IIS; 1STXCT; 1ITIBOII; I
1 mmc; Knot; cums; cBicnm; i
l cosiiT; CC??H: HID: mem: I
1 HCMl: SE1I1IBH: til; TllUXOB; tlB |
I Kitmot: tiiau POCTUTIOIS: i
1 BioicctmiKio*: sioiiDiciioas: HID i
1 POtLOTIOl: POPOLITIOI IXPOSOBI; »»TIS I
1 {CtlDTIOI; T11C1 nSKSRS) IK US t
1 1
1 1
I) 0.77 >g/9 | •) tipid Cltj. SO nlinifirois ar«a, | Ho««. B.
M as. 3 og/g | uMltlT « loithlr •iipllaf. «-2l «k« 1 147*
1 t) tip 14 cur, 3D, •wily «aipllng. $ I irchlrM of
1 «*s. DiaArnfC shupoa cooUlnlwj Si | EaTlconKatil H«»lth
1 t*a beim IM4. | 34(«):444-*4B
1 1
1 MiltbT blood doaors of Titleaa »q«», I
1 3o«th Dakota, Byoila^, lebraika, and I
I lotth Dakota. 1
1 1
1 sn.taii»: BICOI; nil; aim; i
t ceiPuitifE miamois: sons; SOOIB i
1 IITOTl; 10B1B K1KOTI; (IB11SH: |
1 1TCBIBS |
-.-I.. 1
a) 1.8 » or - 1.6 t » ««i«s | Tnkava, a.
og/g (»«t »t) | i) Teaalia | SninU-Iasnaoto, H.
b| 2. 1 • or - 1.« 1 | smaao. K.
ag/g (vit »t) I fioi a dtoop of 61 autopsies, | Terai, I.
1 lorsnslc aedlcal •zaalnatioai, Jap». I 1180
1 til«s, naa age *O.K yr. males, | irckiTes of
1 Man age 37.4 yi- 1 Envltomeottl ^aoltii
1 1 3S(1):3«-*4
1 1JICI mums; IDTorsiIS; J»»; |
1 itOBina: issMit; CJDKOB: COBUT; i
1 cnonint: cottttt itot: BEICOST; i
1 HDIO»; RiGKSItlB; BUCaVISB; |
1 tiBiBRH: inmon; scixoioi; t
i siimni; IITMIOB; TIUDIUI; ZIBC; i
1 6CIO; 5BOBIII: UTEB; KIDHEIS; |
1 C1SIBBD1: CflEBBllOR: BfaBT; II1ISCLZS; I
1 fllCVHS: SPIES! : lOKS; lOBTa; I
< tniis-, coifiHTin miaiTions; sis; i
1 TCREI5IC njDICIII |
1 1
(••XT P»6I) "
CO
-------
Selenlna
7782-»9-2
St
»tl 78.96. HP 170-217 C. B» 685 C. TP 1 aa Bg at 356 C. 10 •• Hg at »29 C
txssnz
•M7
Heart
•448
Kidney
SXPOSOBB SO
Ingestion
•M9
Kidney
••50
(Uney
ngestion
alUTtlCU.
BB»SOD
SC
11
m
IDBBEB
OF CASSS
1
a) 19
b| 3
•I *
) 9
ct 12
11IGB
a) lot given
b) pot given
a) O.SO-*.* »g/g (vet vt
b) 0.87-1.3 19/9 (vet vt
a) 0.37-1.03 ng/g
) 0.31-2. 12 ng/g
) 0.25-0.71 Bg/g
•at vt
Bot given
lot given
•III | GZBIIU, IBFOIB1TIOB
1
1
a) 251.2 ppb | a) Se IX, IT
b) 81.5 ppb | r) Se TI
Fresh vt j Igtopsies
1
I Canadian Indian, northvest Ontario
1
I PISBES; FOOD COBTlBIElTIOB:
I lIBBSTtlll ICIIOTIOB; POPOiHIOI
I 1IPOSDBB; BVBlt aI»S; ORBal lillS;
| IITBB POllOTIOB; BBBCOBIi BEBCOBT
| CIGailC COBPCOtDS: SELEIIffB; BBIH;
| MIKT; KIOIITS: UTZB; PUCERl;
I sum: cinci; IOTOPSIES
1
1
a) 1.6 » or - 1.0 I a) Rales
ag/g (vet vt) 1 t) Fenales
b) 1. 1 » or - 0.22 |
ag/g (vet vt) I Peon a gronp of 61 aatopsies.
I forensic nedical exaainatloas, Japan
j Bales, aean age ao.c yr. Finales,
j tean aoe 37. a yr.
1
| TBICt ILIBIRS; aOMPSIZS; J1PII;
| 11CBIIIH; 1BSSBIC; C1DBIDB; COBUT;
| CBBCBIHII: CCPPSB; IIOI; REBCDBT;
| IIEIOH: IISBISIOB: B1BG1IESE;
| BOP.IDIDR; IBTIBOR: SCHDIOB;
| 3IIMT9B; TIUIXOH: TilaDIOSi ZIBC;
| C01E; BBOBIBt; IITEB: KIDBBIS:
| CBBEBBUB; CEISBBtLOB; B31BT; BOSCXBS;
I tiiCBBiS: spun; loiss; IOBII;
| 9ITUS; COBPIB1IITE ITIIOITIOIS; SIX;
| FCBIISIC BItlCIBE
1
|
) 0.70 09/9 | a) Controls
) 0.52 ng/g 1 t) Vorker qroop I
) 0.33 ag/g I c) Barker gronp n
let »t |
edians | Eaccased refinery and snelter
| aorkers, ages 55-76 yr, exposed to
I heavy netals 1-3 decades, fine
1 bctveen retirenent and death 0-1.5 yr
I in group X and 2-19 yr, gronp II.
I centrals, ages »3-72 yr, who lived 50
1 k« fron the factory. Sveden.
1
| SflDBB; CtOaTERS; KIDBRS; tITXBi
| HISS; COBPU1TITB ETlIDtTIOBS;
| IBDOSTBIII BTEIFBB; BZISOBEBZIT
| IRBODS: 1RIBOBT: USEBTC; UOBIDB:
| CXSm; CBBOBTVB; CCBilT; COPPEB;
| CCLD; HOB; 11BTB1EOB: LE1D;
| niGlBSSI: BEBOTIT: BOlTBDEBtm;
I FBOSFHOBDS: SUBIDIVB: SClBDIDi;
I snsBivi: suns; TIB; TUBGSTEI;
| IIHC: B111TB B1Z1B9S; IIDUSIBIK
I PIIITS; SBEITESS; TBlLBBlnB
1
10*3.* ppb | a) Se II, IT
707.8 ppb | t) Se TI
esh vt j latopsiea
1
| Canadian Indian, nortbvest Ontario
| lISRtS: FOOD CORHIIITIOI:
| IBDBSTSItl IOUOTIOI: POPBlltlOl
| ItPOSDBf; BB»L UB1S; HBBM UlaS;
1 inn POLUTCTOI: micisi; B»cnn
| C151ITC COStCDIBS; SILMIOS; Bllll;
1 niirt; Kinitts-. iiTt*; VLicxna:
| STlBtl: CHltl; MTOFSI1S
1
BZFEBBICI
Cnppon, C.J.
Snith, J.C.
1981
Journal of analytical
Toxicology 5:90-98
ynkava, R.
Snmki-yasanoto, fl.
Inano, H.
Teral, B.
1980
irchiTes of
Eavironnental Health
35 (1) :36— aa
Ernie, o.
Bordberg, G.
•ester. P.O.
1980
Science of the Total
Environnent 16:13-35
appon, C.J.
nita, J.C.
981
onraal of analytical
oiieology 5:90-98
litn ttsi)
N3
-------
77SJ-»9-2
51
Itf 7».»«. n 179-217 c, B> 665 C, V? I u Eg at 3S« C, 19 mm Rg «t 429 C
fCOBTIIBID)
MSSJI
MSI
aa52
M53
ll»ar
irosnE toni
Imgwtlam
IM1TTICU
gnaw
n
»
ec
n»n
or cuss
7
7
a) ft
b) 9
O 11
1
IIBSI
1.2-C.2 »»/g (nt *t|
0.15-3.4 ag/g (nt it)
) O.IH-O.at aoyg
b) 0.12-0.35 »g/g
O 0.11-0.23 ng/a,
'•t wt
a) »ot gim
b) lot glT«>
•BIB | GtEtEll IBPOH1TIOB
1
2.7 * or - ».i I >•!«
g/g (mt «t) 1
1.9 * or - 0.98 1 MOB a groap of *1 aatopaias.
g/g (»«t «t) 1 fatmile aatical •laaiutiami, Japan.
I Bfllctf* Baan aga 40«C yir« Ta>alo»
j a«ai age 37.* TT.
t
1 met ZIEBBBTS; inoMiES; JIPIB;
t IHBIIBR: 1BSEBIC; ciouina: coBUt:
| CB1CSIOS; CCJJIS! 1MB- BlgCOET:
^ iBtni; MSKSIBB; IM«HISB;
I lotmm; IITIBOBI: SCIBBIIH:
| EtlEBlV!!; 711aBlQS$ T&BlftlQB; ZIBC;
| CCIB; BBODIBE; UTEt: nDBBTS;
| CltmUS; CtBEBHUBi BUB1: BISCtESi
i fiBcaus: mm: tnies; torn:
1 llt»13: COBtlBlTITB CTllOlTICIS; SEIi
| rCBEISIC BtCICIEE
1
1 0.19 gg/g 1 a) Coatrols
1 0.20 ag/g I b» lerkcr «TS; SBEITEIS: TtlmSIBB
1
1
a) 269.7 ppb 1 a) S« It. n
b} 176.1 ppb | t) 5* TI
Tna% «t | litopci**
t
I Ciaadlaa IrnJlan, oortivaiat Ontario
| fISBBSJ rCOD COVTMIBItlO*!
I 11IHSTH1I JOUnTIOB; WPOUTIOB
I IIMSOSE; BQBU ItBIS; DBBH 1BB1S;
1 IIIZB rotimoB: iticnn: BEICHBT
I CESIBTC coifcorM: snniiHi BUKB;
| BUR; XIDIItS; LIVEB; FL1CITII:
i SHIEE; ctBitt: inopsiEa
BEFEEEBCt
Tnkaia, B.
Sazvki-Iaaaaoto, I.
lauo, I.
Tarai. B.
994
rchiras of
^nixouental Evaltb
35(1):3*-M
ElOB*. D.
loclkerg. G.
(•star. P.O.
19SO
Sclaaec of the Total
EnvicOBaemt 16t13-35'
Cappoa. C.J.
Salth, J.C.
1981
Joarnal of Inalytical
Toiicology 5:90-98
ittn «*eB)
-------
s«l«nlu«
7782-49-2
Se
l» 79.96,
BP 170-217 C. BP C«5 C. T* 1 aa Bg at 3W C. 10 •• Bg at 4.29 C
(COITII9ID)
TISSB!
4454
lung
4455
4458
Basel*
I exposing som
1
IBltTTICU
H5THOD
n
•i
i
•OHBIl
or cists
•2
a) «
b) 13
0 23
C
4
IUU
0.52-15 ng/g (««t «t|
a) 0.044-0.22 njyj
b) 0.068-1.56 ng/g
e) 0.00 10-0. 301 ng/g
»et »t
0.67-3.3 ng/g (mt vtl
0.57-2.2 »g/g (««t «t|
1MB | SIIIBII. IBrOSBMIOI I tXrCECBCB
1 1
1 _J._._ f
1 1
7.» + or - 10 aa/g | rtaales j Takam. I.
(Mt «) | t sanU-Tanaoto. B.
I Icoa a eroap of C1 aatopales, | leaao, E.
1 forensic aedical elimination*. Japan, i teral, B.
1 Balm. aeai age 40.* rr. resales. I USD
( HI* ag* 37.4 rr. 1 IrchlTM ot
1 I >CYironB«ntal Health
l mcx zvBBZws: IBTOPSISSJ JIPIE; I 35(i):3«-»»
1 iiBBiBis; IISZBIC; CUBIVB; COBU.T: i
I CBIOTIiT*; CCPPZB; 1MB; Bncntr: I
( ItCIOB; BlSHSin: BHUIfSI; 1
l IIUDIBB: aniBOBT; SCMDIDB; i
| JltlBIia; TIUBIW: VIMBIVB; ZIK: I
| eOtDj SBOBTIE; UTEB; KID11TS; I
| C!«lBHJ 55-76 rr, eipoaed to 1 EnTironMot 14:13-35
< aea«T aetala 1-3 decades. Ttae (
j cetMea r«tlr»a«ot aal deatt 0-1.5 yr 1
1 ii groop I aid 2-15 jr, gcoaf II. |
1 controls, ages 43-72 TC, vho Uwd 50 I
j k« froa the factory. Sveaei. 1
1 1
1 iftiEt; cuiims: Kitastss IITEB: i
1 loies: coB»iM?in mintiois: i
| JIBBSIBI»t BISIZBE: niSOSEBIBT I
| I1TB09S; inlBOITi IBS IIIC : CIDBIHB; 1
1 cisiDS: craoBina; COSHT; COFPSC i
| CO ID: HOB; tlBTBUOt; LEIB; (
| tllGlHSS: BSECfflT: BOlTBOtlDB: 1
1 tsospBOKBs: uraiDiUB; scimims i
1 siiiiini; aims; TIB; TDBGSTSS; i
t line: aiaitB Biiugs: IIDOSTBIU i
| IIliTS: SMIIEBS; TJLIDBIDB |
1 1
2.1 * oc - 1.1 fa} Bales I Ynka«a, B.
g/g (««t ot) 1 t) reaales | SnicU-Tanaoto. f.
1.1 * or - 0.76 I I llano, K.
/g (net wt) t Troa a groop of 61 aatopslea. I Terai, a.
| forensic ae4ieal exaaiaatioas, Japan. ( 1»eo
1 Rales, lean age 40.6 rr. fvaeles, 1 Ircbives of
I lean ag* 37.4 rr. | EtTlronaantal Health
1 1 35(1):3«-44
| 151CE nSBIRS; 1QTOPSIK; J»1B; 1
l utBiivB; nsmc: CIOBIOB; COBUT; i
I CtBCBIIl: COPPZE; HOB; HEBCOST; 1
| IBtlTV: B16BESIVB; B1BS1BISI; 1
1 I»*IBIBS: innoir: sciioioi; i
| 3HZBIH1; TI1UIOB; TtBkDIOB; ZIBC: 1
I eciB: B«o«iii: IITH: KIDBEIS; i
I cfimoi: ciaraiiiog; ajisi; RVSCISS; I
l tincssis: spiral: tnvss; tent: I
| BrTILI-. COBPUtTITE CTUOJTIO1S; SSI; |
( fCJIKIC BZBKItE 1
1 1
NJ
vj
-------
Seleala*
7702-W-2
S«
lt» 7B.9S, H 170-217 C, BP 685 C. TP 1 •• Hg at 354 C. 10 •• Bg at «9 C
IISSBB
**57
nil
MSJ
Pancreas
M59
Tltceat*
»»so
Spinal
cord
POSIWE MOII
Ingest Ion
iuiRicu
mioD
i
..
ac
1
1UBBES
r cisss
»
(1
C
> 3
1
a» 1
b) 3
tUSE
lot gireo
Bot glMn
1 1.1-3.S og/q (mt vtl
1 0.»7-1.6 ag/g (vet «t)
a) 23. 3- SO. 1 ppb
b) 6. 3-16. « ppb
a| lot applicable
b) 53.0-180.2 og/g
RBII i sunn. iBTottiTioi i BBrnncB
1 l
1 1
0. 18 * oc - 0.59 | •} Cosea 1 Kaubrocki. E.I.
ppa | r) Bea | Kanabroeki. J.li
0.58 » or - 0.27 | left thaab I Greco, J.
pa | llso re»iew4; kao» levels of 30 t Kaplaa, E.
FT (t I ctker eleieat* 1 Oestac. I.T.
1 1 Br», s.s.
| Bailtkr 20-6C rr oiaa { Gaatafson, r.S.
I 1 1*1800, D.I.
1 »t TOTS; SEX; mis; sstnij ILDRHOH; i iioare, c.i.
I UTiBowt; tusnic: IUIDH; CIDSKTR; i 1979
I CUCin; Cisni: CBBOnni; COBIVT; 1 Selavee of the Total
I CCPPE8; SIEHUItJB; SC1.0: Itoi; LE>0; I Enironaent 13:131-1*0
| IteiESini; BUSUESC; ICEKCOST; |
I IClTBIini; IICKEL; POTlSSIOa; |
I BOBioinH: siinni; smcoi; sima; i
| SOtlOI; STBOITXai; Til; TIHII08: |
I fii»ivB; UK; IIECOIHIB i
1 1
1 1
1 2.3 » or - 1.0 | «> Bales \ Tnkan, 8.
g/g (vet »t) I t) teaales I Snznki-Tasaaoto, R.
) 0.89 t or - 0.62 | 1 »aaao, K.
9/9 (vet vt) 1 tcoi a gro»p of C1 aitopsies, I lerai, R.
j forensic aedlcal exaataatloas, Japan. I 1980
1 (alee, aean age »0. S jc. feaales, j trckiTes of
1 teaa *ry «t | lentral bora tiasae, avtopsf I 1979
| lo detectable Se la 6 other patients j laaals of Seorologj
I aa4 9 controls | 6(l)t21-2»
1 1
1 1! TI oU an dial of progressive 1
1 avacalar dlctcopkr- "7-67 TI old 1
| centrals, dlcl froa chronic ceual \
1 failaxe, breast careiaoaa. and I
I ceroitaTT artcrr diseases. |
1 1
I 1'TIS; 1DV1TS; iOTOPSISS; |
1 1IOSOHUSCD1H DISEISIS; SPIBM. COST); |
| ElOlCdinilTlOW; ClLCfOIi COPPEB; I
I TBCI; litt: RHGtRZStt HETILS-. 1
I sitirriR: zitc i
i i
(HIT *IBB)
-------
TTM-W-2
3*
at« TS.4C.
1TO-2IT C. Bf «*5 C. TP 1 •• S? «t 3S« C. 10 M Bg at »29 C
CCOBTtlVtD)
TISSBB
•Ml
SplMB
M«2
Splwa
MS 3
vrica
««<•
Brine
MSS
9rlm«
EivosnE ion
lBf*StlOB
BgeatiOB
IIllRICll
BKBOD
H
ec
us
l«arl«i. 1 T«r»l, S,
1 fOTCBcle »»alcal extilMttoa*, Jap«o. | 1980
I >*!«*, M*n tcj« 40. < tr. F«ul«a. I Jrchliei of
| MM (TC 37.* TT. 1 ZBTlCOBMBttl B«»lth
| I 35(1):3C-M
1 ttice H.BHMIS: AOTOFSIBS: Jirii: i
I unnirav; »»St«IC; C»»HIt)»; COBIXT; I
I cERonma: comi: itoi: IEICVET; i
I JIDIOI: iieKsniB; uientsi; i
1 imlDiuB: utisowT: SCIPDIUB: i
| StlEtXH; TIH HOB; nUBIDB: II»C: |
I SOID: BlOIIlIi 1ITH; KIDIIIS: |
I ctmtvts cEimun; HIM; HBSCISS,- i
| EllCIItS; SPIBII! LVKSi 10IT1: I
| BIT IIS: COSP1BITITB BT*L(TlTIC«Sl SIX: I
| fCRKSTC HIDICin 1
1 1
1 1
•I 2«6.6 ppb | «l S« II. IT | C*ppOB. C.J.
b) 1*2.4 ppb ( t) Si H | Slltk, J.C.
rresh it | I«top«le» I 1»81
1 I Jcara«l of laalytlcal
I ca>i4i*a IndUa, Boithnest Oitatio 1 Toiicology 5:90-98
1 1
| IISBIS; FOOg COIIISIHTIOI; |
I TiDnstaiu pauonoi; MPOIITIOI i
I IlrOSBlB; DIBU 1BMS: ITFBJ1 1BE1S: I
i mis voiinioi; NICVBT: SBBCOBT i
I oi0iiic coifcttiDS; stimat; BB«»; i
I BUM: KIDMTS; 1ITBI; PUCBBT1; I
I SEXin; Ciiiti: imopsiis i
1 1
79.21 + or - «». 12 I §«sld»ots •«!»» «it«r ftoi nils with | talmtlte, J.I.
g/1 I :e-1800 a? S«/l I Kt*4t R.K.
( 1 Hang, P-l)
1 Iliac, TS | Sckloektcc, B.
1 1 "9°
I I1B BEIICO: BLOOB; B1IB; DBIBE; I Journal of loiloolo^f
I 9ET1L3] SH.IITHB: BBUtUG «1TEB; | ana laTlcoaBeatal
| IIZTMS5: POPOHTIO* nPOSDBt | Health 6:731-736
1 1
t 1
2.3 » or - 8.21 ag/1 I I Gaahehaa. 1.
| | CbMboi. P.
j Bataial. BOB-oecipatieaallT «i posed I 1980
I 11-77 yr old*, tjom. Fiuic*. I Clinlcil Chemistry
| I 26 (9>: 1772-127*
1 sztmni: REIIIS; rsucs; ami: i
( BMSntlBfT BET BOSS |
i i
1 1
063 »j/»l 1 Bapid City, SO, Ml«aH«lo«i aim. I Hon. R.
1 nmklr or aorthly saiplUa. *-2« i>k>. I 1«74
i i archives of
I Maltky blood doBOrs of vatloos age*. 1 BaviroiaeBtal H««ltl
t Seitk Dakota, lyoalao, labrarta, and I 3*|«) :**»-»«8
t lotti Dakota. I
1 1
t sniEToi: BiooD; mil: ram: i
I CCH»BaTITE EVlLVktlOBSi SOUS; SOOTH 1
I C1IOTI; 101TB KlIOTl: ffiBBtSIa: I
i iionis i
1 1
00
-------
JSJ-W-2
cz-i«-r2-si
ft 96.15
TISSUE
•MS
Breath
EtPOSintE 8OBTE
1U1TTIC1L
IETBOD
re/us
•men
or c»sis
8
UK!
'
1.2-UO.O ug/lr
mi
28.9 vg/hr
SIIES1L nmiUVXOI
_
Coapoaii related to noraal
eetabollSB. «o other Oataila glvea
lealthT allltary *a4 ciilliaB
eiploTees. U.S. ilr Force School of
lerospac* l«4icla«, ages 23-*7 jr. 3
IIKSISS: CBtOKIIaTEB BIBIOCUBOBS:
CEIfltIM OtSlKC COIPOMDS;
cnoBoniimsi nvcnn coiponiits;
iBHTi: itcosots: tins: IDOITS
miiEici
C oak la. J.P.
Caap, B.J.
Belck. B.E.
1975
IrcKlves of
iBTiraaaeatal Health
30 (2): 294-295
!2Q-5«-«
C3-l«-?-S
«1 92.20
TISSUE
SKOSOBS BOOT! I
1
1ULRIC1L
IETBOD
ec/is
imisB
07 CaSXS
BaBGB |
1
lot detect «a-5. 2 ag/kr
HEli |
1
0.7 aj/hr
eiHBll UTODUIOl
CaipoBBi froi BikBOBB origin, lo
ether details
-------
Silicon
7MO-21-3
SI
»tW 28.086, IIP into C, BP 2600 C. TP 1 » H, at 172« C
(COHTIIUED)
TISSUE
• •TO
si ir
««7l
Rltaer
HT2
linr
EIPOSVSE SODTl
Injection
n lection
1
1
1
1
I
1
M7J | Injection
l»9 I
AULTTICll
HETBCD
US
us
us
IUHBEB
OF C1SZS
1
1
1
JUCI
lot applicable
at applicable
at applicable
BZH
120 «g*
5* «g<
*000 «q»
SEISE1L IlfOSBJIIOB
P«lie». :• reprasentatirs
FC«-*nslTSi3 treatients are
tabulated. I be leasibilitr of a
tolistic, na-irasa palter foe hair
analysia is catlinea and snpportea.
BITIH; TB1CI ELMERS: HUB:
mSTBJUl: RIlSVBEgilT SETBODS;
eiTJIS; tSOTlHS; COBP1E1IITI
ITAlOaTIOIS; »1UBI»OI1: 1IIIBOIIT;
1ISEIIC: BtEIDA; BBOIIIE; ClDHinS:
ciicwfi: ceicBiRE; cmtoanju: COEIIT;
CCPPBl; 5HIIUH; CTSBIHOB: GOtD;
icoiiE: iBoi: Linauvts lEic;
HSIESI7I; auetnsE: OJRCIIBI;
eCITBDElUB; IICKHI.; PaOSPHOEOS:
ECIISSTOS: BBBItltll; SILEIIVi:
Silicon; SIITEE; SotUBS; SIBOHTItTB;
SD1FDE; III; TIUKDH; THIGSTEt;
Hie; zucoiitm
Caucasian, a«< »0 yr.
Cifeoli it lanqs
ivies; Bain: HOOTS: LIVES; BLOOO
SIBII; siticci; CISI aisrosirs;
IOTOPSIES
Caucasian, 890 40 re*
Iitali in Hag*
laiGS; BBIII; KIDRTS; 11 YES: BtOOO
siBOB: sincoi: cisi BISTOBIES;
laiopsits
Clicuini, >9« *0 re.
liboli ic lanji
iqiGS; BBIII; KIIIETS; LITIB; B10OD
SZEIII: siiicci: cisx BISTOEIES;
leiopsrts
BEfSBESCS
CbUtleborongh, G.
1»SO
Science of the Total
Emironient 11:53-75
Solow>na« E.T.
Jones, O.K.
1»7S
Journal of Forensic
Sciences 20(1): HI- 199
SOlOKIK, E.T.
Jones, J. It.
UTS
Journal of Forensic
Scie«cet 20(11:191-199
Soloions, I.T.
Jonea, J. K.
1975
Joucaal of Forensic
ciences 20(11:191-199
NJ
00
o
-------
7MO-22-*
at! 107.86S, IP 9M.5 C, BP 2000 C. TP I n Bg at 1310 C, 10 •• 19 at 15*0 C
TlSSIt
«*T*
Mir
»»75
Kiaaer
•*7«
Lint
MSVIS IOBIB
iMimcii
BETBOO
I
»
*OBBH
r cuts
> 8
1 21
•) «
« w
IIISE
J < 0. 005-0. 0»S a«/g
I < 0.005-0.18 ag/g
et «t
a) < 0.005-0.032 »4/«
b) < 0.005-0.33 oj/-j
••t rt
iul i CEIHII iiroiamoi i BBFEBBBCE
\ '
| levie*. 2* r«preMBt«ti»e 1 Caittlebocoagfc, 6.
| pre-aaaly>i* treataeata are 1 1980
| tabalated. the feasibility of » t Science of the Total
1 Bcltetlc, no-task policy for hair t Enilronaeat 1»:S3-7S
I aaalysia la eatliaed aad supported. I
I (met; mci ncnrts; Bin; i
I lISTItlll; niSIUIEd BETBOBS: I
I EttaLS; ttotmsi coariiiTin I
I Mimitiois-. limnm; H1IBOVI; 1
I nsnic; Binoa; Btomi; CIDHTUE: i
t ciicrjs; cnains cnciioi: conn: t
I ccrrn; siLtnrn; SEsaiiroe; SOIB: i
I icons; laof: UITKHDB: LUC: I
I a»oi*sio»: uiemsi; SBBCOSI: *
| ICITBDnOBi BICKBLi taOSPBOlOS; 1
| CCtlSSntl; BTOtOIUS: SELIItlH: t
I siircoi; sit TIB; SODIOB; stiomoi: i
I sum: m; winna; monti; i
1 UK; nicciiot I
i "
1 1
) lot give* 1 a) Controls 1 Brane, D.
1 lot giTeo I t) Workers, qroipa I *a4 II 1 lordberq. G.
| I tetter, t.O.
I taoeasei tefineir u< aeeltai 1 1980
( wckec*, aqea 55-76 rr. expoael to 1 Science of tie Total
1 l«»Tf aetal* 1-1 tecalea. tin t Inilroieent 16:13-35
1 t*t«eea retinaeat and death 0-1.S JT |
I ia oroap I ««fl 2-19 Tt, qroap II. I
I Ccatrota. aq«* «3-72 rr. «ao litei SO 1
1 ka free the factory. Svedea. I
| SIMM: CIDIKBS; IIDBCTS; LITJ8; |
1 totss-. coitiuTiTi mniTioss; i
I IIDJSTBIlt 1T6IEII; B!»SOBlBtHT 1
| ttTBODS; HTlSOIt: «BSB«IC: CIDHUJB: |
I.CISIOB: CBEOBIOB: coBiLT: coppu: I
1 coin: iici; unsiiOB: L»O: i
1 iHSaKSt: incnn: SOITBDIIOB; t
| EtOsrHOIOS; NBIDIOI: SCHDIOB; |
| StlEflVl; S11T?R; TI«; TOUGSTM: I
| tllC: BBalTI SillBDS; IIDgSTlIll 1
t mvts; s>itnns; niLotitii i
1 ..._!.__
1 1
a) tot gi»ea | a> coatrol* 1 Brae. D.
b) lot giTea I t] lorkera, gcovps I and XI 1 tordberg. G.
| I (ester, ?.Q.
I te
-------
Itt 107.SSB. n* f*0.5 C. B* 2000 C, TO 1 » Bg at 1310 C. 10 •• Bg at 1S<0 C
(cormtiD)
IISSVB
J.S
MTt
•nil
ixrosvBB BOUT
ilainxcil
BETBOD
n
11
BDBE-SS
or cisss
at 8
b) 20
•1 9
b) 11
ur«i
a) < O.OOS-O.OCO ng/4
b) < 0.005-0.02* ig/g
net «t
a| lot given
b) lot given
BUB 1 eillBaL ItFOtmiOB
J
a) lot given I «) Controls
b) lot given I r) farters, eroepn I and II
1
I Deceased refleerr and snelter
j sorters, ages 55-7« rr, exposed to
I k«a»T netals 1-3 decades, tine
1 tatveen retlrenest and death 0—1.5 rr
1 li goarp I aid 2-19 vr. groip II.
I Centrals, iges *3-72 it, >no lived 50
| ki fcoi the factory. Sreden.
1
| SlIDEI; CIBtTBtS; KIDIBTSl IITBI:
I uies; coapuifin mtnnais:
I IIEDSTIIU BT.8XSII: BBISmBttn
I BITBOCSi aRIBOII; IBSSRCJ C1MIU8;
1 cismis CBBOBing; COBIIT; COIPEB:
I COID; HOI: I1BTBUOB: 1I1B:
I IlietlCSl; BItCOBT; WIT8DIITO:
I iBospBoins; iBBiDioB: sciinimi:
| SmirtH; SIITBI; TIB; TOISSTBI:
I IltCi BU1TB BlZalDS; IIDOSTIIU
| PI11TS; SBBMEBSt tEIlOIIOB
1
1} 0.7* « at - 0.7* | •) lonei
pps f t| Ben
b) 0.3* 4 or - 0.20 I left thnnb
ppn I ll*o revleved: knosn level* of 30
Dry «t | ether ilenent*
1
1 Beilthf 20-60 yr olds
1
I irtjiTS; sn; mis; ESTIEI; itOHiinB!
1 iniaowT: iisEtic; BititrB; ciBsiH:
| CllCItU; CISTO8; CBBOBZOB. COEllT;
| CQPVBS; 6ESB1H1IB: GOtD: IBOI; IEAI>{
| BISIISPJB- BIBMBESB; SEBCOBT;
1 catiBDitVBi ncKiL; ponssiaa:
| IBBIDlaB: SEIBBItB; SItlCOIJ SItTES;
| SCCIOB: STBOITIIIBi Til; TIT1II09;
| TIIIOHJB: UK: ZIICOIIDB
« 1
EEFBIEICE
Brane, B.
lordberg. 6.
(ester, t.O.
1980
Selene* of the Total
Envlronnent 16*13—35
Ranibroctl, E.I.
Kanabroeki, J.I.
Greco, J.
Kaplan, E.
Oeater. T.T.
Brae, S.S.
Gestafson. P.S.
VelsOBy 9.8.
Hoore, C.E.
1971
Science of the total
Bnrlronaent 13:131-1*0
NJ
oo
7««0-23-S
la
Itt 22.»am. tt 97.K C, BF 881.4 C, TP 1 •• B« at MO C, 10 •• Ig at S«< C
TISSBJ
««7*
Slool,
serei
t
1
t
»
BIPOSBK MBIE
1
\
\
1
iiunicu
rnnm
us
\
\
\
t
ItlMXt
OF CASBS
» 260
b) 260
1
1
»-
MBSB
a) lot gitrei
b) lot girea
1
t
i
Bill
1*0.60 « or - 1.W
•eq/l
b) 13B.5S » or - 0.77
•eo/1
1
1
t
«
eBIIML IlrOBMTIOl
•) laisas cltj, ts, Uri-iiter mi
b) taasas Cltr. BO, so(t-«at«r area
IS and BO resident! eatehed for age
(•em aq« 37 and 37.7 T?| , >ez.
liigtn of residence, iiritil and
•conaile states, occupation, inber
cf ehtlim, stoking habits, ht, ¥t.
In hard-water area, slenif Icaat
liczease In hypertension, BCG
•bnocnalltles, ind irperarlceiia.
(lists; H1SSC0H: itottss
C»CIOT1SC«1*I OI3B1S1S:
mirriisiai: noon ssjnn:
ccBfiiaTlTi CTH.OITIOIS: CIMIOS:
cncii«s cBiciitiB: inBiaB:
ii«»sm: IMSPBOIOOS: TOUSSIW:
I sotimj me; sioiccn-nrntioi;
t ntncna »M«
\
nrEBicB
Blerabm, H.L.
nelaehsan. 1. 1
Dunn, J.
•mold, J.
1975
Lancet
1(191«):1008-1016
1
1
-------
So41»
7MO-23-S
la
lt» 22.1*977, n 97.82 C, BP 881.4 C, TP 1 mm gg at MO C. 10 » Sq «t 5M C
(COsTIIVSO)
trssnB
•MO
Balr
_i_
air
M«2
Balr
irosots tout B
iBiinicit
RSTBOD
US
•1
BDBBBB
OP casts
31
22
a) 23
b) 14
0 »2
4) 1*
•) 26
O »0
B1BSB
Bot gi»«n
lot given
a) 3-19* aq/q
b) <7-»0 noyo;
c) <7-1»9 aq/q
d) 12-196 ««•/«
•t <7-9» aq/q
I) <7-«96 «g/«
B«B | GBIIfU IBPOtBlTICB
1
1
1(37 pps | a) leaning disabled
919 ppa | t) Controls
1
1 learning disabled and soraal 3rd aad
1 «tk grade stndemts 1m Canada.
1
1 ciicna; siGissxm; POTISSIOB;
1 SCDIOS; CUB MB; COB11T; COPPIB;
1 IFCI: LBID: UB«iiBSB; IIBC:
1 cnoBtna: itiBiBB; Bttcmt; anus;
1 BUI: caxiom: ciiim
1
1
1 Beyie«. 2* representati**
1 yea— analysis trttatnvnts ara
1 tatnlated. TV* feasibility of a
1 nelistle. no-*ask policy tot halt
1 analysis is outlined and supported.
1
1 iivin; TBici stiazns: am;
l issniLii: BUSDIBBBIT BBTBOES;
I mils: Ptornis; cowitiTin
I IlltOltlOBS: 11DBIIUB; iniBOIT;
1 nsnic; siHoa: BIOIIR; CUBIOR;
I CIICIDB; cairaiK; CBBOSIOB; COIUT;
I coppts: oiniuB: eEMinva; GOLD;
| ICBIll; IBOI; tlBTBlBVI: 1»I;
1 tisBssraa; BiaeiBssi: RSICIBT:
1 iciTBDBna: UCIIL; PSOSPHOSBS;
I IOTIS3I1S; BBBIBIBB: SJLIIKJS;
| SILICOI; SI1TBI; SOOIHI; SIBOBTCTa;
1 SHLP01; TIB; TITlHtlB; TOBG3TIB;
1 IIBC; flBCOBIOB
1
a) 3* «g/q I a) Bale costcols
b» 3 aq/q | k) Fenale controls
e) 1« »q/q | c) 111 centtols
d) W aq/g | dt Rale aaltiple sclerosis patients
e) 9 aq/g | «) Peaale saltiple sclerosis patients
f) 1* «q/q | f) 111 aaltlrle sclerosis patients
aedians \ Staple* fros 7 scalp sites in eack
t sablect.
I CIB1V1: ICtlllS: CBRSll niTCOS
1 StSTIH VISH3E5: BUS; llOBIBOa;
1 ciORiis: cucnR; CHIOBTH; COPPEB;
I SOU; IODIII; aiasiBBSB; aiTUS;
1 3tl!lT01; SItrEB; SOBIOB; S01POB;
I viiion*: UK
1
BBPE1EBCE
Fibl. B.C.
Carkes, B.
977
Science
198{*313):20*-206
chltUcboronqh, G.
1980
Science of the Total
Enrlronaant 1«:53-75
Hyan, D.I.
lolxbeener. 1.
Sturt, D.C.
197«
Clinical Ckenlstry
2«(1t):1«9«-2000
NJ
00
-------
Strontium
7««0-2»-6
Sr
it! 87.62. at 357 C. tt 1366 C. TP ID « Bg at (48 C, 1 u Bg at T«0
TISSUE
««*3
Kir
EIPOSORE BOOTS
1I1LTTICU
ffiTHOD
iron BIB
or CISES
MISS
Bill
GKHBal IIFOSHHIOI
B«Tle». 24 repreaeatatiTe
Fr«-»B«lTSi« treataents are
tabalated. Tee feasibility of a
holistic, »-»ih policy for hair
aaalrsls is oat lined aad sapportea.
mm; TSICI ELIBIITS; HUB:
lOSTBUIl; IBlSOBIinT BKTBODS;
BITU.S; PBOTU1S-. COBtaUTITl
iTiinfiovs; itninnH: jmHoir;
usjrrc: BJBIOI; BBOHIMS; c»xira:
ciicni: cetcsiiB: craonoi; COBU.T:
CCPPBE; StlLIUB; GEESillOB; GOLD;
ICDUE; IBC1; IIRBHVI; IEIE;
BieiESIDI; MVGinSI: IBECIBIt
fciiBBHOB: HCEH: PHOSPHOBUS:
PCIISSIUS; ETOIOIDB; SEIBIIUB:
SIIICOIj SI1TEBJ SODIOB; SIBCrilBH;
SClf OR; III; TXTMim; TOUJSTEK;
fHC; ZIBCailSJB
SEFEBERCE
Chittleboioagh, «.
1930
Science of the Total
EnlcoDient 14:53-75
re en
«tbearl-
101.1*, HP -3t C. »P M5-1M C, n 3».« ati tt 37«.« C
tissvi
«»a»
BIooJ,
•hole
MBS
Rrlie
EIJOSOBE BOUTI
Inhalation
Inhalation
IHITTICH
HETBOD
sc/ns
«c/«s
MOB BUI
OF CiSES
«
I
*
UltiS
a) lot giT«n
b) lot 9 Iran
c) Rot given
Vot gir«n
IEJLI
a) 0.« ng/ml
b) 0.92 » or - 0.26
ng/«l
c| 0.01 09/1!
-
2.12 * or - O.BO
•illiioles
etllUI UF09B1TI01
••) Initial lalae
t) peat, at 6 hr
e) Final valie, at »7 »r
Dcs« «as 90 pp«
a> anS a} estlnatel froa gcaph
Healthy Caucasian 2«-«« yr olds.
72.«-*0.7 kg.
•Off* odor, ilia eye Irritation, van
eeawtlon is face.
STTtmS; SICOO; tllUattOI: lOOLIS;
CITIf; HtTlBCirTES
»S hr lean eicretions o* aetabolites.
ian4ellc acid and phenTlglTOiilic
•eld. Dose «as to ppa.
Icaltay Caaeastaa 2***< rr olfla.
72. 6-90. T ka.
•Cff" odor, aild ojf Irritaltoo, wars
sensattoa in face.
StTtNES; BLOOD; TIH1HTIOI; IDVLTS;
UBIIE; HETIBCLTTES
BEJE5EHCE
B»a«r, J.c.
Icing, J.D.
Karbovskl, B.J.
Chenoveth, B. B.
HcCartj, t.P.
Brian, i.e.
1980
Tozicology and Applied
tharaacologr 53:5a-6J
Baaaer, J.c.
Tonag, J.D.
Rarbovskl, E.J.
Cnenoveth, B.B.
BcCartT, l.P.
Braan, I.B.
1980
Toilcology and Jppliei
Phuraacologr 53:S«-63
to
00
.p-
-------
Siltli*, ntlrt propTl <• Cl)
Prof tarn, 1- fMthftklo)- f» CD
3!77-f5-»
et-Bio-s
01 90.1*. IF -113 C. B» 95.5» C
TISSttE
•age
Breath
EXPOStTBB MOTE
tniTTIClL
SEtBBO
8C-SS
or CUBS
"
S« (387
naplas)
BMSS
lot giv«a
sui
SaoMtric
G1IERH ZVT0194TIDV
B«aanr*l at 25 C a*4 7«0 aa •«
11. 5t oecmtme*
IOMC afl appn oa*-Slgaa Halts 0.39
*«4 5.1 mayl
ecaltkTi. 1B-3S TC old. nonaMlting,
CHcacjo, II. iiqidly controlled
tipatlacntal caaUtiou.
mug; 11COHLS; IlLItOIS; 1DUUS;
ceitnrnun BrosocfiBOis; TOIITILS
CESIE1C COEICHBOS: BHI.TH aiZlBCS;
IimntlO": aiTlEOllSa; antBOLRES;
IOPBI1TTOI TIPOSOM: DEBIE *BB*S
taaeK*
BEHBMH, 6.B.
O'Vaill, B.j.
W7S
Joamal of laalTtleal
Toiicologj 3:225-23*
si lew
n
s
32.06«,
C, fit abort *»».& C
1ISSVX
M87
BrtMlli
*.*B8
Uttlr
»••»
Balr
:IPOSOB1 BOVTE
Inhulitlon
aiunmt
HETBOB
PIXE
n
BOBSIE
or CUES
1
a] *2
b) 10
jHGt ~~
lot ql¥«B
a) 2.T7-3.99*
b> 2.46-3.73T
am |
1
S.9 n«
a) 3,'sr
b) 3.23'
BleUaas
GEIH1I IIFOiaiTIOI
« 1 saaplaS it rat* of 1 I/ail. 2-10
•In aftac baralaq * arc ««Hin E*pr*««BtatiT«
(iv^aBaLTftlc traatBVBtc act
tatvlataa. Th* f«»«lblllti of a
leliatlc, no-*»»k pollei fax hair
aaalTaia 1* cmtlln«4 aad supported.
tlTICT: TB1C! tiimwts; Bin;
ICSTBtHl; BIASQBVBBVT RRBQOS;
irtiis; fBornis: COBPUITITI
fiiimiOES; itvalKiB: IRIBOIT:
1SSCTIC; BUIUB; BIOBIIIj CUMOT;
ciicnrB; CBicsiii: ctmoaius: COBUT:
copvn: smma: OEintnvB: COLD;
»6B«sioi: aiasujss: BEBCOII:
BOtlBDIIHH; 1ICKS11 nOSPEOlOS;
CCTIS3IVBS VBB1BIV9I; SBLEVI1TB;
S1IICOB; SXLTEI; SODIDB; SIBOITHTJ:
SVlfm? Til; CTY1VXDB; TVBGSlEt;
1IBC; IltCOlIOa
a) Coitroll
tl 8alti.fl* iclccoalc patlcata
Saapl** fxoa 7 scalp aitaa la each
jvb 3*et
CIII01; IDOITS; CEITU1 IE B TODS
£T3«B DISUSES; "Att; 1LOBIIQB;
BIDB»E; cucinn; CRIOBIBE; COFFEE;
ccto: I09IBE: BHCUESI; EETILS:
imiins; sitTini sooioii; snrm:
tiiioivs: ziBC
EEPE1EBCB
Unlsaon, t.B.
Dasaaa«l*er. G.6.
Joktuaoa, T.B.
Uncb«ater. J.t.
W7*
lanala of Occapatioaal
BT9l«B« 19:225-23*
ChitU«bozo«gh. 6.
1980
Scl»nc« of th* Total
EnTitOBMut 1«:5J-75
Byu. D.E.
Eolxbeckcr, 3.
Stuart, D.c.
1971
Clinical chnlatCT
21(11| :199S-2000
to
03
Ul
-------
Tellarlaa
13494-sa-*
I«
Bt 127.6. IP 449.5 C. ft 989.8 C, »P 1 ma B» at 520 C
«ss«
4490
xidaey
»wi
Liver
4(92
Laag
nfosm BOOT
kuimcu
Banco
n
u
BBBBEB
OF C1SSS
•1 «
M 19
a) 8
b) 19
8
19
IMG*
a) < 0.005-0.33 ag/g
b) < 0.005-0.2* ttg/g
let *t
a) < 0.095-0.12 ag/g
b) < 0. 005-0. 12 «g/g
Vat «t
< 0.005-0.025 «»/g
< 0.005-1.06 qg/g
at vt
Bsii i CBIBIU. IBPOMMIOB i nramicx
i i
1 !
a) Rot givea I a) Coatrala 1 Brate, D.
b) lot givea | I) Workers, groaps I aad II I Borabarg. 6.
1 | lastor. ?.0.
I laceased reflaery aad laaltai I 1900
j ccrkara, *ge* 55- TC ft, expoaed to 1 Scleace of the Total
I taavy aetala 1-3 decades. Claa 1 Eoiironxint It: 13-35
I tatnaaa ratltaaaat mtt daatl 0-1.5 rr 1
I ii qroap I ul 2-19 TC, gceip II. 1
| Coatroll, aqta 43-72 yr, *to lital 50 (
| ka froi tka factory. Svadaa. 1
1 1
i sitwi: eatiTBSi KiDasrs; iirsi; t
I uiss; comiinn immiois: i
I iiDBSTiiii noiEHi actsomni i
t BIT BOBS j innoit; usnic; i
1 inimna: ciDfliiB: cssim; CBBOBIDB; i
| CCBalT; COfPIl; COLD; IMI; I
1 iiRBitui: LIU; uieiRSB: nictuT: i
I lomotnB: laospsoiiis: BDBIDIOH: i
| SC1IDIDR; SBUIIOf; SIITEI; TIB; I
I TVKSTK: ZIIC; BJ1ITB HEUSDS; 1
| mOSnXal PllITS; SIU1TEBS |
1 1
1 1
a) fat giva* | a> Coatrola | B£vna« D.
b) Bat gim I t| v«rkats, groups I aaft II ! lordbvrg, S.
I 1 Waster, P«O.
1 laeaasai raf laarj aad aaeltar 1 1980
] icckars, a; BIIGIIBSB; BEBCTSI; i
I BCIIBIIBO'l: fflOSPBOIBS: BtTBIBIBi: I
1 scMDins: snttiDB: snrzB; TIB; i
| IHBC5T»: IIBCj BBU.TB MZUtS; 1
| IBOISTIIll ?11»TS: SIBITBBS I
1 1
1 J
Bot given 1 a) Coatrols | Broae, 0.
lot girea 1 r) lortecs, gioaps I ud II 1 Bordbacg, G.
1 | Waater, P.O.
t taoaasad ref laary aad aaaltaz 1 1980
I tcikers. aacs 55-76 yr, axpaaad to t Selaaee of the Total
I Iraarr aatals 1-3 Oacadas. liaa 1 Hnricoaaeit 16:13-35
| tataaea iatlraa*»t «»4 death 0-1.5 yr 1
1 la group I aad 2-19 yr, groar II. 1
I Coatrols, ages (3-72 yr. aho lltai SO 1
j ka Croa the factory. Svedaa. 1
| SMOtB; CICaTXRSS EI9BRS; llTBi; I
| IOBSS; COIPIHTITB ETltHtTIOBS; I
I IBEDSnilt BieiEBS; BKtSBBEIEBT I
| BITBODS: aBTItOBT: »S*IICJ 1
I iiitraivB: ciD«m; CSSTOB; CHBOHIBB; i
I CCIILT: cotrn: coin: isoi: i
| tlKHJUnS; HIS; BaBCllBSI: BJSOJST; 1
I tOlTBOEBtm: tBOSPUOlOT; BDIIDITia: 1
t 3CMOID3: SCItBIOB; SItt'B-. til; t
I 1B1GSHB: tine: Hnm BIHSIS-. \
\ IIDITSTII.I HUTS; SBSLTIIS 1
1 1
to
00
-------
t«rt-Mtrl iinlflt* (8 ci|
nl*«lfld«, fci*f1.*-dlMtkrtet»rl| C»
CI-8U-S2
II 178.3*
tissn
«W3
Brcatk
sifosvn Mm
lutmcu
BITBOD
OC-BS
fJBBEF
or cisss
5% PB7
sa*pla*l
tues
lot glm
n>i
-
0.509 »g/l
0*oa*tllC
eiBtBu, inoBBMi«B
Rcaiond at 25 C aad 7 SO •• Bg
21. M occurroc*
le««t »»1 ivpar o*«-Sl.
Cticaqo. 11. sijiSlr contzoUcl
•tpnlmtil condltlots.
flllTB; I1CCIO1S; I11IIOIS: 1D01TS;
CE10IIIITID miOCllMfS; WllTILE
ciGuic concnos: RIIITB IIZUBS:
niitKTci; imtoiissj imiEounss
ICmiTtOI IIPOSISB; D8B1I UMS
isnsnirci
KtataniDiki. B.K.
BCUCN, 6.1.
0*1*111, S.3.
1»7»
Joarul of taalTtical
Tnicologj 3:225-2M
11
10*. 37, B> 303.5 C. B> l»57 C. T? 1 M Bq at «25 C. 10 •• Bg at 1000 C
1 tissut
MM
cerebrosp
Ival
flald
Saliva
nnsm tens
l»«*«Uo.
-
1BU.KXCU
IBWOS
las
US
IDBBM
Of C1SM
1
1
MB6B
lot givex
a) «-0. 2 ag/al
b) 10. 15-9. IB ag/Aar
isii
0.2 ag/1
.. - ,
a) lot glna
b) Bot glr«i
GCIlnl IITOISITIOI |
! dari after 1 a.
28 jt old, koapitallnd * dajs aft«c
lagwtlag tkalliaa Mltato.
lover abdoalaal pai»v aavcaa.
>TC«r*sthaala of lliba, roalting.
l«tbam, dte«*lMS*, dacraa««d blood
Tt»a«r«. len of scalp aad tody
kalr.
mttios; iiiiL Foiscwiis: CASE
11S1O1IBS: 01I«1; SttlTl; IT1LI:
ftCtS; SOICICt; CEtBBROSVIIU TiaiO
a) 7 aad 23 S«T» a(t«c t g
b) DCT< 7-» aid 23-2« attar 1 9
San valaes aatiaatad froa gzapb
26 JT 014, koapl tallied « day* after
iaq««tl*g tkalliaa calfate.
locer akdoiiial p«ia, aaiee*.
hi^ecaatlieaia of llab*. voiltlag.
letkargr, drevaiaaaa, dacreaaed blood
|t«*nre, Icia of acalp aad bodf
bair.
ICUUHB; Btlll fOISOIIIS: CUt
iisiotizs; nintj sutft: ITUT;
nets; smciiz; cnsBiosmu. naio
XERBHCB 1
1
(ickelal. r.
fioao, T.
iSaardla, I.
retrial, B.
Banto, 1.
1980
icealm at Tozleologr
(3:321-325
Blchelai, t.
Bono, r.
«aardla, I.
recrixl, B.
lano, 1.
1980
trcKlTes of Toxicologi
43:321-325
t-J
09
-------
Italltae
Itl 2»>.3T. II 301. S C. B? 1*57 C. TP 1 »a So at 825 C. 10 aa Bo: .t 1000 C
XXSSVI
419ft
Vrla«
imsns torn
I»«**tlOa
immcn.
•rraoo
us
nun
or ctse
,
itiei
5.6S-0.2? »9^«y
mi
(at * | | i) tot giT«B
1
1
1
1
1
1
1
1
1
t
1
1
— — — . *
1
t
uti i 6! ni»t uroiunai
1
•
a) S.3 Dj/al | a) I?0 aa/8 ir ta «t«dr »t«t»
bl «. 9 m/il I t) 350 •«/« kr plu 100 aq
1 aHopariB«/8 kr to steady atat*.
1
1 t«a-*aok«ri, aa«* 29-35 yr, on
1 iaatklM-fr<« dl*t »8 kr.
1
I I9SI11I.I1; ItalTS: BLOOD PllSfll;
1 otiitt oivs iirsticfio*: noes:
1 CCHMRITITt ITII01TIOIS:
I TBiopmiiits; tmnsi BRIBOIISI;
I imtotrres
i
1
a| 104.9 tor- *.$i! of | a) 250 aa/l kt
dos* | t) JSO ag/* fcr plu 100 ag
t) »*.B »or- 4.5* of I allopariaol/t kr
do** 1 TiMpkrUla* pl«a a«t*boltt«, ataadr
1 (tat*, ta 8-hr arlm. > SOU aa
1 1,3-dlMthylnrtc aeU. Data
1 anllabl« fct IT doa«.
t
1 lea-Mokara. aq« 29-35 ft, on
1 xaatkliw-fr*« aiat M kr.
1
1 itsniui; leniTs: HOOD PUSBI;
t OlttZ; 9(03 mitlCTIOI; DBOSS:
1 CCBtHlTlrr (TlLOIIimS;
I ittotmiinsi snins: imeociSRi
1 KiMotms
1 1
i nnmcx
i
t
1 STTfUl, J.J.
t 'la?. I.H.B.
1 Farka*. J.
1 Birtatl, D.J.
1 197*
1 clinical nacaicolojr
1 anJ Tkarapaatica
1 2«(5):««0-««7
1
1
1
1
1
I
1 CrrgUl, J.J.
t (lav. !.»-».
1 Fatkas, J.
1 Blrtatt, B.J.
1 197»
) clinical Fbamacolo^y
1 M« Tk*np«atics
1 2« (SJ : ««0-«<7
1
t
1
1
1
1
1
1
1
NJ
00
00
-------
melt, ioi«aioaiir?ie*l oatlmts
ItULTS; BBM1 DISSISB; BtTOmSIOB;
noon-, aniBTntntsiTB IBIITS; noe
TKIUTt COBIUHITB ITfllOmOO:
smsran curai; TKOCIMITBS
a) SaokvrSr attar 0.032 if/kg fa
•actaria, IB iasa, 2 >k
t\ Sab*tact9 a>4 dosa aa ia a) v attar
1 ao abatcatiom froi sacking
Staa$T stata 1»»»1. »•«>«
• l^itifieaatl) AlCfaraat.
(aaltfeT 19-(0 ?r olfta, saoiei at
l«»«t t jack of elaanttai/oaT.
tlUSS; 3BOII16; TOB1CCOS; IICOD
tusus coBtumn wuonioss;
IVTlCQUllaVISs BWIB01I3B; TI1IBSS:
TBIOCtlBtllS
xsrtiact
Bognn, B.
ttOXOtf J.
Xarcki, J.
Giert, 3.
lagltli. t.
Bitkov8ka« B.
Colabak, I.
1979
Clinical Chaaistrr
25111:60-63
-- _
SaAaaBB, K.
Shapiro, S.
Taltoa, B.
Carroll, r.t.
SalliTan, T.J.
1979
Clinical Vaariacologr
aa4 TharaDaoticA
25 |3) S 309-31*
p«BtaB* (lo
nssn i
•Ml
Breath
IttOSTOt BOOTI
1»IITTJCIL 1
vmvob
OC-HS
BQRBiS
or cisis
SO (3*7
naplu)
BUGS
Hot «lT«a
Ola I
0.421 og/1
OaT< 18-35 rr 014, nomaoklwi.
vctaa blacki aa< Caucasian.
Ctlcaqo, It. liqlill eoatcoll*!
«iB«ri«*atal condition*.
tBUTB; UCOtOLS: IUI10IS1 UttllS;
CHOBTI1TED BTDBOOIBOIS; 1OHTILI
cteuic coBtcoios: BBUTB BIUBCS:
iiauaTiOB; «rriBoiisa; BRIBOI.TTES:
fCPBtlTlOX lirOSOE!; OBB1B IEJIS
Bxnmcz
Etoto«T»»ii. B*K.
Bctncao. G.I.
O'Mlll. B.I.
1979
JOUMl 01 U»lTti=«l
TmicoloaT 3:225-234
K)
00
\O
*, 1- (8 CI)
CI)
91 776. 13, Vt 235-236 C (4«eo*p)
IISS11
• 502
eiooi.
tervat
ixrosnii BOOT!
inLnicu
IIITIOD
BtlBBIE
OF CISS5
2*3
BUGI
». 5-11.5 ag/100 al
BE1B
7.7 DJ/100 «1
GEiiiii iwrosainos
HCfPIOI'S: BIJSOBI1MT HETBOCS; BLOOD
smn*: Tttis
-
KIEtESC!
Broun, S.I.
•vtbeav^t J.
197*
Joortil of
Pharaacvatleal Sciaaces
«(B):11W-1217
-------
tig
7M9-J1-5
Itf m.C*. V 131.5 C, BP 2507 c. fP 1 •• Bg at 1C10 C. 10 u Bg ft M»0 C
I tissn i ixtosiu totn
i i
• i
t 1
(503 I
lair
a50l
Vale
1
lUtRICU
HCTBOO
.
1
•ram
or CISBS
MICE
nil i esBEiu Mfoiawioi
I
i
i
1 tarln. M rapnsntatira
1 fre-aaalrsf a tr«ta«t« an
1 tabtUtvt. Ths fusibility of a
1 aelistie, ao-msl roller for hair
1 laalysi* la cotliaa* «n<5 «ipport«a.
1 tmn; met HUHTS; nil:
I lesnuti: mmmn serwesj
I (nits; itemise cotPiMTin
1 iTimnoiS: imiliW: iniwntTi
j nsnicj Bum; uonis; caraxm:
1 cucxoi: CBtaiiBt cRonoi: coeitr:
j ccffit: giuim: CTMHIBB: COLD:
1 icoiii: I»os; iiRiiini: l<»:
1 neiMUi: iiiGiissi: sncsin
1 loiTioEioB; nc«ni Mospnows;
I IOT13SHB; IHKlalVB: Sill HOB;
j I JI1TCOI; SIITBB: SOOIIBJ SIICIH0II
1
i
• 1
I
\
1
•ws n
a) 8 1 a) < 0.3-6. 87 s«/g
b) 14 1 b) < 0.3-S..W ««/»
| Bat «t
1 3n tat; tit-, nruiii; TnEstn;
i me; nicoiing
i
1
| 1 ta>*i«v of >ocl4 lltaratar* OB taa>
1 a«c«atlatioa «»* blacoacuttatlon of
1 nlactsl toxic trac» aattli la amua
I kale aa4 aalls and otkcr aaaaaliaa
1 aair. far. atils, elans ail hoofs.
I Ktalatad bf geographic ana.
( *it5«eta-, ttt, a««, cxposara
1 gtiaivct, a»lrsas la pp*. aafl
1 ictaarltr fr«a or»r *00 za>far*Bo*>.
1
t irtrci; iDstiuii: CHIBJI! czniii
I iinici: mtctti iTDOtt list; in
t if HMD; SOUTH mild; somraasr
I mi t oviTte KiiGBoa; ontti stuts:
I fin; laits: imnt 4irin>ii:
1 »s»xc: BOBOI: ciBini: cnoiioi:
1 CCSU.T: ceatts tu*t racoti:
4 iicnt; snmvv: r»: u»oni; in
f (OtlOTIOl; IITUI *OPOHTIOIS:
| tTOICCOBOLKlOls BIOIBDICIIOIS! LtIO
I EOimioB: ropOLiTioi szposiru: run
I poitinios; TIICB Hire rrs: amis
1 lot gl**a 1 a) Covtrols
» fat eima 1 t> lockaca. grovpa Z tad II
1
1 r*c«ui4 rcflMty aad aaolter
1 •oikaca. agaa 55-Tf it, •xpoacS to
I l«»rf aet*l> 1-3 ivctdts. Ti»«
1 t«tw«a rvtitcaeat and dcata 0-1.5 r'
1 it groip 1 »d 2-19 yr. group II.
1 coatcals, agas »J-T2 re. »tt» Iln4 50
1 >i troa tba factory. 5*aia»w
t
| SMOCr; CJDJTIBS; ZIDIBTSt 1ITFI;
I HUBS; coRMiiTin zritDiTiofs:
{ III«STtIlt ITGIEHi msnXBNT
I iwaons: tvtiioti: Msmc:
I itu
o
-------
tin
TMO-31-S
Si
ati m.«9. n 331.9 e, tt 2507 c, TP i ••
»t wio c, 10 •• 19 «t 18»» c
(COIIIiBID)
nasii
•06
HT.T
aSOT
laag
1
ixiosoti toon
IBUTTXCal
RETBOD
n
BI
BBRSSB
or cisss
) 8
t W
•} 8
b( 19
tuat
} < 0.3-3.18 ag/g
b) 0.3-3.70 eg/g
at «t
a) 0.3- 2. 15 ag/g
t) 0.3-3.68 eg/g
fat *t
B»B | GIIZSU XBPOIHUIOB
1
1
) lot givea 1 a) Coattol*
) lot girea 1 t) lockece, groups I and II
1
I Caeaaaed ret taerr and aaelter
| aacfcecs, aget 55-76 TC. expoaed to
1 keavy aetala 1-3 deeadee. Tlee
| batveea retireaoat aad doatk 0— 1.5 yc
I la gcoap I a«d 2-19 tr« group II.
| Ccatrola. agaa «3-72 yr. who U*ad SO
1 ka tzoe tka tactorr- s»«a«a.
1
t SUOII; CU1TCM; HDIITS; lim;
| IlieS; COBP1HTITB BT1101TICBS:
| IIDDST1I11 1JSIIIB: nUOIIBEIT
1 iiiBOBS: tniKiit usmc;
I TH.IH1IT1S; CIIIIOR! C5SCTB: CSIOBIDB;
1 CCBUT: conn: GOLD: HOB;
1 iimiBui: iiu: HKtBtss: incmi;
| BClTBOSIVBt IBOStmOtBS: «DU9T«>:
t SCIIDIH; simm: SIITIB; TIB;
1 ToissTSB: UK: asiin BIXUBS:
| IBPBSTBIll P11ITS ; SBSITBBS
1
a) Bot given | a) coatcols
bt Bot given I ti lortera, groups I aai II
1
1 Keaastd ref latry aad aaeltet
| acifcera, agaa 55-T6 rr, expoaad to
1 aaavr aatala 1-3 deeaiea. Tlae
1 tataeea reticaaeat aai deatk 0-1.S TT
1 la gcoap I aad 2-19 vc> gcoap II.
1 Controls, ages »3-12 ji. aao lived SO
1 *i froa the factory. Swedes.
1
1 iiiin: ciEtfns; HOTEIS: iir»;
I macs; comnmTS mimTioBS;
I 11DOSIIH1 BieilBC: BiaSOllIZBT
1 BITBOBS; miaOBTs USBBIC;
1 lllimni; CiDHTOB; CSSIOT: CEIOBIOH;
I cciui: co»a; COIB: HOB:
1 lllTBim; IUO; BlBGlBKSBt BElClTtT;
1 BoinpEBaa: IBOSWOIBS; BUBIDIOB;
l scininii SZUBIOR: SILTIB; ni;
1 IBBGSTBB; XIBCi BttlTB B1Z1IDS:
1 IMOSTBIll IUBT5: SUBIIMS
1
IStttSICI
Bcaae, D.
Bocdbecg, G.
Beater, 1.0.
1980
seieaee of tka Total
Eaviconaent 16:13-35
Bcaaa> 0.
aoxAbeTg, G.
aestar, P.O.
1980
Scleaoe of tke Total
Enviconaeat 16:13-35
VO
-------
Titallaa
1MO-32-C
II
It* »7.»0, It 1677 C. TV 3277 C, T» 1 U If at 2180 C.
10 •• Bj at 2*80 C
TISSUE EIKSVIE tons IMUTICXI
S PI BOB
»SOS
lott»
1
1 1
1 1
1 1
I
,,0,
Brain
1
1 1
1 1
1 «519
1 Br«th
(Sit
lair
i
Ittalaticn
n
n
i
i
I
put
xmm i ii*e* i BSII i eiiniL nromnoi I OTEIEITCS
or cisis ill 1
i i i i
t ll I
2 | < or • 2.8 «g/g (*«t *t) 1 t.< « or * 2.0 »«/g I »«!«« 1 T»ka»a, a.
1 1 (»«t »t) | » Saioltl-Taawoto, B,
1 1 | »ro« a 4»ap of «1 aatopslaa, 1 aaaao, K.
1 f | femtslc ladteal •xaainati.ODa. Japaa. I fatal. H.
I I | Balw naa *g» »0.6 jt. Paaalas, I 1*80
I | | ««aa ago 37.* TT. | Ireklra* of
III | t>Tlrona*ntal Hoajtk
| I | 111CZ ItSIZITS; aVTOPSIKS: JaPtl: I 35(1):3t-««
1 i i jioiiiDi: itstnc; CIDBIBB: COJU.T; i
t | | CtlOIIiri; COITIS; Ito>; BIICOII; |
1 i i ntxai; iinxstvi: uiamsx; i
| | 1 mniORs 1KIMR; SCllDISg; 1
1 i i SMWIOS; tnuiaii nuDtoi: me: i
l i i eciB; BBOsiH; IITXI; rrpiiis: i
I | | CIIJBSnlJ: CEMBKILVB; HUT; RVSraSS; I
I i f tucmss stittrt imss; ton*: i
I | | BCTU3: COBPM1TJTI CT1LOITI013: 321; 1
I | | TCttlSIC NDICIM |
1 1 • 1
1 1 II
1 a) »OB« d«t«ct«J | a} «oi« 4«t«ct«d I a) lain, cvnbraa, 9 iobl«ct» I Takava, 1.
1 b) < or « 9.5 ag/g («at I i>) •-> » or - C.7 I t) Taaalas. c«r«bria, 2 *obj«ets I 5anki-Tan*oto. B.
1 vt) | o?/g (>«t »t| | c) »«!•«, c 1.* os/» (nt | c) O.JS » or - a. 62 I t) remits, cer»b»lltia, S »ot1«ct« I Teral, B.
1 «t) | mg/g (»et nt) 1 1 WO
|t> < or • 3.6 aq/g (»«t ( J) 1.3 » or - 1.8 1 Fzoa a nconp of 61 «ntopsi«a, I a r china of
1 »t) | »j/q c««t «t) | foraaslc a*iieal axaainatioia, Japa«. 1 Inrlroaaeotil Bcaltli
1 f 1 Bales. MBD ao« ao.« ft. I«»alas, I 35(1):3«-««
i 1 1 i«an aq« 37.* TT. I
III 1
1 I | TMCt nniRS; aOIOISIIS; J»PH; |
I i i mania: itsnic: CJBSIOI: COBIIT; i
l i i cnoBioi; corm: cioi: BBBCUST.- i
1 1 1 I HITS; SKBISIOB; »«»S1IESI: |
1 i i igeioiDR; amsoir,- SCJIBIOI; i
1 1 I snnlDI; T1I1«IO»; MWPItJS: ZIITC; I
1 i i sen: Homi; LITZE: nottis: i
1 1 | CtSZBIO*; CtEZBEUDB; HBtRT; ROSCLXS; 1
I | (iVCBEIS: SPlEEIs 10KSS; 10ST1; 1
1 | anilS; C01P»I»TITI ETUVITIOITS; SBI; I
1 I fOEZISIC BECICIIE f
1 1 1
1
I
1 Wot glYtn
t
12.2 14 1 « 1 saapla4 at rat* of 1 1/aia, 2-10 1 lltMlaaoa, X.I.
I ala aftor tenlng • arc *«Ulaq rod a. I De»«4ela«r, 5.G.
1 1 Johansson, T.8.
1 Oai»erslt» pbraics stop, rlotlaa 1 Blcchoster, J.I.
1 1 1»76
1 KCBIDl; lEOtTS; 3RE1I8: CllCIHR; I inMls of Occupational
| CtlOtlfZ; CIWCIOI; COPPEB: I8OI; I BrgleM 19:225-23*
I IZIB; ntieiiESE; ncrst: POTISSWH; i
l Sturm; T«»nnn; TIUDIITH: me: JIB i
l foituTioi; nets; iiairsmu i
l iimsranzs; TBICS ELEBEETS i
< i
1 i
1 B«»ia». 2« Mpraeitatin I Ctittlaborougk, G.
1 Fr»-aBaljsls trcatmtc ar« | 1980
1 tabulated. Tba fMsiUlity of a I Science of tae Total
I kallstic. ao-«asa policr for kair j Zn*lra>Mat 14:53-75
I aaalTals la entllaod aad snppocted. 1
1 1
1 ff«TK; TMCt SIEKZtTS; Ha»: I
| JCSTBU.I1; 8USOIERER OTISODS: I
| CZTUS; fSOItnS; COMPUaTITZ |
| HllC»TIO»S; 1IDRXJVB; »IT1BOTT: 1
1 nsntic; EuivH: BBCRTIE; citBian: i
1 cueing cBiCBiii: CHSoaitui co ant: i
l ccrecs? sjiiros: sssniliiB: eon: i
1 ICDTIE: ttoi: nrrmiuB; LI»C; i
1 B»a»isns: BHG*IESE; SIBCOSI-. i
( tciTBDEni; ncKn: EBOSPBOSOS; i
i tcmsios; iminitjii; SSLHIOI; i
l stiicoi; sum: SODIUS-. snctrioa: i
1 SOITOB; TI«: Tninm: TVISSTM: i
I IIIC; tltcomH I
i i
tvm •««>
NJ
O
S3
-------
YitaBltS
TMO-J2-S
II
1W 47.99,
HP 1677 C,
3277 C, vp 1 M Bg at 21M C, 1O M Eg at 2MO C
(COimiTED)
TISSUE
Ml 2
Beart
«S13
KUner
a5H
liver
posiitt tarns
itumcaL
RETROD
a
Wat.
BOBBSl
OF GUIS
4
2
) 7
b) 2
ml 11
•1 •<
h) »
I1ICB
< or » 1.1 89/9 f"*
t)
•one ietected
a| < or » 3.5 119/9 (vet
vt)
b) lone detected
•t)
b) lone detected
iin i 6>UML XEromTiokT
I
i
I
0.28 * or - 8.55 I •) Bales
9/4 |ve>t *t) 1 t) Peaales
»on« a«tect«a i
I ftoi a »ro«r of <1 antopsi««.
1 forensic •edictl «E»iiatieH, Japan.
1 Baits, wan « a«a «0.« re. r«««les.
1 f«aa aq« 37.* jr.
\
I fllCZ IL1HMTS; 1OTOPSIES; JU»;
| H.
-------
Iita*l»
7»W-3V«
11
Itl «7.tO. HP 1S77 C. n 3277 C, TP 1 aa Bg at 21*0 C, 10 n (9 at 2«to C
TXSSBI
1*14
t
1...
Etposau toon
1
IIUTTICU
Btnoo
n
I t
(SIS la
Buelo
1
1
(
f
1
1
t
1
1
1 1
t 1
f 1
' . «
* 1
i «st7 i I n
1 Paacroa* I I
1 1 1
« 1 1
t 1 1
1 1 1
1 1 1
1
BKMEt
Of CISZS
a) 2
•» 2
1
1
a) S
b) 2
Mitt
a) < or - 2.7 »?/9 (Mt
Dt 0. 60* 1 S ag/4 (vot vt)
a) *oa« J»t«ct»4
i) < or • O.CS 14/7 (*«t
i
Biti i CEIIUL xiroiimo* i XERUICE
1 l
l <
a) 1. a * or - 1.» 1 a) Balaa | fakan, B.
tg/y (nt »t) I t) rmalas 1 Suaki-TaavBOta, B.
M 7.8 + or - 10 tg/g | I IBMO, I.
(»«t it} | Feat a groap of 61 actopsiaB. ( T»rai, B.
1 foraaslc Badieal «aalaatlou, Japan. I 1*80
| lal«B, a*aa ago *O.C Tt. rcaalae, f Irehlnc of
1 a«aa aoa> 37. a rr. I EBTlroB*a*tal Boaltk
1 1 35(1):36-««
1 ntCE ELtBtns; tBTopsras: Jirti; i
| linXI9B; IfSElIC; CUHIB; COBU.T; 1
l cnoBioB; ccmi: XKIB; sttcmr: i
| I1NTIB; BKBESIOB: BIK1IESB; |
| iHBIBIBS! IHXBOlts SCMBIOfl; |
l smiXBB; trnixm: TIIIBIOB; UK; i
| SCLB; SBOBIBt: UTR; KBIEIS; |
| CtlUBIB; CtiraELLOB; BXHT; BffSCLES; I
| PtKIMS: SPIEXB; 1OTSS; lOKTt; I
I BETUS; CO§PU«TITB BTaigitXCtS; 5BI; 1
I FOEBSIC BZeiCXIB 1
< 1
1 1
al roao aotoctod I a) Balo* | Takaaa, B.
») 0.08 + or - 0.23 | t) roBala* | Saxakl-Tacaaoto, B.
1 Iroa a groat of ft aatopslaa, ( Taral, B.
t faraaile BOdleal axaBlaatioaa. Japaa. 1 1980
1 BalaB, BOBB ago «0.« rr. rcaala*. I Ircklna of
1 aaaa ago 37.a rr. | EBrlrauoatal Malta
1 | 35(1}:36-M
1 TIICE ELSHEBTS: iOTOMISS; jaral; I
I »inBiim: IBIEIXCI CIBBIOB; COBUT; I
1 cnoBiira: corrEt: xioi; SEBCOBT: i
I MBim; BietESIOB: B»ISl»B5t; |
l loeiorjg; atrxBoiT; SCHBHIB; i
t tiannt ixmxm: THIDIOB; IXK; i
I eOlD; raOBXIE; UTEB; CIDBKIS; I
I ciisiKn: criESEtins; asm; HOSCLES; i
I MKXHS: SP1EEI; LHBBS; 10IT1; I
t BRalSi CORPIItTXfE iritOHIOUS; SEX; |
I rcmsrc BIBZCXII i
1
1 a| < oc - 7.5 ag/g (>ot a) 1.3 + or - 2.2 a) «at« I TBka«a. B.
»*> «J/g (»ot »t) t| r«a«l«« | sazakl-tasuoto, B.
b) < oc * 3.7 ag/g <««t •) 1.9 » or - 2.6 | liana, t.
•t| eg/g <««t »t> Itoa a groap of «1 aatopslos, 1 T«ral, B.
for«a aea 37.4 rr. | E«TiroBB
-------
TltaalM
7UO-32-6
Tl
It* 47.90. IF 1677 C. TP 3277 C, TP 1 M Eg «t 21(0 C, 10 •• Sg at 24»0 C
fCOKIISEI))
TISSUE
4S1t
SBlM*
iinsnx BOBTE
1UITTICIL
SET HOD
SI
mm
OF C1SIS
»» 5
b) 3
11WSB
.
») < OX - 4.2 «J/9 («et
"t)
b) < or • 6.* «g/g t**t
•t)
Bill
a) 1.8 » or - 1.8
»9/9 !••* »*>
b) 2.1 * or - 3.7
•9/9 (••* »t)
EHttU IBTOIB1TIOI
a) Bales
t) f«Ml«
riot a.qcoip of 61 nrtop«i€«.
forflasic atdical ezaHlaatioo*t Japan.
Ral«. •••• af* 40. C TT. F««alea,
•tan a9« 37.4 Tr.
ttaCl niailH; aROKIKS; J»i«:
itmnns: iiswic: cuncs; COBILT;
CtBCSTOH: CCR11? IBO1; BIBCTOT:
HEitn; BESIISIOB: meansi:
iimivt; iRUoiT; SCMOIOI:
siiiiiBS: tiTMiim: muiaB; sue;
SCH; MOIIII: LXTSB; KIBIETS;
CEtlBSSH: CIBffltlLOl: RS1BT; HOSCtSS:
I11CBUS; SIIEEI; LMG3; IORTI-,
srriLS: coaeuaTXTi srixoitiois: sn;
TCttlSIC HIEICIII
BI7EEMCJ
Tnkava, B.
Suzakl-IasoBOto, a.
llano, I.
letai, B.
1980
trckiraa of
EOTiroaaeatal Health
35
-------
lolvene (8 CI)
Benzene, (ethyl- (9 CI)
108-89-3
C7-BS
HI 92.13, HP -95 to -94.5 C. BP 110.6 C. IP 36.7 u Hj at JO C
(COBTIfVSD)
TISSUE
4521
Breath
EXFOSHIE BOBTB
IIU.TTICU
BSTSOB
SC-BS
HOHBI5
OF USES
54 (387
samples)
Bluer
lot given
•Ell
9.0 ng/1
Geometric
G1IEB1L IirOSBlTIOI
teasared at 25 C and 760 mm Sq
100* occurrence
tome and op pec one-Sign Units 4.0
and 17.7 ng/1
aealthr. 18-35 yr old, aoasiokiag.
orlan blacks and caacaslaai.
Chica^Ov IX. Higidlf controlled
€lp«rlaental conditions.
B811TB; 1XCCBQLS; HttBOIS; 1D51TS:
CBIOEIIJTM imtOUBBOSSi »OUTHE
CBGllIC COBPCO«BS: HB1LTH 1121805;
iiBiUTioi; arriBOLiSB: BZTAEOLITES:
Ecpnmrow imsvtE: VBBH mis
IEFIE5HCE
Krotoazynslcif B.K.
Brnnean. G.B.
C' 10 ill. S.J.
1979
Joarnal of analytical
Taxicoloar 3:225-23«
Iala«na-2,5-clla«ii« (I CI)
1,«-BrazeiwalaiiM, 2-aethyl-
•f-TO-S
C7-B19-12
il 122.17. ITF S* C, B? 27* C
CI)
tissiri
4522
urin»
IIPOSUSI Botns
1
1
1
1
I miTTICll
BETBOD
I BUB3SS
f OF C1S2S
1
I B1ICE
I
1
BE1«
GUIB1L IIFOBBlTIOf
(•Tie*. local and sr atomic effects
relating to hair dye floravlation.
iaqcedient tests* and experiences in
•ae and aflisals.
tints: Dis!»TTTis: IIOPIISBS: asiKE;
II TITBO 11ILTSIS: IB TITO 1B11TSIS;
BFTIB"! DIES; CIBCIIOGSIT; COSHSTICS;
GIBETIC fFFICTS; BE1LTS HlItBDS;
BITJ90IISB; jrrilOLITSS
BEnSEVCE
Karzalli, F.I.
Sreeo, s.
Haibach. 8.1.
1978
Journal of
CaTirOBMBtil Pathology
•ad Toxicology
1! 50 9- 530
Tolaener o-nitro- (8 CI)
C«Biena, 1-iethrl-2-Bitro- (9 CI)
St-72-2
C7-«7-»-02
BI 137.1, BP -4.1 C, BP 222.3 C, TP 1 •• Hg at 50 C
IISSV*
»5J3
Breath
ElfOSVBE BODII
jtmniciL
BETBOD
SC-BS
BOSSES
or C*SES
s* oa?
siaples)
BalSE
lot glren
BE1B
3.040 s.g/i
Seoietric
Gr»iB»l IIFORBATIOI
Ceasnred at 25 C a*d 760 •• Bg
1». If accarreitce
Io»r and up pec one-Sigia lliits
0.017 and 0. 139 *g/l
B«althT. 18-35 TC old, non«»okt*i.
nt tan blacks aad caacisians.
Cbicatjo, 11. BioldlT controlled
eiptriaaatal coiditioas.
l*E»TB; IICOEOI.S; Illliois; units:
CttOBKMID HTDBOCIBBOBS; TOLITTLS
CBG1BTC COECOntDS: EE1LTI BllattCS;
1IBH.HXCB: BETtBOLISB: BE11IOLITIS;
ECPUL»TIO» EKMSmE: BSBliB IKEIS
IEF£1E>CE
Ecotoszynski, B.I.
Bcaa«an, 0.5.
e'nelll, e.J.
197"
Journal of Inalytlcil
Toilcology 3:225-2M
-------
Total BBC (la porttaes in
CS-BS-O.8
n 290.85
nssn
»52%
Blood
•525
PlaeeBta
'IPOSOBB BOUTB
IBUTTTCal
BBT8OD
sc-BC
CC-BC
1
mass
OF CISBS
a) 25
M IS
e| 10
a| 25
b) IS
e| 10
la*GB
a) 18-85 ppb
1) 62-16S pp»
e) 105-550 ppB
a) 12-53 ppb
b) a 1-1 05 ppb
c| 31-134 ppb
BSaB
a) 52.5 * or - IS. 2
ppb
bl $3.9 « or - 22.6
ppb
c] 20». 2 » or - 141.2
p^ib
a) 2T.2 » or - 11.«
PP*
b) 62.3 * or - 13.4
ppb
c) 90.7 » or - 31.7
ppb
fiBKBlL IBFOBimoB
a) Coattols, fnll-t«ra pr«?n«ncie»
t) Pt«-teca pEegaaades
c) SpoataaeovB ibortima at laaa than
fl vie
EaaltliT* aoa-^xposedf prvqnaat voa9ii.
ages 18-32 yr, tadia.
IBCIt; IBOETIOI; U1ITSS HIOS;
HOOD; piicim: coniiswni
HUUTtOIS: CHLOBII1TED
«T9tQCMBO«S; CEIOBIII O561IIC
CCBP00B9S: KSECTICIDBS; PISrtCIBIS;
ttsticioi Eisioais; POIOI.KICI
IIJOS0BB; PIIGBIKT
a) Controls, fall-tera pregnaacles
t) Pra-tera ETeijiattCies
ci Spoata&coaa abortions at less tSian
3 >k (inclndaa fetas)
Bealthr* Boa-exiwaad. pregnant itoaan.
agaa 19-32 ji, India.
IlCIl; IBOETIOI; UILT3; FIUS;
ttltuillOKS; CBlomilTXD
BIDMCUBOIS: CH1OEIIS OB611IC
CC9KOIOS; lISICIICIIESi P1STICIDIS;
PISTICIDI BtSIDOES: POPDLllIOS
ItHSDlB; PBIGV1BCT
BEIBBEBCB
Saxena, B.C.
Siddiqil. H-K.J.
Setb, T.D.
Krishna Harti. C.B.
Bhargara, I.E.
KattT. D.
1381
Joaraal of lualftical
Toxicolo^T 5:C— 9
Sa-xena, B.C.
Si-ddiqti, 9.K.J.
Seth, I.D.
Krishna Bortl. C.B.
Bbanjara. l.K.
KottT. ».
1991
Journal of Inalrtical
Toxicology 5:«-9
K)
VD
Ictil rot (lo paaUiiqs In CRHIIICI.
'9-M-3
C1»-B»-C15
B< 35*.50
iisstn
»5»
Utpow
IIPOSOM BOOT!
IHinlClt
nrraon
ITWBTB
OF CISIS
BtVGt
BMl
«I1IB*1 IIFOBH1TJOI
B«»ie«
Iipooed persons la the United States,
tfe« «»tli«rlajiis, SxnJati, Israel,
Japan. OSSB, Polanl, Servaaj, laiia.
Ellqacla. P*klstam, listrio.
Eipott*! «a««» at liTpettemlsa,
e lava ted satoa cholesterol^ abaoraal
•tea, oc iafaltaaat of Bcncoanscnlat
fvtctLoa aftac acnte «xpoa«ce to
eoabinatloat of pe»ticilea, tat mast
data ski" DO alters* «ffecta after
loaorteEH occnpatioaal ezposate.
insruri: ITUGUX*; ctsBini; IIDU;
ISHBl! IIP*!: IETBSELIWDS; PISISTII;
ICL1ID; BDSSIl; Stntf; nllTID
Sims: IBIPOSE nssni: BLOOD: BIOOD
ffllSfia; 5ICCD SlSHi: KtTIBSOCTTES:
nvKocms; eiu; VBIBB-. sinis;
flll-H B1Z1BCS; OCCOP»TIO«I1 B1UBDS;
fcfiimo* iieosoi:
IBTEEZBCE
Oeichaann, V.B.
HacDoaald, I.E.
1977
Vcotoxicologr aod
Enflroaaeistal Safetr
ljM-110
(«!IT PUS El
-------
lets.1 >DT (*e postieqs U cmttnt.
50-29-3
CU-B9-C1S
II 3S4.SO
(COfTtWOZOl
1
1
1
t
r
r
i
i
i
i
IHJB1
•527
imlotic
flald
•528
Blood
1
1
1
raposun IOOTE
t
isaimcu
Bx-YHGO
OC-EC
i
>SM I
I Blool, |
I plassa 1
1 1 1
1 1 1
t 1 1
1 1 1
1 1
1 1
1
1
or cuss
50
20
suet
O.S-26. * ppt
•| lot oirsn
b) lot gives
Bill | GBIItll IfrOtimOI | HntmCC
1 1
1 •
1 1
23.83 ppb | *3 positive ipeciseas I saxea*, B.C.
Seoaetric I 1 Sett, I.D.
1 reeosaat meo» sisilax ia f Bahalaa. P.I.
| ««cioeea*o*ic level a»fl dietary t 1*80
1 bablts. Xo occnpatlosal or 1 lateraational Joarnal
I acclaestal eipossre. lockvov, India 1 of Eoviroisestal
I I analTtical Caesisttr
| F1SHCIDBS; CBLOIKUS9 HT9IOC1XBOTS; 1 7:Z«5-25»
I CEIOJIBJ CICIRC coapooiis: cop; 001; i
I en; unit: HBGHICT; «B«IOIIC i
1 iioiB; mcmt i
i \
1 fevlm I Delckaaim, «.«.
1 1 BtcDosaU. *.t.
I Opond persess la tke Halted States. 1 19TT
I tke •etaexlaids, S«e4e>. Israel. 1 teotoxieolotr and
I Japan, VSSI, rolaad, Oereaaj, lodla, t EnviroaMatal Safetf
1 Bulgaria, Paxlstaa. laitria. 1 1:89-110
| 8«Fort«i eases at trperteaslas, 1
j elevated seru ekolesterol. abnoraal I
j M6s, or ispairaieat of Besrenflcel&r 1
j fMctles after acate eipoaara to 1
1 cosbiaatloBs of pesticides, bat sost 1
j dats skos no adverse effects after 1
I long-ten occapatioaal expossre. I
I 1
I KST»U: BDteiiii; eniiii: acin i
1 isian.: J»P»I: nitnims; tuzsttts 1
I idiHi; snssn: SKDSi; mm i
I STH»S: IDIPOSZ Ttssm-, twos; ILOOD i
i ztorocftes; ait: viat; iifisi; ' i
| EMITS B1X11IS; CCCIPJlIIOIU. R1IMDS; 1
1 tcpratno* Mposait; SSOPLISBS; i
1 flSTICIOIS; CHLOEIBI OIGIIIC 1
I CCBPOBIOS |
1 1
1 1
a) 38.18 ppb 1 a) Ixposed I Bich*rd*oB, J.I,
b) 6.69 ppb 1 t) coatrols 1 tell, J.I.
1 1 SaBdlfer, S.B.
I 8*g Croa Soatlt Carolina Pesticide 1 19T4
1 St>o> exposed to slxtare of CDT, I F»rltoae»rtal 7e search
1 patatkloa ail carbaryl. Controla. 1 9:290-29*
1 with so knevs pesticide exposure, I
1 tatc««l «itk exposvl aroip fox aie, |
1 race, sex at. 1
1 <
1 slqaif least correUtioas of tot 1
I elevatioa asd ckoliaestersse 1
j depreaslon vitt elerated svatollc and 1
1 dlastollc blood rcessares. j
I 1
I SCOT* cMoriii: IMOB PUSBI; DOT; i
1 flSTICIBSS; BZI1BOUSR; OCCDPaTIOItt I
| llfMDS 1
1 1
VO
CO
-------
total BDT do pacttio* la CI1BLIH}.
50-2*-J
CH-W-CIS
(1 35*.59
TISSVt
530
laofl.
•S31
Hacctta
mason torn
lxa»-t-toMMl tie
RMsm ion
RCTffOD
ac-cc
IDS BIS
OF CASKS
ppb
200.91 ppb
Go ow trie
esitui
lipowd pcncas la tk» ttitcd States,
US*.
Filq«rl«, Patlitn, lastci*.
l« portal cas» mis
-------
1-TTTPtOpaaB,
<350-«9-8
C11-B 12-12-03
•« 220.22
S-fcrdrorr-. I- (8 cq
(9 CI>
TISSUE
• 513
nood.
plasa*
EIKSnBE 10OTI
IlJeetlOB
inaestloB
1I1LTTIC1L
BBTWJB
•PLC
Flaoroaetry
BOBBxa
or ctsss
5
BU6E
a) 2.3-0.29 aioles/T
b) lot gir«n
cj lot glvea
d) lot gl*ea
«) BOt gives
nil
al 0.97* » or - 0.068
naolea/1
b) 3.25 naoles/1
c) S.SO taoles/1
d) 7.81 uoles/1
e| 11.00 moles/1
GJMBIL mroiuiioi
• 1 lBlti»l •«aaac««««t and 9 hr after
24 (in IT of 0.908 iwiles/lcq.
tiexpowntial decline. leai is 9 hr
tiM-average
11 50 aq doss
c) 190 «a dole
4) ISO •? dcae
<) 200 mq doee
b)-a) 8 ir tiae-arelsge a«ias
c»pited fro gcapkie
at«»-»n4«r-t!»-ciirT« data aftec oral
dose/* ar
H-S2 TC aide, *t 52-»6 k«, nitk
ifocloiie disorders.
**asea. rorltlag
CBves; BBUS TBEIHT; mvo ICIDS;
iioao Ptisai: lEtraososctniR iisnsis;
leans; DIIRUK
1EFEBEIO!
lagaissea, I.
Ilelsea-Kadsk. F.
19BO
Acta Paaraaoologica et
Toxlcolojica «6: 257- 262
Tvnvsten
7»»0-33-T
*
It* 183. 85. HP 3«IO C. BP 5900 C. TP 1 •• 19 at 3980 C, 10 •• Hg at *«90 C
1 IISSOI | EtrOSDRS BOOT! | IHtTTIClL | KOBBIB | EitGE | BB»« | 6EIZBIL HFO8BJIIIOI
1 I 1 HETBOD | OF CIS IS | j
1 1 - 1 11 1
1 t f 1 g
1 *53' II II B€Tlew. 2« npreseatattve
1 "air || II cie-aaalrsls treataeats arc
II 1 II tabulated. The feaxibiUtT of a
II 1 II holistic, ao-vash policy for hair
til t aaaljrls ts oatliael aad supported.
Ill II
III 1 t tiriSV; TP1CI ELZirEBTS: HUB;
III il Ktsmtii: Hzis«E9en HBIHODS;
lit || FITILS; P SOT IMS: COHPlBlTlft
111 II IflI01TIO«S; ItaniOB: IBTtHOlT;
III 1 ISSEIIC; BIRIDI; BBOirJS; CIBSITC:
1 1 1 1 I ClICIOI; CIIOBIIE: CHSOHIOS; COB1LT;
I 1 I 1 terra: SHIIBH; sBsmnirs; COLD;
1 1 ICBIII: IEO»: L1ITI1BDI; IE10;
1 1 BIOIISIITB: BiRGiiEsi: iiscosr:
1 (ClIBOSIBB: HCKrt,; IHOSPSOSDS:
1 ECTaSSItlR: BDBIDIJ9: SBXEIIOB:
I silicon sinra; SODIOR; SIECITIOJ;
1 sin FOB: TI>; TITIUVI; TDIGSIIB;
1 ziic; TiBCOBinn
f i
{BEIT PIGS]
BMI IBS C!
Caittlebocoagfc, G.
1980
1 Science of tie Total
1 EETlcoaaent ia; 53-75
U>
o
o
-------
Illgstm
7440-33-7
*
lt¥ T83.IS, IP 3*10 C, BP 5»00 C, TP f » Bg at 3*80 C, 10 II Sg It 4490 C
(CORIIIBD)
ixssm
453*
KlSaeT
4S3«>
li»»r
4M7
MWI
fosvn toon
iHlTTlCAl
sntoa
n
»
DBBD
CaSSS
e
i«
S
19
*) «
b) 1»
1
1
MISS
< 0.003-0.005 v?/9
< 0.003-0-018 *«/«
t «t
1 < 0.003-O.OM oq/q
I < 0.003-0.01* 09/q
•t wt
•) < 0.043-0.011 09/4
b) < 0.003-0. 15 ng/q
let lit
iHi i sBijiai iiroMaHoi t ssnstics
! !
i i
*>t gl»B 1 •) Co»trol« 1 Br«i«. D.
lot SiTO 1 V> lotlnts. groups I aad II 1 lorlb«ra> s.
1 | vester, P.O.
1 t«c«s«l refiBcrr »»« aaeltar 1 1980
I «rt«rs. a»«« 55-7S jr. siposed to 1 Science of the Total
1 lurr Mt*ls 1-3 a«c«d«a. 11» 1 ICTiconwat 16:13-35
| ltt««» catlm«*t **i Amtk 0-1.S yc I
| 1» qconp 1 nd 2-19 yc. ?rfl«F II. I
| Controls, a?«s 43-72 Tt, (to liwd SO 1
1 k* troi th« f«etorr. 3>«d«i. 1
t sum: cimtiBS; Kioirrs: IITIB; i
1 HISS; cospiiiTin snigmois; I
i iimSTSiit ixeiiRt nasnumi i
I inwus; niiBOii: usnic; I
t mumivB; c»BBJ0»: css:q»; csBo«0B: i
1 CCIU.TI cotni: GOU>; noi: i
i iiiTnm: tuoj lurainss: nicnsi; t
1 KinDBflfl: fBOSPBOIVS; IVIXDIOB; I
1 sciiBius: SIIMIBS: SIIVEB; ni: I
I ivissni: line: HUITH BKIBDS: i
I J1BB3TSIU JUITS; SBHTM3 1
1 !_._. _
1 1
\ lot 9iY« | *t co«*toli 1 Braea, B.
) lot 9ii«» 1 t) laxkers. groups I »»4 11 1 Borlbcrf. 8.
1 1 l«st«r« P.O.
1 t«c«»»4 r«f i»err ••» «Mlt«r 1 1980
I ictlmrs, ««•« »-7« rr, expowi to 1 Seine* of tie Total
1 kMiT Mtalt 1-3 awnfla. Ii»« 1 rn»iron«e«t 16:13-35
| t«twn tetim«t w4 4«»tli 0-1.5 jr I
1 i* qroip I »4 3-19 IT. group II. I
| Cotrola, «9« 13-72 rr> »'"> liwi SO 1
I k* fxoi tk» tietorr. SvelM. 1
1 t
1 SIZDMt C»»>«SS; Utinsj 1IT5BJ |
I itics; omrumn miaiTiois: i
I mvstiiai iiaitis; asaSDiiinr i
I CKBC9S: \irimn; usnic; i
I ttwniaa: caDangi CISIUB: CRtonvi); i
I cceiLt: comii SOLD; noi; i
1 laming: »u>; si»s»«si: HMCOSI: i
I tctnosmn! uoswoiust BOBIDIOH; i
1 5cmim; SHMUJS: sn«i: TI»: i
1 t«iesn«: IIK: HUIIH BIZUIS; i
| IlDOSltlal Pims; SBBITB*! 1
> 1
a) lot 9lT«n I *) Control* 1 Bran*, t.
t) lot alven 1 t) lotkets, o lima 50 I
t ka froa tk« tactorr- Sveiea. I
1 1
| SKDEI; C»»IES: (ItltTS; 1ITSS; |
t taies : coataUTin r»n.uiiio»s: t
I IlCDSTBIaL BTSIBIB; aEaSOHIinl 1
1 BtTBoos: UTUQH: »snic: i
1 Ttmrans; citRios; cssrnB: CBBOBUJH; \
1 cciui; COPPIB; SOLD: isoi; I
I tllTBlim; ItaD; 141MIES2; BMCTIT; |
1 sciTBOMOB: iBOSptoms: BOtlBias: 1
I SCalDimj SI1NID1; SILTE1: nit; I
1 tnisaiEi-, me-. BUMH aiiisis; i
I iBovsniti IURS: SIBHZIS i
i i
-------
mulu
7MO-61-1
I
Itl 238.029. IF 1132 C. B* 3818 C. TP 100 n 8g tt 3270 C
IISSJS
• 538
Satr
HMSBBE iOBTB
• B1LTTICU
HSTBOft
n
man
or cisss
5
I1I6E
0.25-10.4 ag/g
mi
lot gin*
esiiBii iBFOBBinoB
Eilk hair sasTlB*
lector* exposed iateraltteitlr to
aiaalea at the laxtraliaa atonic
E»rgr Co»»isslon *e*eacck
establishment.
iBsraiixi; Bin; ramos; BiisnnBnr
MXBOBS; OCCBP1TXOIU BaillOS;
iiBXOfoctnis: iBw>5T»i»i aioiii!
BEFEUBCX
san tier, <•'•
vr*tt, J.B.
1»60
iBTiroaseatal Besearch
J1:»07-«15
VaaaUas
7»»0-62-2
T
Itl S0.9«1«, Bt f»17 C,
3000 C. TP 1 •• Bg at 2290 C, 10 u Bg at 2570 C
1 IISS1S 1 BXfOStm BOOIB IMLTTICIL IBIiffl 11T6E
1 I BRHOD OF CtSSS
1 1
1
TI1CE tLHIBIS: 1OTOPSIKS; J1P1B:
IIDBIBVI: ItSIBICi ClSniTB: COB11T:
CBROBMB: COPPEB; iao«: BIBCOIT:
IIBID9: IllSIISIOB: B1B61BISB;
IDEUIQI; 1BTIHOBT: SC1BDIOR;
SfLEHIBa: IITMI09; T1MDHJ9: flK:
SC1C; BIOBIBZi IITSB; KIBIBTS;
CIIIBiaii ClHBHLOBi HEIST; SDSCLIS;
F1BCXI1S; SFIIBB; 1VBSS; 10II1;
BII11S: COBFIUTITE ZTlt01TIOB5i SEX;
FOIIISIC BEDKIBE
Siblects froi 17 collection cites IB
the o.s.
SIIBBIBB; BCirBOSTOB; TlBlDIOB;
EIOOB; SSI) SOUTH DlKOTtj III TOBK;
ITCBTBC; BOBT1B1; OBIO; BISSI5SIPPI;
| | THIS; BOBTB D1KOT1; 11SHUGTO1;
a) Bot given
b) 0.0*-9.33 og/g (»«t
•t)
c) 0.03-0.23 ug/g (net
«t)
it 0.10-0.31 ag/g (vet
•t)
| CIllrOBJH; IB IIOH: ISDIIII;
| ICOIStlBl; 1BE1BS1S: TIOBID1:
t
1
riBBOBT; TMCB CIBIUTS
a) 0.11 * or - 0.09 | a) Bales, eoEebcM. 9 sableets
ag/g (vet «t( I 1) Faaales, cmkmm. 2 sabjecta
b) 0.18 • or - 0.21 | c| Bates, c*rebella>, 7 subjects
"9/9 Cet *t) | d) Feaales, oerebellas, S sol-)ecta
c) 0.10 * or - 0.06 1
og/g (cat *t) 1 Itoa a group of 61 aatopaies.
4) 0.20 » or - 0.10 1 forensic M4ic*l ezasiaatiois, Japan.
•g/g (net vt) I I
1 a
1
ales, aeaa age ao.S yr. Pesales,
eaa age 37.4 rr.
1 tElCE niBtlTS; IIROPSISS; J1P1B;
t IIBBIBTIB: JSSEIIC: ClDalOB; COB11T:
1 CBBGBIOB; COPPBB; ISO*: IIBCDXI:
1 iBcint; B16BISIQI: BIBSHISI;
1 latlDIQB; iniROBT: SCimiB;
t «IIJ»IOI1: TITMIOB; T1I1DIUS: II1C:
1 SOLD; B30BJ1I; 11TSI; KIOBtTS:
I cisiBsns; CSITBILLUI: BBIBI; EDSCLIS;
1 menus; spiral; LUSGS; icm;
l i
niLS: CO«S»I»TITI ITU.BHIOHS; SBI;
1 T01IBS1C BIBICIK
1
*EFE1EBCI
Tndan, B.
sazikl-Tasaaoto. B.
Icaio, I.
feral, B.
1984
Irciiies of
BBTiroaaentll Bealta
35(1):36-*»
lllanaT. I.E.
Kobota, J.
losee, t.
Eotb, n.
1968
ircalres of
EnvlronsaBtal Health
16:3>2-3«B
nkavav B.
nznki-TaSQioto, I.
saoo, X.
erai. B.
980
rchires of
EsTirotuatal Bealth
5(1):J«-»4
(«« tkSS)
o
ro
-------
faaafllaa
7«0-«2-2
BP 1*17 C, tl 3000 C, TP I an Bg at 22*0 C, 10 is Bg at 2570 C
(COITIIKD)
nssra
«»j
Breath
MM
Bair
»SM
H»lr
W5
n*ic
MSVIB tOOYf
tUtLom
tlURICM.
BRBOD
I
n
BBBBS i MKS i mi j ouiiu nroiimoB i IIRIZICI
CiSKS 111 *
1 f 1 - - 1
114 1
1 lot gl»e« 1 0.7 if 1*1 siielrt at rat* of 1 1/sla. 2-10 1 IfcselMOS. K.E.
i || ala after bsrsing * arc nltlng roil*. 1 Desaedeleer, 6.6.
1 i i tun detection linlt. | Johansson. T.B.
Ill | Binchester, 3.1.
i | | BnlrersitT rhysies shop, Mariia 1 197«
III 1 annals of Occupational
i | | noiIBl; IBBIW: mini; dicing; 1 Hygiene 19:225-2J«
I | i caioBjBJ: ctaoaioas conns iiois i
I i i mot BI let 1KB; nun.: Krtissiw; t
I i i SBirm: iniHOH; TtuDioa: me; »i« i
i i i tcumoB; imtst mvRim i
I i i mosMHBS ; TBJCB niBiits i
i i i •
I I i »
It 1 a) lot gim 1 a) ft. 04 + or - 0.01 I a) Controls, at blttt 1 eib»o». S.S.
H | b) »ot giv«* I aq/g 1 *) »»ll-t«ri lo* birthMjght, at I Dcvolf*. I.S.
12 | e) Mot glT«B l b) 0.0» * or - 0.02 I tittk 1 1*80
11 I 41 lot glv« I «9/g 1 c) tr*-e«tm. »t btctk 1 »mtrition B»port«
It I •} «ot jlT«m I c| 0.01 « or - 0.01 I 4) Controls, 3 ao 1 Int«raa.tloo»l
10 I f) not 9i»«a 1 •«/« 1 •! rnll-t«rs lo« Birtkmlgkt, 3 so 1 21(3) :3«1-3«9
I |4) 0.«9 * or - 0.12 | ft tr*-t«rs, 3 so I
1 1 «9/9 1 **41ans » ot - SIB 1
| | •) O.S» * or - O.sa | |
I 1 i«/g 1 Konatos In lallfal. fco-Mn froap 1
| I f) 0.22 * or - 0.1* | scan Urtfc*«igkt H80 g. 24-3C rt I
1 I *q/9 1 gcttetloi, l«ll-t«ri lo* birtbnlght I
1 | | group a*an blctk *«l 0.036 ng/g 1 b) Klti pie sderoala patients 1 Bolibecber. J.
1 I aeALans I Sasfles fron 7 scalp sites in each 1 Stuart, B.C.
i i | sabjeet 1 1*7*
III | Clinical Cbenistrr
l | | CltlBl; JOB1TS; CltTUL RBTCOS I 2»(11) ; 1996-2000
1 | i IISTH oistiazs: atn; uoBitoa; i
I i i item*; ciicnjB: cnion»: cop;»; i
1 i i setts Tooiit; BiiemsB: BIIU.SS i
1 i i sitinmit siiTiB: sonoa; soirtus i
| | | 11BUIVB; tlBC I
--,,,-.» - ' ' '
III 1
j j j 1 rerie* ef irarld literatue on the | Jenkins, B.I.
1 | I accaselatioa anfl bioooseeatratlon of 1 1*7*
| | | aelectea toiic trace setals in hsnan | ZTl-«00/t-7*-04*. 1*4
1 1 1 hair «»4 nalln a»4 other saanalinn 1 pp.
| t 1 hair, far, nails, cla«* and hoofs. \
I | 1 Tabalated ri geographic area, I
I I 1 aabjects, sex, age, exposure t
I 1 1 gratiest, analyses in ppn, and I
I | 1 aathoritT free over 400 references. 1
III 1
| | | IIIICl: lOSTIUIl; CMIBl; CIITB11 |
1 i i mild; ruscpE: noun HST: «f i
| | | ttllllO; SOQTB UnlCk; SOITBEIST I
I i t isii: oiRiD KIKDO*: anno sims: \
| | | 1111: milS; BETIEB; 1ITIBOIT; t
l i i itstnc: BoioB; CIDBIOS; CIBCBIOR; i
| | | CQllM; CC??H; »»!; BCTCOBI; f
l ii iicKBit snBinits Tilt Ti»ionnij KB i
1 | | rciirtiof: kilBii POTOUIIOIS; |
I | 1 EICkCCOBIIkTIO*; SIOIBBICkTOBS; tlfl 1
1 i i EOIIOTIOI; vopvimoB zxposni; *un |
| | I tCItlTlOl; ISkCl HIMWISJ HITklS 1
1 1 1 «
(Bin p»oi)
-------
7a»o-SJ-2
t
it* S0.9»i«, BP 1*17 C, B» 3000 C, TP 1 aa Bg at 22*0 C. 10 aa Bg at 2570 C
(COIIXBOXD)
I
1
1
I
1
1
ItSSWS
•s»«
Hurt
«1«7
Miner
1
1
1
(
EiMsms loan
iBimxcu.
BBTHOD
•1
it
(
l
l
r
i
i
i
1 1
I as*« 1 »
I Lira 1
1 1
1 1
f 1 1
1 1 I
1 1 1
1 1 1
1
1
1
1
imia
or cuss
a) *
M 2
•1 7
hi z
l
l
1
MISE
») O.Ot-0.1* ej/» (»et
»t)
b| 0.21-0.23 ng/J Net
«tl
•1 0.08-0.22 04/9 <»•*
«tj
1 lot glT«»
a) 11 a) lot gl»«n
b) 3 b) lot gitea
I
BUB i etiEtii xirotsAiioB i KTMBBCE
! . .»
i i
») 0.09 « or - 0.07 | .) Bales 1 Tofcm, 8.
ag/g (••* «t| 1 IJ Pnal*> 1 S«Mki-raa«K>to, B.
b) 0.22 * or - O.Ot | 1 1BUO, K.
aj/g |mt *t) f fro* * ?roap of 61 Mtop»l«», 1 T«r»l, g.
1 tactmalc ndical «»*ia*tioi*> Jap». 1 1*80
1 Bilu, M» •«• «0.6 tc. Ttralma. \ IrchlTM of
I MU »« 37. • TT. 1 EDTitOlMBial S«»ltk
1 I 3S(1»iJ«-»»
I IB1CI EltBIBTS: JUIOPSIB3; J1F»; I
1 JIDRWHI; 1BSXIC: C1JBHI8: COBU.T: 1
1 cBtonvB: coTTtt: »oi; BIKIBT; i
1 iBentB; BicitsiM: Bueutst; i
l BVBIOITO; imBon: sciroioB: i
1 sntmii: TITUIVV: TIHBIBS; 2i»c.- i
1 C01B; BtOBIIf: IIIEJ4 nOIZTS: 1
1 CIltBtVB: CIHBEUBB; BBllIj IVJCLBSi 1
1 tiBcius: siiBBB; vnest IOBTI; i
I B JlltS; COMIBlTira lTUtHTIO»S; SKI; f
1 MBnsic BinicHE t
i i
U 0.13 * or - 0.05 | •( «»!•• 1 T«k««, B.
•9/7 (••* •') 1 t) I««»l«« 1 Sunki-TamHto, a.
W 0.02 * or - 0.03 | 1 Uaao, (.
»g/g f«»t it) I ttoi a qro«p of «1 »«top«l«», 1 T«r»l. B.
1 fomslc wdlcal •i*aiDttio«a> Japaa. 1 1*89
1 1>1«, M** a«* 40. « Tt. r«ult>, 1 archive* af
1 M«a •?• 37- • re. t C*Tica*M«tal Bvaltk
1 1 3«{1):3t-M
l TIKI rttatns; kmorsitst Jam; i
1 IlgBTBUB: IfSniC; CIDBIDBI COHIT; I
1 cnoaius: ccrrsBs r»o»: BMctar: I
1 1BOIOB; ai«BisioB: stieitist: i
1 IOBIDIDR: IIIIBCBI! SCUDIDI: <
I 3nmvi: TITIVIOB; miDloB: intc: (
1 eoiB: gtoiiM: urn: HDICTS; I
1 CI1BBS3S: CSinilLIB; 9U11; JUSCltS; t
l imctMS: sriitc lotss; »OMI; i
1 «tI«lS: COBMB1TITZ ETIIOMICM; SEI; 1
I 1C1IBSXC SJOICIH I
' '
a| 0.12 » or - 0.07 | a) Bal.a I Tnk«»«, B.
nij/g (>«t «t) I t) !>•»!•> 1 Sazaki-Taavaoto. B.
b) 0.09 • or - 0.12 | 1 »«mo, K.
ua/g (vet vt| 1 Fcoa a gcoap of 61 »top*i<», I tecai. B.
I fcreasic aedlcal ezaaivatioav^ Japan. I 19BO
I BalM. aeaa age «0.« re. r«Mles. I lzeki**« of
| i«a» age 37.4 Tt. 1 iBTiroueiital Health
I I 3S(1»3«-a*
| II»CI ntBEBIS; 10TOPSIES; JlItB; I
1 iimBiB: Msraic; ciosioi: COBU.T: i
| COCBIDB; CCfPZt; IJOI; BllCDIX; 1
I IICKTR: HteilSIVB; B1BS1BISE; 1
1 loexottn; amioti: SCHDJBH; i
1 srusins: -ritinoi: T«»IDIO»: inc; i
1 60I.C; BtQHUf; IITEH; KXDKTS; t
t ClBtBin; CniBEUOB; HX1BT; BOSCLKS: I
I IIBCMtS: 3*UEB; IVBGS; aOllii 1
i B1TUS: COB»UMITS CTHHIT1OMS! S
-------
7««0-«2-2
T
Btl <0.9«|a, m 1917 C, B? 3909 C. T» 1 aa Hfl at 2290 C, IO M Hg at 2570 C
fCOIT»1)ED)
ISSBB
4M9
IM*
»SM
Bvael*
»5S1
1*11
wstws ionic
1
i
1IU.TTIC1L
reraoD
*
man
r CISBS
2
j
> •
) 8
I1KX
0.10-0.24 ng/9 (n*t
1
0.08-0.09 »9/9 (wet
)
) 0.03-0.22 ng/g (mt
t)
) lot giT«n
•HI I 8EMU.L nroiBlTIOB | HFESEICE
1 1
1 1
O.t7 * 01 - 0.10 1 •) teles 1 Takata, B.
q/g (««t «t) 1 t) T««»la« ( Snzakl-nmioto. 9.
0.09 » or - 0.00 I | AMBO. I.
g/g («at vt) I »to« • gro«p of 61 aatopsio*, I T«rai, B.
I forensic Mdlcal •xulutioi*, Japan. | 1*80
1 Kl«>, MU a«* *0.( it. Mnl«s. I iccbl»ea of
1 MU »q« 37.a ft. | loTltonMatal B«altfc
1 | 35(1):3<-*«
1 tucB iLinns: IDTO?SISS: JiPii; t
I U»mi; IRSBIIC; CUIXTU; OOBILT; I
1 cnoBtM: coppisj not: nmR: i
I IllIVB; HKIESIVB; BUGUISI; (
I BKIPtVI; iniROR; 9Cim«l; I
I snnigB; tinsinu: nnoiVB: 7i»c: i
I MID; B10BIM: LITIB; KIDIIIS; I
I cHiBioi: cuKBEitoB: aiiBi: IBSCLES; i
I fimtis; seuzi: 10193; lam; i
| BEtkIS; COBPttlTXVE ETU.01TIOIS; SCI; |
I fCSZVSIC BIBICIIE |
1 1
) 0. 12 » or - 0.09 t •) •«!" 1 tnk»a. m.
vq/g {net «t) | 1) T«al«a | Saxikl-Tanaoto. B.
b) 0.11 » or - 0.06 | | anno. «.
aq/9 («et «t) | Itoi a gtatf of f 1 »»topal«a. \ T*ral. B.
1 fot«BSle wdtcal «iaaliatio>«, Japai. I 1980
I Ial«a( M«B *9* «0.* jz. r«ial«a. I Ircfciica of
I *«aa aq« 3T.a jc. | lB»iron»«»tal Health
1 1 35(1):3C-«»
i i«»cs nsims: amofsus: «ni; t
I iiniinii: nsnic: ODBIOB: COBU.T: i
I CJioamst coptci; HOI: BIBCJBT: i
I iitioB; aisiistoa: uieiiuz; i
I iiBioioa: iniBonr: sciiomsj i
1 siinnia t muna: TIUDIHB; trie-. i
I eciD; BSOSIII: ixvzi; nniiTS: i
| Climai; CZIIBCUVB; BE18t; BV9CI.IS: I
1 tiiCBtis; spini; IOKS: iont; i
| AE1U3; CO^PIWTU! IT»10»TIO»S: SZI: 1
1 fciime BtgiciiB i
1 1
1 1
1 1 tnlm el wnia litvratnr* on th« I J«ikl*s. B.«.
1 aec«»alatloi aa4 bioconcentritlon of | 1979
I ««l«ct«4 taite tcac* Mtala IB taa»n | EPl-tOO/*-79-0«9, 184
1 kale aa4 Dal la sad otb*c aiaaalian j pp.
1 talr, f«rf >aili, cl»s and koofs. 1
1 fab«lat*4 tT qvoqrapUc area, |
1 *abj«cta, s«x. aqe* oxposart 1
1 4cadl«Bt. aialTBos in ppa, and (
1 aitkocitr fcca over too r«f«c«Bcea. i
1 |
1 ItXICl: IDS! Bill »: CMlDl; Cllttll \
\ letllCi; SD10PZ; BIDDLE E1S1; III I
I tittin: sooia iBCTici; SOOTBEIST i
I »«»: DTI1TZD (MGDOBi OJTTED STIIES; (
1 BUB: iiILS; tzTin; tmaoiT; I
1 itsmc; BOEd: cioaiaa; cajcnim; i
1 CCBIIT: ccppiB; izii; HIBCOBT; (
1 iicKtLi snciruii: TII; THIIDIBB; ME i
l iciimoi; nniL posoiniois; i
1 ticicco!iTiHT:o»: BIOIIDICITOIS; LIVD I
1 tciionon: rorotiitoB RPOSDBE: 9»tie i
t ECltOTKM; TUCE ZLBBtRS: BIT 1 IS |
1 1
(BEIT PlGE) " "
o
Ln
-------
Ynafti**
7MO-«J-2
»
itt $0.9*1*, at >9i7 c. B» 3000 c, n i •• 14 «t 22*9 c. 10 u 19 at »T« c
KSSOI
a. 532
VaBCTMB
•TMSBCT IO*TE
1 IUTTZC11
B&TBU1*
n
I «s» n
i
j
i
i
i
i
unit
or cisss
a) 5
b) 2
) 5
M 3
met
a) 0.06-0.15 19/9 I»«t
•t)
b) 0.11-0.23 «9/9 (Mt
vt)
a) 0.11 19/9 (»«l «t)
) 0.07-0.23 «9/9 [»at
tl
i
i t
t i i
BI»I | GEIIUt IirOIIinOI
1
1
1
a) lot 9lm I a] Ial«*
til O.IT t at - 0.09 ( t) rntloB
•9/9 (V*t »t| |
I I Eoa a 4toav of 6t avtopfll*3«
1 for*isie Mdieal •xaaioatioaf, Japca
1 B«l*r« •••• ••• *ff.4 T'« 7*>al«s^
1 Ma* ao« 37.4 Tc.
1
1 met nsiins; inomss: JIP*I:
l tiosiuii; itsmc; cumm: coBiii:
f cnan»i cofw: iio*t mcntT;
t XlrXOfl* R1€VX5HB; fltVGftllSB;
i itznivit aniion; scinin;
l sitnrvnu tmitmt nnoias; UK:
1 eciBj tion»: iivn: EIBIITS:
1 cmnn: cnmittii: ism: insais:
I 91BC1H5? SflBHS L^VSS; AOtTft;
I BETU.S; coiriiinn trttniion; an:
I focnstc atcKiis
i
i
a) O.oa » or - 0.0* 1 i| Ulas
19/9 ("t *t) | t) r*ail<*
11 0.1* * or - 0.09 |
19/4 (**t »tj I Itol i qto«> of *1 aitopsl**.
t focmclc aedical •xaBlaatioM* Japaa.
j ••l*a« ••!> «9» *9. < rr. r«ail«*«
t i«*» «»• 37. < rr.
1
1 i»ci tLBBtin: inorsiss; J»Mi;
l itenioi; unite: cisiioi; COJILT;
cncBim; cctnts i>oi; MKOIT:
Mnoi: iinisiiii: uie»tsi;
tOBTDHB: IITTMIT; SCMDIDIi
SI1HI015 TIUHII9: TtlUIOl: tIKl
citmani ctinuiM; EEIBI: BOSCIKJ;
titoifis: silBCi; I.HK3: loiti;
RItUS: CO1PIB1IIIE IflLVltlCIS: SSI;
reimic neiciri
lErnno
Takaia, a.
Sicakl-lamaoto, B.
tauo, t.
Tarai, B.
1 999
Ircklra of
BiTirauatil Maltk
3S(1|l3«-«*
Yikana, B.
laaao, K.
Twal. I.
1980
IrchiT** of
e&ftroiMital Baallk
35{1):36-»»
CO
o
IIICT omrosRioi sitioai 01
I TISS1B
1
1
1
1 *5M
11094,
fllSll
1 nrosmi toni
I
i
l
r tnirricti
I BEIHOB
t
1
1
I iDaia
I OF CASES
*) 10
b| 8
c) lot
9lT«l
I (IMS
*) »ot given
b) lot 9lm
c) Vat 9tr«a
mi
il 16.3 » or - J.»
a9/Jl
b) 9. 1 » or - 1.8
W/il
0] 52.9 « « - ».7
««c« Ticttlf-ciloiie
ttlttttzltlo*, BO Tttuia 1 deficiency
t) S«T«r« fretalc-calorl*
talmtrUloi ui Titttin l aifidancy
cj IcaltbT eettiol*
l*l>o«ri«bed Thai chUiron, aq«<
1J-60 to. Controls. Tkal children.
•9«a 12-sa >c« jaM aodo«c»iK»>lc
t«ctqro«»d M Mlxwrlfkvd.
UlIllID; CBI1D1H: BIOOD PUSH;
•wsiTioiit Bincitian: IOTSITTOIH
B1S010MS: PEOTWS: TITIIII 1:
III IS MS
fBIZI»CI
siith, r.i.
Sasltlod, I.
tliuugtal. o.
tcltTHIE, C.
Gooi**x, t.S.
dlsnf s.r.
1975
iMticai Jottrml of
Cllileal lutrltioa •
iBj732-T3i
(ISIt FtGZ)
-------
ritatio J
tt!03-57-«
ntcr coMosmoi »nora en nvemmtn
(COITIIITEBJ
nssni -
aS55
Blood.
aorBB
stposvn mm
iiuRicai
BETBOB
tnsa,
01 C15BS
UKS
*) lot ji»aa
b) lot giT«a
c) lot glv«B
d) lot giMB
MM
a) 28.5 » or - I.I
a«/dl
b) 27. « « or - l.»
«9/dl
e) 2».7 » or - 2.2
no/Si
d| 36.7 * at - 1.6
«g/dl
(S.E.)
GS1I111 XirOtllTIOf
a) 102 Bigrait ekillni
b) 5» boys fnw »>
c) 43 girl* team a)
J) coatrola froa ottoc «tidi«s
35.3* of •) k«d <20 ««/U
}-n «o olds, bclo« 3rd pozeoatilo IB
bt, lit, *«d k«scj drci>f«r«BC«,
cbildcoB of BexicaB-lBoricu far*
•OTkors. Controls, yona.
tlldl«-cla*« ekiUcoi, Colorado.
TITUII 1; CBI1DHI: IRC; UIB;
HOOD niSHl: BMOB SIKH!
ccttnkmi ttitmiois: met
it inns; COIOHDO
nmncE
Cbu*. B.«.
RaBbidgai, I.B.
Baractt, S.B.
Boats- Jacobs. B.J.
Leu, K.
elllospl*. J.
1980
lB«ricaa Jootaal of
CliBlcal Batzitioa
33:23*«-23»»
tine
TI«0-66-«
tl
lt« C5.38, HP «1«.S C. BP «•« C, TP 1 n Bg at ««T c. 10 BB Eg at S40
TISSOB
»5C
dc«Bal
alaBd
a«7
lorta
IfOSBK BODTI | imTTIClL
t
BETEOB
US
11
IOBBBS
or ctsis
3
•U6B
•) BOt 9lT«B
b> 1«.0-32.1 aq/q nt «t
S.1-16 «9/9 (Mt »tl
•III
a| 25.8 ng/g nt ¥t
b| lot giw«B
11 » oc - S.C aoyg
(••t «t)
GBI1U1 IITO111TIOI
a| Berkot
t) CoattolB
Jaranaao »ork«r,
-------
Tine
7MO-S6-6
In
It* 65.39. BP a 1«. 5 C. BP 508 C. TP t » Bg at M7 C. 10 n Bg It 5*0
(CORIIOZH)
t
1
1
1
1
1
1
tissfff i Biposras torn inimcu. i BDBBII i SIICB i HH* I eiu'ux nroiamoi i nrzinci
< amen i or casss i i i i
i i i i i
l
«SM 1
lorta 1
1
1
1
1
1
1
•
•55!
ziood,
calls
1
1
1
1
1 »S«0
1 Blood,
1 tlaSM
I r
i i
1 i
i i
I i
i i
I i
1 «S«1 1
1 flood, |
I plasaa |
i r
1 f
( 1
1
1
«5«2
Blood,
plu»
t
1
III 1
MS ») 1 la) lot gin* 4 a) 27.1 ag/g wt rt | *) *or**r 1 Byodo, K.
b> 5 | b) 11.9-2C.t *g/g >*t *t I b) lot glrea 1 b) Cntral* 1 Saiaki. S.
Ill 1 r»roT«. 1.
1 1 | Jain*** ior««r, tS rr old, at 1 Bcskizaia, K.
II | client* FtodociBO Blast tor 30 yr. 1 1980
1 | | Diad at aaxillary and Inm caac«r. | Xatvrutioul archives
1 1 | Controls, 54-71 yr ell. 1 of Oceapatio*tl and
III 1 ziTlKMueital Malta
1 1 1 91(11; 1BXPO3I TISSOB; 1O1T1; SOBJ I «:t«t-I50
I i < aisioB: iBiii: cisun-Lna: CHEWOH; i
I i i xiajZTs; HTM: WBSS8 ECSCLXS: I
l i i HBCBHS: SKI; cBtonvi: carpet; i
1 1 1 BIT US: II»C; IIBDStBIll tiirfS; |
1 I I muiTiai: cccvMTiam suiiDS: i
1 i i ECPOUTIOI inosnc i
i i i i
III l
US 150 r *) lot oirw | a) 18.7 * or - 6.1 I a) ZrytkrocytM. U I-« ao oM» 1 list I, T.
1 I)} lot iriMa | ug/g Hb | t) Irytkioeytu. 1C T-12 10 ali* I 1980
1 e) tot glrea \ b) 27.6 t ot - 3.6 | c) ot jlT«n | ag/g Bb | 4) Erytkraeytea, 21 I1-t5 yr o!3» I Bedical Sciences
1 | I •) >ot glrra 1 c) 37.* * or - «.« 1 •) Irytkrocytu, 52 ad:7-13
f 1 It) »ot J!T« | ug/g Ib I () utakaeytM, « «-10 yr all* I
1 f f 9) *<* gi»« 1 4) *2.3 * or - «.2 | q) uakacytt*. 1* alolts 1
1 1 1 «g/9 Hb | |
J 1 •) «2.2 * or - 5.6 | (taltky »abl«ct». 1
J | ag/g Ib I 1
J 1 C) 0.093 * or - 0.022 I HIC; lOULTS; CBZLOan; J1F1I; 1
1 i noyio (B*7) c«iia i amis: BLOOD PUSBI.- isTTSjocrris; »
1 1 9) 0.129 * or - 0.03} | ItVKOCntS: 1SE |
1 1 ug/lO(E*7) nllc | 1
....... i 1 i
1 1
«S a) 13 •) »ot 9lT«« a) 79.5 « or - 13.6 | a) 1-« ma old I Ushl, I.
M 21 b) »ot gt»«« n 21 c) av»t glT.a bl »*.» * or - 17-» I ej IT-IS yr eld 1 Biroshlaa Jotrnal of
f d) 52 «) lot gt»« «q/dl | d) Walt* | Rcdleal Sciences
1 01 101.0 » or - 22.6 | | 29(1):7-13
1 ng/dl | Malthy aablccta I
1 J d) 9S.9 * or - 18.6 I I
1 1 na/dl | TIIC; 1BOII5; CfilLDSIJ; J1P1»; |
i i mils s sioo c ntstn anttocmst i
1 1 ifwitocrTis: let i
» i « i
1
1 a) 70
1 b) 60
1
t
1 1
1
1
1
t
III 1
1 a] 54.3-131.2 ng/100 al I a) 91.2 * or - t.« t tt Coatrola | Laanrya. I.
1 b) (0.8-1M.1 ia/100 al | no/100 •! | t) F«iJ«nts at follatfl area t Roela, B.
1 b) 77.2 * or - 2.1 | | Bernard, t.
1 04/100 al | lain, uai aoc *2.3 yr, froi I B«ck*t, J.P.
f (S.S.J | C 9* »iomt children 1 Clias*, B.P.
b) lot gtT*i 1 ag/dl | t) 53 boys fro* a] I Baabia^e, K.I.
e) lot glT«* | b| 7«.3 » or - 1.6 t c) *1 girls fro* a) I B»cn«tt, S.I.
i) lot gtnn I ag/'Jl 1 4) control* fro* other atallcs | Hoots-Jacobs, B.J.
( c) 7t.« •> or - 1.5 | fypozlacMia (<6« a
-------
I lac
7440-S6-6
Za
lei «5.J8. tS 419.5 C, IP 908 C, TP 1 aa
Bg at 117 C, 10 » Sg at S90
(conmui
t TISSBB
1
1
1 4563
1 91004,
1 rlama
1
1
1
t
1
1
1
t
1
1
1
1
1
1
I
1
1 45«4
1 11003.
1 strut
\
1
1
1
(
1
1
1
I
1
i 4S«
t Blood.
( aeraa.
I
1
«
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
(
1
1
t
1 45SS
1 Blood,
1 «ena
t
1
1
1
1
1
1
1
1
1
1
1
1
1
POSBH IQOtS
aaUUoa
oestloa
Inoastioa
am RICH
MTBOD
s
IS
us
(HIBSX
F C1SSS
60
45
70
a) 260
1 260
M 15
b) 17
*»»• 1 eSKBIt XirORBlTIOf
1
1
76.* tig/too al I t) lesiaeats of Lleaa (But pollute!
85.7 si/100 •! | area)
89.9 nf/100 •! I t) leaideat* of Bn«Mls (!•*•
onetcic I fcllvtal ar«»)
1 c) Msltoat* of Chaclsroi (control
1 it««)
1 Korean* vitfc aa acctmlatlog of C60 ir old.
I t«ta««t« of the >aM areaa 35 rr.
I l«lfi«i
I
I Birsiaa: mows; \st; BLOOD tnsai;
I mis; c»ama: mo; BMC DEI:
1 Bfins; «ic; ttDvsniti mssiois:
1 iiDusrniii jcttntioij POPOLIIIOI
1 11SOSOSB; DBB» 1BEIS
1
1 Baric*, irofil* of healthy nblects.
1 Bastllm data fox tetenlalng ehaages
1 li Bitritional itatu fro* indastclal
1 {cod pneesitgg t*ctniqn*s.
1
I in XEU»D; u>m,TSi tens; xifurs;
I HOOD ssunu: smij KIDKTS: UTIB;
t Bill: ISTltl; DIRS; TOODSi SOILS;
1 TietitTiai; CURIOE; COPPIS-,
1 Biieinst: imis: TSICB Eirastts:
1 K1C
i
t
&) 1.44 * or - O.OS | a) Itanaai Citr. KS, karl-««t«r axea
aq/1 | t) Mans CltT. BO. ioft-»at«r area
b| 4.28 * or - 0.82 | slwlflcantlj loner lenl cr<0.01) 1m
aq/lg 1 kat4-«ater area.
t
1 KS and no reildeata aatched foe a?e
1 (ceaa aaes 37 and 37.7 rr), MX,
I Icaotn of resldeaoe, aarital aad
1 ccoooalc itates, occvpation, mtber
1 cf cklldrea. saoklaq habits, at. vt.
1
1 ta hacd-natec acea. «l«j«l£icwt
1 iicrease in brpeiteBtloa. ICC
1 akaor>alltl«t« aad bTPcroriceiia.
1
I tllStS; B1SSCOBI: aDOttS;
1 omnoTiscnm DISUSES:
1 Biintnsioi; BLOOD SHOB:
t ccBMimvs mioiTiots: CIOIIOR:
1 cucio!: CEBCBIVI: LITEIVB;
1 HGIISnB; tSOSFHOSODS; rOUSSIIR;
1 50DIDB; II1C; BfOtCcmOLaTIOl;
I cmncns v«Et
1
a) 113 » or - SO I >) lea, lo» tlood prea*ace
»j blood fresanre
og/»l I taafc tcoa vmloes atojj. a«tlaat«d
1 dallr dietary Intake 4.5 a?.
1
t Polynesian icsidenta of Vokelan
1 Iflands, crovded condltloaa.
1 (nceiateiee eooaoar- lea, *eaa a«e
1 45 jt, aeaa fct 1C7 ea, aeaa « 74 k«
1 (oaea, a«ao a«e «* rr. aeaa bt 165
1 ca, aeaa vt 79 kg..
1
1 COPPEB; Zinc; BIOOD SSBOHi BUB;
I «IILS: mint
- - . t
(BEIT P»SB) ....,.,.
HfEEEICE
0»ls, B.I.
anerys, B.B.
ncaet. J-P
Bernard. 1.
«ei
EmTlcoBaeat&l Beaeaceli
24:117-130
Gotbcie. S.B.
Coblnsoa, B.T.
1178
leu Zealand ledical
Joacaal $7 (603): 3-8
llereabaaa, a. L.
Tlelscaaaa, I.I
Dmn, 3.
Inoli, J.
1975
lancet
1(HU): 1008-1016
RcKemie, J.B.
GBtkCl*. I. I.
Prior, I.a.B.
1978
iaericaa Joernal of
Clialeal latrltioa
31:422-42)
o
v£>
-------
time
atw «$,}•. tt »19.5 c. BP »0* C. TP 1 n Bg at MT C. 10 n B< at 5?0
t
t
c
iissn iifosm MR>
ISCT
90M
••RO*
1
I
1
*5<«
Braia
1
1
1
1
1
I
t »s««
1 Brail
1
f
1
»570
Brcat*
I
1
Julia lit Ion
iniYTXCal
IKMOB
US
n
t
ili
PUB
mm
or cisss
«l t
W s
i
luei i mi* i ezirui nrosuTitw i nrimci
1 1 1
II I
a) lot glT« | *) 10.« «g/o w»t rt f •) *ork«r I By»do. K.
b) 1.9-12.5 nj/» nt «t 1 b| lot gi»«« | t) coitcol* 1 Saioki, 3.
1 1 1 tmcmjt, I.
1 1 Japa»*M worker, 65 yr old* at 1 Bcshlzate* K.
1 1 ciroiat* crad«cl»9 »la«t fat 30 ir. 1 1*«0
1 1 Bled of aailUarr a»d la* caacer. | Zctenatloaal archive*
1 | cettrol*, 59-7i ft oia. 1 of Occip«tiOMl tnl
1 1 1 «BTitO»»«»t«l HMlth
1 1 JJtM; HIIPOS1 TI3SUI; lOXTt; SOfB I «:!«!- ISO
f | nlCO*; (1111} CREIKIM; CMEI808; |
1 1 IIDUtS: 1ITSB; MISS; BOSCtIS; I
1 i tncsm; sue cKonoi; CCCPEH i
1 t tiriii: tile: inosTim. PURS: i
1 1 IlllUTICt; COCITPtTIOlU, BltllKS: 1
1 i tcFiunoi txrosns i
i < i
1 I l
•) 8.4-1T tg/g (Mt «t) |i) 11 » or - 3.0 ng/g 1 •) Balm. c«»bt«a, t mbjcets 1 Tifca», a.
b) T,*-9.2 »V9 (o*t «t) 1 (»«t «tl 1 t) r«iali«. content, 3 «b}«ct« I sazaU-TMUoto, s.
c) 9.7-17 tq/f (nt it) | b) ». « « or - 0.9 I c) B«l«, c«r«bell«», C mbl«cti 1 liuo, 1.
9) 7.8-22 wi/g (mt it] | 19/9 (mt irtl 1 d) M»l«i. CKclMllm. • <*b-j«cti 1 T«»l< R.
1 c) 13 « or - 2.S og/tutloi>« Japac. I Eavlroncmtal B«alth
1 (*«t "t( | lalva. ma« »ij« •». 6 rr. F.MlM, I 35(1>:J«-»«
1 j i*a> aa« 37. t fc. |
1 1 1
1 i Tucr nsiEiis; tirotsissi JIPII; i
1 i naarna: nsaics CIBBIOB; COBUT; i
1 i ciicBiui: CCPP!§: HOI: iMcmt: i
l i nrioB: Bieftsni: a««s»«tsz; i
1 i i»»ioii7«.- i»ii»o»r,- scjnign; i
l i auBiius: iiunn; UUDIHIS UK: i
1 1 S01D; BIOBIBI: LITE1: KIDtnS: 1
I i ctKssm; criiBiiiffa: RIII; IBSCIJS; i
1 | EtICBIU; SPIKI; tOWJS; 1OBIH: I
1 1 BIHISi COBMSITITI STIWITICBS: SIX; |
1 1 FCItrSXC BtOICIBB (
II 1
a) dot glm I a) It.* ag/g | a| tor tec - nnbcoa (occipital) f Syoio. (.
b| 11.0-12.* aj/« | 1| lot »ir«» | I) S caitroli - cerebral (frontal) I Small, S.
c) lot aiT*» | e) 13.5 aj/f I e) lorker - cerebellM 1 Foray*, I.
d) lot giT*B I i) U.O ag/g | d) 1 coatrol - c«c«b«llaa I Mialzaka, K.
1 r«t «t ( | 1910
t 1 Jipan««« «ork«r, 65 rr old, at 1 latenttloatl trchlTM
1 1 cbroaat* trodaclat pltat for 30 rr. 1 of occupational and
( 1 tl«d of nzlHarr *ni luv cucor. > CaTlroueatal Hvaltk
1 I cc.tcola, 5»-7» jr old. t M: Id-ISO
1 1 1
1 1 JIP1B; ID IPO SB TISSOZi 1OST1; BOO 1
t 1 eUBOl; BBlIi; cnCBEUIIHi CmEEtVI: 1
I i KIIIETS: lira: HISS: aasciis: i
1 i dictns: sun; cnonoi; caifti; I
1 1 »R1U: tltC; IMOSnlU. PtIBtS: 1
1 I 1I»»UTIO»; COCVPITIOIIL BIH1BS; I
l i termiTioB EIPOSOBE i
i i i
1 1 1
ot gi»« | «.» ng |(1 s«ipl«d at rat* of 1 1/aia, 2-10 f UselBson. E.e.
1 1 all aft«c baral«« * arc »«lalag rods. I 9«n*del««r, 6.5.
1 1 1 Johausog, T.B.
1 1 Oal»erattj phfiics shop, Florida I Vlocbeater, J. «.
1 1 1 H7t
1 1 FIOHDU UBITS; BRUTE; CaLCIOH; I linal* of Occupatlonsl
1 1 ctLOBiit; CBXORIDB; copisi: uoi; I iTgleac 19:225-238
I I mo: alienist; ncicst: MTISSIUB: i
1 1 SOIFOJ: TXT1IIVR: TM1JIDS: XI1C; aXC 1
1 1 polnnioi; mats: iiraasTBiii. \
i \ IYBOSMBICS; nkct xurans i
i i i
twit M6»)
U)
M
O
-------
Hue
7«*0-CC-«
atl .5.38, BF «1».S C. BP 908 C, » 1 u 89 it M7 C, 10 n Sg at SSO
sissm
«71
Utr
»M2
la.il
M73
B*ic
»S1»
lt.tr
ifosan soon
Itqtttlot
iHiTTicit
a MOD
11*
IS*
US
mm
or cms
31
22
t
2
HMg
i Mot «!*••
1 Rot flm
12t.«-201.« 04/9
a) lot fiMD
b) lot «lT«B
CJ lot 9i»«l
A) lot »lw«
mi i cEiziiL iiroiBaTioi
t
1
1
) 139 ft* | •) l«»c»lng «la«bl«d
) 1»0 ppa | t) contrail
1
1 Iticnlnf dlsiblad »id >oc»l 3rl and
1
1« «o «U, on aiml»«ion
b) l«2 «o/g | t> n 19 old. n aliiailog
c) 13S «9/g I c> 10 M 014, r«cor*nd
4) 258 «9/9 | a> 11 10 old. c«oT«r«d
1 Ccppoe-a«(iel«it chlllni.
•
1 C1S« ETST01IIS; CIILmili 1I3Z»XS;
I tut: cofpti; anus: me
«l«l* USE) ' ' -
KBTEKEICE
rial, X.O.
PatkM, I.
1WI
Sclaace
198I»313):JO»-206
Ctlttlvborowih. 6.
1980
Seine* of the Total
f»lro«M«t U: 53-75
Chlttl«l»rot>9b, a.
StMl. B.J.
1980
Sclottco of th« total
tDTlroBKOt 15:25-35
BcaatloU. S.E.
Cotluo, 1.
B*«ttl, 1.
Graba», S.G.
1*80
La»Mt 2(»190) :l«3-ail
LO
-------
line
7100-66-6
n
t« 65.38, HP 419.5 C, BP 908 C, vp i aa Bg at 487 c, 10 aa Bg at 590
(CORTIROED)
TISSUE
4575
Balr
4576
Ralr
4577
Balr
4578
Ralr
BTPOSOBB BODTB
Inojestion
lUlTTICU
HETBOD
HI
HI
IIS
HOSBSB
OF CISBS
a) 16
b) 22
c) 13
d) 11
el 15
f) 22
g) 10
h) 18
i) 13
1) 3
kl 7
1) 12
.
a) 23
b) 19
O 42
e) 26
O 40
a) 17
b) 17
O 30
d) 30
BIRGB
a) Hot given
b) Hot given
c) Hot given
d) Hot given
e) Hot given
f) Hot given
2) Hot given
) Hot given
i) Hot given
fl Hot given
k) Rot given
1) Rot given
a) 108-190 og/g
b) 120-357 ug/g
c) 108-357 ag/g
d) 103-194 ag/g
e) 139-318 ag/g
f) 103-318 ag/g
a) Hot given
b) Hot givei
c] Hot given
d) Hot given
BEIB
a) 218 or - 9 ag/g
b) 225 or - 9 ag/g
e) 200 or - 32 ag/g
d) 225 or - 16 ag/g
e) 232 or - 22 ag/g
f) 225 »r - 296
ag/g
gl 105 or - 37 ag/g
h) 245 or - 52 ag/g
i) 140 or - 49 ag/g
1) 260 or - 87 ag/g
k) 180 or - 41 ag/g
11 175 or - 118
ag/g
a) 150 ag/g
b) 167 ag/g
d 161 ag/g
4) 145 ag/g
e) 168 ag/g
ft 166 ag/g
ledians
a) 216.2 « or - 43.2
ag/g
b) 239.7 * or - 108.5
ag/g
O 181.6 » or - 31.4
ug/g
d) 235.2 » or - 47.2
nqSa
Mysy
G8IIB.U I1?OBHATIOB
a) Controls, at birth, aales
b) Controls, -at birth, females
c) Fall-ten low birthvelght, at
tilth, aales
d) Fall-ten low blrthveight, at
tirth, feiales
«| Pre-tern, at birth, nales
f) Pro-term, at birth, females
g) Controls. 3 BO, Bales
h) Controls, 3 BO, females
i) Fall-tern low birthvelght, 3 aa.
tales
1) Fall-ten low birthveight, 3 ao.
females
k) Pre-term, 3 ao. Bales
1) Pre-term, 3 ao,. females
lUdians » or - SB
Reonates in Balifax. Pro-ten group
mean birthvelght I860 g, 26-36 »k
gestation, fall-term low birthveight
group mean birth weight 2371 g, 38-42
«» gestation, and full-tern controls
mean birthveight 3590 g, 38-42 vk
gestation.
aaiB; amis; ZIBC: COE;EB;
BIRGME3B; VMaDIDB; IODISE; IHPaHTS;
SIX
0) Rale controls
t) Peaale controls
c) 111 centrals
d) Dale tnltiple sclerosis patients
e) Teaale multiple sclerosis patients
<> 111 an It 1 fie sclerosis patients
Samples from 7 scalp sites in each
sab ject
CHID*; igaits: CKBTHIL HEBVODS
STSTEB DISUSES; HUB; alOHHTOB;
BBonuB; catena; CHLOBIBB; COPPEB:
8CID; IODISE; BIBOaRZSB; RBTalS;
SHE", Til: SI17EB; SODIOS; S01FOS;
VI»»DHJB: lire
levle*. Profile of healthy subjects.
Baseline data foe determining changes
in nutritional status from industrial
(aod processing techniques.
RIB tBIlIRO; IDOLTS; FBTOS; IR*1BTS;
BIOOD SEB0I: HUB; KIDIBTS: IITBB:
RIIK; BSVIEl; DIRS; FOODS; SOIIS;
?tORITIOR: CtDBIDBl; COPPBB;
BIHGaBBSB; RR11S; TBICB E1EBEBTS;
me
01 Bothers of infants with scina
tiflda
t) Infanta vith spina bit Ida
c) Control aethers
d) Control infants
Hevborn with cystic spina bifida. and
Bill): ZIRC; IHFIBTS; PBBGHIHCT: TBICE
IIESBBTS: GEBHIHT
BBFBBBBCE
Gibson, B.S.
Dewolfe, B.S.
1980
Bntrition Beports
International
21(3):341-349
fiyan, D.B.
Bolzbecher, 3.
Stoart. D.C.
1978
Clinical Cheaistrv
24(11) : 1996-2000
Gathrie, B.B.
Boblnson, R.F.
1978
Rev Zealand aedical
Journal 87 (603): 3-8
Bergnann. I.E.
Hakoseh, G.
Te«s, S.-H.
1980
laerican Journal of
clinical Bntrition
33:2145-2.150
-------
Zioc
mg-66-f
tm
»*» 65.38.
•P «19.S C, »P 908 C. W 1 mm Rg at *87 c. 10 mm Bg at 590
(COIIIHED)
1 TISSUE
t
1
t »S79
1 >alr
1
t
1
\
\
1
1
1
i
•
1
1 »5BO
1 Hair
1
1
1
1
1
1
1
1
1
1
1
t
I
1 4581
1 Bair
1
1
1
1
1
1
1
1
1
1
1
t
1
t
1
1
1 as 82
t flem.it
•
1
1
1
1
1
1
1
t
1
1
1
1
1
"
1
i
1
tnOSVIS BOJTB
ngemtlon
IMlTTICll 1 IOBBES
BEIBOB 1 OP CISBS
fl
1
$ 1 a) 11
1 b| 13
1 c) 17
1 n 28
1 el 14
1 O 1*
1
1
1
1
1
1
1 a) 96
1 b) 12
1
1
I
1
1
1
1
1
I
I
US | *1 IS
t **) 1^
1 cl 19
1 *) 15
1
1
|
|
1
1
1
|
1
1
1
1
1
|
|
•1 I a) 10
1 b| «
|
i
i
i
i
i
i
i
i
i
i
i
i
i
i
i
i
i
I BIBSB
1
1
1
1 a) «ot given
I b) *ot given
1 c) mot givem
1 d) lot givem
1 e) mot given
1 f) mot given
1
1
1
1
1
t ,
\
1 a) lot given
1 b) lot given
1
1
1
1
1
1
1
1
1
i
1 a) Bot given
1 hi lot given
1 cl lot given
1 dl lot given
1
1
1
|
|
1
|
|
|
1
|
|
|
1 «1 7.0-43 og/g
1 b) 4.9-25 ag/g
1
1
1
1
1
1
1
1
1
1
1
1
t
1
|
1
1
1
1 SE»I
1
1
1
1 a) 138. « * or -
I ag/g
1 W 159.1 » or -
) ag/g
1 c] 108.2 t or
1 ag/g
1 4) 164.8 » or -
I »g/g
1 e| 106.1 * or -
1 t| 121.7 + or -
1 ng/g
1
I
1 at 94.1 » or -
1 ag/g
1 b) 130.7 * or •
1 «g/g
1
1
1
1
1
1
1
1
1
i
1
1 a) 259 » or -
i »g/g
1 b| 241 » or -
|c| 163 * or -
1 d) 144 » or -
1
1
1
1
1
1
t
1
1
1
1
1
i
1
(*«t »t) I a) 24 « or -
(vet »t| | <««t vt)
1 b) 17 « or -
1 (vet wt)
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
(BHT PISE)
1 EiituL intniaTioi
1
i
l
64.1 1 a) 6-11 mo old boys
1 b) 6-11 mo old girls
98.7 Id 12-23 mo old boys
1 6) 12-23 mo old girls
- 47. 0 t e) 24-35 mo eld boys
1 t) 24-35 mo old girls
13.0 |
1 lav Income ccsta Bicaa 6 eto-4 yc oils
47.7 |
| IIBC; COST! Elca; CBILtSEl: KPUTS;
50.7 I iraiL UBaS; B»IB: SEX; TfilCE
| EIRBEITS
1
5.3 | a) aigramt children
I t| Controls Iron otter stmdiea
• 8.3 | a) and b) differed n<0.001
1
1 2-69 BO olds, belo* 3rd percentlle In
1 ht.
-------
tine
It
Its 65.38. «* »1».5 C, Bp 408 C, VP 1 am Rg at 187 C, 10 aa Sg at 5*0
1ISSDE
'
4583
manev
Kidney
0585
Kidney
EIPOSOBE tOOTl
'
1 BILTTICUL
BETHOD
US
Bl
. .
113
BORBBB
OF C1SE3
a| 21
b) 3
a) 1
b) 5
suet
..
a) not given
b) Vat given
c) 1759-3278 ppn
i) 1682-7000 ppn
lah vt
'
a) «.1-»6 og/g (vet vt)
b) ».«-«« ag/j (vet «t|
a) Sot given
b) 31.1-66.6 ag/g vet vt
-
(BEIT
ItElB
a) 3653 pp«
b) 3920 ppn
ol 25 11 ppn
« 3551 ppa
ish vt
a) 39 » or - 29 ug/g
(vet vtj
b) 33 • or - 20 ug/g
(vet vt)
al 3*. 8 ng/g vet vt
b) lot given
f»GE)
GfltUl IVFOGI1TIOI
a) 17 cancer patients
t) 58 non-cancer patients
c) 10 non-stokers (never saofced)
i) S snokere, 1.5 packs/day
««topal«s free hospitals It Sorth and
South Carolina. Blacks and
Caucasians, (dulls, ages 16-91 yr.
Children, ages 4 4ays-6 vr.
SITUS; BOHtS; 1ITSB; KIDBSTS;
RtVtlS; CHTIDEES: CJDSIOB; ?I»C;
l»0; SOBTH CJS01IM: SOOTB CJBOTIS1;
intopsiES; Gioiccmotinoi; BICUL
STUD IBS; «5B; SHOICUO: tOBSCCOS: SEI;
>fQ PltS IS
a) (tales
t) resales
Fros a 4roap of tl a at apsis s.
forensic redlcal exaiinations, Japan.
Bales. M» age 40. t Tt. Females ,
•ean a
-------
ZlBC
7MO-66-6
tn
ItB 65.38, HP (19.5 C, BP 908 C. TP 1 •• Sg at «87 c.
10 •• Rg *t 5*0
(COBTIBIED)
1ISSBE
«586
Mdnay
a5«7
Kidney
•588
Liver
»589
linr
ztosoBB BOOTE
•gestion
IBUnlClI. |
BETHOD
S
US
Bl
BDSBEB
F C1SES
8
9
12
a) 8
b) 7
MICE
1S-»7 «g/g
19-55 ug/g
17-* 2 »g/g
t «t
a) lot given
b) lot given
c) 3220-12850 ppn
d) 720-5800 pp»
lab «t
a) 37-180 ug/g (net >t)
b) 17-91 «g/g (vet ¥t)
•Ell | 6BMB11 IBPOBfllTIOB | BFEBEBCB
| 1
t 1
25 ag/g 1 a) Controls 1 Bruno, D.
32.5 ug/g 1 t) "orter group I | Bordberg, G.
25.0 ug/g I c) locker grew II 1 Bester. P.O.
et «t I 1 1980
edians I leeeased refinery »»d sselter I Science of the Total
I letters, aqea 55-76 yr. exposed to 1 Kmrlronnent 16:13-35
1 i«»»y ratals 1-3 decades. Use 1
| tstMea retirenent and death 0-1.5 yr I
1 it qro«p I aid 2-19 rr. gcoop II. 1
I Controls, agts «3-72 jt. wko lived 50 1
j III troa the factor?. S»«d«n. I
1 I
I SIEON: ciDitns; KNITS: LITEB: I
| IBBGS; COIPlBlTItB ET11BHIOIS; I
| IBOOSTlIU BTCIBBB: BBlSIIlSBBBt 1
| IRBODS: 1RIIOIT: 1BSEBIC; 1
1 muraim; CIOBIVB; cismH; CBBOHIOR; t
1 cceiit; coppn; SOLD: IBOB; i
| IIITBIIOB; 1119; aiBGlBBSI; BEBOJBT; I
1 BQITBDBBOB: IBOSPH01DS; BDBIBIOB; |
I sciBEioa; SIICTIOS; SIITIB: 111; i
1 T01GSTM: tIBC: BI11TI H121SOS: I
| IBDBST1I11 PtlBTS: SSEITIBS 1
| •
| twriev. Profile of healthy subjects. I Gnthrle, B.S.
1 Baseliae data for detersinlig changes 1 lobinson, B.F.
I la ntrltioial status troa Industrial I 1971
j teat poisoaing techniques. I Be* Zealand Hedical
| < Journal 87 (603) -.3-8
| BIB ZE1L1BO: IDOLTS; 'ETtJS; IBF1BTS; I
1 BIOOD SSBOB: Bin: HIBIITS; IITSI; i
| BHK: SBTIIB: DIETS: FOODS: SOUS; I
1 tisn»iio»: cuBina; coppii; i
| B1B61BBSI; BR1I.S; TMCE ElEBEBTS; I
I ZI«C 1
| 1
I 1
a) 5063 ppa | a) 17 cancer patients 1 Hanser, D.I.
b) *120 (pn I b) 58 nan-cancer patients 1 Caloeci. l.T.
c> 6068 ppa I c) Two 10-19 yr olds I Basselblad, T.
d) 3297 ppn I 4) Three 30-39 jt olds I Vllllaas. B.I.
ish «t | 1 Piakerson, C.
| latopstes free hospitals In Borth and | 1973
1 South Carolina. Blacks and j Journal of Occnpatiosal
I Caucasians. Idults. ages 16-91 yc. 1 Bedicine IS (12): 956-963
I Children, ages * daya-6 yr. 1
1 1
| ClTltS; BOBSS; LITEB; KIDBITS; 1
| IIOITS; CBItCBBB: ClDHOBi 2IIC; |
| HID; BOMB CUOIIB1; SOBTB C1BCLIB1; I
| ItrtOKtES: BI01CCHB011TIOB; S1CIU. 1
| SIOEIES; 1GB; SBOKXBG; TOB1CCOS; SEX; 1
| HOPllSIS |
1 - I.,
I 1
a) 97 » or - 59 og/g I a) Bales < Tulcana, fl.
(let «t) I t) Fenales 1 Suxnki-Iasnnoto. fl.
b) 50 » or - 20 ug/g | 1 Inano. K.
(«et »t) | fret a group of 61 autopsies. 1 Teral. B.
1 forensic sedieal ezaslaatioai. Japan. 1 1980
| Bales, aeaa age aO. 6 yr. Peaales. I IrchiTes of
j scan age 37. a yr. t Ea*lroneental Health
t | 3S(l):36-«a
| ItlCI SLI8I11S; lOTOPSIKS: J1PIB; (
1 noaiBn-i; itsEBic: CIDBIHB: COBIIT; I
1 CBBOBina: CCEP^B: IWB: BtBCORr: |
| IIDHl; RICBISIOB: B1BG1BZSE; 1
1 BOBIDIUI; 1BIIBOBT; SC1BOIVB; I
1 StlEBIIB; TIIIBIOH: flBlDIVB: tIBC: I
| GOLD: BBOBIEE; UTEB: KIDBIIS: I
i ciimoB; csBEBEiinn: BEIBI; BUSCLES; i
i iiiciEts: sptEEB; mas: IOBTI; I
| BITltS: COilPlUTITB 1T11O1TIOBS; SEI; (
| ICtllSIC BZIICIBB |
1 1
u>
(BZIT
-------
tl«e
i«ao-«6-6
t«
It* CS.3*. BP »19.S C, BP 908 C, n 1 n «9 at 487 C. 10 n 89 at S90
(COBtlEBID)
1
t
1
1
1I3SDI
as»o
liver
«S91
HTer
1 »s»2
lint
1
t
•5*3
Llm<|
1
1
1
r
inosm Boats
leoeatioo
1
1
1
mimcu
BBTBOD
us
us
1 i
i
i
n
B9BBH
or c»s
«) 1
b) 5
•) 8
M »
c) It
•1 3
W 2
B1BSE
*) lot 9lT«»
b) (2.0-107 og/9 mt •
a) 30-99 a«yg
b) 22-103 «a/»
0) 19-15* ««/9
Wt «t
t) ».3-12 B9/9 («et »t)
b) 10-t6 eg/o (vet >t)
m« i "eiaiiu nrosBuioB I EsreBEBcs
i :
i i
at 123 «9/» Mt «t | •) torter 1 Brodo, E.
b) lot firm 1 t) Coatrola 1 SateU, 5.
I I furor* . *.
1 Jaraaese iiocler, 65 TT alt. it 1 Reaklzaka. E.
1 cbronte rrodaclao. plait for 34 rr. I 19(0
| ti«4 of uxillacr u< luv cue«r. 1 tit«r*«tioul lrchiT«
| ceittol*. S9-7C rr ol4. f of Oce«pttioiial *ti
1 | EnlroiMittl B««lth
1 J1FH: IDIPOSB Tijsnt: IOITI: ton I <6:i«i-iso
1 8IEIOI: BBUI: CIUBXUOI; CEBEEEffE; 1
1 VIDIEYS; LITEB: VIKSl RVSCIZS; f
I HICBE13: SKII: CEBOUIM; COPPBI: |
| «!IU3: tlKs IIDBSTSIIL PltRS; (
I IIB1UTIOI; CCCDPITIOIU. B1Z1BBS; |
1 ECrntTIOB tlfOSOB! |
1 1
1 1
a) (1.0 tj/9 1 a) Ceatrol* I Vrna, D.
b> *?.o 09/9 I t) Voclnc qroap I I «or4b*r?;. C.
c) 66.5 ag/9 1 «) «ort«c qraap it 1 »e»t»r, P.O.
let «t 1 1 1»80
Icdiau 1 t«Ms«4 c*f inerr asi «a«ltar I Sclme* of the Total
1 tartars, a9«« 5S-7S rr, axpaovd to 1 Bnriroamit 16:13-35
1 k«a*r a«tali 1-3 4« limd $0 f
1 k* fcoi tke faetorr. S»«a«n. 1
1 1
1 sitcM: ciDitEis; rnmrs; IITEB; i
1 miss: cogeuain irnajriois.- i
I UEOSTRIil KtSXZIZ: 8U5VEiaZIT |
| IRBOOS: tBTIIOBT: IRSSHC; |
1 TitLinm; ciEmioi; cisitra; cHsoaion,- i
1 ccriti: coppu: eoic: itots I
I Liimmrs: tun: DIISJIESB; BESCOBT; i
I BCLrBOESUd; fBOSPBOBBS: DOBIEIUS; I
1 sciBDini; stunos: 511 TIB; m; 1
I m«5STB»; UK: Stiffs SlZlSfS; |
| IIOOSTtllt Pt»»TS: SR1TISS 1
1 1
i 1
1 f«»l«». Profile of k«alttr «biects. I Gatfcrla, B.I.
I fascllM data for J«t«riinlBo ekame* 1 Robinson, n.r.
r la aatrltloaal «t»to» froi imlattrial I 1978
I feed pol«oata« t«chni7o«». I >•> Zaalaid aedical
| | Joaraal 87(603) :3-8
| Mt ZEU1EC: iOOlTS: MTDS; IVrlBTS; |
| tlOOB SStttHS Hill; IIOKIS; IITIS; |
I iltlt; ttriTS; BIBTS: ?OOSS; SOUS; 1
I fterritioB; CJDBWS: COPPU: i
I BIIClIESt; inal5; IB1CE IIZBEITS; 1
1 tllC 1
1 t ,
1 1
8.5 » or - 3.8 fa) f!al«s 1 lokava, B.
g (vet «t) 1 t) *eaal«E 1 Sanki-Taaaaoto, a.
13 < oc - 1.2 ig/g 1 t laaoo, E.
t «t) 1 rroa a group of 61 agtopslas, I Terai. B.
1 fervaslc aedical exailaatloi*, Japan. 1 1980
1 Bales, «eaa aoe »o. 6 rr. Feiules, t irckivea of
1 ie» »
-------
Mac
74«0-««-6
»t« S5.3B, n »1».S C, Sf »0a C, n> 1 •• Hg It «87 C. 10 » Sg at 590
TISS03
»59»
laag
595
Ivag
•MS
lilk
tosnt tons
lagaatioa
intTTIOL
BsraoD
us
us
1
1
I
IBim | B1KB
OF C15IS |
1
I
1 a) lot givea
1 b| 10.0-13.7 ag/g
1 e) lot glvea
1 d) 12.0-19.1 ag/g
1 a) lot given
1 « 7.5-1J.1 ag/g
1 »et vt
|
I
1
1
1
1
1
1
1
I
1
)
1
1
a) 8 la) «.»-2» og/4
b) 9 | b) 6.2-16 ag/g
cl 11 1C) a..?-* 15.3 ag/g
1 Wet vt
|
1
1
1
1
1
t
1
1
1
1
1
1
t
|
1
1
1
1
1
|
1
1
1
1
1
1
1
1
1
I
Kilt | 6BI1UL XIFOIBmOl
1
1
) 8.5 ag/g | a) lorkar, right apper lobe
lot given | 6) S eoatrola, right upper loba
13.3 ag/g | c) Vockac, right aidtle loba
i Hot given 1 d) 5 coat roll, right aiddl* lob*
) 12.8 ng/g | •) (orker, left lover loba
I lot given I f) 5 coatrols, left lover lobe
at vt |
I Japaaaaa varkec. 65 Tt old. at
1 chroiat* crodveiag plait for 30 yr.
I Clad of aaxillary aa& laag cancer.
1 ccatrols, 59-7* yr old.
1
| J»ll; aDIPOSS TISSUE; 1OET1; BOIE
| RIMO«; IB1II; crBEBEHOB; CIBIEBOB:
1 IIDRIS: lltM; IVIES; BISCLIS:
I f»Ct.
Snzaki, S.
»roy», 1.
1980
lateraatioaal archivaa
of Oceapational aad
tBTiroaaaBtal Bealtb
act 1*1-150
Brnne, 0.
aordberg. e.
Vaster, P.O.
1990
Sciaace of tba Total,
BaviroBMat 16:13-35
Gnthrie, B.B.
Bobiaaoi, a.r.
197«
lev taalaid Radical
Journal 871603) :3-8
(HIT PISE)
-------
Mae
7MO-««-«
fa
ttf «S.3». n 4T9.S C. B» 90* C, TF t M la at »»7 C. 10 aa So at 590
(commtD)
T1SSVI
»S97
Rascle
»S»»
Bascle
t
1
1
4599
lail
1
f
f
MOO
Vail
1
1
1
I
xxtosns sown
1
1
1
i
1
1
1
1
1
1
1
1
I
9
1
'
t
1
1
1
1
Zaovstios
IULTTIC11
ratios
n
us
1
1
1
1
1
t
f
I
1
It
1
1
1
1
»
I
1
1
1
1
us
•rain
or USE
«» *
b> *
1
1 «
1
1
1
1
- -*
(
1 nl 9
b) 11
b) 17 | I
c) 19 <
a is t
-
Hisi
!
•> 10-73 eg/a (vet «t(
b) 11-72 ag/g |*et at)
nil i GEMUL nroiimei i nmiici
l l
i i
S1 » or - 1» ' '
(»rt wt) | t) resales I Sn»ki*Tiraaoto, I.
b) »S » or - 25 ag/g 1 | tnano, I.
(rat *t) | froa a groap at 61 aatepdea, I Terai. I.
1 foreaaie neUeal exaniaattoaa, Japan, t 1980
1 Bales, aeaa age *O.S yr. resales, I IrckiTes of
1 aean a«s 37.« yr. I Environaantal lenltn
1 1 35(1)53*-"
l TMCE tanns; tnorsnst jun; i
1 HOBnOT; 1ISEIIC; ClOSIM: COBUT: |
t cncBTKB; comt: itoi; incnr: t
1 iinnB; msusioB; uieiiissj i
1 laiiBint; iniBorr: sciniii: (
l snnxm; Tntiira; nitBim: nic: i
1 COIB; Btoaif!: urn: noiiys: i
1 1 CIII»n«i CntBEUVI; »ltt; BBSO.es; j
l l EIICIIIS; sttxas wmss-. iciri; i
l l intis; coaritiTin zrutrtTiois; SET; i
1 TCIIISIC BIBICIIE |
. — . 1 1
lot given 66.0 ag/g »et »t 1 | |Todo, X.
1 1 Sasaki, S.
1 Japanese eorker, «S yr old. at 1 raraya, 1.
1 ckroaete srodaclnq pltat for 30 yr. 1 ResUzvka, I.
1 tie*, of aailllary aad lang cancer. 1 19S9
1 1 tateraatioaal Irchives
1 Jim: IBIFOSB Tissue: IOST*; tout 1 of OccaBatloaal and
a) lot given
b) lot given
lot given
>) lot giVM
•) lot given
) lot given
1 BUBO*: mill: cnn»lltr»: cmaoii 1 laTiranaeatal Baaltk
l iiDinsi urn; vnest iirscizs: i *»:i*i-iso
1 tiiciitst sm: CB10M0B: catitt; t
1 BIT US; IIBC: IIDOSTSIU »U«TS; |
| IHUtTtOI: OCCOmiMlt lltUBS; |
i tctmmo* Hposnir. i
i i
» 1M » or - 75 pps I a) (oaan | Jtanabrocki, s.l.
W 153 » or - 68 ppa | t) lea | Kantbrocfci. J.I.
3ry »» 1 I«rt tkoab | Greco. J.
1 llso rerievedt knmn levela 30 other 1 ICaplaa. t.
t eleaeats | oester, I.T.
f 1 Brar. S.s.
1 taalthy 20-60 yr olds | e«staf
-------
time
7»»0-S6-«
It
Itf tt.39, IP 419.5 C. BP 908 C, fP 1 M 89 at M7 C, 10 •• !« «t SM
tcomim)
fXSSBI
Patents
a«02
Pancreas
•603
Piervsx
Skin
foson tons
HUTTICIt
BTTBOO
IS
US
us
r ctsss
7
3
aj 1
) 5
a) 1
b) i
a) 1
M 5
JMCI
1»-«3 ng/g (Mt etj
32-*0 ag/g (vet »tj
1 Bot given
1 2t.1-*l.a tg/9 »et vt
a) lot gin*
B) 15. 7-22.7 »g/g vet vt
a) lot given
b) 5.1-7.9 sg/g Mt lit
Mil | 6SBISU IBIOIUTIOX I BETBinCI
1 1
1 1
29 » or - 9. S *g/g I a) Bales I Tvkava. a.
•et «t) | 1) resales | Saznki-TMasoto, S.
36 • or - a.o ng/j | l laaao, x.
(vet vt) | HOB a groan of <1 sntopsies. < Teral. 1.
1 forensic sedical exanlnatiani, Japan. 1 1980
t Isles, senn age »0. 6 yr- 'analog, | archives of
1 nean age 37. « yr. ( Zsvironsental Bealtli
1 1 35ID-.3S-M
1 TBICB nzBtns; iirroMiEs: Jipti; 1
1 iiiBnm: usnic: CIDBHTB; coBut: i
1 cncBxra; conzt: IBOB; HIBCDBI: i
l lining! aiGitsivs; aiieiBtsz; i
l PVBIBIDI: ixnaofT; actBDira; i
i snnina: tiuBiot; nnoitnj zixcs i
l con; BiOBiBZ: irrra; noxtTS; i
1 cmmm: CIXIBZIUIB: BUM; ansais; i
1 IIICBBISI SP1IKB: LOISS; iOITl; |
1 a tins: coBpiBinn XTUVMICIS; stt; \
1 1C1ZBSIC BIC1CIII |
1 1
a) 37.2 ng/g Mt vt la) lorker I HyoSo, x.
b) Bot given I b) Controls ( Saioki, s.
1 1 rnrnya, B.
1 JicauM vorkec. 61 vr olo, at 1 Besai*«ka, X.
1 caroaate [rodacing plant for 30 yr. I 19BO
1 tied of nezillarr and lung cancer. I International Urcaives
) Centrals, 59-78 vr old. I of Occupational and
1 1 Znviroueatal Health
1 jirjn- IBTJOSI tissai; IOITI-. mm i ««:i»i-iso
< BlltOf; BBtll: CnEBtllDB; CZBIBBOB; I
1 KIlBEtS; IITFJ: LOBSSj BBSC1ZS; I
I IIBCllU; SXIBi CBKOItBB: COPPXB; I
1 Bints-, tixc: icggstiiii. nms; i
1 IIBIlinOB: CCCOV1TIOBU UZ1IDS; \
1 POPOUTIOI BIPOSB1E t
1 |
1 |
a) 22.2 ng/g Mt vt | i) larter | Byodo, X.
b) lot given | t) Controls \ Suzuki, S.
t 1 Parori, X.
1 Jatanase «otker, S5 yr old. at 1 Resfciiakn, X.
1 catenate cretacing plant for 30 vr. 1 19(0
1 tied of aaiillarr and lug cancer. I Ivtenational Uehives
1 Centrals, 59-78 yr old. 1 of Occapational and
t 1 ZBVlronnental Bealtli
1 »I*Bi IBIMSI tlSSBZ; »OBT»J 10(3 I »6:1«t-15(l
1 BlltOT; BI1IB; CnCBZLlOB: CnXBSDB: I
1 KIDIBTS; Ufa: HISS; BOSCIZS: I
I mcit is; SIM; craonsa: cotpii; i
l nnus: me; n&nsTBtti nins; i
l iiauutait cocnrmoxiL utiios; \
1 ECPDimO* XXPOSOI9 |
1 1
a) 10.1 sg/g Mt «t e ,} lorker I Brado, X.
M B»t given | b) Controls ( snvki, s.
1 1 mrayt. 1.
1 Jatanese worker. CS vr old, at I Beshiznka, X.
1 tfttonat* rrodnclxg plant for 30 yr. I 1980
1 I ltd of sutllaET »& l«ag cancer. t International archives
1 Centrals, 10-71 yr old. 1 of occupational ua
1 1 Znvlronsental Health
1 31t»; 1DIPOSI TISSUE; IOBT1; BOIZ 1 »«:1<1-1SO
1 BlltOt; BStll; CtBZlZLIN: CnZESDB; I
1 xiEins: n»n; inxes; ivscus; \
t (IKBZlS: SIM: CB10BTOB; COPPIl; I
t atTtis: sue: IWDOSIBIIL puns; i
( IiaillllCB; QCCDPKTOBU. BIIlltDS; t
1 fcpouTion txposomz i
SO
-------
Tlie
ta
Itl «5.38, H» (19.5 C, B* 908 c, « 1 aa Bg at 4«7 c. 10 en Bg at 5*0
tissus BXfosBi: TOUTS IIU.TIICU.
BZT10D
•COS I-ra- apeetroe
Spinal
cord
1
1 1
1 1
t 1 l
t 1
««o« I n
Spleen f
(
f
f
t 1
1
1
1
1
1 ««07 IIS
(OllZt | »iei 1 nil | 6BI1UL mCIMHOI 1 BZmBBCZ
or cisKS lit i
1 1 1 1
) 1 1 1
a) 7 |a) 39.6-202.5 og/g I a) 83.8 * or - it. 3 | a) Solar nenron disease patienta 1 Karlander. B.B.
b) 12 I b) 3».6-85.9 ag/g 1 ug/g I t) coatrala 1 Sattan. B.I.
1 BIJ *t 1 b) 52.2 * or - l«.3 | Tvatral kora tis-ae. aatopsi 1 1979
1 1 og/g I 1 annals of leitologr
I | arr vt | fatieata died of avotrepklc lateral 1 *(1)t31-24
1 1 1 fclerosts aad progressive aasealar 1
1 1 1 atropkr. aean age, 5«. 6 « or - 13. 1 1
1 1 1 It. Control! died of varioas 1
1 1 1 diseases at 60.9 « or - 11.1 vr. 1
1*1 1
1 l i TIII-; iBoiiss lororsiss; i
1 i t M-KOTseoiai vz-Bi-xs) srnu. coio-. i
1 i i tioicciTioniiof : CJUCIOB: COPFBBI i
1 l l itoi: itic: ureaixsz; anus; i
1 1 l SniBCTI: ZlfC |
i i i t
III l
a) 9 | a) C.S-45 120 I Salsiaen, B.
1 1 1 41 50 | d) 122*282 og/9 1 d) '85 * or - 10.8 | a-/g ta IB acil 1 1981
1 1 1 e) 26 | e) 143-339 ag/g 1 ag/g [ c) Bentine, arbaa area I Ircblves of Oral
1 1 ( f) 26 | f) 169-538 ag/g | e) 1*9 » or - 20.4 | d) tMael. aa in (a) 1 Blologr 2t:1-6
II II «g/g
1 1 1 If) 301 « or - 42.8
II II ag/g
1 1 1
III 1
III 1
III 1
1 1 1
i f i
i i
i f
i
4C08 Xftgeatian US a) 15 a) lot girca
Triae b) 17 b) lot given
O 19 c) lot girea
d) 15 d) tot givea
t
l -
a) 539 » or - 355
ug/2* br
b| 522 » or - 288
•9/24 kr
c| 343 » or - 222
-g/24 kr
4) 127 * or - 251
ug/24 kr
e) Inaael, aa la (b) I
i) laanel, aa in (e) I
latiaated free grapb (a,b,c) |
lg< depeadeat data al» presented. 1
la accacalated la dentine np to age 1
if 1
1
lesideats of Finland 1
1
niltni 10!; SEX; T.KTB; COBP1BHITE 1
ITlIOlTIOirS: BIOMSW1; Tile; SDMI I
JSI1S; K1B» 1BZ15; BBT1IS 1
1
a) Me. lov (load preeeore 1 aer.ea-ie, J.B.
t) Ma, klgh feloed pre-nre I eathrie, I.I.
c) lonea* lov blood presaare 1 Prior, 7.JI.S.
4) voaea, kigh blood presaara 1 1978
Subjects selected by Uood ptessore 1 taerican Journal of
rank fcon previoas stndr. Bstinated I Clinical ntrition
dailr iietari intake 4.5 ng. I 31:422-428
1
folvaeslan residents of Tokelaa t
Islands, cro«del eoaditions, 1
subsistence econonr. Ben, n«an age 1
1! Tr, aean lit 147 en, ne*n vt 74 kg. 1
leaen, aeas age at vr, nean kt 165 1
ca, aeaa vt 79 kg. 1
1
CCEflE; IT«C: BIOOO SIBOS; I1IB: 1
tins; Mill; 1Z1 ZEU1E0 I
1
N5
O
-------
Stic, Kltr<»?«a 3,7, 12, 17-t«tra»athyl-8, T3-Uiiadiproplo«ata<2-||- (8 CT)
*l»c. n.12-ai»tlienTl-J.8.13,17-t«tr»»«thyl-21S.23H-porphiBe-2,H-dipropiiioato(2-)-I(2I).«W2),I(23|,»(2«»)-.
C3«-H30-M-0«-In- 21
II 626.03
TISSUI
»609
Iloot.
call*
Eiiosvn IOOTE
>B»1IIIC»1
BETVOD
WSBHI
OF MSB
2«0
iMGS
a) lot gl»a»
b) lot gtT 3V 33 vk aftai caaoral
trrthcoeTtas
(atlaatad frea araph
Cavaldarabla dlt£«t«moa la rata of
ebaiga aaa plataaa stata for Xa
Iaa4 saaltai torkars
ItntlS; BIOOD; MTTHBOCTTIS;
CC9F1B1TITE tTHOlTIOIS; USOSTtlll
iicinit mi: xnc OIGHIC
ccnposins: iieosmsti itiasraEits;
IIBIUTIOI; CCCBPlTHWil BiJWDS;
SRIITZIS
SSfEBXICE
Baslay, E.I.
llabisk, S.B.
1991
Journal of fba taerican
Inanstrlal Byqiena
l*sociation »2:«2-«6
rlcconlgi
7»»0-67-7
It
Id 91.22. IIP 1852 C. BP 35T7 C
TISSDC
Bale
IIPOSOBE son:
t
lutmcit
BETBOD
IOBBSB |
or CISES
11I6E 1
1Et(
fillllll I«roBB»TIO«
Vavia»« 2V caprasaata,tiTa
pra-a*alT»la tr«ataants ara
tatnlataa. Iba faacibllity of a
bcllatle. no-«a»h policy for hale
laalysls 1* outliaaa «ad supported.
f If III; TB1CI I1HEITS: Bill;
IDSTBllH; >IlSOIZR»t IZIBODS;
»11LS; PBOTHIS: COMIUTITI
IViLV&lIOVS; 1L0BIVQIC; 1I1TBOIT;
»siuc: Slim; BKonil: CICFIIDS:
ciicnn; CKOBIIZ: CBBOIIOB: coiui:
CCPPEB; Sllliai; GE1H1IIOH; £010;
login; iBon; tiRBma: nit;
MGIEStVl; BlIGUKI; BIBCUBI;
tatmimn; HCKBL; CBOSPBCBOS;
fQlaSSIHH; SDBIDIUB; SEIEVIQB:
siiicoi; suns; SODIIB; SIBCSTMH-.
soiroB; in; Tinnm; tuiesni:
II1C; ZI1CCII1IB
BEFEIEICE
Chittlaboroogh, G.
Sctaac* of the Total
tITlXO*MItt 1*5 53-75
N)
-------
1-eataaol. J-**»rt-
C«-B1«-0
II 102.17. If -tS C, SI 1»8.9 C. TP 9.9 •• tl it » C
tissue
»S11
Bre«t»
EIKISVB BOBR
IBIIITICIL
HCTBO9
8C-HS
BOMS*
or cisss
5* (387
saaples)
11(61
Vat 9lTea
8MB 1 C1BZB11 IVFOIUTIOI
1
1
t
1.12 B«/l ( Beanred at 25 C aad 760 II Bo
Ceoaetric | »S.S* ooearmee
1 ze»«r aa& apper osw-sigaa Jiaita
1 C.370 aad 3.3» aoyl
I BMlthr. i*-3S rr old. B«an>)ri«9,
1 «rtia black* »»4 caocasia ni.
1 cficaqo, 11. BtqWlT co«troll«l
1 «ip«rlmttl co«ditia».
1 III1TB; IICOEOIS; II1IIOIS; tDHUS;
1 ciiatinrtt mtocntoiss TOIJTHI
l ciemc coircojDS: mm HUIBDS;
i IHIUTIOI; mimisa; uiiaoims;
1 FCFBiirro* nposni; JBBI» IBIIS
tETEIIICI
Kcota«ia i »
at ixs c
Tissm
««12
Breath
1
1
I
1
1
1
1
1 siresms aonz
1
1
,'
1
1
l
1
l
1
i
iBunicii
HXTBOD
OC-9S
•0SBSB
or cisss
W (387
saaples)
1
*
1
1
1
1 BiBei
Bot give*
1
1
1
1
ms»»
12.3 ag/1
Geoaetrie
6BBIBU IlrOtUTIOB
Caaanred at 25 c aad 760 aa Bg
?.»* oecarrenc«
lower aid afpec one-stga« Halts 3.*3
11 <5 *1.8 aq/1
Bealtkr, 18-35 ji old, nonsaokin-g.
Qttaa blacks aad caaeaatana.
Ckicafa, II. Blaldlr conttoUed
•xpcriveatal coaditlons*
HUTt; IICCBOLS; IILIIOIS; IDI1TS;
CBLOBIMItg JIBSOCJBBOIS; TO II TIL!
CIGIHC COStCJKDS; BE1ITH BIZHftS;
IIB11ITIOI; BtTtBOLISS; BB11BOLITZS:
KJTOUTIOI taosnsi UIBJI 11:15
UrBBKBCE
Krotosxiulci, B.K.
Brnaeaa, Q. B.
O'Seill, g.j.
1»79
Journal of Inalitical
loitcoloqr 3:225-23*
to
10
ro
1>Bat«a*
10»-»8-»
C«-»8
B* 5«. 12, IP -185.35 C, BP -6.3 C, »P 3*80 aa B« at 21 C
I 1ISS»
1
1
•613
Breath
tirosvtt tons
1 IBlimOL
I ireraoo
OC/HS
BUBBH
OF C1SES
8
81HSJ
Bot detectcd-510.0 og/hr
RE1I
78.8 ng/hr
GM1S11 HfOHlTIOI
Ccapond relates to iroraal
tetabolisi. Ho other detaili giTen
Cirogeaic sampling teckalgne.
I«altbT lilltair and clvillail
eiployeea, o.s. ilr Force school of
Mtospac* 9«dlciM, aqea 23-*7 ji. 3
stokers.
tllZMXS; CaiOBIBaTlD HTDBOCHEBOIS :
CElOBtH! OBGltTC COBTODIBS;
cEioioBHiiiiis: naoaiK cosiovins;
IS! KB: ILCOtOLS: THUS; AUDITS
KFIBZBCI
Coakle, J.F.
Caap, B.J.
Reich, B.E.
1975
archives of
EnTiroeaeotal Health
30 mt 290-295
-------
I07-00-S
C«-B6
If 5», HP -130 C, BP 8.J C. TP 100 M Hg it -«.* C
TISSBS
«1»
Breatt
8IPOSBSB Bom
tlltTTICJL
BET HOD
.
ec/ss
IHIBIR
or cisis
s
MIS:
lot detect«d-3.* ng/hr
1E1I
0.« ng/br
critiit nroiiuioi
coapomd froa ukaon orlgla. la
ctfctc to tails given
Crroq«iic KipllD? technique.
KalthT illttarT ail elrillai
•?ploTB«5, g.s. lie farce School of
leroapac* n«dici»», ag«s 23-47 jt. 3
tiokccs.
ItlZElIS; CBIOTI1»TZD 8TDBOC1SBOIS ;
CE10BHB OIG1HIC COHPOnOS;
C8IOBOBHIIJIS: nOOIIK COSPOB1DS;
EI1IIB: 11COEOLS; THIS; 1D01TS
SZ/E1EICB
Conkle, J.p.
Caapr B.J*
Belch, B.t.
1975
IrchiTes of
EBTicountal Besltk
30<2>s290-2W
1-lexuetbiol
111-31-1
B« 119.2*, HP -B1 C, B? 151 C
TISSBB
•«15
Breath
EIMSTJES MUTE
iiiimcii
nilflOD
ec-Bs
•BBBSt
or cisss
5« (387
ncpLes)
B1BGB
lot given
Kill |
1
2.2 ng/1
seoaetrie
1
email nroaauioB
B«aaaced at 25 C ami 760 >a Bg
15. a* occamace
Lc»«T and apper aa«-sigaa Halts 1.0
•id *.« *q/l
BcaltkT, IB- 35 it old, aonsaolcliKi,
gctaa blac\s tad cavcaaiaas.
Cblcaqo, 11. Blgldlr coatiolled
•ipcrlaeatal coadltloas.
tlBlTB; tlCCBOLS; ItUIOIS; ID01TS;
tFLCSIlHID ITDBOClBBOBS; TO11TH.I
CSSIIIC COBPCOTDS; BI11TK BaZttDS:
1IB1UTICI; UTIEOIISB; BII1EO1IMS:
IC?m.»TI01 IIPOSOSE; BBB1B IBI1S
similes
Kcotosilnskl, B.K.
Bcaneaa, G.a.
O'Beill, B.J.
1579
Joacaal ot knaljtical
Toilcologj 3:225-23*
N3
U)
10»-7«-7
«-S1l-0
BB 130.22. B! 18*-1(S C
1ISSUB
16 1«
Br«ath
KIPOSOK FOOT!
ivaimcu.
BBinOD
SC-BS
10BB55 |
OT CISIS
5» |387
aaapteO
BUCK
*ot Bq
17.6* occurr«nc«
Lo««r aad upper oae-slgaa Halts 1.3S
aid 11.9 iig/1
B«alt«T, 18-35 TC old, aonsaokinq.
ntlao blacks aid eaaeailaai.
Chicago, II. Ugldlr conttolled
iipaclxntal coadltloms.
EBfHB: ItCCBOlS; IlLIJOIS: JDItTS:
CBlOIinttD BTDBOCilBCUS: (OUTH!
cieinc coBTcmiis: BB*I.TH HIT»BDS;
IIB4I1TICI; KRItOlIS!!: aZIUOUTZS:
tOPOHTIOB BUOSOBB; 1BB1I IHaS
tmiEBci
rrotosznskl, B.K.
Brnneao, G.a.
O'»«lll, B.J.
1979
Journal of Inalrtlcal
Toilcologi 3:225-23*
-------
1-Peataaol, 2,2,a-trUflthTl-
1S3-O-*
C8-B18-0
II 130
TISSUE
»620
Breath
"
IIPOSOBS BOVTI
IHLTIICit
mama
GC-HS
IOSBEB
or CUES
5» (387
saaples)
XilSE
lot givea
ftKll
1.2 nj/1
Seoaetric
GEIHaL XnOSRaTIOl
ecasored at K c ana 760 •> Eg
»7.«1 occurrence
lover and offer one-Si gia liaitc 2.2
aid 7.9 »q/l
Bealtty, It- IS yr oil, Boaiaokiaq.
atlM blacks and eatcasiaas.
Chicago. 11. BiaLdlr ontrolled
ciptci natal coodltina.
E8IHI: 11CCBOLS; IlLIIOIS; IDH1IS;
CaiOIIltTZD BIOBOClBBOtS: TOUTILE
CISXIC CC9ECOIDS: ailllH mZHDS;
HBlUTIOl; BETIBOLIS9: HIT1EOLITES;
1 fcsonttoi inosoai; IEBH u»s
1 ;
EtnmcE
Krotoszjasklf B.K.
Brwean, 6.1.
O'Mill. a.J.
1979
Jotirnal ot analytical
Toilcologi 3:225-23*
1-P»ntene
109-67-1
C5-H10
»» 70.13, 8P r12» C, BP 30.1 C, TP «00 •• Hg at 12.S C
TISSUE
11621
Breath
tMOSWE SOME
antmcai.
BFTHOD
GC/HS
IOHBSB
OF C13SS
8
sues
lot detected-ISO. 0 ng/hr
an*
3».1 ag/hr
sEtraiz. i«rosaiTica i
Coapoud related to aonal !
MtaboUsi. (o other details
to
1-Propanol, 2,2-dttethyl-, acetate
926-»1-0
130.18
tissn«
««22
Breath
! IPOS US? BOOTI
JlULITIClL
maoo
ec-«»s
IDHBa
or cisis
54 (3B7
saiples)
BHSI
Vot glien
H21I |
t.» ng/a
•Jeoaetric
CtHEll HT01B1I1CJ
ecanrel at 25 C »nJ 7«0 mi sq
38.8V occurrence
Lcner aal apper one-Siqaa liiits 0.86
and *.l na/1
IKalthr, 18-25 rr old, nonsiokiiig.
irtaa blacks an 4 cancaslaiia.
Chlcaqo. Tl. BigidlT controllea
ezperiaeBtal coaditiofta.
IBI1TB; HCCBOIS; IllIIOIS; 10DLTS:
CElCBimTIO IHIEOClBBa»5; T011TIL5
cisinc coBPcnos: BIIITH HIUJDS;
UBitiTici; BZTaroLisa: BEIIKII.IIES;
fCFUtlTIOK IIPOSISE; IBBal IBEIS
KtttZtCt
Krotosrinsfci. 9.K.
Brtraeaa, a. a.
C'leill, B.J.
1979
Joaroal ol analytical
ToilcologT 3:225-234
-------
1,3-tropaBVdlol.
ST-S3-*
C9-SW-l2-Oa
«t 2t«.2S. at 10«-106 C
nssvt
•623
plant
ntromc ions
laoaatioi
iiumcu.
RSTBOD
ec
mrnSI
or cuss
i
iue>
12.S-7 ag/al
nil
lot applicable
CEIHII nrosiuici
1 aa< « lr aft*r SOD a« i> aolntioa.
Xaitial nlaa, 12 «-crclob*ta(cd>)p«BtalM«, 1,1a,2,2.3,3«,«,5.5.5a,Sb.«-4od«c«cWorct«kraro-
33*5-8S-S
C10-C112
SI ««!.«, IP (85 C, TP CIIO(I-C) u ng at SO C
1 iissnt i sxrosmt totrti i intmciL
1 1 | IRBOO
i i
1 i
•(» i ec
aAipom I
1
1
1
f 1
1 I
f I
I
1
1
1
1
1
1
t
1
1
1 1
»0»!SS IHGI 1 BK1I 1 CEIIUt IlfOIBlTIOl
or cisss i |
i i
1 |
M» •) lot 9i»« 1 a| 0.172 » or - 0.937 | •> !«•• 9-1* yt
b) lot ji»«» i pp» | tj >?» 15-M rr
c| lot jir«o | b) 0.2«3 * or - 0.039 I e) !«•* «5 Tt or >
4) lot «ira | ppa ) ') Ust Sottt caatral ceatts
I •) lot glim | e| 0.297 » or - 0.077 | •) Sotta Itlaatie cams
1 f) lot aim | ppa ( It Mat Sovtb Caatral cersos
I g) lot glna I d) 0.292 t or - o.oig | q| caacadaaa
h) lot gtT«n | ppa I b) loa-ca«cab •) T - IlpiJ axtractatla
1 ppa | lataclal a41«tad. Ml«ate4 iata
1 fl 0.252 » or - 0.03D | taaaft on alta« Spwlal Study, ri 7«.
1 »Pa | liaitations cf aaaplc Mlactlon
1 h) O.«06 » or - 0.102 | ntaotolaw r»atrict iitarpntatton
1 opa | cC cvaalts.
f 1) 0.322 * or - 0.085
1 PPa Simlcal patlut* aid eatarata in all
1 1) 0.2«9 • or - 0.023 eoaatlai >itt «ir«r as* aarloo 10 TCI
II II I PP» u, re. ai. n, «s, ic, sc, 71.
II II 1 S.I.
II t 1 1 OeoMtrlc ««i* lUBJtll; n.01191; GK3BSH; lonisiila:
1 ' II 1 HSSISSirPX; K>»TB C18O.III: SOOTH
1 1 1
1 1 1
1
1
t
1 »625
I tloot.
I »bol»
1
t
1
1 1
i SC-BC
l
1
I
») 3S
b) 12
1
1
i
i
I CICOtlll; THIS; UIKSt II5S02:
I IHSICTICIDBS; Eioicccrsouuoi: rooa
1 CCITMII1TIOI: PBSTICIDBS
1
1
a) lot 4et*ct*d
b) lot 4at«cted
a) lot d«t«ot«d
b) lot dctvcteil
-
a) toTa Caaal r«aiA«ata
r) Tolaateaxi
Halt of a«*tar«a«Bt, 0.22 to/v
Cloaalr aatci*3, iia«lt«a«oia control
taatlas oera aot prortieiJ for
• minis alcaq alta those ttoa tt« 36
lera cual ares rcsiiaats a»apl<4.
lactlif eeaaiaqfal control or
litcrttare data r«litin to ti»
sl?aiflcanca of ta« lo« raaldvaa
tctti la ta« field «aple» aialmd.
no 4efiiit* coaclaaloas caa ba oravii
froa tk« tssolts c«ported.
Kaidvats of lav Tork. Controls,
aifloToas of ta* SBTiroiMatal
Trotectloi IOABCT aid mltorsiti
stoieata, lorth Caroliaa.
Ill TOBK-. ICRfl C»OU»; B1009;
BHSOEMI1T IITBOOS! CBWBIII OJGIIIC
CCHOOnS: CBIOJOBIIIIISS;
iiiiciLoicBinns: poLTcatosinTro
IIIHItLS; TWVL1TIOI IIKPSUBE
S»EIE*CI
taiaiaqer. C.
•atta, D.
sptraeiDO, C.
Illliau, S.
i»sa
IPS 54«/!3-«O-02«, (08
pp.
rlatol, 0.1.
180
P1-600/1-80-OJ6, «0
P.
u>
N>
-------
1.3,«-Betheno-2H-CTClobuta(cd|pentalan-2-one,
H3-SO-0
C10-C110-0
II MO.68. TP OI10CB-71 •• 84 at 25 C
,1a.3,3a, «,5. 5,5«,5»,C-o:ec«cUorooctaaydro-
TISSUE
*626
Blood,
•kola
KXFOSmi BOOTI
ininicu
BKTHOD
9C
IOBBJS
OF CASES
tea
UI6I
») .009-11.1 ppn
b) .003-*. 1 ppl
e) .003-0.39 ppa
d) .003-0.45 ppn
•) .003-0.031 ppa
f) -OOS-O.OH ppn
g) .003-0.00* ppn
h) 0.005-0.0325 ppe
mi
») 2.53 ppn
b) 4.60 ppn
e) 0. 10 pp«
4) 0.06 ppi
e) 0.011 pp*
f) 0.008 pp»
9) 0.0035 ppi
h) 0.011 pp»
6KIIHL IIFOIR1TIOI
«) ST ill •i;loT of Lif« Scl«aca
Prodocts Co
b) »8 nuffacted aiploy***
c) 30 £«iilT MBimrs of aiployets
d) 30 employes of llllvd Che*ical
Ccrpor*tioB pnvioislT In Icpona
CIO duct ion
«) 23 aiplofMs of uearbT b*sin«ases
() t saraq* tnataent plant enployees
q) 2 cab OT truck drlnrs
k) «0 residents within 1.6 1» of Life
Science frodocts Co
Besldants of Hop«well, Ti
Significant difference In frequency
of irnptoaa In kepome vockecs aa
ccnpared to area residents: Bashf
•ervananess, teesor, Tlsnal
difficulties (p<0.001), plvuttic
tain and velqnt loss, (p
-------
1.*:;,8-DlsetkaBmapktb.aleae, 1,2.3.*,10.10-kaxacttoro-f.«>*a.5,*,*a-kex*kydro-. eaido.exo- (8 CI)
1.*:$.8-DiaetkMoaapktkalene. t,2.$.*.10,10-kexaCaloro-1,*.*a.S,8,ea-bexabriro-. (1alpaa,talpka.4abeta.5alpka,8alpaa.tab*ta)-
3C9-00-2
CI)
B» 3«5.tl, RP 10* C, TP «I10(E-«) an Bg «t 25 C
«ISSITB
IC28
iMlottc
fluid
*«29
Blood
«*3o
ni tt
i
«
I
I
•631
Placenta
»6S2
Placenta
EIPOSTOZ son
IftOestioa
aitiTTicai. i IVBBS> i tun
SEtHOD J or CtSSS I
1 1
1 I
9C-K ( 50 1 1-152 ppb
1 1
1 1
1 1
1 1
1 1
1 1
1 1
1 1
1 1
1 1
1 I
OC-IC 1 t) 25 I 4) lot 4et«ctable-23 ppb
I b) IS | C) 9-80 ppt
1 C) 10 |e) 18-70 ppb
1 1
1 1
1 1
I 1
1 1
1 1
1 1
1 1
1 1
1 1
( 1
1 1
1 1
oc 1 a) 21 | a) tot detected
I b) 2« f b) 0-0.0*0 pp«
1 c| «5 1 CI 0-0.0*0 ppa
I t) «5 I 1) lot given
1 1
1 1
1 1
t 1
1 1
1 1
1 1
1 1
1 1
( 1
1 1 1
1 1 1
1 OC-BC | 50 I 2-1587 ppb
1 1 1
C
1 1
I (
/ I
1 1
1 1
1 1
1 1
1 1
I |
1C- EC | a) 2S | a] lot detectable- 15 ppb
1 b) IS | k) lot Jot ectabl e-110 ppb
1 e| 10 | e) lot detectaUe-2* ppb
I |
1 1
1 1
1 1
1 1
1 1
1 1
1 1
1 t
1 1
Bill 1 GEIZIlt XimMIIO* 1 IWMEICE
1 1
1 . . _ 1
1 I
20.76 ppb 1 18 posit IT* speclnas 1 Sarena, I.e.
Geoaetcie 1 | Sett, T.P.
1 Pregnant reeea. similar in I Bahajaa, f.L.
1 sccioecoaoaic level aad dietar? | 1980
1 babits. 10 oceapatioaal or i Intinational Joanal
1 accidental exposare* lacknov, Xodia f of Znvironatttal
1 1 analytical clieilstrr
1 FIST 1C ID IS; CatOHItnO BTCSOC1BBOIS; | 7:2*5-751
1 CBICSIJ! OBSJHC COJIPOOIBS; EDI; 3DI; 1
1 IDT; IIDI1; EBESIUCI: IBIIOtlC 1
1 J1DID: PHCIIT1 1
1 1
i r
a) 11.1 * or - 7.3 I •) Co*trolit fall-ten pre;ia«cle< I Sanaa, I.e.
ppb I t) Pre-teri fr»Ua. I 1*81
1 1 Journal of analytical
1 !•«»: IBOBlioi: 1DOLTS; rnos; I ToxicologT 5:<-*
I noci: Piactni: COBPIBITHF i
I tmamois: cuotruTta i
| ItrBOCaSSCIS; CB10XII! OROHIC 1
I COCCOIDS; I1SECTICIDIS; PISIICIDES; 1
I rtsnciDi stsiooBS; popuiiiici i
I jitosoBS: piteiiicr «
1 1
1 1
a) lot detected I a) Siral icthers, fat basia 1 Pozo lota. t.
b) 0.00* pp> | r) grbaa setters, fat basil 1 Becrera Barteache. 1.
c) 0.003 ppa 1 e) 111 aetheia, fat basis I Polo rillac. L.B.
d) 0.0000* ppa | d) 111 aothets, saol« silt basis I loper-Cieenez, 8.
1 Oata for mi of all pesticides aid 1 Jodral Tillarejo, B.
1 ceiparisns sltb rallies of otker 1 Iglesias Perez, J.
1 lavestlgatore aiven \ 1979
1 1 Bevista Espanola d«
1 »n rains aothcrs free Cordoba region, t Pediatrla
1 3Fai> 1 J5(20S):»3-11«
1 1
1 sftj»: tmiTS: si«: CBLOBHI oieinc i
I coipooioj; ptsTicnts; IGBICOIIOBE; i
1 ID11L lltIS; DRBlf USaS I
1 1
1 1
158. 7 ppb 1 «« poiitiY* ipeciie«« 1 Saxena, B.C.
se«etrle I I Setk, T.B.
1 Ere«naat vonan, aiailar in I Bahalan, P. t.
1 locioecoionlc lerel and dietary 1 1*80
1 babits* lo cecapational oc I Tateraatienal Journal
1 accidestal «rposare. luctmo*. InSla 1 of Cnvicouaatal
1 1 analytical Chealstrr
1 CISTXCIDIS: CBLOBIlim BTDWCUBOIS; I 7:2*5-251
I CBIOBUE 0161IIC COBPOH1DS: toE; DDE: I
I ItT. IIDI1: PKB6IIKT; IBIIOIIC 1
1 line; pLjcim i
' 1
1 1
»1 » or - 3.96 ppb | a) control!, fall-tern pregnancies 1 Sanaa, B.C.
17.9 « or - 2«. 1 1 t) Pre-tern tregnanciajs 1 Siddiqai, B.lt.J.
>b I cj spontaneoas abortions at l*s* tbaa I Setk, T.D*
IS. 9 • oc - 7.6 |8 «k (incudes fetas) I Xrisbna Bnrti, C.I.
pb t 1 Bkargaia, a.K.
1 Bealthy, non-exponel, pre^iant aonen. I Rntty. D.
1 age* 18-32 yr, ladla. I 1981
1 1 Journal of analytical
1 lIDIa; aBOITIOl: 1DOLIS; moS: 1 Toxicology 5:6-9
1 nocoi pxtCEnt: coiPiunn I
1 fTllVaTIOIS; CBLOIHUZI 1
1 IHBOCUBOIS; CHIOEIK OXGI1IC \
I cciiomis: iiSECticnis; PESTICIDES-, \
\ tISTICIDt BlSraVBS: VOIBLatlOl 1
11 t 1 IMOSUMt fltetlKT (
1 1 1 __..... 1 1
OJ
M
oo
-------
1,«:S,8-Dinetbanonapktkal*M, 1,2,3,a,10. 10-nerackloro-«,7-«pOT7-1,»,»a.5,6.7,8,8a-octanT4ro-. «uoo,«xo- (SCI)
2.7:3.«-Din«thanoaa?hth(2.3-b)oxir«lie, 3,«,5,6.»,»-b.«iacliloro-1a,2,2a.3,«.«a,7,7a-octabTtro-, (1«alpha,2b«ta,2aalpha.3b«ta.Sb«ta.6aalpha,7bet»,7«alph«)- (9 CI)
60-57-1
I* 380.93. BP 176-177 C, TP 7.78X10(1-7) » 89 at 20 C
TISSUE
•633
Idlpose
*63*
adipose
•«J5
Iniotlc
fluid
rosns SOOTS
lULTTICaL
BET HOD
GC
SC-EC
RUBBER
or CISES
60
SO
UEGE
<0. 05- 1.16 ppa
1-3 ppb
Bill | GEIllaL IlfOSHlTIOB
|
1
1
J
1 Exposed persons in the United States,
1 the «ether lands, Sweden, Israel,
1 Japan, OSSB, Poland, Geruany, India,
1 Evlaarin, Pakistan, Austria.
1
1 Beported cases of hypertension.
1 elevated serin ckolesterol. abnornal
1 lies, or iipairnent of neareauscular
1 function after acute exposure to
1 conbinations of pesticides, bat nost
1 datn show no aSnrs* effects after
1 Icnq-tern occupational exposure.
| IDSTBIa? BOXGlBIl: GBRRaEY: X1DI1;
| mm: JlPtl: IETB1JLMDS; PaKISTW;
I ICLMD: 1DSSI1: SVE9EI; BIITED
I SHIES: tDIPCSE IISSOE; B1OOD: BLOOD
| tUSHa; BIOCO SEME; EITTBEOCTT1S-.
| ItmoCTTES; BI1K; DBIBE; K1TIEB;
I BIILTH HIClBtS; OCCOPlTIOlll R1X1BDS;
I topniTio* EXPOSORE : IEOPIISRS:
1 CISnCIDIS; CEXOBIIE OBGallC
1 ccRponas
1
t
0.26 ppu I Peripheral kidney fat, routine
1 cntholoaical exaninations
1
1 Iges 6 no-92 yr. Belgian
1
I t»sim: iDTopsiES: IDIPOSS nssas:
1 EIOlCCqilUlITIOI; PESTICIDES; DDD:
1 ICE; DOT; DIILDKII: BBPTICHLOB
1 ItOSIDE; RSXaCnOBOEEEtSlE: URDUS;
1 CrtCIIRS OR61RIC CORP001DS
1
1
2.«2 ppb | 2 cositi*e specinens
Seonetric I
1 Vreqaant voaea, sinilar in
1 tccioecononie leiel and dietary
1 tab its. 10 occupational or
1 accidental exposure. Locknoi, India
I
1 EISTICIDtS; CHLOtnUTID BTDBOC1SBOIS;
1 CCIOSIIS OSGI1TC CORP01KDS; EDO; DDE;
1 CCT; n»It: PtESRllCt; 1B«IO«C
1 IIOID; PlaCtrta
lEfEHERCE
Deichnann, f.B.
RacDoaald, I.E.
1977
Ecotoxlooloay anfl
EnTironnental Safety
1:69-110
De^onckheere, V.
Steurbaat. I.
Tecstraeten, E.
Kips, B.I.
1978
Toxieological European
Besearch 2 (2): 93-98
saxena, H.C.
Seth, T.D.
nahajan, i.L.
1980
International Journal
of EuTlronnental
Inalytlcal Chenistry
7:2«S-2S1
LO
ho
(HIT
-------
1.«:S,«-VlMtkUMtpktk*l«M, t.2,J,«, 10,«»-a««clil 3,»,5.6,9.^-fc«l.ckloio- ta,2.2»,3,8,6«,1,7.-oet«kTteo-. ll««lpi«,Jt>«t«.3«alp»»,
«0-!T-1
C12-1I-C1S-O
«t MO, tj. IF 17«-177 C, T* 7.7*««(M> u Of at 39 C
a, H>«t.,6..1pli«, 7b»t«,7«.lpi4) -
CI|
1
l_
IISSBI
«3«
Blood
f
««J7
Slwid,
cell*
1
f
t
»tos«xs to
l»tRXClI,
••MOO
»
IWBSI
or cuss
MKX
i RUI
t
EEftut matnnat
Kile*
trroae4 (wcicta ia tie 9aite4 States
tke letaerlago*. Snjaa, Iiraal,
Jipio, 7SSB. Polaad, saraajf. Itdia,
6«fact«< caa«4 of aYP*ct«aaiGa«
1 elevated eecaa caoleaterol* abadnal
I ties, or lipairaeat of (eareaaaealar
1 faactioa aftec acute aiposuta tp
1 caabtnatioaa af peatlei&ea, tat aost
1 iata aao* ao adverse effect* after
1 lc»«;-tecai occ«p«Uo»al exranre.
I lusTBii; BDtsisii: extdiiT: HOTI;
I ICIUB: SDSEIl; SIlBtl; MltllD
I mns: witcst nsstrsj steccs ttooc
I Hijtocrrss; HIE: aiint: ss7iia:
1 E111I3 HH1EIS; DCCUTiTHUU SUlttDS:
I FCPOHTIO» IlfOSffBE: HOPtJSBJ;
| ftS^ICI»!S; CBIO«»! OtCllTC
( Kt fOaltS: lIOTllSiS; PISI1CIJBS;
I cncem OIGUIC COIPOHBDS
i
1 *«!av
1
1 tipo»4 p«t»ots la tM anitad states.
1 taa Ketherlaada* Svedea* Cacael*
1 Japan. OSS», Poland, Secaanr, India.
Eolijarla, Piklstao. Hatrla.
B.port.i oaes «f ariwcteB.ic*.
!!5s. or iapatraeat of aeireanacajar
(aaetlag alter aeota etooiua ta
ccabittatitfa* of peaticid«av bat a0at
Jata ako» vt aAvetse effect* aftec
leaf-ten occopatioaal «ipo*ura.
icsTBii; aoiemi: GEBUIT; nmi;
ICI.1I!>: S5SJ11; SWHEt; UStllD
miss-, isiecse IISSUB; sj.coc: noofi
ttisnt; iiocc siftw: EiiriEocrns:
itmcocnss: IIIK; «*»i; atrz»:
BIllTJ BIZJBCS: OCCOF11IOUI IIIIKOS:
tcenmoi nnson; nonues:
IISTICI3IS; CBLOBIII OIE1IIC
CCSPOO«3
tzntnci
twlckaaaii, I.B.
KacsoftaUi ?•£•
1977
Ecototlcolo^T aal
rarlruaeatal Safety
1tS9**t 10
Deichaano, I.B.
McBoaall, >.t.
1977
3c0tdxlcol&9y aa&
eorlraMantaJ Safety
1:89-1*0
U)
OJ
o
-------
1.atS,«-OlMta.aBOU.pBtsalam«, 1,2,3.4,19, W-JiMacHoTO-«,7-«po»-jr1»*.»a.S,«,7,0,8»-octa«f«ro-, ««do,ezo- ft cl)
2.7:a,$-DiMta.aaaaapata(2,3-b|oxlxeM. 3,aT5,6,9,*-besacU.9ro-U,2,2a,3,6.6a,7,7a-octahrara-.
it ii i GEituL tnoiuTia* i (znmcs
1 1
1 1
I IfTiav I Deiciaann, ».B.
1 1 a»cDon»U, H.t.
I Eipos«a persons la tin OniteS states, ) 19T7
1 tl« I*tk«rl»4a, 5r«l«B, leraal, 1 Icotolieolojy and
t I>p*>( OSSB, Falmsi, (S«rnBT> I»ilia. t CnTlcaueital 5af«ty
1 toiler U, T«U«t>«, lartria. I 1:69-110
4 1
I E«port«d cu«a of kypcrteaaion, 1
I 4l«vat«d •«€«• cbol«kt4coj.c ab*4r*ftl t
1 lisa, or liptlrxit of n«oro»aacnl»r I
I (giction aft«c «cnt« •ipo«nre to 1
1 coitiutloia at p«stlcia«9, bat lost 1
1 iitt Stan 10 alT«rs* affects after 1
1 lem-t«n occupational «rposire, f
1 1
I losTRii: BULcuit; eraiui: ni>i>: I
i i si in.: Jm»; innmins; luistti; t
1 101 110 ; 1USSII! SnOH; QllttO \
t STUBS! ID t POS1 TISSOS: BT.OOB-. BLOOD I
1 FUSBl: nOOC StElI; SBTTBBOcnBS; I
1 itnocTiis; mit: mm: tmn; t
1 HUTU R11MBS; OCCOPJTIOIU RlZUItS: 1
I ECPtnitioi uposne i
i i
1 1
O 0.2 ppb « al Rural tiacla I rtoklm* J.
bl 9.2 ppb t t) Qtbaa ll»clts 1 Prtoater. l.i,
c) 0.3 ppb j c) Dcbn c**ca«lau 1 Cceason, J,f.
d) 0.* ppb t i) Kuial ca«eaalanm 1 Ra«Mt, T.
| 1 Kim«*. T.
1 ortam an! total r*ald«ats of sc, 1 laucc, D.t.
1 iifaats, chlKna, .Salts, «M«tlT. t 1972
1 1 li«rica> Journal of
1 SOOTB CKOlIll: AJOITS; CBIIDfiSI: 1 Public Health
1 I1CUI STV91ES: BIOOO PltEBl; 4 6201 = 615-451
1 CCimilTITZ ITllUTIOIS; DOI; PDE; 1
I cti: niBuilii PISTICICJS: i
1 KncHto»rmjo BI?H«IT.S: HI \
\ tCHBTtO»: TOOD COIIUIimoi; 1
1 tisiictot BisiDOES: nmiTion i
I tirosn*: (ITUL UEIS-. tie it istis t
«.) 0.031 p?i 1 *l »nt«l «»tb*r«, rat baelr 1 Foza Lota, R.
b) 0.010 ppa | t) Dtbaa aothats, tat ba«i« 1 Bercara lartaicha. 1.
O 0.020 ppa | c) 111 a«tb«t>, fat basis I Polo Tillar, I.I.
i) 0.0005 ppa 1 SI til aotb«r», (kola silt basis 1 Lopai-Sl»an«i, B.
1 tata lor na of all BMticiBtn aid I Jodcal Tlllar«jo, a.
I ccaparivoaa vltb »»l»s of otter I T<)l«$ias Petal, J.
1 iarcstl^atocs qiraa I 1)79
1 1 (arista Xapanola a«
I lacciaq aotb«ts fcoa CocJoba realm, t Milattia
1 S^aln 1 3S(2l>6l:*J*1tO
1 t
1 stm; utritsj friu: CHLOEIIZ OBSIITC i
l coepcons; ptsncijis; ISBICTLTTIEJ: i
1 tOBIL U!1S; OBB1» UB15 I
1 1
1 1
UI.2 * oc - a.3«.z | coapated on tat a41asteA basis t savaa*, I. P.
ppb | Fauna of a«au for all gaogiaphlc 1 X«efe, 1, i.
I c«qlais I tcsaaci, 3.0.
1 1 laealar, B.«.
1 Kcaln? aotfurs, IT. S.I. 1 Ipplebaaji, ».«.
I 1 Coos, I.*.
1 UIITID STiirs; IOOITS: ans: i rort, 5.1.
1 CCBP»1»IIH ITILVIIIOIS; CBLOBIC | 1941
1 cremc CD8IOOIDS; DISLDBII; | laerlcaa Joarnal of
1 ItSIICIDK; laCTmol I Epl4««lolo«r
1 1 1 W3 1«| i »U-»2J
t 1 1
Oin PIS!)
-------
t.»:5,8-Di»etliaaoaap«t»alene. 1,2.3,4, 10>10-kexacU.aro-6,7-epoxr-1,B,Ba,S,«>7f8,am-octaavdra-, eodo,exo- fl CI>
2.7:3.6-!)lMthanaaapktb.(2.3-b10xixeBe, 3,*,5,6,9. 9-hexaCBlora-1a.2,2a.3,C.ea,7,7a-ectaavara-. (1nalpBa,2beta.2allpha.3beta.Sfceta,6aalpha,7beta.7aalpna)- (9 CIJ
C12-B9-C16-0
!1 380.93, IIP 17«-177 C. TV 7.7W10B-7} •• Bg at 20 C
(COITC(VED)
• Tisstn
4642
•ilk, tat
4643 |
Placenta I
1
t
IZPOSBIS BOOT!
aflLTTIClL
RETBUU
OC-BC
'
1
f
SC-EC
nnsa
or cisss
50
SHOE
a) lot given
b) lot given
c) tot given
d) Hot gives
e) lot given
1-6 ppb
nil i ecimi. XBFOBRtnoi
I
i
a) 0.086 * or - 0.063 I a) 1972, 40 saaples
ppa | b) 1973. 38 saaples
b) 0.99S * or - 0.072 1 c) 1971, 19 sanplas
ppa I d) 1975, 20 saaples
e) O.OSO * or - 0.040 I •) 197C, 19 saaples
ppa I f) 1977, 20 aaaplea
t) 0.062 * or - 0.021 1
PPB I 100-141 lactatlng VOKE, 2 aonths
e) 0.052 * or - 0.025 1 after delivery- Besidents of Osaka
ppn 1 Erefectare, Japan, Taxied diets and
1 ctTironnantal coclitions.
t
t EISTICIOES; DHIDSII: CBG1IIC
1 CBICBIW! COBPODiaS; Ja»l; UOIIS;
1 tlCTlTIOI: BIIK; BtOlCCDBIIUIOl;
1 EOITCHLOBIB1TED EIPBEITLS
1
3.93 ppb I 2 positive speciBeas
seosetric F
1 (xegaaBt «OB«B, linllat in
t aocioecoaoaie level and dietary
1 habits. Bo occapatioaal or
1 tcciflental eiposare. Lacknon, InJia
1
1 PIStlCIDZS: CBLOCIIinO E1DBOCIRBOJS;
I CEIOBIXB oseinc coapovras; HDD; DDE;
1 DDI; IIBIl: PSICUJCI; 1BBIOIIC
1 IIOID: PllCIITa
i
SEFEUBCE
Takashlji, T.
ratanabe, I.
Tosnida, S.
KnnitaJ «.
19T9
International archives
of Occupational and
Xnviioaaeatal Health
03:1-15
Saxena, B.C.
Sett. T.D.
Baha-laa, P.I.
1980
International Journal
of inviromental
Analytical cheaistry
7s24S-251
I
u>
NJ
2-B«t«BOl, 3-mottrl-
S98-75-*
C?-H12-0
If 8S.1S. 128 C
1 TISSUE
«CM
Breata
I
1
1
1
1
EIPOSORS iom
1
1
1
r
i
i
1H1TTIC11
HRB09
GC-BS
g»BR
or cists
54 (387
staples)
1 BUGS
lot given
9EU
0.378 ng/1
Seoietric
GIIIM1 IVFORBITIOI
Beaaoxed at 2S C and 760 mm Eg
15. 5f occurrence
Io>«c and upper one-Siqna Units
0.123 and t.16 ag/1
Bialtbv, 11-35 TX old, noBSBoklnq,
nrtan blacks and cancasians.
CaieBgo, II. Pioidly controlled
ciperiaeatal coadltioas.
f«UT8: iicoiots; HI.IJOIS: IDOITS;
CP.LCBIUTZD BTDBOCtlBOIS; TOUTILE
CteillC COIFCUIBS; 8I11TB BIHSCS:
I'RIUTIOli SSTAEOLISI; BETaBOIITISi
tcfouTioii riposai:; IBB lit JEHS
misstcs
Kcotoszynski, 3. 1C.
Brnnean, 6. If.
C'Keill, H.J.
1979
Jonrnal of analytical
Toxicology 3:225-231
-------
2-Jataaone
78-»3-3
C4-B8-O
If 160.27. BP 74.57 C. TO 71.2 H Iq «t 20 C
tlSsOS
•««s
Breatk
4646
Breath
EIPOSOBS BOOTS
1IUTTICIL
nrrHOD
8C/BS
SC-BS
•naiss
or cisis
8
54 (387
sasples)
Mies
lot det«ct«d-60.0 agykr
•
lot 9ir«n
nil
1«.« ag/kr
3.6 ag/1
Geosetric
6ZBZUL iiroBHTioi
ccaiomd related to norul
ictabollaa. lo other detalla gives
Cryoqeaic saapliig teekaiqiM.
Dcaltkr a Hilary and clTlliao
«iFlOT««s. U.S. Hi Forc« School of
Mz«spac« a«Jlciii«. aqes 23-»7 yr. 3
stokers.
imnis: CBICIIIKBI BIDBOCIBBOIS;
cnoilK oseuic coatonns:
CHioBOBiiiiwis: nnoiiis COHJOOMS;
IIHTB: HCOBOLS; THIS; 1 DOITS
Iiasnrei at 25 C ud 760 •• Si
53.2* occvrrcmce
Icier aad spper one-siqaa Halts 1.48
and (.8 aq/1
KcaltkY. 18-35 jt old, aoaiaokinq.
actaa blacks aad caacaaiaaa.
Cblcaqo. 11. XiqidlT coBtiollcd
eipcriMatal conditloaa.
»(UB: IICCBOIS! ILIIIOIS; 19QITS;
CEICBIBKZB FIDSOC1BBOIS; T011THE
ctsanc coBtooios; aztua BIUBDS:
HBaUTiev: aniBouss; BIHBOIITES;
tcfoiKioB inosm: IBBIB utis
SETCBIBCI
conkle, J.P.
Caip, B.J.
Selch, B.E.
197S
arckiTas of
Znviroaaaatal Health
30 (2) : 290-295
KiotosTTH«kif B.K.
Brvneaa* 6. 8.
O'Helll, B.J.
1979
Journal o£ inaljtlcal
Toiicoloql 3: 225-234
U)
2-Bataaoae. 3,3-diaetkyl-
75-»7-8
C6-B12-0
•I 100.16, » -«».8 C, BP 106 C at 760 aa 18-35 TC old, sonaaoklng.
otliB blacks aad caocasiana.
Chiciqo, TL. Blgldlr controlled
eipcrlseatal coadltloas.
HIITI; 11COBOLS; IUIIOIS; JDTJITS;
CllOBTIaTtl ETOBOCHBOIS: fOltTILB
CS«»TC COIFCOIDS; BB1LTB BaZUDS;
iiamTic": lETteoLisH: sziiBotms:
EOfOUTIOf IXPOSQIE; H1B1B UBtS
BtrEBIBCE |
1
1
Ktotoszyaski., B.K.
Braaean, G.H.
O'Helll, H.J.
1979
Journal of analytical
Toxicology 3:225-234
-------
IH-
&!«-«»-«
c»-ie
Bf W.12, I? -105.55 C, BP O.S8 C. Tf 1M2 u
«t 21 C
tlSSIf.
««(t
Breath
EltOSTOJ BOOJE
HlIttlClL
BITHOB
ec/ss
IDWS8
or CASES
t
111SE
lot d*teeted-»0.0 »9/«r
Bill
10. S toyhr
GIBtlal imrOtBtTIOI
Ccifonid relate.1 to mraal
•etaooli*!. lo other ieti.ll: aitn
Crjoaeaic saaplXaa technique.
Realthr lllitary «ed eiTlllaa
eiploreea, tt.S. Ur force School at
lermptc* Betticiae, a«es 21-47 jr. 3
»ok«r*.
ItltntS; CBIOUHTED mtOCUlCIS;
cfltosiiB cieinc cospomiDS:
tiKJtosEtztwzs: riaotiix costoatass
mattes
Coakle, 3.1.
Caep, B.J.
Velch. B.E.
W75
Ireaivea of
foTironBCBtal Health
38 (2J *2*0-295
•
2-Bit«ae. til-
5»0-1»-1
C«-B»
II SC.12, IIP -1M.I1 C, EP 3.7 C, TP 1»10 u Bq at 21 C
Tissue
*«*•
Br«ati
1
ItNSVH BOITB
1 IIUTTICU
mtoa
ocyss
•tJBBIB
OT C»S!S
a
t»ei
lot d»tect«d-23.0 «4/hr
Bill
4.8 09/hr
GUtBll IHOSI1TIOI
Cciroiid telat*! to Mtul
Mttholtsi. lo other details given
crroouic nmtl±ag teekaioie.
leiltaT •ilitarr and oliilian
eeplojees, U.S. lit force School of
lerospace iredicia«. «3« Z3->7 rr. 3
stokers*
llltniS; CBICEI»«EB BTDSOCtBSOilS:
cEioBtiB otetnc conotmst
ciiotoiiizivES: renoaiR ccnro0»!>s:
t1Z»l; tlCCfiOU; THIS; UDITS
tmsttct
Comtle, J.I.
Ca«p, B.J.
leleh. B.I.
197S
>CCbiT«> Of
Inriioaratal Health
30 (2)! IJO-295
OJ
u>
2-Etarl-l-P«>t«eoI
C7-BM-0
Bl 114.23, BP 16»-16t C
postings IB CBWUTIE).
( TIS5V1
1
1
1
1 treat h
1
I BirOSDJ! IOOTI
1
1
' "SCToJ"
i
1
ac-iis
IOBI3B
or cisis
S» f387
niples)
1I1GE
lot ?iT«*
'EH GBIIBI1 IlrOIHTIOB
0. 27i 09/1 Btained at 25 C and 760 la Bif
eeoaetric | 3<.9t occurrence
1 lover ud epper ooe-slga. Halts
1 0.14* tad 9.729 09/1
1
1 lealthT. 18-35 ?r old, nomaoXtnq,
1 vrtan blacka and cavcaaiaia.
t Cbicaga. TI. Blgldlr coitrolled
1 tip«riieat*l cotlltloti.
1 tlllTT; UCQCOIS: IlLIHOlSi IOOLTS:
1 CflCBISHEB BTDSOC1BE01S; VO11TI1E
( CECaflC COBPCCUDS: BU1TB BltlRCS;
1 IWUlTIOIt BCTaBOLISS: BBIlSOlITSSj
I »CPOI»TIO« BlfOSOlB; IJB3H 1BEAS
1
EEfEBEIC!
KrotosTTBali. 9.1.
Bmneaa, G.R.
C'leill, B.J.
1979
Jourul of loalrtical
ToilCOloqT 1:225-23*
-------
2-MraiM
!»2-»3-s
I* 8».16. IP t«1.3S C. BP 68.5 C
TISSB!
»651
Breath
tXfOSOBZ BOOK
luinicai
1ET8CO
OC/HS
•mass
or cists
8
MKZ
lot detected- 17.0 ug/kc
«a»
«.0 ag/hr
GBIIUL xiroMitiov
ccafoatd ranted to aona.1
MUbellM. lo other detail* giwa
Cryogenic ailpllao: tackliqo*.
B«ltkf illltiCT u4 cifillaB
(•plains, o.s. itr Torco school of
ictaaiwec H«4icU«, «qes 23-»7 yt- 3
stokers.
tllZHES; CBtOEIIlTJII HTDXOCUBOMS:
CBIOMIB OI61IIC C08PODIBS;
cmcionitziis; rtnoBUE COBPOIIDS:
II1HI; ItCCBOtS; TSIU: UDITS
-
taisact
Conlcle, J.P.
Ca«p, B.J.
Belck, B.t.
1975
IrchiT** of
IiTicoBMital Health
30 |2) : 290-295
2-Octaool
C8-B1S-0
BI 139.2, "P -31.6 C, BP 178.5 C, TP 1 •• Kg at 32.8 C
I 5ISS1!
1
«C52
Breath
•«53
Breath
IlfOSOM BOWS
inimciL
"r™o»
«/BS
SC-BS
BWBHI
or CISES
8
S» (387
staples)
B1«GJ
lot detected-98.t uq/tr
lot given
mi
12.3 ug/hc
O.M ng/1
Geoeetric
etnui nreiunoi
Ccifoigi related to Docaal
netabolise. lo other details given
Cryogenic stapling technique.
Maltiy ailltary aad ciTllian
eaployeea, B.s. »lr force School of
lerospaee Bedlcine, ages 23-47 yr. 3
IIHEISS; CBlOBlniTBD HTPBOCiBBOBS:
CELOBIHB OBfiUlC C01POUBPS;
cnoBoanzztu; rLiOBiis COBTOVIDS;
HIITB: 11CCBOLS; THIS; 1DD1TS
(ensured at 25 C and 760 an Bg
31. 31 occnmice
toner and of per one-siaaa liaita 0.26
and 3.1 Bq/1
lealthy, 18-35 yc old. noaasokieg.
nrfcan blaclcs and caticasiana*
Chicago. II. Blqilly cant tolled
eiptrieestal conditions.
IB.EITB: I1CCBOIS: IUI10IS; IDdttS;
CBLOSIHTIE BTDBOC1B30BS; TOUTILE
CIJIWIC COBtCOIDS; BltlTB B1Z1BD5;
11BIUTICI: BETltOLtSS; aETlSOLITBS:
fCPOLiTiot ZIPOSUBB: DBBIB iitis
tmntct
Coakle. J.P.
Caap, B.J.
telch. B.».
1975
Itchlves of
ZnTlronneatal Health
30 (2): 290-295
Ironean, G.M.
O'Helll, B.J.
1979
journal of analytical
Toxicology 3:225-23*
-------
2-Peattaoae, a-mtkyl
108-10-1
C6-B12-0
B« 100.2. HP -S».T C. IP 116.85 C. TP 16 ee
1ISSVB
•S5»
Breath
txtosms torn*
iBunxcii
BETSOB
ec/HS
BIB an
OF CaSES
a
BlBGB
Bot detected-2*. 0 ag/g
IE1B 1 email. IBPOBB1TIOB
1
I
1
».2 ag/hr i ceapaaad related to aoiaal
1 tetabolisa. (o other detail* ?iiea
j Cryogeaic aaapliag techaigae.
I
1 Bealtk) ailitary aad cUiliai
I eaployees, U.S. air Force school of
I lereapace BediciBe. ages 23-«T jr. 3
t fiokecs.
1
| tlBtini; CBIOBIIHEB BIOBOCUBOBS:
( cno*in orsiBic coitoans;
| CBtOBOtEBZIBfS: flOOBIBE CORPOITBOS:
t tBIlTI: 11COBOLS: TZI15: ID01TS
SEFEBnCZ
conkle, J.P.
cup, t.a.
ire lea. 9.E.
1975
ircni»« of
ZBTinvaeatal Health
30(2|t290-295
2
-------
2,2-Oia«thrlactaBol (to
2310-14-1
C10-I22-0
11 158.29
t> caiman .
nssn
*«S7
>t*atk
moson toon
alaimcu
RETBOD
ec-as
ioun
or casts
5* (3*7
staples)
1MG1
lot 9l**B
asu
0.317 ng/1
MOM trie
cuttii iiroiunoi
laatsni at 25 C aad 76« la Sg
31.0* oceariaac*
IOB«T aad appar oaa-Slou lislta
0.109 aad 0.915 *oyl
ttaltBT. 18-35 TT old. BOBaaokiaa;.
ittai Macks aad caacasiaas.
Cklcaga. II. Flqldlr coatcoll«d
«xp«rla«atal oaadltioaa.
mm; >icoioisj HUMUS; IDIHS:
CU.CIIIIT1D BTDBOCIIBOIS; TOIITH.!
CIBHIC COBPCT1D3! BBILTH BillBtS:
IlBiUtlO*: BMISOHS!; HgT>9OlITlS;
ICVOUTIOI IINSOH: OBB»» ISEIS
-
Krotasxiaakl, B.X.
Bnneaa. a. I.
C'Mill, B.J.
Journal o{ taalftlcal
Tozleoloaf 3:225-23*
I.2,3,3-letr»»»tiTlh«i»ii« (lo postings IB CBCTUI1].
13«7S-81-5
CW-K2
81 1*2.32. B> 1«0.3 C
TISSUE
Bnatk
EIPOSOBI POOTI
llllTTICIL
RETROD
GC-KS
tnasis
or osxs
5* (387
aaaplcs)
MI6>
lot giT«n
Btil |
1.3 aq/1
GeoMtrie
GBIIHL IITOMITIOI
e«a»t«4 at 25 c aid 7CO at Bq
lenc au4 appac oac-Si^aa Halts 0.35
aad *. 8 «q/l
KilttT, 18-35 TT old. BoaaaokiBq.
aztaa blacks aad ca>ca*iaaa.
Cklcaqo. 11. BiqidlT coatzoll*!
BBHTB: aicciois; nmois; IDOIIS:
CIlOBTlaTn BIDSOCltBOIS; TOUTIlg
Cf3i«ic coiicnns: SIII.TB BIIMBS;
HIlttTKl; F.3T1BOIIS9; BETaBOlCTIS;
EOPDUTIOH tIPOSOIX; T>SB11 UEaS
nFZlNCI
KiatoaxiasU. B.I.
o'i«ill! aljl
1979
Joataal of aaalrtical
•torloolo^i 3:225-23*
U)
--J
2,3,3-TriaBthTla«xaa« (lo postiags in CBZflLIfEl.
C9-B2-O
t» 12«.2!. It 137.7 C. TP 10.1 aa H«j at 25 c
1ISSOE
MW
Sratk
EIPOS9BE BOOT!
nurricn
BETHO9
6C-SS
lOMSt
or cisxs
5* (387
saaplas)
nisi
lot giT«a
Sill
0.730 ng/1
Seoaetcic
6IIIBU IiroiHHIOl
e«aaar«4 at 25 c aad 760 aa tq
18.*' occarr»e«
£c«*c aad upper ona-Sloaa Halts
C.U7 aad 3.62 aa/1
Kalthr. 18-35 yr old, nonswikiaqj
aitaB blacks and caacasiaas.
Ckicaqo. Tl. ItqldlT cant colled
ciB«rlB*Btal eoaditioas.
BiiiiB: iiccBois; miiois: inoits:
cncnitTZD ETDROCltBOlSj tOUtllB
CE61ITC COBtCtTIOS: BEIHB BIHSOS;
IIB1UT1CI; alTlEOLISS; BElaBOtltZS;
BZ7EIEHCE
KOtOBllUBki. B.K.
Bcnaaa, S.I.
O'letll. B.J.
1979
Joaraal of aaalrtical
Toiicoloqr 3:225-23*
-------
2.3.3.*-T«traaetarlpeitaae {*> postiaas la erasure).
167*7—38—9
C«-B2-O
(1 128.25. BP -102.123 C, IV 1*1.551 C
fisstrs
»6SO
Breath
Eiposvss aooit
IHttTICII.
BBJBCD
ec-B5
BOBBSB
or cjsu
5» (387
•aa pics)
MK>
lOt ?ina
1
III!
0.39* «9/l
Geoaetric
ezizsiL nroBUtioi
E*a«nr*4 »t 25 C aa« 7«0 « Bg
10.»* ocetrreac*
Imer and opper oae-Sl«aa liaits
0.113 ana 1.41 ao/1
Kattlif, l»-35 rr «1*. oou«o)ti»9.
acfc*i blacks aad caicasianfl.
Ckicago, II. SlgiSlT controlled
ar«a at 25 C *n4 7*0 aa H<)
«. It occarreaca
lowr and upper one-sigaa Halts
0.020 sad 0.712 aiHiTic>: RRIBOUSB; BIKEOITTISJ
tCPtn»TIO» -IPOSBBE; DBB1B UtlS
1
BlfMMCI
Krotosx^aakij B.K.
Bruneao, e.g.
O'Veill. S.J.
197t
Journal of analytical
loJicolegy 3:225-23*
1
1
U)
U)
CO
3-Heptanow, 5-aetarl-
5*1-85-5
CS-B16-0
F> 128.22, BP 160.5 C, TP 2.0 •• Bg at 25 C
1ISSOB
•«62
Breata
nvosm! BOOTS
mi men
BETIOD
OC-BS
ITB9BIS
OF CUES
5* (387
Maples)
I»E>
Bot firen
BB1B
0. SOS BO/1
seoaetric
GTiiEiL ziroaaiTiov
-
leaaared at 25 C and ISO aa Hq
5.27 occvzrence
lo»«r aad upper one-Slqaa liaits
0.200 aal 1.27 IKJ/1
Bt«lthT, 19-35 yt o!4, aoasaoklav.
ittan blacks and caacasitns.
Chlcaqo, II. sioUlr COB trolled
eiperiaeatal coaditlona.
mm; ucctois; ituiois; IDOITS:
CEICBIWIT'D BTDBOC1BBOIS: 10HTHS
ClGllIC COttCOtDS: BEtLTl BitlBtS:
UBIHTIOH; (mkEOLISB; BIT1EOLITSS:
icponnoif EiposaBi:
-------
3-Bexanona. 2,«-diaethTl-
i86»i-7o-e
CS-H1S-0
RI 128.21. !F 1(5 C
TlSSm
•663
Breath
ZKtOSdBZ E001I
ilaLTTICal
aiTBOD
SC-HS
IOBBIS
or cisss
5« J3B7
staples)
BaISS
lot giTen
BUI
_
0.311 ng/1
seonetric
61)1111 IirOBBlTIOJ
Eeasnred at 25 c and 760 ia He
25. 3% occurrence
l««er and npper one-Siqaa liiits
0.134 and 0.«9» noyl
BaaltkT. 18-35 -r ol4, nonsaokinq.
art an blacks in a Caucasians.
Chlcaqo, II. ElqWlT cOBtlollad
«pcrii«>tal coadltioaa.
EiUTH; 1ICOCO1S; IU.HOIS: ICO ITS;
cnoBintiD noiocasmis; SOUTHS
C»OJ»IC COBPCOSDS: 9SJITB H12»SES;
IIIaLHIOl; inaEOllSH; BITJBOIITSS ;
tCrOLtTIOl IIP030IB: 3BBi» 12B1S
Bimnci
Irotosijuslti, B.K.
Braneaa, C*8.
C'Mill. I.J.
1979
Journal of analytical
Toxicoloql 31 225-23*
52B-97-2
C€-B12-0
H« 100.16. BP 1SS-15T C
TISSUE
•66 1
Snath
MPOSUJ! M)BT»
tSILTTICll |
BBTBOt |
1
SC-IIS
iBBBta i
or cisss t
S« {387
saaples)
1
BUGS |
1
lot given
Bill
1.1 »g/l
Geometric
SIIEBaL moiliTIOII |
1
1
t«as*r>a at 25 C a»d 7*0 ai Bg
Ifi. 3T occurrence
loner a»a offer oie-Sigaa liiits 0.28
aid 4.3 no/1
Bcaltay. 18-35 Tr old. noosaokinq.
oTtu blacks ana caocaalaoa.
Ckicaao. It. Biqidlr contcolled
€ipccia«iital conditions.
ESt«TH; alCCBOlS; IUIIOI5; tDOITS:
CBIOBIU1ID BTBBOC1BBOBS; »011TI1B
CBCtlltC COBPCOSB5: BEaLTH B1I13CS:
1IH1HTI01; IWTIBOLISB; KSTIBOLITES;
EC?aHIIQ« IITCSOIE; OBBH IBEIS
5ETI8EBCE
Krotosmskt, B.K.
Eraneaa. G.«.
C'Seill, H.J.
«79
Journal of tnal^tlcal
TOilcoloqy 3:225*23*
3-PentaBoae, 2-«ethrl-
C«-B12-0
B» 100.16. BP 1K.S-115 C
itsso-
a66-i
Breath
zirasma scan
allLTTICal
BITBOB
SC-BS
IVB9EB
Or CaSSS
5« (387
saaples)
BUGS
lot given
isTi j
0.86 ng/1
3e one trie
GElIBal XITOStaTIOl
leasgrel at 25 c and 760 aa Bq
31.3V occurrence
lever and upper one-Si gaa liiits
C.023 and 0.33 nq/1
Bealthr. 18-35 yr old. no»nokinq.
artan blacks and caacasians.
Ckicaqo. II. Siqiair conttolled
eiperine-tal conditions.
fUMTH; itCCBOlS; IHHOIS; 191I.TS;
CELOBIWHTED CTDBOCfcBBOBS; TOX&TXIE
CtGlKC COIfCnDS: BlllTH BltARDS;
I«B»HTIC«; HE/tatoLis^: SEHEOLITIS;
tCfOLlTIO* IIMSOttE; H9B1J IBEtS
BETEBEBCE
K 0
Crimean. G.g.
C'Heill, B, J.
1979
Journal of analytical
Toxicology 3:225-23*
-------
Cauarln, 3-(alpha-aeetonylbrazylJ-4-iirdroxi'-> sodian salt (8 at
2I-1-Se»*opyra»-2-oae, t-hyaroxrO-O-oxo-l-phenylfcatrl)-. aollai salt (9 CI)
129-OS-S
C19-DKr-Ot.il
ill 331.34
nssn-g
4792
Blood.
plasna
4793
Blood,
plasaa
4794
Blool,
plasaa
tttOSmt BODIB
Ingestioa
inqestioii
Ingest Ion
imTTIClL
»ST«0»
•PIC
colorlietry
Colorlnetry
ITJBBIS
or cisss
9
_ .. ._ -
10
1
BUGS
a) 0.25-0. 51 •g'/l
b) 0.16-8.61 »g/l
_
a) 15-2 m/el
b) 15-0.3 wj/sl
c) 14-0.9 ng/el
8-0.9 oq/el
mi 6!»mi irrosBiTiot
) 0.40 nq/1 a) Snokers, after 0.032 if/kg, 1H
b) 0.45 ng/1 I dose, 2 »*
I t) Sablects and dose as In a) , after
1 1 no abstention fron sacking
j Steady state levels. Means
1 elaniflcaatly different.
i
1 Bealthy 19-60 yr olds, sacked at
I least 1 pack of ciqarettva/day.
1
I Itticoaqnlant effects (lengthened
1 protnroebln tines) .
1
1 IBISS: SROKITC: TOBICCOS; BIOOD
| S11S1M COSe»BMIT« ITliniTIOIlS;
1 imcoasntaiis: RnisoLisi: MIYMSS-.
\ TPIOCTUl^IS: iDOlTS
1
a) lot applicable | a) 0 and 1«9 he after 1.5 ag/kg of
b) lot applicable 1 S|-> evantioaorpn
e) lot applicable | t) 0 and 168 he after 1.5 ng/kg of
| t \+) evantlcaorph
| c) 0 ud 168 hr after 1.5 lo/ki) of
1 «,S(»,-) raccnte
| locaal 21-51 yr olds
1 Crothrovtln tine >as highest 48-72 hr
1 fcllovlnii adilnlitratlon. S(-) forn
j above] greatest effect in increasing
1 prothroebtn tine and In decreasing
| ccothrom&in activity.
1
I itiirs: Btooc piisBj; saves
t
I
lot giren I 24 and 144 hr after 1.5 »Vk?>
j tatinated free graph.
j Spiroitolactone, 200 nq/day, 7 flays.
1 had no significant effect on
1 axea-ander-tle-cnrfe of (arfarln.
j lata also for other sablects.
j Healthy snblect. no other drug foe 2
I ao.
1
I Increased prothronbln tiles. Effect
j aiiinlshed by splronolactone-liduced
I aiotesii.
I CSOGS: 1BDG IKTmCTIOR;
| 1ITIC01CH1KTS; BLOOD °L15H1:
| BIOFFTICSj IC01.TS: CC«P»t»TITt
. ,. 1- ....... ... .
BzreiEicz
Bachnann, K.
Shapiro, 8.
Fulton, B.
Carroll, r.T.
SalliTan. T.J.
1979
Clinical PhamacologT
and Therapeutics
25 C3f. 309-3 IS
O'Beilly. 1.1.
1974
cllaical Pharnacology
and Therapeutics
16 (2) : 348-354
0'P.eilly, S.».
1980
Clinical Fbarnacology
and Therapeutics
2712)5198-201
(IEIT PtSE)
-------
Ce»MTt», J-f»lpk«-»c«tonTl!>e««rU-«-lLTdla salt (« CI)
39-t-ae»opruB-2-oae. •-lrdrffir-3-fS-oio-'-PliejyllMjll-. xodloa salt (9 CI)
129-W-*
C1«-816-oa.ia
1« 331.3*
(COITflDED)
1ISSDS
»lt>oj.
plasaa
srrosvn ROHM
• MLTTTCH.
HWHOD
Of C1SE5
9
8MU
a) 3**-5.2* tag/si
b] 1.03-1.81 aj/ed
c) 1.C2-2.5C a9/*l
a) 0.88-1.22 og/.l
e] 0.79-1.25 »g/Bl
mi i amtu iiromnoi
1
l
ii| 1.275 oayil I »«/a»T
c) 2.158 «g/il 1 b] 5 eautloeec, » patients, t. S-10
A) 1. 108 ag/al I tj/4»T
•) 0.978 ag/al 1 c) laeeaiie (arfacia. ( patleatx.
1 5.5-12 ag/atr
1 leyda?
| e) s eaa.e timer, • Taluteers, 5
f Steady state lerels
i
1 coinlettiq inticoaqalant taerapf for
1 leep vet* ttieabofls. lo other
I «Slcvtloss. laer 28-70 71.
1
1 Doses fot qood aaticwaalait coatrol
1 qceater Cor t warfarin tbaa far 5
1 vwfarla {• < 0.005).
1
I noes: iiriccicDHns: BIOOB nisai:
l tismiss nisi ersuses; centntstn
- ^
BUEIHCI
Sreckeirid < 1
OCM, 8.
Le«is. S.J.
«ibbcMs, I.
197^
Clinical Pharaacology
and Thecapeetics
tS(*)i«2a-«o
B,.lphi-4ia«thTl- (S CI)
I.tlpla-diistkyl- (« ci|
CW-K1-S
n t^.2«, B» WS c at Ttg *• 85,
c at 20 •• :« (11 foci)
u>
-J
00
flJSOI
«7»«
Bile
RJTFOSW BOOT
Inject IOB
imirncu JOSBSI
UTTBOD OF CISS5
ec a) i
b) 1
jiiss i mi
a) lot applicable 1 a) 0.44 ag/dl
b) (ot applicable I bl 0.57 eg/dl
1
GJIJHI nroiimo*
a) CY«rdos« death
b) Delta 1>i haaqUe
It- 23 TT old blacks, histories of
-------
CTClokexaaeethvlailae, f.alpha-diaethrl- f« CI)
CvelolexaDeetaiiiaaliie, I.alpha-diaettTl- (9 CI]
101-W-*
CW-MI-I
» 155.28, SP 205 C tt 760 •• Vg. 92-93 C at 20 •• B«
-------
ycoeianeeT' ». alpta-diMt ayl- (» CI|
Cjclol>e»aj>eeth»«aai««, ».alpto-4i»etaTl- (9 CI)
101-M-S
B» 155. It, B? 205 C at 760 » Ha, 92-93 C at 20 •• 89 |dl Con)
tISSfl!
•tot
3ria*
1
HB01
Tltreoaa
1 humor
1
1
1
1
1
1
1
I
f
1
TMfosmt BODM t imnmt
f HBTBOB
1
t
!»-)ection
To -faction
ac
ec
XTRBSS
o? cu:s
i
•) 3
B) 1
tins'!
tot applicable
a) 0.05-9.22 aq/dl
b) tot applicable
WM 1 GBinii irroMitios
1
i
1
*.95 ag/41 | cterdose death
1
1 14 TT old black, history of 4m«
1 aktise.
I
1 Basslve deaeeasatloa of alveolar
1 lialnq cells, focal litre-alveolar
1 lesorrhaoe, *ad ante passive
1 congestion. Increased Anabcx of
f aononaclear cells IE aortal «re» of
1 liver.
1
j c»oes: siii: Btooo; nnns: Lira;
l mm TiTPFons sanof; stae JBUSI;
1 C1SI ItrSTOBItS; CORFHlTIfE
I min-novsi THIS
i
\ — -
a| 0.12 ag/dl I a) Orertose deatas
b) 0.05 a?/dl t t) Death tf tai^iag
1
1 11-27 vr old blacks, histories of
1 9tog abuse.
f
1 BypeYaetlvltv. vsconffcioasness death
1
1 caresehTsa coafested. eoBsist»Bev of
1 rotfcec. severe aedical hrpertropiir
1 aad iatisa kfperplasla of the saall
1 aoscalar arteries of the lanqs.
1 llveolar septa Utekaiied, aecoadarr
1 to diffuse f Ibrosis and acote passive
1 cetaestioa.
1 BMSS; BIlBs BI.OOD: KHKEIS; UT»B;
I otri*: VITJICOS BBHOS; !>*rs tsist;
f cisi nsnntst cmtntmis
1 tTHtOlTIOHS: TK1S
1
VI'BKSHCS
DiKlio. T.J.B.
Harriott, J.c.
Joaraal of forensic
Science* 22ni:«2-1Si
Bilalo, T.J.I.
earriatt. J.c.
1977
Joarnal of Forensic
Sciences 22(1) :IS2-15B
OJ
00
o
oiane, 2,2.»,S.*,8-lieMaetaTl-t.8-dlplienrl-, cia-
HI «2». BJ
TtSSUS
Blool,
»«i»a
riPostrM BOOTB
Icjastion
iHilTtlCH
5BTHOD
as
or cisw
T
»MO!
1.1-5.0 ag/1
SSI I
3.5 mg/1
eiHUl HJO^llTlOl
teaks, *-8 hr after 102 ag. slagle
Jose. Sleiieseatlal decline.
4ea ettfc nrostatle carciaoaa aad
• etasti«es (toae, liver) .
fieneral lipraveseat, relief ef pain
ft 100 iq 3I/dav. la aUe effects.
B»&eS: 9R"S mmpT; CBEHOTWIUPT;
>EOn»15; SIX; 1DOITJ; 5>tDI>; B10OD
STJOf
(EltSXBCE
T libra at. 1.
Striadberg. B.
let a PaaraacDlojiea et
Tosicolojlca 36(S«ppl
lit} 1 139-1*7
-------
D-streptaelie,
37517-28-5
B» 585. 92, BP 203-204 C fsesguihrlntel
TISSH
4803
aloe*.
sens
BIPOSMB ROUTI
Injectloa
IfUTTICll
1BTHOD
BadloaetrT
IniyaatLc
meat
OF C1SSS
t
HIGH
•) lot applicable
bj lot applicable
JEII
a) 21.5 ag/mi
b) 18.3. us/ml
__ .
GKIIHl MTOSIMIOI
•} teak. 1 Ir after 30 «i» IT of 5
ng/*g
t} Teak, 1 be after «» aim It of 5
s«/*g
Total of IS ig/kg/2* »r diTided la 3
loses.
53 TC old leoteai* patient lit*
noraal renal fa net Ion.
csnes: BSUG TBisi?!-. miBioncs;
CHiiO'SE't: THIS; nonaSRS; HOOD
SIBBS
SBrSKBCS
Fraaer, I.G.
Clearr, T.
Fraakel, I.S.
Kohl, S.
Pickering, t.r.
I*"1?
Cli«ical Phactacologr
&nd Therapeatics
26 (5]: 635-640
D-Strvptaaine,
C18-B3«-I»-011
n •i«.S8
TISSdl
»80»
BlOOi,
sera*
1IPOSTO? EOOfB
Inlectlon
ammcil
HETHOD
aicrobiological
BOBBIE
OT CISSS
16
EtIGI
15. 1-20. » ng/»l
b] 0.7-2.6 aq/al
c) 15.0-22.* «9/«l
d) 0.9-1.8 i?/al
n»
al 17.1 ng/al
b) l.a ocj/al
c) 17.4 ng/il
d) l.a ag/al
C'lISll I»TOBBSIIO« |
!
a) IB, peaks. Peak tUe 1 hr
t) IB, tcovqks at 8 hr
el 20 ain TV. peaks. Peak tiae 30
il«
4) 20 ait IT, tr»«(jha, at 8 lr
10 aqAg/8 hr for 2* dr.
1-1S fr olds, Texas
HTlatQTICS; BLOOD SIB 11; CBHDSU;
tltJS: COXFaMTIR TTSI1HTIOIS;
nmm; imciion; STIRGBET
BEFESEJCE
Tile bar, J.t.
fassiesz, H.
«elso«, J.D.
1980
Joacaal of "ejiatrlcs
««(<): 1981-1 091
CO
Dlbeii«(b,e)oxepla-aelta(11{6in,gaHa)-propTlaalae.
1-?ropaBaaiie, 3-Albat (b,«) oiepln-H («B|-rliaene-I,B-llaetkyl-. hjiSrochloclde
1S2»-2?-»
CW-B21-1-O.C1-E
B1 If. 91, ft IBa-185 c, 189-189 C
8 cl)
CT)
tissm
(80S
Blool,
plana
IIPOS8SE lOtTTE |
1
Xngestlon
UllTTIClt
HETBOD
oc/ir
"OHBIS
or CISES
1
mot
Sot applicable
8EII 1
1
2123 >a/»l
GTimt moiaanoi
Gaak. Data for aixed doKepia-RCl and
aaitrlptTliae-HCl oTerdose also
available.
Ciecdose patient, a?« 23 Tr.
QS; o? 100 asec or ateater en roatine
•C5, »nl one or nore of tie folltnicq
atnoraal Setf tendon r«flei«s.
ventriolar rate of 120 beatc/nin or
greater, riqht handle tranch block.
atrial and ventrlcalar preaatare
ccatractlona, lanctional and
idioventlicalar arrhTthalas,
ttaconsclansness, respiratory support
>«cessacT, ocaad «il seizures, and
acath.
IOVGS; HKTIt'PfESSITE 1CEHTS; BW03
ftisii: IFQG masi: IISSODBI
SEFEKFCB
Erlggs, J.T.
Spilt er, D.G.
Petit, J.«.
Zieglec, T.E.
W77
Animal of the aaerican
Kedlcal association
238|2)s135-13S
-------
tlqitosll (» Ct)
Card- JO fI2) -enolide, 3- ( (0-2,6-aideoxy-lieta-B-ribo-kejtopyeaiiosyl- (1-»)-O-2, 6-dideo*T-»«ta-D-ribo-a«,ropyranosil- (1-« ) -2,6-aideojT-beta-D-rlbo-heiOBTraaosrl) OIT) -1«-hT4roxr-.
<3b*ta.5beta)- (9 Ct>
HI 76S.92, HP 256-257 C (anhydrons)
TTSSJS
MO*
nooi.
pla»a
ixeosms ROUTE
Ingest Ion
tutrrrcai
BEIHOD
RU
BtUBXB
OF C1SSS
21
EJICE
9.5-1S» »al/l
MUI
_
fot applicable
GEVEB1I, IIFOSUHOI
.
ICter aaititenaice doss or ussiie
overdo 98
Cardiac patients and siBjects ritJt
digltaiin peiBoninq.
»8»»C«; IDIIITS: C»8»TOTISC9HB
tlSMS^S; &1000: BLOOD P1ISB1; DRUG
TBII1JT; C08MB1HTI STSL01ITO1S; I»
tITBO triITSIS
EIFtBESCE
Scherciann, J.B.
Boarloc, B.
1980
Clinical Chttcistrr
26:670-671
Ciqoxla (8 CT)
C*r4-20(2?l-eni>lll«, J-((O-Z,«-M4eo*y-b«la-B-ril»-»e»opjraiiosjl-{1-a) -o-2
(« CI)
ITI 780.12, IIP about JS5 C (4ecoip>
IISSB!
• 807
Unlotic
flnl4
«898
Bile
«609
Slool,
fetal
EIPOSU5E ROOT
iBlectioa
Tn-Jecttoa
n1«ctlo«
ililTTICIL
RETBOD
Btl
CC
s«4lo«etry
BT1
»n»BSi
OF C1SES
5
a) t
» 1
a] 3
b) 12
BUSS
lot detectibla -1.5
nq/il
a| fat applicable
b) Wot applicable
a> 0.85 - 3.99 ng/«l
b) 0.20-1.10 nq/il
BE»P | client urosaiTioi
t
1
1
lot applicable I at Selirair, after 0.2 >q IT.
|
1 Italians ql«n digital Is dnrlig
1 Tceqnaicf.
|
I EIOGS: ITlIt; PEEGS1ICT; BLOCS SEBDR:
I imOTIC TIHW. 01BIIICH. COED; TC1ST
1 tisHSfs; DBoe TUJPIPT
i -
l
a| f. l« of dose I 9> « of In -tec ted radioacti-ritr in 50
b) 10. 7< of dose I il after 38 hr. nose, 150 aci
1 31-digoiin-12alph«. >90"= «as
J ai90* «M dlqciin.
1
1 Tatieats vith aeate reoal failure, on
1 faintenance doses.
C
1 cities; ORoe TBXE1PT: nrriBoiiT^s;
1 DBI«»; Bill; C»I»D1; CO>IP»B»TIT-
1 I»JHO»TI01iS; BISB1SSS; SST»BOI,ISI»
1
a) 1.SS * or - 0.35 1 a) < 1 kc after dose. Tallies lower
(SE) ao;/il f tian latenal serai, ? < 0.001
b) 0.55 * or - 0.08 | b| 74-690 tit after lose
(S«) nq/«l I Cord bloal at dellrerr. after 4.2 kg
1 IT to withers.
t
1 Ttaliaas qiT«n digitalis iSncinq
( vreoaaacr.
1
1 cmes; iTitT; PPEGVUCT; Btoco siaon;
1 lesioiic riuio: OHBIUCAI COED; RSIAT
1 tlSFlS^S; DFTO TSEtlCT
1
IinSESC!
Podeletti, 1.
Porciani, H.c.
Sciaooe, G.
1979
International Journal
of Clinical
Pltarfeaeologr and
Bioj>har«acT t7 (2): 32-83
Caolt, n.R.
Sagdan, D.
Haloaey, C.
Ihwd, a.
Twee Wale. s.
1979
Clinical Phariacolo9T
and Therapeutics 25 [S
pt 1):»99-513
•
Padeletti, L.
Porciani, I.e.
Sciaoae, G.
197«
Internatiotial Joarnal
of Clinical
Pharmacology and
BiopliarMcr 17 (2| :82-83
(HIST PUSH
00
-------
Clvoxin (B CD
Cira-20(22)-«olide, 3-(
(3k«t*,5beti,121>*ta)- f9 CI)
20830-75-5
-D-clbO"-heiopyranosyl)oi7)-12,1t-dihrar<»r-»
•I 180.92, U a boat 265 C (ieco«p)
1IS3VS
«10
ood.
plasca
• 811
lass*.
»812
Blool,
vlasaa
• 913
Blood,
sens
BTJOS01B BOTH
lection
nvestian
ftgestloa
Injection
Injection
IBUTTICat
HETHOD
Ell
laataoassay
m.
Rla
TO BOSI
0? C1SZS
3
) 21
b) 11
*
5
11ISE
J.3-7.5 naoles/1
6.3-13.9 naoles/1
0.7-5.1 nnoles/1
7.2-18.8 iaolas/1
] 0.38-1.20 naol/1
b) 5.24-22.C6 nnol/1
a] 3*-0.3 «a/nl
b) 16-0.42 *g/nl
3.18-10.67 ng/nl
mi i etiisit itroiuTioi
1
i
1
%.* naol«s/l t a) teaks, n.5-75 nin after 50 sg
10.5 moles/1 | (oral), joanger patients
2.6 »aoles/l | t) Pea*a. 15 nin after SO »g IT,
11.* naoles/1 I TC«q«r patients
1 c) Beats, 1-a hr after 25 nq (oral).
I tlderlT patents
I a) Peaks, 13 nin after 25 ng IT,
1 elaerlT patients
1
I 6 tenales, aoea 31-61 yr, and a group
| of ! feesles and 2 sales, a-ees 72-91
I jr. til rlth eecdiomegalT aid on
I ctfcer nedications.
1
1 ewes: tett BETJBOIISH; BLOOD ;usi»:
| 111VT DISMSIS
i
1
1 Int applicable | a) Talue* by Ell. tercemt of
b) lot applicable t cto«s-r«icti»ity to dlgltaiin
1 ) Initial •easaranttnt snS 76 hr
b) lot girei 1 alter 15 og/*g IT bolus
I t) initial seasarment and 80 nr
t after 10 eg/kg IT boles and after 8
I lays on 200 *J aainUlne. 2t/day
I T«tlBate9 fro* graph
I
1 IKaltay 21-26 yr olds.
1
t fosltive inotroplc effect of diooxln.
1 ainUished bT gnlnldine.
1
1 DIOGS: nipimit: noon PUSH; MOLTS;
1 KOCB >KTSSmt: VtIS UTEBJCTIOS
1
8.2* ng/nl 1 Calculated 0 hr (peak! ralaes
1 adlastel to b«laa IT lose after *> nin
1 11 of e.8-«.« ag/kg. Biextonential
1 dfdlaa.
1
I 3^-76 yr old patieata, serere renal
1 iapairnent, congestive heart failare.
1
| CH1G5: 1)806 TWE19T; BIOOD SESOII;
| 1ITH.TS; DISUSES
t
lErErarct
Cusack, 3.
Kelly. J-
3*Halley, K.
loel, J.
^aTftn, J.
Horgan, J.
1979
Clinical Pharaacologr
and Therapentics
25 (6): 772-776
Schvrrnau, I. B.
Bcnrdon, B.
1939
Clinical Cheaistry
36J619-671
stelness, I.
laUorff. S.
Bansen, P. 8.
Klaergard, B.
tack, S.
Eqebla.d, B»
1984
clinical Vharaacology
and Therapeutics
27 [61 s7^1— 79S
Koap, J.S.
Jasko, *i.J.
fl.ool, C.B.
Kaali, 9.1.
197?
Cllaical ?baraac
-------
ligoxin (8 CD
Card-20(22)-enoli4e, 3-{(O-2,«-diaeojtj-beta-D-ribo-hexopyranosyl- (1-«)-O-2,«-dideoxy-beta-D-ribo-l«>xo{>yranosyl- (1-»
Ubeta,5bet>,12beta)- (9 CI)
20830-75-5
C41-H6 4-014
as 780.92, BP about 265 c (deconp)
(COKTIKHED)
-2,6-dideoxy-beta-D-ribo-heilopyranosyl)oxy)- 12,14-dlhydroxy-,
TISSUE
181*
Blood ,
serai
4815
Blooi,
•era •
4816
Blooi,
am*
4817
Blood,
serai
1818
Urine
EXPOSURE BOO
Ingestion
Tngestian
n -feet Ion
ngestion
IRllRICU.
HETHOD
HI1
BI»
Ell
CC
adioaetry
RUBBER
or CISES
11
a) W
b) 55
c) 8
1
al 6
b) 12
2
HIKES
a) 0.4-1.4 ng/sl
b) 0.4-1.1 ng/sl
c) 0. »-1.3 ng/»l
a) 0.0-0.7 ng/al
b) 0.8-2.3 ng/nl
c) 2.4-4.9 ng/nl
a) Hot applicable
b) lot applicable
c) Hot applicable
) 1.10-4.30 ng/al
) 0.20-0.95 ng/al
(at given
Hat given
lot given
lot given
lot given
Hot given
REIR | GERIB1L IBPOBHiTIOK I BHERERCB
1 1
1 I
a) 0.736 * or - 0.3ft I a) Before bias sappleaent 1 Roods. H.V.
ng/il 1 i) litter 9 days on bran supplement | Ingelfinger. J.I.
b) 0.736 * or - 0.19 j c) 10 days after bran discontinuation I 1979
ng/al 1 22 g bran/day In 2 servings. »o { Clinical Pharaacology
c) 0.74 t or - 0.29 1 significant effect oa digoiin. I aad Therapeatlcs
ng/al 1 I 26(1): 21-23
1 libalatocy residents of I
I rehabilitation center taking digoxlo |
1 > 1 nonth. iges 79-81 yr. veights I
1 99-80 k9
1 | Zaropean Journal of
I 22-94 yr olds on digozln or I Clinical Pharmacology
1 aialtorin. 1 1S:»11-»15
1 1
1 DJOGS: 9KDG TH5B1PT; K1XS1S; BLOOD I
I snai: IEIBT DISEISES i
i i
I i
a) 11. C ng/nl I a) after overdose I Rovett, D.I.
b) 6.0 ng/al I t) ICter charcoal henoperfasion I 1980
c) 1.4 ag/nl 1 c> 3 days later 1 Journal of the laerican
1 I Medical association
1 82 yr old 1 299 (14) r 1558
1 Cizziness, venltlag, atrial I
1 fibrillation I
1 1
1 BRITGSt BLOOD S«D5: HSRODIILTSIS 1
1 1
a) 1.87 » or - 0.36 I a) llthln 1 hr of dose I Padeletti, L.
(3 EJ ng/il 1 b) 75-690 nln after dose I Porclani, B.C.
bl 0.54 « or - 0.07 | it delivery, after 0.2 eg. IT. 1 Scinone, G.
(SE) ag/nl 1 I 1979
1 Italians given digitalis daring I International Journal
1 cr«goancy. 1 of clinical
I I Pharnacology and
1 c«oes; rrnT; PRESWIRC?: BLOOD srann: i fiopdarnacy 17<2):82-S3
1 I9RIOTTC FIOID! OSBIIIC1L COBDJ 9S1ET )
1 DISBISIS; OSOS TB881PV |
i 57.86* of dose 1 a) Total radioactivity. 6 controls I Gaalt, 9.B.
13.4** of dose 1 b) Total radioactivity, 6 patients 1 Sngden. D.
54. 50* of dose I c) Diooxla, 6 controls I Raloney. C.
14.70* of dose 1 d) Digoxin. 6 patients 1 lh«el, n.
3. 36' of dose I •) Total netabolltes. « controls f Tveeddale, !I.
0.79* of dose | f) Total Mtabolitos. « patients 4 1979
1 5 day cnanlatlve eicretlon after 150 I Clinical Pharnacology
1 aCi (« ag) 3B-dlgoxin-12 alpha daring I and Therapeutics 25(5
1 fasted state. 1 pt 1): 499-513
1 1
1 « healthy 24-51 yr olds. « 38-70 yr 1
1 cH patients ilth •iniial renal I
1 function, on henodialysis 3s/**. 1
1 1
1 O'lSS; DBVe TRB»T: K!T1BOLR«S: |
1 0*1*1; Btl?: C1R1D1; CO4P1BITIVE I
1 ITtlTIlTIORS: DISEISES: 1ET1BOIISK |
1 1
U)
oo
-------
Iplpodophrllotoxln, 4«-deset«rl-, •-r4,C-O-2-thenvlideae-bata-D-glacopyrana«ide) f» CI»
!!f JJ' r V : 'i't!? Plli*0,f2;3"2ir 1 •i:2.1?.I01-:S 'S!?' ""**• S> * • te • »-t«t«»rdro-5- f t-hydroiv-3, 5-di«etho«yphenTl) -»- {(4. 6 - 0- 2-th lenrlse thylene) -beta- D-gluoopTranosTl) oxy-.
f 5R~ (^atLpbAy 3afwt •« DttalPJl41cVDttCB CM*) 11 ~ f 9 CT1
2»7*7-29-2
C32-B32-013-S
HI «5«.7»
TISSVI
Ml*
B1004,
plasaa
4*20
Urine
BirosoK HOOTB
I«1ectloii
iB-Jwrtloa
a mmcii
SETHOD
JtaUontrr
SadioMtET
IUBEH
or c»sis
s
s
illGI
20.96- 39. 1« og/il
lot given
U*l
26.3* ug/mi
««.** * or - 8.2K of
dose
SEIIUI IIFOSK1TIOI
f«»k». 0 hi after 30 «Ln IT of «7
mq/H *, tritium-labelled draq.
Iriexponentlal decline
Patients vith adTanced cancer
tenkopemia. antiaeoplaotie response
in 2 patieitt
CSOSS; DBOG THBEIPT; CHEHOTaiBlPT;
I'OPLisHS; Lttmesii: BLOOD nisu:
nviwi; CEPtBBOspiiit rLoin; nets;
ICOLTS; DISIISIS
CMalatlTe 72 he excretion after 30
•In IT of 67 «q/aq • tritiui labelled
drnq. 78.7t of adnacT radieactiTitr
it eetabolite
Catients Kith advanced cancer
lenkopenia Intineoplaatie response
in 2 patients.
CHUGS: «B5« THZS1PT: CHEHO'BIBIPT;
piopiisis: Ltomii; BLOOD nisii;
nin«: C!PtB»ospi«i TWID: nets;
ItOlTS; BISIISIS
BiriEEFCE
Cceaven, P.J.
alien. L.B.
19751
Clinical Pharnacologr
and Therapeutics
18(2):227-233
Creaven, t.3.
alien, 1.1.
197Sb
Clinical PhanacologT
and Therapentics
18(2):227-233
00
latcadiol (8 CI)
lstEa-1.3.S(10)-triene-3,17-diol. (ITbeta)- (9 CI)
?0-28-2
C18-R2I-02
« 272.»2. SP 173-179 C
1ISS01
4821
Blool,
plasna
«822
Illk
^tpososs Botrac
Vaginal
vaginal
aialTlICU.
HFTBOD
*ia
ma
B01BJB
OF C1SIS
a) 3
b> 3
a) 3
b) 3
SUE!
a) 30-3000 pg/nl
b) 45-2590 pg/nl
a) 27-1050 pg/nl
b) 40-259 pg/nl
mi i
i
I
&) Hot applicable
b) lot applicable
a) lot applicable
b) lot applicable
Gzmat iiroasaTioi
a) Initial ncasnrenent and 3 hr after
SO «q suppository. 23 hr values
caaged Iron 5C 100 pg/nl
b) Initial neasurenent and 3 hr after
100 ng soppository. 23 hr values
ranged fron 65 400 pg/nl. Istinated
Iron graph.
Bealthv laetating volunteers.
SKSOTDS: BOBHOKM: «LK: LaCiaTIOB;
-------
Ethane, 2-broao-2-cklor»-1,1.1-triflaoro-
151-67-7
C2-B-Br-Cl-F3
e« 147.31, BP 50.2 C. 20 C at 2W H »q
TISSUE
M23
Blool
*82«
Breath
BIPOSOBE SOOT
Inhalation
Inhalation
aElLYTICIL
BETROD
OC-EC
SC/HS
IOBBEE
OF CiSSS
•1 10
b) 10
1C
IMS!
•) 12.55-33.40 ««/•!
bj 16.55-36.95 ag/nl
a) 0.01-0.15 ppa
b) 0.05-0.56 ppa
C) 0.02-0.42 pps
d) 0.07-0.55 pps
e) 0.2-0.5 ppa
f) 4.0-5.0 ppa
•Ml | GEIEUL I1FOTHTIOI
1
1
I
a) lot given | •) Inestketlsed *ltk » Vain nitrous
b) lot given j oiifl«, 8 I/Bin oxygen and 0.<*
| halothane vapor
| b) iMstkctind >ltm 8 1/ain nitrons
1 oiia«. « 1/iin orr?«n, and 0.*8.32 C, TP «0 aa -hj at 19 C
iissm
Ilool
ETPOSOBJ BOOTE
lagestioa
atalYTICll
HZTBOD
Breath analrxer
B0HBZS
OF CISSS
10
iiies
a) Hot given
b) lot given
(Ittt
BS1B
a) 1.0 g/1
b) 0.95 g/1
Pllt)
esiiut rifosHnioi
a) 1 hr after 1 gAq ethanol in
orange i«ice * 1 ^locose capsvle
t) t hr after 200 sq cannabidiol • 1
?/*g etaaaol in oranqe jnice
fitisatel fron graph.
««altiY 21-33 rr oils, *t 52-85 kg.
Broesiaiss, dizziness, relaxation,
f««linqs of dreaainq, abnornal
>«arlng.
tMIIL: IDQIIS: BIOOD: DB06
IITniCTIOl; 05063; XLCOHOtS
BEFESBfCI
Consroe, P.
Carliai, 8.1.
Zulclter, 1. P.
laoeria, L.I.
1979
Psrehopkarnacologr
-------
m»l aleokol (8 Cl)
ttnaaol (9 CD
St-17-S
C2-BC-0
PI 46.07, I* -117.3 C, BP 71.32 C. TP BO •• Bg at 19 C
(COBflBDED)
TISSUE
4826
Blood
4827
Blood
4828
Bloo«
nrosms Boots
aqestlon
ageatloa
laqestlOB
lurrtrcil
HETBOD
SC
Breath aaalrrer
BOBBSB
or CASES
*
11
BIBGB
0-430 ag/100 ml
) Bat given
) Bat givea
) Bat given
) Bat given
•1 0.38-0.06 ng/al
bj 0.3-0.63 ag/al
e) 0.*2-0.88 ag/al
i»
§111
71.1 mg/mi
) 0.44 * or - 0.05
mg/mi
b> 0.30 + or - 0.02
•d/«l
c| 0.»8 « oc - 0.08
•q/«i
4) 0.67 * oc - 0.08
•q/«l
(S.B.)
a) Bot gi*et
b) Bat glTea
c) Bot glraa
GIBIUL IBrOBBlTIOB
llcakol and pcopoxyphaoe fond.
Co toners' ca««s tro« 3 Calitornla
cea*tl«*.
tivra: osnes: BLOOD: IICOHOLS; CISB
BISTCBI1S; SOICIBB; 9RV6 1BHSB
B«» p«ak. 0.* be after 0.2S q/tq
cttaiol, pcetceatMnt vlth 0.7 aq/kg
Ca carblaide
t) leas neat, 0.75 hr after 0.25 q/k«
• thanol, prvtraatMBt nith placebo
c) Rean peak, O.S kr after 0.5 g/kg
ethaBot, pretreataeat vttli 0.7 *gAg
ca carblaid*
i\ Bea* peak, 0.5 kr after 0.5 g/kg
etkanol, prctreataent >itb placebo
f«ak tlaes estlaateJ fraa qrapk.
tleokelles, ages 23-*« TC. Iraq-free.
noraal cardiovaacclar, kepatic, aad
renal faictioi.
Ithaaol-CB carblilde interactloa
caused Increased bleol aeetaldekrie.
tackrcacdla, fecnaiei ataatolic
tlool pre>8«re, aad decreased etkaael
attabolts* (at 0.5 qAq etkaml
dose) .
tSOSS; D30G IRIBtCTIOB: JOTITS;
I1COBOIIC BE«ni>GBS: BlOOBi
BIlkBOlISH; BBT1B01ITBS; BLOOD
ffZSSIIBB
a) 60 BBd 1BO a IB after O.»1 g/kq.
iBltlal a«aa«reaent, 0.2 aq/al at 20
>la
t| 20 aa4 60 atn after 0.«3 g/kg.
Tlaal •easoreaent. 0.38 aq/Bl at 180
Bla
c) 20 aafl CO aU after 0.85 gAq.
final aeasareaeot, O.S8 mg/mi at 180
BtB
EctiBBted freB graph
fioae alataistered as vodka, tonic.
liae. aad sugar.
Bealtky, PSTcaalogr st««ents IB
Sleden, aqes 20-32 Tr, «t 60-70 kg.
l«»n cOBSvaptloB of pare alcohol, *5
cl/ao.
Core fmliaga of euphoria, lessenlig
of tension at kigkest dose. Bore
aegatln feeliBqs at Lover doses.
Treqaeat coisvaers derlred greater
affective benefits than rare
drinkers.
S»EBK»: BLOOD: PSTCBOT*OPIC DB153:
HPH>T'»»T«L PSYCHOIOGT; ILCOROLS
BBfEBSBCB
Crarey. B.R.
Shav, 9.T.
Bakaaara, G.S.
197*
Journal of Forensic
Sciences 19(11:72-80
Erien, J.r.
Peackey, J.B.
looals, C.I.
Eogers, B.J.
1979
Clinical PharaacologT
and ?kerapeatics
25 («) : as* -463
Perssoa, L.
sioberg, 1.
STCBSSOB, 5.
19SO
Psrckopkaraaco log T
(8:295-299
oo
-J
(HIT P1I3E)
-------
Itbyl aleobol (8 en
Itfcanol (9 CI)
Ct-17-f
tt~lt.ll. BP -117.3 C. BP 78.32 C. »P « » «« •*
~«5I5i niosm MOTI «»£"£"
«829
Blool
• 830
Blood
•831
Slooi
• 832
Blool
• 833
BlOOl.
plasna
Ingestlon
Ingest ion
Ingest ion
____
Ingest ion
Injection
. — ~~
• — •
GC
BMC
19 C
iflBBSB
or cisss
i
i
"
a) 7
b| »
a) 6«
b) «7
c) 18
5
ICOBT
"~ iiioi
a) lot applicable
b) Bot applicable
Hot given
a) 0.622-1.098 mi/ml
b) 0.672-0.889 ng/»l
a) 120-5*0 sg/il
b) 120-5*0 19/11
c) 1*0-360 ng/dl
•ot given
HOED)
mi
a) a. 98 g/1
b) 0
3«0 ng/al
a) 0.833 » or - 0.162
ma /ml
H 0.793 * or - 0.10S
a) 268 * or - 10
b) 272 » or - «3
ng/dl
cj 260 » or - 13
__
110 * or - 11 ng/100
•1
— etBHttl IBTOBBlTIoi
t) 16 fcr after dialysis
•Icohol-intoiicated 6 yr old, »t 20.2
ccaatose at 3 fcr, hypotkeEnia. «eak
noise aad unfletectable blood
pceuare, respiratorr arrest.
HCCBOtS; IBSWIlI CTIIDBBBi C»SE
BISTOBTSSS l»T»e«
II yr old pbarsacist, salcide,
overdose of ether drags
BSUCS; BBUO UBS>; SHICIDB:
insn^nn BETBOBS; «••""•!.„.
eiooo; ITTW: aim: KIBBKS; B«»I».
• ICOHOLS
— • • —
a) Dose, 0.5 g/tg, 12 hr after 0.7
",/kg ci carblaide. Peak tine, 0.58
t,°Bo»e?'"5'Ig/kg. • kr after 0.7
no/kg ca carbialde. Peak tine 0.«7 «
or - 0.07 kr
lleokolles, »ean age 32 » or - '*• JT
yi. nean body »t 68.7* » or - zz.»J
kg, Canada.
ClIaDa: OISEISZSi BIOOO; DB96
IMEBICTIOB: DSO« TBSB1PI:
CC1MB1TTTE ET»H»*IO»S: HCOHOIIC
IHIBISW: BiTiBoiiss: HETIBOIITES
a) Total saacle
t) Ben
c) «oeea
CllnicallT scber patieatB adaittel at
a kospital emergency roo«
it BITS: sst; BMKJD: onus tpossj
ucosots
peak, 60-75 nin after dose of 0.8
B«althT 22-39 rr olds. Tennessee
Tt»?s»i: icw.TS: BLOOD P«SIU: BFBG
IlTEftkCTtOB; CORPkBlTITE EVklBATIOWS.
iSRSEBCE"
ernbbaner. B.B.
schvarz, ».
irckives of Toxicology
•3:317-320
_« —
Qaeree, E.».
Dickson, S.J.
Hissen. »•*.
Panaell. L.K.
1979
joanal of analytical
Toxicology 3:253-255
peacney, J.X.
caglana, S.
Bobinson, G.I.
Re»y, R.
Brian, 3.T.
19B1
clinical Piamacology
and Tkerapevtics
Drso, 1*
Gavaler, J.S.
taa Tfciel, B.H.
19S1
life sciences
28:1053-1056
Desaond, P.T.
Patvardhan. R.T.
Schenker, S.
Roriapa, »•'•
1980
European Journal of
Clinical Phariacology
18:275-278
|IEIT *.»*»
U)
00
00
-------
Ithyl alcohol (8 en
tthanol (» CI)
60-17-5
C2-B6-0
BS US.07. HP -117.3 C, BP 78.32 C, VP 90 »
at 19 C
(COmilVED)
08 3»
Blool ,
•hole
Ingestion
SBTHOD
GC
OF CASES
0
B1BGB
a) 0.2910-0.551 ag/sl
b) 4.05-12. SO ao/ul
»B»B
a) 0.019 ng/nl
b) 8. DO ag/al
GBBMiL IBTOBMTIOH
a) tthanol. lean peaks. Peak tines,
O.B13-O.S27 lir
h) acetaldehyde, lean peaks. Peak
Uses. 0.33-0. 59 hr
Beans of 3 eiperinnts. Ethanol
dose, 0.25 q/kq as 15t solution 12 hr
after 0.7 igAg Ca earbiiide.
Iraq-free alcoholics, ages 00-52 yr,
»t 66.5-96.0 k«. *lth norul
cardiovascular, hepatic, and renal
function.
Tachycardia caused br ethanol and
Ca-carbliide interaction.
CBOGS; alCOROLS; IDHLTS; CM1DI:
BIOOD; OBD6 IBTBBaCTIOH; DBOG SBUSE
BEFBBEBCE
Brian, J.r.
feachey, J.B.
loonis, c.I.
1990
Clinical PharaacologT
and Therapeatics
27(3):»26-K33
IthTlailne, 2-(diphenylnethoiy)-H,B-aiaethyl- (8 CI)
Ithanailne, 2-(dipheDyl«ethoiy)-H,H-aiBethyl- (9 CI)
55-73-1
C17-H21-K-0
BS 2^.35. BP 150-185 C at 2.0 n Hg
TISSTJE
81004,
eXPOSBEB BOOTE
Injection
Ingestion
AFilTTICiL
BCTBOD
GC
GC/HS
BOB BBS
OF CiSBS
BUGS
a) 99-196 ng/«l
b) 37-83 ng/al
HBAS
a) 100 ng/nl
b) 55 ng/al
SE
GEIZBU IHPOBfliTIOB
a) Peaks, after SO eg IT. Continuous
decline froa 1st saaple at 1 hr.
Bean of 37 ng/al at 8 hr
b) Peaks, 2-3 hr after SO ng, oral.
(lean of 22 ng/nl at 8 hr.
Bealthy 22-33 yr olds, light neal
before All dose.
sedation and antihistaBine effects
positively correlated vith plasia
level. Intlhistanlne effect but no
sedation at 25-50 ng/nl.
CHUGS: SSMtlVBS; » DOITS; BIOOD
Fitsni: HEiPcioGic HIIIIFESTITTOBS
1ETEBEBCE
Carrnthers, S.G.
shoeaan, D.R.
Hignite, C.Z.
•zarnoff. D.I.
1978
Clinical Pharnacoloqy
and Therapeutics
23(0): 375-392
oo
clic acid (8 CI)
-Glntaalc acid. B- (»-(((2-a>ino-1,O-dlhydro-O-ojo-S-pterialnyl)lethyl)aiino)benioyl)- (9 CI)
19-B19-H7-0«
0836
EIPOSUBE POOtB
Ingestion
•HalyTICiL
1BTHOD
RDBBH
or cisEs
40
Bot given
(BUT
HE1H
138.9 * or - 11.5
lu/nl
PtOE)
GEBSBii iirosntnov
Prior t-> follc acid treatment. Ifter
3 X 10 iq per day for 30 days, levels
increased about 5 fold.
lorao- and cligosperaic patients.
Bo change in spern count, V gotile
item, or ONI content per cell after
folic acid treataent.
IS91EL; 9B1GS; DBOG THBSJPT;
TiT«ni
-------
To lie Kit (8 CT)
c *CM'
CH-S1»-»7-C6
II M1.»0
- i*
(Commit)
tissue
«837
Blood.
sene
•838
Exrosms loot
Iioestion
I B 90S t 100
IfilTTXCaU
METHOD
Bicroblological
•HIBES
OF C1SBS
<
«o
t»ei
a) 106-261 «g/il
b) 7«-m eg/ml
c) 300- « 80 ng/.l
d) 170-330 ng/nl
lot given
01*1
l) 167 ng/el
b) 122 B9/»l
C) «1« «g/ll
d) 263 ng/sl
•«.S « or - 7.1 Itl/Bl
eiinit immuTio*
•I Predinlrsls, 1 ng/dnr dose
b) FostaialTsis, 1 iq^Aay dose
c) PraillslTSis. S loylaT dose
4) PostdlalMis, S «a/aay dow
Cialysis stittcd 1 kr «ft«r do««.
D«clt»« during dialysis was 26-53?
Stable ancphrlc pattats aailtained
tj h«*o41alT»is 6 hi. 3I/*k.
CB06S; D90S TBBI1PT; BIOOD SISOH;
CISHSBS; COW1SJT1TE ETltNTIOIS;
TIT1HI1S
~
Prior to folic acid treataent. Jft«r
3 T 10 >?/daT for 30 days, lerels
ion about 3 fold.
lorao- and oligospetaic pattats.
lo chaa
-------
Cntiiicla
1»03-«6-3
iMCt COIPOSXTXOI BIKtOVI 0* BIDITElglllD
It 102-IOf C
(COIYIIOKD)
Mil
senn
Saspirtto
secretion
Urine
UOS9U sootB
Peritoneal
iBlectloa
Ingest ion
Inhalation
Injection
lagestlon
iMLTTiciL
RRBOD
m
Ucrobiologlcal
lOHBH
or cisis
7
8
11MS
3.9-l.a ng/nl
a) ». 6-42.0 ag/sl
b) 13.6-22.0 ag/el
c) aao-12 aq/nl
4) 0.30-1. M ug/nl
•) 12.6-95.8 ag/nl
b) lot given
mi
lot given
a) 22.0 ng/nl
b) 17. » nq/al
c) lot applicable
4) lot applicable
a) 35.7 ag/Bl
b) 19.3 ag/sl
6BIM1L HFOMHXOI
6 and as br after too sg dose added
to 6 kr, 2 liter peritoneal dialvsate
{1.5< deitrose). Initial
aeasareneBt, 1.7 09/1! at 1 kr
Binge of aaans
Chronic renal failure patients
undergoing continuous anbvlatory
ceritonenl dialysis, 27-67 yr old, vt
57.3-89.3 kg.
IIDin DISE1S1S: BLOOD SBKOK:
miBiotics; DS«C Ttmipi;
HlSTBlUBltT IR80DS
a) Traekeal aspirate, 1 hr after »0
nq, aerosol
B) spatas indvxrea by tracheal
aspiration. 1 hr after *0 sg, aerosol
c) Bronchial secretions, 0.5 and 6 hr
scans after 2 eqAg, eadotrackeally
n Bronckial secretlOBS, O.S and 1 kr
Mans after 2 nq/kg, II. Final
aeaaorenent, O.S aq/sl at C hr. c)
and d) estisated fron graph.
• tracheotonized 51-63 yr olds, la
searosargieal nait and « adults vhose
tronchlal secretions were tested for
aeoplastic cells. Belgian.
BtieiOl; 1B011S; BIOOD; B1OOB SnOH;
•ITIBIOTICSi nSPIllTOBT SBCBRIOIS
a) 0-C hr levels after 2 nq/kg HI
b) 0-< br levels after 2 nq/kg,
endotracbeally
51-63 vr olds, hospitalized for
cranial traaaa, tracheotoaized.
IIlGItll; 1DIHTS: BLOOD; BLOOt SSSOU;
1RIBIOTICS; IESPIRHOP.y SZCCRIO1S
CEFEtEICB
Pancorbo, S.
Conty, c.
1*81
Intinicrobial igeats
and Ckesotherapy
Odio, t.
Tan Laer, !.
Klastersky, J.
1975
Journal of clinical
Fharnacology 15:518-524
Odio, W.
Tan Laer, !.
Klastersky, J.
1975
Joanal of clinical
Pharnacology 15:518-52*
-------
Glocttol. 1,4:3.«-dianhvdro-, dinitrate. 0* (« CI)
t-eioeitol, l.ttS.t-dianhrdro-. dinitrate (9 CI)
81-33-2
C«-B8-»2-08
B» 236.1«, IF 70 C
TISSUE
48**
Blood,
serua
•8*5
Brine
El POSHES BOUT
Snbllngnal
Ingestion
iBiinieii
HETHOD
SC
Badionetry
BOBBSS
OF CISBS
10
2
I1BGB
a) Bot givei
b) Rot given
c) Bot given
8-97* of dose
BBil | SElISal IB'OBBITIOB
J
1
a) 17.9 * or - 3. 1 I a) after 5 ig. Peak time 10.0 » or
ng/nl | 1.8 ein
b) 9.0 * or - 0.8 | b) 2-isosorbide dinitrate
na/il I (netabollte) after 5 eg isosorblde
c) 38.* * or - 3.* I dinitrate. Peak tine 52. 1 « or - 9.
ng/nl 1 sin
s« | c) S-lsosorblde diaitrate
I detabolite) after 5 ig isosorbid*
| dinitrate. Peak tine tl.t » or -
I 1«.« atn
| leaks
I
I Bealthv volinteers. Federal Republic
1 of Gcriaiv
1
1 Beadache, nausea, light-beadednesa.
1 decrease in Hood pressure, increase
I In neart rate. Severe hypotension
j and reversible bradvcarlla in 3
1
| G1P.MBT: AUDITS ; BiOOD SEBDB: DTOGS:
I innBOLisH; aETiBoixras
1
Bot applicable I 4-120 hr emulative excretion after 5
I ig UC- labelled drug. Ixcretioa 92*
I coiplete by »8 hr. 80* excreted as
I colar naterial. Vncliaaged drag
I detected oily in 0-3 hr ncines, as
1 <1* of dose. Boat polar nateriel vas
1 conjugated isosorbide.
1
1 Volunteers with narnal renal and
I hepatic function.
1
I OBOGS: HETIBOIISB: IRlBOimS;
I OB HE: ADMITS
SEFEBEBCZ
Sporl-Badnn, S.
tetxien, G.
Kantian, B.
liede, T.
Ibsbagen, D.
1980
European Journal of
Clinical Pharnacology
18:237-2**
Down, ».B.
Chasseand. i.T.
Groady, E.K.
197*
Journal of
Pharmaceutical Sciences
63f7):1W7-11»9
UJ
VD
ro
Glatanic acid, »-(P-(( (2,n-aiaaino-«-pteriSinTl)net»rl)»»ino)beiixoTl)-. L- (8 CI)
t-eietaaic acid, »-|t- (((2,«-diaaino-«-pteriiii>7l)BetliTl)aaino)benzorl) - (9 CI)
C19-H20-B8-OS
HI *«0.(3
HSS9B
• 9n$
Blool,
serai
FTSOsms Botrri
In -feet ion
illlTTICJL
fIBTBOB
J.._L_J..L _, j_ _| ll_ !!_.!_!
I
HOB SIB
OF CISBS
12
MBSB
a| 10{E-aj-1.SI10(B-7)
noles/1
b) Bot given
c) lot given
d) Bot given
e) Bot given
RE1S | GBI1HI IBP01B1TT.OB
1
t
a) lot applicable I a) Baiqe 0 and 2* hr after
b) 3. 6 » or - | aaspectfiel dose. Biexponential
2.0X10(E-6) noles/1 | eliilnation c| Bephrotoxlc
c) 1.6 » or - 1 c) Bonvephrotoxle
1.0:iO(£-6) noles/1 | d) Systeiicallv toxic
d) 3.2 * or - | e) Bontoxlc
t.8I10(E-6) noles/1 ( t)-e) toiicity after 250-350 ig/sq •
e) 1.6 * or - I followed by leocovorla rescue
1.2X10(E-<) noles/1 I
I 2?-69 vr olds with ndvaaced
j aetastases.
1
I lanoea aad/oi vositing, aococitis.
1 Itukocrtopenia. platelet count
I suppression, nephrotoxicitv.
t lyelosappression, elevated serai
I creatlntne.
1
I DRUGS'! ORTG IBSBaPT: SEOPLISHS; BLOOD
t SIKH^; aOOLTS; aBHOnTIB COBPQVBOS;
\ CBMOTS^llPt
IB'EBEBCZ
Glode, l.B.
Fitnan. S.S.
Fnsainoer, f.P.
Posowsky, A.
Papathanasopoalos. B.
frei, T.., Ill
1979
Cancer 'Sesearch
39:3707-371*
-------
C20-R22-I8-05
il 454.46. gP 185 C (decoBp)
f ISSOB
Mood.
plasn
4848
Blood.
seres
-
4849
Cecebrosp
Inal
18-50
Orine
EXfOSOR ROUTE
Injection
Talectlon
injection
Tn lection
HBTBOD
BPIC
tnxy.atic
RH
m
HPLC
BDBB31
OF C1SES
3
3
3
4
.
81(01
a) 0.6X19(1-3) -
0.5X10(E-6) soles/1
b) 0.8X10(B-3) -
1X10 O-C| soles/1
c) 1X10 (S-4| -
0.8X10 (S-51 coles/1
a) 8X10|E-4t-9X1»(E-8)
•oles/1
b| SX10(B-4) -3X10(1-8)
aoles/1
•oles/1
b| 4X10(B-6)-7X10(B-8)
aoles/1
at 6,986-16,633 ag
b) 230-984 ag
RBIB
at lot givei
b) lot givea
c) lot given
at lot given
b) lot given
_
a| lot given
b) not given
») 10,952 + or - 4079
b) 486.5 * or - 337.9
aq
GBIEUL IBPOIMTIOI
at 6 aid 48 kr after 6 br IT, HPLC
c| 6 aid 48 kr after 6 kr IT, eazvse
Inhibition aetfcod
e) Metabolite. 7-Hyaraxynetkotrexate.
12 and 48 kr efter 6 br IT, BPIC
aetkoa
Cose, 290 >g/kq
latiaated ft on qrapb
«-22 yr old osteosarcona patients
CCRPHHITE miOlTIOBS:
CBITOTRBllPT; VBRBO ST1TIS; BOW
tISIlSTC; BBOVLaSSS; 910OD PUSH
a| with proteaecid, 1.7 g/sq s
orally, in 4 doses/day
bl lithont probeaecid
Talaes are 1-120 hr levels alter 15
•In IT of 3.0 q/sq n. Coatlnnoas
b {exponential aecllae. Data also for
constant infusion.
Cancer oatients. ages 20, 24, and 47
Ti.
lo toxic effects.
tines; t»us nrrmctioi:
CRIROmSlPI; »K>«l»SBS: BLOOD SBBUfl:
ciREStostiiiL riniB: SJTIBOIISII:
IID1TS! CB1IOREI
a) Bith proteaecia. 1.7 q/sq • orally
in 4 ao«es/diT
b) without fcobenecid
24-72 kr qeonetrie aeaas after 3.0
g/sg B IT over 15 aln. Large
standard deviations. Data also for
continuous In fa 3 ion.
Cancer natieats, ages 20, 24, ana 47
lo toxic effects.
HBSS; SRDG WTESJCTIO!!;
CBIHOTHMIPT; KOPlaSHS; BIOOD STSV1;
CtlZBROSPTftU. n,BIB; ICKlBCtlSH;
1B1ITS; cmiE8»W
a) (letkotrexate *
7-hTaroxy-sethotrexate t
2 . 4-aianino-R (1 0) -aethylpterolc acid
b) 2,4-Pla«ino-1l(10) -aethvlpterolc
acid
0-48 hr cneqlative excretions a'ter
ttart of >50 aq/kq, «-hr IT. Total
aeses 11.5-22.1 q.
Cancer patients
CF1GS: CHIHOTH'El'T: IT Sim ;
IIUBOLItrS; BBJS3SB1HIIT HETHODS;
ITOPLiSIS; ElStlSZS
——"——•
IBTEEEICB
Bovell. S.K.
•anq, T.-B.
Rosoya. B.
Satov. D.v.
1«80
Clinical Chenistry
26:734-737
Bovell. S.8.
Olskea. B.I.
Rice, J.I.
1979
Clinical Vharsacology
and Therapeutics
26 (S) :641-«««
Bovell, S.B.
Olshen, B.».
Pice, J.I.
1979
Clinical Phanacology
and Therapeatics
26l5):*41-6»6
-
Donekover, B.C.
Rande, K.E.
DraXe, J.c.
Cbabner, B.I.
1974
Clinical Pharaacoloqy
an4 Tkerapeatlcs
2f(1):53-72
OJ
VO
-------
6014
TMO-57-5
l*f 19«.»«5
iissSi
»8S1
BlOOd.
plasia
91oo4.
••ran
Betas
irla«
, HP W«*.7C C. V
"EXPOSOM soots
Injcetlo.
I.tactlot
I.loctlo.
Tajoctloa
p 2700 C. 1* 1 •• •«
auimcu
us
US
us
MS
at 186* C. 1
*'siao»i
aim
_— — — • " ~~~~~
810 .4 e«.alatl»« 4os« °*Bj.«»atol4 patlnt
Llf«-thr«at«.U9 tfcro.boeTtop.ala.
»«COT«CT att«r pr^alsoa* ana
«l.«rcaprol tkorapT-
SCIB: BSISOIIIBBBT nmoosi »«!"«!?"
mBBT-IS: SFMl POTSOBTW6; tISMSIS:
J"«sT I" »»«»5 BWOB SraOT:
BMM
-
a) 1st 2« kr
Pa*l««t« •«» cfc.taatol4 arthritis.
•fan aq« 57.1 • or - 11.3 Tr.
sen: WHS: «»«"»'"» "'"ISi'
etoeo s^soii: ITKBI: nets: BI«M»I
tmnBOLtsi: aDOtTS
— — UTBBMCB
ClUlc.1 Pb«r»acolo9T
and Tb«rap««tics
15|»»s35»-3«0
pal.«r, »i6.
1979
JOBTBB! of »nalrtl«al
Toilcology 3:2«2-2a5
Crennan, D.B.
pal.er. D.G.
1979 , ,
aoacnal ot inalytical
Tolieologr 352B2-2B5
Cll.le.1 Pkar.acol09T
an 4 Tknapevties
«{t)!35a-3«0
to
-------
C10-S16-I6-S
If 252.38
Biooa,
plasma
Xageatlo*
SBTBOB
__
BPIC
OF CISES
6
MISS
a) 0.02-O.S og/al
b) 0.3-1.5 ag/al
BUI
a) tot givea
b) lot glTen
GEIElll IfPOlBaTXOi ""
a) 60 aia after 200 eg dose
t) 300 ain after 200 ag dose
Istiaated froa qrapk
Realthr 2»-3fl yr old*. wt 65-78 kg
50* Inhibition of gastric acid
secretion with aean plasaa level of
0.78 ag/al.
IC11TS; B100T PL1SI1; IBTOIOMC
noes; nines
IEFESMCE
Gagler. 8.
Pocks, e.
Diekaann, B.
19S1
clinical Paaraacologr
and Therapeutics
29(6)s7*a-7»8
lazolidiaedione.
C8-BC-I«-05
n 238.16. II 270-272 C (deconp)
CT)
*85*
plasaa
-
4857
Uttae
lalectloa
Ingest ton
Inoastioa
laqestloa
«TBOD
me
Colorleetrj
•PIC
OF cms
6
a) c
b) 6
UIGE
a) 51.9-75.5 ag/al aia
b) 56.8-76.1 no/al aia
c) 59.5-75.5 og/al ain
a) 10.59-34.58% of dose
b) 3.67-U.13K of dose
a) 26-320 ag/al
b) 18-8* ag/al
Bill
~
a) 63.2 » or - 10.3
ng/al ain
b) 68.0 4 or - 6.6
c) 66.6 « or - 6.5
ag/al ain
a) 22.2* * or - 8.*3t
of dose
b) 9.52 4 or - 3.69*
of dose
a) 132 » or - 116
nq/al
b) 59 * or - 23 og/nl
6111111 IIFOllaTIOi
a) Oral, fasting. 50 ag dose
r) Oral. «ltk food, 40 ag dose
c) IT, 47.0-56.0 Bin infusion.
area ender concentration/tine carre
data
Healthy 25-35 yr olds, wt S2-80 kq.
itniTS; BIOOD PUSH; DBDGS-. osi»-;
cntBOUKS
—
a) 100 ag dose. Peek at 3.0 » or -
1.6* ar
•1 100 ng wltk "> g B
-------
Bydantoln. 5,5-diphenyl- (8 CI|
2.4-IniaazoUalnedione, 5.5-4iphenyl- (9 CI)
57-41-0
C.H-B12-112-02
B« 252.28, 8P 295-298 C
TlSSUg
4B59
Blood,
plasma
4860
91001.
plasta
4W1
BlooJ,
plasna
48S2
B lool.
plasia
(863
Blood,
plassa
ITWSHBS HOOTS
Tnqestion
Ingestion
Ingestion
1 11 lection
-
mumcu
BETBOB
SS
BM.C
Badionetry
sc
ColorinetrT
,__,
colorivetry
-
B0BB8B
or CISBS
7
2
a) 70
b) 39
.
10
12
BABGB
a) 1.13-1.11 nq/»l
b) 0.013-0.112 ag/al
c) 0.56-7.31 ng/«l
9) 1. OS- 3. 03 nq/ol
e) 0.011-0.053 ug/sl
f) 0.22-0,72 ag/il
a) 2.16-2.46 ug/nl
b) 0.0429-0.0554 og/«l
C) 0.560-0.602 nq/ll
a) Rot givofl
b) lot given
.
a) 0-32.5 ug/ll
b) 0-29.0 og/ul
a) 7-0.4 ag/al
111 4-0.38 ug/ol
/
-
(BUT
8E»S
a) Hot giTan
b) trot glren
O Hot given
d) lot given
ej Bat given
f) dot given
a) 2.31 ug/il
b) 0.0492 ag/ml
c) 0. 983 ll!J/»l
a) 14.134 » or -
10.987 no/ml
b( 12.90 > or - 9.152
lld/Bl
a) 15.4 »g/»l
b) Not given
a) sot applicable
b) not applicable
P»GF)
G1BSB11 IBFOBH1TTOB
a) pheaTtoinf oreaics
b) Tree 4-OB Ktabolite, uteiica
e) Conlngated 1-OH letabollte.
nteaics
d) Pkenrtoln, controls
e) nee 4-OB n«tabollt«, controls
f) Conjugated 4-OB «etabolite3.
controls (0-7 lays)
0-11 flays, 6 hr after 0.1 q/day, an
dose.
28-67 yt olda vith chronic renal
failure, nealtby 28-37 vr olds.
D11GS; DISD1SKS; HmcOHVOlSitlTS;
E100D ?t>5K>t OEIBE; COIIPAEHTHE
tVSimTIOBS; KIDIBT DISEaSIS:
BITaBOlISK; XBIJBOIITBS; SSEDBB;
I CUTS
,
a) Malta, at 1 hr, dlphenvlhTAantlon
c) Peats, at 0.5 and 6 hr.
p-bTdrotTphenyl vetaholite
c) Pe»*3, st 12 hr, p-hTdroiyphenTl
letabollte as qlocnronlde conlagate
Cose, 80.8 nq 14-c- labelled
dlphenTlhrdantoin acid.
B«althy 24 and 32 Tr olds, tasted
c«(ore and after dose.
ICOlTSi BtOOd PllSlla:
HTICOHVDLSIirtS; DBTOS; BBTiHOllSB :
KtTiBOHTRS
a) Bales, 2-4 hr after 5.68 • or -
6.24 nq/Vg
It Tenales, 2-4 hr after 4.37 » or -
2.90 iq/kq
Patients on nalntenance doses for
seizures.
IflTCOIVtlLSaBTS: DBBS THEBIPI: BLOOD
V11SHI; SET; DRBG IRT5BHCTIOB;
tlPBCHTlBTDanOIlS
.
a) Deternined by
alcrospectrofhotonetrie nethod. (lean
ditference between duplicate
dgternlnations, 1.0 aq/nl
t) fy a Mcro-nethod at a pabllc
hospital laboratory, 12 specinens
lean difference between nethols, 1.3
oq/il.
DBH6S; aBTTCCBVnLSanS; HKtSBfERKT
BFtBODS; B10QD PlUSBa
a) 10 nln and 72 hr after 250 ng IT
at K nq/iln. Blaiponential decline
b) 15 an] 120 hr after SOO >g IB In 4
sites. Initial seasnrenent, 1.6
oq/nl. tstlBated froe qraph.
Sealthv 20-31 ft olds nt. 57.9-79.5
*g.
DBOI55; KBTtCOBTni.SaB1S: BIOOO PtiSIU;
HOtTS; OBIBI: CONPaBITITI
fvumnoBs: RITUOIISB
BE?E«EBCE
Borqa, 0.
Boppel. c.
odar-cederlof, I.
Garle, 9.
1979
clinical Pharmacology
and Therapeutics
26(3) : 306-314
.
Albert, K.s.
Ralinark. a.f..
Saknan, E.
«e Idler, D.J.
Vaqner, J.s.
1974
Besearch Costtanicat'ions
In Cheslcal Pathology
and Pharnacology
9(3)!4«3-4«9
Schaeffer, D.J.
Janardao, K.G.
Soiani, S.
-------
BTdantoiB, 5,5-dlpheBjrl- (I CIt
- c»
C15-B12-»2-02
II 252.26. DP 295-29* C
(COITIIVED)
»86»
Blood,
plasaa
•865
Blood.
plasaa
• 866
Blood,
plassa
1867
11004,
—
Injection
Ingestlon
Inqestion
Injection
Infection
alaLRTCll
HBTBOD
Colorlsetry
GC
GC
GC
Badlonetry
- -
lOHEES
or cisis
i
6
1
1
„ .
MICE
108.5-0 og/al
a) 9.0-3.9 ug/al
b) 7.6-3.3 nq/Bl
a) 11. 9-10. « og/al
b) 11.1-10.3 Bg/al
9.5-3.75 BBOles/1
SHI
lot applicable
a) lot given
b| lot given
a) lot applicable
b) lot applicable
lot applicable
(MIT P.GB)
GEIIB1L IirOSBlTIOI
2« hr aad 11 days after last dose of
. Soae data estiaated froa
graphs.
tealthy 22-32 yr olds, fasted 8 kr
before-3 hr after pheaytoin .
ttoes; BIOOD FUS«I: JDTLTS:
CC1PIB»TITE EVllOUIOIS
a) Entering heaodialyzer
t) leaving heeodialyzec
Talves are froa 90-330 Bin of
heaodialysis starting 12 hr after a
fourth daily dose of 900 >g 17. S3.6
•9 total drug in dlalysate after 9
hr. 31-38« of plasaa drag
Frotein-boand.
21 yr old unite nale with history of
renal failure, essentially annric.
hospitalized for renal transplant.
DIMS; DHOG T.BEH1PT; BIOOD PLISHlJ
1COLTS; DISUSES; imCOIVOLElIITS
«-20 hr after 10 ain It, 100.21 »g,
labelled dose. IT infasioa of 100
•g. para-hydrozyphenyl aetabollte
over 1« hr.
Healthy snblect. nonnedicated >« «k.
MUGS; RET1EOLISR; (miBOHTES;
EltT«E3; 4DOLTS; H1IITED KIBGEOB;
HOOD BtaSHl: alTICOITOLSIITS; OTOG
IITmciIOl
— — — — — ______ ___ — _
" BEnancl
Praltt, l.».
Zsiren, G.T.
Patterson. J.B.
Dayton, P.e.
Cook, c.E.
•all. B.E.
1975
Clinical Fharaacology
and Therapeutics
18(H:112-120
Fraser, D.G.
ladien, T.H
Sotherland^ E.v.
1980
Clinical Pbanacology
and Therapeutics
27 (Z): 165-169
Idler, D.S.
Hart la, t.
Gaabertoglio, J.G.
Tozer, T.H.
$pire, j-p.
1975
Cllalcal Pharnacology
aa« Therapeutics
18(1):65-69
Peracca. E.
Bakkl, X
Bichens. ».
1978
Clinical Pharaacology
and Therapeutics
2«(1).»6-51
_. „
CO
-------
Bydaatola. S.S-4i»heayl- (8 CD
2,*-I*llexoUdI.M41oM.
C 15-112-12-02
fl 252.26. «r 255-2*8 C
TISSUB EIPOSOBB BOOTE | 1BU.TTIC1I
1 BVTBOD
1
1
»i68 lagestion OC/iS
Blood.
Beraa
1
1
1
1 |
1
«IC9 f lagestiaa BI1
Blooi. 1
sent I
1
1
1 1
1 1
1
•870
Saliva
f
1
1
1 «871
ITOBBSB
OF CISSS
W
7
MICE U1B | EBIBUI, nWIBMIOI
1
1
1
a) O.i-23.2 *g/l a) Vat «i*ea I t) taaae of 'peaks
b) 0.33-22 ao/1 fe| fat give* 1 »( Baaea of *eaa«
1 C, *, 8. <>d 12 kr after doses
1 raiflaa trot 4,0-17.9 ag/kg/day.
1
1 IpproxiMtvly 2 ao-20 yr olds
I lospitalizad for seinres.
1 itnss; DIHC IBEUPT: ciiiDBEf;
( TiPirtS; imooirOLSutS: BLOOB smrn
i
1
a) 9-22 "iolos/1 a) fat given ( a) 2* kr after 300 a?
b) O.SB-3.C aioles/1 b| Bat giren 1 t) 72 kr attar 300 a*
I 1550 aa aspitla at 72 hr loirered
1 plteavtoin by 2T.*t otec 2 hr values.
j fitleated free ?rapk.
1
1 lealtkv 23-3« yr olds, Tt 50-80 kg.
1
I tioss: Dene trtitictioi: BEOOD snoa:
I IBBITS: SHItl: tniCOBTOlSlBTS;
I iBuetstcs: JUIPTIIIICS; BIB
I I fflllBB! VRiBOUSB
1 -------- J
laoestio* Bit 7 a] 0.«8-l. i vaoleayl a} Vot given I a) 2» he after 300 eq
1 b| 0.055-0.18 i*ol«a/l b) »ot aivea I k) 72 kr after 300 •«
j I Eatieated frca grapk
1 1
1 Sealtky 23-36 re olds, »t 50-80 kg.
1 1
1 i tnss; one insBicnoB; BIOOB SEBIIB:
I I jstJiTS; siiiri: i»ricoiTtn.s»rrs;
| I MllGFSICS: imPTBETICS; »U
1 THIUV: miMtXSI
1
XaeestioD
1 Urins |
1 1
1 1
1 1
1 1
1
1
1
•
1
«872
Vriae
lafectioa
BS « a) O.M-1.2JT of lose a) 0.92* ot dase | a) tkeeytoia
sc
b) 0.78-2.01 of dose
c) S2-9VX af dose
12
_____
a) 156. 1-22«.3 •<_
b) 183. t-«25.3 aq
_ .
b) l.ac of lose I b| Ree <-OB letabollte, e)
lETEIEtCE
DOdCOB, f.S.
1990
Clinical Pkaraacology
and T*erapea.tic9
27(5)s70»-7«7
Paiton, J.I.
1980
Cllaical Phanacology
and Rierapeatics
27 (2fs 170-178
taiton, J.».
i9»a
Clialcal Pharaacology
aad Tkerapeatics
27 (2>! 170-178
. .
orga, O.
ippel. c.
c) 77« of doae | Conjugated a-OB aetabolite f odar-cederlof, I.
1 steady state artaary recovery fraa t Carle, B.
1 12-kr daytiae collections. Beaas af r t979
t * days after 0.1 agxdar, IB dos*.
1
1 Bealtkr 28-37 yr olds.
i
I cues; DISUSE! kiriconnisuts;
i ficco tttsii; OB in; coirutiraTt
t ETltnilOBS; KDIBT DISS15B5:
1 BttlBOLISIJ UTkBOlITSS; S»IEEWJ
1 ItfllTS
1
a) 187.« >q | a) 2S8 aa IT at 25 aq/ala
b) 3*1.8 *g I t| 509 a? Tlf ia » sites
1 120-kr eaealatlve excretloaa of
1 9-p— hydroxypbeayl-5-pkeaylkydafttoin.
1
1 Icalttiy SO- 31 yr olis et. 57.9-79.5
1 *fl.
1 ISMS; irricoaTJisins: BLOOD HaSRt;
i HOLTS; ntm: ccwmtiTE
1 ITIM1TTOHS; BnkBOlISfl
1
Cliaical ?haraacology
and nerapeatiea
2«f3|:30«-31*
Kosteabaader, B.B.
Bapp, t.P.
RcSovera. J.P.
roster. T.S.
Terrier, 0.6.
Blacker. B.B.
guloa. B.C.
riakel. l.«.
1*75
Clialcal Fharaacolo^y
ana Ttenpeatics
18 (») j »»9-«56
VO
00
-------
Bydaatola, 5,S-dipl«Byl- (8 CI)
2.«-Isl4azolidlMdione. 5.5-dlphenrl- K CI)
57-«1-0
C1S-B12-B2-02
if 252.26, » 295-2*8 C
(CORIIVED)
tissni
4873
Crime
EXMSVBE BOUTS
r»1«etioB
Tngestioa
.
aMZTtlCll
BRBOD
ec
BOBBER
OF C»SBS
1
I1I6E
261.*-38.« na/dar
Ull
tat applicable
6EIIUL ZTF01B1TXOI
Car 1 *nd « after last dose of 500
•q/dar, (101 precrllMd dose), falves
iKlaa* •- »d p- hTdcoiT phenyl
•.
5.S re oU, *t 19 *taqna aad lateral
qaie aystaqaas foe T 4*ra or leas
after last «o»«.
BROGS; CHILBBCT; USOH5I1;
itnoowToisiRs: BLOOD msti; mm;
eisttotiTESiniL SISTSS: BBUS TBIB»PT
BEFEREICE
froitt, l.».
Iwiren, S.T.
Patterioa, 3.E.
Darton, P. 6.
Cook, C.E.
wall. a. I.
1975
Cllalcal Pharaacolo^r
and Therapeutics
18(1):112-120
Ijdraiia*
302-01-2
H-I2
B1 32.05. » 2.0 C. BF 113.5 C at 760 n Bg, SC C at 71 aa 89. 170 C at 5 ata
1ISSBE
Htlne
EXMsuts soun
MUniCU.
HBXBOD
ec
E0BBES
0? cisss
IIB6E
a) lot given
b) Bot given
c) lot given
d) lot given
HE.B
a) 0. 48K of dose
b) 0.075S of dose
et 1.0* of dose
d) 0.21% of dose
GVItltli XBFOSfl&TlOB
a) Slo* acetylators. 100 sg dose. 7
a«b -Jests
h) ?ast aetrlatots. 100 sg dose, 13
aeblects
e) Slow acetrlators. 200 nq dose, 9
cableets
d) Fast acetTlators, 200 aq dose. 11
2* br nrlnes. Sim and fast
acetTlators differed at both doses.
p<0,02 and 0.001. resBeetiTelT
(TpecteaslTe patieata
HTJS3; 18111; BIITBS KIB6DOI;
BflSinVHBR BBTBOOS; BIZTflXS;
SITIBOITSH; IRtBTFSRElSIVI 169RS:
ccsp.sativz mtaiTiois
KFEBEBCE
Tlnbrell. J.I.
Bar-land. S.J.
1*79
Cllalcal Pharaacoloqj
and Therapeatics
26(1): 81-88
OJ
VO
VO
-------
co-sc-o
B« m.17, in
nssit
»8T>
Blool.
glasia
M76
•lool.
plasaa
1
1
> 1B*-1«8 C, BP 2
EIPOSHBB BOOTS
Ingestlon
Ingestian
DO C (sole decoap)
imYTICU.
BOTBOD
HP 1C
-
BPIC
BOSSES
OF C1SBS
15
*
~~ iiiss"
a) 0.7-0.17 «g/nl
b) 1.8-0.5 nj/sl
e) 0. 1-0.65 ug/nl
,
0.03-4.3 »g/»l
'
BEaB
a) Rat 9 Iran
b) Wot given
c) Bot glren
Hot jlTOB
— GZHSII iBPOBBiTioi
al 2 and 8 ar Mans after 69 »g
S^S'S's.'LSS'SSc M .,
r".e"&~Kon£.toi.. 2 ..* 12
hi after 60 iq »ethiM*ole. 1 patient
tt«.lo«l7 "treated '»-f7.JrKo" ,
.,p«rt»iroU patients. «t »».5-SS.8
kg. United «io-"•
Bclsrty, B.C.
Kalk, »-J-
1980
British Journal of
clinical P»ar«acologr
9:137-1»3
Knight . B.I.
Otter. B.
to*. L.C.K.
lleiander. "-B-
1980
British Joarual of
Clinical Phar»acolo»T
9!l«5-1»7
-..t*xr2-.etj7tl-y(. °»a,
o
o
- ttsg,g —
• 177
Jlool.
pla-na
•878
Blool,
plasaa
p different forss
flfOSVB! BOOTS
Ingest ion
Ingestion
155 C, 16Z c
lialTTIcil
»rTBOD
ec-sc
us
BBBBSl
OF CaSBS
«> 1
M 1
5
.1 _
B1BSI
•) 68-7.2 ag/nl
b) 390-120 ng/nl
0.31-0.63 ng/Bl
l«r
. . — —
gin 1
., ,ot applicable I •> Change ^^^'H"^.
b> Bot applicable 1 »s™;| Vstag error (2.0 sg/*»)
! Presatvre Infants »ith patent dnctns
I arterlosas. 27-28 »k qestational age.
! Failare to achieve permanent d«otal
1 elosare.
T ereaaed senn bilimbin. aecreased
J iriaarr e«tp«t, redooea platelet
I aggregation. SI bleeding.
! tsnss: WOG TBSBIPT; IBFIBIS:
| fUBSTtflMIl; CIBDIOTISCUL18
| TX9I&SBS: B1COO PLISnfc
« .1. .«m 1 Stead* state levels after 25 ng
O.K79 «g/nl J 3T/anT for «-» 4«T»-
' BealthT 22-29 yr oH nedical
students, on no other arags for >1»
I dat«-
1 D11GS- WDSB; CEinXTOID IOTHSITIS-.
1 BIOOB *USM: coaniKttB
| IftlOmtTOHS; CHIOSW OTS111C
t vmn
BERBBCE
rriednan. I.
Whltaan. T.
Balsels. B.J.
Sersan. B«. Jr.
Harks. K.B.
T«sell. Z>s.
1976
Joarnal of Clinical
Pharnacologv
18 (S-«): 272-279
llvan, G.
orne, ••
Pertilsson, 1.
rkstrand. t.
Palner. L.
Clinical Pnaraacology
•«d Therapeatlc*
1«(3)s36»-373
1
«____
-------
C19-H1S-C1-B-0*
•• 357.81, M diffsrest fora* 155 C. 162 C
CIJ
ixssn
»B79
Blool,
plena
••80
Blool,
clasaa
*mi
a«r«n
BlfOSBBB R001E
.
IngestioB
Inject Ion
Inlectlon
BBTHOD
BC-BC
CC-BC
OC-BC
BUBB3B
OF CUBS
at 2
b) «
c| 3
aj 8
bt 9
37
MICE
•t 0.027-0.052 «
-------
ItOD
It" 5S.S«7, BP 1535 C (pore), 1000-1300 C (cast). 1500 C (novgfct). 1300 C (steal), BP 3000 C. TP 1 u Hg at 1787 C. 10 •• Hg at 20«0 C
TISSOB
4882
Brine
BXPOSOBE BOUTS
Ingest ion
IU1TTTC11.
BBTROD
us
IVHB2B
OF CASES
10
sues
•) lot given
b) Hot given
mi
a) < 2 ppn
b) < 2 ppn
CIIEB1L IIFOBBaTIOI
•) lean daily intake (supplemented)
ef 66 mg, fecal lass af 111 sg, Jata
froi 2* 7-dav experimental periods
t) Bean daily intake (nnsepplenented)
of 18 mi, fecal lass af 16 sg, iata
Iron 19 7-day experimental periods
University stadents and enpleyees, a
narse and a teacher. Unlliparous,
ages 19-Z9 yr.
TIIfESSEE; 01IIZ; ISOW; calCIOH;
B1S>BSIQH: BIREBUS; PHOSPHORUS;
CUTS; IHtBiL BBMBOIISB; PEEGMlICT
SiriSEHCE
iste, j.e.
Schofield. r.E.
Gran, R«B*
1979
ineriean Joaroal of
Clinical Intcition
32:2««-291
leonicotlnic acid hvdraziie (8 CI)
V-PTridineeatbezrlie add, kydrazide (9 CD
5»-85-3
C6-H7-»3-0
II 137.15, RE 171.* C
TISSU!
0883
Blood,
vhole
EIPOSDH RODTE IHLTTTClt BOBBBS
ItETHOB 0? CASES
In-tection Flaoronetry a) 1
b) 1
|
1
1
1
|
i I
I
«88«
tJriB*
1
Digestion
Sadiosetrv
~
7
8»GB
a) 28-0.9 ag/nl
b) 22-3.0 ag/nl
a) 2. 2- 3. 61 of dose
b) 9.0-12. »t of dose
c) 2.0-5.1* of dose
d) 16. 1-32. S* of dose
e) ««.0-52.«S of dose
f) 32.6-3».3T of dose
9) 37.2-51.0' of dose
h) 25.5-38.7* of dose
Mil 1 "SEBIBIL tiroBBltlOI
1
1
1
a) lot applicable 1 a) Rapid aeetylator. 10 and 250 nln
b) Mot applicable I after f..2 sin IT of 670 nq
I b) Slo. acetylator, 10 and 425 nin
1 after •!.» nin IT of 681 nq
1 Tiezponential elinlnation. Estinated
1 fro* graph.
1 Healthy Caucasians, 29 and 50 yc old.
1
1 DBUGS: I'TiBClITES: RlSOREIEirT
1 5E1BODS: OSIIB; BtOOD; JLDILTS;
1 PITIBOLIS1; COBPJRITTTE ETlLtHTIOItS
1
a) 2. OT of dose 1 a) Isoniazid, 3 fast acetylatocs
b) 10.91 of dose 1 b) Isoniazid, 4 slov acetylators
c) 3.6* of dose I c) Isoniazid kydcazones. 3 fast
d) 26.51 of dose I acetylators
e) 09.2* of dose I d) Isoniazid hydrazoaes, « slow
f) 32. I1 of dose | acetylators
g) sa.«« of dose I e) leetrliseniazid, 3 fast
h) 30.5* of dose 1 acetylators
1 f) Icetrllsoniazid. « slov
1 neetylators
1 g| Isonicotlnic acid netabolites of
1 acetylisoniazld, 3 fast acetylators
1 b) Iscnicotinic add setabolites of
1 acetylisonlazid, * sloe acetylators
I Values for 2«-hr urines after •>
1 sg/kg.
1
1 Bealtky 26-39 yr aids, on nornal
1 diets and taking no nelications. to
1 hepatic or renal disease, fasting 12
1 br before and after lose.
1
1 CBTCS: OSVG THSS4PT; HRtB01IS8:
IIUYtltO: UBIBC; COBP1B1TI?!
1 ITlLOiTIOKS: tDOLTS
1
HMEBESCE
Boxenbann, R.G.
Biegelnan. S.
197*
Joarnal of
Pharmaceutical sciences
63(8|:1191-1197
Hitchell, J.K.
Thorgeirsson, 0. P.
Black, B.
Tinbrell, J.5.
Snodgrass, ».P.
Potter. t.Z.
Jollov, D.J.
Feiser. H.5.
1975
Clinical Phamacology
and Therapeotics
18(1): 70-79
inn *»sei
O
ro
-------
Keaieotiaic acid hydras-lde (8 d}
4-PrrlllBocartnxTllc acid, hrdrazldei (» ci)
S4-B5-3
C8-H7-I3-0
CI 137.t5, HP 171.4 C
(COITIIOBD)
4885
Urine
BlfOSDBE BOOT!
Injection
1111 IT 1C U.
BBTBOD
—
Colorisetrr
IVIBra
or cisss
a) 1
b) 1
1U«B
a) 0.8-0.025 ag/ain
b) 1.0-0.15 Bg/ala
- -
BB1I
a) lot applicable
b) lot applicable
Giinii moBUTioi
a) Bapil acetrlator, 10 and 570 aia
after 5.2 ain IT of 670 ng
t> Slow acetrlator, 10 and 570 aia
after 5.4 aia IT of 681 ag
values for Isoaiarld plus its
brdrazoaes. Bstlaated fros graph.
Bealthr caaeaslass, 29 and 50 yr old.
BBAIGS; 1BTIBOIITBS: M1SOBBBEBT
RI1B093: QBIIE; BIOOO; »6tltS;
RETHOIISB; COBPHWITB ETIUJITIOIS
BETEBEICB
Boxeabaaa, B.e.
Klegelaan, s.
1174
Journal of
Pharaaceatical Sciences
63(8):1191-1197
I«oalp«cotic acid. 1->«tb}l-«-pae>fl-. atari «at«t H ci)
J^'i?*? iUMearbonrlle acid. 1-aethil-a-phenyl-. ethyl «»t«r (9 CI)
5 f™«»2— »
C15-B21-I-02
R« 2«7.35. flt 196-189 C
1
1
«886
Blood
»8«7
Blool,
plasia
«8S8
91001.
acna
EICOS4BS MVTB
lalMtlan
I«1«ctlon
r«i«ctioR
•
1BU.TTIC11
imoD
ec
9C
OC
•DBBSB
Of CiSES
«) 2*
b| 13
a) 1
b) 1
a) 6
b) 8
c) 6
BUSS |
1
•) 11-162 ag/»l
b) 40-99 ag/al
a) »-0.3 «*/•!
b) 30-0.* aq/al
a) lot applicable
b) lot applicable
c) lot applicable
(HIT
Mai
a) 95 » or - «3 ng/al
b) 6* + or - 22 nq/al
a) lot applicable
b) lot applicable
a) 12* » or - 11
nq/al
b) 13* « or - 24
»a/»l
c) 130 » or - 22
nq/Bl
PICI)
GCItlal IIFOBBaTIOB
al ViBllleal cord. TeaoBS, at birth
*) Uablllcal cord, arterial, at birth
Bothers received 50 mg darlag labor
levels decreased as drag-birth
Intervals lacreased
14 black. It caacaslaa Beoaates. BOBB
4*atatlOBal age 39.4 wk, eeaa birth
at 3310 g.
OBIGS; pirsiiKT: BIOOO: OKIE:
SWlBOlTtlS; 0«IO; 7HBIHCH COBD:
IMB01»
a) 15 all aad 9 hr after 5 aq/kq
S»se. laitial eeasareaent 3 aq/al at
5 all. irterial vessel clasped
tetveea 1st and 2nd hr
t) Initial aeasBreaeat and 9 hr after
5 aa/ka dose, irterial vessel
clasped betveea 1st aad »tn hr
Sargieal patieats vith peripheral
vascBlar disease
ClSDIOTlSCIJtlB DISUSES) BIOOD
E11SH1; IIIIGESICS; DBQG TBIB1OT:
oancs
a) Bea, peak at 1 hr follovlag 50 sg
II of the hrdEochloride
t) losea. peak at 1 hr follovlag 50
ag IB of the h7drachlorlde
c) Vosea OB regiaea of
eatrogea-progestia oral
contraceptive, peak at 1 hr folloninq
50 sg It of the hTdrochlorlde
lealthv 21-2* ft olds
IC01TS; BIOOD: BtOOD SBBUB;
II1LGESICS; CBVG HTCT1CTIOB; OB1L
ccnticBPTiTis: DBDG TBEIIPT:
IIICOTTCS; VBIIB
lETBIIEtCZ
Kahaert. B.I.
Rvhaert, t.s.
Ta, 1-S.l.
LIB, D.C.K.
1979
laerican Joarcal of
Obstetrics aad
Srnecologr
133 (8): 909-91*
Koska, I.J., III
Kraaer, t.6.
Rosagaoli. i.
Sabavala, P.B.
1981
laesthesla aai
laalgesia 60(1): 8-11
-
Stasbaagh. J.I.
Vaiaec, I.w.
1975a
Jonraal of Clinical
Pharaacologr 15:46-51
O
LO
-------
S7-82-1
C 15-B21-I-02
II 2*7.35. SP 186-189 C
TISSUE ~ IIKSnl MOTE
• 889
orlne
•890
Drlne
«891
Urine
1
'
*-plperiainec
77-17-8
Bl 233.3*
IISSOB
«892
Blool
Injection
Injection
Injection
•xrosots tome
Injection
IHLTTICtL
RETBOD
«C
ec
oc
ilUTTICIL
flSTBOD
«C/»S
IBB BIS
b) 8
el 8
2*
8
r (9 CI)
b) 10
(COBT
8 USE
a) »o* applicable
b) lot applicable
c) lot applicable
lot applicable
0.5- 1H. 25 ag/»g
creatlnlne
"~ MISS
a) 5-38 ng/sl
b) 2-*2 ng/al
HUSO)
IE1I
a| 3.17 ng
b) 3.66 ag
e) 3.67 ag
3.27 ng
lot given
GBMlll IIPOtBaTion
a| 6.3t of aose, sen
b) 7.3^ of aoae, iionon
e) 7.«« of aese, »onen taking
eatrogen-progestin oral
contraceptives
*l hr ensalatlve excretion after so
•<) in of the hrarocliloriae.
Bealthf 21-28 yr ol«»
1B01TS- OBIIE; HllGESICS; DBOS
IRBIICTIOB: osn corrtiCErnvES:
DIBS IBBtaPTi BtOOD» BWOD SBROH!
IIICOTTCS
— — • : — —~—^~~~
«l hr c«nnlatlve excretion, following
50 ng« IB as hyacocbloriae
B«althv 21-30 yr oias
n|T|£. alKl'CZSTCSS COHPftBaTITB
EV»HJ»TIO»S: B»*coTics; oaoss
—
Bothers recelvea SO ng anriag l«bo'-
revels (estlnatea froa graph) anMag
first 3 aays of life. l*"»J* '•Fj;fll
•1th aay of collection ana arag-blrth
Interval. Clearance not conplete at
lays.
1* black, 16 Cascaslan neonates, nean
aestatlonal age 39.* «k. nean birth
•t 3310 g.
nines- PiBSilicy; BIOOD: OBIIE;
BII1BOLTTE3: OHO: OSSI1.IC1L COBD:
IKBOII
tEFEUICZ
Stanbangh. 3.t.
(alner, !•••
Journal of Clinical
pkarnaeologr 15s»«-51
Stanbangh, J.E.
•alner, I.I.
19T5b
Jonraal of Clinical
Pbacnacology 15:269-271
Knhnert, B.B.
Knbnert, P.B.
to, t-s.l.
tin. D.C.K.
anerlean Jonrnal of
Obstetrics aaa
Gynecology
133(8) :909-91»
iizii
a| 17 * or - 1* ng/nl
b) 15 » or - 13 ng/al
GSIIBII. IIPOSB1TI01
•t Onblllcal eora. venoos. at "jfjj|
c "•blllcml coci, arterial, at birth
nothers received 50 ng noperiaine
Jnrlnq labor
levels nnrelatea to arag-blrth
Interval.
1* black, 16 caacaslan neonates. jean
qestatlonal age J9.» vfc, nean birth
•t 3310 g.
CBOGS: PII6IMCT; BtOOOS OBI*!:
BtTWOtlKS; OHIO; niiBiliCM COID:
IIWBOPI
fBCZBB**-*
Knhaart, B.S.
irahnert. P.B.
IB, »-s.t.
Lin, D.C.K.
1979
Inerlcan Jonrnal of
Obstetrics ana
Gynecology
133(1): 909-91*
litir PNSBI
-------
XsoBlpscotIc acid, a-Bhearl-, «tfcrl ester (» CD
ac"' «-H"«Tl-. etkrl ester f> CI)
C1I-B19-I-O2
It 233.3*
tissm
*M3
OrlB*
•89B
flrlae
urine
S7W-77-*
«-OT-C12-»
M 239.55
TISS1I
»89«
Blood,
)>!•*•«
ETFOSVIE BOOIB
fCOMIIVED)
iBJeCtlOB
Injection
lajectioa
OC
ee/ns
•tUBBI
OF cms
a) 8
b» 8
3 8
2*
a) lot applicable
b) fot applicable
c) lot applicable
lot
0.6-3.75
cnatlala*
Mil
a) 3.3* mg
b) a. oi 19
c) 2.53 19
3.69 ag
lot giT«n
7.e-dlckloro-1.2,3,*-tetrakTdro-, hydrocklorUe
1-B
BXPOSOn 1O01B
aiutncu
BETBOD
»BB!B
or caszs
(BIT* •!<:•)
esiiui TiroBiitioi
a) C.7* of dose, eea
b) 8.01 of dose, woaea
c) 5.1* cf dose, loaan taking
contraceptives
•8 fcr caanlative excretion after 50
BO, IB of aevexldlne kydrocklorlde.
BealtkT 21-28 Tr olds
ami: iiucMics; OBOG
•I0»; 0111 CORS1CBPTITES;
«JO« MSBMTJ aiOOD; BMOB 31108:
HtCOTJCS
«« kr cnanlatlve excretion follovlao
50 ag. M as kvdrocklorlde
BealtkT 21-30 jt olds
iiic«Tics; ranes
Cotkers received 50 «q dose
Beperldlie daring labor, levels
leitlaated froa grapk) daring first 3
days of life, levels varied with dav
of collection and dr«g-birtk
Interval. Clearance not cotplete at
3 days.
1* black. 1C Caacaslan neoaates, aean
geatatloaal age 39.* »k, B«aa blrtk
vt 3310 g.
Dines; -piisiucy: SIOOD; nun:
ertiBoiiTss; onio; ntsnicii coiv;
•IIBOBl
BWMIJCS
Staabangh. J.E.
•alaer. 1.1.
1975a
Joaraal of Clinical
PkarBacologr 15:«<5-51
Staabangk. J.!.
•alner. l.B.
1975b
Journal of Clinical
narnacologr 15:269-271
Kahnert, B.I.
Knkaert. p.B.
19. l-S.l.
IlB, D.C.K.
1979
laerlcaa Journal of
Obstetrics and
O
Ul
133(8):909*91«
6s»ui iirosuTioi
.,. X.UU1
° s Kt
lealtby 21-33 yr olds, vt 59-95 *g.
llld gastrointestinal effects attec
kr. Fatlgae or sleepiness after 2
! «KT«S: BLOOD PLISHI,
Clinical fkarsacologr
and Therapeutics
25(6): 837-8»3
-------
IT987-77-6
C9-B9-C12-B.C1-B
BB 238.55
(COBTIBOBD)
Kalthy J1-33 Tr oias. «t 59-95 kg
•114 gastroi«testlaal effects after 1
Ji. ?atig«e. or sleepiness after 2
br.
Dabb, J.*«
State, H.B.
llexanaer, T.
latoccia. ».P.
GeeiT. ••
pe»ai«ton. B.G.
clinical Jharaacology
B»a Therapeatics
25 («J : 837-8*3
I-lscorblc acii
50-81-7
tissoB
•898
*899
plassa
BIPOSOBS tOVTt"
ingestiOB
I.gestlo*
illtTTIC«i
or cisss i
i •
, J a) 5».89-7J.83 ug/10(B*8|
i b)"*. 19-77.97 ug/10(B*8)
l cells
cTi*. 88-60. IS ug/10(B»8)
1 cells
i d) *S.07-*3>85 ag/10|B»8)
j '•71M.61-al.13 «g/10|B*8)
i f) BS. 95-37.8* ag/10|B»8)
| cells
1
1
1
1
1
t
1
1
s ! a) .57-2.16 ag/100 .1
6 J w -6»-2.83 ag/100 al
I el . aa-2.63 ag/IOOal
d .13-2.17.9/100 al
. .36-2.60 .g/100 .1
| f) .30-2.66 .g/100 al
1
1
1
1
1
I
1
1
1
t
\ \
» — l — "
sir r «««" »""""•
b) Bot gi»ea j Jf*!0I*,!a'12*Br*aft«r*W« ag plas 300
e) Bot girea J» .^^.licylic acid (»s«.
4) Bot gi«. j J^JHe talae. 63.7* ug/10(E«8) cells
?! It ai»en 1 c' '•' *** * *r **J*r «S g|
II ™ » I 19 *S1. Preocse Tane. *
I na/10(l«8) c«ll«^r iflM M plnj M0
I ag aS(. Predose »alue, *3.»8
1 «00 ag »S». Predose Tain*. «3.«1
1 09/'j"(" ' , after 2000 .g plas
i 600 ag »S»- Predose »alne, «2.7S
I 09/10(^*8) cells
1 leukocytes
I B«althy stadents. aoasaokers,
! S.iJersitT of 9«bUa. Trela.a.
! T»n»iii): »D«IS: WOOD; SIOOD PIIS»»!
1 ItDKOCTTZS; II116BSICS; VBOG
j ii?mc*ioi; Tir.gBS; TitMnr c
ii05 u<3 2 hr after 500 ••
b) Bot gi»ea j '"J's'.JU^'hr'aft.r'sOO ag Plas 300
s - '-« S.Ss'S.jr^'SJift^ soo
e) Bot gi»ea !• n 5 a««" hr after 500 ag plas 600
f) not giTea I «£ J-^ Pr«jMe »alae. 1.0* ag/100
j a? 0-5 aad 2 hr after 1000 ag plas
1 600 ag *S&. Ptedose raise. 0.63
! J^J!' «d 2 hr after 1500 ag Pl««
1 600 .9 »S». Pceaose Talae. 0.66
| fTo1!? ..a 2 hr after 2000 a, Pl«
! 600 a, »S». Predose »alue. 0.65
1 ag/100 al
! icalthT stadeats. noiisaokers.
T 4 *•* rtff Utttl.L'B It^lASO*
l ', unuit: wflitsi B«.OO»S sioot pussi;
> , IMKOCTTBS; »'^*^!:,I"BH c
*( . \ — "~
lEFEBEBCE
•>_«, • 5
J,O n f n»*«
(ilsoa, C.S.B-
journal of Clijical
Ffcaraacology 15:36-45
loh, U.S.
vilsoa. c.».s.
joaraal of clinical
Pharaacology 15: 36-* 5
|
J
t
1
1
-------
t-PcsllM, 1-(3-Bereapto-2-«ethvt-1-o*opropyl)-. (S)-
«2571-8S-2
C9-B1S-I-03-S
II 217.31
TISSOt
»900
Blood
*901
urine
nrosBBS soon
Inqestion
Inqestion
alUTTICll
BETHOD
ILC
Badiocetry
ttc
Sadiovetry
ITTBBKI
OF C»SBS
10
10
EIIGB
a) lot given
b) lot given
a) lot qivea
bj lot give*
c) lot given
4) lot given
BUI
a) 800 » or - 7(
ng/al
b) 1580 » or - 90
ag/al
a) 38.1 » or - 1.99*
of dose
b) 1.»8 » or - 0.15*
of dose
e) 26.2 * or - 1.11*
of dose
Jim ff JM f.M JIAMM
Q| W.Vn OZ QOSv
(S.E.)
GZIISlI IIFO1I1TIOI
a) Bean peaX at 0.93 * or - 0.08 kr.
»cliaa4*d ietg
t] B«as peak at 1.05 » or - 0.08 hr.
total caaioactlTitj (as captopril
•qaivalanta)
Ifter 100 mq. labell«4 dos«
laalthr, 18-35 ft old eancaslaaa. »t
S». 2-85.0 ka, fasted before and after
dose.
IITIRTPSHTBISITX 1GERS: BLOOD:
I1III: FICIS; RR1BOLITIS;
BIDIOISOIOPfS; UOI.TS
a) Captopril
b) Captopril dlsalflde
e)
-------
•7-22-7
rasa—
»»OJ
Bll*
•*0»
91004,
plama
(905
Vrla«
tifoson BOOM"
Injection
In1«ctioa
ln-)«ction
illlTTICil
SSTHOD
taaloMtn/BWC
—
BaBioaet rr/9*1*
I01BR
or casts
i
1
i
»»••»
21.7-1. •< «* a°**
28-0.5 •»ol««^
21.6-1.5* of «o««
•at applic«til«
lot applicable
tot applicable
jaekoom. ».*•
S«ad«r,
Cllmical WiaraacoloaT
and
JacfcsoB, D.T.
castl*. 9-c-
Cl la leal SharaacologT
and Tk*r»p»aticB
2»|1) ! 101-107
Jackson. O.V
castl*> B-C-
Bm««c, B.I.
Clialcal
and
2» (1)-101-
o
00
titkia'
-93-
6.9«1. «* «°-5» C< BP '"*
•>i»*on »""
-------
•-BeBxeBedlsalfoBaalde. 4-CBloro-f(t)-MthTl-»O)-(tetra»7dro-2-BethTl farfsryD- (8 CI|
1,3-Benzenedlsulfanaaide, 4-chloro-»f1|-a«thrl-»(1|-{(tetrai7aro-2-setByl-2-faranyljBethrl)-
719S-27-*
C 13-B 19-C1-B2-05-S2
N 382.90, 8? (41- foraj 1*9-150 C, (d- for*) 1*6 C. (1- for*) 146 C
CT|
1 nssnB
i
i
t 4907
1 Blood,
1 cells
1
I
1
1
1
1
|
1
I
1
1 4908
| tlool.
1 plasaa
I
1
I
1
1
1
I
I
1
1
I
I 4909
1 Oriae
1
|
•
•
1
•
•
1
I
1
I
1
1
POSHES SOtTTE
gestion
ngeatioB
Ingestioa
iiaimcii
HMHOD
oc
oc
QC
IOBSB1 | 81ISI
or cisss i
i
1 a) 1.82-3.53 sg/1
1 b) 1.49-2.51 sg/1
I c) 0.83-1.05 ug/al
I d) 0.11-0.54 ug/al
•
I
1
1
1
1
1
1
1
1
1
1
t
I a) 68-128 ng/al
| b) 76-84 ag/al
1 c) < 5 Bg/al
1
1
1
1
1
|
|
1
1
I
1
8 1 a) 0.3-1.11 of dose
| b) 12. 0-14. W of dose
I c) 34.6-54.2% of dose
t
1
1
1
1
1
1
I
1
1
1
1
1
ISM | GBiniL nrOIBITIOI
!
•ot gives 1 a) Peaks, 1.0-5.5 hr after 50 ag, 6
•ot givea 1 subjects
•ot givea 1 t) Peaks, 2 hr after 25 ag, 2
lot given I subjects
1 c) Peaks, S-ozo-aefroslde after 50 mq
1 aafrusida, 3 subjects
I d) Peaks, open acid aetabolite, S-8
1 tr after SO ag Befraside. 3 subjects
1
1 Bealthy 21-24 yr olds, vt 61-84.5 kg.
I no other aedleatioa at least 1 aoath
1 and fasted before dose.
1
1 OSDGS; DIBFtTICS; XlalY; BtOCD
| IllSRa; EBRBBOCITES; BSIIE;
I tttaBOLlTES: 1DD1IS
1
|
) lot given I a) Peaks. 1.5-5.5 hr after 50 ag
) 80 ng/al I b) Peaks. 2-2.5 hr after 25 ag
c) lot applicable I c) S-oxo-aefruslde and its open acid
1 analogue. Dose route and tisa of
1 saaple not specified.
1
1 Healthy 21-24 rr olds, vt 61-84.5 kg.
1 BO other abdication at least 1 soath
I and fasted before dose.
t
I Itnes; DIOBETTCS; ITaLT; B1OCD
I fll$*>; BUTTHBOCTTES; TOIIJ;
I IIllBOLITZS; 19OHS
1
1
a) 0.49* of dose I a) Excretion of anehaaged drag
b) 13.1* of dose I extrapolated to infinite tiae after
c) 46.2% of dose I '0 or 25 ag, 8 sabjects
1 b) Bxcretioa of 5-oxo-aefrnside
1 aetabolite at infinite tine after 50
1 ag. 4 subjects
1 c> Excretion of open acid aetabolite
1 at infinite tiae after 50 sg, 4
1 subjects
1
1 lealthT 21-24 rr olds, vt 61-84.5 kg.
1 ac other aedicatioa at least 1 sonth
1 and fasted before dose.
i
I BWGS; DIURETICS; ITU.T: BIOOD
| ?l»S«lj EBTTBROCTT1S; BSISSj
I B'TIBOVtTIS: IDOLTS
1
SBTSSIBCB
'leuren, H.L.J.
vervey-vaB Viaaea,
C.P.v.
Tan Bossna. J. H.
1930
European Journal of
Clinical Pharaacology
17sS9-69
Fleurea, H.L.J.
Tervey— van Hissen.
C.P.I.
fan Eossun, J. a.
1980
European Journal of
Clinical Pharaacology
17:59-69
Tleuren. B. l.J.
vervey-van Tissea,
C.P.u.
Van Koaaua, J. M.
19«0
European Journal of
Clinical Pharaacology
17:59-69
-------
BetnaaesalfoMBilide. »'-f1-hydroxT-2-(iBoproprta«lno|«tliTl)- (8 CI)
Bethnnesalfonanlde. *- (•-O-hyaraxT-2-((1-metIiylethyl|a»!lno)etByl)phenylJ- (9 Cl)
3930-20-9
C12-MO-I2-03-S
81 272. IS
1
!
tISSD!
Mio
Blood
•911
BlOO],
plasaa
1
1
1
»912
91004,
plasu
«913
Blood.
sens
91»
tain
BIPOSUSJ BOOT
Ingestion
Ingestlon
1
1 I n lac t too
1
1
1
1
I
1
Ingestion
Ingestlon
I
1
1
E iMinicii
HETHOD
GC-EC
flaoroeetry
Plaorontry
'laoronetry
9C-EC
108 BIB
OF C1SS
1
12
1
HUGE
»ot given
•C70-450 nioles/1
3-5* of dose
1.4-1.7 «9/l
lot given
given
Ssli T e*Bii»i nMtunoi I BMBMCS
,'
I I
10.0 ng/sl 1 lotopsy, alter 3.2 g 1 Bontagna, H.
I I Groppi. 1.
| 47 yc old subject I I960
1 | irehlTM of Toxicology
| Si otic, aqltatvd. Convulsions, 1 «3: 221-226
I ttaarcacflia, abnocaal KG. reinced |
1 tlood pcessqr*, cardiac arrest, 1
1 fibrillation, death. I
1 1
| 1ITTRTPERTIISITE 1GEWTS; SUICIDE; I
1 IT1LT; nsns IBVSI: IOTOPSIES; t
I HISmiBWT BITHOffS; 9MII; HURT; I
I I01ICS; LITEF; KieiTETS; BLOOD; tTBIUS; I
| C15E 8ISTOIXES 1
-1 1
lot giT«n I 2 and 40 hr waia after 320 ng/dar 1 Johansson, S.S.
| I Recall, 8.
I Healthy 20-30 rr olds, vithin 10* of 1 (ilhelBSson, c.
1 nornal weight. 1 Tea in, J.l.
| I 1980
| fttJnced restioq and exercise heart 1 Clinical Pharaacologr
j Tates. ledvced blood pressure. 1 and Tkerapentics
| I 27(5|sS93-601
| ElffSS: SIID1I; BIOOD PllSRi; t
| 1RIRTPEBTIIS1TE JGSHTS; COHPJS4TITI |
I IT>LOatIOHS; 1DU1IS; B1000 PSESSTOE I
1 1
1 1
lot given 1 Beans, 0 and 1(5 nin after 1 ng/kg. I Schnelle. X.
I IT. Dose preceded by stimulation of I Kiel*. G.
I teta-receptors *lth isoproterenol. I Schisz, A.
| | 1979
I BealtkT 22-35 yr olds. | Journal of Clinical
I 1 Flarnacology 19:516-522
I eeta-adrenerglc blocking effects on 1
j heart rate, diastollc pressure, and I
| plasm lactate, glvcos*, pycavate, 1
| and free fatty acids. j
1 1
I HOGS; sfBRin; BLOOD Plisiu: BLOOD I
I fsissngs: IIIIHTPBFTHSITB »GE»TS t
l - t
1 t
1.C8 * or - 0.07 | a) Peaks, 2-3 hr after 160 ag. I Snndgnist, H.
/I | Elexponential decline 1 Unttila, 8.
1.»5 * or - 0.09 I t) lean peak, at 3.4 * or - 0.2 hr, 1 Sison, t.
/I | after 160 sg nith 25 ng I Feich. J.!.
I hiiroeUorothiazid*. 1 1979
j 1 Journal of Clinical
| 8«althy 25-57 yr olds, rt 53-86 kg. 1 Pharnacology 19:557-5«»
I 1
| CHUGS; iRTiaTPEF.T»SITS aGHIS; 1
I BIOBETICS; BIOOD SK10!l; OBIRZ; 1
I CC<)P»8»IT< ETI1QITIOI5; 1DDL*S |
1 1 .
1 1
59 »n yr old satject 1 1990
| | archives of Toxicology
| Clotic, agitated. Convulsions, 1 *3: 221-226
1 biadycardia, abnornal ECG, redacod I
1 tlood press»re, cardiac arrest, 1
1 fibrillation, death. 1
1 t
I miHTPTBTNSIVE IGtRS; SUIC1DI; 1
| IllLT; BBUG 1BDS1; 1TIOPSIES; 1
1 BIISOSMSIIT BET HODS; BB&II; B115T: I
I IIIIGS; LlflB: KID«ETS: BIOOD; U8I1E; 1
1 CIS! 1ISTOST1S I
1 1
(KTt lint)
-c-
h-'
O
-------
-------
MthanesBlfcBanilide. »•- f l-hTdroxy-2-(isopropylanlBO) ethyl)- 16 CI)
Rethaaesnlfonanide, B-{a-(l-avdroTy-2-| (l-aethylethvl) asiao) «thrl> phony 1) - |9 CH
3*30-20-*
C12-H20-I2-03-3
n 272.36
(COITIBVED)
TISSUE
«ei»
orlne
•*20
Urine
1
EXPOSURE BOOT!
Ingestlon
Ingestlon I
1
IBaLTTICAl '
SETBOD
ee- EC
riaoroeetry
fmBBB
or CISES
i
12
sites
Wot given
Rot given
•EIF | GEIZB1L moSHTIOI
1
1
I
»15.7 ag/ll | letopsy, after 3.2 q
|
1 47 rr old subject
1
1 Hiotic, agitated. Convulsions,
1 bradyeardia, abnornal ECO. redncel
I Hood pressure, cardiac arrest.
1 fibrillation, death.
1
1 IBtlBTPElTSSSIYI 16SITS; SUICIDE;
I mil; DIVS isnsi; itrropsiBS;
I IIISmnZIT BBTHODS; BR1IH: BUST;
I -tOISS; IITEH: KIDRTS; BLOOD; TUQUE:
I CISE BISTOBIIS
1
1
TDK of dose | 72 hr enialatlve eicr«tion after 160
1 14. Slight IT higher Tallies rtth 25
1 19 hTdrochlorothiaxlde.
1
| H«althr 25-57 rr oils, vt 53-86 kg.
1
I DBBGS: IWTIHTPISTBJSITB »GSfTS:
| CIDBBT1CS; BtOOO SB BUS; OBIS!;
I COHrUJkfXVE ZT1101TIOIS; ID BITS
1
BETEEEICE
HoDtagaaf V.
Groppl. 1.
1*80
Archives of Toiicologi
13:221-226
Sondgoist, B.
inttlla. B.
Slaon. 1.
Belch. J.I.
1979
Jotmal of clinical I
Pharnacologr 19: 557-56 a |
1
1
I
9orphlMH-3-ol, 17-nethrl-
77-07-S
C17-B23-I-O
HI 257.3S. "IP »«-19» C
IISSVS
1*21
Bile
«922
Blool
A
| ETFOSORS BOUTE
Ingestion
TngeatioB
\
\
1IUTTIC11
BETBO9
TLC
nc
RV83EI
or cisss
1
i
Hives
Mot 9! rea
Hat given
mi | czuniL urosBiTioB
J
t
24.0 ag/«l |
1
I «1 vr old, ht ICO ci, »t 61.23 kg.
1 CiliforBia.
1
1 Boderate aioait of frothT heiorrhagic
1 flail in tracbeobronctal tree.
1 tolerate pnl*oaarr ed«ni and liiiial
I evphrseaa. vaftcnlar engorgeaent of
1 liver, spleen, kidneTs. «odnlla, and
1 sflaal cord.
1
1 tBlSS; BtOOD; IITSB; BB4II; LDIGS;
1 KiDiiis: mitt: BUB; CISE HISTOEUS;
I E«OG *•«$!; CUIrORni; SDICIDB
1
1
2.7 ng/nl I Eiazepa* alsc detected.
1
1 M vr oil. ht 160 en. «t 61.23 kg.
1 California.
1
1 Boderate aaonnt of frothy aesorrhaqic
1 fluid in tracheobroBChlal ttee.
t BoSerate palioaarr edesa and nlninal
t cnvnTseaa. vascnlar enqorqenrat of
1 liver, spleen, kilneTa, nedilla, and
1 atl»»l cord.
1
I osiss; BLOOD: LTTM: BBMI; io»5s;
1 niDIETS; USI1B; BTLB; C1SI BISTOSIUS;
I t«a« IB1SE-. calttOBlIa: St)lCIS«
I
SSrEBEBC!
Tnrner, J.I.
Pichards. E.G.
1977
Journal of Inalrtical
Toiicologj 1:103-104
Turner, J.E.
Plchards, B.G.
1977
Journal of Analytical
Toxicology 1:103-10*
-------
Berphlaae-J-ol, 17-Mtfcyl-
77-07-S
C17-B23-I-0
81 257. It, OP m-m C
tissue
«»23
Br*l>
MM
Kidney
eifosoBE jotrii
Xageatioa
Xngeation
M2S |
line I
*«6
t«ng
Ingestlon
Ingestion
» III TTICH
BETBOD
nc
TIC
TIC
TIC
IDRBSI
F C1SKS
1
B1BGE
t giren
Ot glV«n
•ot gl*«n
lot given
8B1I | 6EIMAI nrOBBlTXOI 1 BETEBEBCE
1 f
1 1
8 ng/g 1 I Turner, J.S.
| I Bt chard*, B.C.
I 41 yr oU. ht 1«0 en. »t 61.23 kg. 1 1*77
j California. 1 Journal of analytical
I 1 Toxicology Is 103-10*
j Boderate aaoant of frothy henorrhnglc 1
I flaid li tracheobcottCial tr««, I
1 iod«rat« pnlaoaarr «4eia and linlaal I
1 «i(itT3aia. vascilar enqorqeient of I
| li»«r, splcei, kilnefs, aadalla, and I
| «$laal cord. I
1 1
| B1HSS; BLOOD; IITEB: B81II; tOI6S; 1
| tlftlETS; DIIIX; BTL1; C»SE BISTOEI1S: 1
1 tsns iBosz; citirosin; SOICIDJ i
» >
1 1
% ag/g 1 1 Turner, J.E.
| I Blehards. P.G.
| 11 yr old, ht ICO ca, «t 61.23 kq. 1 1977
| California. I Journal of analytical
| . ) Toxicology 1: 103-10*
1 8o8«rata aacgnt of frothy bcaorrhaqlc 1
| (laid l» tcacbeobconclal tr««, 1
I io4«rato palaonary edeaa and ainlaal j
1 •aviyseaa. *a>c«lac eagorgeaent of i
1 liT«r, spleen, kidneys, nadnlla. and j
I tflnal cord. I
1 I
| DSDCS; B1OOB; LITEB; Bill I; LBKSS; |
1 KIDBBTS; DBIK; BILE; C1SE BISTOBIZS; I
I cios lensi: citiroBm; SOICIDE i
. . . . i i
1 I
5.* ng/g I Ilaxepaa also d«teet«d. 1 Tomer, J.E.
1 1 Blcharda, B.C.
I *1 yr old. ht 160 ca. «t 61.23 k
-------
Rerphinan-3-al. 17-«ethyl-
77-07-6
C17-H23-R-0
8* 257.JS, IP 191-199 C
(COITIRTED)
1ISS3B
•927
Urine
BXPOS1TBE ROUTE
Ingestlox
1
I
aRUYTICal
HBTHOD
MC
BOSBZ3
or c»sss
i
I
I
sues
lot giTen
§EiI
2.3 B»/al
CEIZBAl XnOlIWIOl
«1 rr old, lit 1«0 ca. wt 61.23 kg.
California.
floderate aaOQBt of frothy heaorrhagic
fluid in tracheobroaeial tree.
•derate pnlsonarr edeaa and ainiaal
espnyseaa, Tascnlar engorgesent of
liTer, spleen, kidneys, aedalla, and
spinal cord.
DROSS; 81000: LITER; BBIIB; IDRGS;
KTDRST.S: OB HE: BITE; CISE HISTOFIIS:
IBIS *30SE; CILIFOBRIl; 5HICIDB
IETEREICB
Tacner, I.E.
Eicharda, E.G.
1977
Journal of Inalftical
Toticologi 1:103-104
Borphiii»«-3,1«-diol,17-(crelob«tTlaethTlJ-
«2«08-S2-2
CZ1-B29-I-02
»I 327.51
CI)
1 TISSUE EXPOSURE BOOT! I IHLTTICil I ETOBS3 I BARGi
I METHOD J Or CASES I
1 1 1
1 ... .1
f «928 Injection BPLC 6 a) 0.15-1.* ng/sl
1 Blood, Ingestion b) 0.75-2.1 ng/al
| plassa c) O.U-O.W ng/al
1 d> 0.19-1.0 ng/sl
-
.
• j
. 1
1 I
1 1
• 1
1
1
1
r
1 1929
urine
In-fectioa
BPLC
BEAR 6ERBBA1 IBFOSR1HOH 1 SEFE8EKCB
1
1
a) Rot giTen a) tfter 1 ag as tartrate, IT I Garer, B.C.
c) Rot gireo c) HTdroxybatorphanol (wtaballte) 1 Bong, R.
1) Rot giTen I after 1 ag as tartrate, IT 1 HonkoTic. I.
I dl Bylroxwbatorphanol (aetabolite) I Svigor, J.E.
t after 2 ag as tartrate, IB I Tan Barken, D.R.
1
a) «
b) <
1
1
a) 12- set
bj 29-67"
a| Rot giTen
b) Rot giTen
labelled doses 1 Sayth. E.D.
Ectisated fro* graph 1 1980
I Drag Setaboliss and
B«althr 22-28 Tr olds, wt 56-86 kg, I Disposition
Canada 1 8(0) :230-235
1
C1RAD1; ADDItS; BLOOD ttlSBA; DEIWB; |
UIICSSICS: COflMRATITE ETIltHTIORS; 1
RfTABOLISB; RET1BOLITES |
1
1
a) 10 ail 96 hr after 1 aq as I Garer, B.C.
tartrate, IT I TasiljeT, B.
h) 10 aad 120 ar after 2 ag as | Rong, R.
tartrate, IB 1 Honkoric, I.
labelled doses 1 Snigor, J.E.
l«aa cnaolatlTe percentage of 1 Tan Harken, D. B.
radioactiTitr 1 Sayth, B.D.
1 1980
BealthT 22-28 Tr olds, »t 56-86 kg, I Drag Betaboliea and
Canada I Disposition
1 8(9) :230-23S
C1WID1: ADVLTS; BLOOD PLASBA: ORIRE: 1
IRtLCESICS; OMPIBATITE ETRLOATIORS; 1
nrtiBOLis-i: IETABOLITIS i
-------
57-27-2
CT7-BW-B-03
•I 28S.33, up 197 c rtetastable plase), 25* C (decosp)
- (»
TISSUE
•930
Blood,
Plena
•931
Blood.
plassa
EtPOSVn 80DTE
.
Injection
Injection
IBM met i,
BETBOO
^— — — — — —
m
SC-EC
i — i5ii
or CISES
8
30
B) 320-700 ag/nl
b) 51-62 ag/Bl
.
a) 1.900-3 ng/nl
b) 60.3-72.2 ag/Bl
flllV
•1 555 ng/nl
b) SS ag/sl
-
a) Bot given
b) 6«.5 ag/al
GIBEB11 IBFOBBITIOB
— .
a) Peaks, issedlately after 10 sg IT
to 4 ssbleets. estlsated fros graphs
rj Peaks 15 SB after 10 Bg IB to 5
t objects
adBialstered as solfate.
Beamy 26-32 yr olds. «t 62-100 kg.
oapleasaat, dyspaorlc seasatloa
terslstlBq »-« kr after infusion. 1
ssbject aaeseated aad waiting.
(f(«cts less severe after
iBtraaascnlar injection.
MUSS; IttlBOLISB; BtOOO PllSftl;
SISSICHOSBTTS; CONPlBtTIVE
lUtOlTIOMS
- — _
a) 2.S and B to after 0.15 sgAg
single dose before sargery to 2
gioops, ages 1-6 yr and 7-15 yr. Bo
effect of age
b) BUiaon concentration necessary
foi sapprestUg clinical slges of
(aln daring nrgery, ages as IB a)
aad ages 0-1 yr
Bat a available for seltlple doses.
S.edU. calldrea. ages 1-15 yr
laalgeslc effect disappeared at
«6.3-«2.7 ag/al.
DIV63; DBOG TBTBlpy; tBllGESICS;
piis5iri«"mBi! snBHi BIOOI)
- — •-• .
BEFEBEBCS
Staaski. O.R.
Sreeablatt, D.J.
LomnstelB, E.
Clinical Pharaacology
ud Therapeatics
2* (1): 52- 59
_
Dahlstros. B.
Bolae. P.
reychtiag, H.
woack. G.
Paalzo*, I.
1979
Clinical Pharaacology
ana Therapeatics
2€(3):35»-365
Ui
llCOtlM (« CIt
SJ!"!?" 3'"''**fcTl-2-"E«Ual«TH-. (S>- (9 CI)
C10-B1»-»2
.. H..II. « <-eo c. BP 2,7 e .partial d«o.P) .t 7« .. „. 123-,25 e .t ,7 ..
TIS19B
<932
Blood
BXPOSnS BOOTE
Inkalatlon
kBURIClt
BETHOB
"
Badioaetry
BOSBBS
or c»sss
•1 6
b) 1
a) 0-66.a «g/i
b) I.S-K.a
a) 21.18 «?/l
b) Bot applicabU
(BEIT P*SE)
QEBIBtL IlfOMlTIOI
b) 1«»n, IkC-cotlBlse level 10-60 «in
after saoklng began. Kxceeded
nicotine levels at 30 and «0 Bin
tata OB arlne and feces levels also*
29-60 TT old habltnal snokers.
Itstalned frcs sioklng fros sldnlgtt
ptior to stvdy.
0-13 beats/Bis Iscrease IB heart
««t«. Carbozyhesoglobla increase!
fros 2.9« to «.«2%.
lirnoiBS; SBOKIBS;
IIlsO SDOII: BIOCDI HBTIBOlISBj
SEPEBEBCE
Irnltage. i.
Bollery. c.
Roasesaa, T.
Kehner, E.
le»i», p.j.
Turner, D.
1978
Clinical Pharaacology
and Tketapeutlcs
23(2):1*3-151
-------
•933
Blood,
plan*
Blood.
plasaa
• 935
BlOOl.
plana
«»36
float,
plama
«937
alool,
plant
»93i
lahalatlOB
XaaalatiOB
InhalatioB
XaaalatioB
iBhalatin
Bhalatioa
m
sc
Hm
GC
m
11
10
150
11
a) lot applicable
b) Hot applicable
a) 9B.«-286.7 aeol/1
b) 52.4-326. 6 BBOl/1
C) 2». 7-77.1 BBOl/1
at 10-30 B9/al
b) «-22 Bf/Bl
3-63
a) lot «iT«ii
b) tot gl««B
») 6.5 + oc - 1-«
b) 9.9 + ot - 2-2
a) 1*S.« * or - «.0
BIO 1/1
b) 180.0 « oc - 90.0
BBOl/1
cl 52. » » or - 17.3
mol/1
«.13
a) 1».25 * or
_ — y_l
b) 13.0 » ot - 7.07
M/Bl
19.5 nq/il
a) 252 » or - 1M
B,/15 alB
b) 25«7 « or - 122*
nq/15 Bin
SBOKIfSs •»»""'
g^
BII1FOS
a r.> -— «- »
•in
H.bit«l neton, .««» 20-39 T*. »"«
had aot sao1t«a «IBC« pt«»io««
«i«nlaq.
SMICIIG; ncennt wiiccos: jinn
BUMS: »OTMS8 BtOOD Pl»SB»
i
| natsnyaaa.
CJ
, an
j pt i|ts-
1
25(5
S«
„ S.3kl., ...al br.Bd. 10.7
,7
5 hr
Stokers, raqlaad
B«ITEB KI»5DOg: IMlMs BLOOt
»
: TOB»CCOS
20-39 »r aU «o*«. 1. flood health,
Baiit*lBi»
• sMMdWl* ItlCGTTWs TCBICCOS * JXc»w5
\ Inm VOTtlS! BIOOB TUSHl
1
-
pharBacoloqr
I
I
t
_l
-------
BlcOtlBO (S CI)
C10-B1*-B2
BB 162.23. BF <-•» c. BP 247 C (partial decoap) ,t 745 aa Rg. 123-125 C at 17 aa Bj. n , .. „„ „.«,,„
TISSBB
4939
4940
orln
BXM3VBS BOOTB
iBkalatioa
"
iBtalatlom
IBUYTXCll
oTTBOO
_
III
-
CC
..
BVBBSS
or CISBS
so
(COVT
11BCB
•) 1.0-2.8 ao/24 kc
b) 0.6-2.1 Bg/24 kc
lot giToa
IBDED)
BB1B
•I 1.7 * or - 0.84
•9/24 kr
b> 1.78 » or - 1.02
•9/24 kr
133 * or - 19 (SB
aq/100 al
SEHBIL iBrosBtnoB —
•1 9 days oa 22.5 * or - 6.34
M » Says OB 27.25 * 51 - ".5** **°h
ciq»ratte«/a«T. o.«0 mo BicotiB« each
20-30 TC old aaoker* IB good haaltk,
aaUtalaloq aoraal saoklnq habits
StCnBS; BICCTIBB; BLOOD PI1S81-
1QBICCOS; COHfraVaTITB BTAlniTTna^*
IMITS; BMOCIOBIIS; BMBI
SaBdoa saaplea. Bo correlation with
dvclarol naabac of clqarettea saok«d
n _
I « » * *tteB.alBq iafarctiw
ItULTS; BE1PT DISWSBS; OBIBB;
SwaSSJ'1!? mi«w»BS: BEiSOBEBBBT
IHS™ ' "ICCTI*1! BlTaSOlITISs
SDVKIV3
BBFBUBCB
Bill. P.
flarqaardt, B.
1980
Clinical PharaacolooT
•ad Therapeutics
27(5):6S2-658
_
IllCOZ, B.G.
Haqhes, J.
Bolaad. J.
1979
British Bvdical Journal
2 (6 197): 1026-1 021
J
«a.3B-I-03
It 13».7«. n 110 c U.co.p) . B? tecoip to S.203 at 200 C
rani
4941
Blood.
Plena
4942
Otlae
EXMSVU BORS~
_.
01
tBatRIClL
1BTBOD
Coloriaetrr
•
— __
Coloriactrr
BOBBSB
or c»sis
M 2
hi 2
-
8
SIMS
— ____
•J 68-9.0 llg/Bl
b) 30-2.3 ««/•!
15.0-71, n of dOM
BEtB
-
M Bot sirea
b) Bot qiren
lot glT«B
CEBIBII IBfOBBHIOB
•» roso of 600 a,/aq B. IT
t) DOS* of 300 *q a, IT
Initial aeaaarea«Bt and 24 he after
latlaatet froa orank
DBncS; CBBflOTBBB&PT: BBOfLkSBS; 9LOOD
BTT1MTS; 01SB&SBS *
30C-SOO aq/aq B
J5"I!.Ir.01* C«><*E P»tl«at». »t
57.3-90.9 *q
B»BSS; CBCBOTBSBtPT: «EOPLlSiS- BLOOB
J""»s WIBU umisi oittum
«IT»»T«S; DISMSBS
•-
BEKBEBCE
Ball. S.B.
Toang. K.
Ben]aBlB, B.S.
Stevart, 0.
ValdiTl«ao, B.
Bolikiaa, ».T.
loo, T.I.
1979
Cliaieal Phanacology
aad Thenpeatica
2S(1j:*2-87
Ball. s.v.
Tonag, S.
Bealaala, U.S.
Stewart, p.
Taldl*l«so, n.
Bollklaa, l.T.
loo, T.I.
1979
Clinical Phanacologr
aad Therapeutics
2S(1):S2-87
-------
litrogeu
7727-37-9
II
»t» H.0067. « -210.01 C, BP -195.79 C. TP 3« at a at -1*6.9 C
TISSUE
»9«3
flrine
EIPOSOBE EOffTB
Ingestion
llalTTIClt
BBTBOD
Chea
ins BIS
OF C1SSS
19
| RUSE
I
1
lot given
nut
7.6 » or - 1.6 g/4ar
SIirSIL nFOSfllTIOft
Expressed as teaa of 59.3 9
protein/day. Data fro* «7 7-day
experisental periods.
University stndenta and employees, a
nurse and a teacher. fnlliparons,
ages 19-29 yr.
ill sebleets In positive nitrogen
balance.
TIR*:SS:E: nji»E; IBOII; CIICIDI;
BIGBESITSs IMWatS: PHOSpaOBBS;
OtSIS; RIKEtll BETIBOITSB: PFEC!H»CT
BEFEBEBCB
Ishe, J.8.
Schofield. F.I.
Grsa, B.B.
19T9
Aaecican Journal of
Clinical littritioa
32:286-291
Iltroglyeerin (8 CT|
1,2.1-Sropanetriol, trlnitrate (9 ci)
5?-63-0
C3-B5-B3-09
Sf 227.09, SP 2.8 C (labile), 13.5 C fstable)
| TISSB!
1
I
|
f I9»«
1 91ool
I
1
1
1
1
1
1
1
| ETPOSDRE BOUTB
1
1
1 Incest Ion
I
1
1
1
1 mimcm
I 1ETHOD
r
I GC-EC
1
I
1
|
1
1
t
1 BOH BBS
I OF C1S5S
1
a) 10
b) 10
1
| I1IGE
1
|
I a) 0-0.3 ag/sl
I b) 0.1-10.0 ng/al
1
1
1
1
1
I BEil
a) Not applicable
b) Rot applicable
1 GBHEBiL IIFOSgiTIOS
1
I a) 9.S-H he after 7.5 »q
I mstained-release dose. Vone
I detected at E hr
t) 0.5-« tr after 10 19 sastained
release dose, lone detected at 5 hr
Cardiac patients
ISR1EI: DISIiSTS; HII8T DISElSBSi
BIOOB; DBOG 1HMIPT: BBTSS
SEKRMCB
Girant, I.
Salaac, F.G.
1978
Ezperientia
3«(5):«U-64«
00
Oftocin
«0-5S-6
C«3-!M«-I12-C12-S2
t\ 1007.23
TISSfB
• MS
Blood.
plasna
f.WOSOE* ROOtE
Tnvestion
alitTTIClt
BET BOO
Bit
•OHMS
OF C1SES
13
B1RSS
a) 1.S-10E.9 M/al
b) 27.5-181.3 pa/1
c) 0.2-9.9 po/nl
d) 2».5-31.5 pg/«l
l!ll
a) Rot g ire a
b) Bat given
c) Bat given
i) Hot given
6en
O and 1) range of neans
9oaen betireen 35 and '0 vk gestation.
flealthv 20-59 Tr old ten, lit 55-70 kq
D8HGS; »S"1«1»CY; 8100B PUSH;
CCHP»H!ITI»« HltOiTIOHS
| BEFEBEFCE
1
Darood, I.T.
Tlilcarkala, O.
Fachs, F.
1980
American Journal of
Obstetrics and
Gynecology 138(1) :20-2»
1
1
-------
c-aeetophenetidiae (8 CI1
leetailde. «-(0-ethoiyphenyl)- (9 CI)
€2-911-2
C10-H13-B-02
H 179.21, HP 139-135 C
1906
Blood,
plasaa
4917
Blood,
plasna
»9»8
Blood.
plasia
«9»9
Saliva
W50
flrlne
Invest ion
Ingestlon
Ingestlon
In
-------
ehenothlaziie, 10-f2-t1-*etkyl-2-plperiaTl)«tliYl»-2-(aethyltU,o}- (8 CI>
10H-PfcBnotki»zlne, 10-(2-C1-«et»yl-2-piperiainyUethyl)-2--
50-52-2
CZ1-B26-B2-S2
•I 370.56. BP T2-TI C. BP 230 C at 0.02 •• Bg
1ISS1B
MSI
Bloat,
KTPOSQYS BOOT!
.
T&g«stloa
1HLTTICAL
ttCTBOfi
Che..
Finer o»et rj
IOHBKX
OF CaSSS
19
-
UB6B
1100-»000 ng/nl
SMI
lot applicable
-
etiiui IIFOSUTIOI
Ifter increasing doses of 1-10 ng/kg
e«et 9 >k
21-65 yr old psychiatric patients
la correlation betveen plasia levels
and clinical affects. Plasia levels
correlated «ltk dose.
S1EDBB: aDIJITS: IERTOUS SYSTEM
DISEASES; BLOOD; BLOOD P1»SB1; DBOC
IZEtlPT; TailQtJIlItraS; COBPIRHITE
iniffiTioiiSi punos
i
IETZBEICE
B«rgllng, E.
Bjornaal, I.
(Ireland, t.
Papp, ».
(old, S.
ms
Journal of clinical
Pharaacologr 15:178-1»«
Pkenotklizim. 2-chloco-ia-|3-(dl»ethTla«in«)pcoprl)- («
10B-?fc««athlaliB«-10-prop»n«aln«, 2-cklora-l,l-4iMthrl-
SO-53-3
CTT-B19-C1-B2-S
CI)
TISSUE
BlOOl,
!iPos»B! tours
I.,esti.n
a*lLRIC*l
HETBOD
QC-SC
ffOIBEB
Of CISES
a) 10
b) a
c> •
M«SB
a) lot gives
b) Bot given
c) lot given
BE1I
at 8.0 * or - 2.3
b) 13. S * or - 2.7
ng/sl
c) 20.3 * or - 2.3
6BBM1L IBPOBBlTICI
a) 0.8-3.0 sg/ka/day
c) 6.1-11.0 sg/kg/day
•-1S yr olds iltk psychosis, lental
retardation or schizophrenia
Siae effects: salivary drooling.
drossiness. urinary incontinence.
tlld seizures, sedation, withdrawal,
lild treiors, rigidity. Inproveient
in target syiptons at plasia levels >
30 nq/il (op tia» «0-*0 ng/il) .
CBHSS: BSOG TREBIPT: 51000 PUSH:
CBTLDIIW: B!B TOBH; BMT1L
•TTIBDITIOB: IEBV90S STSTE1 DISUSES:
BfBBOlOSIC BlBirESTaTIOWS
BEFEBEVCI
Rivera-Caliilli, L.
erlesbach, P.E.
Perlintter, B.
1979
Clinical Pharmacology
and Therapeutics
Iktlialazine, 1-krdrazino- (« CI)
1(?Bl-Pktkalazinone, krdrazooe (9 CI)
e€-s«-«
C8-H8-M
BI 1«0.1«. ft 172-173 C
TISStT!
»9*J3
Blool,
plasia
\
\
1
!XPOSOm 5OOTE
Tn lection
•
ABILTrTCal.
BETBOB
BP1C
t
B1SBM
or cisss
2
i
11 BSB
a) 0.02-0.9 UB
b) 0.02-2.8 vB
c) 0.8-1.9 nB
4) 0.6-1.2 OK
1
«E»»
a) Bot given
b) Bot given
c) Vat given
d) Bot given
1
I
GEtmt IirOENaTIOI I (ZTEREBCE
1
1
1
a) Sapid acetylator I Hidden, T.I.
b) Slo* acetylator 1 Shepherd. l.B.B.
e) Bydralazine pyravic acid kydrazone 1 BOay. J.I.
(aetabolite). rapid acetylator 1 tin, B-S.
d) Bydralazine pyravic acid bydrazone | 1980
(aetabolite) , slow acetylator 1 Clinical Phanacology
Itter 0.1 ag/kg IT as hydrochloride 1 an! Therapeutics
txtiiated froa graph 1 28 (M : 736-7*2
1
Hypertensives in TT I
1
1ITIS; UDOllS; BT»»5T?1SIOI; BtOOO 1
ELiSflftt aBTIBTPrHTElSIWS ftGBBTS; I
1 CC*91*\TTTI ITHITUTIOHS: BSTIBOITSB; 1
I «W»BOtTT!S 1
1 1
-------
fhthalallne, 1-nvdraziao- f8 CI)
t(2B)-Pktkalail«<»«, hydraxow ft CI)
a«-54-«
C8-B8-I4
If 160.18. IP 172-173 C
(COITIIOBD)
TISSUE
MS*
Urine
EinSOlE BOOTS
1B11TTXCA1.
METHOD
oc
EPIC
BOHBSB
OF CISES
a) 29
b) 18
MICE
a) 8.0-11.7*
*) 10.4-1*. 1*
Rill
a) lot given
b) lot given
GEBZm IirOSBlTIOI
a) 2* hr excretloas (including
aetabolltes) after 50-150 sg/day
t) 24 hr ezcretians (inelnding
netabolltes) after 200-300 sg/day
Slow an* rapid acetylators
Hypertensives, United Kingdos
tcuus; BTBBBTZirsios: roiiB;
»1TIHI?MTE»SIVE aGEBTS; 0196
THIiaCT; ItllBOLXTES
BSFB8ESCS
TUbrell. J.I.
Rarland, S.J.
FaccklBi, T.
1981
clinical Pharnacology
an! Therapeutics
29 (3): 237-3*3
•iperaTlne. 1-(»-aninc»-6.7-dlnetl>oxv-2-«i»inazolinyH-4-(2-f»roil)- (8 CI)
Mperaziae. 1-<»-aniwi-«.7-disetliozy-2-«.alnazolinvl)-4-(2-fara.nvlcarboiijlJ- (9 CI)
1921*-56-9
C19-H21-B5-04
n 382.*2, SB 278-280 C
1ISSDI
MIS
Blooi.
Tlasaa
I
•956
Blooi,
plaaia
posnm BOUTS
Inq«stlon
HHLTI3C1L
S FT HOD
HPLC
laoroa«trr
HP1C
IOTBJX
or cms
7
7
HTCS | RSI* 1 GEIIB1I IIFOBRtTIOl
1 1
1 1
1 1
a) 8.6-3.2 ng/al I a) lot given 1 a) 5 control*, 3 and 8 hr alter 1-2
b) a.3-1.9 ng/nl 1 b) lot given I *g, single 4ose. 5.9 ag/nl at 1 hr
e) 12.3-1.3 ng/il I c) lot given | H 12 renal fatient*, 3 ana 8 he
1) 6.7-0.8 ag/nl 1 9) lot given t afttr 1-2 *j, slnqle Jose. ». 1 nq/ml
e) »2-18 ng/nl 1 e) lot given I at 1 hr
f) 3»-» ng/nl 1 f| Cot given 1 c) Controls, 1 an4 10 hr after 3-8
1 1 «q/4»T at steadv state. 1.8 nq/nl at
» 1 0-hr
I I 4) Benal patient*, 1 and 10 hr after
| 1 3-8 ng/dar at steady state. 1.2
I I ng/al nt 0-hr
1 1 e) Controls, 1 and 10 hr after 9-20
I I ao/da? at steadv state, 31 ng/al at
1 1 0-hr
1 1 t) lenal patients, 1 and 10 fcr after
I I 9-20 eg/day at steadT state. 19
1 1 ng/el at 0-hr
| | e)-d), 11 sablects. Xstinated fron
( I graphs.
1 1
1 1 21-67 vr olds vita hypertension and
1 1 varying degrees of renal function.
1 t
I I lovered Hoed pressure
1 1
I | ernes; 9*ne iBBtm; KIIIEI DISUSES;
1 | BTPERTIHSIOl; SIOOO PBESSTJIE: BIAOO
1 I tllSRl: COHP»S»TIT! MHH1TIOSS;
I 1 ItOlTS
1 t
a) Bot given ( a) ».0 * or - 1.4 la) 1 ng dcse
b) Wot giv«tt I ig/nl It) 1 ng dos« * 80 ng propranolol
c) Bot given I b) 4.8 * or - 0.8 I c) 1 ng dose * 100 ng prinidolol
1 ng/nl 1 (eats
1 c) 2.7 » or - 0.7 I
1 ng/nl I Healthy, nornotensive 25-35 yr olds
1 1
t 1 UUtTS: B1CCD VlKHt;
I | »fTIFTP!BT»»SIV! jr.ETTS; DUG
1 | IRCBICTIO*
I 1
tlFESEBCE
oxenthal. D.T.
'obbs, D.
ffrise, R.B.
«oeey. T.I.
artinez, E.(.
Oaesti. e.
1980
Clinical Ihamacology
and Therapeutics
27 (6): 779-783
Elliott, B.I.
IM, r.
Snsner, D.J.
Hera llth, P.I.
Fell, J.I.
1981
Clinical pharaacology
an 4 Therapeutics
29 (3) l 303-309
N)
-------
e, 1-(1-pb«aylcyclofc«yl)
77-10-1
C17-B25-1
B« 2B3.3!, «f »< <
plasia
M59
Blool.
viol*
Brain
Heart
Kidney
:. BP 135-137 C at 1 •• Bg
BIPOSOBB BOTTTB
sc
OC/IIS
9C
ec
IS
SO
10-812 »9/l
10-180 ag/al
lot a«*«et«a-12.»00 ag/a
0,050-0.060 og/g
0.060-0.190 ag/«
,35
73 3 ma/ml
.Ot
not
l^_
(1KI PWM
I Bailey.
1 Shan -
a;rr..?9^.trpb..cyriiai^.si.r.a s
B^rSW-S-S*. ? car
•cciaent. 1 «lciae.
.
joaraal of .nalytical
£"™lo,T 3:235-237
cuiTOBti*:
MOOD: BRM»:
»UTOPS1«S
! BBtisSi nane »B«SB, if THBO UUTSXS: I
i SWOB! BIOOD —«« '
I _i.
"t I Claray.
I I Crarey.
eh«iattT
| attrlbatad to araq.
MBITIBS: BIOOB8 BSU«S
3:235-237
1 C»1ITO*»I»1 C»»«BS! M.COB: BSHi;
I Bailey,
Sfca», -
i
i
! ?oS"io,; 5^34:537-
1 ilBICIira: aOTOPSlSS
N5
N5
-------
Fiperlllne, t-(l-pbenylcrclohexyl)-
77-10-1
C17-B25-1
If 2*3.38. IP 46 C. B? 135-137 C at 1 •• Hg
(CO«TI>VEO)
1ISSVE
4963
liter
4964
tang
EXPOSBBE EODII
«IIirrlC«t
BET BOD
6C
«c
•raBBB
or CASES
6
4
BIKE
0.028-5.100 ug/g
0.090-0.640 ag/g
IE* I
lot given
_
Bot gir«n
6E1TEB1L IIFOB91TIOI
Eese anknomi
aatopsies, 18 ft old vonan, 17-26 IT
cia ten. Death pheneyelidlne-Eelat«a
bat not attributed to Iraq. 3
hanicides, 2 Sr«g OTerdoses, 1 car
accident. 1 soicHa.
CailTOHlIk; ClDftTZBS: BLOOD; BR»I»;
KIDIZTS; 1TT1S; WIGS;
BIOICC01UL»TIO»: 9BOS iBOSI; fOBEISIC
HZtlCIlE; JOTOPSIIS
-
tese nakaovB
latopsies, 11 yr oil vocan, 17-2* Tr
oH «•». Death pheacrclldine-relited
knt not attritrat«4 to druq.
CtllfOSUta: C1D1TE8S: BIOOD: BSklll;
KIDIETS; iiTti: mes;
tlOlCCQSDtlTIOIt; OBOS iBOSI; FOHCTSIC
1IDICI1S
BEFEBEBCE
Ball«T. O.R.
Shaw, H.F.
EobinsoB, P.I.
Cuba, J.J.
1979
Joaroal of Analytical
Tolicoloqj 3:235-237
Bailey, D.I.
Shaw. R.F.
Pobinson, P.T.
Gabaf J.J.
1979
Journal of inalytical
Toilcoloqy 3:235-237
t Iparidln*. 3- ((1,3-b«niodioiol-5-yloxT> »«tayl) -*- («-f laoroplwnyl) -, trans- (-) -
t1B6»-08-7
C19-B20-T-I-C3
II 329.39
K3
LO
1ISSBB
• 965
BlooS.
plasma
•irosom IOBTE
Tnqestlon
1»»ITTICH
RETBOD
QC
HJBB!S
OF C1SES
6
BUG!
a) 1-11 ng/il
b) 19-47 ng/al
c) 55-106 nqAil
d) <3-8 ng/d
e) 8-37 ng/al
f) 35-86 ng/al
B:IB
al 7.67 ng/«l
b) 33.7 ng/il
c) 72.0 ng/al
1) lot gl*e«
e) lot given
n Bot given
GEBtBIl IBFOBB11IOI
a) PeaVs, 0.38 ngAq
c) P«a\ir 0.77 agAq
c) teaks, 1.14 ag/kq
a) StealT state, 0.14-0.18 ag/kg/9aT
e) Steady state, 0.34-0.45 iq /leg/day
f) Stealy state. 0.68-0.89 «g/ltg/aay.
(2 sublects)
Single-4os« stady («-c) , 3 cases.
peats at 2-8 hr. laltlple-dose study
(d-f) , 3 cases, steady state reached
< 1
-------
PlperlftlM, 3-lt»-«ethorypheiK«y)«ethyl»-1-sethyl-»-phe«yl-. (3H-tr»»s)-
5S8S9-S8-*
CZO-«25-B-02
If 311.»S
1ISSWS
Blood,
plasaa
«9«7
Vriae
EIPOSOBE ROUTE
Ingestlon
Injection
Ingest Ion
IBalYTICal
HRBOO
sc
ladioaetry
tOIBSB
or casss
•1 '
b) i
2
Bal6<
a) 40-3.5 ng/al
b) 55-5.8 ng/al
a) 61-8 K of
radioactivity
b) 3-7.2 ag
c) lot given
RCtl
a) fot applicable
b) lot applicable
a) Bot gives
b) Bot given
c) 0.0*2 ag
a) 5 aln and 27 hr after 20 Bin If of
2*. 5 eg. continuous blexpoaential
decliae
I) 3 Bad 50 hr after (00 eg, oral.
Initial valae, »1 ag/al at fl.S hr.
Bealthy volaateers oa BO other dregs.
lealting 1.5 hr after SOO ag dose.
DBOGS: HST1BC1ISB; »KIDEPSESSITE
I6CTTS; BtOOt PUSH; CORP*B1TITE
lYUVmOfS; BSTIBOtltBS; OKlBI
a) cnsvlatlve ercretion op to SO hr
after «»0 eg of 1*C-labelled drag.
lost as eetatolites. laoant
iadepeadent cf arine acidity (pB
*.f-7.9)
b) Is fesoxetiae, pH 4.8-5.3
c) ts feaoietiB*, pB 7.2-7.9.
Healthy 37 yr olds, BO other dregs.
Toaltiag 1.5 hr after COO ag dose.
mass: siTitciiss; IBTIOCPIESSIT:
1GBWTS; BIOOD P11SII1: COHPM1TITI
It»initIO»S; HZT1BOIITJS) OBIWB
~ nrzB2Bci
IMd, J.
Christeasea. J.I.
Beehgaard. (.
flolaader, L.
Larssoa, B.
acta Pharsacologica et
foxicologlca 44s 177-184
land. J.
ChriBteasen. J-»-
Bechgaard, I.
HolBBder, L.
larsson, B.
1979
acta pharBacologica et
Toxicologica 4»s177-1«4
NJ
PIati»a, dia»ai«edichloro-, cia- f8 CI)
tlatlaaa. dlasBlBedichloro-, (SP-«-2J- (9
C12-H«-M-Pt
lit 300.01;
tlSUB!
«««e
BlOOi.
plasaa
«9««
giool.
EXPOSOSK BOBTI
In lection
iBlectioB
---
aminictt
ISTWD
us
us
10R8ES
or cisis
8
1
a) 30.*-13.3 iaoles/1
b) lot givea
Rot applicable
IIITT
a) lot glrea
i) 1.S + or - 0.6
moles/1
8.69 ag/Bl
PIG1)
| GEIMiL IBPOtHTICI
a) 1 aa4 B hr after start of 1-hr IT
of 70 ag/sq a. Biphaslc decline
b) 21 days after 1-hr IT Of 70 eg/so.
•
Icn-protelB-Boand Pt < 0.5 aaoles/1
ty 45 hr
Patients vith breast aad ovariaa
carciBoaa, with aoraal renal and
hepatic fnactloB.
tSUSS; CHEBOTBBB1PT: ISOP1JSBS; BLOOD
iiisifii npltff: PHT1WB
_T —
it ead of 15 aia IT. Bose, 17S ag
(100 ag/84 a). BiexpoBential
d«elt*e.
a« yr 914 «ith ovariaa
aJenocarclnoia.
MOSS: ciMonretm: PIITIIOB; BIOOO
titsiii: RtopiisRs; atniSi cwcmoits
BIFEESHCi
Goraley. P.!.
Bull, J.R.
leEoy, l.P.
cysyt. B.
1979
Clinical Pharaacology
and Therapeutics
25(31:311-357
Tenorkea. J.E.
ran der Tijgh. D.J.F.
Pinedo. H.B.
1980
Research Cosaanicatlons
in Cheaical Pathology
and Pharaacology
28 (21 '. 3 19-3 28
-------
Platlaaa, dlauinediehloEO-, ci«- (8 ci)
Platlaia, diassinedirtloro-, (SP-»-2|- (»
1J««3-27-1
CI)
C12-B6-»2-Pt
Rl 300.05
(COITXVffED)
TISSUE
4970
Brine
4971
Brine
EIMSUn BOOH
Injection
Injection
iMtTTIClL
a ETHOS
us
cc
us
IBBBSS
OF C15S5
8
1
MI6I
2-23.5* of dose
21-0 nq/nl
nil
lot given
lot given
GEimi nvciiiTioB
B«an cnnvlativw excretion 0.5-24 hr
after 1 hr IV of 70 nq/sq n. 1».8«
excrete! bv 2 hr.
Patients vith breast and ovarian
carclnona, vith nocnal r«aal an4
tepatlc function .
OITieS; CIZBOTBEIaPT; MOPHSBS; BLOOD
E11SH1? UBIVZ* PL&TIVQ1
S and 50 hr after start of 6 hr IV of
131 nq (V aq/sq n). Initial
•easnrenent, 3.4 aq/al. SatinateS
fion qraph.
lestienlar cancer patient, Barvland.
piiTinx: nzTais; DKHS THZIIPT;
CBZBOTHERaPT; B10PLJIS11S! QBIVES
RlBTlalD: *ZlSDSt!tEIT SBTEODS
BEPEIIVCE
Gornler, P.I.
Boll, J.H.
LettOT, A. P.
CysTk, B.
1979
Clinical Pharaaeoloqr
and Therapeutics
25 13) : 351-357
tetoy, ».?.
Vehlinq, I.
Cornlev, I.
Eqoria, H.
ostrov, s.
Bachar. V.
viernik. P.
1980
cancer Treatnent
Teports 64(1): 123-132
fctassina:
•>a
I
39.098. IP 63.2 C, BP 765.5 C, TP 100 an Hq at 590 C
ro
TISSOS
•972
irlae
IIPOSORE BODT5
Taqestloa
i«»inie»i
BETHOD
Plane photonetr?
lUBBIB
or cisss
12
sues
a) 12.3-56.0 a!q
b) 19.6-61.9 aEq
c) «1. 6-65.1 ntq
3) «1.«-6«.7 alq
R<>«
a) 43.0 * or - 11. a
aEq
b> *0.6 * or - 11.«
aEq
c) 50.5 » or - 7.6
al
-------
*tegna-1,4-aien«-3.20-aione. 11beta.17.21-trlhvdroiT- (8 CI)
Piegna-1,4-«ene-3.20-dione. 11.17,21-trihydrorv-. (llbeta)- (9 CI>
50-24-8
M 360. «». n 240-241 C (decoap)
1ISSBE
4973
Blood,
sera*
BTPOSORI B001S
Injection
Ingest ion
1MIYTXCU
HBTHOD
1
EH
HOBBSB
or cisss
a) 12
b) 3
O «
d) 4
S1IGE
a) Rot given
b) lot given
c) lot given
4) 2.200-90 ng/nl
IBAR
a) 198 * or - 9 ng/il
b) 299 » or - 27
ng/nl
c) 761 « or - 177
ng/nl
3) lot applicable
• —
a) lean peak after 10 nc"
TISSOB
•97»
Blood,
plasia
EIJOSBK ROOTI
Inject Ian
tngestion
ilAiniCll
BITHOB
SadioeetEf
I OB BIS
or CISES
3
B11GE
a) 2.32-3.49 ng/nl
b) «.2-».7« ng/nl
c) 0.35-1. SS ng/nl
d) 3.86-».59 ng/»l
BEII
a) 2.90 ng/nl
b) ».»5 ng/»l
c) 0.85 ng/nl
a) *. 21 ng/nl
a) rlaniaolide, IT
b) «8eta-OB netabolite after
flnnisolide, IT
c) flanlsolide. Oral
d| «B9ta-OB netabolite after
flanUallde, oral
0-8 hr average level (area under the
cnrv*/t) after 2 ng.
Healthv nen, 68.2-95.9 kg, no other
n«dicatlon > 2 vk.
riDES; IHTI-IITUBBITOBT 1CI»TS:
COFKCOSIHOIBS: SBT»BOIISB;
BtMBOtlTIS: BIOOB PI»SH»; BBIM:
CC»P»»IITITI BTatOaTICSS; iBOITS
BET£B£BCB
Chaplin, B. D.
Rooks, «•» II
Strenson, S.H.
Cooper, S.C.
Herenberg, C.
Cha. *.I.
1980
Clinical Pharnacologr
and Therapeutics
27(3);»02-«13
-
to
,. ,. «,
50-02-2
C22-B29-r-05
Bl 392.«5. DP 262-2«« C, 2S8-271 C (Irth patent]
1TSSOE
Blood.
plasna
'
\
\
\
\
\ .- —
EXPOSOBB BOOTS
Ingestion
1
1
\
\
—\
llALTTICAl
BETBOD
BIl
V
\
—\
BtJBBEB
or CISBS
1
B1RGS
a) 0. 5-4.4 ng egaiv/nl
b) 15.5-35 ng/nl
c) 185-38 ng/nl
a) 63-40 ng/nl
I
tirr
BEAR
a) Rot given
b) Rot applicable
c> »ot applicable
a) Rot applicable
E 9161)
1
1 _
*) Pretreatnent valaes 1 Baggan, D-B.
t) 10 nin ana 1.5 hr after eight 1 Teh, F.C.
1.5-ng tablets, rinal value. 35 1 Batalia, B.
mynl at 10 hr 1 Ditzler, C.A.
c) 10 nin ana 10 hr after 10-30 nin 1 BcBahon, P.O.
« oVana'lO hr after 12 ng as 1 Clinical Pharnacologv
eliiir. Initial value. 63 ng/nl at ) »»d Therapeutics
10 nin ' * l J
Intinated fro* graph. 1
1
normal 1S-26 It olds. fast«d 1
overnight. '
1
Dines: COH?»BMITS STIWWIOIS; BLOOD i
PtlSSV; TJUIBt; WTltS; H!?i>OLIS8 1
-------
Pr*gna-1,«-cJiene-3,29-dione, 9-flaoro-t1b«ta,17,2t-trikrdroij-16alpha-«eth/l- (8 CI)
rTe«na-1,*-g»a-1,0-dtene-3,20-aione, 9-tlnoro-l1,n-aihjarory-16-aethjl-21-(pKosphonootj)-, (11bet».16alpha)- (9 CI)
312-93-S
C32-H30-T-08-P
II *72.*«
TISSUE
»977
Bloal,
plisai
KieOSnffE BOOT!
Inlectlon
llURICal
HETBOB
BI1
imiBSS
or cisss
*) 8
b) 8
c) 8
«) 9
BUGS
a) 22.7-78.0 ag/al
b) T7.0-158 ag/al
c) 157-207 ng/»l
d) 6*5-1,217 ng/al
BE A I
») *9.1 «g/*l
b) 117 oq/«l
C) 187 ng/al
d) 896 ng/al
GZIIB1L IITOBHITIOI
a) 0.03 aq/kg dose
b) 0. 1 aq/kg dose
c) 0.20 aq/kg dose
9) 1.0 ag/kg dose
^-intercepts of seai-log plats of
dcxaaethasoae alcohol concentration
»« tiae after indicated doses.
Horaal 18-26 yr olds.
D3UGS: G10COCOBTICOIBS: STIBOIDS;
I1COD P11SR1; IDOLTS; aBTlBOHSB;
ItTkBOlIIES
SCrt&EHCE |
Hare, I.E.
Teh, K.c.
Ditzler, C.I.
RcRahon, F.G.
Hugger, D.S.
1975
Clinical Pharaacologr
and Therapeutics
18 (3) : 330-337
VxopionaniliOe. «-{1-phenethTl-»-piperLdTll-, citrate (1:1) (« CI)
tiopaaauide. «-»he«Tl-"-{1-(2-phenTlethIl)-»-piperidlBTl)-, 2-ajdroxr-1.2,3-propanetricarbx»Tlate (1:1) (9 CI)
MO-73-8
C 22-R28-12-O.CC-H8-07
II 528.*S, 1? 1*9-151 C
ITS SHE
*»78
Blood.
9«t«u
EIIOStltE BOOH
Injection
liilTTICil
HETBOD
Ilk
108 BBS
or cuss
a) 5
b) t
e) 3
Bivei
a) 352.8-8 ng/al
b) 91.6-5 ng/al
c) 55.3*1 ng/al
am
a) lot applicable
b> Kot applicable
c) lot applicable
GE11S1L IirOBRlTIOl I
1
a) 1.0 ug/sq a
b) 0.5 ag/sq a
e) 0.1 »g/sg, a
tinge of Beau, 0-2 hr after dose
•
28-C9 fr olds, vita nearo- or neck
cancer surgery.
DBDGS: OBOG TBSB1PT; BUMS SEBUI;
cnniostint rtaio; asiiii; isutis
nrnEBCE
Schleiier, 9.
Benfaalni, B.
Eisele, 3.
Henderson. 6.
1978
Clinical Pharaacology
and Therapeutics
23<2):188-194
-------
. ^U-1.2.3-pr0p»«tri«rb«Tl.t. ,1,1, (, CD
990-73-8,
C22-B28-I2-O.C6-B8-07
11 528. »5. BP 1»V151 C (COITIBVE9)
*!»«
•979
Cerebrosp
inal
fluid
•989
urine
EMOSSBE 80HTE
Injection
Injection
IMiTTIClL
BETBOD
BIk
BI1
—
BBBBSR
OF CIS3S
1
1
B1WGE
0.1-3 ng/nl
tot applicable
Bill
Wot applicable
21 * of dose
GEIEBAL i«rUKB«IiV>«
5 and 30 ala after 1.0 ng/sg •.
final neasmrenent, 1.25 ng/nl at »
BE.
leorosnrgical patients
DBDGS; DBD6 tBZRWT; BIOOD SEBOS:
CEBEBEOSPIBIL FlCWS BBHB; kDOITS
C«e«lati*e excretion in M-hr nrines
after 1.0 ng/sg n
lenrosvrgical patient
OBOGS: DBOG THEBIPT; BIOOD SEBOB;
CEBtBBOSPIBtl FIBIB! USIBBS IDBWS
_. —
Schleimr, K.
Senfanini. E.
Eisele, 3.
Henderson. S.
1978
Clinical pkarnacology
end Therapeutics
23(2)t188-19»
Schleiner, a.
Benfailni. E.
Eisele, J.
Henderson, C.
1978
Clinical Pharnacology
and Therapeutics
23(2):188-19«
...
propionic acid, 2-rp-c»loroplie»orTl-2-net»yl- J8
Frcpanoic acid, 2-<»-chloropbenorr)-2-nethyl- C9
862-09-7
C10-B11-C1-03
II 21«.66. HP 118-119 C
tISSWE
• 981
Blood,
pi a ana
EIPOSDBX BOOTE
Ingestion
»»»tmc«i
B ETHOS
9PLC
tmess
or cisis
*
I1I6E
lot giren
am
96.1 * or - 17.7
«1/nl
lean steady state valves, 2 I Iq/day
for « «k.
Bealtkr 22-35 TT olds, no nedieations
for 2 preceding »*.
EiOGS: eturcmii: BIOOB PI»SB»: DSOS
IHBBIJT: »BBWS: CORPIMTITE
tf»lB»TIO»S: BE11BOLITES: CB1OIME
CBSAHC COIPCIIIIDS
BEFEHEBCE
Bjornssoa, T.D.
Reffin, P.J.
Svezey. S.
BlaschVe, T.F.
1979
Jonrnal of Phamacology
and Experlnental
Tterapeotics
210(3) :316-321
— —
to
00
Propionitrile, 3-anino- (8 Cl)
Fropnnenltrile, 3-anino- (9 CII
151-18-8
£f ToTo!. BP 185 C at 760 nn Hg. 87-89 C «t 20 nn Hg, «6-«9 C at 5 .. Hg. 50-55 C at 3 n. Bg
TISSOE
•9«2
Vrine
^
BTPOSJB! FOOT*
Ingest ion
kllllTTICkl
BE? ROD
Photoaetry
\
\ . —
BOBBSB
OF CISES
1
8i»G!
Hot given
9E>B
16.3 « or - 0.6* of
dose
GIBIB1L IBTOBBinOB
Steady state excretion, days 2-U on
2?0 »g/6 lir. Brine collected at drag
aanintstratlon.
1< yr old blaclt »ltn nassive *e lo ids
renoved surgically.
WIGS; 99.UG IBSBkPI; OBI1E:
BRUCLISBl BETkBOlIIES; EBITUSS
BETEBEBCE
Fleisher, J.R.
Peacock. I.B.
Ctvapil. B.
1978
Clinical Pharnacology
ana Therapeutics
23(5)i« 29-52*
-------
pyridiae, 2-(alpha-(2-r 1
1
sires
a) 0.01-0.14 ag/al
b) lot gives
c) lot given
Sot given
Rot given
a) lot qiT«n
b) lot given
lot given
HEIR
a) 0.112 * or - 0.062
«g/Bl
bl 1.9 ug/al
c) 30 ng/al
5.3 ag/g
.
4.0 ng/g
a) «.« ng/g
b) 115 ug/g
1*9 ng/il
Givnti nroBunoi
a) 3 Ml«s. 3 f«t*l«s, n«ta »t £7.17
» or - 8.2 Itg. 2 hr after IS «g of
the lalaatc
b) Ivtopsv, It yr oil »al«, possible
o*cc4ose
e) Jutopsj, ** yr old, snlclte
Dunes; DSOS unsi; SUICIDE:
iiriopsigs: cisi BisTOtiis;
«iis»«tliyl)-, hydroxide, later salt, <«B-trans) - ?9 CT)
iO-59-9
CW-B17-I3-0*-S2
ill MS. 50
TISSUS
>988
Blood,
plassa
Ttposns? gonre
Injection
aHLTTICIL
RETBOD
WLC
BORBIB
or CISES
t
BlIGE
a) 32.8-40.* ng/al
b) 0.9-2.6 ag/al
(SETT
HZll
a) 36.8 ng/»l
b) 1.65 ag/al
P»Ct)
GIlEBat IHPOailTIOS
a) If tec 5 iln
t) after 7 hr
Dose, 10 sin IT of 1 g
Healthy 27-*7 yr olds
tBBCS; IMTIEIOTICS; S»EDK; DliTin!;
EICOB pusiu; HDUITS
SEFEEERCE
Rrvldsson, &.
Borga, O.
alvan, G.
1979
clinical Fliaraacology
and Therapeutics
25(«):870-87$
-------
lyridlnivn. 1-a2-c»rtory-8-oio-7-(2-(2-thi*iiyl) aeetMl4o-)-S-thla-1-aTabicjclo(a.2.0) oct-2-en-3-yl) »ethyl|-, hydroxide, tuer salt (« CD (T»»)
PyrHiBiaa. 1-(f2-carborr-8-oio-7-{{2-tnienrlacetTl|«Bi»oJ-S-thl»-1-a«biciclO'(».2.0)oct-2-en-3-rl) ««t*yl)-, hydroxide, liner salt, (6S-tr»nsJ - (9 CD
50-59-9
C19-H17-I3-0«-S2
R« »15.50
(COITIIDEO)
Tissue
•989
urine
SIPOSOBt BOOTS
In -(set Ion
alaLTlICal
nTHOD
RPLC
IVIBEB
or CUBS
*
IM6I
•at giTon
Mil
_
71 * or - 1OT of dose
SB* Hll I»K»BalIOI
30 hr excretion after 10 »in IT of 1
9
Healthy 27-m yr olds
usffss; iHTrpiDircs; SWBDB»J mire;
EtOOD PLlSai; 1 DOITS
BSKBWCE
IrTidssoa, i.
Bocga. 0.
HT»B. s.
1979
Clinical Fbariacologr
ana Tkerapentics
±5 (6) 1 870-876
_
trriainiiiB, 2-fociTl-1-ietbrl-> chloride, oxin (8 CI)
tTridinlm, 2-(CBTac«Ti«i"o]«ethyl|-t-iethTl. chloride (9 CI)
51-15-0
C7-H9-»2-O.Cl
«« 172,«3, 8« 235-238 C (decoap)
IISSD3
•990
Blood,
plasna
t
1
1
• 991
urine
ntOSHBB B00TB
Tn-tectlon
Inlection
I
ilALTTICll
HSTHOD
BIIBBSB
or cisis
6
5
B1ISB
at 18-0.6 ag/nl
b) 18-t.D ag/nl
a) «ot given
b) lot glTen
•Eat | GEIER1L IlFORHaTIOl
J
1
a) tat applicable f at after 5 sg/kg IT. < subjects
b| tot applicable I t) Ifter 5 nqAa * 2.5 hr IT of 100
j ng/hr thiaaine, * snblects
j Bange of leans, 0.05 and «,0 hr.
I Beans significantly different after 6
1 tin
1
I 20-27 yr olds
1
1 Rild to noderate risnal synptons
t lasting 5-10 nin
1
1 rtires; mva HTESJCTIOJI; BIOOD
r »L«SB»: 08111; COWPMlTXTE
1 ITliaHTIOWS; IDOLT5
1
a| 72.4 t or - 3.3? I a| 0-1.5 hr excretions after 5 eg/kg
b> 38.2 * or - 9. Of I IT, 5 snblects. 97.0 * or - 1.0^ by
1 6 br
1 bt 0-1.5 br excretions after 5 ng/kg
1 « 2.5 hr IT of 100 ng/hr thia*ine. «
1 subjects. 75.9 * or - «.6X by « hr
1 1} and b| significantly different, P
1 < 0.001 in 0-1.5 hr excretions and t>
1 < 0.01 in 0-6 hr excretionsi
1
1 20-27 ft olds
1
1 Rild to noderate Tisnal synptons
1 lasting 5-10 «ln
1
1 c^iGS; oias IITEBICTIOI: BLOOD
1 SIIS11: USIBE; CORPtBHTITl
1
BETEBEBCE
Josselson, J.
Sidell, F.R.
197«
Clinical Phatnacology
and Therapeutics
2*(1|;»5-100
Josselson, J.
Sidell, F.B.
1978
Clinical Pharnacology
and Therapeatics
2« (1|: 95- 100
U)
O
-------
«.
C9-H13-R2-02
HB 181.2*
IISSJE
-
«992
Blood.
Plassa
»«3
Blood.
Sena
EXMSVRB BOOTH
Ingestioa
Tn-fection
SETHOD
8C
GC
.
—
BOBBER
or casss
i
5
Biiei
2.7-18.* ng/sl
-
a) 700-1800 no/si
bj aO-60 sg/sl
RB1R
lot giren
"
a) lot given
b) Rot given
Giimi iRFOBEitioR
Dose. 60 sg as broaide, 31 daily
flyasthenie patient. U.K.
BBTTSS; 3LOOD PL1SU; BEaSOBZBEBT
RtTRODS; OR1TO KIR«D09
— — — — — ^_^__ .
a) Initial Icrala
n) iftac 3-a kr
rose. 2 ain IT of 0.35 ag/lcg «ith
0.03 ig/kg atropia*.
2«-»7 yr old surgical patients »itK
nonal r««al fraction.
B1CCO SIBOH; DRUGS; DS05 TltBHI:
BBttS tRTIPaCTTOR: STI*SE»t
fi£7EBEHC8
DS»i900, S.C.
Preatis. B.».
Dchghan. *.
Chan, K.
1980
H«thoas and Findings in
Experimental and
Clinical PkacaacologT
2(21:77-82
Cronnelly, B.
Miller* R.D.
Sheiner, L.B.
1900
Clinical Pharaacology
and Tberapeatics
2B(1):78-61
Eyridoiol (8 CI)
5-hTdro«T-«-««tajl- (9 CI)
CS-ill-R-03
H* 164.18. BP 1«0 C
?TCimiiln«, 2,a-diaalno-S-(3.»(5 .
CK-B18-H-03
e« 290.32, DP 199-203 C
TISSTJE j
1
Sil*
1
.1
Ingestion
BETROD
Blcroblological
HOBB58
or Casss
-
a) «
b) 8
e» S
BUG!
-'
a) 67-177 ug/1
b) 189- 3«8 sg/1
c) 2S«-«S« ng/1
.
«S»R
a) 129 * or - 39 ug/1
b) 239 * or - 51 ag/1
c) 31» » or - 52 ng/1
GIRIUt IRFORRITIoi"
a) < 2.5 sg C-6/day
fc) 2.5-5.0 sq »-6/a«y
c) > 5.0 sq B-t/day
Bo effect of stage of lactation.
Healtby. lactatlag 2»-«2 yr olds.
ITIK; Tieilll; TXTimaS; DIMS;
I ICIaTTOR
IEFBBBRCB
«e«t, F.O.
Urfcsey. 4.
1976
Aseriean Joamtl of
Clinical Ratrltion
LO
TISSO!
-
Blool,
Plassa
ETPOSOBE BOOTE
Ingestioa
kRlLTTIC4t
RBTB09
BPLC
ROBB3T
R1RGE
a)
b)
c)
d)
f)
Rot
Rot
Rot
Rot
Rot
Rot
applicable
applicable
applicable
applicable
applicable
applicable
1BII
a)
b)
c>
»
e)
f)
0.
0.
0.
0.
0.
0.
57
92
6*
36
10
01
vg/sl
og/al
«g/sl
«g/sl
ig/sl
»g/sl
(REW ?4GE|
GCRERll IRFOSfliflOR
a) 0.5 »r
b) 2 fcr
c) « kr
d) 12 he
•I 2« kr
ft as KE
Tlaes after dose of 100 sg
Rcraal sablects
HICflD: BT.OOO P11SB1; OSIRE:
»RTIBIOIICS: BP06SJ CORPIBITITE
HAIOITIOHS; HEaSOEBWlT BETBOBS
1EFEBERCE
Seinfeld, P.E.
Racasleb. T.C.
1979
Journal of
Ctroaatography
1«»:73-8«
-------
BTrrole-2-ac«tic acid, l-sethyl-S-p-tolnoyl- (8 CI)
IB-frrrole-2-aeeti.e *="« 1-s*tnTl-5-<«-setarlben«>n>-
2*171-23-3
C15-B15-B-03
BB 257.38. B? 155-157 C (dec)
TISSUE
5001
nrlne
EZPOSHBE BOUTS
lagestion
IBilTTXCU.
•IWHOD
Sadiosetry
nc
BOBBBH
or CASKS
5
B1BGI
•1 24.3-5.73 ng
b) 191-2*0 sg
c) 2«.3-57.0 ng
a) 32.5 * or - 13.9
sg
b) 216 * or - 18 sg
c) »1.» * or - 13.S
GiBEBii 1 1 retain os
_ — — —
a) Tolnetin
b) Balor setabolite
c) Tolsetln con 1 agates
0-2* hr excretions after 300 ng
C1*-labelled dose
idnlnlstered as sodlvn salt
Patients vith rheenatoid arthritis >
1 TT, fasted before and after dose
BBBGS; »BD6 TBSSlMs JISEISES;
BHZIWTOIB 1RBBITIS;
• 1OTT— TBFLaBBWOBT aGXVTSj BX>OOD
PIIS1U; BETIBOLITES; OBIBE
BEFIBEHCJ
Grindel, J.B.
Blgd&lof, B.a.
Blostitieks, 3.
1979
Clinical Pharnacology
and Therapeatics
26 (1)t 122-128
fwtole-2-a«tic acid. 5-|p-cl>loEOb«»»Tl)-n»-dlii«tarl- (8 «»
1«-?Trrole-2-ac«tlc acid, 5-(*-ehlorobe»*OTl|-1.«-ai»«thyl- 19 CI)
33369-31-2
C15-H1«-C1-I-03
II 291.75
nssn
5002
Blood,
5003
riposora BOOTE
<.,„«,.
Xngestioa
liiiiricaL
BETBOD
BPLC
BW.C
BUB BEX
OF CISSS
2*
2*
iiioi i
a) Bot glren
b) Vet giren
c) Hot gi*en
a) Wot given
b) Bot given
c) Bat given
Bill 1
a) 2.47 » or - 1.15
b) *.*2 * or - 2.2*
c) 7.9* « or - X.07
a) 23.16 * or - 5.87
b) »3.80 » or - 19.55
c) 83.93 * or - 26.95
GSBIBU IBTOBBKIOB
O «ean peak. «* » or - *7 sin after
50 ng
E) Bean peak, 57 • or - *5 nln after
100 ag
c) Bean peak. SO » or - 66 sin after
200 sg
Peaks significantly different, p <
0.0001.
BealthT sales, scan age 2* yr. fasted
> 12 hr.
DB96S; BLOOD S11SB1; 1&01TSJ
miGBSXCS; HBI«S
a) after SO ig, 3»< as vnchanged drog
ft) after 100 sg. 19.3V as nschaBged
a tug
c) after 200 ag. 23. M as unchanged
drag
0-12 hr cnnnlatlve excretion of
unchanged and coalnqated drug.
BealthT sales, ne»n age 2* rr. fasted
> 12 hr.
taOGS: BLOOD PLaSBt; IBOITS;
BEFEBEICE
Bayak. S.K.
»g, K.T.
Gottlieb, S.
Plostnleks. 0.
1980
clinical Pharaacology
and Therapeutics
27 (3): 395-401
Barak, B.K.
Bg, K.T.
Gottlieb, S.
Plostnleks, J.
19 SO
Clinical Pharmacology
and Therapeatics
27 C3) : 395-401
OJ
OJ
-------
«6-5«-2
C20-H2«-«2-02
ia 12*. m. m
ussnE
500*
BlOOl,
plasna
5005
Blood,
plasna
5006
Blood,
plasma
5007
urine
? 17«-173 C
EX MISUSE BO TIT J
Ingestion
Injection
Injection
IB»ITTIC»I
Tluoronetry
ILC
Tlnoronetry
flBoroaetry
TIC
Fluor osetry
BOBBER
OF CiSBS
5
«) 9
b) 8
6
a» »
b) 8
itIGE
a) 1.6-3.6 «g/«l
b) 1.5-3.7 ng/nl
a) a. 3-0. 26 ng/1
b) 2.75-0. 165 «g/l
Mot 4lr«n
a) lot qirea
6) Bot gi»en
' »E»»
a) 2.3 * or - 0.7
n
-------
Salicylic acid (8 ci)
Eentoic acid. 2-hydrory- (9 CI)
€9—72—7
C7-II6-03
Hi 138.12. tt 157-159 C, B? about 211 C at 29 •• Eg
TISSUE
5008
Biood.
Plasaa
5009
Blool.
Plasaa
5010
Blool.
plasaa
5011
Urine
BIPOSDSB BOOH
Ingestion
Ingestion
Ingestion
.
Ingest ion
Amnicii
HBT HOD
BPIC
•
HPtC
8PLC
ec
HPIC
BMBsa
18
a) 7
b) 7
18
B1BGE
a) 0.098-33.1 ng/nl
b) 0.69S-36.5 ng/*l
c) 0.783-37.5 ng/sl
0-55.2 ng/sl
aj 0-7» ng/1
b) 106-276 ag/1
a) Dot giren
b) >ot glTsu
c) Sot glrm
1 ————__
HEIR
a) 21.9 ng/«l
b) 22.9 og/al
c) 22.7 ug/»l
lot given
a) lot applicable
b) 1S7 »g/l
al «07 * or - 90.5 ag
b) 393 * or - 69.3 ag
e) 369 » or - 77.7 ig
?j '«« «« »9 aspiria
t) Ifter aei », Bg-sallcylate
c) Ifter 500 a? caoliae
Bg-trisalicylate
leid**1*** °f abOBt ^°° "* salicrli<=
0»ec 16 l>r.
filial £? ?ol"t~"' « «»-« *«.
iissoni; loowsj BIOOD nasiut
J?I«i »!;l6E««i »WI-lm»B!»T08T
BFass COBPMMITB muiTMtss
0 «ai a hr after 1000 ma
MlicylaalicTlic aci«. Clearance by
2* hr. Ijtlaated fro* graph.
SIJ.*!!01" IBBI*S: WOOD H.1SB*!
iiilSEsics; ini-iiniBnioti IG-HTS-
BI1SBBMMT BETBOBS; DOTGS 15!"S>
a) lo.est a»4 highest nlaes o»er 2»
hr following tngeation of a single a
9 dose. ieT«is peaked at 2 hr and
, « ff511'*4- Considerable
indiTH.al variation, dne to
"'Sand'5*9 U •€t»bolls" o£ P"»«»
dUirliL'l,5^ *•! f0110'1'" *-i«
aally dase of 3 g of benorylate.
Bealtliy 21-67 yr oUs. nt »«-100 kg
FBIBCE; IBDItS; BWOOj BIOOD PllSBi-
DMGSJ II fluo HllySIS
' __
Jj «*« «9« ., aspirin
"*«r *81 •« «
-------
salicylic *ei« acetate (8 CI)
BensolC »eia. 2-<«cetyloxy)- (9 CH
50-TS-2
C9-B8-0*
SI 180.2, IIP
5012
Blood,
plana
135 C
EXPOSUBB BOUIE
Ingestion
liunicu
METHOD
-
OF CASES
.
6
Silos
- — ~
a) lot gi»en
bl lot gl»«n
nil
a) 81 ug/el
b) 76 ag/nl
— "etimi HFOSBiiioB
.) Bean pea* at 1 hr. 1200 »g aspirin
t\ Bean peak at 2 hr. 1200 «g * 500
sg naproxen
IstUated from graph. „„-__,.
Irea-«naer-the-cnr»e not different
•it* naproxen. P>0.05.
Healthy 23-«fl tr «!««. fastefl
oiexolqht.
rsnesj Datre nweaicTioi:
MM-iin»Bawosi »GHTS: »BJt«:
flCIS; BtOOD PIIS81: CO«P»S«1VB
IfllVkTXOIS
— MrtBEBCS
. — . — •
Segre. !.J.
Chaplin. B.
rocckielli. I.
Hankel. B.
SeTelias. B.
197*
Clinical Pharnacology
ani therapeutics
15<«»8i7»-379
Salicylic acia, ionf1-1 (8 CI)
Eentoic acid, 2-hydroxy-. ion(l-) (9 CI> (T1U
S3-36-S
cl~**?°?. .., ,rn ^ «n .hnnt 211 C at 20 aa Bg
HI 13«.t2, «
TISSBS
5013
«lood,
pla*n«
50 1«
Blool,
plasaa
S01S
Blood.
plaava
p 15V159 C, BP a
EIPOSME SOBTB
Tnfe*tion
Invest ion
Boat zii •«• »l «« ••
allirTXCll
NZTBOB
.
-
ColoclMtrr
loissa
OF C1SSS
2
6
BUGS ~"
a} »ot applicable
b) lot applicable
10»-157 «4/al
• (BUT
iili
a) 25.7 ng/100 »1
b) IS. 7 ng/100 «1
lot given
«aSI)
— SEBBB1L IBFOSBlTICra
a| *«born, ««bllical cord rein
U birt" after «.S -MO
rcaser, D.G.
London. T.B.
iTens, B.P.
Sntherland, E.B.
1980
Clinical Pharnacology
and Therapentics
27{2):16S-1«9
-------
Salicylic «cld. load-) (9 CI)
Beazoie acid, 2-hydroxy-, ion(l-) (9 CI| (MI)
63-36-5
CT-B5-03
it 138.12. HP 157-159 C, BP abovt 211 C at 20 » Bg
(COBTMDBD)
TISSOB
5016
Blood,
plasma
5017
Blood,
seram
5018
Blood.
senm
5019
Blood,
sera*
••020
BlooJ,
seram
EXPOSURE SODTE
Ingestion
.
IngestiOB
Ingestion
iBgestiom
Ingest Ian
imtTICII
HBTBOD
rlaorometry
colorlietry
riaorosetry
BBBBJB
or cists
a) 1
b) 1
C) 1
d) 6
«> 6
12
7
20
9
81BQE
a) 9-0.2 og/al
b) 20-2 ug/Bl
c) 28-7.5 ag/al
d) 28.8-73.2 ag/ml
e) 54-120 ag/ml
a) 7.13-34.6 ag/100 ml
b) 0.582-6.06 ag/100 ml
Bot given
4.4-33.0 ag/100 ml
_ .
a) 10-26 mg/1
b) 29-58 ag/1
c) 106-181 ag/1
d) 122-236 ag/1
«) 175-286 sg/1
f) 215-292 ag/1
(BEIT
HE»S
a) Bot applicable
b) Bot applicable
c) Bot applicable
d) 40.1 » or - 17.3
ug/al
e) 77 + or - 24 ug/al
_ ....
a) 19.67 » or - 7.62
•g/100 al
b) 2.73 * or - 1.69
•g/100 ml
-
0.53 + or - 0.08
mmoles/1
14.47 mg/1 00 al
a) 15.44 ag/1
b) 44.56 ag/1
c) 147.89 ag/1
3) 189.56 ag/1
e) 243.78 ag/1
f) 254.50 ag/1
P«GI)
6E1ZB1L IBFOSUnOB
a) 0.5 aad 6 hr after 15 al dose
b) 2 and 9 ht after 30 ml dose.
Initial leasorvmeat, 11 ug/al at 0.5
e) 3 and 9 hr *f ter 60 ml dose.
Taltial aeasare*eat. 12 ag/sl at 0.5
d) 1.9 hr after «0 ml (peak meaB
level)
e) Peak level after 60 al/6 hr for 5
doses
8.77 sg sallcyelie acid/al
Bealthy 28-38 yr olds, »t 50-82 kg
• DOITS; BBIBIi BLOOB TUSB1; DSOGS;
IBatBtStCS
*) Total, correlatioa with saliva
levels, r-0.708
t) Free, correlation «lth saliva
levels, r-0.944
Tise-averaged steady-state levels.
nsval dose 8C aqykg/day.
7-17 yr olds with rheamatoid
arthritis.
I»B« TBVK1PT; 1MIGESICS; SatlTI;
BIOOD swan; CHUBSSB: B.MBSMOIB
1BIBBI1IS: Dm.SBS; COMmirfB
miOMIOBS; ILIIBOIS; HBlSBBBnBIT
flITBODS
Beaa peak at 0.5 hr after 900 ag plus
one 6*0- eg sustained release tablet
of phenytoin. 27.4* redaction of
phenytoia IB 2 hr.
Bcalthy 23-36 yr olds. »t 50-80 kg.
ttOSS; DSB6 TBTEBkCTIOB; BIOOD SfBO»:
»t BITS; sum; aBTicoBvoisirrs;
mtGEStcs: IBTIPTBETICS: m
ZtallBt; HEI1BOLISB
Ifter 5 days on 50 sg/kg/day buffered
acptriB in 5 doses.
Bheamatold arthritis patients, ages
20-86 yr.
D10CS; BflnRlTOID lETHHITIS; BIOOB
sisoa: nini; jBBttSs BISEJSIS:
fllTlBOlISH; BITlBOtlTSS
a) 0.66 B4/kg/hr
b) 1.0 mg/kg/hr
c) 1.8 ag/kg/hr
C) 2.1 eg/kq/hr
e) 2.7 ag/kg/hr
f) 3.0 ag/kg/hr, 6 snb-lects
Steady state levels
Scalthy 25-40 yr olds, OB no
aedlcation >2 wk and ao sallcylates
'3 VIE*
rtTJSS; HHTI-HriilHAtOBT 1GIBTS;
1B116ESICS; BIOOD PUStl: PMTEIBS-
OSI«E: C01>P>BITITE ITHLDtTlOlCS:
BITlBOtlSHj 1D01TS
- J
SIPEBEUCE
reldaan, S.
Chen. S.-l.
Pickering. L.E.
Cleary. T.G.
Ericsson, C.D.
Raise. B.
1931
Clinical Pharmacology
and Therapeaties
29 (8)5 7 88-792
Levy, G.
Procknal, J.I.
Olafs. B.
1980
Clinical Pharmacology
and Therapeaties
27 (5) j 6 19-627
Pazton, J.B.
1980
Clinical Pharmacology
amd Therapeaties
27(2):170-178
Gapta. B.
Sarklssiaa. I.
Paalns, B.e.
1975
Clinical Pharmacology
aad Therapeaties
18 (3): 3 50-355
rarst. D.E.
Tozer, T.I.
Relmon, K.L.
1979
Clinical Pharmacology
«md Therapeaties
26(3):380-389
U)
-J
-------
(3-36-5
L7-B5-UJ
10 138.12. It
TISSOB
5021
Salira
5022
Urine
5023
Or ioe
502*
Drine
5025
Brine
157-159 C. BP al
"EHOSTOB «o55F
Ingestioa
Ingestion
Ingestion
Ingestion
Ingestion
oat 211 C at 20 •• I
1I1LITIC11
HETBO*
Color iietry
Coloriaetry
coloclsetcy
_
tg
BUSBIB
or cases
12
2
-
-
20
9
a) C
b) 6
(com
~ Hies
O.M6-3.58 sg/100 nl
5«0.7-603.2 ag
1.28-1.86 sgAg/ac
92.4-105-8* of dose
_— -^— ^— • ~
a) 87.0-103.9X
b) 56.0-94.1*
»OBD>
BBlt
1.67* or - 1-03
mg/100 il
581.95 sg
1.51 ag/kg/br
96.83* of dose
a) 95 » or - «.«
b) 77.2 * or - 13.0*
Iia«-a»eraged steady state levels.
nsnal dose 8C sq/kg/day
7-17 yr olds with rheaaatoid
arthritis.
BIOOBTSBBOB;'cHItBB««S »*""!!??)
MIBBITIS: BISZiSBS; COHPlBlTItB
!T»HI1TM!IS: ItlHOIS; WaSOMSWT
BZTHO9S
ticretia* in 2»-hr orlaes. after 300
•g buffered aspirin. Talues
deternlaed by ne» aethod coapare to
>6«.0-a53.9 ag. deterained by
often-ased colorinetric aethod.
aealtliy 22 and 24 yr olis.
HBTI-TWlfcNRlTOTTT ACSBTS
*«-ret:ion of total salicylic acid
afSr 5 da?s on 50 .gAl/«»f battered
asririn in 5 doses. Boderately
correlated »ith »eraa le»els, r-0.50.
Bhenaatoid arthritis patients, ages
20-<« yr.
BMGS: BBW!I»TOI» aBTBBITIS: BIOOD
sci>Qfl; ?Bl*r.; ADOLTS; DISBASSS;
imBOttSB: BfTlBOlITSS
Daily ariae reco»ery. neans alter
1.0. 1.8. 2.1, 2.7. 3.0. and ».0
sg/kg/hr at steady state.
BHlthr 2^-«0 yr olis, on no
abdication >2 -k and «o salicylates
tsosst m-i-nriasHiTOH »<•«*;;:
naiGEStcs: EIOOD w**";,""?115-
m*f: cospaMTirt entMTiois;
BITIB01ISB: aBDXTS
— — *
,1 Total oatsat after 60 ml dose
b{ Total oatrnt after 60 si erery 6
br for fiTe doses
6.77 aq salicyclic acid/al
Bealthy 28-36 Tr olds, «t 50-82 tg
IIUITS: im««: BIOOB Piassa: ososs:
»1«16ISTCS
~ BZmEBCE
leyy, G.
Procknal. J.*-
Olafs, B.
pachaan, !••••
1980
Clinical Pharaacology
and Therapeutics
27 (5) -.6 19-627
— —
chioa, >.l.
oayenelakve, I.
197»
joarnal of
Pharnaceatical Sciences
63(»):630-632
Gupta, I.
Sarkissia*. !-
Paulas, H.B.
1975
Clinical Pharaacology
and Therapeutics
18(3)t350-355
Tnrst, D.I.
Toier. T.».
Kelson. K.L.
1979
Clinical pharaacology
and Therapeatics
26(31:390-389
reldaan. S.
Chen, S.-l.
Pickering, l-K-
cleary. '-G.
Bricsson. C.P.
Boise. B.
19S1
Clinical Pharaacology
and Therapeatics
29(6)5788-792
CO
oo
-------
Salicylic acid. *-aaiao- (« ci)
Erazoic acid. «-anltto-2-avdroxv- (9 Cl)
€_"*4i^6
C7-B7-1-03
81 153.13. IP 150-151 C
IISSQB
5026
Blood,
plaaia
5027
Uxine
Ingestios
Ingest ion
BPTB08
•OB BIB
OF CUES
12
-
12
B11GE
a) »-»9.98 ug/al
b) 155.M-* ug/il
c) 121.09-5 ng/sl
d) 139.51-6 ag/«l
-
a) lot given
b) lot given
c) lot given
d) Rot given
1111
a) lot applicable
1) Rot applicable
c) Rot applicable
d) Rot applicable
a) 77.2* of dose (3.1
9)
b) 92.8% of dose (3.7
q)
c) 98.55 of dose (3.9
g)
d) 98.21 of dose (3.9
g)
SEIIMI nrosBiTioi
a) 0.25 and 3.5* hr after
aaiaosalicylic acid. 21 ag/al at S
hi. b) 0.83 and 6 hr after la
aninosalicylate. 57 «g/al at 0.25 hr
cj 1. 10 and 6 hr after K
aalaosalicylate. 32 aq/nl at 0.25 hr
3) 1.02 and £ hr after Ca
aninosalicylate. 30 «g/»l at 0.25 hr
Corrected to 70 leg vt and * g
free-acid-eqaivaleat dose.
lealthy volunteers, no drags or
alcohol for 3 «k, fasted overnight
before and S hr after dose.
D*nBS{ CO-P1B1TIT! mint-IMS; BLOOD
EUSHl; UBTM
a) *BlnosalicyUc acid
b) la aninosalieylate
c) K-asinosalicylate
d) Ca-aiinosalieylate
2* hr cnsalative excretions after * g
doses 1» forns In a)-«). 52.3-56.7*
of dote excreted In aeetylated £or«.
Healthy volunteers, no drags or
alcohol for 3 «*. fasted overnight
cefore and 5 hr after dose.
WOSS; C08P1SIHVE STMnwiORS: BlOOfl
tEFEBElCE
Ran, S.a.
Pentlkainen, P.J.
azarnoff. D.I.
197*
Journal of
Pharnacvntical Sciences
63(5):709-711
Van, S.3.
Peatikainen, P.J.
azarnoff, a.i.
Journal of
Pharuceatical Sciences
CO
VO
Salicylic acid. 5-( (p-(2-pTriaTlsulfaaoTl) pheayl) azo>- (SCI)
155^5^1** 2-n7a«*I-5-({«-((2-PjridiiijlasinoJsnlfonTl)phenjlJa»o)- (9 Cl)
cie-m«-i«-os-s
BI 398.39, BP 2*0-2*5 C (decoap)
1ISSO!
5028
lenlotic
fluid
JIPOSOSI BODTB
Ingest ion
IHalTTICJt
RCTBOD
- -
BTIBBI8
or CASES
5
BUGS -'
a) lot given
b) lot given
c) tot given
d) lot given
e) lot given
-------
^sa^^ "
il 398.39: « "0-2« C taecosp) (COITMOM)
| II3SOK
5029
Blool,
fetal
5030
Blood.
sena
5031
lilk
"'mosrai BOTJM '
Xnqestion
Xngestios
Xngestion
-
IHLTTICIL
or C»SBS
5
5
3
-
~ IHeT"
b) lot gi*an
c) wet given
4) Sot given
e) <0.5 ng/sl
a| lot given
b) lot gives
c) »ot given
8) lot given
e) <0.5 ng/sl
a) Wot given
b) tot given
c) Cot given
a} »ot given
BEftl
a) a. 2 * or - 3.0
b) 11.0 * or - ».0
c) «.9 » or - 1.8
4) 0.6 * or - O.S
ag/sl
e) lot applicable
a) 7.3 » or - «.0
b) 10.6 « or - «•*
o) 3.T » or - 2.»
ag/sl . ,
1) 0.5 * or - 0.3
e) Hot applicable
a) 2.7 » or - 1.8
ag/sl
b) 10.3 » or - 1.6
c) l.» » or - 0.7
Bg/m
_ — •
a) Salphasalaxine
b) Total salthapyriaiB*
e| icetylatea snlphaprriaise
3) acetylatea svlphapTriaine
glocaroniae
«1 Total S-aniaosalicrlic acia
Reasarea at aeliverr- »ose. 0.5 g.
pwerperiav. Blooa froa OBbilical
cocas.
Salients with nlceratlve colitis who
tscac* preonaBt while oa therapy.
HHIOTTC rtniD: BIOOB SBEOH:
eistsoimisTiMi STSTBBI »J"» _.
giBXlTC*! COBBS »S96 IHSS1M8 BB06S;
iRlBOLIS": BRIB01OTS: MBCntCt;
I1CMTIOW
a) salphasalazin*
b) Total salphaprriaine
e) ac*trlatea sslphaprriaine
a) acetvlateJ s«lphapTriaine
2)U»t™"-ani«o»UcTUc acia
•easirea at aelirerT. Oose. 0.5 g.
•i/aav anriag preanancr ana
EierperitiB.
Fatleats with olcerative colitis Bho
bacaae pregnant aorinq therarr.
HSIOTIC FIOID: BIOOB SEBBSs
SISTFOIWtfSIIMt STSKB: HXU:
nazxiicii coFD: DSBS iBBHaK; DBWS;
llama*'' "ErlBOlIT1!Si P"CT*
a) SBlphasalaiine
b) Total salphapTriaUe
et ieetflatea s«lphapTrtai»«
a) acetrlatea snlphaprriaiM
C.5 i »«/aar aaring pregnancy »•*
paerperias.
patients »lth olceratit* colitis who
heeane pregnant while on therapy.
UIIOTIC ?l«Ds BWOO SZ80II:
sSrSrs.s'.sniWS^Dio.i,
aiTiBoixsii! BR»BOIIT*S: PBSGWUCT:
t»CT»TIO«
BZTVBBld
Troelove, S.C.
British Beflical Joornal
2{620«):1S53
nan, I.X.I.
Troelove, S.C.
1979
British Beaical Journal
2(«20»):1551
Khaa. l.I.A.
Trnelove. S.C.
1979
British Bedical Journal
2(620»):15S3
-_ ""'"
-------
frarteine (8 CI)
7.1«-aetkaBO-2I.CI-aipyrido(1.2-a:t'.2<-e) (t.S)diazocice. lodecahydro-, (7S-(7alpha,7aalpha.14alpha. 14abeta))- (9 CI)
90-39-1
C15-826-12
Bf 23*.37. IP 173 C at 8 an Bg
US-HE
5033
Brine
mason BOOTS
-~«"
AI1LTTIC1L
HSIBOD
GC
BOSSES
or CASES
1
BAM:
a) lot applicable
b) lot applicable
BSAB
__^____________— __^-^-_
a) 85% of dose (170
aa)
b) < « of dose (< 2
aq)
GtllSIL IIFOBBATIOI
Is sparteiae
b) As 2- and 5- denydrosparteiBe
0-2* br emulative excretion after
200 Bq as salfate
70 kq, vaite sale pbenotyped as "poor
setabolizer" according to capacity to
t-hydroxylate aebriso-aine and
sparteine.
C?OS3; IB-lBCLIsa; BTriBOlIIES;
01IK; COSPltltlVB ETllaKIOIS:
SID1TITK; BTMOtlCS! AMIPICMICS;
AHIETPEBTEISXTE IGMfS;
BEFEBEICB
Inaba, 1.
Often, S.T.
Fa Ion, i.
1980
Clinical Pharmacology
aad Therapeatics
27 (4) : 5*7-549
S»lfa»ila»ia«, H1)-(3.«-di«ethTl-5-isoiaiolTl)- J8 CI)
z«Bzm«sulfcuiid«, B-a.iBo-1-(3,»-di»thrl-Vlso«axolTl) - 19 CI)
127-89-5
C11-H13-13-03-S
II 267.30. IP 19* C (also reported 195-198 C. 192-195 C)
iissas
5033
a ilk
Birosm: aom
Tl^eation
llainiCAl
HRBOB
BUN BBS
OF CASES
6
11*88
-
a) lot gives
b) lot given
c) lot given
d) Hot given
Mil
a) 18 + or - 8.4 >g
b) 0.45 » or - 0.21%
c) 22.8 + or - 11.51!
d) 77.1 t or - 11.5X
GBI1SU IIFOilUTItm
i) Total salfisoxazole
b) t of laternal dose
c) * of total svlfisoxazole recovered
as snlfisoxazole
3) * at total snlfisoiazole recovered
as >*-acetvl salfisoxazole
tos« 1.0 q every 6 hr for 2* br. 48
III collection period
Caucasians, ages 19-27 yr
EOlKHHfllD'S; BI01CCD1DIATXOI;
HCMtlOl; KT1BOUTK; KAISAS;
IBUUS; ^IH; DKOSS
.
5IFEHEHCE
Kauffsaa. B.E.
O'Brien. C.
Gilford. P.
1980
Pediatrics
97 (5): 839-841
Snlfaailaiide. ltt)-(4.6-ai»ethyl-2-PTri«iaiBrl)- (8 CI)
Bea«nes«lfooaai4e, 4-a»ino-I-(«,«-Si«thTl-2-PTri»iaiiiyl)- (9 CI)
178-1T9 C, 198-199 C. 205-207 C)
C12-B14-14-02-S
Si 718.32. BS 17* C (also reported:
| TISSUE 1
1 1
1 1
503*
Blood.
plassa
iiposms BOUTS i
Ingest ion
»»nmcAi
!!Z?SOI
BOBBER
cr CASES
5
BUG:
a) 30.8*60.4 qg/»l
b) 73.3-122.5 ug/sl
(IEXT
Bill
a> 41.2fi 4 or - 11.53
»q/»l
b) 103.84 » or -
11.58 ag/al
._ . ..
PACE)
GE«iB*L iironnATioi
a) Peaks, 1-3 lir after 10 igYkq. b)
leaks. 1-6.6 hr after 40 aq/kq.
t«altby 2?-3« rt olds. »t 7»-96 kg,
fasted 12 hr before to 2 kr after
dose.
01IIE; BLOOD PLKSH; DB7BS;
miAaoiisa: IETABOIITSS
BEFESBItCE
da Soaicb. ?.
lalka, D.
Slaughter. E.
Elvin. A.T.
HcLeaa. A.J.
1979
clinical Pharaacology
and Therapeutics
25(2):172-193
-------
Silranilanidc, «<1|-
C10-B11-I3-03-S
Bl 253.31. HP 187 C
- (9
5039
Blood,
plasna
50*0
Blood,
eer»
50*1
Far fluid
Ingestlon
____.
__
Ingestion
BETHOD
TLC
coloriietry
HWC
BPIC
OF C1SBS
1
.
7
7
BUGS
--
26.33-1*.* ng/nl
Hot given
,
2.81-25.7 Og/ll
BE*1
Mot given
»».6 « or - 22 ng/sl
8.21 * or - 7.0 ug/nl
SE1IUL IIFOX8HIOI
0.5 and 25 hr after 160 nq
ttlMtnoprl* and 800 ng
smtaiettoxazole.
CBHGS; 11TIBIOIICS; BLOOD PL1SH1-
BMSBSEHIT HETBOSS
— — — __ ._
, T^ olds vith chronic serovs
otltis sedla.
BIOOB SMDB; F»B THUD* **'
" ' ' ~
'
2tlti' Ol4s *it!l CBronic s««'os
— _rt » iHrECTIOHj CBUDBZX j
BEFBBBICE
Sigel. C.H.
Grace. S.s.
vienol, C.».
Hltchings. G.B.
197*
Jonrnal of
Phariaceatical Sciences
63 (8): 120 2-1205
Kliiek, J.J.
Bates, T.B.
nightingale, C.
letnann. ».B.
zieniak, J.I.
Qnintiliani, P.
1980
Jonrnal of Pediatrics
96 («) :1087-10B9
Klinek, J.J.
Bates, T.B.
Hlgntlngale. C.
lehninn. «.B.
zienniak, J.I.
fluintillani, P.
1980
Joarnal of Pediatrics
96 (6): 1087-1089
£il«»silaiid€. I(1)-2-pTridrl- IB CI|
a-aniBO-B-2-pyridinTl- (9 CI)
OJ
C11-B11-I3-02-S
El 2*9.29. HP 191-193 C
50*2
Blood,
sera*
BX?BOD
IDBBEB
OF CiSSS
15
~~ B1IGE
0.8—28.6 vg/el
BUI
18.17 ng/sl
1
s
e
at
a<
1
D
1]
r«
CI
CI
SHIBJL IIF01MTIOI
and 9 hr after 22-68 ng/*a
snlfasalaziiic in doses divided
jllY 2t or «/lay. Inclodes
trlat«a and glacuronidized
netabalites. 10 rapH acet7lators,
12 raT»id hydroiylators.
yr olds, «lth Crohn disease or
olcerative colitis.
ill b«t one in coaplete clinical
r»ls«ion after >1 vk Uerapy.
; onus IBEBIW; umBoiHEss
CETIDSEl; ?LCOD SntBB; BrUSOLISH
BEFE5EICE
Goldstein, p.p.
llpers, D.B.
Keating, J.p.
1979
Joatnal of Pediatrics
95«):638-6*0
-------
.. 3.7-di.Tdro-3.7-dl.eth,l- f*
t3-67-0
Si~ieo!l7?2B* 357 C. BP 290 C (Bubli.es)
1ISSOI
50*3
filooJ,
Flaasa
50M
Rilk
504 S
SlllTI
IIPOSOBE aOBTE
Ingest ion
Ingest ion
Ingestion
Iliimcit
HETHOD
BPIC
BPLC
BPLC
»OHBEB
OT CiSIS
6
•
<
6
| B»GB
».5-7.8 sg/1
3.7-7.5 ag/1
a. 5-8. 2 ng/1
5.7 »g/l
5.3 «g/l
5.7 sg/1
GB1IS1L HFOTBatltH
Hter 113
-------
ineopbviiine (a cq
1F-Puriae-2,S-dioiM, 3.7-aibvdro-1.3-aisethjl- (9
C7-B8-B4-02
El 180.17, BE 270-27* C
(COBTIBHED)
5047
Blooa.
plasaa
5048
Blood,
plasaa
5049
Blooa.
plasaa
5050
Blool.
plasaa
Ingestion
IngestiOB
Ingestlon
In lection
BETBOO
BPLC
BS1C
GC
BPLC
or cisss
14
4
12
1
a) 9.3-17.1 ng/1
b) 4.3-8.9 ag/1
c) 13.3-51.3 ng/1
4) 7.9-20.4 ag/1
a) 0-135 ng/nl
b) 45-110 ng/nl
ct 60-165 ng/Bl
d| 70-195 ng/al
e) 95-185 nf/nl
g) 125-190 ng/al
f) 145-195 ng/Bl
h) 45-160
a) 9.7-4.9 ng/sl
b) 21.1-11.6 ng/al
a) 8.25-0.6 ng/al
b) 17.5-0.85 ng/Bl
ct 12.0-0.50 ng/al
dl 17-0.7 ug/nl
BUI
at 12.8 ag/1
b) 6.5 ag/1
ct 25.2 ng/1
at 13.2 ng/1
at 49 » or - 30 ng/nl
b) 79 * or - 15 ag/al
c) 106 » or - 22
nq/nl
d) 118 * or - 27
ng/Bl
e| 133 * or - 19
nq/al
ft 16314 ng/nl
g| 173 » or - 11
ng/al
hi 99 » or - 6 ng/al
(S.E.I
a| «ot giv«a
b| Bot given
at lot given
b) Bot given
c) Bot given
at Bot given
SlIMll XBrOBSmOB
at Peaks after 5.6 *g/kg. total body
vt basis
It Peaks after 5«6 ng/kg. ioeal body
•t basis
c| Stealy states, 0.9 ag/kg/hr. total
tody «t basis
at steal? states. 0.9 ng/kg/hc. Heal
Ccee as aainophvlliae.
Cbese 23-5H yr olds
tBtJSS; BLOOD PLaSHI; TBIOPBtltlBIS:
CCBPIB1TIYE PfltOSTIOIS
~
a| Ifter O.«i hr
I) ifter 1 hr
c| Ifter 1.S hE
at Ifter 2 hr
e| Ifter 3 hr
fl Ifter 5 hr
9) Ifter 7.5 hr
h| Ifter 24 hr
relieving 300 ng aose of caffeine.
volunteers. Canada
C1BIDI; ID01TS: BIOOD PIISB1;
mBETTCS: DEOGS; ROSCLB BELITJUTS;
CCB.PM1TIVI ETILOITIOBS: BCTIBOUTBS
a| Beaas after 225 ng/12 hr
t) Beaas after 450 ag/12 hr
Administered as aalnophvlline,
sustained-release capsale
Healthy 20-33 yr oias, one snoker.
Bo caffeine-containing beverages for
24 hr ana tasted overnight before
etndy.
ion dose effects: nild headaches.
anxiety, and palpitations. High aose
effects: naisea, voaltiog, insoania.
aaiiety, headache. Syaptoas nore
likely at plasna levels of >1? o^/al.
tlHTBD KIBG9CB: IDOLTS; BIOOD Pl»S»I-
MOGS
a| Control trial (no antibiotic)
b| Orng * tetracycline
c) tmg » etnhronycin
4) Drug * cephalexln
*> nln ana 2» hr post-infusion.
latibioUcs given as loading dose of
•!00 no DIBS 250 nq/6 hr, oral. « nin
IV of 5 nq/kq aninopliTliine after 4th
antibiotic dese.
flealthy 21 tc 33 vr oias. no
lanthine-eontalnlnq foods t beverages
t store and after dose.
Tachycardia and slid treanloasness.
tSOGS; 1BTISIOTICS: TBlOPHTtLIHSS:
E1COD PllSBD; 1 DOITS
(KIT P»SE)
8IWBEBC3
Gal. P.
Jnsko, B.J.
Tnrchak. i.g.
Franklin. B.I.
1978
Clinical Phamacology
and Therapeutics
23 (4) : 438-«44
Sved, S.
Bossle, B.D.
BcGilveray, i.j.
1976
Pesearcb Conaaoications
in Chenlcal Pathology
and Pharaacology
13 (2t: 1*5-192
Trenbath. ?.P.
Boobis. S.».
1979
Clinical Pharmacology
and Therapeutics
26(51:654-659
Pfeifer, H.J.
ereenblatt, D.J.
Frie4aan. p.
1979
Clinical Pharaacology
and Therapeutics
26 (It : 36-40
Ui
-------
theophylline (9 CI)
1B-Puri.n«-2,6-dione
5E-S5-9
C7-BS-I4-O2
II 180.11, »B 270-274 C
3.7-dihydro-l,3-ainethyl- (9
(CORIROED)
T m'
TISSUE
5051
Blood.
plasma
5052
Blood,
tlasaa
Hood,
plasna
S05»
Blood,
serai
KXPOSOKS SOOTI
Ingest ion
Ingest ion
-
Infection
nunicii
BETHOC
BPLC
HOMES
OF C1SES
18
1
~" JMGB
a) 0-14.9 «g/»l
b) 0-12.0 ug/nl
c) 1.5-14.3 «g/nl
1) 1.5-14.0 «g/nl
«) 7.7-11.6 ng/nl
f) 6.5-11-9 ug/nl
a) lot applicable
b) 120-31 mg/1
a) 0-24.0 ng/1
b) 3.9-17.0 ug/nl
c) 8.1-35.2 ag/ml
a) 6.3 * or - 4.7
uq/ml
b) 6. 3 + or - «.S
ag/»l
c) 10.2 * or - ».*
ag/ml
1) 9.2 * or - «.3
ag/»l
e) 9.S » or - 1.1
na/al
f) d.8 + or - 1.9
ag/il
a) 1*6 ig/1
b) Rot given
a) 6.7 ag/al
b) 8. 3 ag/il
c) 15.2 ug/«l
a) Tablet, 0.5 hr
t) Elixir, 0.5 hr
e) Tablet, 1 hr
6} Eliiir, 1 hr
e) Tablet, 0 hr
f) Eliiir, » hr
I lies after 375 >g dose in fora
stated
patients vith chronic obstrgctiTe
long disease, lean age 59.4 re.
IDEtralla
Significant tronchodilation
JDStSltli; &EOITS; DISEJSES; BLOOD
PtaSHl: BUTBETICS: DBOGS; nSCS.1
RIUT11TS; CCUPiSlTITE BT»LB»TIOKS :
E!S«B»TOFI ETSTEI
a) 16 hr after 1.S75 g as
sustained-release tablet
t) 0 and 170 ain of charcoal
heioperfnsion
15 yr old, 43 kg overdose patient
iTpotension and tachycardia after 10
ir, then cardiorespiratory arrest.
icldosls, hypokaleaia, cardiac
arrhTthaias, tachycardia after
resascitation. aspiration pnennonia
and acute renal failure after
teaoperfnsio.
IEWJPBTLL1HES; L»»IGE; HTJCTE»SIOI;
BHLT1 1»?»StS: DSOG 1BOSEJ OHTED
KI*SBO'!: 91CCD PlaSHi; DFOSS
BeTiew
Chronic dose torieity: anoreria,
nausea, voaiting, abdoninal
disconfoct. Serious toaieity
(cerebral seiznres, oardiac
arrtrthliss cr respiratory or cardiac
arr«st) is infrequent.
mm: TBEOPHTLLIIES; DISE.SES
a) Tine 0
t) Change following 6.0 ng/kg IT
aninophylline
e) Peak levels
isthnatie 0.5 to 20.9 yr olds, on
2.7-9.S no/kg oral tbeophylline
lailting, trenors
III YORK: CHIIOSI*: BLOOD SIB01I; DPBG
**niPTl THfOPHTLUMS
BEfEBEKCE
Hartnett, B.J.S.
Darlin, G.E.
Grahaa, G.
1974
nedical Joarn&l of
lastralia 1 (14) ;532-53S
Jefferys. D.B.
Baper, S.B.
Helliwell, B.
Berry, St. 3.
Crone, ?.
1980
British Redical Journal
280(6224) :1167
Piafsky, K.!!.
Ogilrie, B.I.
1975
Rev England Jonrnal of
eeflicine
292(23) :1218-1222
canavan, J. V.
Ellerstein, B. S.
Soil IT an. T.D.
1980
Journal of Pediatrics
97(2) :3C1-303
(HIT PUGS)
-------
Iheophylline (8 ci)
' 3'7-*illTa™-1.3-"»«thyl- f9 en
C7-H8-1»-02
•I 180.17, HP 270-274 C
5055
Blood,
sera*
5056
Blood,
sera*
S057
Blood,
sera*
5058
Blood,
sera*
lagestion
Ingestion
-
VRHOD
IPLC
CC
Enzyne
Inmnoascay
HPLC
(COITIlUfD)
ttUSBfB
OF CASES
20
21
20
B1VGE
a) not given
b) Sot given
a) 1.7-26.2 ng/1
b) 1.7-26.6 ng/1
a) 0-44 unoles/1
b) 20-65 aaoles/1
c) 27-70 aacles/1
6.7-23.5 aval
Bill
a) 5.92 * or - 2.»
•g/i
b) 2.52 * or - 0.96
a) 9.27 » or - 6.2
•q/1
b) 9.26 * or - 6.2
•
-------
3.7-ailTdro-1.3-«i.eth,l- (9 en
•8-55-9
rl 180.17, H
TISSUE
5059
Blood,
sens
5060
Blood,
seraa
50*1
eiooi,
serai
5062
carebrasp
iBal/TSBt
ricslar
flail
P 270-27* C
~ EISOSUBB 80ME
lBlectlo»
lBge*tioD
Injection
"~»B_1TTIC1L
KTBOD
HPLC
snc
ac
HPIC
IDS BBS
OF CISBS
4) «
b) 7
14
15
S
—
(C01TJ
"~ iiicl
a) 0-12.* BO./B!
b) 0-8.? BO/sl
a) 11.5-0.5 B«/sl
b) 15. 1-0. « «9/»l
3.9-19.5 a«/Bl
4) let giTen
b) lot o,i«n
• IEDI
sir "~
. —
a) Mot giTen
b) Hot gi»en
. . ____
a) lot gireft
b) Hot gl»«»
11.0 * or - 5.1 «J/nl
a) 5. 25 « or - 3.5
b) 2.16 » or - 1.06
•1/1
-GHSB11 nWiiWIOI
a) 0 «B« 20 tin .ftet lOBdiiiq lose of
6.0 •g/fc9 (20 •!» I»I »«a then 0.9
.,/kq/hr for 100 B!B. SteaflT state
of 11 B<|/il at «0-2«0 Bin
b) 0 »»« 20 BiB after loading lose of
t ma/Ya (20 BiB IT) aB< theB
,.I!t«aBCe dose of 0..5 .,/lc,/hr to
»chl«»8 s«rn« letel of 5 n^/Jl-
Stea«T at«»« of 7 •O'"1 •' 3
•ealthT 22-33 yr olds, fasted 8-12 hr
before, aad duriB? BtqlT-
080SS; TBZOPHmiKS: B100D SfSOH:
HEOHS
a) Basse of B«aBS, I-2*™* 2* hr
after 300 Bg as aonalcotolic
BBiBOpirUl"* "olrtioj. ^I;lt}»1
.easoreaent, 1.8 «
-------
Mtkn- C9
;«-S5-9
C7-B8-M-02
Ct 180.17. « 270-27* C
(COITI19BO)
USSM
50*3
9riB*
nnsaHS BORE
lBl«CtiOB
AlLLYTlClt
RET BOD
BaAlOeMtCT
cc
•BflBBB
or C»SBS
3
I1BGE
a) a.7-10.7*
b) 5.3-11. 2*
c) 16.0-18.M
d) 19.0-23.2*
e) 26.1-33.2?
f) 33.9-38.3*
q) 13.1-25.3*
k) 10.6 20.5?
1 •
a) 7.3* 1 a) TkeopkylllBe. asaal diet
b) 9.0* 1 b) TkeopkvlliM. BethTl*aatkine-rEe«
2 2UT* 1 c| 3-SetkTliaatkiae {Betabolite) ,
e) 29. *« 1 !•««! diet
fi 35.9* I d) 3-»et»Tl«atiia« (Betabolite).
a) 18.3* 1 •«thTl»aithi««-fr«e diet
k) 17.7* 1 e) 1.3-DiBetkYlacic acid
1 (setabolUe) . eseal diet
1 f| 1.3-BlBetkTluic acid
1 (aetabolitel, B«tkTl««»tkiBe-fEee
1 diet
1 B»al diet
1 k) 1-HethTl»tie acid (Betabolite) ,
1 a
-------
tl,lo»«thene-2-s«lfosanide, I.I-
-------
*«boc«rari»e
C37-BM-I2-CC
•1 609.80
"I (T.ij
Tf'12f-ai»*««'T-«.«'-«i««t*«r-2.2.,2.-trl-tbIl- 19 CD
TISSUE
5967
Blood.
Flassa
BIPOSOBB BOOTI
Injection
— _____
BETBOD
—
in
BOSSES
OF CASKS
10
B1B6B
•) 5-6 ag/ml
b) 0.45-0.95 aa/Bl
e) «-«.« «g,sl
4) 0.5-1.5 ag/Bl
Bill
a) lot given
b) lot glTen
c) Mot given
d) Rot given
" SSBIBII isTomnoi ~
•1 tornals. 3 lit
t) local*. 120 Bin
c) Imal f« Hares. 3 sin
Jl Benal failares. 120 tin
J«?f ^J'J* aos" of °'5 "*^' "•
I8tl»t«9 fro« gcapki. Data alao
9iT«» foe 0.3 iq/tg dose.
!.J*?*1:.'l*Ctllr* "C^'r patt««ts
«2.? J'lH**** wltt <*w>»ie «»«-«ta^
r««al fallira, prior to !ciaBeT
traa*pu>t.
IciporatT patalyaU correlated »ith
flr«9 I*T«I. Half laitnl effect at
0.3i . ,t - 0.03 nq/il.
jsnss; one Tnnm: gnscis
!S«lnS' BIOOD 1»*»»l KIBKI
CISMSIS; COWIBITIT8 ET»lniTIO»S
BIFEBHCE
Sketaer. l.B.
Stanskl. D.B.
Toieh. s.
Hiller. S.D.
Haa, J.
1979
Clinical Phariacologr
and Tkerapeatics
25(31:358-371
. 5-flioro- (g ci|
C«-B3-f-12
•» 130.0». HP 282-283 c (iecomp)
IISSV8
S068
Hood.
Flasu
--
S069
Blood.
plasu
BXVOSOBS IOOTC
IP dialyais
-
Injection
Invest ion
1IHTTICII
RTBOD
BPIC
— — — — — ^_—
BPLC
•OEBSI
OF CiSIS
1
11
B1ICB
3. 2110(2-5) -1110(8-71
•olea/1
a] 6.4-29.5 og/nl
b) 3.2-17.8 ug/nl
c) lot detectable-0. 1
ug/al
d) 1.2-11.3 «g/nl
e) 2.9-12.2 ng/al
f) 0.1-0.9 uq/nl
(IIR
iili
lot applicable
a) 13.4 » or - 9.«
>q/nl
b| 7. a * or - 6.1
nq/al
c» 0 «g/il
11 5.6 * or - ».9
«q/«l
«» 7. a 4 or - 3.9
nq/Bl
f) 0.3 + or - 0.3
«0/Bl
P1GE)
S'lIJlL nrCBMTIOI
1? "J,180 •i* *«•' start of » hr.
" «J»j7Sl« contalnln, * nnoles dri,.
Initial eeaiuenent. 6X10 (E-6)
?S«"!/Jl ''•titoneal lenls about
ta'k »ia»«- Batinated froi
Jatient «ith MliqaaBt disease in
IntraaMoniaal space.
Eo«e-ltBitiB9 tojiclty:
Ii;i«?;?rr""l8B' """^Ttopenia.
»cositis. laasea, rash, alopecia.
CoiBlete or partial mission IB 2
•ith OTarian caacer.
MOM! CHHOT1EB4PT: IHTIMB; BtOOD
PltS-ll; PniTOHMl FIOIBj IECPLISBS
a) 5 Bin after 250 ag. IT
t» 10 Bin after 250 ag. IT
e) «0 Bin after 250 aql IT
! « "J" after 50° •>• oral
e) 20 Bin after 500 aq. oral
f) 60 ala after 500 aq. oral.
CarciBoaa r«tl«nts, after
•attectoaies, Enoland.
01ME9 RKVCR; I9BWSJ ClSCHOtlS;
HCOD VLISIl; DBOGS; CO!)P»B»TITt
If»ln»TIOIIS: CHBOTBIB1PI
Sper«r. J.I.
Collins, J.».
Deflriek, B.I.
Brennaa, B.T.
Baeltpitt, i.B.
Lander. R.
BeTita, T.T.. Jr.
"Ters, c.E.
19SO
Cancer Research
»0t 567-572
Phillips. T.I.
Powell. 1.
Griere. F.J.
Belling. P.S.
1980
Journal of
Pkaraaeeotlcal Sciences
C9(12|:U28-ia3i
-------
Oracll, 5-flooro- (8 CIJ t»lt)
S.a(1B,3H)-Pvrimidi*edione. 5-fl«oro- (9 CIJ
51-21-8
Ca-IJ-?-B2
Bt 130.08, IP 282-283 C (decoapl
(C01TIIOED)
1ISSBB
5070
peritonea
1 fluid
BIPOSOM BOOT!
-
lllLTTIClL
RTHCD
BP1C
BOB BBS
or cisss
10
811GB
VOt $iYiM
1B1I
17.6 » or - 7.9* of
instilled
concentration
a br after 21 dialysate containing 5
aB-i BK drag. Bonoexponentlal
decline
Patients «lth aallgaant disease ia
intzaabdoslnal space.
rose-Halting toxicity:
•yelosappression, tbroabocytopeaia,
ancositis. laasea. rash, alopecia.
cosplete or partial reslssioa la 2
i 1th ovarian cancer.
91D6S; CHIBOTBBH1PT; S1BTHBB; BLOOD
SUSHI-. PEBITOHBAL EUJ1D; BECPIASBS
EirEBEBctt
Speyer, J.L.
Collins. J.B.
Dedrlck. t.L.
Brennan, 8. P.
Eackpitt. I.E.
Lender. B.
DeYita, ».t.. Jr.
Hyers. C.E.
1980
Cancer Besearch
•0:5*7-572
CI,
51-52-5
C7-B10-B2-0-S
BI 170.25
tISSBB
S071
Blood,
seraa
5072
Bilk
BZPOSVM SOOTS
Ingestion
Ingestion
numcit
SETBOD
Badioa«try
Sadioaetry
or CISES
1
1
~
0.0018-0. OC02*
radioactive dose/al
0.000 3-O.OOOW
radioactive dose/al
Bot given
(at given
C and 2* hr after 100 sg
Fropyltkionracil containing 100 nCi
labelled drag
m*: seras aoa-protela boand S
activity ratio » 0.55.
lactating aether
CBDCS; BSOS THIBIM! BLOOB S1BUK:
BIIK; LICTlTIOBi SCOTIMD
6 and 2» kr after 100 ag
ciopylthioacacil containing 100 ncl
latellel drag
Bilk: serna non-protein bound s
activity ratio - 0.55.
tactatiag sother
D51JGS; BB06 TIBS1M; BLOOD S1EBS;
•IK! HCT1IIOB; SCOtl»IB
BZrEREKtt
lov. L.C.I.
Lang, 3.
Alexander. ".0.
1979
Lancet 2(8150) :1011
Ion, I.e. K.
Lang, J-
llexander, 1.0.
1979
Lancet 2(8150) : 10 11
.£>
ro
Orea. 1-|(p-chloropke«yl|snlfonTl»-3-propyl- (8 CD
EenMnes.lfoaaaide. a-ckloro-«-{fpropTla»ino) carbonyl)- |9 CI)
9«-20-2
CI 276.75, •? 127-129 C (also reported 125-127 C|
IISSO!
5073
Blood,
aeraa
SIFOSVIS B01TTZ
laqestian
1I1LTTIC11
SET BOD
OC
ROBBER
or CASSS
97
34-667 ttBOl/1
. . _
tot giT«o
Cese* of 125-500 ng
33-90 n old patients «itb
•atartty-oaaet diabetes
tJOGS; DMBWSS: BLOOD SIBU8; SUDSK
BirEBEICS
Becgaan, 0.
Cbristensen, I.
Jansson, B.
nihola, B.-B.
ostaan, J.
1990
European Journal of
Clinical Pharnacology
18: 1«-1*9
-------
Valeric add. 2-propyl- n CZI
'cla' '
CC-B16-02
If 1M.21, IP 120-121 c ,t t« .. fg. ,2..l3o e at 20 .. B,
nssm
son
Blood.
plama
ilood.
plasea
Blood,
aeraa
lagestloa
lagestloa
tagestloa
1I1LTTICU.
ntBos
«e
— _
DC
ec
ntstft
or cists
76
6
6
Hisi
a) lot givea
b) Mot glvea
c) lot girea
41 Bot girea
•1 tot gir«a
f) lot givea
31.8-S2 ag/al
a) Bot glTea
b) Bot glvea
Mil
a) 65.1 + or - 20.3
b» 91.7 * or - 35.2
e) 5*. 6 » or - 26.5
4) 33.8 » or - 28.2
ag/al
e) 63.1 » or - 51.9
ag/al
f) "3.8 « or - 2«.e
ag/al
not gi»«a
aj 3*.* « or - 5.1
b) 27.1 * or - ».«
veittii nrotuTioi
a) ifter 785 * or - 259 mg/day.
atlzares eettrolled
h) ifter 785 + or - 259 ag/day.
aeizares aot controlled
c» after 1002 * or - « 15 ag/day »
Fheaobarbltal. Hlztna coatrolled
u) izter 1002 * or - 415 *a/A«v *
P.«»ob.rblt.l. ^1,.«. .,? T
controlled
el tfter 12«8 » or - S18 ag/day »
coBtroll*d e*ft*Bl**ata. aeizairas
1} ifter 1268 * or - SIS ag/day »
Ifileptlc chlldrea. Federal Mvablle
of Seraaay «-P«DI.IC
laereaaad appetite aad might gala.
jaatcoiateatiaal diatarbaacea.
tiaaaleat hair loss, fatlgae
CH1E1T; CB11DRKM; CBBTB1L BnyoOS
ITlLVaYIOlS
2."day2 b%S*It218 " 2V2*T f°r
at 10 hr. Tatlaated froa graph.
_ ^
ef aay drag. ** °la C*"e*sl"ul' fc««
trass ; BROS nrnicrioi; IBTJMS;
liSSE."*8"1* SSBWItSSj ByfBOTICS:
imcarynsiBTs: WTWOIISB
a) Bay «
b) Day 22
il^lll"f a*«»4y-atate levela ea 250
ag/12 hr oa daya 1-22 aad 200 ag/day
carbaaazaplae days 5-22. Day * V ?J
levels dlffereat. P<0.0005.
* T^ oLfls^ BO othcc dcvos
SBOOS: D»5C UtraiCTlOl:
iittconvoisins: H.OOB SHBB; »ootts
B2FZBBBC1
Klotzff 0.
1980 *"*
lateraatlanal Journal
of Clinical
Pharaacology. Therapy
aad Toxicology
I8(l0):«61-ae5
Patel. I.B.
le»y, ».H.
Co tier, I.E.
1980
Clialcal Pharaaeology
aal Therapeatlcs
27(»>:515-521
Bondle, T.I.
l*»y, I.B.
Cutler. e.E.
19T»
Clialcal Pharaacology
aad Therapeatlcs
2«(5|s« 29-63*
JS
-------
».i«ic .en. 2-propyi-. .
Pentanoic acid. 2-propyl-, sodlm
Kf 9-66-5
C8-B16-02.*a
II 1*7.23
1ISSOB
50TT
Blood.
plasna
BIPOSU1S toori"
Inoestlon
iBumcu
METHOD
_
ec
•OBBEB
or cuts
10
a) 2»2-«11 oaoles/1
b) «62-11»2 unoles/1
c) 335-842 asoles/1
..
~ BBAI
a) 397 + or - 109
nsoles/1
b) 679 * or - 235
aaoles/1
C) SOS * or - 157
nsoles/1
QliUll ISrOBBmOB
•
• ) Banqe Of llnimaS
t) Banoe o( sa«is«es
c) Baoqe ol teans
ifter si* s««tbs o« daily nalntenance
doses calculated (fro. single-dose
(«00 a,) data) to yi*!* •""• °J 5"
»oleg/l. «•• to peak after sinale
dose. 1.8 » et - 1.0 hr.
9-67 T* old «pileptics. vt 27-91 kg.
JS08SS D»DO «EB»*f: IHTICOBTCISISTS;
BIOOD nisn: »osn»ui: COBS»«»TITB
IT»LO»TIOBS: DXSUSCS
BEFIBBIICB
— .
Schapel. S.J.
Bera*. B.C.
Doeclte, C.J.
O'MillT. '-a-
Bcecer »•»•
Bisckbletk. B.B.C.
SaftSXW, L.».
Stanley. *.«•
1980
European Journal of
Clinical Pharaacologi
17:71-77
- (9
5J-I3-9
C27-B38-B2-C
"MSSOE
5078
classa
t 2*3-2*6 C at 0.
ETPOSOBE- B001B
•
Inlectlon
- —
91 SB Bg
HETIOO
Plnoronetry
BOTBZS
or USES
a) 9
b) 6
BIB6B
a) lot given
b) »ot giv«n
a) 52 * or - 7 ng/nl
b) 95 + or - 16 ng/nl
SB
gilEBll IBTOBilHOB
. • •
a) Besponder*. dose 0.066 *or- 0.099
t)9/»on-respe.ders. dose 0.189 *or-
Sesnonders kad ventricular rate of <
100/nin after < 5 eg. Boj-responders
kad ventricular rate > 100/iin after
dese of «p te 5 nq.
20-70 yr old patients vitl atrial
fibrillation or atrial natter.
tecraase in ventricular rate.
Transient decrease in systolic blood
treasure In sone.
MD65: B100B PllSSl! HE1BT 01SE1SSS;
IIOCD PBBSSOSI; 1501TS
BEWBEBCE
Doalnie, 3.
eclllister, E.G.
f«o, c.-S.
•eddy. C.P.
Snravicz, B.
1979
Clinical Pharnacology
and Therapeutics
26 f6): 7 10-71*
7«8-9«-5
C1I-B17-I
11 151. ZO, 9f
1ISSOE
S079
BlOOi,
plasna
1
\
\
\
\
"BMOS9BB BOKt"
laqestioa
~~ iB»tyticii
RETBOD
ec
i .
BOBBSB
or CISBS
al «
bl »
ej 5
1
.1
a) 65-13* ng/»l
b) 275- »67 nq/nl
c) 597-1373 ng/nl
1
SB»I~ ~~
a| 103 ng/nl
b) 32* ng/nl
c) 1282 ng/nl
nelians
I
1
.« _..
GBBEBll IBrOB»»TIOB
a) Dose of 0.39-0.»7 nq/kq/12 hr
bl Dose of 1.29-1.6* ng/*«/12 nr
C) Dose of 2.07-2. «0 ng/1tg/12 »r
levels tkronqliont dose interval at
tteady state
lealtky 19-3€ vr olds, vt 51-79.5 *g.
fasted before and after dose
| B»1<5S: BICOD Pl»S1l? UBIBS; ClBWk!
BirEKBCE
»o*.i, J.T.
Sitar, U.S.
cqilvle. B.I.
1979
Clinical Pharaacologv
and Tbecapentics
26 (6): 7 29-7 36
-------
1-ldauatanaalne f§ CD
Tricvcl3<3.3.1.1(J,7))decan-f-aaine f» CT)
7*8-94-*
C10-I17-I
N 151.2*. B* 160-1*0 C. 180-192 C
ICOITIIIBD)
TISSOB
5080
urine
Birosni soni
Img«stioa
lIUTTXCn
SETSWB
GC
posses
OF C»SBS
») 4
b) 4
cj S
iiiee
«| 0.68-1. 8W of dose
b) 0.85-1.41* of dose
C) 0.11-1.4T* of dose
Mil
a) 1.07 « or - 0.53%
of dose
b) 1.075 » or - 0.2»<
of dose
e) 0.««6 » ot - O.SSt
Of dOSe
CEItBlL IIF08I1TIOI
•) Bose of 0.39-0.47 19/119/12 kc
b) Dose of 1.29-1.64 iqyltq/12 br
c) DOM of 2.07-2.80 *q/koyi2 br
!i««tio> OB dir '5
BMltbT 19-3« rr olds, *t 51-79.5 kg.
f»»t«a b«forc and after dos«
IHD6S; BLOOD PUSH; OKIE: CilUk;
1 COLTS
IERBKIC!
aoki, T.I.
Si tar, D. S.
OqllTie, B.I.
1979
Clinical Pharmacology
aad Tberapentics
2«(6):729-73«
1-ttopaftOM, 1-t4-(a-bTdro*ipb««Tl-l-1-»«tbTl-a-plp«ridTl)- (8 CI1
1-ftopamOB«,1-|»-(3-brdroxjpb»«Tl>-1-»^bTl-4-plp«riaiBil)- (9 CI)
•69-19-4
C1S-B21-1-02
11 247.33, H 156-157 C
ussni i
5081
Blood,
plasnn
I
j
1
1
\
1
1
I
1
1
EXPOS18B BOOTS 1
1
Injection
InqestioB
aliLTttciL
SC/1S
1
1
1
1
1
1
1
I
IDHBSB
or OSES
5
1
1
1
U16E
a) 20.7-49.8 ««/•!
b) 8.97-12.69 ng/al
BBal
a) 35.1 * or - 5.92
ng/nl
b) 10.79 » or - 1.86
nq/nl
1
5MIEJ.L ItTOBBMIOl
a) 0-6 br averaqe levels. 10 mg IT
after recovery from anesthesia, 4
patients
b) 0-8 hr averaqe levels. 10 mg.
crallv. 2 davs post-surgery. 3
patients
Coapatel from area-nnder-tbe-cnrve
data.
Hoee-svrgery patients, ages 20.7-48.0
yi. Heights 55-82 kg.
StlBEI; BIOCE PlaSHl; MU.6ZSICS;
evoes; xtsconcsi SUECBBT
BETEBEBCE
Bondessen, 0.
arner, 5.
anderson. P.
Boreas, i.o.
BartTlg. P.
1930
European Journal of
Pharmacology 17:45-50
1,2-»ropaaediol, 3-lp-cbloropbe»oxy)-. 1-eacbanate (8 CI)
1.2-Pcopanediol. 3-<4-cbloipb«no»y|-, 1-carbanate (9 CI)
886-74-8
eiO-B12-Cl-»-04
•1 24S.61, HP 89-91 C
HSSOS
5082
flood,
acrnn
ET.MSOR BOOT! 1
1
Inqestlon
HtllTIClL
RE7HOD
GC
BOS BE!
OF CISSS
4
HUGE
9.29-3.4 ag/nl
BBlI
Rot applicable
GI1IB1L ItrOSH&TIOl
fanqe of Kans 1 and 8 br after last
ef multiple dose regimen (400 mg/6
hr). Initial value, 5.35 aq/«i at 0
t>r.
lor Hi 28-37 yr olds.
tHIGS: ItlSBSEBIIT B1TBODS; ILOOD
snmii: itnLTS: CBLOSI^E oiciinc
ccusoims
BITBBSBCI
Kaiser, D.6.
Sba«, S.R.
1974
Journal of
Pharmaceutical Sciences
*3C7)5 1094-1097
-------
1,t-B«phtkalaaedlone, 2- l3,3-dlchloro-2-rropenTl)-3-kTdroxT-
36»17-1«-0
C13-B8-C12-03
n 283.11
IISSOE
5083
Blood.
plnsna
SOB*
Drine
EIKSBll BOOTE
Injection
Injection
tBU.YT.XCU
RZTHOV
BadlonetcT
Badlonwtry
B01BEB
or ctsss
3
at «
bl <
2.9-0.88 ag/nl
a) 23.5-18.7* of dose
b) 7.4-1*. « of dose
Bet applicable
a) 33.1 » or - 3.5*
of dos*
b) 11.7 » or - 5.9*
Of dOM
Initial neasvrenent and 2« hi after
14 nq/sq n, IT.
Cancer patients
MUSS; BIOOB Pl»SH»; VBIBI;
BIOPLlSBSi CBIBOTBEB1PT
at Cnn«lati*e ercretlon of labelled
draq, 0-* hr after 10 nq/sq n, IT
• b) c»9lati*e excretion of anckanqed
draq 2» kr after 10 nq/sq n, IT
Cancer patients
DBDC.S; BLOOD PIlSBti OBIBE;
BIOP11S8S; CBMOTBIii?!
aisais^rara <7,s,-,i.iph..2b,t..»b«t,,5.ipk.,7D.t.,»- fs ^
CT7-S21-B-0»
Bl 303.35, RI 59 C
TISSBS
5085
Urine
ZIPOSOBS BOOTE
Injection
Serial
aBlLTTICtl
RETROD
—
BOB1SB
or CUBS
— — — — —
11BGB
a) 7.8-1.0 aq/hr
b) O.S2-0.»5 nq/kr
BE1B
at Bat qiren
bt Bat qiren
__._
a| 2-3 and 5 hr after 200 nq 19 as
kTirobroeide
t) 12 and 72 hr dnrinq transdernal
application, estinated dose 0.5 nq
over 3 daws
Ittinated fron graph
HealthT 16-55 rr olds with kistories
of notion sickness
Side effects: dry noith, drowsiness.
Blurred Tisicn
•BOttSs tISIBZ; DBOO THIS1PT: BSOGS
KFEBIfCB
BcKelvey, E.B.
Lonedlco, B.
in. I.
cbadwick, B.
loo, T.I.
1979
Clinical pkarnacoloqr
and Therapeutics 25(5
pt 11:586-590
HcKelTey, I.B.
toned ico. R.
In, I.
Chadvtek. B.
loo, T.I.
1979
Clinical PharnacoloqT
and Therapeatics 25(5
pt 1)jS8«-590
SSYZSEffCS
Price, B.B.
schnltt, 1.6.
ncsalre, J.
Shaw, J.E.
Trobonqh, 6.
1981
Clinical Pharnacoloqy
and Tkerapeetics
Ui
-------
M 303.35. If 98 C, BP 187-188 C »t 0.1 ••
89
nssvs
SOB*
Bioo4,
plena
BuosdBE MBfB
• _
iBgestioa
Xatraaacal
»8TBCI>
8C
or cms
7
•1MB
a) lot giTen
b) lot glT«a
c) lot glTea
<1) lot given
e> lot giTen
iii*
aj 12.9 + or - 2.2
ag/al
b) 31.3 » or - 3.0
«g/»l
O W.9 * or - «.«
ag/sl
1) 170.* + oc - 62.5
ag/ai
a) 2*2.0 « or - «7.3
ag/al
SB
czimi nroBBHioi
a> *1.2 lie «ft«r 0.19 iq/kg.
1»*««»»1 «oltitioB. * sob tacts
k) »7.1 ,1. after 0.38 .q/k,.
1»*™«»«J *clitio«, 7 subjects
c| 35.0 Big after 0.38 aq/kg.
J?*™»"«J {CTTStals). 3 sabjects
«) 90.7 sla aftec J.O BqAq.
lBtr»asal Mlitiai. 5 sBbjects
rapme/l's^t.-0 -^ "Utl"
^.SrlSiS.!.?"'*" -"•*"••
SlgJiBq^-'ft ?r"' "" M'33 Tt'
JJ^'J81^'1™*10 M08S' »»»wsi
ir.mmn>! "°t"! cos""Tln
BIKBBHCS
•lUiasoa. P.
TBB »rk«. C.
JatlM, p.
Barash, p.
BfClt, ».
1980
Cllaieal mnacology
acd Therapeutics
27(3):386-39«
CI1-B2S-02
B» 312.BB. gp 238-2«2 C (* fora). 239-2*1 C (- fora)
3
1ISSH8
5087
Blood,
plasaa
EHOSVBE BOOTE
-
laqestloa
BETBOD
.
Bit
OF CISSS
15
BlBGB
a) 1.55-7.55 ag/al
b) 0.95-2.90 ag/al
c) 1.52-«.Bfl ag/al
4) 0.24-1.20 ag/al
e> 0.2»-0.87 ag/al
f) 0.12-0.20 ag/al
(BBR
BUI -
a) 3.90 ag/nl
fc) 1.90 ag/al
c) 3.10 ng/Bl
4> 0.79 ng/Bl
e) 0.*3 ag/al
ft 0.16 ag/al
PISB)
GBinil IBPOBB1TIOB
• ' .
dl 43 K
ettraiiol ** * 3" *' «thiayl
e) 3 br after 30 nq
<) 23 br after 30 ng
lactatiag feaalea la Snedea
!I«BH: IDITITS: BLOOD PL»S1»- ^n.|f
t'CCISTOGHS; COBPtlMITE '
"*11V1TIOBS; UCTKTIOH
MPESBBCB
Bllsson, s.
Hygrao. it.
Jolansson, B.D.B.
1977
laerican Journal of
obstetrics and
Gyaecologr 129:178-18*
— ,. , _
Ui
vj
-------
i^o-t1^.^;^^!:'^?.^,^1^
S533-00-2
SS1"^?***2 sr •>••• f*f r '+ '"«••>• 'v»-2«1 c '- fo™> irowTTiBHi .. --...,n.r;
B • J 1* e ^^» •*«
TISSUE
5088
Rilll
BIWSBBS BOBM
Hitmen
SSTHCD
__
Ilk
ioiia
or cis is
15
— iiisi
. —
a) 0.16-1.50 Bg/Bl
b) 0.29-2.50 ag/al
c) 0.08-0. «5 Bg/Bl
d) 0.16-0.63 Bg/al
f) ol22-ll 10 Bg/Bl
2} Q.06-0.20 Bg/al
) 0.10-0.30 ag/al
it Bone detected
}) lone detected
BE»»
a) 0.51 ag/al
b) 1.05 ag/il
c) 0.22 ag/ll
d) 0.38 ng/al
e) 0.3» Bg/Bl
f) 0.5* ag/al
g) 0.11 ag/Bl
b) 0.17 ag/Bl
1) Hot applicable
j) lot applicable
~ " GIlIBal IirOBBWIOl
,) freaarsiag. 3 hr after 250 ag » SO
ag ethlayl ettradlol
50 ag ethiayl estradlol
c) Prenar.lBg. 23 hr after 250 ag *
50 ag ethlByl estradiol
i? UostBarsiag, 23 hr after 250 ag »
'0 OQ ethlayl estradiol
if Wea.relig. 3 hr after 150 «g » 30
an ethiayl estradiol
fl po«tB«rsiBg. 3 hr after 150 ag »
30 ag ethlayl estradiol
9) Piea.rslag, 23 hr after 150 ag *
30 aq ethia-yl estradiol
i) pistaarsiBg, 23 hr after 150 ag *
30 ag ethiayl estradiol
I) P?eBar»iig, 3 hr after 30 ag
1 Postaaraiag. 3 hr after 30 ag
811* erpr«a«ed before aBd after
feediaa tiae
tactatiag feaale* ia swedea
s«BM: atons: BLOOD PUSH: units
PBOGJSTOSISS; COSPlSlTllS
lilssoa, s.
Johansson, E.D.B.
1977 ,
laerieaa Journal of
Obstetric* aad
eyaecology 129:178-18«
Ul
00
C10-H13-B3
IISSOB
5089
Orlae
5090
1
1
i
"BXPOSBSB soo«
-
lagestioa
lagestioa
1
.\ —
1IU.TTIC11
RgTBOD
ec-ic
sc
1
1 „_
IBSBIl
or cisBS
80
i
I
i
•'
IlnSS
a) 1.6-56.*" of dose
b) 0.»-37.9» of dose
c) 3.0-88.3* Of do«e
a) Wot applicable
b) lot applicable
1
I
1
at 1S.2»« » or -
12. 0« of dose
b| 8.260 » or -
6.9T6^ of dose
cl 23.515 » or -
15.026* of dose
a) »H of dos« (9.6
b) < 1* of dose (<
0.2 ag)
1
1
— 6111111 MTOMMI01
a) Debrisoqala
ti «-OH debrisoqnla
c) BebrisoqaiB « »-0!I debrisogaia
0-8 hr eicreticm* after 12.8 ag as
salfate.
Healthy, 18-«5 rr old Ghanaians.
(asted before dose.
CHUGS- saa*i; u«I": RnkBOllsn:
tfTlBCtltfS! IDSltS
a) is debriscojaiBe
H is a-hydrorydebrlswgalne
0-8 hr ca«l»tiTe eicretioa after 20
ag as heiisalfate
70 *g, white aale phmotypel as "poor
,€t»bollter" accotdiBg to capacity to
«-hydroiylate debrlsogaUe BBd
Sfartelne.
BMGS: 1STXSCLISB! SFtlSOLIIIS!
mini coi!»«wi«* BT»W»TIO»S;
"SlTItSSS ITPWOtTCS: WriIPTllMXCS;
ilTHT««t*isi»i wins:
1 IMIMMttSBlC »6SWTS
1 .
BcnsnrcE
woolhoase. >.B.
ILadoh, B.
Hahgoab, 1.
Slcxin, T.P.
Idle, J.B.
Salth, B.I.
1979
Clinical Pharaacology
aad Therapeatics
2€<51S58«-591
laaba, T.
OftOfl, S.T.
Falov, w.
1980
Clinical Pharaacology
aBd Therapeatics
27(«):5»7-5»9
1
•
-------
C22-B29-»-O2
II 339.«8, II 75-76 C
ea.
,- „.„
5091
Blood
5092
Flood
5093
Blood,
plasaa
509*
Blood.
plasaa
Ing«stion
'
lagestloa
lagestioa
lagestloa
BETBOD
. ,
GC
.
oc
sc
.
GC/HS
-
BHIBZ3
OF CiSIS
16
30
14
.
8
1MSS
0.15-5.8 ag/100 al
0.13-2.** ag/ai
a) 150-7 ag/1
b) 78-3 .« ag/al
c) 280-95 ng/al
d) 180-38 ng/al
a) 290->1000 aaoles/1
b) 620-920 naoles/1
flEIT
liii
1.03 ag/100 al
0.60 + or - 0.51
a) 63.5 ag/al
b) 36.17 ng/al
c| 170.8 ng/al
d) 109.17 ng/al
- -
a) lot giren
b) lot giren
MGI)
GB I III! IITOBBHIOI ~~
fatal cases ia which only
ttopoxyphene fonad.
Coroners' cases, ages 2-62 yr, froa 3
California counties, cause of death.
sticlde, accidental, or aadeterained.
lltEl; BtUSS; BLOOD; IlCOBOlSj C»S»
•Tsmncs; sncxoE; BBOS IBBSE;
Cextroprapoxypheao poisoning
latalities. ilcohol and/or other
drugs la aost cases.
Coroaers eases, ages 16-67 yr.
lorthera Ireland
Coaa, death
Congestion and edeaa of laags. la
lose, cerebral edeaa.
"JOS; BtOOB: OBIIB; SHICIBBJ »BD«
IBHS8; ItmiB; CUB RISTOBIES-
fCBIISIC 8BDICIM
a) 7 anephrics, 1 aad 2» hr after
dose. Initial aeasnreaeat. 135 ng/al
*J 7 controls. 1 and 2* hr after
dose. Initial aeasnreaeat. SO ag/al
cj lororopoxyphene in 7 aaepnrics, 3
nad 2a hr after dose. Initial
aeasnreMiit. 57 ag/al
d) lorpropoxypheae in 7 controls. 2.5
and 2» hr after dose. Initial
aeasureaent. 40 ng/al
rose, 130 a
-------
C22-B29-B-02
II 339. »8. IF 75-76 C
(COBTIIOED)
TISSUE
5095
Blood,
plasaa
5096
Hood,
•hole
5097
liver
5098
Urine
5099
nine
BXjosoBS BOOT:
IngestlOB
IngestioB
Ingestion
Ingestion
Injection
IngestlOB
mimcii
BIT BOD
GC
GC
TIC
IB
ec
«
Sadioaetry
BOB BIB
OF CaSSS
10
a
a) 16
b) 6*
17
8
B1BGB
85-10 ng/nl
a) 93.75-338.75 ng/nl
b) 99.38-318.75 ag/nl
c) 618.75-1362.5 ag/al
d) 647.5-1*50 ng/nl
a) 1.2-35.3 ag/100 g
b] 0.2-38.* ag/100 g
O.OB-6.99 ng/dl
55-75* of total
radioactivity
lot applicable
a) 217.5 Bg/nl
b) 217.5 ng/sl
c) 1013.75 ng/nl
d) 1025.0 ng/nl
a) 11.78 ag/100 g
b) 9.32 ag/100 g
1.61 * or - 2.0*
ag/dl
lot givea
1 GSBIBiL IBTOE nation
1 and 12 hr after 65 ag dose as
hydrochlorlde 1z/»k. 10 vk
Bcalthy 25-3* yr old sea. average »t
8».« kg
ElOOD; BLOOD PL1SI1: inlGESICS: OBOG
TIZBaPT; COSPmtm 1T110MIDBS
a) ProBoxyphene, before heBodinlysis
b) Propoxyphene, daring henodia lysis
•c| lorpropoxypheae, before
d) lorpropoxypheae, during
130 ng propoxyphene/8 hr, 7 doses.
3-6 hr dialysis following each dose.
Idainistered as hydroehloride.
Inephric 36-55 yr olds.
EBOGS; BLOOD: COBPlBKItB
ITitWlTTOWS; IDBITSS HETlBOtlTfiS:
IBJIBMCmS; KIBWEI DISUSES;
BEBODI1T.TSIS
a) ratal cases in which only
b) llcohol and proporypheae found
Inltipl* drags found in nany canes.
In 9 cases of known dosage, fatal
dose vas 15-65 ng/kg.
Coroners' cases, ages 2-62 yr, froa 3
California counties. Canse of death.
suicide, accidental, or ondeterained.
IT.VIJ. 9BBGS: BLOOB; 1LCOSOLS; USE
•ISTOBIES: SOICIDS: OSOG »BBSZ;
CBILDIM; 19ULTS
textropropoifphene poisoning
fatalities, alcohol and/or other
drags in nost cases.
Coroners* cases, ages 16-67 yr.
lorthern Ireland
cena, death.
Congestion and edeaa of lungs. In
ccne, cerebral edeaa.
BB3GS; BLOOD; UBin; SUICIDE; DBUG
lEOSS; IBEUIB
0-7 dav cnnnlative excretion after
deses of K5, 130 aad 190 aq, oral,
aad 65 ng IT of »»C-la1)elled drug |3
uCl) .
Healthy 21-29 yr old*.
ttUSS; tlalGCSICS: BLOOD pLaSBt;
ItQlYS; CO^PIB&TITB BTlLOh?IOVS:
n«iB: nn.ina.nui »aoioisoropis
~~" B27EBBBCE
Slyvka, G.«.l.
Belikian, l.P.
Ihyatt, P.l-
Beyer, B.C.
Journal of Clinical
Pharnacology
15(8.9) : 598-60*
Giaconini, IC.fl.
Gibson, T.P-
levy, G.
1980
clinical Pharnacology
and Therapeutics
27{») :508-51»
Cravey, R.R.
Shaw, 9.F.
Kakaenra, G.B.
197*
Journal of Forensic
Sciences 19(1) :72-80
---
Carson, D.J.L.
Carson, S.I>.
1977
lancet If 80 17) :8M-897
Gran. L.r.
Scaoa, J.
lay. «.l.
Beltberg, J.
Bodin, l.o.
1979
Clinical Pharnacology
and Therapeatics
26(»l:B73-«82
-------
2-aapfctkaleaeacetlc add. 6-eetJroxy-alpha-aetkyl-. {•)- (9 en
'***"***6 •""' «-~tk««r-«W-~tkTl-. (3)- (9 CIt
C1«-B1«-03
H 230. 2C, n 155. J C
TISSUE
5100
Blood.
plaaaa
5101
Blood.
•eraa
EifosatE xomz
lagestioa
lagestioa
i Batmen
BRIOfi
oc
BPIC
•OBBH
or CISBS
-
5
FUSE
a) lot glvea
b) Bot given
lot given
mi
a) 67 ng/mi
b| 62 a«/al
»6. 1 * or - 5.6 ng/al
eiEERlt IRrOSRlVIOB
a) Deaa peak at 1 kr, 500 ag doae
b) Beav pea* at 2 kr. 500 ag doae
Flaa 1200 ag aaplrla
tatiMtel froa grapk.
aapirla. KG.!?!""* " T
Bealthy 23-»fl yr olds, faated
everalgkt.
Fines : BIDS mmcrioR:
im-nru«BiioiT touts; IDOITS;
HCtS; BLOOg tLkSBa; CORPllaTITE
FVUOKIORS
Steadv state level* folio v lag 3T5
ag/12 kr on 4avs 11 to 20 of
•atateuaco dose of mtfarla (10 ag
dally). RO effect OB boud or free
(taadv-state varfarin levels. Wo
effect oa protkroabla tlaes.
Eealtky 25-C< yr olds, «t 7».1-88.5
tg.
muss: iniccismins:
IBTI-TmiBRtTOBT 1GERTS; BtOOB
SIRO^; IDDITS; COBPUaTITt
tvjtnttiois
BBnBBBCI
Segr«, E.O.
ckaplla. B.
Forcklelli. B.
sevelios. H.
aad Tkerapeattc*
15 «) : 37B-379
Jala, 1.
Deflation, r.6.
Slattery. J.T.
1979*
Cliaical Pharaacology
aad Tberapeatlcs
25(1):61-«6
2-pipccliiaeaoetlc adl,
C13-H17-I-02
Bf 219.31
iissg:
5102
Bloo4,
aeraa
5103
Blood,
MMSORS BODTB
lageatloa
Taqeatioa
lllLTTICkL
RXTBOD
BPIC
HPIC
•OBBSB
or CISBS
2
1
a) 590-200 ag/1
b) 0-320 ng/1
0-85 vg/1
a) lot given
b) lot given
lot applicable
Cintll IirOHMTlOi
a) 1.0 »ad 3.S kr after
aetkylpkealdate. 35 ag 3x/day.
iBltlal aeasareaeat. 220 ag/1
tl Initial aeasoreaeat aad 2.2S kr
after aetkylrkealdate. 10 ag 3T/day.
Tlaal aeaavreaeat, 210 ag/1 at 4 kr
latlaated froa grapk
Sltalinic acid aetabolite of
aetkylpkeallate
Bfperactlve 9 aad 1* yr olda
CHT10SBI; SU»VIOS BISOEDEBS; BLOOD
SIBO»: »RTIMPRJSS1TE IGEBTS; DSOGS:
«laSO»E«E»I HITBOBS: RETiBOLISN;
BlllBOlITfS
Initial valae and 2.0 kr after 15 ag
dc»« of aetkylpkanldate. Fljial value
25 ag/1 after 8.5 kr. Vstlaated froa
grapk. Bitallalc acid aetabolite of
aetkylpkenidate.
Byperactlve 12 yr old
CBTimER; BEB1TIOB DISORDERS; BLOOD
SIBOH: MTIBEPBESSITE AGESTS; DBDGS:
H«S»BE9StT HE»BO»S; 1BMBOUSH:
BITIBCIITIS
BErEBERCB
Soldla. S.j.
Bill, B.B.
BUI. J.G.
1979
Cllalcal Chealstry
25(1)s51-S»
_
Soldia. 5.J.
Ckaa, 7.—P.H.
Bill, B.B.
Svaasoa. J.».
19T9
Clinical Ckeaistry
25(3):«01-«0<
-------
2-PiperldiBeacetic «dd. al»ba-pb«Byl-. ""tkyl ester
113-M-1
C14-B19-B-O2
II 233.10. U 7«-7S C
TISSU!
510*
Blood.
serai
EIPOSHB BODTB
InOeSt iOB
1M1TTIC1I
RETBOD
BPLC
•
BOSSES
or cisis
1
B1B6E
a| CS-0 09/1
b) 82-21 Bg/1
,,_ , — —
1B1I
a) lot girea
b) Rot glren
GEBEB1L IBTOSHBTIOB
<) 30 Bin and T he after IS *J
t) BItaliBic «cid (Betabollta) . 2.5
and 8.5 hr after IS ag
aethrlphenidate
istlBBted trca graph
Byparactt*e 12 re old
CBIIDBEB: BEB1TIOK OISOBDBBS: BXOOD
SIBOS: aSTIDmESSITE WlltSj DBtJGS;
«»SBFBiBBT IBTHODS; RRIBOIIS*;
•nUOLXflS
BEFEBEBCE
soldln. S.J.
Chan, Y.-P.B.
till, B.B.
SwaBSOB, J. 8.
19T9
Cllalcal Cheslstrr
25 (3): 401-404
C1«-B21-«-02
259.3«, » 96 C
1ISSOB
5105
Blood,
plasaa
5106
Blood,
plasaa
5107
Blood.
»
BXPOSOBS BOOTE
Ingestlon
lagestloB
ngestion
n lection
IBllRICli
IBTBOD
rlBoroBCtry
oc/as
\
1
\
—\
BOIBEB
or cisss
12
a) 17-140 ng/nl
b) Bot gi»«B
c) »ot gi»en
a) 571-2* BBOles/1
b) 79-44 BBOles/1
a) 13-1.4 ng/nl
b) 8.0-1.1 ng/nl
c) S5-3.7 B9/B1
— (Bt,r
a) 48.6 ng/nl
b) 77.2 * or - 11.1
c) 41.4 » or - 9.4
a) tot glrea
b) Cot 9i»en
a) Bot glrea
b) lot giTen
c) lot glyea
t tiif\
a) Before s«rgery " "c.lllster. E.G., Jf.
r) it the end of surgery, corrected 1 Bonrne, D.w.
for dilation 1 *«' T- «• ,
c) 10 alB after bypass dlacontisned 1 Ericteon. J.L.
Dose. 40-320 aq/oay to 12 hr before 1 VBchtal. C.C.
surgery, b) different froB a) and 1 T|**' !>p-
Waits OB long-tew propraaalol 1 and TherapeBtics
therapy for angina pectoris. 1 25(1) n-7
tndargoing aorta to coronary t
•rtery-saphenons »ein bypass sargery. 1
CBUGS; o^ne 7BSBi?T; siooo nisii; 1
ITOITS: BBlBt DISUSES: SOBGEBI 1
a) 2 BBd 24 hr neans after 16 ng/days I Johansson, S.B.
t) 16 and 24 br Beans after 160 1 •=C»1J» "•
US/day la slcn-release fors. 6S 1 WllhelsssoB, C.
iioles/1 at 2 hr J *|*Jn' 3' '
Bealthy 20-30 Tr olds, rithln 1M of 1 CliBical Pbarjacology
---—-I fjalnlifr 1 •&« TftBjr4p*tttiCS
Bcrsal .eight. f 27fS).M3.601
Bcdaced resting heart rate and 1
cierclse-lBdnced tachycardia. 1
reduced tlood pressare. I
ETOGS; SIECIBi BLOOD PLlSHt; t
•STIBieWTIBSlTE 1SSWTS: COSPISWITE 1
nitoiiions: molts: BLOOD PBESSBRB i
•) Initial Bcasaresent and T2 hr 1 walle, T.
after 0.05 sg/Xq IT. 3 soblects 1 Conradl. I.e.
t| 2 and 1* he after 20 ag, oral. 1 Halle. O.K.
Initial aeaeorenent. 1.3 nq/al 1 Tagan. T.C.
e) 2 and 16 hr after «0 Bg, oral. 1 Gaffney. T.J.
Initial aeasareBeBt* 5.4 ng/Bl 1 *979a
B«ge of «.« "rtliated fros graphs. I Clinical Pharaacology
tata also available for loag-ters 1 and Thera pent Ics
aoses «« for napthoiylactlc acid 1 26(5) :548-SS»
(Bitabolite) . <
\
KcalthT. 22-30 yr olds. »t 6J-S3 lq. t
IGWtS; »lOOt PI.BSBM TOIBE 1
1 .»
-------
2-Propanol, 1-(isopropylasinol-3-(1-naphthyloiy) - (8 CI)
2-Propanel, 1-<(1-iethylethTl|asino)-3-(1-na)>hthalenyloxr)- (9 CI)
525—66-6
C 16-B21-I-02
II 259.34, BP 96 C
(COHTIHDED)
HSSOB
5108
Blood.
plasoa
5109
Blood,
plasma
5110
Blood,
Flasaa
5111
Blood,
plssoa
.
El POSH BE ROUTE
Inqestion
Inqestion
Inqestion
aULYTICAL
HETHOD
Fluorometry
GC
HP1C
Pluoronetry
mjHBBH
OF C«SBS
s
25
7
sues
-
a) 45-222 ng/al
b) 37- 28J no/«l
5-121 ng/Bl
a) 2-7 ng/Bl
b) 13-51 aq/ll
C) 57-279 ng/Bl
4) 19-174 ng/nl
e) 534-170 ng/nl
f) 1667-509 ng/Bl
9) 15-8 ng/Bl
h) 4372-4288 ng/ml
_. _ . . . _
a) lot given
b) Dot given
e) Dot given
-
IBM
a) 169 » or - 72
nq/Bl
b) 169 « or - 79
nqyul
lot given
a) Hot give
b) Hot give
c) Sot give
d) Hot give
el Hot give
f) Hot give
q1 Hot applicable
h) Rot applicable
ng/Bl
b) 93. S * or - 44.8
nq/ll
o) 115. 1 » or - 56
nq/ml
SSHSBit IHFOSBaTIOH
a) Propcanolcl
h) Propranolcl 4. qnlnldlne
Ivecaaa steady state 0-6 he after
80-«q dose. Qainldine dose, 200 mq.
aealthy 22-H6 yr olds.
CHUGS; DRUG IRTERaCTIOH; BLOOD
PH31J: JHTIIHBHTTHHIC JGESTS: >DH1TS
tcse, 1$0 oq/day.
Thrcotoilc 17-65 yr olds.
nausea, lethargy, insoania.
ligbtheadedness, and diarrbea.
Cecreased neart rate, vt change
sl9nlf Icantly related to plasma
levels.
D1ITED KIHCDCI: BLOOD PUS HI; DBBG
TEEB1PT; DBDG5
a) 0.5 and 2 he after 20 nq. 3 ng/sl
at 8 hr
b) O.S and 2 br after 80 ng. 18
nq/al at 8 hr
c) 0.5 and 2 hr after 320 mq. 118
nq/il at 8 hr
d) Raphtboxy lactic add (HIA) ,
letabollte, 0.5 and 2 hr after 20 ing.
40 nq/nl at 8 hr
«) HL> 2 and 8 he after 80 19. 242
&9/B1 at 0.5 hr
f) Hit 2 and 8 br after 320 nq. 705
ng/nl at 0.5 hr
g) Before and after heBodialysls,
unspecified doses
h) H.I before and after heiodialvsis
Given as hydrochlorlde
a)-f| locial dales. Other
•etabolltes also aeasured.
6 nornal 23-32 yr old Bales, fasted
before and after dose. 14 21-65 yr
o!4s on long-term hemodlalysis.
IHTIHTPSBTIRSIVB aSBHTS; DRUGS;
BIT1BOI.ITBS: BLOOD PtSSIS; PPOTMHS;
tPISB: KTIRET DISEtSES: HEBODIiLTSIS;
ItOlTS
hydralazlne
e) Peak, propranolol * SO aq
kydralazice
Cata also for absorption studies.
Horootensive 19-31 yr olds, vt 4«-90
kg, fasted before dose.
Decreased pulse rate, blood pressure.
Faintness with hyiralazine plus drag.
imttYPBRTtHSIVB IGBBTS; BLOCD
pitsii: 1BDITS: Ditne IBTEB»CTIOS:
ELOOD P!tESSnKE: EHZTKES: ltiSTBM.Il
BEFEBEHCE
Fenster, P.
Perrier, D.
Hayersobn, H.
Rarcns, F.I.
1980
Clinical Pharmacology
and Therapeutics
27(») :4SO-4S3
Feely, J.
Stevenson. I.R.
Crooks, J.
1980
Clinical Pharmacology
and Therapeutics
28(1): 40-44
Schneck, D.H.
?ritchard, J.r.
Gibson, T.p.
Vary. J.B.
Bayes, S.B.. Jr.
1980
Clinical Pharmacology
and Therapeutics
27 (6): 744-755
ffdean , &.J.
Skevs, R.
Eobik, 1.
Dudley, P.J.
1980
Clinical Pharmacology
and Therapeutics
27(6):726-732
(H3IT
OJ
-------
2-Ptopaaol. 1-oJ-3-t1-Baphthal«Byloir»- 19 CI)
525-66-6
CK-B21-I-02
II 25*.3». IP 96 C
TISSUE
5112
Blood.
plasaa
5113
Slood,
plasaa
Blood.
5115
Blood,
nposniB BOOTB
Injection
lagestioa
Ingest Ion
iBlOCtlOB
Tagestloa
• MlYTICAl
BCTBOD
Flaoroaetry
ec
Flaoroaetry
ladioMtry
Sadlosetry
Flaorosetry
BDRBBB
OF CASES
10
24
IS
5
•) 25.4-24.3 Bg/al
b) 31.3-31.7 Bg/sl
a) 5.5-152.5 ag/al
b) 56-290.0 sg/sl
c) 97.5-580.0 ng/al
d] 67.5-1,330.0 ag/al
3.2-15.6 ag/al
a) 30-63 Bg/»l
b) 39-142 eg/si
a) Vot glvea
b) lot girea
a) 69.4 ng/al
b) 158. 1 eg/al
c) 339.0 ng/al
d) 607.6 ag/al
5.40 ng/al
i) 41.5 ag/al
b) 79.2 ag/al
a) d-Propraaolol after iafMloa of
d-fora
b) dl-Propranolol after infusion of
dl-fora
1-4 br range during 4-hr Infusion of
0.04 ag/kg/hc
Data shov that propraaolol depresses.
•ithovt altering the glucose carve.
glacose-stitalated insulin levels.
lealthy. noa-obe»e 25-37 vr elds, oa
SCO g carbohydrate diets >3 days.
dl-fora redaeed blood pressure
rsoes! BLOOD PLUIA: CMIOI:
BITISOII5B: ELOOO SEBDB: BOtBOHBS;
HOOD P»«SSOBB; ABBTTS
a) 40 eg 2i/day
b) «0 ag 2x/daT
c) 169 ag 2i/dar
d) 2*0 ag 2 I/day
t.*-2.S hr after aornlag dose
2«-62 yr olds, «ith essential
hypertension.
lever blood trestares and pulse
rates. Fatigue, di«laess. chaage in
tovel habits, algbtsares.
IS9SS1 91106 TBBPaPT: ABTIBTPBBTESSIVE
leiirs: SIOCB PBISSOBS: BTFIPTEISXOI;
It BITS: MItIB HBGBOS; CO»P»BIH»E
tmOkTTOWS; MUSES
— —
Steady state levels after 7tb dose of
«0 ag/8 br. aad 40 ad of
3B-propraBOlel IT
Icraal 23-55 yr olds, vt 56-92 kfl.
esucs: BsriBoiisi: IDCLTS; BIXXJE:
BtOOD P11S!11; AICOROLS; SSISBSSBWT
a) stealy state, 80 ag/8 hr
r| Stealy state, 80 ag/8 hr plas
eblorprosailBe. 50 aq/8 hr
Idalts, 4 aoraal aad 1 hypertensive,
ages 21-33 yr.
giOGSt 9B3G laTEHCTTOI; TZ*nSS!3;
ctocQ pits'i: aooiTS: BT?tsrt«slol;
ilFEBEfCB
Brers, B.C.
Bope-eill, B.P.
1979
clinical Pbaraacology
and Therapeaties
25t3):303-308
Serlin. B.J.
OrM, B.l'B.
Baber. l.S.
SibeoB, fi.G.
Lavs, t.
BreclceBridge, A.
1990
Clinical Phanacology
and Therapeaties
27 {•!): 586-592
xonha«s«r, 9. B.
vood, l.J.J.
yestal. B.E.
Wilkinson, c.e.
Branch. B.A.
Sband, D.6.
1978
Clinical Pharmacology
and Therapeaties
23 (2): 165-174
vestal, B.E.
Korabaaser. 3.8.
Bollifield, 3.9.
Shand, B.C.
1979
Clinical Pharaacology
and Therapeaties
25 (1»: 19- 24
(•Bit PIGI)
-------
Bl 2S».3«.
IBSM
S11C
Blood.
»!•*••
5117
Moo4,
5118
BlooA.
5114
Mood.
*«r»«
5120
Blool,
whol«
"BIPOSIB BORI
Hontloi
luiTTIOU
HBTBOD
ec/is
BUG
n»oroi«try
B»LC
or cuts
-
5
3
35
_
•1 S
»l 2
ct 1
4) 1
IS
(con
file?
b) 75-2*9 »o/»l
c| 73-2SO mq/ml
•- .
C-31C n»/.l
•) >0-57 ng/ol
b) 50—80 kf/ol
c) lot «pplie«bl«
<) *ot cppliabla
33-1W sg/tl
II KIT
'Itno)
~ JB1B f
__l.
•1 63.6 ig/.l j
b) U2.2 •«/•! !
Cl 1*2.2 4/.1 {
1
I
Wot 9iVM *
1
i
i
|
Bot giT*» !
'
!
1
j
J
1
1
1
_!.
«l Bot given i
b) Bot givoft |
c) 120 Bq/il i
d) 212 no/il i
J
J
•
J
1.
72 nj/,1 J
1
1
I
1
Bleu! " • — 1—
«inu
MFBBBICE
assrsatr— ••—
itpzmisioi:
M; CO«»lB*Ttl
nts»: OBIM
SSL
I i^*SrCk CO"»«iC«tiOB
' " i^Iif?1 ?«t««oio,,
co.plTi.,
Ln
-------
-Baphtbyloxy)- (8
JSS-6S-6
C16-B21-I-02
II 259.3*, BP 96 C (COIIIIBBD)
iissns
5121
Urine
5122
urine
5123
urine
EtfOSUSI KOOTB
Ingestion
Ingestion
Ingest log
IMLTTICIL
BBTBOD
GC/BS
HM.C
ec/ss
or cisis
5
2«
B1IKB
lot given
a) lot girea
b) lot given
c) lot giT«n
d) lot girea
a) lot given
C) lot giTCB
a) lot gives
b) lot giv«B
c) lot given
d) lot given
BE1I
Ik* it dose
a) 8. 3 * or - 1.6* of
dose
b) 13.5 * or - 2.S*
of dose
c) 15.0 * or - 6.5*
of dose
d) 39.2 » or - 2.8*
of dose
£) aa.6 * or - 5.2*
of dose
a) 3. 1* of dose
b) 9.2* of dose
c| 16.0* of dose
d) 18.0* of dose
tally excretion OB chronic therapy of
eo to 960 ng/day (every 6 kr) .
Hypertensive patients.
DB0GS: SSTIBOJ.ITBS: IBTIHYSBBTEISIfB
IEEITS; BLOOD PtlSBI; OBIIB
a) Propraoolcl, 67 naole dose
B) Propranolol, 268 ««ole dose
e) Propranolcl, 1072 nnole dose
d) Propranolcl » setaboUtes. 67
anole dose
e) Propranolol * aetabolites, 268
f" Propranolcl » setabolites, 1072
stole dose
Given as hydroehloride
•8 hr excretions
lorsal 23-32 yr olds, fasted before
and after dose.
MTIBYPESTBISiyE IGBSTSi DBOGSs
JITtBOlITIS; BtOOB P11SB1; PBOTEIISj
OBIIB; KIOlEy DISEtSIS: BEBOBI1LTSIS;
lEOlTS
— — " "~
a) «0 ng/day
b) 160 sg/day
ci 2*9 eg/day
d) 320 ng/day. * excreted daily as
the glnearonide after long-tern
tterapy *ith dose indicated.
Bypertension or coronary artery
disease patients.
CBGGS: B8UG TBTTglPT: BTPEBTBBSIOWi
C»SBIOT»SCTO»B OISEAS^SJ COBPIBITITE
M»IIHTIO*S: BIOOD pisssi: OBIIB
— — •
~ TirEBEHCE
—
walls, T.
conradi, B.C.
•alle, O.K.
Fagaa, T.c.
Gaffney, T.S.
1979 a
Clinical Pharaacologv
and Tkerapeoties
26 (5) : 5«8-«»
Schneck, D.«-
Pritchard, J.P.
Gibson, T.J.
Tary, J.B-
Bayes, 1.8., Jr.
1980
Clinical Pharsacology
and Therapeotics
27{6):7»«-755
Halle, T.
Conradi, B.C.
valle. U.K.
ragaa, T.C.
Gaffney, T.E.
1979b
clinical Pharnacology
and Therapeutics 26(6):
686-695
-------
13*55-52-2
C 1S-B23-W-02
II 2«9.39
i-co-BllylpheBoxT)-3-{i*opropTlaBiBO|- (8 d)
1-}<1-BeihTlethrlU«i«o)-3-(2-{2-propeBrl|phe»«r}- C»CI)
tissai
512»
Blood,
plana
5125
Blood,
plasaa
IZIOSnC SOBTB
Inqestioa
Infection
laqestion
iiiinicu
nraoD
ec
GC-SC
•DHBIS
r cisss
1
1
«
iiiii '
a) 29-90 BBOlAS/1
b) 8-9 » aaoles/1
C) «-122 BBOles/1
4) 22-9* BMles/l
a) 100-15 FBoles/g
b) 37-12 psoles/g
c) 115-3* caoles/q
4) 125-12 naoles/g
e) 200-6. 5 pnoles/g
5Ii i "" GEitMi nrosHttioi i SEfEBEics
i j
a) «0 BBOles/1 ! •) alprenolcl. 90 .la after 0.2 q 1 «"f*«; p'
b) 38 ».ol«8Xl 1 b) Ilpra«olol, 90 .i» «ft«r 0.2 g. 36 !«"«»• p-
c) 80 naoles/1 1 »t after last ot 10 doses J Borg. K-o.
?> ss »«ol*a/l 1 i«atobacbltal (0.1 g/Say) » "aglanfl. K.
4) 55 .iol.s/1 1 *«"™j;4ro)tj..ipl.1. 90 ai. after 1 »« Bahr. C.
l fl 2 a ^ i9'9
«i 1 a?kTae8«I-al|,r.»olol. 90 ai; after 1 "Vi"!^?"01*"
i 0.2 q. 3« ar alter last of 10 loses 1 «a.;k!"*«£ie8
| peatobarbltal (0,1 g/«aT) 1 25(«) :«23-«27
| t«*tobarbital effect OB Beaas 1
| siqviflcant. P<0.01. 1
i «
I ICBsaolciaq 23-31 TT olds, nith BO 1
1 «Tl4euce of iis«ase or flrog Intake. 1
| iBhibltloB of exercise tacblcardU 1
I taring » 7 he period vas reduced froa I
I «.0 to 10.7* br peatobarbltal 1
| (redectloB correlated »lth plasma 1
1 levels). '
tines; HBTIBCLISB: BWTSIS; I
BTTn^nsToi: BLOOD PLISHI: C« In eierclse heart rate 1
correlated «ith log plasaa lerel. 1
CSIGS: stfMii: JLDHWS: HIPEBIBSSIOH; i
HTlBOtltlS: BLOOB PLtSHl; IBOTIUS 1
2S839-7S-8
C13-H«-i»-03-S
II 31«.»Z. HJ 71.5-72.5 C
1ISSHI
512«
ElOOd,
plasna
sxrosnfts some
-
lagestloB
alliniOL
HCTBOO
OC-BC
IOHBSK
OT CaSSS
BMGB
173-3 BBOlesA
i»1
Rot giTen
GIlIBlL Iir08»»TtOS 1
2 «aS ao he «eins after 20 eg/day
Sealtby 20-30 Tr olds, within 10« of
noisal weight.
Seduced resting aad exercise heart
tates. Seduced tlood pressure.
Etaes: snosi: BIOOD PUSIII:
laTIHTPIITWSITI 4GEMTS; COnflKWTYE
gt»LUlTIO*S) 1DQ11S: BtOOD IBESSttSI
Johansson, S.F.
HcCall, II .
wil&elasson , C.
Tedln. J.I.
1930
clinical Pharaacology
and Therapeutics
27(5) : 593-601
(IE1T PISE)
-------
^^
J6839-75-8
C 13-B2»-««-03-S
81 316.»2. BS 71.5-72.5 C
1ISSOC
5127
Blood,
sera*
5128
Urine
EtPosnBS SOOTI
Inaestion
IngestioB
ilaLTTICIL
BETBOD
GC-SC
GC/HS
Radionetry
_____ _— — —
BOBBBI
OF C1SES
IS
3
IMSB
a) 0-86 ng/ll
b) 30-156 ng/n.1
c) 39-171 ng/«l
lot giTen
Bill
a) 42 ng/al
b) 77 ng/*l
c) 96 ng/nl
77 * or - »% of dose
J__._ ' " —
a) 20 *g/aay
t) ao sg/day
e) CO nq/day
Ifter 3rd week. 2-« hr after M dose.
23-56 yr olds, slid to soderate
etsential hypertension , » no-25 yr.
C black. 11 unite.
flood pressure, heart rate, and
plasia renin actirtty decreased.
EBDGS; oans THSR»PT: HTPMTIISIOK:
IIOCD SE^OB; conPatwiys iy»toatio»s
lose. 10 nq C1«-ttnolol
2* hr excretions
Bealthy yolnntears
I)BIR«: 1TT1BCLISS; SMS; DSOCS
SEFESEHCE
Slnoa, 6.
Kiowski, >.
Julias, s.
1978
Clinical Pharnacologl
and Therapeutics 23 (2) :
152-157
Tocco, D.J.
Duncan, i.E.V.
delnna, F.I.
snith, J.L.
Falker, S.».
TandenheaTel. S.J.*.
1980
Drag Hetaboliss and
DispositiOB
8(«) : 2 36-240
2-eropaBOl, 1-(2-CTClop«tilpliei»»r»-3-( d.
3«507-aa-9
C18-B29-»-02
R« 291.*
00
ussm
5129
Bloo4,
plaaia
5130
Urine
IIPOSDIE BOOTS
InoestloB
Inoestlon
»»»tmc»i
CETHOC
HaoroKtrT
Flvoroietrr
ID8BES
OF C1SSS
12
12
MICE
a) 403-3*56 ng/il
b) 37«-2191 »g/«l
c) 283-661 ng/»l
a) Rot given
bj lot gl«en
e) lot gi»en
> ' \
a, ,239., . or - 225 j »*J.;«e'«.Ti.^S,tta" \ ~">,
7 * °' - '" oS^r'.^.r,^^,— ^ ! SSK.^.
SS" * or - 31-7 i ?-^s- ^."i^.1"1 ""* i SFt! J:T-
1 HsalthT 21-«S yr olds. »t 160-180 I Joarual of =li=ic«l
! lb""o iruqs > 10 4ars. fasted 1 Phar.acolo, y 19:«15-a23
I before and after dose. 1
j HeJnctlon in restinq and eserciae 1
i heart rates and systolic pressure. 1
1 giastolic effects less consistent. 1
1 EFUSS! »ITIHIPWT!»SITI »SI»TS: BLOOD I
| H'SSflBS: BLCO9 PllSBi: OBUI; IDOITS 1
1 _ ]
Swis ilH-lL .,„»... liife,.
. • t HOTOSt *• E«
•ealrty 21-»5 yr olds. «t 160-130 t ftevart, J.T.
1 Its. «o *r«gs > 10 ««ys. fasted 1 1979
before a.« a«.r do«. . *:~^,^;^t«l
I telnctioa IE restlaq and eiercise 1
I heart rates and systolic pressure. 1
I Clastollc effects less consistent. 1
i '
1 C*0es-. MTlSWCTtWISTT! \G!«TS: BIOOD 1
1 H'SSHT1!: ?1COB M.»S^\: T!SI*t; WOltS I I
1 — — ' '
-------
CH-B25-B-03
It 267.3*
TISSOX i nrosBBB Boni"
5131
Blood.
Plasaa
5132
Blood.
plasaa
5133
Plasaa
513*
Plassa
iBoestioB
Ingestloa
iBOestioa
Tagestioa
lUlTTICal
HBTBOO
SC
8C
SC-BC
9C-SC
or CISBS
5
a) 12
b) 8
lues
•I 1237-20 Beoles/1
b) 605-56 BBOl.s/1
a) 27.1-76.1 paole/g
b) 53.5-1*7.7 paole/g
c) 162.6-aio.S piole/g
4) 130.6-199.B peole/g
, ...
a) Bet given
b) 111-325 eg/el
a) 68.1-«67.1 ag/sl
b) 120.S-1C66.7 ng/sl
OESI
a| Bot gives
b) Bot gives
a) 60.0 psole/g
b) 106.1 paole/g
c) 265.8 psole/g
4) 166.5 paole/g
a) 323 « or - 98
b) Bot given
a) 198.9 « or - 37.7
b) «26.1 + or - M.I
(S.S.J
(MIT Pas*)
SBBHB.1 I,™.,™,
a) 2 aad 2a lr seaas after 200 tg/day
b) 2 aad 2* hr seaas after 200 sg/day
a» slov-relcase fors
Bealthy 20-30 yr olds, withia 10« of
•orsal velght.
tadaced resting aad exercise heart
rates. Seduced blood pressure.
MOSS; StIDZI; BIOOO PLlSfll;
• RlBt*EBTI(SiyZ iGtltS; COBPlBaTIVB
iTaLn*no«s; iDviTs; HOOD PKSSTOZ
a) 25 ag/day, 2-5 days
b) SO eg/day, 3-7 days
c) 100 ag/day, a-9 days
d) 50 ag 3z/day. 25-72 days
iverage levels for 1st 7.5 br after
dose, (area-aBder-tae-coxve/tlae) .
30-«6 yr olds, witk hyperteasloB
0.5-3 vr.
iBtlByperteasive at all doses, p <
0.05, lomred palsa rate, all doses.
c < 0.01. B.Hi pi. doses lomred
Flasaa renin activity IB a of 5
eases.
tlOGS; OIOG TBKSiPI; BIOOO nESSQBB-
lIlIHTPBBTtBSITZ KBITS; SVBDEB;
atTltS; COaplBlTITE ?T»LU»TIOIS;
XTCOD msvi
— —
a) after 1 «k oa 200 ag/day.
tiastollc iressere responsive to low
dose (qroap t)
b) 1 and * vk. Dose 200 sg/day 1st
«k, 300- BOO eg/day *th vk. Olastollc
rtessere respoasive oaly at higher
doses (qroBC B>
Ul s«*1ects given 50 ag 2I/day
hydrocBlorotUazide > 9 vk before
ictoprolol.
21-« yr olds. »t 55-105 kg, vith
tlld to soderate hypertension.
It diced blocd pressare, redacel heart
late aad plassa reain activity.
tlzzlaess aad fatlgae.
rsness BTPS»TBBSIO»; 91000 pizssnas-
BWSBTICS: IBTlBIPEBTEllsiyi 1C! UTS;
BIOOB PHS1I; 1DDITS
a) Jfter single, 100-ag lose. Peak
at 1.7 » or - 0.2 hr
10C-600 ag/day. Peak at 1.6 * or -
0.2 hr
adsialstered ai tartrate.
Rynerteisive 30-69 yr olds, fasted
before first dose.
Elaed pressure and heart rate
decreased .
EBOSS: DIDO TBMIPTS »BTiBtsz»TWsiyi
16SBTS; HYPmiBSIOII: BtOOD PllSKt;
EICCD PMSSIJUE; CIMIDI; 1DVLTS
BBTESERCB
-
Johansson, S.E.
Recall, a.
Vilhelsssoa. C.
Vedia, J.i.
mo
Clialcal PharsacologT
and Therapeutics
27 (5): 593-601
Collste, F.
Baglaad, (.
VOB Bahr. c.
1980
Clinical Pharaacology
aad Tierapeatics
27(«):aai-a«9
yelasgnei, a.T.
Van, S.R.
Haroade, B.r.
1979
Clialcal tharaacology
and Therapeutics
2«(5):'!5?-561
Ryers, U.S.
Thiessen, J.J.
1980
Clinical Pharaacology
and Therapegtics
27(6)8756-762
vO
-------
2-Propa.ol. ,
37310-58-t
C1«-H25-«-03
•I 267.J«
(COiTHBED)
1ISSOB
5135
Blool,
Flasia
-
5136
Blood.
plasaa
5137
urine
1IPOSDJK HOOTB
In oast ion
Inoestion
-
Inoestion
IMLTtlCtl
HRBOB
ec
OC
ec
Saaioaetrr
IDIBSB
or cisss
C
B
10
HteB
a) «ot applicable
b) lot applicable
e) lot applicable
a) 360-1200 naoles/1
b) 230-1100 moles/1
a) lot applicable
b) lot applicable
c) let applicable
4) lot applicable
—
a) 135 »J/»1
b) 77 ng/al
c) B9 »g/«l
a) tot glten
b) tot giten
a) 2.7« of dose
b) 3.5* of dose
c) 97.5V of dose
4) 99.6? of dose
a) Bean pea*. 87 »u'
. 2*0 "i
tablet (59« released by 2 »«
e* lean pea*. 28i .i», slo. release
tablet (3»« teleased b» 2 hr> -
180 ml. single «««• •• tartrate.
Be.lthT 23-2J »«•"
bt b«for« ana » fcr aft«t
caused MXia» 17-
rat*
Iffwt.
l*r*ls. r>9.9«. K0.001.
DB»«$! 9100B tlURll 3SHJ
CC9VM1TITI IT110HIOSS:
SKBEir; BlOOt PSZSSBRB
a) ?eak». 1-3 »' «"« «-' * JS hr
t P«ak«. 1-2 *r alter 0.1 9. 36 hr
aft«r 10 «aT« i««tobarbUal 10.1
Ke.-U«l«-t»e-c,rT. r.4«rt by
after paatobartital treat««nt.
BealthT Swedish «t«d«it8. ages 2*-37
", no«*ao*er«. tast.a OTetalqht to 2
it after «OS€.
tunes- DSOS nrwictioi:
"MD MisS»: BIOOD misson: S«B»M:
IC1LTS
«toprolol. slo«-r.lease
^e aetoprolol.
riatoactiTitT. slo.-r.lease
* raaioactiTitT.
72 fcr etcretloas after 50 •«
ttitl««-labelle4 d«» as tartrate
10 lieaXtiT 25-*6 Tr oias. fastea
10-12 hr 1-«t<:r« » • fcr aftet aose
caaael «aiiia» 17-19t
rate. »•*« »!»» »»
J«ects eorr.late4.ith
ItTels. r>0.96. P<0.001
E»ieS! BIOOB Pl»S8»:
cei«»i»TiT! miowt
SISDIW, BtOOB PHZSSOW
»»loes-
m.,,
»BOHS:
c-s.
icta pharsacoloqlea et
toiieol09lca36(Suppl
I.
seiaeian. P.
Collste. S.
Borq, r.-O.
von Bahr. C.
«79
Clinical Phar«acol09T
as3 th«tapeatlcs
26 (3) s 326-329
teqaraii. C-B.
johasson, 6.
Jordo, 1.
SoUsll. 1.
»cta ?iar«acologica et
Tozlcoloqica 3*
-------
2-PyrldlMacetaaite.
2-Pyriilaeacetanide,
1737-09-5
C21-H29-B3-0
BB 339.»7. IF 9*.5-95.0 C
- c. ex,
IXSSBB
51*1
Blood.
Blood.
elassa
51*3
Blood.
seraa
BIMSDB3 BOBIZ
--
Xagestion
lagestioa
•
lalection
AULTTXCiL
BETBOB
BM.C
me
ec
-
BOBBEB
OF C1SBS
a) 5
bt 6
6
9
a) *.5-S.» sg/al
b) 5.0-7.1 ag/nl
3-0.2 v«/nl
at 2.6*-1.85 ng/al
b) 1.71-1. »0 «g/al
c| 0.66-9.«0 og/al
dl 1.9-0.1 «g/sl
1 BEIB
a) *.9 • or - 0.6
b) 5.9 * or - 0.2
«g/sl
Bot given
a) Bat applicable
B) lot applicable
e) Bot applicable
1) Bot applicable
. _
t) 200 ng « i/Jay aainteaance dose
Byocardlal iafarctloa patients, ages
««-73 yr. «t 62-90 kg.
Bpocs; inmiiii: RSIBT DXSEISBS:
BICOD nisii: sine TBSBIPT; iftttiis
2 and 58 ir after 200 sg dose as
Tbospaate. Initial aeasareneat. 1.8
ag/nl at 0,5 ar
Baage of seals, estiaated froa grapb
Fatients vltb renal Insaffleleacy
regnirlng loig-tera aenodlalysis
ItlllTS: BBMT PKB»SIS; IIBBR
EISM5M: HniBBBTtmic IGIITS: OBVG
ICEBIPT
a) 150 sg dcse. followed by 8 «r If
b| 75 sg dose, folloned by 8 or If of
cj 25?sg dose, followed by 8 »r If of
2.5 aq/hr
d) 2 and 30 fcr after 2 ag/kg bolus
IT, 8 sab-teets. Bstisated fron graph
at -e) 0.5 and B br after start of
dcse, 1 snblect.
Borsal volunteers
BBitw KiBeec"; IDBHSJ BLOOS SIBBB:
iBTiisaananc iciBts; DXTOS
ttnazfcs
Ilett. I.F.
Badsen, B.B.
foods. J.D.
1979
Clinical Pbanaeology
and Tberapeatics
.
Sevka, B.J.
Ratthews. S.J.
Blghtiagale. C.H.
Izard. B.f.
Fiellsan. 1.
cho«, a.s.s.
1981
Clinical Fbarnacology
aad Therapeutics
29(3):322-326
Lawrence. J.H.
Brysoa, S.B.
Snsner. D.J.
1979
Biopharnaceatics and
Drag Disposition
1:51-57
•-J
N)
137-5B-6
68-69 C. BP 180-181 C at » an Bg, 159-160 C at 2 an Bg
TISSVK
S14»
Blood,
plasaa
BXPaSBBS BOOTB
Injection
Inaestion
(octal
1I1ITTIC1I
arraoo
oc
HlflBtS
OF C1SSS
B1ISB
a) 0.3»0-0.59« ng/1
b) 0.085-0. «60 sg/1
c) 0.2*3-0.829 ng/1
(Ittt
RIB
a) 0.«9« + or - 9.09*
ng/1
b) 0.26* * or - 0.11&
c| 0.529 + or - 0.22J
nq/1
ntsi)
at «0 aln Tf
11 oral lone (capsale)
c) Kectal dene (agaeoas solatioal
0-8 kr average levels conpated fton
aiea-«nler-tbe-cnrre/«90 nla. 5os«,
200 aq If, 300 ag oral or rectal.
lealtar 23 to 26 »r olds. «t 65-85
kg, fasted before dose.
vsoesj ^BT»»Bla»DS: 81003 fi»S"»;
CC>m»iTTf» lfHO»TIO!IS; iBWlTS;
ftOCO
BEFB9BHCE
de Boer. *.G-
freiner. D.9.
Battle. H.
Prosit, 3-
Gabbens-Stibbe, J.R.
1979
Cliaical Pharaacology
aad Therapaatics
2«t*):701-709
-------
fI;f.'"fr*°JT^U**' *-Mi«t»rl««l.o)- (8 CD
m-sJT* 2-'dl«t^1"1"»-«-».«-«l"t»riS«rii- (9 CD
CU-B22-B2-0
•• 23«.33. BP 68-69 C. BP 180-181 c .t • .. B,. 159-160 C at 2 .. Bg
T1SSBB
51*5
Blood,
Flana
-
Blood,
•hole
B&PQSOU 1OOH
iBjeetloB
iBJeCtlOB
Ingest ion
lectal
IBURICil
BZTBOB
as
ec
ttriBft
or cms
6
" iiifii ~~
1.8-3.2 ag/al
•) 0.30-0.57 Bg/1
b) 0.079-0.35* Bg/1
c) 0.206-0.60 ag/1
! BBll
2.5 ag/sl
a) 0.398 » or - 0.098
Bg/1
b) O.m » or - 0.102
Bg/1
c) 0.377 » or - 0.1*2
ag/1
GJItUl IBFOIBITIOB
— • _
§2 'I0?*1** *••»• followed hT°12 kr
IT °" 30 Qg/kg/sin. Levels of 2
aetabolites also aeamred.
leaal failure patients OB caroaic
heaoaialrsis. either anephric or «ith
creatiaiae clearances of < 5 al/»in.
Bo congastive heart failure or liver
»c central nervoBS avsten toxic itr or
changes in heart rate or Mood
pressure.
BOTGS: BBTIBOHSB; B10OB PIISB1;
DISBftSBS
a) 60 Bin IT
r) Oral dose (capsule)
c) Beet a 1 dose (aqneovs solution)
9-9 hr average levels coaputed froa
area-nnaer-tbe-c«rve/«SO ain. Dose.
200 Bg If. 300 a
-------
28-1,2,»-BenzothladialIiie-7-salfOBaaid«. «-chloro-3,»-dihTdro-2-nethrl-3-(((2,2.2-trlf laoroathrl) thio) Methyl)-, 1.1-diozide
3»6-18-»
C11-B13-Cl-F3-l3-0«-S3
tl «3*.*0, He 202.5 C, also reported as 207-217 C
tISSOS
$1*8
Blood.
plasia
51*9
Urine
EXMSOBB BOOM
Ingestion
iBgestioB
aUiniClL
(1ST BOD
OC
GC
IDHBE8
OF C1SBS
18
13
MWI
0.61-1.0* ng/ml
11.62-32.5m of dos*
mi
lot applicable
20.3*1 of dose
GEIEMI IBFOBHTIOI
Bange of seans, 1-48 hr after 1 »q.
Peaks at 5 hr in nost patients.
83.5V protein-bound at 10 ng/nl.
Bcnoexponential eliiiaation.
Serial 16-*S rr oils, fasted
etetniqlit before and 2 hr after dose.
BBOGS; DIOPFIICS; BBiSOSEBBHT
RITDODS; B10CD PUSH; UPIHE
0**6 hr cuialatife excretion after 1
• »q-
Xorial 18-45 TT olds, fasted
oierniqht before and 2 hr after dose.
|
DBOSS; DIUSTTICS; flElSHBES!KT
NtTBODS; BLOCD PUS!I1; UBI»! I
FEfEFSJCE
Potts, D.C.
TVOI6T, T.B.
1978
Clinical Pbaraacologr
and Therapeutics
23 (2): 2*1-2*6
Robbs, B.C.
Tvoney. T.B.
1978
Clinical Pharmacology
and Therapeutics
23 (2): 2*1-246
2R-1.*-Beazodiaz«pin-2-one,
2B-1,a-B«nzodiazepii-2-one, 5-{2-chlorophe«fl|-1,3-dibrdro-7-nltro-
U22-61-3
C15-H10-C1-I3-03
II 315.72, IF 236.5-236.5 C
TISSUE
51EO
Blood
5151
Blood,
plasia
EIFOSOIB aottrt
Ingest ioa
Ingestion
aUlYTTCU
BBTHOD
rac
BalioMtry
SC-EC
RadlOMtrr
nc
BOHBIS
or cis is
i
i
niei
12-1.0 ag egnlT/sl
a) 17-6.2 ag eqoif/al
b) 17-1.0 ig egdiT/il
IE1I
lot applicable
a) Rot applicable
b) lot applicable
G!»!B»t IIFOaUIIOR
1 and 96 hr after 2 19 of aicronized
clonaTepai-2-14C, deternined by
GC-ZC. Aqreed vith TIC, cadioiettr
valaes. Biezeooential decline.
DBOGS; IMSOJEBIIT SFTHODSJ BIOOD;
iiTico»Tnts»iras: connaiTife
EfaiuaTiows; BLOOD PUSIA
a) Total 1»C
b) 1*C-clona2epan
1 and 120 br after 2 ag of licxoniled
clonaiepan-2-1*C
BB1SS; 1EIS01ENMT HTT80DS; BIOODj
UTTCOWTBlSalTS: COHP»B»T1T!!
MatViTtOllS; BLOOD PU51J
SZFEIEICE
de SilTa, 3.1.7.
fnglisi, C.T.
HQnno, 1.
197*
Journal of
Pharnacentical Sciences
«3(«): 520-527
de Silva, J.J.F.
Pnqlisl. C.T.
Banco, I.
197»
Journal of
Pharmaceutical Sciences
63(4): 520-527
-------
C t»-Bf 7-C1-I2-0
•I J2».«3, BE t*s-l«« c («l«o
'- CcycJopropvl.,*,,!, -t,3-dl.Taro-S-pa«rl-
t*«-i*7 q
TISSUE
-
5152
BlooJ.
Plasaa
5153
uriw
KIMSntS MBTB
Iage*tioa
Inqwtio.
1M1RIC11
BRBOD
«C
«C
imtat
or cists
—
5
-
5
flS5 i ~
I **** 1 SMERal IIFOlaaTIOf
f l'
S! £ gJS - B'USI * " - 10° / S rtete
?! s &:.• i .bur • « - » ?,*
3 - #= 22" ' — "• <
BKK i £§••-- jg«
i HI . r " 11 ! s~ ~^«rs'sr.r -
1 f) 179 * or - 33 | prazepaa
1 ng/nl j
1 2U2i5 * ot ' " ! SESV"""*"'- " 56"H *9> "e
1 h) M * oc - 38 «,/.! |
1 1 «1»»IKEPI1M5 OIITSD KH6DO1I:
j 1 IBUlTSi LlfSSj D81IE! HWIBOIISI
8 !:K:S S S t5 : S : ^:S i \\ SKss-^-
j | Betabolltes In 2» hr speciieits »£tec
J 1 30 •« PCazepM, * dose excreted
| 1 rasttnq non-sBoken, vt S6-«» kq. age
1 1 20—%1 yr
| 1
' 1 BMZODttZMHES; DKTSB KIWSDOB:
• 1 IMITS; ITT«; D8IIII; «W1%OIISS
nrnacs
Chasseaod, i.f.
Taylor. 7.
Eroate, E.E.
1980
Jooraal of «tariacr anl
Phanacologj 32:652-653
Chaaseana, L.T.
Taylor. T.
Brolie. E.E.
1990
Joarual at ?karaacy anl
Phanacoloqj 32:652-653
il 2B».7S. at 125-126 C
Ul
1ISSOI
515*
eiooa
S155
Bloe4,
plasu
5156
Blood.
plasia
IIPOSBBE tOUTE
Ingest ion
laqestloi
Tnoestlon
Jllirticu,
•mcB
ec
. —
ac
sc
!•• • L _
IVUBSB
or ciszs
5
5
5
B1BGZ
1M-130 .9/11
225-20» »g/al
25-22 ag/al
(MIT
isii
lot gi»«»
lot given
lot glTen
PISE)
G'llgll IiroBBlTIOi
10 «q, 2.5 hr later, 1000 1 heparln
Reaaued before »ad 15 »in after
teparln. corresponilnij free icnq
values. 3.6-6.9 x)/al.
•craal 23-»0 »r olds.
IIPIUS; "BOMIWSi SBT«BOLISB: B1OOD:
31COB PUSH; i»oe I«T8E»CIIOII:
CHD5S; HOSC1I PELAT1TIS
10 aq, 2.5 hr later. 1000 0 heparln.
««a«rel before and 15 aln after
hcvarlft. Corresponding free droo
values, J.S - S.9 aq/al.
Ior.il 23-HO yr oils.
1TPIBS; PROTIMS; SET»B01IS»: BIOOD-
steoo ntsui; BUDS i»TE»icTi6ii-
MUGS; IUSCIE EPUltlHTS
10 aq, -1. 5 hi later 1000 0 heparln.
neasnrel before and 15 .In after
teparin. Cocrespondlnq free 4rnq
values, 0. 42-1. 01 nq/al.
loraal 23-»0 yr olds.
IT?IBS: PPOMIIIS; BWUBOIISB; S1OO3:
BtCOO ?t»S1S: DBOG IHTEMCTIOK;
tS!IGS; IIHSCIB TIIHTiirrS
— _
SlriBUCE
Footledge. p.A.
rltchell. S.B.
IlornssoE, T.B.
Sltloner, 1.
llnnolla, •!.
Shan a, D.G.
1480
Clinical Phar.acology
an! Therapeutics
27(4)!528-532
Tontledge, ».».
Kitchen, B.B.
Blornsson, T.D.
Skinner, T.
linnoila, n.
Shand, B.G.
1980
Clinical Phariacology
and Therapeutics
27(»):52«-532
Toutledge, P.I.
Fitchell. B.B.
Bjornsson, T.P.
Skinner, T.
linnoila, R.
Shanil, D.G.
1930
clinical Pharaacoloar
a»d Therapeutics
21 m: 528-532
-------
2B-1, »-B«B*oaiazepU-2-oaa. 7-chloro-1,3-dihydro- 1-nethyl-5-pheBil-
C16-B13-C1-12-0
HI ZV«. », n
TISSUE
5157
Bleed,
plasaa
5158
Blood,
plasma
5159
Blood.
plasma
El POSHES BOOTE
In lection
Ingestiea
Ingestiot
UllTTICja
BBTBCD
OC-EC
GC
oc
IOBBSS
or CASES
*
2*
1
(con
iaVSB
at «00-2.5 mg/ml
bl 290-6 ng/al
c) «50-« ag/al
At 520-8 ng/al
e) 3.5-«7 ng/al
f) 3.5-16 ng/al
g) 3.5-36 ag/s.1
h) 7.7-28 ng/al
a) lot glvea
b| lot given
e) lot gives
d) lot gives
a) lot applicable
b) lot applicable
ct lot applicable
fill!
mi
at lot given
b| let given
c) lot given
d) lot given
e) lot gives
ft let given
gt let given
h) lot given
at Hi ag/al
b) 97 ng/al
cl 102 ng/ml
d| 76 ag/al
a) 1007 ag/al
b) 1250 ng/al
e| 2*30 ag/al
rial)
at Initial eeasanaent and 6 days, 2*
it Initial aeasnreaent and 9 dnys, 69
yt eld male
ct Initial aeasareaent and 7 days, 29
yr old female
d| Initial meaaareaent and 8 days, 62
yr eld female
e| DesaethyldiaTepaa, initial
measurement and 2 days. 7.0 ng/al at
7 days, 2» yr old aale
f| Desmethyldiaiepaa, 0.25 and *
days, "lateaa » 9 days, 69 yr-old
•ale , . .
q) Desmethyldiazepam. initial
measurement and 3 days. 22 ng/ml at
7 days, 29 yr old feaale
h) Desmethyldiazepaa. Initial
measurement and 2 days. 20 ng/al at 8
days, 62 yr old female'
9ose. 5-10 sg. IT
Sacking associated with higher
clearance valaes
Healthy snblects
BSDGS: DltZIPMS; BEIZODIiZEPlSBS;
IGI: six; MCOD Plasm; SSOKIIS:
BF'BBOlISllj HBTaBOHTBS; COSPIBMTVE
EVal9ATIQlV5t aDtfLTS
at Snblects, high nenroticism, 1.5 hr
after dose
tt Controls, 1.5 hr after dose
c) sabjeets, high nearoticisn, 6.0 hr
after dose
d) controls, 6.0 hr after dose
s mg dose. Controls differed
significantly at 1.5 hr.
Healthy 19-21 yr old Japanese, no
ether drags, evaluated for
nenroticisa, dosed after aeal.
rmres; as»zotnti?ii!s; sBDMtyss;
HOOD P11SH1; 1DOLTS; I30BOXOGIC
Hlf TF^STITIOV5; CO^PIS&TITZ
IllLUflOFS; J»P"
a) nay 1 of 7 days on placebo
b) Day 1 on 10 ng ilazepaa
«1 9ay 1* OB 10 a? diazepan
tata also for H-desaethyldiaiepaa
• 1 yr old dlazepaa abnser.
Iisalraent of eye-hand coordination.
performance la tasks requiring
sustained areasal. information
ctecesslng, and short tern e«sory.
MUGS! StCOO Slim; HBMB01ITES; DUDS
lt«S«; BHMfitS
BtrUBEBCE
Greeablatt, D.J.
Ulen, B.D.
Baraatz, J.S.
Skadar, B.I.
1980
Clinical Pharmacology
and Therapeutics
27f3ls301-312
Vakano, S.
Ogawa, 1.
Kavazn, Y.
1990
Clinical Pharmacology
and Therapeutics
27 (3) : 370-37*
— , —
tinnoila, H.
Ervin, C. ».
Erendle, 1.
Skinner, T.
Bovtledge, P.I.
1980
Icta Pharaacologica et
Toticologica *7:75-77
-------
C16-H13-C1-I2-0
•I 28*. 7«, BF 125-12C C
TISSBE
—
5169
Blood,
plaasa
5161
Blood.
Flasna
SK2
Hood,
Plasaa
51«3
Blood,
sems
EXMSOtS tOOIB
Injection
Injection
iBaestioB
IB -lection
—
AfaLTTlCAL '"""
•RHOD
ac
GC
--
CC-BC
SC
or CASSS
i
23
.
a> 12
b) 14
7
H-U«TJ.» yea)
B) 240-12.5 ng/al
b) 1750-28 ng/al
0.09-2.73 ug/Bl
a) 1*0-12.5 ng/nl
b) CO-IS ng/nl
a) 350-2*5 ng/nl
b) 400-325 ng/nl
c) 410-3*0 ng/nl
dj 105-100 ng/nl
•Ell
a> lot aivei
b» lot given
0.96 uq/al
a) lot applicable
b) tot applicable
a) lot given
b) lot given
e) Rot qlvea
d) lot given
(•EXT PAG1)
SEIEE1L IfFOBRATIOV
a) Initial icasarenent and 72 hr
b) Initial seasurenent and 9« hr.
pro treated «ith C.O aq cisetldlne
Istlnated fron graph
Dese. 0.1 nq/kq.
Bealthy volunteer, fasted before
dose.
Sedation when pretreated nits
cinetidine.
BMJSS; DBTJC inrSACIIOR;
Tp.AiQon.itns; eissiHT; BIOOS PLASHA:
SIEATITSS
level required for sedation. Dose,
3-70 acj IT. Dose- and
level-correlated r>0.84«, p<0.001.
»»•- and dose-related, r— 0.«S.
f U.wDl.
Cardiac patients »lth arrhythnUs
treated by elective cardioversion.
C906S; BKW5 THSBIPY; SEDATITBS; BLOOD
ELASflA; AGV; 88 AST DISUSES
-
a) Controls. Peak at 2 hr
t| Alcoholics. Peak at 2 hr
•eans. 2-«8 hr after 10 ig. Peaks
differed. P<0.01. 3.5-hr values
differed, P 5 yr.
On hypnotics and neuroleptic draqs.
DiaCS ; D«B6 THIFA?!: AljCOHOLIC
B1VEBA6ES; FIILAID; BLOOD PIAS«A:
CCSPARATIfS JVAIOATI01S; ADDWS;
vflSCLE REIAIMTS
a| Reans at 4 and 8 hr. aineral
•ater given at 5 hr
tl (leans at 6 and 8 hr. Initial
icasurenent, 380 nq/nl at » hr.
Carbohydrate neal at 5 hr
cl deans at C and 8 hr. Initial
•easnrenent. 390 ng/nl it « hr.
Tatty neal at 5 hr. i)
l-aessethyldlazepan neans at * and 8
•r. Initial neasurenent, 10* ng/nl
at « hr. patty neal at 5 hr
tstlaated fron graph. Dose, 0.3
•9/kq diazepaa. IT.
Bealthy volunteers, neaa aqe 21.4 *
or - 1.7 yr, no previous diazepan
eee, Finland.
latique after fool 6 hr after dose.
Ability to dlscrialnate flickering
light not correlated •ith sernn
levels.
caass: ?IKLI»; BUSCLI RELAXAOTS-
S10CD SB81B; CO'CHATTY* EVAlnitIO»S-
»1TABO'.IS?I; IOTTOLOSIC 1AIIPISTATIOHS
IEPEEERCE
Klotz, 0.
Beinaan, I.
1980
Rev England Journal of
Bedicine
302(18): 1012-1014
tiaidenberg, a. B.
Levy, H.
varner, H.
Continho, C.B.
Sckvirtt, R.A.
In. s.
Cheripko. J.
1978
Clinical Pkarnacology
anl Therapeutics
23(«):371-37«
Sellnan. B.
PeMarlnen, A.
Kangas, L.
Raijola. E.
1975
Aeta Pharaacologica et
Toricologica 36:25-32
tinnoila. 1.
rorttila. r.
Rattila. R.J.
1975
Acta Ptiarucologica et
Toricologica 3*:181-18«
-------
2B-1.«-B.«odi.T.pi.-2-on,. 7-c.loro-1 ,3-di.ydro-1-.ethrl-5-,*e.rl-
«29-1»-5
C16-B13-C1-B2-0
11 2e«.7«. BI
1ISSOB
51«»
Blood,
Ser«
125-126 C
EirosvBB looiz
Injection
iHLiticii.
BETHOD
oc-ec
IOBBM
or cisss
2S
(coBTi
" iiiG!
•) 750-35 •«/•!
b) 600-55 ng/al
e) 25-«0 ng/nl
4) 3O-60 ng/ml
IDE91
BMB
a) Hot giv«ft
b) Bot 9-i«n
c) lot gi»en
d) Bot gi»«n
GEBEBll IBFOBHaTIOH
a) Initial neasnreneat and 72 ht
after 0.2 nq/kq. « Canscasians
tl Initial measurement anfl 72 hr
after 0.2 nq/k
-------
6M-7S-1
C15-I11-C1-H-02
•I 286.71. |( 205-206 C
.B-2-OM. T-CBloro-l,3-dihrir«-3-«7«rorr-S-p»e«rl-
1135(1
5167
Blood.
Flasaa
51CS
Brine
Bifosnts toots
Ingastioa
laqeatioa
IMtnmi
RRBOB
6C-EC
6C/BS
ImiBSH
or cisss
...
a) It
b| 20
3
BAKB
») «27-1«17 ng/Bl
•) lot given
b) lot given
c) lot given
A) lot given
BE1I
a) «22 « or - 37
Bg/Bl
b| 837 « or - 51
Bg/nl
SE
a) 5. 2 * or - 0.5*
(520 * or - 50 tig)
b) M.7 + or - 9.0*
(»170 » or - 900 agi
c) 7.7 » or - 0.5«
(770 » or - 50 ng)
4) 67.3 * or - 1.7*
(6730 » or - 170 og|
GEXISAt XlfOKBiTIOl
a) Bei
b) Voaea
leaks. 2-3 hr after 30 aq, single
dosd
Peaks negatlvelT correlated «ith body
• t »r - -0.«3. P < .01). Higher
clearance also associated vith heavy
clqarette snoUnq.
lenlthr 22-«« yr olds fasted
oveniqht and 3 hr after dose. B».
aiSSACBBSMTS; *BBHS: AGE; SET;
ELCOD PllSBl; DCDCS; SEBA1IVES:
IfAlOATIOBS: SBOKIIS
a) Unchanged drag, 0-8 hr
t) Conjugate. 0-8 hr
c) Onchanged drag, 0-24 hr
S) Con1«gate, 0-2» hr
Dose. 10 nq
JIPll; BIOOB PllSPU; OBIIE; DRBGS;
— —
BEfEBElTCE
Greeablatt, D.J.
Bivoll, 9.
Rarafttz. J.S.
Shaier, B.I.
1980
Journal of Pharnacologv
and Szperineatal
Therapeutics
215(11:86-91
Biqnchi. S.
nrabe, g.
shlobara. T.
1979
Jonraal of
Chronatographr
16 «: 55-61
' ,3-ai»Tdto-5-phe.rl-
C15-B11-C1-1J-0
1« 270.73
-P-
•vj
vd
HSSOS
5169
Mood
S170
Blood
cirosoB*. ionii
tigestlon
laoestlon
iiiLnicu.
RTBOD
ec
. — . -
niBEt
OT CISZS
S
-
1
15-H U9/«1
— — ,
•ot give*
(KIT
HB1I
lot glYeu
0.7« ng/al
PtSS)
SilCUL IIFOSfllTXOI ~
10 wj. 2.5 hr later 1000 B heparla.
fcasurei before and 15 Bin after
aenarln. Cocrespooding free 4ruq
values, 0.62-1.01 aq/nl.
Iccaal 23-«0 yr olds.
IIPIBS; p»oiti»S: SEnioiisa: BWOD:
StCOD Pl»S«»: 9»BG IKTSFlCTIOJ;
HISS: aoscii BEL»S»IITS
-
ivtopsr saeple
«< jf old pharmacist, suicide.
cverdose of other dcaqs
BSBSS; 9B!JG 18HSI; SUICIDE:
itnopsits; CISF Bisiowfs;
llSSOSSHIilt METHODS; |EW ZE»1»1ID'
"5"' 11T'*! »P1IIS! itmaETsj BBHM:
SL CO BOL5
IEFEIERCE
-
Soatledge. p. A.
rttehell, B.3.
Bjocnason, T.O.
Skinner, T.
Hanoi la, n.
Shand, D.G.
1980
Clinical Pharnacologr
and Therapeutics
2T(»): 528-5 32
Oaeree, E.I.
Clckson, S.J.
(lissen, ».».
Pannell, 1, it.
1979
Journal of Inalftical
Toiicaloqj 3:253-255
-------
2B-1.a-Be»«>«iaz«pli>-2-one. 7-ehloto-l .S-dihTaro-S-phenjl-
lflM-11-5
C15-B11-C1-I2-0
11 270.73
TISSUE
5171
Blood,
5172
Blood,
nlasM
.
•173
Blood.
plasna
BIFOStllE ROBTI
Inoestlon
Invest Ion
Ingest ion
ISAI.TTICAL
BETHOD
GC
8C-BC
«C-BC
BOBJM
OF CASES
"
1
8
"
12
(CORJ
JAKE
a) lot applicable
b) lot applicable
e) lot applicable
— "
759-37«8 ttg/1
72-16S ng/nl
BUEDI
a) UOO ng/al
b) 990 ng/nl
c) 3110 ng/nl
.
Bot gi»en
138 »or- 8.8 ng/nl
SE
GEBIBA1 IBFOBHATI01
_ ' ~
a) DnT 1 of 7 days on placebo
b) Day 1 OB 10 ng diaiepaa
e) Bay 1« OB 10 ag diazepaa
M yr old diazepaa abnser
lapairaent of efe-haBd cooraination .
cerfornance in tasks requiring
sustained arousal, infornation
processing, and short tern nenory.
EB06S: BLOOD SMBU; BOTABOLITES: DUOS
IBOSE: 9IAZMMS
Rean steady state values after
1.0-3.1 nq/kq.
lEllepsy patients
BICBTS11; HBBfOOS SYSTEM BISZASBS!
nooo: BIOOB PLASM: IBTICO»WLS»BTS!
CBBB THESMTs BKOSSi TaMOKW««»S
IB tI»«O »«1IISIS: SEASOBEBEBT
BITHOBSi BMtOSIAtSSHBS
Peaks, at 2.S-72 hr (nean 13.1 hrj
after 20 ng irazeoan.
Eealthr 22-«2 Tr olds, »t S6.8-88.*
kg. Tasted before and after dose.
SB1SS: DIAZIFAHS: BEBZOBIASIPISIS;
USE- SBf! SICItJIS: BIOOD PL»S»AS
BITABOLISB: CO1?ABATI« STAtBATJOBS
1 SETBRBirCB
<
linnolla, B.
Ervin, C.B.
Brenlle. A.
Skinner, T.
Foutledge, S.A.
1980
Acta fharaacologica et
Toiticologica HI: 75-77
Paidnke«7ch, D.
Bodin, B.A.
DaTeaport, F.
1980
Clinical Chenistry
Allen. H.D.
Greeablatt, D.J.
Haraatz, J.S.
Shader, B.I.
1979
Journal of Clinical
Pfcaraacology 19!«as-a50
00
0
;: ?3L«S=ffiMZ'^^
-.
C15-BIO-C12-B2-02
81 321.1«« Hf
IISSDE
517«
Blood.
plnsna
166-16* c
HIFOSMB BODII
IB-tectiOB
Ing«*tion
aiURicii
RETROD
8C-BC
BOHflSl
or CASES
10
— BABSE^
n) 17.6-60.7 ng/nl
b) 18.0-36.4 LJ/al
• " IBBIT
— BEAB
al 38.»2 » or - 13.25
ng/nl , „
b) 28.85 * or - 6.13
ng/nl
US I)
•
—
a) Peaks, elderly. Peak tine, 0.9" »
cr - 0.19 tst) nr after 1.95 » or -
0.83(SD) ng orally, 10 subjects
M Peaks, elderly- Peak tine. 1.03 »
or - 0.16ISI) «r after 1.85 • or -
0.7a(S01 nq IB, 10 sublects
Seae data for TT doses.
Bcalthy 60-8« tr alas, vt W.s-111.«
Crovsiness. sedntion. sleep for 1 to
6 fcr.
tBOSS: 111IIOtIA''WItBS: A6t: BtOOB
I1AS1A: 1«Ilti SBOKItS; COISABAtlfB
ItAllATIOBS
Wrssnct
Greenblatt, tt. J.
»11«B, B. 9.
locslskar. A.
flaraatz, J- S.
Staler, P.I.
1979
Clinical Pharaacology
and Therapeutics
2e(1)s103-113
1 .
-------
C1S-B10-C12-12-02
•t 121.i«. n 166-168 c
TISSUE
5175
Blood.
Plan*
5174
Win
5177
nrlae
nmssn torn
lageatioa
iB-Jectioa
lageatioa
auinioii
HFfBOD
QC/IS
«C-IC
ec/is
OF CUES
3
9
3
BIB6I
a) 28-6 i,/.i
b) 18-1 ag/al
*) lot give*
b) Bot given
e) Bot gl*«
_
a) Bot given
b) Bot given
e) Bot give*
d) Bot given
BSaB
a) Bot given
b| Bot given
a) 835 of dose
b) 80*1 of done
c) 67V of doae
a) 0.10 « or - 0.02*
«1-5 » or - 0.3 ng)
bj 26.1 * or - 3.6T
(391.5 » or - SO «g|
e| 0.59 * or - 0.2*t
(8.85 » or - 3.6 «g|
dj 68.3 .or - 5.2*
(1024.5 * or - 78 eg)
CEBEMt momTIOB
".•'i!*? of ****** anchanged drug. 2
and 2* hr after 1.5 aa. Initial
BCBBweaeBt. 2» Bq/al at 1.5 hr
*'*"*? °f aean«, conjagated drug, 3
!««£ ht :fttf 1>S '«• I»itial
acainreaeot. u »g/«i «t 1 hr
tatinated fien graph.
«P1»: BtOOt FL19U; 01IBE: tSOGS;
inllQUttltCTS ; HE1SOB? BEHT HETEODS
a| IT
II Oral
c| In
72 br emulative excretioa of
glncacoBlde in elderly vol.nteers.
lecoasted for 80-90* of totnl
clearance.
Browaineas. sedation, sl^p tm , to
«B8S: BinOBIKEPIBBS: iSE; BLOOD
* DBI VE$ SHOK3V5 : COHPIBITTTE
a| Onchaaged drag. 0-6 hr
>) Con1«g>te. 0-8 hr
cj OBchanaed drag. 0-2« hr
«) Conlvgate, 0-2a hr
Ccae. 1.5 eg
IBIVQUmms; BEtSOTESEBr'aWFODS
BETSRBBCB
Rigachl. s.
Orabe. B.
Shiobara. T.
Journal of
Chroaatographr
16»: 55-61
-
Greenblatt, B.J.
Allea. B.D.
Locniskar. 1.
Haraatz, j.s.
Shador. E.I.
1979
Clinical PhireacolooT
and Therapeatlcs
26 (IJs 103- 113
fligachl. S.
Qrabe, E.
Shiobara, t.
1979
Journal of
Chronatographr
00
CS3-B31-I-O2
M 353. •». Bt 193-217 C
„
iissm
5178
Blood,
flaaaa
BHOSms 10011
laqestlon
BITHOD
rants
or cisss
BIBGB
a) 0.023-0.118 ««/•!
b) 0.055-0.193 ao/al
c| O.OST-0.123 nj/al
at 0.060 og/ml
b) 0.1ia »,/,!
e) 0.069 ng/al
I»FOBH»TIO»
•» »J«tTlaet«adol. Peak at * hr.
0-a«d »»-hr. none detected
II lorieetTlaetaatol. »ealc at a-8
hr. Oatectatl. «t 0 aad »8 hr
cl BUoracetTlaethadol. Pl.teau at
hr. Only sliqht teclUe at «8 hr
B«»a males .fter «o-«» «,. 72 hr
after preTlcm doae.
»4
-------
3-BeptanOD«,
C2'HB27-1-0
81 309. »9
TISSUE
5179
5180
Mood,
5181
Blood,
seres
5182
liver
BIPOSOBS SOOtE
legation
Ingest Ion
Ingest Ion
Xagestion
1I1LTTIC1L
BSTHOD
GC
BIl
•MBSE
or CISES
1
a) 6
b) <
a
1
««ISB
lot given
a) 138-220 ng/sl
b) 311-580 ng/nl
32-7.3 ««/•! Oeoeatrlc
•cans
lot given
(HIT
0.36 ng/nl
a) 182 ng/al
b) "20 ng/*l
lot given
19 ng/g
MSEJ
aatopsy sample
II yr old pharmacist, suicide
EBOG5: BBIJG IE9SI; SUICIDE;
10TOPSTSS: CIS! HISTOSIES;
qiaSTBMMT BETHODS; »E» ZT1UID;
BtOOD; U»W! UP HI; KIDIEIS; BRall;
I1COBOLS
a) lean daily levels vith maintenance
dcse of »0 tg/day. Level before
dose, 116 nq/nl
t) Rean daily levels »ith inintenanoe
dcse of 80 »g/d»y. level before
dose. 2(5 ng/»l
qenoexponential decay.
20-37 yr olds, fron Tt State Drug
abuse control coulssion. Oa«d
heroin S-22 yr b«t, no druqs for 2-8
•onths.
fo Increased niosla.
BM6S; BIOOB PLiSMj TJSIIE: ISCES:
tt» TOSI; C05PiR»TITE ETaLOKIOSS:
asiiBoiisiij srriBOiiTss
2 hr an! «8 hr after 15.2 » or - 1
• g/kg/1.79 sq * body surface area.
Initial neasnrecent, 28 ng/*l at 1 hr
Estimated frcn graph.
Healthy, nonpregnaat 21-29 T' oUs,
In folllcalat phase of secstmal
cycle, on.
Hethadone-indnced respiratory
devres«lon and nlosis lasted > IS hr.
Staadv state ventilatory response
carve for CC2 inhalation «as
Usplaeed, and papillary constriction
Increased.
COZGOl; atttlTS: BIOOB rZEOS;
IttlSSSTCS; CBOSS; BOB ROUES:
ii?eoTicS) ii TITO tiiirsis;
1* yr old pharcaclst, suicide
DBOGS : DRUS UUSE: saiciDi;
IOTOPSHS; CiS^ HISIOBI5S:
BtOCB! tTVS?: DBHJ: «B«ETSS Bsil*:
iiccnoi-s
" BEFEBeBCE
Oaeree, E.I.
Dickson. s.J.
Rissen. 1.*.
Pannell. l.K-
1979
Journal of analytical
Toxicology 3:253-255
verebely, K.
Tolavka, J.
Rale. s.
Besnick, B.
1975
Clinical Sharsacology
and therapeutics
18(21:180-190
olsen, G.D.
vilson, J.:.
Robertson. G.E.
Clinical Pharnacology
and Therapeutics
29 (3): 373-3 60
Queree, S.a.
Dickson, S.J.
Pannell, L.K.
Joarcal of analytical
Toxicology 3:253-255
CX>
NJ
-------
c:i-§27-i-o
Bi JM.tf
TISSUE
-
5183
Or ice
izfvsnn SODTE
T rtlon
lIUTTXCal
HBTBOD
nriBn
OF C1SKS
C
~~ iiiei "
—
a) 13.2-25.3 X of doee
b) 28. 9- 60. « X of dose
(COITIIOID)
B) 19.16* Of dOM
b) «1.M of dose
CH-B20-I2-02
M 308.37, IF 105 C
PIH«L
•1 tfter single «0 or 80 no dose.
3" erereted as pTrrolidine
*) Chronic •tlateuaca dose o» »o or
8« •g/J»T. ««f ercretoj as
2«-hr seines.
20-37 Tr olds, from It State Drug
1!>VM coatrol Coamisaloa. Use!
for 2'8
>o increased iloits.
"ires-. BICOD
" «>««
BRiBOtltBS
DS«E: IECIS-
IT.LHllaiS
BEPEfiEITCE
K.
TolaTka. j.
Hale, s.
Penick, B.
1975
Clinical Phutacologr
and tberapeatlcs
TISSUE
518*
Blood.
plnsna
BXPOSmg tOBTE1
Ingeation
aiunicu.
IETBCO
ec
BOBBEB
OF CaSES
<
1
1
~~ iliei
a) 12.48-17.05 ag/il
*) 30.77-«(.33 ag/nl
c) 51.18-88.11 ag/nl
UtB
--
»» ;»•« «,/.!
b) 38. ai ag/nl
c) 75.20 ag/nl
6BIEBAI IIPOBMiTIOR " """""
a) Ifter 100 M
t) after 300 nq
c) Ifter fOO nq
Peak lorels
Bealthr 23-29 vr olds. Trance
^***CE: 1DOLTS; BLOOD PLaStta;
FEFSSE9C2
Sioofi. ».
Colossi, D.
Caudal, T.
Schoeller. J.r.
Hasslas, P.
1980
Journal of
Pharmaceutical Sciences
00
58-25-3
C16-B1*-C1-I3-0
!I 299.75, BP 23C-236.S C
.e-
TISS1!
-
S18S
Clool.
Flasia
MPOSUEE 100TC
lalection
IMITTICU
BfTBOC
-
BPIC
HgSBB
OF CISBS
5
a) C500-200 no/«l
b) 6800-180 n-j/al
c) 0-1000 ng/al
d) 0-2000 ng/nl
lot given
Hot given
Rot given
lot given
(fEIt pact)
» A J "•»». 1 "« 30 hr after
«.n.
1980
Enropaan Journal of
Clinical PtarnacolwiT
18:275-278
-------
banrl-. «-oxid« IB CI)
.-. *-oxid« |9 CI)
St-25-3
It 2OT.75. 1*
113301
s«6
Blool.
pla«M
5187
Bleoa,
ser»
234-23*. 5 C
HMSntS BOMB
IB Action
Inlectlon
I notation
kMlTTICkl
HETHOD
Ha
imsn
OF C1SSS
•I 11
H 11
c)7
a
(COIM
•" ilies
•} 3.6-0.03 »g/»l
b) J.6-0.16 ««/»l
e) 2.0-0.2 o«/»l
— '
at 1.0T-1.TT «g/»l
b) 1.00-1. SO »g/«l
c) 0.2»-0.8« «9/«l
d) 0.20-1.15 ag/»l
•USD)
SB»1
a) »ot applicable
b) lot applicable c)
lot applicable
a) 1.32 «g/«l
b) 1.»2 ng/al
c) 0.56 «g/«l
d) 0.«« ug/al
— SIStHL IITOBIMIOI
^ ~
•1 Hen
c! •«••£ on oral contr«ceptlT«s
!«.,« of «a««. iBiti.l .e.s«r«»ent
ail 56 hr after 0.6 iq/kf. IT.
Il«rpoii««tial elUlnation.
17-39 rr old »n. 21-«2 yr «W «ro»«B-
J«-29 it oW «o««o. o« or»l
contraceptive > 6 •«
111 norial.
BHZOtliZroHIS; DS06S; OBll
ecm»c5wt«si irnnts: s«i: BIOOD
Misa.rww»»"*« w*"*"0"8'
§M»EOHSB: miHK
a) 1 hr aft«c oral lose
il 2 br after oral dose
c) 1 br after I" io»e
i) 2 br after III flose
Do«e. 2? aq a« hTar««"oria«-
CealtbT «en, t»stln:«28-831
Gottschalk. 1- I-
Biener. 3-
DinoTO, B.C.
research Coiaanicationa
in Cbepieal Pathology
anl fhaciacologr
8(1) :697-702
oo
2S232-5»-8
C7-B10-I2-02-S
Kf 186.23, «
fissni
5188
Hood.
•ecu
S1OT
•ilk
E 122-125 C
"EHOSOH ioo«
Ingestlon
_
tB^estio*
_ — . —
immcu.
9, J.
Alexander, V.D.
1979
lancet 2(8150): 1011
-------
SSSSSSfc
JC«e«-S6-2
«S«-H27-Cl-f5-«-0
II 523-99, W 105-107 C
te
^
| lISSQt
1
1
I 5190
I 11004,
| DlUia
s
1
1
1
1
1
1
1
EIPOSOH IOWE
Tmqestioa
1
«
tmnicai.
nSTBOB
SC-BC
I
I
i __
•nun
or cisss
•I 7
W e
c) 8
I
I
I
EIIGI
«) 3.75-9 «9/»l
b) 6.25-12 »g/*l
cj 8.75-25 »$/•!
1
1
1
1
1
1
1
BED
al 6.25 »g/»l
b) 9.2 ng/ml
c) 18.75 ng/»l
1
1
1
1
I
at 30 «q weekly
b) SO iq »««1ilT
c) 120 «q »e€*lT
•tealT state leTela. «sti»ated £ro»
cr&ph. te»«ls corr«latefl «ith Sose.
r-0.81. ?<0.05.
Bcspitaltiea 27-59 Tr oli
sckiiophcenics in qooi phT«ic»l
1 k *«»*s. 13-15 hr after 250-aq
3 o:"o 5/S i «b^». »-« kr •«« *~ "°-ti
S oil! 3/S • ^5- 2™ hc a£t" fo"r 250"9
! «fcpea*s, 12-28 «r after «ll tablets
1 e) teatv 8-12 hr after 500 wi in
i | aqaeovs suspension.
i
I tolnnteers, 21-»5 yr old. dosed 2-3
1 ht after llqold, 360-calorle
I tteakfast.
| CSBSS; liTTBIOTICS; »B01TS; BLOOD;
I USISICT Of COMBBII; COHP»SITIT!
1 IW1WITI01IS: I»*ECT1O*
1 __
Cesjardins, B. E.
Eaaplin. C.L.
»o« 3re4o«, 3.
Sarry, K.G.
Canfleld, C.J.
1979
clinical Pharaacology
and therapeutics
26{3):372-379
, . ., i 1
CX3
-------
,-Thi.-1-«.cicyclo(3.2.0) h.pt._e-2^.rbo,ylic acid. 3.3-di,.t.,l-6-«C n3-|^l1Tl..lfo.,l|-2-O«-1-i.iaazoUai.rl)<:«bo,Tl)a.l««)Pl.«TlacetTl) .a»o)-7-oxo-.
<2S-»alpha.5alp_a.6beta(S«)))-
51*81-65-3
C21-B25-IS-08-S2
II S39.63
1ISSOB
5192
Blood.
plasia
5193
Blood.
519»
nriae
EXtOSOBE 800TI
Injection
' Injection
Inaction
1I11YTIC11
BETHOD
Bicrobiological
Microbiological
Microbiological
BOB BIS
OF C1SSS
27
10
10
MIGB
a) <1-253 * or - 129 »g/l
b) <1-20« » or - 81 ng/1
c) <1-252 * or - 75.4
•g/1
d) <1-23» t or - 66. a
•g/1
a) lot givci
b) lot given
c) lot given
d) lot given
lot given
a) lot given
b) lot given
c) Bot given
d) lot give*
a) 30*.* * or - 56.2
•g/1
b) 78.3 * or - .7.1
•g/i
c) 7.2 * or - 2.5
•q/1
d) 0.22 * or - 0.17
WJ/1
53.9 * or - 8. SOU of
dose
a) sableets »ith creatlnine clearance
greater tlan or equal to 60 al/ain
t) Sableets «ith creatinine clearance
30-59 ml/ail)
c) Snbleets *ith ereatlnine clearance
10-29 nl/.in
d) Sttbleets with creatinine clearance
<10 nl/ain
Bange of neans over 24.5 hr
Ifter 30 ain IT of 3 g
•Idolts with varying renal function.
age 32. » » cr - 11.5 to 57.7 + or -
21.5 yr, Indiana.
immil; aTHlITS; KIOIBT DISUSES;
BICOB SUSHI; HTiBioTics: DBOGS:
CC"!?»H»TITE iTAin.IIOWS
a) 0 hr
b) 1 hr
c) 4 hr
d) 1C hr
Ifter 33 Bin IT of »000 »g. Values
adlusted to 70 kg body Height.
Bealthy 20-H9 yr olds, »t 66.9 » or -
£.0 kg.
CIDeS; DUOS IBIE1PY: HTIBIOTICS;
HOOD SSBDS; U8IBB; GJBMST.;
UTK-IOB: CCBP1BITIT! BTitO»TIO»S:
jtnws
1
0-2« hr atcretion after 30 nln IT of
(000 aq.
Bealtby 20-49 yr olds, »t 56.9 * or -
6.0 kg.
BFOGS: nans THISIPT; irpiBiorics:
HOOD 5!Sni: DUIE: 8339111;
IS«I«IO»; CCBP»B»TIT? BTitHlTIO*S:
— -
Ironoff, G.B.
Sloan, B.S.
10ft, F.C.
Belson, P.I.
nanell, D.B.
Ilelt, S.i.
1980
Clinical Pharaacology
and Therapeutics
28(») : 523-528
Lode, H.
Toaas, «.
Foeppe, P.
Wagner, J.
1980
chemotherapy 26:81-90
lode, n.
Toaas, V.
Foeppe, P.
eaqner, J.
chemotherapy 26:81-90
oo
,-,hi.-1-.»«CTClo 13.2.0, n.pt.-e-2-c.rboxylic ^id, 3,3-di_^hTl-7-«o-6- «((,(2-oxo- 1-iU..i.lUt.,l| carbonyl. a.im,,pbenylacetyl,a.ino, -. (2S- (2.1Pha.Salpha, .beta (S«,,, -
37011-«6-0
c;0-B23-IS-0€-S
at ««1.5«
TISSOB
5195
Blood,
BTPOSOBS IOD1E
Tnlection
numcii
RET BOD
licrobiological
IDICBB
07 C1SIS
7
BHGB
260-17 ng/*l
BE1B
lot given
CIIEB1L I»rO«»aTIO»
deans, 5 iln and 0 hr after 2.0 g,
I«. Continuous biezponential decline.
•stiaated frcn graph.
22-72 yr old henoiialysis patients,
lost with end-stage renal disease.
Dew Turk.
HOGS: viTnioncs: BIOOD S^PBI:
KIB1IST »TS-«SIS; HEIIOMilTSIS: 1CT
ICHK
BEFEB!I!CE
Aletta, J.!!.
•eu, B.C.
1980
Clinical Pharmacology
an] Therapeutics
27 (»): 563-566
-------
2.0J b.pt...-2-c.EboiTUc
o.,l| a.
C2S-B2S-I6-0«-S
HI CTO.C3
BRBOB Ot CaSSS
.1 lot qi*en *) 3*5.0 * or ~ *5-5
•t1*l£ XB^ftCtiOA HlCTODlOlO^iCetl •» *• tjjfc* 4v«*k BQ/1
Blooo. CJ «ot ii,«, b) 102.5 * OE - 21.8
""' «> 10t «1'- c?'lO.« * or - ..3
d) 0.92 » or - 0.50
nq/1
1 , ' '
'
i i
i _ — i •
5197 Lotion 1 Slcrobiolooical | 10 1 »ot qlyen 32^ * or - «.3« of
urine I ,
'
1 1
1
I
1
1
1 !
! ._ .
i , ... -'
j
;i ? s i --»."•
e> 1 nr ' X0*™*' p-
Ifter JO .in W of WOO «q. Talnes 1 "^"^ ,6.B,-90
ad*1iiste4 to body *t of 70 Kg* i **° "
i
1 sir loos infections caused bj Bay 1
1 «-senslti»e orqanisns. Seraany. 1
1 "
1 Soft stool, aiarraea. nausea, eaesis. I
| headache, vectiqo. exanthe aatoas 1
1 rash, Secreased thronbocytes. 1
1 exhaustion, tachycardia, aeteorisn. 1
I 1
tBOGS; D«US TBBB1»I: »«lBIt«ICS; I
B100D SB3WI: DBIIB; SESSHt: J
IITBCTIOIl! CCBSHatlTI BTaLOWIOTS: 1
— ____———— |
0-2« hr excretion in healthy suMects I Lo4e. H.
alter 30 »in IT of »000 nq. K«Bpe P.
I wealthy 20— a9 yr olds, wt 66.9 * or - Waqaer, J«
l-sensiti»e orqanisns. Germany.
Soft stool, diarrhea, nausea, esesls,
headache, Tertiqo, erantheiatous
rash, lecreased throsboeytes.
exhaustion, tachycaraia. neteorisn.
MUSS: DUOS tHIBlPT! HTIBI01ICS:
I1TICTIOI: CC»?»BaTIT! STalOWIOBS;
UOtTS
1
1
1
1
1
1
1
1
1
oo
-j
6.|nt(^thyl-2.3-dloxo-1-,iSer.xi.yl,carbo,Tl)..i.o,phe.,lac9tyl,a.l,o,-3.3-di«thyl-7-oxo.. (2S- ,2alpha.5alpha. 6beta (S-, „-
6H77-96-1
CS3-B27-15-07-S
Rl 517.«1
IISS5B
5198
Blood,
sernn
SttOSOBE BOUT I
In-Veetion
alalTTlCal
BETHOD
Bicrobioloqical
1
I
BOHEEB
01 CaSSS
b) 6
IUGS
b) 353-22 uq/nl
aim
a> lot given
b) lot qiven
al Beans. 0 and 270 ain after en4 of
30 nln IT of »q/8 hr. day 1. Day »
peaks -lignificantly hiqher
t) leans, 0 and 270 ain after end of
'a nin IT of 6q/6 hr on day 1. Day »
oeak, »10 uq/nl
»9ainister«a as sodiua salt
licalthy 18-50 yr olds, within 10* of
Heal lit
t«1SS: 11TIBIOTICS; B1OOO SEBU1:
Catra, T.K.
"orrison, J.X.
lasseter, K.C-
1979
Clinical Pharnacoloqy
and Therapeutics
26(1) -.H1-53
(IEIT *IGI)
-------
«1*77-9«-1
Ci3-B2Vi
If S17.«1
acia.6-,«,(,*-«t,,l-2.3-diox0-1-piP«..i.,l,«:arbo.vl,..i-o,phenyl.c.tn.»i.o,-3.3-di.ethyl-7-oxo-. (2S-«2.1pk..5.1pha.6»>eta ,*.,„-
IISSOI
5W9
OriM
siposraB IOOTI
IB-faction
aliLYTXCU,
RETHCD
Sicrobio logical
IOHBBS
or CISBS
£
cuei
*) 89. 73-80.05* of dose
b) 66.92-8C.9S* of oo«e
a) 76.03 + or - 8.98*
of low
b) 73.02 * or - 7.15*
of dose
Jm, B . — — — —
» Day 1
C-8 hr cumulative excretions at tor 30
•In TV of »g/8 hr
Bcalthy 18-50 jt olds, nithin 10« of
Ideal »t
tSOGS: SHTTBIOTICS; BIOOD SBBOS:
OMR; CO»P»8lTI»B BT113AIIOHS
FZriBEHCZ
Batra, T.K.
Morrison, J.I.
lasseter, K.C.
JOT, v.l.
1979
Clinical Pharaacologi
an! Therapeatics
26(1)s»1-53
26787-79-0
(beta-lap»thale»es«lfoii«t« trihvdratej
IISSHE
5200
Blood.
plasma
5201
Blood.
sens
5202
Flood.
5203
Bilk
EUOSHRS BOOH
Ingestion
- -
Injection
iBqestioI
Iaq«*tlon
aiumcu
RB9BCB
.
Sierobiological
licrobioloqical
lOIBSB
OF C1SSS
8
6
6
a) 0.9-0.1 ug/Bl
b) 1.8-0.15 og/al
c) 3-0.1 ug/»l
a) 86-332 ug/il
b) 57.7-19,3 ug/Bl
e] (5.6-14.8 ug/al
7.0-1*. « «9/al
9.10-0.81 og/al
a) lot give*
b) lot given
c) lot givei
a) 1*1 » or - 26
og/sl
b) Not gives
c) Rot given
tot givea
lot gives
..._
a) iBtaet prodrng, sethoij»etliyl
«tt«r. at 0.5 and 1.5 hr. Initial
value. 0.12 ng/Bl. Unspecified dose
if prodraq
I) laoricillin. at 1.2 and 8 hr.
Initial value 0.3 uq/sl. Unspecified
dese of pcodraq
C) laoxieilliD. 1.* and 8 hr.
Initial value, 0.1 nq/al, unspecified
{ese of anoiicillia
lstiaat«d frca qraph.
I1TIBIOT1CS: BL009 P1»S»1:
ccapiviTifi EV»LO»iio»5: BBTIBOIISI;
rces
«) PaaVs. P«ak tine gear 5 ain
b) 30 anl 2*0 (in levels, arterial
serua
C) 30 and 2*0 ain levels, venous
lft«r 1 » »a aaoxicillin IT at start
of 5 he dialysis
17-7* vr olds. »t «3-6B kq. vith
renal insufficiency.
riiics: ttTiBicrics: DISE»S»S; SIOOB
SI501; ID HITS
1 and 2 hr after 1 g. final
icasnrenent. 9.3 nq/al at 3 hr
1>-288
00
00
-------
, Iboat $ br
nul4
»«rr
T
CkroBle circhosla patiaata
BIOOD SBSOS;
"«"'
a) Fatleat 1
b) PatUat 2
c) Fatlaat 3
5 of 150
bT costlwous
* SLOOD SSBn8!
a) Cirthotlcs. 542-639 aq IT
t) Conttols. .boat 600 a? IT
.«,
act aaasaall iapalt«a. loona.
f.sted
mo^r"1'*"' '-''-""tbn-. dichloria,
t12-B1«-.2.2Cl
«1 «08. HP 300 c (teeo.p)
le.is. s.S.
Jasko, w. j.
1975
Clinical Pharaaeologr
an! Thetapentics
lavla, 6. t.
Juslo. B.j.
1975
Clinical Pharmacology
a»3 Tberapeotics
EooTet, s.
Gilbert, c.
Ganleboot, C.
faction, p.
19«o
British B«iical Journal
280(622«)s1l6»-iis?
00
S.p.
Jnslto, v.j.
1975
Clinical PhacaacologT
and Therapeutics
18(«):475-«B«
TISStJt
5208
Biooa
tlPOSOSB ROUTE
—
Inqeatloa
.
aiuTtfcii
RITBOD
Colortaetcy
ROHBES
OF C1SIS
a| 1
b) 1
c) 1
aiisi
aj lot applicable
b) lot applicable
c| lot applicable
a) l.t pp.
b) 3.7 pp.
C) 19. » pp.
'" 3 ht
hr
*r«»: BIO°D; TO1"5 S03CTDE;
TTSTOBIKs MSTHMUKOS
BEFZIERCE
...
Orost. S.H.
Dome. J.d.c.
-------
-, 4ichlori«»
1» 10-42-5
C12-B14-M.2C1
t» 408. IP 300 C (decoap)
(COITIWUED)
J9-B32-014
1 €04.81
«SSBE
5,0,
BOWB
IIIMMCU,
BETBOJ)
C.lorl.etrT
IMB™
OP C1SSS
'GEH11I. IBFOBBaTIOB
C) lot
.. f, „
g »'
a) 25 rt old (an 3 hr after inqestion
'" -0'" 2* te '"«
„„ .„.„ 5 hr aft«
for days 1-7 for ,).
Talnes
PISTICIDBS; B1OOD: BRIIS: SBICIDE;
CISE HISTOBIIS; IBTHEBIMBS
i-B*«eth»l«PiPOdophyllotoxin ethyliaeiw-beta-B-glaeosida
1ISSQB
S210
Blood.
Tlana
5211
Cerebcasp
inal
fluid
EIPOSHBI BOBTB
Inj«etion
Infection
1UITTIC11
RZTBOD
Balloietrr
BaiiomttT
BBBSBK
or ctsss
I1B6I
2*. 31-45. 88 ug/al
0.015-0.13 «g/al
31.11 ng/al
lot applicable
teaits, after 1 hr IT of 363-5*0 mg.
tritiatel dose. Bierponential decar.
lonresponding cancer patients, aqes
•1-63 ye, *ith adequate renal
function, 2-8 *1t after preTions
ch««otharapT.
shite blood cell conn* decreased
0-63* at da? 8.
MOSS: MIS TBWAOT; CBSHOTBIEHT;
««CPt»SlS: EtOOD P&AS11;
CMEBSOSPlml F1BIB; TECM
2-26 hr after 1 hr IT of 363-130 aq,
tritiated dose.
Rourespoadinq cancer patients, aqes
«1-S3 TC. «ith adequate renal
function, 2-8 v* after prerions
clecetharapT.
«ite blocd cell count decreases
0-63* at dar 8.
BSBSS; 1SOS IHER»PI; CH!HOTHES»Pt:
ifcpusis; BIOOB ptusai:
C«EE9tlOSPT!l»l FLOID; TECES
»an Bij*, ».
KUl. Yi '
Do«e. J.B.C.
t. l.S.P.
5 of Toxicology
31:129-136 I
I
SEKSEBC!
Crearen, P.J.
alien, L.a.
Clinical Pharmacolo^j
and Therapeutics
18 (2): 221-226
Createn, P.J.
Allen, L. fl.
Clinical Pharaacology
and Therapeutics
18(21:221-226
-------
^^«^«5-!,
5212
Mool.
vlasna
Iigeation
nc
tellometrr
ec/HS
»> S.52-U.71
*> 2.68-10.22 ng»
c) 2.06-9.17 ng/«l
«• 8.72 » or - 1.4»
13 * ot - 1J»
u . or - 1.05
(SI)
a) Peaks
21-«8 Tr oia«, Biciigan
Iberts, 7.5.. Jr.
Pbiloponlos. B.S.
Feineke, I.g.
»lick. S.B.
1981
Clinical Pharmacology
ana Th«npeutica
29(1)! 81-93
-------
5-Thia-1-«abicyclo(«.2.0)oct-2-ene-2-carboxyllc acid. 3-(((5-Mthyl-1.3,a-thiadiazol-2-yl)thio)i«tliyl)-8-oxo-7-|2-(1B-tetratol-1-yl) aeetanido)- (8 CI)
5-Thia-1-a*aticyclo(».2.0)oct-2-ette-2-c«rboxylic add. 3-(((5-iethyl-1,3,«-thiadiazol-2-yl)tbio)Bethyl)-8-oxo-7-((1S-tetraxol-1-ylacetTl)aiino|-, (6F-trans)- [9 CI)
C«-B1»-I8-O»-S3
RS «««.5, «P 198-200 C
(CORIIISD)
TISSDI
5216
Orln
5217
OtiM
EIPOSUSS BOOH
Injection
Inflection
AEALYTICAI,
BETBOD
Rierobiological
EPIC
IDHBEK
OF CASES
IS
6
HISS
a) «1-7M of dose
b) 17.3-56.2* of dose
n) Bot given
b) lot given
c) lot given
RE1I
a) Rot applicable
b) lot applicable
a) 801 of dose
b) 51 + or - 8t of
dose
O 83 * or - It* of
dose
GEXCF.II. IIFOBRiTIOR
a) Controls
b) Breiics
emulative excretions »-»8 hr after
500 ig 11. Data also for iiltiple
doses*
I
loriai 25-»0 yr olds. »0-73 yr old
ureiic mi vith cardiac and renal
diseases.
rBBGS; ABTIBIOTICS; BLOOD SEBUR;
DSIIIE; ADOL1S; DISEASES; CORPABAtXTE
IfllBlTTOHS
a) Freoperative, 1 snblect
t) During surgery
c) Postoperative
5 hr emulative excretion after 7-10
•in IT of 1 or 2 g (exact dose not
given) .
•8-71 yr olds. 52.7-197.S kg, »ith
cardlopnlsonary bypass surgery.
EfiUGS; ARTIBIOTICS; REASOBEHnT
RITBODS: DBIIE; BLOOD SEED!!: ADOITS;
SDBGEBT: BII5T DISEASES: COHFABATIYE
tTAIOATIOHS
1
BEFEBSRCE I
Belling, P.O.
Craig. t.A.
Anidon, G.L.
Kunin, C.R.
197»
Clinical Fhariacology
and Therapeutics
15(»):3M-353
Riller, K.s.
"ecoy, B.C.
Chan. K.K.B.
Fischer, E.P.
lindsay, V.G.
Seifert, B.D.
Zaske, D.F..
1980
clinical Fhariacology
and Therapeutics
27 («): 550-556.
5-Thla-1-azabicyclo(*.2.0)oct-2-ene-2-carboxylic acid. 3-flirdroxy«etIiyl)-»-o)B>-7-(2-|2-thieBTl)*eetamido)- acetate (ester) (3 CT)
;-Tkla-1-axatieyelo(«.2.0)oct-2-ene-2-earboxylic acid, 3-({acetyloxy)Hthrl)-8-oxo-7-((2-thienylacatyl)anino)-. (CD-trans)- (9 CI)
113-61-7
Cie-H16-I2-oe-S2
BB 396.«»
NJ
llSSdl
S218
eiood.
serai
5219
Blood,
sent
EXPOSURE B001I
Injection
Infection
IIILTTICII
BETBOD
BPLC
Bicrobiologlcal
»0g BEX
or cisis
i
«
J1IGE
a) 60-12 nq/al
b) 100-23 ug/nl
c) 30-3.7 ug/nl
a> 1«.5-7.7 og/nl
e) 68-1*. 5 ug/al
f) 9.0-1.H 09/1!
5.9-0.7 qq/tl
-
HEIR
a) Rot given
b) Wot given
c) Rot given
d) lot given
e) Rot given
f) Rot given
lot given
GEItBkL IRFOSIUTIOI
a) Cephalothin. day before surgery
t) Cephalotkln, day of surgery
c) Cephalothin, day after surgery
d) Deacetylcephalothin, day before
surgery
e) Deacetylcephalotbin* day of
surgery
f) Deacetyleephalotliin, day after
surgery
30 and 120 sin after 2 g cepbalothin.
IT. Other patient data available.
5« yr old patient. «t 8» kg.
cardiopulsonary bypass snr'gery.
CBtISS; TODS tB!BA?T; IRTIBtOTICS;
»IOOD SEBHH; BElSTOJIJirT HMHODSj
SntGIHT: NNIB01ITES
1 and 1 hr after 1 g
Vange a! leans
iruLTS: Bioct s»soi; BTIK;
11TI3IOT1CS; DBDGS; HCTWIOB
BEFE5ERCE
Killer. 1C.».
Chan, K.K.K.
McCoy, H.G.
Fischer, B.P.
lindsay, U.S.
Zaske, D.E.
1979
Clinical Pharmacology
and Therapeutics
26(1):S«-62
Kafetzis. D.H.
Siafas, C.It.
Georgakoponlos , P. i.
Papadatos, C.J.
1981
let a ?aediatrica
Scanainavlca 70:295-288
(Itlt Fast)
-------
5-TW«-l-«MUCTClo(«.2.ff|oct-2-«.e-2-c«rlx>rrlle acid. 3-fhTaro*7»etBrl»-8-o*»-7-(2-f2-tBleByl|aceta.ido) - acetate fester) 18 CI|
S-TBia-1-«afeicrclo <«. 2.0) oct-2-«'Be-2-earlx«|rlic acid, 3-«(ac«tjlo*r)Beth7l|-e-o*»-7-((2-tBieBTlacetTl)aBi»o>-, (8S-tran9)- (9 CI)
1S3-41-7
C«-H1«-»2-0«-S2
11 "«•"
TISSOB
5220
. . . _
SKPOSOBS BOVte
In1«ctiatt
1H1TTICIL
BITSOB
licrobiological
ITTBSIH
or cists
11IGI
0.0-0.16 iig/Bl
BS1I
Bot giren
GZIZBaL HFOSB1TIOI
2 an! 6 he after 1 9. Initial
aeasureeent , 0. 27 uq/al at 0.* he
?a>ge of Mi us
HCOUS ; BIOO9 SZB1IR: HILK:
IITIBIOTICS; DBDGS; IKCTktlOI
SEfEHISCE
Fa fell Is, D.I.
Siafas. C.K.
C*otqakopoaloE. P.I.
?apadatos, C.J.
1981
Icta Paediatrica
SciBlinaTica 70:285-288
S-»i»-1-axaUcTCl»<».J.O)oet-J-«fte-2-carb
-------
5-Ihi.-1-.»Ucyqlo«,.2.0>oct-2-e.e-2-carb<»nic.cid. 7-
«0»25-«1-3
CSO-B21-»"MJe-S2
eg 51*. «o
1- (c.rto.T«thTl,-1-H-tetr«.l-5-rl)thic, .ethTl)-8-oro-. <68-tra«s>-
TISSUE
5225
Blood,
Tlasia
_
EIPOSOEE none
Inflection
IfalTTICU
HETHOD
•OBBEB
OF C1SES
_
Hiss ~
210-8 09/1!
lot given
"GE1IML IIFOMWIO*
C.S an« 12.5 hr after 32.3 ig/kg IT
Istiiated frci graph
Eata also foi logs, rabbits.
1ITT"IOTIC5: B1O09 PlASIiJ
CCBP18MITE mi.O»TIO»S: IBTaBOlISB;
COGS
EEFEBEFCE
Siyth, S.D.
Rottendorf, G.H.
1980
Toiicoloay and Applied
Phariacology 53:179-195
•i-t.i.-1-.x.tlcyclo (•>. 2.0) oct-2-e,e-2-c.rbo«Tlic .cid. 7- (
SC370-12-2
C16-H1T-I3-CE-S
Hi 3«3.*2
» -3-ietnTl-8-«o-. (6K- C6alpha.7bet» (**) ) ) -
TISSUE
5226
flood.
serai
522T
Blool.
serai
5228
Blood,
serai
5229
Bilk
5230
Urine
EIPOSDEI ROD1B
Tngestion
Ingestion
Ingest ion
Ingest Ian
Ingestion
lillTTICil
HETHOD
•icrobiological
lierob iological
Dicrobiological
Hierobiological
Hierob iological
ID8EIB
OF CiSSS
13
20
6
6
13
.
U»GB
a) 8.981-0.298 ag/il
b) t7.841-C.619 ag/il
a) 0.3-33.4 ig/1
b) 12.0-56.5 ig/1
c) 0.1-3».8 ig/1
11.6-21.6 ag/il
0.10-1.6* ag/il
a) lot given
b) lot given
1 sii»
a) lot given
bt Hot given
a) 5.92 ig/1
b) 27.38 ig/1
c) 10.8* ig/1
-
fot given
dot given
a) 89.92* of dose
(221.8 ig)
b) 86.3*^ of dose
(«31.7 ig)
VISE)
a) leans, 1.5 and 7 hr after 250 ig.
Initial value, 3.282 ag/»l at 0.5 hr
b> Beans, 1.5 and 7 hr after ?00 «g.
Initial value, 6.369 og/il at 0.5 hr.
Health T 20-29 yr olds, «t 62-85 kg,
fasted before and daring stady.
TSOGS; UTIBIOTICS: BIOOD SIFU1;
•cons: iTkiu nsmE
a) 0.5 hr after 1 g
t) 2 hr after 1 g
c) 12 hr aft« 1 g
feaV nithin 2 hr in 70^ of patients.
26-77 yr olds, »t 43.8-130.2 kg,
fasted overnight-* hr after dose.
C»BGS: USTIBIOTICS; 1301TS; UHISE;
UCOD PLtSill
1 and 3 nr after 1 g
lange of leans
icni'S; B100D SEB1J9; SItK:
1ITIEIOIICS; DE06S; tlCT»TIO»
1 and 6 after 1 g. Final
•easnreient, 1.16 ug/il at 9 hr
Cange of leans
t CULTS; BIOOE SEBOB: SILK;
urtisroTicsj DRBGS: HCTITIOI
a) 259-ig icse
t) 500-ig dose
0-2« hr excretions
Bealthy 20-29 yr olds, «t 62-85 kg,
fasted before and luring study.
ttUGS; »«TTBIOTICS: BLOOD S5B11:
SEtltTS: ITalt; UBISB
Prenna, R.
Eipl, S.
1980
Cieaotherapy 26:98-102
Catter, P..E.
Blair, *.D.
Kelly, B.B.
1979
Clinical Phanacology
an! 'herapentics 25(5
pt 11:511-521
F.afetzis, O.A.
Siafas, C.a.
Georga^opoulos, P.i.
Papadatos, C.J.
1981
»cta Paediatrica
Scandinavica 70:285-283
Fafetzis, D.t.
Siafas, C.a.
Georgakopoalos, P. a.
Papadatos, C.J.
1981
acta Paediatrica
scandlnavica 70:285-288
Prenna, B.
Fipa, S.
1980
Cheiotherapy 16:98-102
-------
S-Thia-1-atabiCTClo («. 2.0) oct-2
5C370-12-2
C16-B17-I3-CS-S
gi 363.«2
-•w-2-c.rbo.rlic add. 7-{(ami»c(*H,raEO«rpl«arl)ac«trl>a.i.o|-3-.eT:l,yl-8-oxo-. {6«-<«.lP»».7bet.OI«)»-
(COITIMED)
TISSUE
S231
Brine
Bitosvis BOOII
Insertion
illlCTICaL
RVTHOD
_
licrobioloq-ieal
mm
OF CUSS
19
B11CJ
'
10.6-105.81 of dose
Bill
68.3* * or - 26. 8* of
dos«
0-«8 hr cuanlatlre excretions after 1
9
2S-77 YT «"«. «» »3.8-130.2 *I significantly different. 1
1 Healthy cancasian 19-28 yr olds. »o 1
1 Etrennoas exercise. 1
• 1
1 CSHGS' 1ITIBTOTICS; aQDLTS; SEX: 1
1 BIOCO SEBOS; COBPa»»TITB EVMDWIOHS; 1
1 nine J
i _ '
a) 88< of dose (»18 I a) Bales, ^•JJJ^J'ljJj",, J Erannick, llj!
bl 73% of dose (3*7 • | c) "ales, *ej*°^*14 \ seis"*E!s*'1'
I?' 80* of dose (380 ! J«-S"cZi«Utiv«*.xcr«tlOBB j 18 (2)": 215-220
flNo* of dose (332.5 ' Bealthv Caucasian 19-2S rr olds. Ho 1
lqt | Etrennoas eiercise. 1
i 1
1 t'BBS: HtlBIOTleS; JBB1TSJ SSI; 1
1 noco ««u«; eovsnvnn EV»to»Tio»s; i
I «M« J
1 1 .—•-—. — ' —II 1 — — ...
Ln
-------
-e-«o-. ,6B-(6alpha.7beta (*.)!)-
Cl8-B18-»«-OS-S2
11 "62. 5»
IISSBI
523«
Blood.
plasna
5235
Brine
Birosnts BOOT i
Injection
Injection
AlALTTICAl
HETBCO
BPLC
BPLC
BOHBEB
OF casss
12
at 1
b) 1
5-,.l.-l-.t.blcyclo(..2.0,oct-2^..-2-c.rbo«,lic acid. 7-t2-,.l
ilB6S
a) 70-126 ug/«l
b> 46-80 ng/1
c) 21-37 agynl
d) lot given
e) lot given
a) 600-100 »g/»l
b) 350-100 ag/nl
a) Bot given
b) Bot given
c) Bot given
d) 81.68 » or - 1«.5»
ag/nl
e) 3. S3 * or - 1.2»
ag/nl
a) Bot given
b) Bot given
a) After 10 lin, daring dialysis, 6
catlents
*) After 30 ain. daring dialysis. 6
catlents
c) After ».5 hr of dialysis, 6
patients
d) 28 hr aean, interdialyeis, 3
patients
«) 28 hr neat, 6 controls
tese, 15 ng/kg.
52-52 yr olds, «t 5»-68 kg. »ith
chronic renal failure, on
heaodialTsis. Healthy controls.
IBU6S: ANTIBIOTICS; BIOOD P1AS1J:
tlSBASKS; 9HIBE: CORPABATITI
a) 22 yr old »lth *rlne ontpat of 600
•I/day, 2-hr and 12-2» hr eicretlons
after 15 ag/kg
t) 52 yr old »lth nrlne ontpot of
<100 nl/day, »-hr aad 15-20 ir
eicretlons after 15 ng/Xg
f.3.6 and 68.2 kg patients, lith
chronic renal failure.
ElOeS; AWIBIOTICS; BLOOD ?LASHA:
tTSEASK; OSIBS; CO«PASATIT1
IVILOATIOBS: ADULTS
1 — • — —
BEFEBEBCE
Ganbertoglio, J. 6.
Aziz, B.S.
lin. 2.1.
Graasz, B.
Baughton, J.L.
Eenet, L.Z.
1979
Clinical Pharaacology
and Therapentics
26(5):592-599
GaaDertoglio, J.S.
Aziz, B.S.
lin, E.T.
Grausz, E<
Paaghton, 'J.L.
Benet, I.Z-
1979
Clinical PharnacologT
and Therapeutics
26 (5) : 592-599
onbenylacetyll aninol — 3— nethyl— 8— ozo*. (6B— (6alpha. 7beta(R*)))— (' C!}
C16-B17-I3-C«-S
II 3»7.«
HSSHB
5236
Blood,
a«rna
.
S237
Bilk
EtfOSVn ROOTB
Ingestlon
Ingestlon
--
1I11TTIC11
HITIOD
licrobloloqical
Bicroblologieal
BOBBH
OF ClSIS
S
«
OICI
.
22.9-13.6 uq/al
0.20-0.50 uq/il
8EiI
lot given
Wot given
GtlEBaL IIFOaBaTIO*
1 a«d t hr after 1 g. Final
aeaanranent, 2.7 ng/al at 3 hr
-------
z) az«pi..-s-e.rbo«.ta.
C1S-I12-V2-0
•t 23*.2«. IF 204-20C C
1ISSVI
S23t
Blood
523*
Biooa.
tiasi*
S2»0
float.
Plan*
Jlool.
s*mi
crnsna MO*B —
lB,qej«tioB
-'
1IU.TTICIL
ratsas
•s
cc
OC/BS
•onn
or cisss
2
S
10
6
HfGI
•1 lot giTm
b) lot give*
c) lot given
41 lot given
•1 lot glvci
f) lot gives
9) lot given
h) lot given
1) lot gives
J) lot give*
-
7.80-3.10 ag/Bl
•) ».6-7.7 Bg/1
b) 0.31-1.01 ig/l
a) 1.55-3. 12 ng/il
b) 1.79-2. tO ng/Bl
C) 1.33-2.10 «g/Bl
BMI 1 GSIEMl Iiro«l»TIO»
_ 1—
b! »'s5 ".i?^1 ! I.1 c«"«««Fl»«. "tier, 2nd d.r
« 5'S !»l^t * CjcbawMFl... child, 2nd d.T
2 7 . HJ ' c) 1(>."-ePo*T c«rba.»T«pin«
« i'J *°KJ ' «««t«l»Ht«). .otker. 2nd da;
S S:i ::i;i | !ia1S;;''ei>OIT *«»••*««*". =«id.
!! o'2 !^J^J ' t1 C«rt«»»«Pl««. "ether. 3rd «.T
l! !; n ( , ' f| c«>»««*«Fi»«. cllld. 3rd day
i! "sv.:^1 i Ua's.;1-'0" «*•""-*«. •«-.
1 b) 10,11-cpory carbaHz*piB«. child,
1 3id day
1 t| Catbaiazcplae. mother. 30th day
1 jl CacbaaaicFlne. child, 30th day
1 »»liea for «tt«r delirerT-
1 Patient took 8 «flA« cacbauzepine
1 aid « «q/*
-------
«B-eib«M Cb.fl «xepi»e-S-c«rtox»mia«
115-B12-I2-0
CI 23C.26. » 204-206 C
1ISSIS
5242
lllk
5243
5244
ori»e
BiroSOBE BOflTB
Ingest ion
-
IBILTTICU.
BETBCD
OC
CC
BOBBEE
OF C1SBS
1
7
5
IIKS
a) lot gi»«n
b) lot given
c) (ot given
d) lot given
e) lot given
t) lot given
1.17-1.7* as/1
a) 0.35-0.87* of dose
b) 1.02-1.41* of dose
c) 32.7-60.6* of dose
d) 5. 17-8. SOT of dose
BEIB
at 7.5 a Ml/1
b) 2.6 u nol/1
e) 5.5 n aol/1
d) 1.8 u aol/1
e) 7.5 a aol/1
f) 4. 4 n sol/1
1.37 ag/1
"
a) 0.52* of dose
b) 1.14* of dose
c) 49.9* of dose
d| 6.80* of dose
. —
a] carbaiazecine, 2nd day
t| 10,11-epoiy carbanazepine
(tetabolite), 2nd day
c) Carbasazecine, 3rd day
d) 10,11-epoiy carbaaazepine, 3rd day
e) carbatazeplne, 30th day
f) 10,11-epory carbanazepine, 30th
day
Patient took 8 ng/k? carbanazepine
and 6 ig/kg dlphenylhydantion daily
durinq gestation and lactation.
DROSS; BIOOD; lactmos; BEWSOBI:
IIT1BOIITES: BIIK
U— — —
liter daily doses of 5.3-21.0 ng/kg.
Saliva and plasaa levels r-0.991,
ratio-0.26 + or - 0.01.
17-63 yr olds on lonq-tern treatment
for epilepsy.
IS06S; slTICOBVUlSMTS; BIOOD PUSH*:
SS1TTR* CO^Plfi4'I^S BYUi U1HO1VS »
-------
SO-*7-S
C18-B22-I2
Bl 2<«.37. B* 172-17* C at 0.02 aa Ba
TISSUE
52«
Blood,
plasaa
1
1
1
1
|
1
neoson BOOTS
Ingest Ion
iiunicit
HETBOD
Sit
1
1
I
1
1
1
1
1
1
1.
IOHBSS
OF CIStS
al 1
14 1
c| 1
1
1
1
t
max
a) 43-30 ng/nl
b) 18-1.9 aij/al
c) 7-0.4 ng/nl
1
1
BB1I
a) lot given
b) lot given
c) lot given
1
1
1
1
1
1
1
i
GEVEBaL IITOBBaTIOB 1
a) 7.5 and 72 hr, patient »lth lo«
Beta phase values
b) 7.5 and 72 hr, patient «lth »edinn
Eeta phase values
e» 7.5 and »8 hr. patieat «ith hiqh
Beta phase values
liter 50 nq as the hydrochloride.
ictinated £ron qraphs •
leta phase, aonoexponential tecninai
decline
tegtessed patients, in qood rhyaical
health, fasted overnight and » hr
after I.*, dcse.
MOSS- 0»lJG T.BBBUI: IBMBEWBSSXTE
a«EITS; S100D Pl»S«l; SBTUOLITES
BEVEBERCE
Brnnsvick, D.J.
Aasterdaa. J.D.
nendels, J.
Stern, S.I.
1979
Clinical Pharaacology
and Therapeutics 25(5
pt 1): €05-610
i Jibe Ib tlazepine-5-propananine. 10,1vaihl4ro-»-nethvl-, nononT«irocBi.oiitt« »> v-^i
««-28-S
C18-B22-I2.C1-1
C« 302.88, » 214-218 C
1 iissni
52»7
Blood.
plaaia
1
1
1
1
l_
1
Blood.
pla*aa
_— "UBCII 1 "" ' bliinai. iiruan.-*-.
1W | BETBCD » O» C»SBS _ _
9 m) 12_30 mfl/ml ., 21.,, »,/.! a> 3 hr after M> aq <
Injection w- 1^. fo-28 no/*l hi 19. n ng/ai =1 uc a
lose
Healthy 20-59 yr olds. London.
1 tnq la *
1 1 IB9SS; B100D Pt»S1l»: IDtJWS;
1 | CCS91BMIVJ »f»m»TIOIS: 01ITED
1 1 1 micnoi
1 .1 _
1
Inqestion 1 5C
1
_ — |
J b) lot given 1 b) 71 « or - 37 ng/al 1 « ^j^atter1?1^
1 ! 1 bedtlse.
I | 'aaretie boys, sean
I Increase in plasaa
I staadln?. Sise in
I Eiy aoath.
i
caainc
» 7* no/day at
aqe 9.8 » or -
norepinephrine on
sopine pulse rate
1 D*nes; canwEi: SLOOB ?BESSOSB;
I neon ptissi: DFOS
i
TBtBlPI
| BirESERCE 1
5
1 Ehsannllah, F..S.3-
I Qhose, K.
1 Flrby. B.J.
1 Turner, ?.
1 altts. D.
1 1977
1 PsychopharaacoloqT
1 52:73-77
1
1 lake, C.5.
1 l!i*kelsec. S.J.
1 Papoport, J.I.
1 Fopin, I.J.
1 1979
1 Clinical Pharaacoloqy
1 an9 Therapeutics
1 2«C5):««7-€53
. 1
' '
!
— — (MIT B»B«
.O
vO
VO
-------
C18-H22-B2.C1-B
II 392.18, IP 21«-21B C
(CORIIVED)
15SO-1580 »g/«l
1570 ng/«l
GE1EB1L
Ccaks. Data for nlied
desipr*iine-BCl and iilprailne-BCl
overdose also aTallable.
Overdose patients, ages 17 an* 22 Y*-
OJS Interval of 190 nsec or greater
on ro«tin« ECS, aaa o«o or lore of
tb« follovlng
atnornal deef tendon reflexes,
ventricular rate of 120 beats/Bin or
-------
CD
CW-B2«-«2
1ISSOI
5252
Slood,
flasma
I
1
1
1
1
1
I 5253
I Hood,
1
I
1
1
I
1
1
1
I
Bitoson -ow« tinmen
BRBOB
Ingestion OC
1
1
•
1
1
1 1
I 1
| Ingest ion 1 Bit
1
1
1
IOSBM
or etas
1
i
i
i
.
__.-_ , .-„ miiti zmsuTKH
28 « or - 21 ng/ml It » »S after 2 «k on 7S mo/day at
bedtime.
lincetic boys, mean aqe 9.8 » or -
1.9 yr.
try month. Increases In sapine and
1 standing p«lse rate, diastollc blood
1 pressure, and plasma norepinephrine.
1 cizziness on standing, seduced
1 ecvresis.
| MUSS; C-119S-B: B100B PBESSOSE;
1 U.COD eilSUl: B806 TBSBa»I
I 1 — ~
1 . t m\ mi** MI won 1 al -t alp rM -.!»€• Bio-tponfintlal acclln
| a) 20-0.8 ng/-l «1 »* 9£« t> Deseethylinipramlne (aetabolite) .
| bl 13-* ng/ml BI sot given i goBOeIpl>seiltial decline
1 | 7.S an* 90 hr after single dcse of i
1 l mq as th« hydrochlorile
1 | titlmatea from graph.
I ncalthy -tolnnteer fasted o-ernight
1 and » hr after US. dose.
I '. nsoss: BBHG IBBHUT; MTIBBPBESHTB
t J leiins: sices ntsats B-TtBOLiiss
~j EEFESUCI
1
1 ____
1
I Lake, C.B.
1 MlUelsen. l.J.
I Sapoport, J.I.
I Fopin, I.J.
| 1979
1 Clinical Pharmacology
1 and Therapeutics
I 26(5)s«»7-653
1
1
1
• 1
,
e 1 Brnnsvick. D.J.
I tisterdai. J-0.
I Rendels. J.
0 | Stern, S.L.
| 1979
I clinical Pharmacology
and Therapeutics 25(5
pt 1):605-610
Ln
O
113-52-0
C«-B2m-«2.Cl-H
^
"
l~
I
Hood,
tlasma
1
1
iXIOSVR. S001I
,.,-sUo,
iinmcu.
HIIHOD
ec/sr
1
1
i
or c-sss
1
BUGS 1
1
Bot applicable
1
1
1950 -a/ml 1 leak. Bata for mixed i.ipraalne-HCl
1950 »g/ml i ^ aesipramlne-HCl orerdose also
I available.
| Cterdose patient, age 29 yr.
1 CIS of 100 msec or greater en routine
| ICS. an! one or nore of the following
1 atnormal de«p tendon refleies.
1 ventricular rate of 120 beats/iin or
| greater, right handle branch block,
| atrial and ventricnlar premature
I contractions. Innctional and
I Idioventricnlar arrhythmias.
i unconsciousness, respiratory support
I necessary, grand aal seizures, ana
1 death.
1 CB«GS; M-I3M1BSS1TB ICMTS: 3MO9
1 imsnt: trvc, IBOSE; ntssoosi
i —
Biggs, J.I.
Spiker. D.G.
Petit. 3.S.
Zleqler. 7.B.
19T7
Journal of the amerlcan
Fedical Issociatloa
238(2) : 135- 138
1
1
1
-------
SB-mbe«o{a.« ciclok«pt«.«-«.lt.<5,.J»..a)-propll«.i»«. 1.
1-Propaaa*lae, Vt19,11-dibydro-5H-dib«««o(a.a)CTclob«pt«B-5-Tli dene) -»-aetByl- C»
C 19-H21-1
11 263.37. IP 213-215 C
tXSSBE
S255
Blood,
plasaa
5256
Blood,
plasaa
_
5257
Blood,
seen •
BIKS9BE BOOTS
iBoestioa
IngestiOB
iBjectioB
lagestioa
uitmcn
HETHOD
SC
"
Badioaetry
GC
...
itnBEB
or cms
12
c
9
I1IGI
—
a) 31-38 aa/Bl
b) 52-38 ag/al
a) 670-1500 br a«/l
b) 1430-3030 br ug/1
50-B50 ag/al
a) lot applicable
b) lot applicable
a) lot gi»en
b) lot given
lot gives
--
GiilBii iKosamoB
a) 0 and 2« br after 6 daj regleeB of
3 1 25 eg/da? as tablets. 36 ng/«l
at 7 hr
tl 7 and 2» br alter S Say re«iBen of
7« BO/Say slB^le tablet. laitial
Btasnceaent, »1 »<1/»1 at 0 hr.
B«altliT 18-60 Jl Ol4s
«I1T!D KIIGDCE: BLOOD; BtOOD Pl»S«»;
icons: niHtons STSIOT DISMSSS; DSDS
THIg»PT; COMlBiTITE gT»lOWIO»S;
IITIDBPMSSITE »SS»TS
a) Jfter SO *j iac-labellea dose.
t) after *0 Bq 1«c-labelled dose, IT
Irea nnder the carre data
BtalthT. 21-28 ft olds OB »o otber
i«dicatioi>.
SCM sedative effect in Boat.
HFBSS: Di»a»fK: BLOOD FllSHi;
COHP»B»TITI IfllHTIOSSj IDOLTS
— — — ' ' —————— —^
12 be after last dose of 50 *j 3x/«ay
fcr 2 »*. Talnea estiaatefl froa
qtapb.
Jcspitalired patients.
D10SS; BIISOSBBIIT BITHODS; CE»B»BK;
IIOOD SBHOS: »»TIDJPFBSSITI »SSITIS
tEKSEHCI
Hacker, H.B.
staaffer, S.c.
Clayton, F.G.
lakra, B.B.S.
Gaind, B.B.
1975
Journal ot Clinical
Pbartacologi 15:168-172
— —
Graa, L.F.
OTero, K.T-
1975
Clinical Fbaraacology
and Tberapeatics
18(31:305-314
Jorgensea* &•
1975
Acta Pbaraacoloqica et
Toricologica 36:79-90
o
ro
^^^^
•l°277?39, at Hydrocbloride 196-H7 C
1ISSOB
52S8
Blood.
plasBa
EHOS0B3 SOOTB
IngestiOB
.
IHLTTIClt
RBTBOD
'"
sc/as
OF CiSSS
12
SatSE
a) 29-151 ng/al
b) 5-179 ag/al
c) 5-21 ag/al
d) 53-130 ag/al
e) 26-112 og/al
f) 12-258 Bg/Bl
(BUT
flBll
a) 81 * or - «o ng/al
b) 71 + or - 57 ag/al
c) 12 « or - 5 ng/al
4) 91 « or - 30 ng/al
e) 82 + or - 27 ng/al
f) 176 » oc - 6»
nq/«l
?15B)
GIBZBll IIPOBHKIOS
laitriptTliBe
nortriptiliii*
10-Hy^ro*yaaitriptyliBe
10-lTlroxyaaitriptTlihe conlogate
10-Hyiroiynortriptyline
., 10-MTdro»yBortriptyline connate
HlaiaaB steady state Tallies on SO ag
aaitriptyline, 3r/day.
61. «-10». 1 kg aen.
EBBGS; SBMBCIITES; WlStJBSB'BT
BJ18OBS! BiCCD PL»SH»: WTIDIPBISSItB
Garland, t.».
Boccino, K.B.
Bin, B.9.
Capano, J.
Fann, ».t.
1979
Clinical Phar»acology
and Tberapeatics
25(6):8«»-856
-------
•O-M-6
it rn.39, n «TdrocM.oria« »6-m c
1ISSVI
5259
Blood,
plaaaa
1
I 52*0
I Blood.
I plaaaa
1
1
1
5261
Blood,
1
1
1
i
inoson BOOTS i«M--«i i«
SBTBOD Of C
Ingestioi 6C 12
1 __ _____
I Xagestloa 1 8C/BS 20
i i
i
!
i
(
1
! lagestioa 1 8C »{
I 1 D>
1
1
1
1
1 1
1
I
1
1
I
BJS Bines
ISIS
a) (0-50 ng/al
b) 90-*5 ng/al
1 {
1 ... ,
1 a) 25.6-58.6 ng/al 1
1 b) 11.a-27.« ng/al
| c) 29-151 ag/al
| d) 5-179 ng/al
'
1
1
1
1
1
1
1
2 a) »7.5-7 ag/al
9 b) 20-2*0 aq/al
1
1
a) lot applicable a) » a»a 2» hr after 6 aaT reglaen of
b) Bot applicable ..LareaSn^SO^/.l'^1'"^^ 6
ana 2» hr after 6 daY regiaen of 75
ag/day single tablet. Initial
xasaremnt, 50 ng/al at 0 hr.
Healthy 18-60 IT olds
i
1 flllTIB KlUStOS; BLOOI; B100D fllSKl;
1 HUMS; DBtIG TEEBWT; COBPiBATIT!
M»1UWIOIIS; HTID*»BSSSIT! 1GISIS
a) 39.» ng/al •) Peaks about » hr after 75 ag as
at 71 t « - 57 ag/S 75 •^•'tphule^for.' Irt'SlT"
i dose of 50 aq 35t/day for aoath. 12
I :
-------
8 3
SM-M-8
CJO-823-B.C1-B
tl 313.85. if 19S-M7 C
TISSUE
52(2
Hood.
Tlasea
EXPOSmi BOOTS
_
Ingest ion
BITBOD
oc/Tir
BUBBEB
or c»SBS
7
BHGS
11M-2190 ng/nl
mi
1639. »3 ag/nl
eilEBll IIFORlATIOl
lean peaks. Data for slxed
anitriptyline-SCl ana doxepin-8Cl
overdose alsc available.
Overdose patients ages 19-»5 yr.
OSS of 100 ssec or greater en routine
ICG. and one or sore of the follooing
abnornal deep tendon reflexes,
ventricular rate of 120 beats/sin or
gieater. right bundle branch block,
atrial and ventricular prenatare
contractions, luactional and
idioventricular arrhythnlas.
unconsciousness, respiratory support
necessary, grand nal seizures, and
death.
BUSS; WtltfPBESSITt IGEIIS: BLOOD
EIASm; BS06 aBOSEj 1ISSOOSI
SIFEBEBCE
Biggs. J.t.
splker, B.G.
Petit, J.I.
fleqler, T.B.
UTT
Journal of the aaerlcan
Eeaical Association
238f2) s 135-138
I-ol. 3-(1,2-di«thylheptyl)-7,8.9,10-tetrahidro- 6,«,9-trl«ithyl-
C25-B38-02
*f 370.63
ussas
52«3
SlOOd.
Flassa
ElfOSIB! BOBtl
injection
UllTTICiL
BBTBOD
tic
Sadlonetry
BDK8SH
or cists
3
BIKE
"
a) 1800-30 dpa/al
b) 1*00-11 Ip«/«l
(Itll
IISaB
a) lot applicable
b) lot applicable
—
GUISll IfTOEUTIOI
a) total radioactivity 0 and 72 hr
after dose
tj Unaltered drug 0 and »8 hr after
lose
range of leans after 200 nq
1»C-latelled drag. It. Estimated fro.
graph.
lornal 21-23 yr °w casnal larihaana
stokers, to habitaal drag usage.
TachycarSia starting ID ^-20 aln and
lasting »-« hr after dose.
Hypotension peaking at 1 hr, listing
> 12 hr. Dininess on standing. Dry
•ooth and dcovslaess after 2 hr.
tnthoria in 1 patient.
CBBGS; S5TJ9CIISS: ILOOD PL1SBI;
(rai»B: Fscis;
5EFESSKCI
U1
O
lenterger, L.
HcHahOD, B.
Archer, B.
Ratsaaoto, !C.
Bowe, F.
197*
Clinical Pharnacology
and Therapeutics
-------
-7.8.9.10-t.tr.n,d,o- 6.6.,-trl.t.yl-
Bl 370.63
JISSBB
•rlne
cirosoii BOOTS
-
Injection
iliimcit
BRBCD
Badionetry
iolSS
OF CISSS
3
(COIT
iiiei
a) 2-3* of dose
b) 5-8* of dose
c| *-16* of dose
[BUBO)
nai
—
a) Bet given
b) lot given
c) (ot given
" SBIJWL IBFOmTIOB '
a) » hr
b) 2* hr
c) 7 days
Cnnulatiye excretions as S of total
""J»;t}»ity. after 200 ng IT
HC-laeelled drog. Ha-|or excretion
•as in feees (53-61* in 7 days) .
Bornal 21-23 yr old casual narihuana
nokers. 10 hahitnal drtig Bsage.
Tachycardia starting in 5-20 ni. and
lasting «-6 hr after dose.
Sypotension peaking at 1 hr. lasting
L . ""inass on standing. Dry
south and drevsiness after 2 hr.
loihoria in 1 patient.
BBMGSs IBTIBCIISB: B100B PUSHi;
BSFZBEBCZ "
lenberger, I.
HcRahon, a.
Ircher, B.
Hatsnnoto. K.
Eo»e. H.
197»
clinical ?harnacology
and 7herapeotics
15 (») -360-386
C«-H11-«5-o3
II 225.2»
1ISS1S
52,. ¥lth
aJvanced cancer
WSS! CIMCTTOa.Wr; BLOOD rUSBk;
jsKSLiSr-siiois,?' "WIMW!
a) 0.5 «g/)tq
b) 1.0 ng/*,
c) 2." ng/Xg
J) 5.0 ng/*q
Cviulative 72 hr excretion of
fluchan^ea drag after 1 hr IT
»9-82 yr oia,. ,t 41-117 *q. ,lth
a<]>anc->l caacer
MUSS; CRVBOTHnin; BIOOB H»S1*-
ffisstjur.ga-jss?"""""
———_____
de nlranda, p.
•hitley. S.J.
Blon. H.E.
Keeney, B.I.
Barton, ».
Cocchetto. o.f.
Good, s.
Penstreet, 15. p. HT
Mrk, l.s.
Page. s.\,
Hlion, 5.B.
1979
Clinical Pharnacology
and Therapeutics
26(6):718-728
de Miranda, p.
mtlev. S.J.
Elan. n.t.
reeney, R.».
Barton. 1.
Cocchetto. O.F.
eool. s.
Reistreet, s.p. in
rirt, I.B.
Page, D.A.
Zlion, G.B.
197«
Clinical Pharnacology
»»d Therapeutics
26(5) ; 7 (8-723
-
O
Ui
-------
7B-»uro(3,2-o» |1)beMopTr»n-7-o»e. f-»etlor»-
218-61-7
C12-B8-0*
El 2U.1I. ft 1*8 C
USSUE
S2«7
Blood,
plasia
Blood,
tlPOSOBE BODTE
iBgestiot
iBitnxcai
BRBOD
00 BC
8C-EC
_____ _ — — —
BVB8SB
or CUBS
5
5
a) 6*-2t* Bg/sl
b) 180-590 Bg/sl
-
J50-700 na/Bl
BMB
a) 177 ag/Bl
b) 32« no/nl
lot given
a) Peaks, fasting. Peak tines V2.5
hr
t) Peaks, after intake of standard
breakfast. Peak tines 1-2.5 kr
liter 40 aq as 10 »q tablets. Peaks
in a) and b) differed significantly.
tealthy sales vith noraal renal and
hepatic function, fasting 10 kr
before dose and on no other drags.
OSOGS; SKIB DISEASES; SWSDEB;
D1IBITI01ET BiPIltlOB; JOODS; BWOB
PIISHI; COIPIBltlTB SV11U1TIOBS
Bang* of peaks 0.5-2 hr after about
0.6 so/kg as fast-release tablets.
Ill had < 30 na/Bl bT 5 hr.
SllghtlT pigvented, adults vith
fcorlasis.
Irrthen* in response to ov exposure.
leniitivitT related to sens levels.
r«0.78, p<0.001.
tinos; a SO^EIEBT H7TBQPS;
SItlTITIS; iBTTDEPFSSSIT! aGMTS;
PICOD M.ISSI; FIEBItS; BBT»BOt«SS
.
Jlndal, S.P.
Vestergaard, P.
1980
Journal of
Pharsaceutical sciences
-------
J.10-Secoc»ol«st»-5.7,10(19)-ttl»»«-3b«ta.2S-aiol (g CI)
«.tO-S«cochel«st«-S,7,10|W)-trie»«-3.2S-diol. (3beta,5Z,7!)- <9 CI)
H3S6-17-3
C27-HM-02
BE •oo.fi';
IISSOI
5270
Blood
1
1
1 5271
I Blood,
plas»
titosns soots aiunicu IQBBSI »»•« »111
RETROD OF CaSIS
b) lot give! b) 32ls nnol/1
c) lot giT« <=) 28.0 MOl/1
4) lot given d) 20.0 n.ol/1
f) lot given f) 29.3 naol/1
I
I 1
a) »t delivery. fro« nothers on
vitaiin supplement
b) Fron control lothets. at aelirery
c) Fro« cora. «ith vitania s«pple»ent
a) Fron cora controls
e) Fro* lnfants-»ith vitanio
:
-------
509
5087?-IQ1
REPORT DOCUMENTATION i... REPORT NO.
EPA 560/5-81-008 A and B
4. Till* and Subtitle
Chemicals Identified in Human Biological Media, A Data
Base, Third Annual Report, October 1981
2' EIS-163/V3/
_li _and_P2
Accession No.
| 5. Report Oat*
7. Author(i)
M. Virginia Cone. Margaret F. Baldauf, and Fay M. Martin
•. Performing Organization Name end Address
Chemical Effects Information Center
Information Center Complex/Information Division
Oak Ridge National Laboratory
Oak Ridge, Tennessee 37830
12. Sponsoring Organization Nam* and Address
U.S. Environmental Protection Agency
Office of Toxic Substances
Exposure Evaluation Division (TS-798)
Washington. D.C. 20460
IS. Supplementary Notes
8. Performing Organization Rept. No.
10. Proiect/Task/Work Unit No.
11. Contract(C) or Grant(G) No.
(O EPA IAG No. 78-D-X383
(C)
13. Type of Report & Period Covered
Annual Report 9/80-9/81
14.
1«- Abstract (Limit: 200 words)
A comprehensive data base of chemicals identified in human biological media
(tissues and body fluids) has been established under the direction of the Environmental
Protection Agency's Office of Toxic Substances Exposure Evaluation Division. This
centralized resource of body-burden information was inspired by the concern of government
scientists over continuing reports of toxic chemicals in human tissues and body fluids.
Body burden is a reflection of exposures to food, air, and water contaminants,
ae well as Pharmaceuticals. The systematic acquisition of body-burden data will facil-
itate a more relevant assessment of human exposure to toxic chemicals and xenobiotics
than was previously possible using environmental contamination levels.
Data were obtained primarily from the open literature through manual searches of
selected journals. Retrospective searching to 1974 is complete and has yielded over
3800 pertinent documents of which approximately 1600 have been entered into the data
base as of this report. These sources identify over 800 chemicals which have been
found in human biological media.
17. Document Analyst! a. Descriptors
Body burden
Human tissues/body fluids
Residues
b. Identlflers/Open-Ended Termi
e. COSATI Field/Group
18. Availability Statement
RELEASE TO PUBLIC
19. Security Class (This Report)
UNCLASSIFIED
20. Security Clan (This Page)
UNCLASSIFIED
21. No. of Page*
944
22. Price
(S**ANSI-Z3».18)
See Instruction! on Reverse
OPTIONAL FORM 272 (4-7
(Formerly NTiS-35)
n«n*rtm*nt o* Commerce
-------
511
EPA 560/5-81-008B
ORNL/EIS-163/V3-P2
INTERNAL DISTRIBUTION
1. S. I. Auerbach
2. M. F. Baldauf
3. M. V. Cone
4. J. T. Ensminger
5. W. Fulkerson
6. H. B. Gerstner
7. F. M. Martin
8. C. R. Richmond
9. G. D. Robbins
10. Biology Library
11-12. Central Research Library
13. Document Reference Section
14. ICC Publications Office, 2001
15-24. ICC Resource Center, 2001
25-26. Laboratory Records
27. Laboratory Records, RC
28. ORNL Patent Office
EXTERNAL DISTRIBUTION
29. Philip L. Johnson, Executive Director, Oak Ridge Associated
Universities, P.O. Box 117, Oak Ridge, Tennessee 37830.
30. Office of Assistant Manager, Energy Research and Development,
Department of Energy, Oak Ridge Operations Office, Oak Ridge,
Tennessee.
31-57. Technical Information Center, Department of Energy, Oak Ridge,
Tennessee 37830.
oU.S. GOVERNMENT PRINTING OFFICE: 1981-546-067/347